word,frequency,log frequency
the,54656,10.908814277148242
of,53943,10.895683212499748
and,42446,10.655987958795587
in,30056,10.310817587253805
to,24755,10.116782767795524
a,17163,9.750511182936638
with,16013,9.681156171322476
for,12015,9.39391114817057
is,11049,9.310095205113175
patients,9641,9.17378011666438
The,9200,9.126958763037132
was,8103,8.999989642460726
that,7477,8.919586920999915
were,6522,8.782936356349264
asthma,6303,8.74878098951311
are,6002,8.699848026000312
as,5905,8.683554728631462
on,5902,8.683046555502886
by,5871,8.677780256064185
be,5428,8.59932602095476
influenza,5404,8.59489469908009
stroke,5325,8.580167990577626
from,4720,8.459564078579602
an,4570,8.42726848388825
or,4461,8.403128235128264
this,4190,8.340456012916183
infarction,4011,8.296795865770052
have,3988,8.291045131081729
acute,3847,8.255048902752295
myocardial,3804,8.24380842366528
disease,3609,8.19118600464279
In,3412,8.13505390861157
COVID-19,3365,8.121183242078828
SARS-CoV-2,3249,8.0861025356691
has,3199,8.070593539949519
clinical,3128,8.048149101665201
at,3117,8.044626279767337
study,3048,8.022240916806537
risk,2898,7.971776122880628
been,2885,7.9672801789422
after,2833,7.949091499830517
not,2775,7.928406026180535
We,2672,7.890582534656536
treatment,2646,7.880804344674901
A,2642,7.879291485082271
virus,2440,7.799753318287247
This,2409,7.786967002614872
may,2408,7.786551806428712
pandemic,2400,7.783224016336037
than,2308,7.744136627627991
which,2279,7.731492029245684
between,2240,7.7142311448490855
can,2232,7.710653323501202
we,2152,7.674152921281675
infection,2114,7.656337166430183
these,2109,7.653969180478774
during,2091,7.645397699428633
severe,1989,7.5953872788539725
respiratory,1964,7.582738488914411
more,1963,7.5822291942764615
Background,1885,7.541683099882111
but,1878,7.537962659768208
had,1872,7.534762657037537
children,1799,7.4949862339505335
2,1794,7.492203042618741
associated,1774,7.480992162869525
vaccine,1752,7.468513271496337
their,1727,7.454141078146678
cases,1716,7.447751280047908
health,1686,7.430114138561801
mortality,1673,7.422373700986824
also,1653,7.410347097821024
studies,1652,7.409741954080923
data,1608,7.382746449738912
factors,1589,7.370860166536716
coronary,1571,7.359467638255621
group,1569,7.358193752733032
therapy,1551,7.346655163176539
coronavirus,1543,7.341483852363161
years,1478,7.298445101508147
use,1477,7.29776828253138
most,1466,7.290292882446597
all,1452,7.280697195384741
who,1431,7.266128779556451
control,1425,7.261927092702751
other,1414,7.254177846456518
care,1413,7.253470382684528
symptoms,1410,7.251344983372214
it,1395,7.240649694255466
results,1383,7.232010331664759
used,1368,7.221105098182496
such,1304,7.1731917424865985
diagnosis,1290,7.162397497355718
high,1279,7.153833801578843
vaccination,1246,7.1276936993473985
review,1223,7.109062135687172
management,1219,7.105786129481271
ischemic,1218,7.1049654482698426
among,1215,7.102499355774649
its,1205,7.094234845924755
increased,1194,7.085064293952548
patient,1188,7.080026499922591
both,1186,7.078341579557671
age,1180,7.07326971745971
significant,1173,7.067319848653476
time,1170,7.064759027791802
first,1164,7.059617628291383
using,1155,7.051855622955894
no,1145,7.0431599159883405
should,1122,7.022868086082641
However,1114,7.01571242048723
new,1107,7.009408932708637
viral,1101,7.00397413672268
compared,1092,6.9957661563048505
1,1090,6.993932975223189
syndrome,1086,6.990256500493881
To,1083,6.9874902470009905
two,1082,6.9865664594064265
early,1081,6.985641817639208
different,1078,6.982862751468942
one,1074,6.97914527506881
those,1061,6.966967138613983
only,1058,6.964135612418245
important,1055,6.961296045910167
including,1051,6.957497370876951
well,1042,6.948897222313312
left,1036,6.943122422819428
rate,1026,6.933423025730715
ventricular,1023,6.930494765951626
population,1023,6.930494765951626
potential,1008,6.915723448631314
there,984,6.891625897052253
will,979,6.88653164253051
p,972,6.879355804460439
against,970,6.877296071497429
development,964,6.871091294610546
viruses,961,6.8679744089702925
present,959,6.8658910748834385
analysis,950,6.856461984594587
human,944,6.8501261661455
testing,940,6.84587987526405
higher,938,6.843749949006225
less,931,6.836259277277067
3,929,6.834108738813838
vaccines,920,6.824373670043086
test,914,6.81783057145415
evidence,912,6.815639990074331
significantly,911,6.814542897259958
about,904,6.806829360392176
response,899,6.80128303447162
role,897,6.799055862058796
reported,895,6.796823718274855
could,889,6.790097235513905
within,861,6.7580945044277305
artery,861,6.7580945044277305
case,858,6.754604099487962
number,858,6.754604099487962
current,856,6.752270376141742
function,850,6.745236349484363
groups,844,6.738152494595957
showed,831,6.7226297948554485
hospital,828,6.71901315438526
95,824,6.714170529909472
days,823,6.71295620067707
It,820,6.709304340258298
into,816,6.704414354964107
H1N1,815,6.703188113240863
effective,815,6.703188113240863
found,813,6.70073110954781
effects,806,6.692083742506628
infections,802,6.687108607866515
cardiac,800,6.684611727667927
when,800,6.684611727667927
transmission,787,6.668228248417403
strokes,787,6.668228248417403
outcomes,782,6.661854740545311
positive,782,6.661854740545311
severity,779,6.658011045870748
due,774,6.651571873589727
heart,772,6.648984550024776
prevention,771,6.647688373563329
over,769,6.645090969505644
death,765,6.639875833826536
incidence,765,6.639875833826536
These,765,6.639875833826536
cells,764,6.638567789166521
changes,764,6.638567789166521
-,756,6.628041376179533
without,756,6.628041376179533
2019,756,6.628041376179533
increase,753,6.6240652277998935
cause,746,6.61472560020376
common,745,6.61338421837956
research,744,6.612041034833092
our,738,6.6039438246004725
chronic,736,6.601230118728877
medical,734,6.598509028614515
novel,730,6.593044534142437
diagnostic,728,6.590301048196686
outcome,721,6.580639137284949
available,719,6.577861357721047
public,711,6.566672429803241
based,704,6.556778356158042
blood,701,6.55250788703459
onset,700,6.551080335043404
caused,700,6.551080335043404
effect,696,6.54534966033442
airway,693,6.541029999189903
2009,690,6.536691597591305
tests,687,6.532334292222349
There,685,6.529418838262226
detection,685,6.529418838262226
diseases,680,6.522092798170152
specific,678,6.519147287940395
CI,678,6.519147287940395
rates,677,6.517671272912275
AMI,677,6.517671272912275
levels,673,6.511745329644728
some,673,6.511745329644728
system,670,6.507277712385012
performed,667,6.502790045915623
findings,666,6.501289670540389
impact,662,6.495265555937008
MI,662,6.495265555937008
prevalence,661,6.493753839851686
identified,657,6.48768401848461
low,654,6.483107351457199
individuals,654,6.483107351457199
strategies,654,6.483107351457199
major,653,6.481577129276431
developed,649,6.47543271670409
trials,646,6.470799503782602
lower,644,6.467698726104354
related,641,6.46302945692067
whether,637,6.456769655572163
samples,637,6.456769655572163
immune,633,6.450470422144176
spread,632,6.448889394146858
information,632,6.448889394146858
period,631,6.447305862541213
therapeutic,631,6.447305862541213
months,631,6.447305862541213
provide,630,6.4457198193855785
through,630,6.4457198193855785
model,630,6.4457198193855785
observed,629,6.444131256700441
many,621,6.431331081933479
following,619,6.428105272684596
primary,618,6.42648845745769
morbidity,618,6.42648845745769
cell,618,6.42648845745769
need,614,6.419994928147142
three,608,6.410174881966167
recent,605,6.405228458030842
bronchial,598,6.393590753950631
possible,597,6.391917113392602
total,595,6.38856140554563
Asthma,595,6.38856140554563
they,591,6.3818160174060985
aim,590,6.380122536899765
countries,588,6.376726947898627
Although,585,6.371611847231857
measures,585,6.371611847231857
mechanisms,571,6.3473892096560105
subjects,570,6.345636360828596
level,566,6.338594078203183
activity,565,6.336825731146441
large,564,6.335054251498059
report,560,6.327936783729195
Objective,560,6.327936783729195
determine,559,6.326149473155099
rapid,557,6.322565239927284
several,557,6.322565239927284
before,551,6.311734809152915
10,551,6.311734809152915
assess,548,6.306275286948016
identify,547,6.304448802421981
complications,541,6.293419278846481
global,539,6.289715570908998
imaging,539,6.289715570908998
people,536,6.284134161070802
protein,532,6.2766434893416445
drugs,530,6.272877006546167
women,530,6.272877006546167
evaluate,529,6.270988431858299
outbreak,528,6.269096283706261
adults,526,6.26530121273771
6,525,6.263398262591624
year,525,6.263398262591624
illness,522,6.257667587882639
approach,519,6.251903883165888
epidemic,518,6.249975242259483
differences,514,6.2422232654551655
reduce,514,6.2422232654551655
history,513,6.240275845170769
methods,513,6.240275845170769
treated,510,6.234410725718371
known,509,6.2324480165505225
4,508,6.230481447578482
flow,506,6.226536669287466
efficacy,505,6.22455842927536
inflammation,504,6.222576268071369
method,504,6.222576268071369
considered,502,6.218600119691729
life,501,6.2166061010848646
5,501,6.2166061010848646
characteristics,498,6.210600077024653
shown,498,6.210600077024653
limited,497,6.208590026096629
further,497,6.208590026096629
asthmatic,496,6.206575926724928
association,493,6.20050917404269
improve,492,6.198478716492308
how,492,6.198478716492308
B,492,6.198478716492308
emergency,492,6.198478716492308
future,490,6.194405391104672
mean,487,6.18826412308259
intervention,487,6.18826412308259
anterior,486,6.186208623900494
sensitivity,486,6.186208623900494
failure,479,6.171700597410915
each,477,6.1675164908883415
Influenza,477,6.1675164908883415
suggest,476,6.16541785423142
similar,476,6.16541785423142
respectively,474,6.161207321695077
events,474,6.161207321695077
type,471,6.154858094016418
infarct,470,6.152732694704104
demonstrated,470,6.152732694704104
hours,469,6.150602768446279
confirmed,468,6.148468295917647
often,468,6.148468295917647
lung,466,6.144185634125646
better,464,6.139884552226255
studied,457,6.124683390894205
aimed,456,6.1224928095143865
purpose,456,6.1224928095143865
vs,456,6.1224928095143865
Our,456,6.1224928095143865
general,455,6.12029741895095
article,454,6.118097198041348
presence,454,6.118097198041348
infected,452,6.113682179832232
likely,452,6.113682179832232
factor,451,6.111467339502679
if,450,6.1092475827643655
evaluated,450,6.1092475827643655
Stroke,449,6.1070228877422545
knowledge,449,6.1070228877422545
normal,448,6.104793232414985
being,447,6.102558594613569
antiviral,446,6.100318952020064
because,446,6.100318952020064
exercise,445,6.09807428216624
size,444,6.095824562432225
seasonal,444,6.095824562432225
included,444,6.095824562432225
responses,444,6.095824562432225
P,444,6.095824562432225
deaths,443,6.093569770045136
understanding,440,6.0867747269123065
any,437,6.07993319509559
conditions,436,6.077642243349034
remains,434,6.073044534100405
addition,432,6.068425588244111
long-term,431,6.066108090103747
antibodies,430,6.063785208687608
highly,429,6.061456918928017
while,428,6.059123195581797
reperfusion,424,6.049733455231958
2020,422,6.045005314036012
describe,422,6.045005314036012
effectiveness,422,6.045005314036012
n,420,6.040254711277414
models,420,6.040254711277414
greater,419,6.037870919922137
guidelines,419,6.037870919922137
negative,419,6.037870919922137
result,418,6.035481432524756
drug,418,6.035481432524756
phase,417,6.0330862217988015
RNA,417,6.0330862217988015
out,417,6.0330862217988015
various,415,6.028278520230698
did,413,6.023447592961033
functional,413,6.023447592961033
antibody,412,6.021023349349527
cerebral,412,6.021023349349527
12,411,6.018593214496234
assessment,411,6.018593214496234
right,411,6.018593214496234
causes,411,6.018593214496234
worldwide,410,6.016157159698354
exposure,408,6.0112671744041615
inflammatory,406,6.0063531596017325
quality,406,6.0063531596017325
20,405,6.003887067106539
especially,402,5.996452088619021
agents,401,5.993961427306569
assessed,399,5.988961416889864
pulmonary,398,5.986452005284438
value,398,5.986452005284438
work,397,5.983936280687191
brain,396,5.981414211254481
strains,396,5.981414211254481
would,396,5.981414211254481
still,395,5.978885764901122
prognosis,393,5.973809611869261
interventions,393,5.973809611869261
surveillance,391,5.968707559985366
pressure,387,5.958424693029782
occurred,386,5.955837369464831
tested,384,5.950642552587727
relationship,383,5.948034989180646
recovery,380,5.940171252720432
per,380,5.940171252720432
course,376,5.929589143389895
very,375,5.926926025970411
might,375,5.926926025970411
chest,375,5.926926025970411
features,374,5.924255797414532
status,374,5.924255797414532
increasing,373,5.921578419643816
Health,372,5.918893854273146
reduced,372,5.918893854273146
presented,371,5.916202062607435
15,368,5.908082938168931
previous,368,5.908082938168931
secondary,367,5.905361848054571
particularly,367,5.905361848054571
investigated,367,5.905361848054571
healthcare,364,5.8971538676367405
wall,363,5.8944028342648505
cardiovascular,363,5.8944028342648505
investigate,363,5.8944028342648505
detected,362,5.8916442118257715
them,362,5.8916442118257715
Patients,361,5.8888779583328805
initial,360,5.886104031450156
up,360,5.886104031450156
obtained,360,5.886104031450156
strategy,360,5.886104031450156
world,359,5.883322388488279
elderly,358,5.8805329864007
peak,358,5.8805329864007
revealed,357,5.877735781779639
support,357,5.877735781779639
follow-up,356,5.87493073085203
regarding,356,5.87493073085203
made,354,5.869296913133774
conducted,354,5.869296913133774
admission,352,5.863631175598097
help,352,5.863631175598097
evaluation,350,5.857933154483459
monitoring,349,5.855071922202427
As,349,5.855071922202427
however,348,5.8522024797744745
multiple,348,5.8522024797744745
include,348,5.8522024797744745
show,348,5.8522024797744745
30,347,5.849324779946859
China,345,5.84354441703136
needed,345,5.84354441703136
elevation,345,5.84354441703136
RT-PCR,345,5.84354441703136
Here,344,5.840641657373398
late,344,5.840641657373398
molecular,343,5.8377304471659395
leading,343,5.8377304471659395
examined,343,5.8377304471659395
literature,343,5.8377304471659395
critical,343,5.8377304471659395
improved,342,5.834810737062605
social,339,5.82600010738045
under,338,5.823045895483019
practice,338,5.823045895483019
host,337,5.820082930352362
community,337,5.820082930352362
avian,336,5.817111159963204
serum,335,5.814130531825066
standard,335,5.814130531825066
underlying,334,5.811140992976701
ST,332,5.805134968916488
assay,331,5.802118375377063
mild,330,5.799092654460526
complex,330,5.799092654460526
United,330,5.799092654460526
order,330,5.799092654460526
50,329,5.796057750765372
allergic,327,5.7899601708972535
populations,327,5.7899601708972535
laboratory,326,5.786897381366708
process,325,5.783825182329737
develop,325,5.783825182329737
area,325,5.783825182329737
ratio,324,5.780743515792329
described,324,5.780743515792329
aged,323,5.777652323222656
genetic,323,5.777652323222656
discussed,323,5.777652323222656
humans,322,5.7745515455444085
therapies,322,5.7745515455444085
burden,322,5.7745515455444085
approaches,320,5.768320995793772
even,320,5.768320995793772
main,318,5.762051382780177
immunity,317,5.75890177387728
24,316,5.755742213586912
weeks,315,5.752572638825633
tissue,315,5.752572638825633
importance,315,5.752572638825633
recurrent,313,5.746203190540153
score,313,5.746203190540153
useful,313,5.746203190540153
same,313,5.746203190540153
parameters,312,5.7430031878094825
prevent,312,5.7430031878094825
pneumonia,312,5.7430031878094825
infectious,312,5.7430031878094825
season,311,5.739792912179234
frequency,311,5.739792912179234
atrial,310,5.736572297479192
key,310,5.736572297479192
young,309,5.733341276897746
All,309,5.733341276897746
admitted,309,5.733341276897746
currently,309,5.733341276897746
since,308,5.730099782973574
Objectives,308,5.730099782973574
second,306,5.723585101952381
objective,305,5.720311776607412
older,305,5.720311776607412
developing,305,5.720311776607412
decreased,304,5.717027701406222
poor,304,5.717027701406222
criteria,303,5.713732805509369
States,303,5.713732805509369
four,303,5.713732805509369
difference,303,5.713732805509369
lead,302,5.71042701737487
improvement,302,5.71042701737487
small,302,5.71042701737487
appropriate,302,5.71042701737487
asymptomatic,300,5.703782474656201
thrombolysis,300,5.703782474656201
reaction,300,5.703782474656201
symptom,299,5.700443573390687
areas,298,5.697093486505405
H5N1,297,5.6937321388027
received,297,5.6937321388027
discuss,296,5.69035945432406
0001,296,5.69035945432406
pathogenesis,296,5.69035945432406
systems,296,5.69035945432406
reduction,296,5.69035945432406
gene,295,5.68697535633982
individual,293,5.680172609017068
fibrillation,293,5.680172609017068
performance,293,5.680172609017068
given,293,5.680172609017068
occlusion,292,5.676753802268282
range,292,5.676753802268282
provides,292,5.676753802268282
challenge,292,5.676753802268282
100,291,5.673323267171493
outbreaks,291,5.673323267171493
For,291,5.673323267171493
affected,291,5.673323267171493
persons,290,5.66988092298052
specificity,290,5.66988092298052
direct,289,5.666426688112432
trial,288,5.662960480135946
angioplasty,287,5.659482215759621
OR,286,5.655991810819852
inhaled,286,5.655991810819852
ischemia,286,5.655991810819852
few,285,5.652489180268651
assays,285,5.652489180268651
recommended,284,5.648974238161206
protection,283,5.645446897643238
7,282,5.641907070938114
rapidly,282,5.641907070938114
Introduction,281,5.638354669333745
collected,280,5.634789603169249
experience,280,5.634789603169249
During,280,5.634789603169249
change,280,5.634789603169249
benefit,279,5.631211781821365
index,279,5.631211781821365
CT,278,5.627621113690637
acid,278,5.627621113690637
strain,278,5.627621113690637
physical,277,5.6240175061873385
where,277,5.6240175061873385
either,277,5.6240175061873385
according,277,5.6240175061873385
established,276,5.62040086571715
recommendations,276,5.62040086571715
day,276,5.62040086571715
across,274,5.6131281063880705
14,274,5.6131281063880705
analyzed,273,5.60947179518496
influence,272,5.605802066295998
safety,272,5.605802066295998
paper,271,5.602118820879701
condition,271,5.602118820879701
pain,270,5.598421958998375
environmental,270,5.598421958998375
detect,270,5.598421958998375
required,270,5.598421958998375
inferior,270,5.598421958998375
single,270,5.598421958998375
defined,269,5.594711379601839
so,269,5.594711379601839
volume,269,5.594711379601839
controlled,268,5.5909869805108565
dose,268,5.5909869805108565
education,267,5.58724865840025
frequent,267,5.58724865840025
now,267,5.58724865840025
thrombolytic,267,5.58724865840025
obstruction,267,5.58724865840025
epidemiological,266,5.583496308781699
followed,266,5.583496308781699
childhood,266,5.583496308781699
Thus,265,5.579729825986222
versus,265,5.579729825986222
ischaemic,265,5.579729825986222
andor,265,5.579729825986222
An,264,5.575949103146316
essential,263,5.572154032177765
suggests,262,5.568344503761097
fraction,262,5.568344503761097
must,261,5.564520407322694
Therefore,261,5.564520407322694
although,261,5.564520407322694
diagnosed,261,5.564520407322694
previously,261,5.564520407322694
ECG,260,5.560681631015528
epidemics,259,5.556828061699537
hospitals,259,5.556828061699537
optimal,259,5.556828061699537
vascular,259,5.556828061699537
damage,258,5.552959584921617
workers,258,5.552959584921617
protective,258,5.552959584921617
proteins,258,5.552959584921617
IgG,257,5.54907608489522
determined,257,5.54907608489522
hospitalization,256,5.545177444479562
survival,256,5.545177444479562
techniques,255,5.541263545158426
adverse,255,5.541263545158426
injury,254,5.537334267018537
additional,254,5.537334267018537
measured,254,5.537334267018537
disorders,254,5.537334267018537
recently,253,5.53338948872752
occur,253,5.53338948872752
25,253,5.53338948872752
depression,252,5.529429087511423
frequently,252,5.529429087511423
school,252,5.529429087511423
wave,252,5.529429087511423
family,251,5.5254529391317835
least,251,5.5254529391317835
decrease,251,5.5254529391317835
target,250,5.521460917862246
flu,250,5.521460917862246
neurological,250,5.521460917862246
healthy,249,5.517452896464707
potentially,249,5.517452896464707
part,249,5.517452896464707
million,249,5.517452896464707
values,249,5.517452896464707
attack,248,5.5134287461649825
variants,247,5.5093883366279774
characterized,247,5.5093883366279774
stress,247,5.5093883366279774
11,246,5.5053315359323625
shock,246,5.5053315359323625
five,246,5.5053315359323625
treatments,245,5.501258210544727
receptor,245,5.501258210544727
whereas,245,5.501258210544727
particular,244,5.497168225293202
estimated,244,5.497168225293202
become,243,5.493061443340548
involved,243,5.493061443340548
regions,243,5.493061443340548
proportion,242,5.488937726156687
setting,242,5.488937726156687
efforts,241,5.484796933490655
air,240,5.480638923341991
challenges,239,5.476463551931511
adult,239,5.476463551931511
exacerbations,238,5.472270673671475
best,238,5.472270673671475
local,237,5.4680601411351315
prior,237,5.4680601411351315
basis,237,5.4680601411351315
published,237,5.4680601411351315
overall,237,5.4680601411351315
interval,237,5.4680601411351315
rare,236,5.4638318050256105
identification,236,5.4638318050256105
Despite,234,5.455321115357702
suggested,234,5.455321115357702
symptomatic,234,5.455321115357702
relative,234,5.455321115357702
controls,234,5.455321115357702
Of,233,5.4510384535657
rehabilitation,233,5.4510384535657
binding,233,5.4510384535657
lack,233,5.4510384535657
correlation,233,5.4510384535657
STEMI,232,5.44673737166631
ejection,232,5.44673737166631
mechanism,232,5.44673737166631
understand,231,5.442417710521793
genes,231,5.442417710521793
emerging,231,5.442417710521793
dysfunction,230,5.438079308923196
myocardium,230,5.438079308923196
percutaneous,230,5.438079308923196
remain,229,5.43372200355424
reports,229,5.43372200355424
men,229,5.43372200355424
ability,228,5.429345628954441
plasma,228,5.429345628954441
estimate,228,5.429345628954441
affect,228,5.429345628954441
spike,228,5.429345628954441
duration,228,5.429345628954441
inhibitors,228,5.429345628954441
seen,228,5.429345628954441
After,228,5.429345628954441
past,228,5.429345628954441
patterns,228,5.429345628954441
occupational,227,5.424950017481403
oral,227,5.424950017481403
pediatric,227,5.424950017481403
screening,227,5.424950017481403
indicate,226,5.420534999272286
surgery,226,5.420534999272286
001,226,5.420534999272286
animal,226,5.420534999272286
8,226,5.420534999272286
13,225,5.41610040220442
isolated,225,5.41610040220442
Acute,225,5.41610040220442
medication,225,5.41610040220442
authors,225,5.41610040220442
suspected,225,5.41610040220442
reviewed,225,5.41610040220442
16,224,5.4116460518550396
One,223,5.407171771460119
unknown,223,5.407171771460119
arterial,223,5.407171771460119
60,223,5.407171771460119
sample,222,5.402677381872279
leads,222,5.402677381872279
angiography,221,5.3981627015177525
costs,220,5.393627546352362
h,220,5.393627546352362
unit,220,5.393627546352362
expression,220,5.393627546352362
PCR,220,5.393627546352362
focus,219,5.389071729816501
cohort,219,5.389071729816501
40,219,5.389071729816501
contribute,218,5.384495062789089
therefore,218,5.384495062789089
do,218,5.384495062789089
daily,217,5.37989735354046
region,217,5.37989735354046
hypertension,217,5.37989735354046
compare,217,5.37989735354046
physicians,217,5.37989735354046
via,216,5.375278407684165
good,216,5.375278407684165
baseline,216,5.375278407684165
percent,216,5.375278407684165
program,216,5.375278407684165
induced,216,5.375278407684165
yet,215,5.3706380281276624
provided,215,5.3706380281276624
distribution,215,5.3706380281276624
occurrence,215,5.3706380281276624
lesions,215,5.3706380281276624
last,215,5.3706380281276624
subsequent,215,5.3706380281276624
participants,214,5.365976015021851
perfusion,214,5.365976015021851
airways,213,5.3612921657094255
Purpose,213,5.3612921657094255
proposed,213,5.3612921657094255
event,213,5.3612921657094255
attention,213,5.3612921657094255
approximately,212,5.356586274672012
despite,212,5.356586274672012
national,211,5.351858133476067
combination,211,5.351858133476067
indicated,211,5.351858133476067
necessary,211,5.351858133476067
Coronavirus,211,5.351858133476067
reducing,211,5.351858133476067
successful,210,5.3471075307174685
times,210,5.3471075307174685
state,210,5.3471075307174685
randomized,210,5.3471075307174685
variables,209,5.342334251964811
Among,209,5.342334251964811
regional,209,5.342334251964811
vaccinated,209,5.342334251964811
hospitalized,209,5.342334251964811
administration,209,5.342334251964811
At,209,5.342334251964811
thus,209,5.342334251964811
relevant,208,5.337538079701318
contrast,208,5.337538079701318
little,208,5.337538079701318
asthmatics,208,5.337538079701318
six,208,5.337538079701318
then,208,5.337538079701318
examine,208,5.337538079701318
activation,208,5.337538079701318
conclusion,208,5.337538079701318
9,208,5.337538079701318
December,207,5.332718793265369
play,206,5.327876168789581
Severe,206,5.327876168789581
underwent,205,5.3230099791384085
cancer,204,5.318119993844216
Furthermore,204,5.318119993844216
contact,204,5.318119993844216
independent,204,5.318119993844216
correlated,203,5.313205979041787
National,203,5.313205979041787
emergence,202,5.308267697401205
mechanical,202,5.308267697401205
discharge,202,5.308267697401205
Since,202,5.308267697401205
AF,202,5.308267697401205
With,202,5.308267697401205
US,201,5.303304908059076
combined,201,5.303304908059076
median,201,5.303304908059076
training,201,5.303304908059076
extent,201,5.303304908059076
diabetes,200,5.298317366548036
difficult,200,5.298317366548036
segment,200,5.298317366548036
smoking,199,5.293304824724492
degree,199,5.293304824724492
confidence,199,5.293304824724492
corticosteroids,199,5.293304824724492
end,198,5.288267030694535
absence,198,5.288267030694535
sensitive,198,5.288267030694535
005,198,5.288267030694535
carotid,197,5.2832037287379885
problems,197,5.2832037287379885
mainly,197,5.2832037287379885
commonly,196,5.278114659230517
predict,196,5.278114659230517
highest,196,5.278114659230517
production,195,5.272999558563747
signs,195,5.272999558563747
persistent,195,5.272999558563747
18,195,5.272999558563747
experimental,195,5.272999558563747
serious,195,5.272999558563747
pregnancy,194,5.267858159063328
pandemics,194,5.267858159063328
resulting,194,5.267858159063328
types,194,5.267858159063328
circulation,194,5.267858159063328
chain,193,5.262690188904886
predictive,193,5.262690188904886
concern,193,5.262690188904886
19,193,5.262690188904886
resistance,192,5.2574953720277815
17,192,5.2574953720277815
posterior,192,5.2574953720277815
responsible,192,5.2574953720277815
cardiogenic,192,5.2574953720277815
regression,192,5.2574953720277815
economic,192,5.2574953720277815
relation,192,5.2574953720277815
examination,191,5.25227342804663
moderate,191,5.25227342804663
No,191,5.25227342804663
antigen,191,5.25227342804663
ongoing,191,5.25227342804663
prognostic,190,5.247024072160486
I,190,5.247024072160486
benefits,190,5.247024072160486
MRI,189,5.241747015059643
active,189,5.241747015059643
animals,189,5.241747015059643
fever,188,5.236441962829949
problem,188,5.236441962829949
pattern,188,5.236441962829949
disability,188,5.236441962829949
investigation,187,5.231108616854587
comprehensive,187,5.231108616854587
systemic,187,5.231108616854587
died,187,5.231108616854587
attacks,187,5.231108616854587
measure,186,5.225746673713202
cellular,186,5.225746673713202
terms,186,5.225746673713202
mutations,186,5.225746673713202
capacity,185,5.220355825078324
S,185,5.220355825078324
does,185,5.220355825078324
specimens,185,5.220355825078324
Most,185,5.220355825078324
survey,184,5.214935757608986
resulted,183,5.209486152841421
presenting,183,5.209486152841421
design,182,5.204006687076795
much,182,5.204006687076795
usually,182,5.204006687076795
widely,182,5.204006687076795
selected,182,5.204006687076795
fatal,182,5.204006687076795
applied,181,5.198497031265826
comparison,181,5.198497031265826
targets,181,5.198497031265826
T,181,5.198497031265826
ST-segment,181,5.198497031265826
reverse,181,5.198497031265826
having,181,5.198497031265826
March,181,5.198497031265826
tract,180,5.19295685089021
survivors,180,5.19295685089021
old,179,5.187385805840755
around,179,5.187385805840755
European,179,5.187385805840755
whom,179,5.187385805840755
routine,179,5.187385805840755
II,179,5.187385805840755
form,179,5.187385805840755
technique,179,5.187385805840755
alternative,179,5.187385805840755
delay,179,5.187385805840755
vessel,178,5.181783550292085
majority,178,5.181783550292085
preventing,177,5.176149732573829
stenosis,177,5.176149732573829
led,177,5.176149732573829
aspects,177,5.176149732573829
context,177,5.176149732573829
antigenic,177,5.176149732573829
On,177,5.176149732573829
pathways,177,5.176149732573829
increases,177,5.176149732573829
systematic,176,5.170483995038151
New,176,5.170483995038151
later,176,5.170483995038151
65,176,5.170483995038151
manifestations,176,5.170483995038151
mice,176,5.170483995038151
Group,176,5.170483995038151
intensive,175,5.1647859739235145
application,175,5.1647859739235145
pathophysiology,175,5.1647859739235145
activities,175,5.1647859739235145
emerged,174,5.159055299214529
average,174,5.159055299214529
While,174,5.159055299214529
transient,174,5.159055299214529
tool,174,5.159055299214529
cost,174,5.159055299214529
issues,173,5.153291594497779
means,173,5.153291594497779
analyses,173,5.153291594497779
remodeling,172,5.147494476813453
network,172,5.147494476813453
Moreover,172,5.147494476813453
requires,172,5.147494476813453
promising,172,5.147494476813453
relatively,171,5.14166355650266
mass,171,5.14166355650266
evolution,171,5.14166355650266
Myocardial,171,5.14166355650266
week,171,5.14166355650266
pregnant,171,5.14166355650266
clinically,171,5.14166355650266
settings,171,5.14166355650266
oseltamivir,170,5.135798437050262
substantial,170,5.135798437050262
series,170,5.135798437050262
arteries,170,5.135798437050262
unclear,170,5.135798437050262
surgical,169,5.1298987149230735
needs,169,5.1298987149230735
site,169,5.1298987149230735
magnetic,169,5.1298987149230735
demonstrate,168,5.123963979403259
procedures,168,5.123963979403259
require,167,5.117993812416755
wheezing,167,5.117993812416755
70,167,5.117993812416755
threat,167,5.117993812416755
medicine,167,5.117993812416755
male,167,5.117993812416755
nasopharyngeal,167,5.117993812416755
scores,166,5.111987788356544
epidemiology,166,5.111987788356544
medications,166,5.111987788356544
body,165,5.10594547390058
sex,165,5.10594547390058
upper,165,5.10594547390058
high-risk,165,5.10594547390058
date,165,5.10594547390058
long,165,5.10594547390058
access,164,5.099866427824199
programs,164,5.099866427824199
polymerase,164,5.099866427824199
replication,164,5.099866427824199
80,164,5.099866427824199
presentation,164,5.099866427824199
tomography,164,5.099866427824199
intravenous,164,5.099866427824199
action,164,5.099866427824199
Data,164,5.099866427824199
variant,163,5.093750200806762
agent,163,5.093750200806762
PCI,163,5.093750200806762
explore,163,5.093750200806762
like,162,5.087596335232384
receiving,162,5.087596335232384
third,162,5.087596335232384
Two,162,5.087596335232384
isolation,162,5.087596335232384
scientific,162,5.087596335232384
75,162,5.087596335232384
lesion,161,5.081404364984463
circulating,161,5.081404364984463
natural,161,5.081404364984463
COPD,161,5.081404364984463
preventive,160,5.075173815233827
48,160,5.075173815233827
90,160,5.075173815233827
enzyme,160,5.075173815233827
international,160,5.075173815233827
questionnaire,160,5.075173815233827
child,160,5.075173815233827
interest,159,5.0689042022202315
H3N2,159,5.0689042022202315
strong,159,5.0689042022202315
echocardiography,158,5.062595033026967
ie,158,5.062595033026967
alone,158,5.062595033026967
accurate,158,5.062595033026967
angina,158,5.062595033026967
risks,158,5.062595033026967
21,158,5.062595033026967
predictors,158,5.062595033026967
resonance,158,5.062595033026967
processes,157,5.056245805348308
28,157,5.056245805348308
accuracy,156,5.049856007249537
allergy,156,5.049856007249537
address,156,5.049856007249537
cerebrovascular,156,5.049856007249537
Recent,156,5.049856007249537
delivery,156,5.049856007249537
aims,156,5.049856007249537
clear,156,5.049856007249537
progression,156,5.049856007249537
experienced,156,5.049856007249537
subtypes,156,5.049856007249537
treat,155,5.043425116919247
±,155,5.043425116919247
recorded,155,5.043425116919247
odds,155,5.043425116919247
prospective,154,5.0369526024136295
complication,154,5.0369526024136295
AH1N1,154,5.0369526024136295
electrocardiographic,154,5.0369526024136295
causing,154,5.0369526024136295
field,154,5.0369526024136295
taken,154,5.0369526024136295
placebo,154,5.0369526024136295
measurements,153,5.030437921392435
exacerbation,153,5.030437921392435
Using,153,5.030437921392435
structure,153,5.030437921392435
appears,153,5.030437921392435
implications,153,5.030437921392435
thrombosis,153,5.030437921392435
complete,152,5.0238805208462765
stage,152,5.0238805208462765
home,152,5.0238805208462765
components,151,5.017279836814924
swabs,151,5.017279836814924
They,150,5.0106352940962555
account,150,5.0106352940962555
what,150,5.0106352940962555
dynamics,150,5.0106352940962555
Clinical,150,5.0106352940962555
reliable,150,5.0106352940962555
cough,150,5.0106352940962555
interaction,149,5.003946305945459
achieved,149,5.003946305945459
obstructive,148,4.997212273764115
ACE2,148,4.997212273764115
abnormalities,148,4.997212273764115
safe,148,4.997212273764115
pathogenic,148,4.997212273764115
cognitive,148,4.997212273764115
designed,148,4.997212273764115
hypothesis,148,4.997212273764115
documented,148,4.997212273764115
make,147,4.990432586778736
sought,147,4.990432586778736
real-time,147,4.990432586778736
existing,147,4.990432586778736
Several,147,4.990432586778736
carried,147,4.990432586778736
doses,147,4.990432586778736
services,146,4.983606621708336
26,146,4.983606621708336
World,146,4.983606621708336
crucial,146,4.983606621708336
saliva,146,4.983606621708336
younger,145,4.976733742420574
occurs,145,4.976733742420574
central,145,4.976733742420574
April,145,4.976733742420574
recognition,145,4.976733742420574
certain,144,4.969813299576001
classification,144,4.969813299576001
consecutive,144,4.969813299576001
identifying,144,4.969813299576001
country,144,4.969813299576001
implementation,144,4.969813299576001
elevated,144,4.969813299576001
interactions,144,4.969813299576001
impairment,143,4.962844630259907
administered,143,4.962844630259907
fully,143,4.962844630259907
point,143,4.962844630259907
options,143,4.962844630259907
biological,143,4.962844630259907
suggesting,143,4.962844630259907
involvement,142,4.955827057601261
35,142,4.955827057601261
advances,142,4.955827057601261
immunization,142,4.955827057601261
policy,142,4.955827057601261
female,142,4.955827057601261
stem,142,4.955827057601261
Disease,141,4.948759890378168
targeted,141,4.948759890378168
structural,141,4.948759890378168
LV,141,4.948759890378168
way,141,4.948759890378168
variation,141,4.948759890378168
providing,141,4.948759890378168
consequences,141,4.948759890378168
side,141,4.948759890378168
resources,141,4.948759890378168
predicted,141,4.948759890378168
1918,141,4.948759890378168
recurrence,141,4.948759890378168
able,140,4.941642422609304
quantitative,140,4.941642422609304
min,140,4.941642422609304
January,140,4.941642422609304
complicated,140,4.941642422609304
uptake,140,4.941642422609304
environment,139,4.9344739331306915
questions,139,4.9344739331306915
generally,139,4.9344739331306915
29,139,4.9344739331306915
receive,139,4.9344739331306915
bypass,139,4.9344739331306915
23,139,4.9344739331306915
ventricle,139,4.9344739331306915
loss,139,4.9344739331306915
occurring,139,4.9344739331306915
Both,138,4.927253685157205
describes,138,4.927253685157205
eg,138,4.927253685157205
motor,138,4.927253685157205
annual,138,4.927253685157205
preparedness,138,4.927253685157205
far,138,4.927253685157205
parents,138,4.927253685157205
focused,137,4.919980925828125
implemented,137,4.919980925828125
unique,137,4.919980925828125
recognized,137,4.919980925828125
markers,137,4.919980925828125
staff,137,4.919980925828125
muscle,137,4.919980925828125
conventional,136,4.912654885736052
coverage,136,4.912654885736052
22,136,4.912654885736052
consistent,136,4.912654885736052
45,136,4.912654885736052
episodes,136,4.912654885736052
simple,136,4.912654885736052
sites,136,4.912654885736052
Many,136,4.912654885736052
allow,136,4.912654885736052
genome,135,4.90527477843843
great,135,4.90527477843843
31,135,4.90527477843843
C,135,4.90527477843843
By,135,4.90527477843843
significance,135,4.90527477843843
hyperresponsiveness,135,4.90527477843843
disorder,135,4.90527477843843
toward,135,4.90527477843843
improving,135,4.90527477843843
tools,135,4.90527477843843
beneficial,135,4.90527477843843
waves,134,4.897839799950911
centers,134,4.897839799950911
in-hospital,134,4.897839799950911
prophylaxis,134,4.897839799950911
variable,134,4.897839799950911
entry,134,4.897839799950911
facilities,134,4.897839799950911
oxygen,134,4.897839799950911
etiology,134,4.897839799950911
swab,134,4.897839799950911
adherence,133,4.890349128221754
urgent,133,4.890349128221754
load,133,4.890349128221754
clinicians,133,4.890349128221754
close,133,4.890349128221754
sudden,133,4.890349128221754
Finally,132,4.882801922586371
Results,132,4.882801922586371
Respiratory,132,4.882801922586371
rupture,132,4.882801922586371
infarctions,132,4.882801922586371
source,132,4.882801922586371
understood,132,4.882801922586371
motion,131,4.875197323201151
location,131,4.875197323201151
directly,131,4.875197323201151
expiratory,131,4.875197323201151
department,131,4.875197323201151
expected,131,4.875197323201151
FEV1,131,4.875197323201151
cytokine,131,4.875197323201151
influenza-like,130,4.867534450455582
WHO,130,4.867534450455582
short,130,4.867534450455582
computed,130,4.867534450455582
members,130,4.867534450455582
hemorrhagic,130,4.867534450455582
almost,130,4.867534450455582
reference,130,4.867534450455582
selection,130,4.867534450455582
Hospital,129,4.859812404361672
along,129,4.859812404361672
rather,129,4.859812404361672
ventilation,129,4.859812404361672
adolescents,129,4.859812404361672
together,129,4.859812404361672
When,129,4.859812404361672
plan,129,4.859812404361672
goal,129,4.859812404361672
abnormal,128,4.852030263919617
scale,128,4.852030263919617
treating,128,4.852030263919617
limitations,128,4.852030263919617
mRNA,128,4.852030263919617
assessing,128,4.852030263919617
search,128,4.852030263919617
progress,128,4.852030263919617
throughout,128,4.852030263919617
variety,128,4.852030263919617
hand,127,4.844187086458591
ILI,127,4.844187086458591
Wuhan,127,4.844187086458591
nature,127,4.844187086458591
timing,127,4.844187086458591
every,127,4.844187086458591
biomarkers,127,4.844187086458591
swine,127,4.844187086458591
seasons,127,4.844187086458591
practices,127,4.844187086458591
growth,127,4.844187086458591
limit,127,4.844187086458591
N,127,4.844187086458591
shows,127,4.844187086458591
surface,127,4.844187086458591
affecting,126,4.836281906951478
retrospective,126,4.836281906951478
SARS-CoV,126,4.836281906951478
analyze,125,4.8283137373023015
students,125,4.8283137373023015
hemodynamic,125,4.8283137373023015
Because,125,4.8283137373023015
nasal,125,4.8283137373023015
South,125,4.8283137373023015
periods,125,4.8283137373023015
considerable,124,4.820281565605037
infarcts,124,4.820281565605037
decision,124,4.820281565605037
man,124,4.820281565605037
phenotypes,124,4.820281565605037
concerns,124,4.820281565605037
stable,124,4.820281565605037
set,124,4.820281565605037
thrombus,123,4.812184355372417
nursing,123,4.812184355372417
month,123,4.812184355372417
professionals,123,4.812184355372417
Overall,123,4.812184355372417
neuraminidase,123,4.812184355372417
extensive,123,4.812184355372417
reviews,123,4.812184355372417
immediate,123,4.812184355372417
minutes,122,4.804021044733257
possibility,122,4.804021044733257
widespread,122,4.804021044733257
conclude,122,4.804021044733257
half,122,4.804021044733257
statistically,122,4.804021044733257
airflow,122,4.804021044733257
presents,122,4.804021044733257
largely,122,4.804021044733257
modified,122,4.804021044733257
estimates,122,4.804021044733257
psychological,121,4.795790545596741
variability,121,4.795790545596741
reactions,121,4.795790545596741
already,121,4.795790545596741
revascularization,121,4.795790545596741
planning,121,4.795790545596741
produced,121,4.795790545596741
nucleic,121,4.795790545596741
probably,121,4.795790545596741
appear,121,4.795790545596741
effectively,121,4.795790545596741
susceptibility,121,4.795790545596741
others,121,4.795790545596741
trends,120,4.787491742782046
seven,120,4.787491742782046
involving,120,4.787491742782046
seems,120,4.787491742782046
HA,120,4.787491742782046
includes,120,4.787491742782046
points,119,4.77912349311153
availability,119,4.77912349311153
origin,119,4.77912349311153
stages,119,4.77912349311153
timely,118,4.770684624465665
longer,118,4.770684624465665
visits,118,4.770684624465665
find,118,4.770684624465665
Early,118,4.770684624465665
measurement,118,4.770684624465665
May,118,4.770684624465665
Coronary,118,4.770684624465665
procedure,118,4.770684624465665
adequate,117,4.762173934797756
calculated,117,4.762173934797756
stimulation,117,4.762173934797756
coronaviruses,117,4.762173934797756
decisions,117,4.762173934797756
36,117,4.762173934797756
adjusted,117,4.762173934797756
indicates,116,4.7535901911063645
sequence,116,4.7535901911063645
sleep,116,4.7535901911063645
vitro,116,4.7535901911063645
increasingly,116,4.7535901911063645
D,116,4.7535901911063645
represents,116,4.7535901911063645
maternal,115,4.74493212836325
necrosis,115,4.74493212836325
physician,115,4.74493212836325
allergen,115,4.74493212836325
poorly,115,4.74493212836325
subtype,115,4.74493212836325
highlight,115,4.74493212836325
approved,115,4.74493212836325
sequences,115,4.74493212836325
thrombectomy,115,4.74493212836325
27,114,4.736198448394496
cytokines,114,4.736198448394496
strongly,114,4.736198448394496
segments,114,4.736198448394496
Control,114,4.736198448394496
From,113,4.727387818712341
towards,113,4.727387818712341
peripheral,113,4.727387818712341
RBD,113,4.727387818712341
successfully,113,4.727387818712341
rats,113,4.727387818712341
undergoing,113,4.727387818712341
species,112,4.718498871295094
domain,112,4.718498871295094
consider,112,4.718498871295094
component,112,4.718498871295094
percentage,112,4.718498871295094
angiographic,111,4.709530201312334
allergens,111,4.709530201312334
forms,111,4.709530201312334
plays,111,4.709530201312334
pathology,111,4.709530201312334
wide,111,4.709530201312334
formation,111,4.709530201312334
summarize,111,4.709530201312334
done,111,4.709530201312334
Further,111,4.709530201312334
living,110,4.700480365792417
compounds,110,4.700480365792417
continued,110,4.700480365792417
represent,110,4.700480365792417
making,110,4.700480365792417
Europe,110,4.700480365792417
hemorrhage,110,4.700480365792417
achieve,110,4.700480365792417
remained,110,4.700480365792417
serological,110,4.700480365792417
42,110,4.700480365792417
units,109,4.6913478822291435
cannot,109,4.6913478822291435
place,109,4.6913478822291435
Africa,109,4.6913478822291435
block,109,4.6913478822291435
Organization,109,4.6913478822291435
candidates,109,4.6913478822291435
pathogens,109,4.6913478822291435
eight,109,4.6913478822291435
consumption,108,4.68213122712422
situation,108,4.68213122712422
atopic,108,4.68213122712422
Q,108,4.68213122712422
validated,108,4.68213122712422
IgE,108,4.68213122712422
completed,108,4.68213122712422
infarcted,108,4.68213122712422
free,107,4.672828834461906
Study,107,4.672828834461906
SARS,107,4.672828834461906
arrhythmias,107,4.672828834461906
susceptible,107,4.672828834461906
whole,107,4.672828834461906
term,107,4.672828834461906
delayed,107,4.672828834461906
personal,107,4.672828834461906
convalescent,107,4.672828834461906
More,107,4.672828834461906
mm,107,4.672828834461906
primarily,107,4.672828834461906
mutation,107,4.672828834461906
finding,107,4.672828834461906
hospitalizations,107,4.672828834461906
facilitate,107,4.672828834461906
residents,107,4.672828834461906
Some,107,4.672828834461906
affects,107,4.672828834461906
bacterial,107,4.672828834461906
whose,107,4.672828834461906
inactivated,106,4.663439094112067
targeting,106,4.663439094112067
atherosclerosis,106,4.663439094112067
states,106,4.663439094112067
basic,106,4.663439094112067
upon,106,4.663439094112067
temperature,106,4.663439094112067
poultry,105,4.653960350157523
38,105,4.653960350157523
55,105,4.653960350157523
membrane,105,4.653960350157523
prolonged,105,4.653960350157523
inhalation,105,4.653960350157523
profile,105,4.653960350157523
differ,105,4.653960350157523
behavior,104,4.6443908991413725
suffering,104,4.6443908991413725
plans,104,4.6443908991413725
concentrations,104,4.6443908991413725
Medical,104,4.6443908991413725
special,104,4.6443908991413725
UK,104,4.6443908991413725
another,104,4.6443908991413725
distress,104,4.6443908991413725
controlling,104,4.6443908991413725
variations,104,4.6443908991413725
protocol,104,4.6443908991413725
Current,104,4.6443908991413725
June,104,4.6443908991413725
establish,104,4.6443908991413725
gender,103,4.634728988229636
records,103,4.634728988229636
release,103,4.634728988229636
infants,103,4.634728988229636
properties,103,4.634728988229636
Japan,103,4.634728988229636
laboratories,103,4.634728988229636
innate,103,4.634728988229636
vitamin,103,4.634728988229636
reporting,103,4.634728988229636
cent,103,4.634728988229636
utility,103,4.634728988229636
noted,103,4.634728988229636
February,103,4.634728988229636
transcription,103,4.634728988229636
Three,102,4.624972813284271
males,102,4.624972813284271
framework,102,4.624972813284271
numbers,102,4.624972813284271
enhanced,102,4.624972813284271
derived,102,4.624972813284271
vivo,102,4.624972813284271
suitable,102,4.624972813284271
QRS,102,4.624972813284271
propose,102,4.624972813284271
diagnostics,102,4.624972813284271
comparable,102,4.624972813284271
electrocardiogram,102,4.624972813284271
discusses,101,4.61512051684126
isolates,101,4.61512051684126
families,101,4.61512051684126
ill,101,4.61512051684126
prevalent,101,4.61512051684126
excess,101,4.61512051684126
globally,101,4.61512051684126
awareness,100,4.605170185988092
ensure,100,4.605170185988092
VE,100,4.605170185988092
34,100,4.605170185988092
overview,100,4.605170185988092
detecting,100,4.605170185988092
females,100,4.605170185988092
traditional,100,4.605170185988092
neutralizing,100,4.605170185988092
communities,100,4.605170185988092
American,100,4.605170185988092
prediction,100,4.605170185988092
functions,100,4.605170185988092
linked,100,4.605170185988092
collection,100,4.605170185988092
efficient,100,4.605170185988092
working,100,4.605170185988092
larger,100,4.605170185988092
41,99,4.59511985013459
Only,99,4.59511985013459
Treatment,99,4.59511985013459
impaired,99,4.59511985013459
detailed,99,4.59511985013459
0,99,4.59511985013459
concentration,99,4.59511985013459
continue,99,4.59511985013459
Scale,99,4.59511985013459
PTCA,99,4.59511985013459
decades,99,4.59511985013459
skin,98,4.584967478670572
anticoagulation,98,4.584967478670572
H7N9,98,4.584967478670572
success,98,4.584967478670572
2021,98,4.584967478670572
guide,98,4.584967478670572
37,98,4.584967478670572
view,98,4.584967478670572
here,97,4.574710978503383
stenting,97,4.574710978503383
objectives,97,4.574710978503383
Chinese,97,4.574710978503383
divided,97,4.574710978503383
maximal,97,4.574710978503383
lungs,97,4.574710978503383
investigations,97,4.574710978503383
statistical,97,4.574710978503383
rhinitis,97,4.574710978503383
us,97,4.574710978503383
above,97,4.574710978503383
inhibition,97,4.574710978503383
device,97,4.574710978503383
systolic,97,4.574710978503383
communication,97,4.574710978503383
inhibitor,96,4.564348191467836
definition,96,4.564348191467836
live,96,4.564348191467836
repeated,96,4.564348191467836
dynamic,96,4.564348191467836
maximum,96,4.564348191467836
concept,96,4.564348191467836
reduces,96,4.564348191467836
explain,96,4.564348191467836
marked,96,4.564348191467836
explored,96,4.564348191467836
concerning,96,4.564348191467836
continues,96,4.564348191467836
associations,95,4.553876891600541
differential,95,4.553876891600541
Prevention,95,4.553876891600541
predicting,95,4.553876891600541
2010,95,4.553876891600541
newly,95,4.553876891600541
thoracic,95,4.553876891600541
receptors,95,4.553876891600541
32,95,4.553876891600541
endovascular,95,4.553876891600541
manage,95,4.553876891600541
reasons,95,4.553876891600541
summarizes,95,4.553876891600541
Aim,94,4.543294782270004
If,94,4.543294782270004
descending,94,4.543294782270004
agreement,94,4.543294782270004
providers,94,4.543294782270004
comorbidities,94,4.543294782270004
sustained,94,4.543294782270004
protocols,94,4.543294782270004
enrolled,94,4.543294782270004
IAV,94,4.543294782270004
proven,94,4.543294782270004
physiological,94,4.543294782270004
intracranial,94,4.543294782270004
nurses,94,4.543294782270004
balloon,93,4.532599493153256
prehospital,93,4.532599493153256
corticosteroid,93,4.532599493153256
until,93,4.532599493153256
residual,93,4.532599493153256
choice,93,4.532599493153256
recipients,93,4.532599493153256
determining,93,4.532599493153256
rural,93,4.532599493153256
signaling,93,4.532599493153256
depends,93,4.532599493153256
Based,93,4.532599493153256
evaluating,93,4.532599493153256
immunological,93,4.532599493153256
technologies,92,4.5217885770490405
embolism,92,4.5217885770490405
offer,92,4.5217885770490405
effort,92,4.5217885770490405
introduction,92,4.5217885770490405
technology,92,4.5217885770490405
middle,92,4.5217885770490405
mediators,92,4.5217885770490405
growing,92,4.5217885770490405
anti-inflammatory,92,4.5217885770490405
bleeding,92,4.5217885770490405
recovered,92,4.5217885770490405
question,92,4.5217885770490405
inform,92,4.5217885770490405
rest,92,4.5217885770490405
influenced,92,4.5217885770490405
comparing,92,4.5217885770490405
r,92,4.5217885770490405
typical,91,4.51085950651685
2019-nCoV,91,4.51085950651685
schools,91,4.51085950651685
perception,91,4.51085950651685
matter,91,4.51085950651685
analysed,91,4.51085950651685
heterogeneous,91,4.51085950651685
regular,91,4.51085950651685
atherosclerotic,91,4.51085950651685
marker,91,4.51085950651685
indicating,91,4.51085950651685
deficits,90,4.499809670330265
exposed,90,4.499809670330265
vital,90,4.499809670330265
observational,90,4.499809670330265
substantially,90,4.499809670330265
distinct,90,4.499809670330265
determinants,90,4.499809670330265
renal,90,4.499809670330265
beginning,90,4.499809670330265
septal,90,4.499809670330265
oxide,89,4.48863636973214
behavioral,89,4.48863636973214
monitor,89,4.48863636973214
his,89,4.48863636973214
concluded,89,4.48863636973214
NIHSS,89,4.48863636973214
specifically,89,4.48863636973214
winter,89,4.48863636973214
class,89,4.48863636973214
clinic,89,4.48863636973214
steroids,89,4.48863636973214
RT-qPCR,89,4.48863636973214
infarct-related,89,4.48863636973214
issue,89,4.48863636973214
city,89,4.48863636973214
ST-elevation,89,4.48863636973214
fact,89,4.48863636973214
demographic,89,4.48863636973214
take,89,4.48863636973214
continuous,89,4.48863636973214
anxiety,89,4.48863636973214
vulnerable,89,4.48863636973214
repair,89,4.48863636973214
vessels,88,4.477336814478207
started,88,4.477336814478207
TIMI,88,4.477336814478207
pathway,88,4.477336814478207
researchers,88,4.477336814478207
epidemiologic,88,4.477336814478207
pharmacological,88,4.477336814478207
next,88,4.477336814478207
heterogeneity,88,4.477336814478207
plaque,88,4.477336814478207
33,88,4.477336814478207
enhance,88,4.477336814478207
intensity,88,4.477336814478207
define,88,4.477336814478207
IgM,88,4.477336814478207
SD,88,4.477336814478207
initiation,88,4.477336814478207
October,88,4.477336814478207
proved,88,4.477336814478207
exhaled,88,4.477336814478207
worse,88,4.477336814478207
Studies,88,4.477336814478207
efficiency,87,4.465908118654584
transmural,87,4.465908118654584
respect,87,4.465908118654584
cycle,87,4.465908118654584
allows,87,4.465908118654584
devices,87,4.465908118654584
insights,87,4.465908118654584
step,87,4.465908118654584
emotional,87,4.465908118654584
post-stroke,87,4.465908118654584
meta-analysis,87,4.465908118654584
advanced,87,4.465908118654584
closely,87,4.465908118654584
mg,87,4.465908118654584
induce,87,4.465908118654584
trend,86,4.454347296253507
indirect,86,4.454347296253507
logistic,86,4.454347296253507
activator,86,4.454347296253507
contacts,86,4.454347296253507
Australia,86,4.454347296253507
real,86,4.454347296253507
triggers,86,4.454347296253507
cross-sectional,86,4.454347296253507
standardized,86,4.454347296253507
ED,86,4.454347296253507
rhythm,86,4.454347296253507
self-management,86,4.454347296253507
short-term,86,4.454347296253507
avoid,85,4.442651256490317
syndromes,85,4.442651256490317
subgroups,85,4.442651256490317
transport,85,4.442651256490317
reinfarction,85,4.442651256490317
spectrum,85,4.442651256490317
rarely,85,4.442651256490317
easily,85,4.442651256490317
AH1N1pdm09,85,4.442651256490317
regard,85,4.442651256490317
laboratory-confirmed,85,4.442651256490317
plasminogen,85,4.442651256490317
protect,84,4.430816798843313
personnel,84,4.430816798843313
policies,84,4.430816798843313
sampling,84,4.430816798843313
amount,84,4.430816798843313
latter,84,4.430816798843313
nitric,84,4.430816798843313
ages,84,4.430816798843313
platelet,84,4.430816798843313
invasive,84,4.430816798843313
admissions,84,4.430816798843313
earlier,84,4.430816798843313
promote,84,4.430816798843313
highlights,84,4.430816798843313
networks,84,4.430816798843313
mostly,84,4.430816798843313
experiences,83,4.418840607796598
expressed,83,4.418840607796598
hundred,83,4.418840607796598
antigens,83,4.418840607796598
degrees,83,4.418840607796598
43,83,4.418840607796598
urban,83,4.418840607796598
opportunity,83,4.418840607796598
Recently,83,4.418840607796598
internal,83,4.418840607796598
Given,83,4.418840607796598
illnesses,83,4.418840607796598
spontaneous,83,4.418840607796598
classified,83,4.418840607796598
Other,83,4.418840607796598
taking,82,4.406719247264253
subgroup,82,4.406719247264253
titers,82,4.406719247264253
face,82,4.406719247264253
pathological,82,4.406719247264253
post,82,4.406719247264253
improves,82,4.406719247264253
mental,82,4.406719247264253
fatality,82,4.406719247264253
Rapid,82,4.406719247264253
century,82,4.406719247264253
250,82,4.406719247264253
final,82,4.406719247264253
white,82,4.406719247264253
nine,82,4.406719247264253
aortic,82,4.406719247264253
November,82,4.406719247264253
varied,81,4.394449154672439
length,81,4.394449154672439
rise,81,4.394449154672439
requiring,81,4.394449154672439
observations,81,4.394449154672439
IV,81,4.394449154672439
roles,81,4.394449154672439
epithelial,81,4.394449154672439
III,81,4.394449154672439
practical,81,4.394449154672439
47,81,4.394449154672439
Asia,81,4.394449154672439
sources,81,4.394449154672439
predictor,81,4.394449154672439
images,81,4.394449154672439
sequencing,81,4.394449154672439
initially,81,4.394449154672439
practitioners,81,4.394449154672439
potent,81,4.394449154672439
signal,80,4.382026634673881
compliance,80,4.382026634673881
immediately,80,4.382026634673881
July,80,4.382026634673881
assist,80,4.382026634673881
NA,80,4.382026634673881
phenomenon,80,4.382026634673881
raised,80,4.382026634673881
clearly,80,4.382026634673881
resistant,80,4.382026634673881
creatine,80,4.382026634673881
exposures,80,4.382026634673881
AH3N2,80,4.382026634673881
characterize,80,4.382026634673881
room,80,4.382026634673881
discharged,80,4.382026634673881
August,80,4.382026634673881
CDC,80,4.382026634673881
equipment,80,4.382026634673881
reversible,80,4.382026634673881
exist,79,4.3694478524670215
appeared,79,4.3694478524670215
completely,79,4.3694478524670215
probability,79,4.3694478524670215
supply,79,4.3694478524670215
example,79,4.3694478524670215
lacking,79,4.3694478524670215
light,79,4.3694478524670215
authorities,79,4.3694478524670215
suffered,79,4.3694478524670215
equal,79,4.3694478524670215
46,79,4.3694478524670215
stay,79,4.3694478524670215
sufficient,79,4.3694478524670215
ways,79,4.3694478524670215
center,79,4.3694478524670215
antivirals,79,4.3694478524670215
perioperative,78,4.356708826689592
showing,78,4.356708826689592
improvements,78,4.356708826689592
44,78,4.356708826689592
transmissibility,78,4.356708826689592
liver,78,4.356708826689592
addressed,78,4.356708826689592
follow,78,4.356708826689592
HCWs,78,4.356708826689592
metabolic,78,4.356708826689592
serial,78,4.356708826689592
failed,78,4.356708826689592
deterioration,78,4.356708826689592
always,78,4.356708826689592
aid,78,4.356708826689592
water,78,4.356708826689592
responsiveness,78,4.356708826689592
reflect,78,4.356708826689592
barriers,77,4.343805421853684
referred,77,4.343805421853684
emphasis,77,4.343805421853684
proper,77,4.343805421853684
contribution,77,4.343805421853684
kinase,77,4.343805421853684
subject,77,4.343805421853684
recommend,77,4.343805421853684
distancing,77,4.343805421853684
consensus,77,4.343805421853684
FeNO,77,4.343805421853684
offers,77,4.343805421853684
mellitus,77,4.343805421853684
hemisphere,77,4.343805421853684
possibly,77,4.343805421853684
cavity,77,4.343805421853684
Vaccination,77,4.343805421853684
database,77,4.343805421853684
service,77,4.343805421853684
line,77,4.343805421853684
ones,77,4.343805421853684
transplantation,77,4.343805421853684
woman,77,4.343805421853684
numerous,77,4.343805421853684
socioeconomic,77,4.343805421853684
Italy,77,4.343805421853684
Infarction,77,4.343805421853684
acceptance,76,4.330733340286331
greatest,76,4.330733340286331
shift,76,4.330733340286331
large-scale,76,4.330733340286331
Research,76,4.330733340286331
sera,76,4.330733340286331
recanalization,76,4.330733340286331
gold,76,4.330733340286331
platform,76,4.330733340286331
thought,76,4.330733340286331
resolution,76,4.330733340286331
Compared,76,4.330733340286331
lineage,76,4.330733340286331
therapeutics,76,4.330733340286331
spreading,76,4.330733340286331
generated,76,4.330733340286331
Currently,76,4.330733340286331
sputum,76,4.330733340286331
corresponding,76,4.330733340286331
aspirin,76,4.330733340286331
progressive,76,4.330733340286331
diverse,76,4.330733340286331
threshold,76,4.330733340286331
challenging,75,4.31748811353631
confirm,75,4.31748811353631
ranged,75,4.31748811353631
independently,75,4.31748811353631
intervals,75,4.31748811353631
guidance,75,4.31748811353631
reason,75,4.31748811353631
grade,75,4.31748811353631
immunogenicity,75,4.31748811353631
dependent,75,4.31748811353631
crisis,75,4.31748811353631
full,75,4.31748811353631
alterations,75,4.31748811353631
extraction,74,4.30406509320417
ARDS,74,4.30406509320417
candidate,74,4.30406509320417
indicators,74,4.30406509320417
beta,74,4.30406509320417
Syndrome,74,4.30406509320417
weight,74,4.30406509320417
multivariate,74,4.30406509320417
atopy,74,4.30406509320417
perform,74,4.30406509320417
perceived,74,4.30406509320417
hygiene,74,4.30406509320417
aggressive,74,4.30406509320417
observation,74,4.30406509320417
antiplatelet,74,4.30406509320417
outpatient,74,4.30406509320417
branch,74,4.30406509320417
minor,74,4.30406509320417
warfarin,74,4.30406509320417
though,74,4.30406509320417
IS,74,4.30406509320417
psychosocial,74,4.30406509320417
noninvasive,74,4.30406509320417
Over,74,4.30406509320417
TIA,74,4.30406509320417
reactivity,73,4.290459441148391
amplification,73,4.290459441148391
quickly,73,4.290459441148391
robust,73,4.290459441148391
remaining,73,4.290459441148391
2013,73,4.290459441148391
perspective,73,4.290459441148391
induction,73,4.290459441148391
aneurysm,73,4.290459441148391
According,73,4.290459441148391
culture,73,4.290459441148391
zone,73,4.290459441148391
became,73,4.290459441148391
venous,73,4.290459441148391
managed,73,4.290459441148391
media,73,4.290459441148391
AT,73,4.290459441148391
CK,73,4.290459441148391
fall,73,4.290459441148391
International,73,4.290459441148391
attenuated,73,4.290459441148391
recombinant,73,4.290459441148391
September,73,4.290459441148391
serve,73,4.290459441148391
uncontrolled,73,4.290459441148391
BP,72,4.276666119016055
East,72,4.276666119016055
amino,72,4.276666119016055
birds,72,4.276666119016055
altered,72,4.276666119016055
likelihood,72,4.276666119016055
broad,72,4.276666119016055
fluid,72,4.276666119016055
Also,72,4.276666119016055
evidence-based,72,4.276666119016055
magnitude,72,4.276666119016055
biology,72,4.276666119016055
collateral,72,4.276666119016055
diagnoses,72,4.276666119016055
summary,72,4.276666119016055
obesity,72,4.276666119016055
Global,72,4.276666119016055
stent,72,4.276666119016055
52,71,4.2626798770413155
curve,71,4.2626798770413155
visual,71,4.2626798770413155
diastolic,71,4.2626798770413155
decade,71,4.2626798770413155
pathophysiological,71,4.2626798770413155
algorithm,71,4.2626798770413155
smooth,71,4.2626798770413155
pooled,71,4.2626798770413155
pollution,71,4.2626798770413155
containing,71,4.2626798770413155
open,71,4.2626798770413155
organs,71,4.2626798770413155
causative,71,4.2626798770413155
markedly,71,4.2626798770413155
learning,71,4.2626798770413155
Emergency,71,4.2626798770413155
dissection,71,4.2626798770413155
2003,71,4.2626798770413155
characteristic,71,4.2626798770413155
temporal,71,4.2626798770413155
count,71,4.2626798770413155
organ,71,4.2626798770413155
focusing,70,4.248495242049359
determination,70,4.248495242049359
preclinical,70,4.248495242049359
Spanish,70,4.248495242049359
depending,70,4.248495242049359
operation,70,4.248495242049359
genomic,70,4.248495242049359
virulence,70,4.248495242049359
North,70,4.248495242049359
Additionally,70,4.248495242049359
64,70,4.248495242049359
platforms,70,4.248495242049359
nervous,70,4.248495242049359
influences,70,4.248495242049359
positivity,70,4.248495242049359
initiated,70,4.248495242049359
none,70,4.248495242049359
limitation,70,4.248495242049359
language,70,4.248495242049359
cumulative,70,4.248495242049359
behaviors,70,4.248495242049359
transmitted,70,4.248495242049359
kidney,70,4.248495242049359
Such,70,4.248495242049359
unprecedented,70,4.248495242049359
Children,70,4.248495242049359
spatial,70,4.248495242049359
databases,69,4.23410650459726
Kong,69,4.23410650459726
perceptions,69,4.23410650459726
hour,69,4.23410650459726
disparities,69,4.23410650459726
68,69,4.23410650459726
lateral,69,4.23410650459726
modalities,69,4.23410650459726
obtain,69,4.23410650459726
Nevertheless,69,4.23410650459726
beyond,69,4.23410650459726
structures,69,4.23410650459726
ACE,69,4.23410650459726
employed,69,4.23410650459726
2015,69,4.23410650459726
Due,69,4.23410650459726
scan,69,4.23410650459726
profiles,69,4.23410650459726
reached,69,4.23410650459726
applications,69,4.23410650459726
discovery,69,4.23410650459726
72,69,4.23410650459726
attitudes,69,4.23410650459726
priority,68,4.219507705176107
products,68,4.219507705176107
53,68,4.219507705176107
dominant,68,4.219507705176107
39,68,4.219507705176107
involves,68,4.219507705176107
steroid,68,4.219507705176107
63,68,4.219507705176107
speed,68,4.219507705176107
phenotype,68,4.219507705176107
longitudinal,68,4.219507705176107
valuable,68,4.219507705176107
inpatient,68,4.219507705176107
consideration,68,4.219507705176107
Hong,68,4.219507705176107
Covid-19,68,4.219507705176107
E,68,4.219507705176107
decline,68,4.219507705176107
African,67,4.204692619390966
population-based,67,4.204692619390966
fast,67,4.204692619390966
anticoagulants,67,4.204692619390966
hyperreactivity,67,4.204692619390966
85,67,4.204692619390966
background,67,4.204692619390966
DNA,67,4.204692619390966
breath,67,4.204692619390966
demand,67,4.204692619390966
57,67,4.204692619390966
produce,67,4.204692619390966
respond,67,4.204692619390966
predominantly,67,4.204692619390966
neurologic,67,4.204692619390966
embolic,67,4.204692619390966
59,67,4.204692619390966
tissues,67,4.204692619390966
minimal,67,4.204692619390966
educational,67,4.204692619390966
dogs,67,4.204692619390966
superior,67,4.204692619390966
adaptive,67,4.204692619390966
trigger,67,4.204692619390966
called,67,4.204692619390966
controversial,67,4.204692619390966
seem,67,4.204692619390966
peptide,66,4.189654742026425
edema,66,4.189654742026425
prospectively,66,4.189654742026425
sensitization,66,4.189654742026425
prophylactic,66,4.189654742026425
airborne,66,4.189654742026425
transplant,66,4.189654742026425
intracoronary,66,4.189654742026425
plus,66,4.189654742026425
acquired,66,4.189654742026425
medium,66,4.189654742026425
commercial,66,4.189654742026425
America,66,4.189654742026425
critically,66,4.189654742026425
articles,66,4.189654742026425
molecules,66,4.189654742026425
closure,66,4.189654742026425
PEF,66,4.189654742026425
mediated,66,4.189654742026425
Cardiac,66,4.189654742026425
dental,66,4.189654742026425
interpretation,66,4.189654742026425
cryptogenic,65,4.174387269895637
74,65,4.174387269895637
lifestyle,65,4.174387269895637
catheterization,65,4.174387269895637
entire,65,4.174387269895637
generation,65,4.174387269895637
hemagglutinin,65,4.174387269895637
cold,65,4.174387269895637
steps,65,4.174387269895637
remote,65,4.174387269895637
manner,65,4.174387269895637
kits,65,4.174387269895637
angiotensin-converting,65,4.174387269895637
introduced,65,4.174387269895637
devastating,65,4.174387269895637
Four,65,4.174387269895637
changed,65,4.174387269895637
USA,65,4.174387269895637
relevance,65,4.174387269895637
millions,65,4.174387269895637
life-threatening,65,4.174387269895637
utilization,65,4.174387269895637
methacholine,65,4.174387269895637
programme,65,4.174387269895637
dust,65,4.174387269895637
focuses,65,4.174387269895637
B117,65,4.174387269895637
managing,65,4.174387269895637
characterization,64,4.1588830833596715
donors,64,4.1588830833596715
breathing,64,4.1588830833596715
thereby,64,4.1588830833596715
undertaken,64,4.1588830833596715
diagnose,64,4.1588830833596715
universal,64,4.1588830833596715
questionnaires,64,4.1588830833596715
contributing,64,4.1588830833596715
cluster,64,4.1588830833596715
radionuclide,64,4.1588830833596715
wastewater,64,4.1588830833596715
regimens,64,4.1588830833596715
causal,64,4.1588830833596715
quarantine,64,4.1588830833596715
extremely,64,4.1588830833596715
partial,64,4.1588830833596715
WORDS,64,4.1588830833596715
household,64,4.1588830833596715
stratification,64,4.1588830833596715
dementia,64,4.1588830833596715
injection,64,4.1588830833596715
wheeze,64,4.1588830833596715
TRUNCATED,64,4.1588830833596715
highlighted,64,4.1588830833596715
endothelial,64,4.1588830833596715
lowest,64,4.1588830833596715
CS,64,4.1588830833596715
ICH,64,4.1588830833596715
58,64,4.1588830833596715
evolving,63,4.143134726391533
pathogen,63,4.143134726391533
viable,63,4.143134726391533
manifestation,63,4.143134726391533
fewer,63,4.143134726391533
modern,63,4.143134726391533
forced,63,4.143134726391533
accurately,63,4.143134726391533
HR,63,4.143134726391533
exercise-induced,63,4.143134726391533
ranging,63,4.143134726391533
et,63,4.143134726391533
helpful,63,4.143134726391533
picture,63,4.143134726391533
Test,63,4.143134726391533
homes,63,4.143134726391533
twice,63,4.143134726391533
antithrombotic,63,4.143134726391533
predominant,63,4.143134726391533
MERS-CoV,62,4.127134385045092
Germany,62,4.127134385045092
prompt,62,4.127134385045092
hesitancy,62,4.127134385045092
EF,62,4.127134385045092
advantages,62,4.127134385045092
limits,62,4.127134385045092
concomitant,62,4.127134385045092
qualitative,62,4.127134385045092
coronavirus-2,62,4.127134385045092
statins,62,4.127134385045092
lives,62,4.127134385045092
content,62,4.127134385045092
reliability,62,4.127134385045092
lacunar,62,4.127134385045092
point-of-care,62,4.127134385045092
inadequate,62,4.127134385045092
Department,62,4.127134385045092
own,62,4.127134385045092
uses,62,4.127134385045092
shedding,62,4.127134385045092
adopted,62,4.127134385045092
correlates,61,4.110873864173311
anticoagulant,61,4.110873864173311
volumes,61,4.110873864173311
subsequently,61,4.110873864173311
alcohol,61,4.110873864173311
69,61,4.110873864173311
adaptation,61,4.110873864173311
explained,61,4.110873864173311
University,61,4.110873864173311
Heart,61,4.110873864173311
monitored,61,4.110873864173311
actions,61,4.110873864173311
accompanied,61,4.110873864173311
epitopes,61,4.110873864173311
itself,61,4.110873864173311
minority,61,4.110873864173311
1997,61,4.110873864173311
elements,61,4.110873864173311
near,61,4.110873864173311
enable,61,4.110873864173311
typically,61,4.110873864173311
electrical,61,4.110873864173311
indices,60,4.0943445622221
except,60,4.0943445622221
severely,60,4.0943445622221
Western,60,4.0943445622221
NS,60,4.0943445622221
her,60,4.0943445622221
Its,60,4.0943445622221
directed,60,4.0943445622221
histamine,60,4.0943445622221
humoral,60,4.0943445622221
anti-SARS-CoV-2,60,4.0943445622221
feature,60,4.0943445622221
Centers,60,4.0943445622221
online,60,4.0943445622221
Institute,60,4.0943445622221
Canada,60,4.0943445622221
fusion,60,4.0943445622221
uncertain,60,4.0943445622221
cholesterol,60,4.0943445622221
met,60,4.0943445622221
bronchitis,60,4.0943445622221
Care,60,4.0943445622221
disturbances,60,4.0943445622221
outside,60,4.0943445622221
updated,59,4.07753744390572
annually,59,4.07753744390572
kit,59,4.07753744390572
methodology,59,4.07753744390572
surfaces,59,4.07753744390572
bilateral,59,4.07753744390572
congestive,59,4.07753744390572
regulation,59,4.07753744390572
distal,59,4.07753744390572
impacts,59,4.07753744390572
71,59,4.07753744390572
95CI,59,4.07753744390572
declared,59,4.07753744390572
correct,59,4.07753744390572
77,59,4.07753744390572
hosts,59,4.07753744390572
proximal,59,4.07753744390572
particles,59,4.07753744390572
defect,59,4.07753744390572
aerosol,59,4.07753744390572
neural,59,4.07753744390572
clinics,59,4.07753744390572
India,59,4.07753744390572
immunotherapy,59,4.07753744390572
validity,59,4.07753744390572
selective,59,4.07753744390572
51,59,4.07753744390572
favorable,59,4.07753744390572
get,59,4.07753744390572
team,58,4.060443010546419
mixed,58,4.060443010546419
intermittent,58,4.060443010546419
uncomplicated,58,4.060443010546419
seroprevalence,58,4.060443010546419
autopsy,58,4.060443010546419
silent,58,4.060443010546419
clarify,58,4.060443010546419
insight,58,4.060443010546419
beliefs,58,4.060443010546419
tracing,58,4.060443010546419
poststroke,58,4.060443010546419
73,58,4.060443010546419
62,58,4.060443010546419
core,58,4.060443010546419
participation,58,4.060443010546419
absolute,58,4.060443010546419
ICU,58,4.060443010546419
drift,58,4.060443010546419
Following,58,4.060443010546419
arrival,58,4.060443010546419
presentations,58,4.060443010546419
examines,58,4.060443010546419
decreases,58,4.060443010546419
discussion,58,4.060443010546419
specimen,57,4.04305126783455
barrier,57,4.04305126783455
Ischemic,57,4.04305126783455
health-care,57,4.04305126783455
considerations,57,4.04305126783455
vary,57,4.04305126783455
actual,57,4.04305126783455
peptides,57,4.04305126783455
ECMO,57,4.04305126783455
simulation,57,4.04305126783455
true,57,4.04305126783455
option,57,4.04305126783455
AIS,57,4.04305126783455
consisted,57,4.04305126783455
principles,57,4.04305126783455
integrated,57,4.04305126783455
readily,57,4.04305126783455
serology,57,4.04305126783455
Previous,57,4.04305126783455
deep,57,4.04305126783455
supported,57,4.04305126783455
slightly,57,4.04305126783455
distributed,57,4.04305126783455
monoclonal,57,4.04305126783455
Future,57,4.04305126783455
nocturnal,57,4.04305126783455
give,57,4.04305126783455
Understanding,57,4.04305126783455
space,57,4.04305126783455
al,57,4.04305126783455
54,57,4.04305126783455
diffusion,57,4.04305126783455
feasibility,56,4.02535169073515
geographic,56,4.02535169073515
inclusion,56,4.02535169073515
infect,56,4.02535169073515
intention,56,4.02535169073515
Aims,56,4.02535169073515
2016,56,4.02535169073515
meet,56,4.02535169073515
dyspnea,56,4.02535169073515
Drug,56,4.02535169073515
birth,56,4.02535169073515
largest,56,4.02535169073515
49,56,4.02535169073515
streptokinase,56,4.02535169073515
prescribed,56,4.02535169073515
correlations,56,4.02535169073515
thrombotic,56,4.02535169073515
began,56,4.02535169073515
Brazil,56,4.02535169073515
lipid,56,4.02535169073515
worsening,56,4.02535169073515
consequence,56,4.02535169073515
government,56,4.02535169073515
elucidate,56,4.02535169073515
chemical,56,4.02535169073515
unstable,56,4.02535169073515
vector,56,4.02535169073515
nearly,56,4.02535169073515
zoonotic,56,4.02535169073515
humidity,56,4.02535169073515
non-invasive,56,4.02535169073515
spirometry,56,4.02535169073515
pigs,56,4.02535169073515
apparent,56,4.02535169073515
indoor,56,4.02535169073515
nor,56,4.02535169073515
NP,56,4.02535169073515
NSTEMI,56,4.02535169073515
insufficiency,56,4.02535169073515
insufficient,56,4.02535169073515
soon,55,4.007333185232471
Vaccine,55,4.007333185232471
unvaccinated,55,4.007333185232471
below,55,4.007333185232471
clearance,55,4.007333185232471
hypothesized,55,4.007333185232471
05,55,4.007333185232471
lines,55,4.007333185232471
Each,55,4.007333185232471
tachycardia,55,4.007333185232471
radiological,55,4.007333185232471
PFO,55,4.007333185232471
generate,55,4.007333185232471
maintenance,55,4.007333185232471
campaign,55,4.007333185232471
registered,55,4.007333185232471
allowing,55,4.007333185232471
fatigue,55,4.007333185232471
eligible,55,4.007333185232471
transluminal,55,4.007333185232471
MR,55,4.007333185232471
considering,55,4.007333185232471
Asian,55,4.007333185232471
amantadine,55,4.007333185232471
appearance,55,4.007333185232471
ELISA,55,4.007333185232471
pH1N1,55,4.007333185232471
matched,55,4.007333185232471
attributed,55,4.007333185232471
antagonists,55,4.007333185232471
Korea,55,4.007333185232471
relationships,55,4.007333185232471
correlate,54,3.9889840465642745
RR,54,3.9889840465642745
changing,54,3.9889840465642745
lethal,54,3.9889840465642745
discovered,54,3.9889840465642745
base,54,3.9889840465642745
cost-effectiveness,54,3.9889840465642745
diagnosing,54,3.9889840465642745
contributes,54,3.9889840465642745
83,54,3.9889840465642745
BNT162b2,54,3.9889840465642745
persistence,54,3.9889840465642745
exists,54,3.9889840465642745
usual,54,3.9889840465642745
patent,54,3.9889840465642745
route,54,3.9889840465642745
apply,54,3.9889840465642745
100000,54,3.9889840465642745
genomes,54,3.9889840465642745
precordial,54,3.9889840465642745
Administration,54,3.9889840465642745
pleural,54,3.9889840465642745
01,54,3.9889840465642745
density,54,3.9889840465642745
oxidative,54,3.9889840465642745
respondents,54,3.9889840465642745
echocardiographic,54,3.9889840465642745
atypical,54,3.9889840465642745
excellent,54,3.9889840465642745
provocation,54,3.9889840465642745
B1351,54,3.9889840465642745
document,54,3.9889840465642745
88,54,3.9889840465642745
stability,53,3.970291913552122
expansion,53,3.970291913552122
organizations,53,3.970291913552122
accepted,53,3.970291913552122
protease,53,3.970291913552122
fundamental,53,3.970291913552122
involve,53,3.970291913552122
travel,53,3.970291913552122
performing,53,3.970291913552122
gain,53,3.970291913552122
reach,53,3.970291913552122
1000,53,3.970291913552122
Methods,53,3.970291913552122
gaps,53,3.970291913552122
analytical,53,3.970291913552122
developments,53,3.970291913552122
Pandemic,53,3.970291913552122
electronic,53,3.970291913552122
starting,53,3.970291913552122
hazard,53,3.970291913552122
bronchoconstriction,53,3.970291913552122
CNS,53,3.970291913552122
regardless,53,3.970291913552122
usefulness,53,3.970291913552122
accelerated,53,3.970291913552122
update,53,3.970291913552122
fibrosis,53,3.970291913552122
containment,53,3.970291913552122
episode,53,3.970291913552122
inhibit,53,3.970291913552122
supporting,53,3.970291913552122
trauma,53,3.970291913552122
bronchodilator,53,3.970291913552122
postinfarction,53,3.970291913552122
varying,53,3.970291913552122
linear,53,3.970291913552122
concepts,53,3.970291913552122
food,52,3.9512437185814275
globe,52,3.9512437185814275
goals,52,3.9512437185814275
departments,52,3.9512437185814275
he,52,3.9512437185814275
encephalopathy,52,3.9512437185814275
Within,52,3.9512437185814275
position,52,3.9512437185814275
excluded,52,3.9512437185814275
resource,52,3.9512437185814275
validation,52,3.9512437185814275
named,52,3.9512437185814275
start,52,3.9512437185814275
94,52,3.9512437185814275
LAD,52,3.9512437185814275
cities,52,3.9512437185814275
Mexico,52,3.9512437185814275
measuring,52,3.9512437185814275
Whether,52,3.9512437185814275
Human,52,3.9512437185814275
refractory,52,3.9512437185814275
functioning,52,3.9512437185814275
fetal,52,3.9512437185814275
window,52,3.9512437185814275
demonstrates,51,3.9318256327243257
b,51,3.9318256327243257
person,51,3.9318256327243257
experts,51,3.9318256327243257
latest,51,3.9318256327243257
mitigate,51,3.9318256327243257
brief,51,3.9318256327243257
mobile,51,3.9318256327243257
2012,51,3.9318256327243257
Risk,51,3.9318256327243257
cardioembolic,51,3.9318256327243257
pharmacologic,51,3.9318256327243257
counts,51,3.9318256327243257
preferred,51,3.9318256327243257
distinguish,51,3.9318256327243257
throat,51,3.9318256327243257
France,51,3.9318256327243257
ventriculography,51,3.9318256327243257
Even,51,3.9318256327243257
Thrombolysis,51,3.9318256327243257
metabolism,51,3.9318256327243257
smaller,51,3.9318256327243257
78,51,3.9318256327243257
themselves,51,3.9318256327243257
experiments,51,3.9318256327243257
recruited,51,3.9318256327243257
arrhythmia,51,3.9318256327243257
Management,51,3.9318256327243257
filling,51,3.9318256327243257
hypertensive,51,3.9318256327243257
neonatal,51,3.9318256327243257
simultaneous,51,3.9318256327243257
indications,51,3.9318256327243257
retrospectively,51,3.9318256327243257
biomarker,51,3.9318256327243257
remodelling,51,3.9318256327243257
facility,51,3.9318256327243257
escape,50,3.912023005428146
96,50,3.912023005428146
adjustment,50,3.912023005428146
transfer,50,3.912023005428146
microvascular,50,3.912023005428146
exhibited,50,3.912023005428146
terminal,50,3.912023005428146
30-day,50,3.912023005428146
she,50,3.912023005428146
COVID,50,3.912023005428146
programmes,50,3.912023005428146
subacute,50,3.912023005428146
scenarios,50,3.912023005428146
movement,50,3.912023005428146
002,50,3.912023005428146
false,50,3.912023005428146
estimation,50,3.912023005428146
infectivity,50,3.912023005428146
seizures,50,3.912023005428146
once,50,3.912023005428146
neuroprotective,50,3.912023005428146
behaviour,50,3.912023005428146
diversity,50,3.912023005428146
applying,50,3.912023005428146
2014,50,3.912023005428146
bronchodilators,50,3.912023005428146
2005,50,3.912023005428146
contributed,50,3.912023005428146
2006,50,3.912023005428146
neuroimaging,50,3.912023005428146
neutralization,50,3.912023005428146
61,50,3.912023005428146
health-related,50,3.912023005428146
just,50,3.912023005428146
why,50,3.912023005428146
82,50,3.912023005428146
matrix,50,3.912023005428146
era,50,3.912023005428146
ratios,50,3.912023005428146
quantify,49,3.8918202981106265
clusters,49,3.8918202981106265
exhibit,49,3.8918202981106265
RV,49,3.8918202981106265
randomly,49,3.8918202981106265
haemorrhagic,49,3.8918202981106265
lineages,49,3.8918202981106265
NO,49,3.8918202981106265
participated,49,3.8918202981106265
91,49,3.8918202981106265
routinely,49,3.8918202981106265
66,49,3.8918202981106265
HI,49,3.8918202981106265
detail,49,3.8918202981106265
CMR,49,3.8918202981106265
Multiple,49,3.8918202981106265
sometimes,49,3.8918202981106265
86,49,3.8918202981106265
mathematical,49,3.8918202981106265
cohorts,49,3.8918202981106265
triggered,49,3.8918202981106265
diabetic,49,3.8918202981106265
uncommon,49,3.8918202981106265
unusual,49,3.8918202981106265
preparation,49,3.8918202981106265
share,49,3.8918202981106265
immunoglobulin,49,3.8918202981106265
subset,49,3.8918202981106265
massive,49,3.8918202981106265
Herein,49,3.8918202981106265
achieving,49,3.8918202981106265
automated,49,3.8918202981106265
patency,49,3.8918202981106265
reactive,49,3.8918202981106265
believed,49,3.8918202981106265
56,49,3.8918202981106265
valve,49,3.8918202981106265
utilized,49,3.8918202981106265
link,49,3.8918202981106265
diet,49,3.8918202981106265
Bronchial,49,3.8918202981106265
reveal,49,3.8918202981106265
mouse,49,3.8918202981106265
smoke,49,3.8918202981106265
89,48,3.871201010907891
sinus,48,3.871201010907891
Diagnosis,48,3.871201010907891
99,48,3.871201010907891
random,48,3.871201010907891
combat,48,3.871201010907891
2000,48,3.871201010907891
00001,48,3.871201010907891
M,48,3.871201010907891
incident,48,3.871201010907891
Association,48,3.871201010907891
briefly,48,3.871201010907891
67,48,3.871201010907891
regulatory,48,3.871201010907891
blockers,48,3.871201010907891
difficulty,48,3.871201010907891
postoperative,48,3.871201010907891
extended,48,3.871201010907891
distance,48,3.871201010907891
shared,48,3.871201010907891
supports,48,3.871201010907891
intracerebral,48,3.871201010907891
contain,48,3.871201010907891
trivalent,48,3.871201010907891
gastrointestinal,48,3.871201010907891
infusion,48,3.871201010907891
Center,48,3.871201010907891
parental,48,3.871201010907891
implement,48,3.871201010907891
Information,48,3.871201010907891
former,48,3.871201010907891
79,48,3.871201010907891
continuing,48,3.871201010907891
recognize,48,3.871201010907891
lavage,48,3.871201010907891
England,48,3.871201010907891
seroconversion,47,3.8501476017100584
composition,47,3.8501476017100584
Approximately,47,3.8501476017100584
parts,47,3.8501476017100584
Australian,47,3.8501476017100584
stratified,47,3.8501476017100584
neuronal,47,3.8501476017100584
careful,47,3.8501476017100584
arrest,47,3.8501476017100584
titer,47,3.8501476017100584
provision,47,3.8501476017100584
Rankin,47,3.8501476017100584
strength,47,3.8501476017100584
offered,47,3.8501476017100584
attributable,47,3.8501476017100584
implantation,47,3.8501476017100584
modeling,47,3.8501476017100584
Food,47,3.8501476017100584
NPS,47,3.8501476017100584
product,47,3.8501476017100584
multiplex,47,3.8501476017100584
accounted,47,3.8501476017100584
pump,47,3.8501476017100584
76,47,3.8501476017100584
allowed,47,3.8501476017100584
Little,47,3.8501476017100584
CABG,47,3.8501476017100584
salvage,47,3.8501476017100584
optimize,47,3.8501476017100584
tolerance,47,3.8501476017100584
registry,47,3.8501476017100584
doctors,47,3.8501476017100584
geographical,47,3.8501476017100584
contagious,47,3.8501476017100584
High,47,3.8501476017100584
implicated,47,3.8501476017100584
Society,47,3.8501476017100584
intake,47,3.8501476017100584
emergent,47,3.8501476017100584
97,47,3.8501476017100584
pool,47,3.8501476017100584
potentials,47,3.8501476017100584
coefficient,47,3.8501476017100584
biochemical,47,3.8501476017100584
Significant,47,3.8501476017100584
Viral,47,3.8501476017100584
scarce,47,3.8501476017100584
feasible,47,3.8501476017100584
institutions,46,3.828641396489095
subjective,46,3.828641396489095
mothers,46,3.828641396489095
receptor-binding,46,3.828641396489095
poses,46,3.828641396489095
complement,46,3.828641396489095
lost,46,3.828641396489095
calcium,46,3.828641396489095
easy,46,3.828641396489095
visit,46,3.828641396489095
Cox,46,3.828641396489095
believe,46,3.828641396489095
makes,46,3.828641396489095
i,46,3.828641396489095
antibiotic,46,3.828641396489095
Spain,46,3.828641396489095
advice,46,3.828641396489095
200,46,3.828641396489095
caregivers,46,3.828641396489095
return,46,3.828641396489095
bias,46,3.828641396489095
preliminary,46,3.828641396489095
eosinophils,46,3.828641396489095
precise,46,3.828641396489095
decreasing,46,3.828641396489095
R,46,3.828641396489095
situations,46,3.828641396489095
storm,46,3.828641396489095
suffer,46,3.828641396489095
87,46,3.828641396489095
separate,46,3.828641396489095
prevented,46,3.828641396489095
2011,46,3.828641396489095
glucose,45,3.8066624897703196
overlap,45,3.8066624897703196
interact,45,3.8066624897703196
collaboration,45,3.8066624897703196
affinity,45,3.8066624897703196
namely,45,3.8066624897703196
avoidance,45,3.8066624897703196
locations,45,3.8066624897703196
replacement,45,3.8066624897703196
decision-making,45,3.8066624897703196
weekly,45,3.8066624897703196
appropriately,45,3.8066624897703196
project,45,3.8066624897703196
93,45,3.8066624897703196
encountered,45,3.8066624897703196
energy,45,3.8066624897703196
enhancement,45,3.8066624897703196
comparative,45,3.8066624897703196
2008,45,3.8066624897703196
reductions,45,3.8066624897703196
approval,45,3.8066624897703196
simultaneously,45,3.8066624897703196
enables,45,3.8066624897703196
external,45,3.8066624897703196
cord,45,3.8066624897703196
parameter,45,3.8066624897703196
usage,45,3.8066624897703196
irreversible,45,3.8066624897703196
delays,45,3.8066624897703196
Italian,45,3.8066624897703196
campaigns,45,3.8066624897703196
maintain,45,3.8066624897703196
force,45,3.8066624897703196
Institutes,45,3.8066624897703196
categories,45,3.8066624897703196
summarized,45,3.8066624897703196
ten,45,3.8066624897703196
Importantly,45,3.8066624897703196
SPECT,45,3.8066624897703196
pharmaceutical,45,3.8066624897703196
overcome,45,3.8066624897703196
RT-LAMP,45,3.8066624897703196
Americans,45,3.8066624897703196
guideline,45,3.8066624897703196
101,44,3.784189633918261
300,44,3.784189633918261
minimize,44,3.784189633918261
Middle,44,3.784189633918261
prominent,44,3.784189633918261
2017,44,3.784189633918261
comparisons,44,3.784189633918261
difficulties,44,3.784189633918261
heparin,44,3.784189633918261
Doppler,44,3.784189633918261
solution,44,3.784189633918261
0005,44,3.784189633918261
adapted,44,3.784189633918261
EIA,44,3.784189633918261
ischaemia,44,3.784189633918261
interventional,44,3.784189633918261
principal,44,3.784189633918261
ward,44,3.784189633918261
parallel,44,3.784189633918261
Primary,44,3.784189633918261
assessments,44,3.784189633918261
morning,44,3.784189633918261
sodium,44,3.784189633918261
First,44,3.784189633918261
Left,44,3.784189633918261
debate,44,3.784189633918261
zanamivir,44,3.784189633918261
extension,44,3.784189633918261
phases,44,3.784189633918261
81,44,3.784189633918261
evolved,44,3.784189633918261
He,44,3.784189633918261
What,44,3.784189633918261
antibiotics,44,3.784189633918261
historical,44,3.784189633918261
definitions,43,3.7612001156935624
gained,43,3.7612001156935624
requirements,43,3.7612001156935624
intrinsic,43,3.7612001156935624
Unit,43,3.7612001156935624
declined,43,3.7612001156935624
CoV,43,3.7612001156935624
multidisciplinary,43,3.7612001156935624
material,43,3.7612001156935624
eosinophil,43,3.7612001156935624
York,43,3.7612001156935624
viability,43,3.7612001156935624
nonspecific,43,3.7612001156935624
opinion,43,3.7612001156935624
bronchospasm,43,3.7612001156935624
systematically,43,3.7612001156935624
memory,43,3.7612001156935624
spring,43,3.7612001156935624
put,43,3.7612001156935624
representative,43,3.7612001156935624
≥,43,3.7612001156935624
coding,43,3.7612001156935624
regimen,43,3.7612001156935624
households,43,3.7612001156935624
assigned,43,3.7612001156935624
undergo,43,3.7612001156935624
aware,43,3.7612001156935624
Analysis,43,3.7612001156935624
2004,43,3.7612001156935624
velocity,43,3.7612001156935624
MIs,43,3.7612001156935624
2007,43,3.7612001156935624
volunteers,43,3.7612001156935624
gas,43,3.7612001156935624
ferrets,43,3.7612001156935624
sickle,43,3.7612001156935624
Hg,43,3.7612001156935624
confirmation,43,3.7612001156935624
differentiate,43,3.7612001156935624
platelets,43,3.7612001156935624
differentiation,43,3.7612001156935624
vaccinations,43,3.7612001156935624
output,43,3.7612001156935624
ICS,43,3.7612001156935624
coagulation,43,3.7612001156935624
Use,43,3.7612001156935624
focal,43,3.7612001156935624
Evidence,43,3.7612001156935624
nucleocapsid,43,3.7612001156935624
enzymes,43,3.7612001156935624
released,43,3.7612001156935624
curves,43,3.7612001156935624
Japanese,42,3.7376696182833684
domains,42,3.7376696182833684
territory,42,3.7376696182833684
mapping,42,3.7376696182833684
workplace,42,3.7376696182833684
reperfused,42,3.7376696182833684
cats,42,3.7376696182833684
schoolchildren,42,3.7376696182833684
wild,42,3.7376696182833684
advantage,42,3.7376696182833684
urgently,42,3.7376696182833684
warranted,42,3.7376696182833684
greatly,42,3.7376696182833684
representing,42,3.7376696182833684
varies,42,3.7376696182833684
deviation,42,3.7376696182833684
skills,42,3.7376696182833684
positively,42,3.7376696182833684
lowering,42,3.7376696182833684
localized,42,3.7376696182833684
efficiently,42,3.7376696182833684
description,42,3.7376696182833684
forward,42,3.7376696182833684
topic,42,3.7376696182833684
act,42,3.7376696182833684
experiencing,42,3.7376696182833684
rational,42,3.7376696182833684
spite,42,3.7376696182833684
added,42,3.7376696182833684
theoretical,42,3.7376696182833684
84,42,3.7376696182833684
occluded,42,3.7376696182833684
demonstrating,42,3.7376696182833684
advance,42,3.7376696182833684
secretion,42,3.7376696182833684
validate,42,3.7376696182833684
influenza-related,42,3.7376696182833684
quantification,42,3.7376696182833684
high-throughput,42,3.7376696182833684
end-diastolic,42,3.7376696182833684
City,42,3.7376696182833684
indicator,42,3.7376696182833684
vertical,42,3.7376696182833684
never,42,3.7376696182833684
boys,42,3.7376696182833684
implementing,42,3.7376696182833684
equally,42,3.7376696182833684
circadian,42,3.7376696182833684
multifactorial,42,3.7376696182833684
depend,42,3.7376696182833684
know,42,3.7376696182833684
created,42,3.7376696182833684
all-cause,42,3.7376696182833684
power,41,3.713572066704308
surrounding,41,3.713572066704308
complexity,41,3.713572066704308
exact,41,3.713572066704308
partly,41,3.713572066704308
hope,41,3.713572066704308
Those,41,3.713572066704308
pathologic,41,3.713572066704308
attempt,41,3.713572066704308
IgA,41,3.713572066704308
call,41,3.713572066704308
immunocompromised,41,3.713572066704308
opportunities,41,3.713572066704308
tobacco,41,3.713572066704308
reproductive,41,3.713572066704308
apoptosis,41,3.713572066704308
Mortality,41,3.713572066704308
immunologic,41,3.713572066704308
ultrasound,41,3.713572066704308
bone,41,3.713572066704308
perinatal,41,3.713572066704308
syncytial,41,3.713572066704308
classes,41,3.713572066704308
original,41,3.713572066704308
nurse,41,3.713572066704308
antioxidant,41,3.713572066704308
ovale,41,3.713572066704308
participate,41,3.713572066704308
System,41,3.713572066704308
Mean,41,3.713572066704308
specialized,41,3.713572066704308
epithelium,41,3.713572066704308
tertiary,41,3.713572066704308
too,41,3.713572066704308
pose,41,3.713572066704308
influenza-associated,41,3.713572066704308
acceptable,41,3.713572066704308
recommendation,41,3.713572066704308
capable,41,3.713572066704308
permanent,41,3.713572066704308
case-control,41,3.713572066704308
becomes,41,3.713572066704308
bundle,41,3.713572066704308
herd,41,3.713572066704308
Surveillance,41,3.713572066704308
Network,41,3.713572066704308
OA,41,3.713572066704308
concurrent,41,3.713572066704308
alter,41,3.713572066704308
conduct,41,3.713572066704308
etiological,41,3.713572066704308
restricted,41,3.713572066704308
mast,41,3.713572066704308
balance,41,3.713572066704308
thromboembolic,40,3.6888794541139363
sets,40,3.6888794541139363
nationwide,40,3.6888794541139363
defects,40,3.6888794541139363
92,40,3.6888794541139363
miRNAs,40,3.6888794541139363
Trial,40,3.6888794541139363
perhaps,40,3.6888794541139363
classical,40,3.6888794541139363
searched,40,3.6888794541139363
HCP,40,3.6888794541139363
asthma-related,40,3.6888794541139363
acids,40,3.6888794541139363
passive,40,3.6888794541139363
placed,40,3.6888794541139363
lessons,40,3.6888794541139363
febrile,40,3.6888794541139363
subjected,40,3.6888794541139363
southern,40,3.6888794541139363
aerosols,40,3.6888794541139363
accumulation,40,3.6888794541139363
operating,40,3.6888794541139363
double,40,3.6888794541139363
becoming,40,3.6888794541139363
carry,40,3.6888794541139363
PubMed,40,3.6888794541139363
masks,40,3.6888794541139363
paediatric,40,3.6888794541139363
modelling,40,3.6888794541139363
inhaler,40,3.6888794541139363
society,40,3.6888794541139363
scintigraphy,40,3.6888794541139363
carefully,40,3.6888794541139363
etc,40,3.6888794541139363
located,40,3.6888794541139363
quite,40,3.6888794541139363
survived,40,3.6888794541139363
neither,40,3.6888794541139363
ever,40,3.6888794541139363
investigating,40,3.6888794541139363
uncertainty,40,3.6888794541139363
BHR,40,3.6888794541139363
LVEF,40,3.6888794541139363
scales,40,3.6888794541139363
randomised,40,3.6888794541139363
coupled,40,3.6888794541139363
fitness,40,3.6888794541139363
processing,40,3.6888794541139363
sequelae,39,3.6635616461296463
province,39,3.6635616461296463
evolutionary,39,3.6635616461296463
complementary,39,3.6635616461296463
grafting,39,3.6635616461296463
Science,39,3.6635616461296463
Six,39,3.6635616461296463
MSCs,39,3.6635616461296463
existence,39,3.6635616461296463
transition,39,3.6635616461296463
Assessment,39,3.6635616461296463
criterion,39,3.6635616461296463
follows,39,3.6635616461296463
equivalent,39,3.6635616461296463
myocarditis,39,3.6635616461296463
evident,39,3.6635616461296463
reagents,39,3.6635616461296463
contained,39,3.6635616461296463
120,39,3.6635616461296463
missed,39,3.6635616461296463
But,39,3.6635616461296463
specialist,39,3.6635616461296463
theory,39,3.6635616461296463
influencing,39,3.6635616461296463
list,39,3.6635616461296463
ACT,39,3.6635616461296463
EVT,39,3.6635616461296463
scans,39,3.6635616461296463
Various,39,3.6635616461296463
biologic,39,3.6635616461296463
see,39,3.6635616461296463
portion,39,3.6635616461296463
rule,39,3.6635616461296463
task,39,3.6635616461296463
ligation,39,3.6635616461296463
aetiology,39,3.6635616461296463
proliferation,39,3.6635616461296463
tumor,39,3.6635616461296463
mode,39,3.6635616461296463
thickness,39,3.6635616461296463
circumstances,39,3.6635616461296463
quantified,39,3.6635616461296463
limiting,39,3.6635616461296463
again,39,3.6635616461296463
activated,39,3.6635616461296463
record,39,3.6635616461296463
reflux,39,3.6635616461296463
sentinel,39,3.6635616461296463
resuscitation,39,3.6635616461296463
select,39,3.6635616461296463
multicenter,39,3.6635616461296463
Hence,39,3.6635616461296463
eventually,39,3.6635616461296463
Type,38,3.6375861597263857
enough,38,3.6375861597263857
surveys,38,3.6375861597263857
localization,38,3.6375861597263857
definite,38,3.6375861597263857
returned,38,3.6375861597263857
directions,38,3.6375861597263857
safely,38,3.6375861597263857
exclusion,38,3.6375861597263857
conserved,38,3.6375861597263857
rescue,38,3.6375861597263857
Zealand,38,3.6375861597263857
Unfortunately,38,3.6375861597263857
oxygenation,38,3.6375861597263857
scientists,38,3.6375861597263857
adjuvant,38,3.6375861597263857
allergies,38,3.6375861597263857
yr,38,3.6375861597263857
immunoassay,38,3.6375861597263857
mandatory,38,3.6375861597263857
neutrophils,38,3.6375861597263857
effusion,38,3.6375861597263857
Laboratory,38,3.6375861597263857
maintained,38,3.6375861597263857
defining,38,3.6375861597263857
adjusting,38,3.6375861597263857
Poland,38,3.6375861597263857
pronounced,38,3.6375861597263857
Initiative,38,3.6375861597263857
droplets,38,3.6375861597263857
self-reported,38,3.6375861597263857
poorer,38,3.6375861597263857
substances,38,3.6375861597263857
FDA,38,3.6375861597263857
antigenically,38,3.6375861597263857
prescription,38,3.6375861597263857
penumbra,38,3.6375861597263857
mucosal,38,3.6375861597263857
mask,38,3.6375861597263857
examinations,38,3.6375861597263857
autoimmune,38,3.6375861597263857
partially,38,3.6375861597263857
PEFR,38,3.6375861597263857
expensive,38,3.6375861597263857
bind,38,3.6375861597263857
deficiency,38,3.6375861597263857
Increased,37,3.6109179126442243
first-ever,37,3.6109179126442243
autonomic,37,3.6109179126442243
centre,37,3.6109179126442243
Few,37,3.6109179126442243
RSV,37,3.6109179126442243
axis,37,3.6109179126442243
slow,37,3.6109179126442243
recording,37,3.6109179126442243
Between,37,3.6109179126442243
Atrial,37,3.6109179126442243
science,37,3.6109179126442243
Epidemiological,37,3.6109179126442243
endarterectomy,37,3.6109179126442243
polymorphism,37,3.6109179126442243
mitral,37,3.6109179126442243
centres,37,3.6109179126442243
modality,37,3.6109179126442243
Changes,37,3.6109179126442243
prepared,37,3.6109179126442243
stimuli,37,3.6109179126442243
anatomy,37,3.6109179126442243
valid,37,3.6109179126442243
panel,37,3.6109179126442243
regarded,37,3.6109179126442243
glycoprotein,37,3.6109179126442243
dry,37,3.6109179126442243
turn,37,3.6109179126442243
gap,37,3.6109179126442243
combinations,37,3.6109179126442243
surrogate,37,3.6109179126442243
disease-2019,37,3.6109179126442243
planned,37,3.6109179126442243
industry,37,3.6109179126442243
inpatients,37,3.6109179126442243
describing,37,3.6109179126442243
practitioner,37,3.6109179126442243
pathophysiologic,37,3.6109179126442243
owing,37,3.6109179126442243
summer,37,3.6109179126442243
lymphocytes,37,3.6109179126442243
domestic,37,3.6109179126442243
interferon,37,3.6109179126442243
minimum,37,3.6109179126442243
cardiopulmonary,37,3.6109179126442243
northern,37,3.6109179126442243
relating,37,3.6109179126442243
125,37,3.6109179126442243
technical,37,3.6109179126442243
childrens,37,3.6109179126442243
investigators,37,3.6109179126442243
emission,37,3.6109179126442243
abdominal,37,3.6109179126442243
headache,37,3.6109179126442243
Blood,37,3.6109179126442243
003,37,3.6109179126442243
nosocomial,37,3.6109179126442243
suspicion,37,3.6109179126442243
intended,37,3.6109179126442243
CVD,37,3.6109179126442243
pericarditis,37,3.6109179126442243
mother,37,3.6109179126442243
fight,36,3.58351893845611
direction,36,3.58351893845611
AI,36,3.58351893845611
angiotensin,36,3.58351893845611
triage,36,3.58351893845611
eosinophilic,36,3.58351893845611
tasks,36,3.58351893845611
mimic,36,3.58351893845611
reflects,36,3.58351893845611
reproduction,36,3.58351893845611
Phase,36,3.58351893845611
PSD,36,3.58351893845611
arise,36,3.58351893845611
Questionnaire,36,3.58351893845611
depressive,36,3.58351893845611
promise,36,3.58351893845611
D-dimer,36,3.58351893845611
at-risk,36,3.58351893845611
AH7N9,36,3.58351893845611
004,36,3.58351893845611
similarities,36,3.58351893845611
maps,36,3.58351893845611
Kingdom,36,3.58351893845611
Ct,36,3.58351893845611
1999,36,3.58351893845611
Registry,36,3.58351893845611
quick,36,3.58351893845611
translation,36,3.58351893845611
introduce,36,3.58351893845611
migration,36,3.58351893845611
hypotension,36,3.58351893845611
negatively,36,3.58351893845611
instability,36,3.58351893845611
neutrophil,36,3.58351893845611
smokers,36,3.58351893845611
pathogenicity,36,3.58351893845611
Israel,36,3.58351893845611
back,36,3.58351893845611
Conclusions,36,3.58351893845611
Taiwan,36,3.58351893845611
She,36,3.58351893845611
lockdown,36,3.58351893845611
efficacious,36,3.58351893845611
head,36,3.58351893845611
formed,36,3.58351893845611
OAC,36,3.58351893845611
Guidelines,36,3.58351893845611
None,36,3.58351893845611
unchanged,36,3.58351893845611
hence,36,3.58351893845611
intermediate,36,3.58351893845611
mitigation,36,3.58351893845611
environments,36,3.58351893845611
race,36,3.58351893845611
malignant,36,3.58351893845611
mismatch,36,3.58351893845611
tended,36,3.58351893845611
×,36,3.58351893845611
hypertrophy,36,3.58351893845611
informed,36,3.58351893845611
troponin,36,3.58351893845611
structured,36,3.58351893845611
fixed,36,3.58351893845611
attending,36,3.58351893845611
plaques,36,3.58351893845611
X-ray,36,3.58351893845611
deficit,36,3.58351893845611
computer,36,3.58351893845611
illustrate,36,3.58351893845611
algorithms,36,3.58351893845611
multivessel,36,3.58351893845611
screened,35,3.5553480614894135
nucleotide,35,3.5553480614894135
version,35,3.5553480614894135
scoring,35,3.5553480614894135
border,35,3.5553480614894135
physiologic,35,3.5553480614894135
definitive,35,3.5553480614894135
immunized,35,3.5553480614894135
broadly,35,3.5553480614894135
surveyed,35,3.5553480614894135
climate,35,3.5553480614894135
territories,35,3.5553480614894135
excessive,35,3.5553480614894135
consistently,35,3.5553480614894135
contractility,35,3.5553480614894135
transfusion,35,3.5553480614894135
teaching,35,3.5553480614894135
contractile,35,3.5553480614894135
pro-inflammatory,35,3.5553480614894135
diffuse,35,3.5553480614894135
collect,35,3.5553480614894135
1-year,35,3.5553480614894135
scar,35,3.5553480614894135
CoV-2,35,3.5553480614894135
circulatory,35,3.5553480614894135
newer,35,3.5553480614894135
pollutants,35,3.5553480614894135
contraction,35,3.5553480614894135
titres,35,3.5553480614894135
encourage,35,3.5553480614894135
Program,35,3.5553480614894135
non-specific,35,3.5553480614894135
designing,35,3.5553480614894135
elicited,35,3.5553480614894135
ii,35,3.5553480614894135
imperative,35,3.5553480614894135
reversibility,35,3.5553480614894135
explanation,35,3.5553480614894135
disruption,35,3.5553480614894135
suggestive,35,3.5553480614894135
predischarge,35,3.5553480614894135
S1,35,3.5553480614894135
instrument,35,3.5553480614894135
conclusions,35,3.5553480614894135
ms,35,3.5553480614894135
antihypertensive,35,3.5553480614894135
non-Q,35,3.5553480614894135
infant,35,3.5553480614894135
General,35,3.5553480614894135
phylogenetic,35,3.5553480614894135
yielded,35,3.5553480614894135
powerful,35,3.5553480614894135
house,35,3.5553480614894135
optimization,35,3.5553480614894135
human-to-human,35,3.5553480614894135
bronchoalveolar,35,3.5553480614894135
meeting,35,3.5553480614894135
accounts,35,3.5553480614894135
Five,35,3.5553480614894135
maintaining,35,3.5553480614894135
constant,35,3.5553480614894135
saline,35,3.5553480614894135
stronger,35,3.5553480614894135
Vaccines,35,3.5553480614894135
silico,35,3.5553480614894135
French,34,3.5263605246161616
assistance,34,3.5263605246161616
entity,34,3.5263605246161616
ultimately,34,3.5263605246161616
remission,34,3.5263605246161616
pre-existing,34,3.5263605246161616
p0001,34,3.5263605246161616
induces,34,3.5263605246161616
Patient,34,3.5263605246161616
hospitalisation,34,3.5263605246161616
details,34,3.5263605246161616
users,34,3.5263605246161616
polymorphisms,34,3.5263605246161616
SARS-CoV‑2,34,3.5263605246161616
agonists,34,3.5263605246161616
childs,34,3.5263605246161616
specialists,34,3.5263605246161616
Medicine,34,3.5263605246161616
coinfection,34,3.5263605246161616
precision,34,3.5263605246161616
displayed,34,3.5263605246161616
TCM,34,3.5263605246161616
comorbid,34,3.5263605246161616
theophylline,34,3.5263605246161616
category,34,3.5263605246161616
inhalers,34,3.5263605246161616
digital,34,3.5263605246161616
virological,34,3.5263605246161616
thrombi,34,3.5263605246161616
highlighting,34,3.5263605246161616
kinetics,34,3.5263605246161616
complicating,34,3.5263605246161616
basal,34,3.5263605246161616
pectoris,34,3.5263605246161616
attempts,34,3.5263605246161616
x,34,3.5263605246161616
extensively,34,3.5263605246161616
Regional,34,3.5263605246161616
delivered,34,3.5263605246161616
materials,34,3.5263605246161616
professional,34,3.5263605246161616
mobility,34,3.5263605246161616
die,34,3.5263605246161616
Abbott,34,3.5263605246161616
learned,34,3.5263605246161616
enhancing,34,3.5263605246161616
originated,34,3.5263605246161616
horses,34,3.5263605246161616
400,34,3.5263605246161616
willingness,34,3.5263605246161616
Evaluation,34,3.5263605246161616
Province,34,3.5263605246161616
mucus,34,3.5263605246161616
lymphocyte,34,3.5263605246161616
thorough,34,3.5263605246161616
septum,34,3.5263605246161616
aphasia,34,3.5263605246161616
scanning,34,3.5263605246161616
cigarette,34,3.5263605246161616
contemporary,34,3.5263605246161616
economy,34,3.5263605246161616
differed,34,3.5263605246161616
brought,34,3.5263605246161616
adequately,34,3.5263605246161616
possibilities,34,3.5263605246161616
magnesium,34,3.5263605246161616
teams,34,3.5263605246161616
identifies,34,3.5263605246161616
double-blind,33,3.4965075614664802
reservoir,33,3.4965075614664802
ethical,33,3.4965075614664802
CAM,33,3.4965075614664802
loads,33,3.4965075614664802
institution,33,3.4965075614664802
CHD,33,3.4965075614664802
emphysema,33,3.4965075614664802
instruments,33,3.4965075614664802
vectors,33,3.4965075614664802
vein,33,3.4965075614664802
interplay,33,3.4965075614664802
Education,33,3.4965075614664802
screen,33,3.4965075614664802
night,33,3.4965075614664802
complexes,33,3.4965075614664802
removal,33,3.4965075614664802
allocation,33,3.4965075614664802
topics,33,3.4965075614664802
gradually,33,3.4965075614664802
acutely,33,3.4965075614664802
cleavage,33,3.4965075614664802
C-reactive,33,3.4965075614664802
necessity,33,3.4965075614664802
examples,33,3.4965075614664802
synthesis,33,3.4965075614664802
AH5N1,33,3.4965075614664802
pneumoniae,33,3.4965075614664802
Seasonal,33,3.4965075614664802
relies,33,3.4965075614664802
Central,33,3.4965075614664802
bacteria,33,3.4965075614664802
etiologies,33,3.4965075614664802
clinician,33,3.4965075614664802
contains,33,3.4965075614664802
attitude,33,3.4965075614664802
isolate,33,3.4965075614664802
referral,33,3.4965075614664802
producing,33,3.4965075614664802
walking,33,3.4965075614664802
private,33,3.4965075614664802
agencies,33,3.4965075614664802
Accordingly,33,3.4965075614664802
relaxation,33,3.4965075614664802
unilateral,33,3.4965075614664802
respective,33,3.4965075614664802
mood,33,3.4965075614664802
shed,33,3.4965075614664802
well-being,33,3.4965075614664802
Their,33,3.4965075614664802
transportation,33,3.4965075614664802
fluorescence,33,3.4965075614664802
satisfactory,33,3.4965075614664802
Lung,33,3.4965075614664802
otherwise,33,3.4965075614664802
emerge,33,3.4965075614664802
designs,33,3.4965075614664802
106,33,3.4965075614664802
deadly,33,3.4965075614664802
dietary,33,3.4965075614664802
standards,33,3.4965075614664802
establishment,32,3.4657359027997265
congenital,32,3.4657359027997265
addresses,32,3.4657359027997265
asked,32,3.4657359027997265
D614G,32,3.4657359027997265
postmortem,32,3.4657359027997265
explores,32,3.4657359027997265
moderately,32,3.4657359027997265
military,32,3.4657359027997265
establishing,32,3.4657359027997265
Pediatric,32,3.4657359027997265
solutions,32,3.4657359027997265
cortical,32,3.4657359027997265
Eight,32,3.4657359027997265
promoting,32,3.4657359027997265
haemorrhage,32,3.4657359027997265
integral,32,3.4657359027997265
interviews,32,3.4657359027997265
aspect,32,3.4657359027997265
How,32,3.4657359027997265
alert,32,3.4657359027997265
feedback,32,3.4657359027997265
two-dimensional,32,3.4657359027997265
K,32,3.4657359027997265
dialysis,32,3.4657359027997265
apparently,32,3.4657359027997265
Community,32,3.4657359027997265
aspiration,32,3.4657359027997265
cessation,32,3.4657359027997265
create,32,3.4657359027997265
served,32,3.4657359027997265
publications,32,3.4657359027997265
resolved,32,3.4657359027997265
copies,32,3.4657359027997265
CKD,32,3.4657359027997265
Chronic,32,3.4657359027997265
infrequent,32,3.4657359027997265
IQR,32,3.4657359027997265
genetically,32,3.4657359027997265
attempted,32,3.4657359027997265
conjunction,32,3.4657359027997265
sensory,32,3.4657359027997265
sign,32,3.4657359027997265
interviewed,32,3.4657359027997265
correctly,32,3.4657359027997265
foramen,32,3.4657359027997265
Canadian,32,3.4657359027997265
DWI,32,3.4657359027997265
ambulatory,32,3.4657359027997265
remarkable,32,3.4657359027997265
tendency,32,3.4657359027997265
bird,32,3.4657359027997265
extracted,32,3.4657359027997265
heavy,31,3.4339872044851463
pressures,31,3.4339872044851463
Allergy,31,3.4339872044851463
exclude,31,3.4339872044851463
104,31,3.4339872044851463
participating,31,3.4339872044851463
macrophages,31,3.4339872044851463
statin,31,3.4339872044851463
socio-economic,31,3.4339872044851463
commentary,31,3.4339872044851463
faster,31,3.4339872044851463
modifications,31,3.4339872044851463
strict,31,3.4339872044851463
disproportionately,31,3.4339872044851463
dissemination,31,3.4339872044851463
prone,31,3.4339872044851463
helps,31,3.4339872044851463
immunoassays,31,3.4339872044851463
expert,31,3.4339872044851463
took,31,3.4339872044851463
de,31,3.4339872044851463
transmissible,31,3.4339872044851463
damaged,31,3.4339872044851463
off,31,3.4339872044851463
CPK,31,3.4339872044851463
Secondary,31,3.4339872044851463
suboptimal,31,3.4339872044851463
Another,31,3.4339872044851463
pollen,31,3.4339872044851463
driving,31,3.4339872044851463
bedside,31,3.4339872044851463
genetics,31,3.4339872044851463
Numerous,31,3.4339872044851463
scenario,31,3.4339872044851463
enzymatic,31,3.4339872044851463
treadmill,31,3.4339872044851463
income,31,3.4339872044851463
fail,31,3.4339872044851463
estimating,31,3.4339872044851463
emphasize,31,3.4339872044851463
posed,31,3.4339872044851463
persist,31,3.4339872044851463
analyse,31,3.4339872044851463
repeat,31,3.4339872044851463
CK-MB,31,3.4339872044851463
Allergic,31,3.4339872044851463
determinant,31,3.4339872044851463
gives,31,3.4339872044851463
examining,31,3.4339872044851463
image,31,3.4339872044851463
down,31,3.4339872044851463
mmHg,31,3.4339872044851463
observe,31,3.4339872044851463
anti-influenza,31,3.4339872044851463
proportional,31,3.4339872044851463
indication,31,3.4339872044851463
psychiatric,31,3.4339872044851463
vaccinate,31,3.4339872044851463
GINA,31,3.4339872044851463
statistics,31,3.4339872044851463
morphology,31,3.4339872044851463
000,31,3.4339872044851463
aneurysms,31,3.4339872044851463
interpreted,30,3.4011973816621555
School,30,3.4011973816621555
applicable,30,3.4011973816621555
warning,30,3.4011973816621555
Occupational,30,3.4011973816621555
dyspnoea,30,3.4011973816621555
ethnic,30,3.4011973816621555
perspectives,30,3.4011973816621555
Subjects,30,3.4011973816621555
intense,30,3.4011973816621555
serologic,30,3.4011973816621555
protecting,30,3.4011973816621555
extracorporeal,30,3.4011973816621555
display,30,3.4011973816621555
mRS,30,3.4011973816621555
dual,30,3.4011973816621555
AHR,30,3.4011973816621555
top,30,3.4011973816621555
constitute,30,3.4011973816621555
broader,30,3.4011973816621555
injuries,30,3.4011973816621555
employees,30,3.4011973816621555
impairments,30,3.4011973816621555
fear,30,3.4011973816621555
detectable,30,3.4011973816621555
university,30,3.4011973816621555
Percutaneous,30,3.4011973816621555
unlikely,30,3.4011973816621555
fibrinolytic,30,3.4011973816621555
outpatients,30,3.4011973816621555
deal,30,3.4011973816621555
ago,30,3.4011973816621555
community-based,30,3.4011973816621555
infancy,30,3.4011973816621555
premature,30,3.4011973816621555
predicts,30,3.4011973816621555
Yet,30,3.4011973816621555
modification,30,3.4011973816621555
waste,30,3.4011973816621555
coping,30,3.4011973816621555
behind,30,3.4011973816621555
VOC,30,3.4011973816621555
closed,30,3.4011973816621555
covered,30,3.4011973816621555
Singapore,30,3.4011973816621555
prepare,30,3.4011973816621555
hemispheric,30,3.4011973816621555
abnormality,30,3.4011973816621555
studying,30,3.4011973816621555
herein,30,3.4011973816621555
encouraging,30,3.4011973816621555
undergone,30,3.4011973816621555
restrictions,30,3.4011973816621555
evaluations,30,3.4011973816621555
relief,30,3.4011973816621555
narrative,30,3.4011973816621555
routes,30,3.4011973816621555
T-cell,30,3.4011973816621555
anatomical,30,3.4011973816621555
infiltration,30,3.4011973816621555
tPA,30,3.4011973816621555
spinal,30,3.4011973816621555
IABP,30,3.4011973816621555
endemic,30,3.4011973816621555
pooling,30,3.4011973816621555
untreated,30,3.4011973816621555
missing,30,3.4011973816621555
calls,30,3.4011973816621555
cost-effective,30,3.4011973816621555
2018,30,3.4011973816621555
peaks,30,3.4011973816621555
Public,30,3.4011973816621555
biosensors,30,3.4011973816621555
ideal,30,3.4011973816621555
repurposing,30,3.4011973816621555
culprit,30,3.4011973816621555
ineffective,30,3.4011973816621555
regularly,30,3.4011973816621555
Quality,30,3.4011973816621555
PET,30,3.4011973816621555
black,30,3.4011973816621555
benign,30,3.4011973816621555
EMS,29,3.367295829986474
getting,29,3.367295829986474
cortex,29,3.367295829986474
killed,29,3.367295829986474
facilitating,29,3.367295829986474
CL,29,3.367295829986474
addressing,29,3.367295829986474
pretreatment,29,3.367295829986474
subunit,29,3.367295829986474
sensor,29,3.367295829986474
harmful,29,3.367295829986474
fetus,29,3.367295829986474
Multivariate,29,3.367295829986474
1998,29,3.367295829986474
assumed,29,3.367295829986474
BA,29,3.367295829986474
BAL,29,3.367295829986474
post-MI,29,3.367295829986474
instances,29,3.367295829986474
simulations,29,3.367295829986474
dosage,29,3.367295829986474
circumflex,29,3.367295829986474
relate,29,3.367295829986474
multivariable,29,3.367295829986474
mite,29,3.367295829986474
thousands,29,3.367295829986474
graft,29,3.367295829986474
thromboembolism,29,3.367295829986474
driven,29,3.367295829986474
SARS-COV-2,29,3.367295829986474
intentions,29,3.367295829986474
giving,29,3.367295829986474
trust,29,3.367295829986474
CEA,29,3.367295829986474
generalized,29,3.367295829986474
Similarly,29,3.367295829986474
raise,29,3.367295829986474
isothermal,29,3.367295829986474
modes,29,3.367295829986474
nitroglycerin,29,3.367295829986474
consultations,29,3.367295829986474
substitution,29,3.367295829986474
purposes,29,3.367295829986474
promptly,29,3.367295829986474
alteration,29,3.367295829986474
conservative,29,3.367295829986474
obvious,29,3.367295829986474
peaked,29,3.367295829986474
Right,29,3.367295829986474
paradigm,29,3.367295829986474
eosinophilia,29,3.367295829986474
toll,29,3.367295829986474
reasonable,29,3.367295829986474
scheme,29,3.367295829986474
haemagglutinin,29,3.367295829986474
ambulance,29,3.367295829986474
low-income,29,3.367295829986474
intra-aortic,29,3.367295829986474
coming,29,3.367295829986474
fourth,29,3.367295829986474
adapt,29,3.367295829986474
mechanistic,29,3.367295829986474
generating,29,3.367295829986474
operations,29,3.367295829986474
innovative,29,3.367295829986474
instead,29,3.367295829986474
shortly,29,3.367295829986474
properly,29,3.367295829986474
threats,29,3.367295829986474
narrowing,29,3.367295829986474
probable,29,3.367295829986474
hr,29,3.367295829986474
finally,29,3.367295829986474
02,29,3.367295829986474
2002,29,3.367295829986474
billion,29,3.367295829986474
healing,29,3.367295829986474
rationale,29,3.367295829986474
rt-PA,29,3.367295829986474
segmental,29,3.367295829986474
cure,29,3.367295829986474
Virus,29,3.367295829986474
officials,29,3.367295829986474
continuously,29,3.367295829986474
pairs,29,3.367295829986474
iv,29,3.367295829986474
Northern,29,3.367295829986474
H9N2,29,3.367295829986474
Participants,29,3.367295829986474
facilitated,29,3.367295829986474
undetermined,29,3.367295829986474
elevations,29,3.367295829986474
arteriography,29,3.367295829986474
thrombocytopenia,29,3.367295829986474
04,29,3.367295829986474
hospital-based,29,3.367295829986474
115,29,3.367295829986474
accessible,29,3.367295829986474
epicardial,29,3.367295829986474
intracellular,29,3.367295829986474
Flu,29,3.367295829986474
occlusive,29,3.367295829986474
doctor,29,3.367295829986474
importantly,28,3.332204510175204
pharmacotherapy,28,3.332204510175204
98,28,3.332204510175204
110,28,3.332204510175204
102,28,3.332204510175204
physiology,28,3.332204510175204
helped,28,3.332204510175204
drive,28,3.332204510175204
toxicity,28,3.332204510175204
compromise,28,3.332204510175204
500,28,3.332204510175204
fit,28,3.332204510175204
shortness,28,3.332204510175204
deposition,28,3.332204510175204
seek,28,3.332204510175204
optimized,28,3.332204510175204
rising,28,3.332204510175204
covering,28,3.332204510175204
running,28,3.332204510175204
come,28,3.332204510175204
challenged,28,3.332204510175204
synthetic,28,3.332204510175204
Turkey,28,3.332204510175204
mainstay,28,3.332204510175204
teachers,28,3.332204510175204
datasets,28,3.332204510175204
mV,28,3.332204510175204
Infarct,28,3.332204510175204
caring,28,3.332204510175204
anaphylaxis,28,3.332204510175204
avoided,28,3.332204510175204
paucity,28,3.332204510175204
Until,28,3.332204510175204
antagonist,28,3.332204510175204
learn,28,3.332204510175204
Survey,28,3.332204510175204
favourable,28,3.332204510175204
counterpulsation,28,3.332204510175204
SBP,28,3.332204510175204
hypoxia,28,3.332204510175204
seropositive,28,3.332204510175204
transformation,28,3.332204510175204
entities,28,3.332204510175204
run,28,3.332204510175204
eye,28,3.332204510175204
12-lead,28,3.332204510175204
huge,28,3.332204510175204
electrocardiography,28,3.332204510175204
Indeed,28,3.332204510175204
mediastinum,28,3.332204510175204
mutant,28,3.332204510175204
consistency,28,3.332204510175204
tailored,28,3.332204510175204
remdesivir,28,3.332204510175204
held,28,3.332204510175204
combining,28,3.332204510175204
thickening,28,3.332204510175204
conducting,28,3.332204510175204
Committee,28,3.332204510175204
born,28,3.332204510175204
portable,28,3.332204510175204
biopsy,28,3.332204510175204
categorized,28,3.332204510175204
organization,28,3.332204510175204
presumed,28,3.332204510175204
regulate,28,3.332204510175204
survive,28,3.332204510175204
1993,28,3.332204510175204
Development,28,3.332204510175204
MERS,28,3.332204510175204
Avian,28,3.332204510175204
impacted,28,3.332204510175204
CD4,28,3.332204510175204
dramatic,28,3.332204510175204
wards,28,3.332204510175204
anesthesia,28,3.332204510175204
preventable,28,3.332204510175204
glycosylation,28,3.332204510175204
endotypes,28,3.332204510175204
attended,28,3.332204510175204
worker,28,3.332204510175204
Healthcare,28,3.332204510175204
AB,28,3.332204510175204
inducing,28,3.332204510175204
placebo-controlled,28,3.332204510175204
persisted,28,3.332204510175204
aging,28,3.332204510175204
MB,28,3.332204510175204
match,28,3.332204510175204
unrecognized,28,3.332204510175204
d,28,3.332204510175204
adoption,27,3.295836866004329
catheter,27,3.295836866004329
fashion,27,3.295836866004329
intact,27,3.295836866004329
pericardial,27,3.295836866004329
termed,27,3.295836866004329
middle-aged,27,3.295836866004329
epitope,27,3.295836866004329
delta,27,3.295836866004329
Strokes,27,3.295836866004329
profound,27,3.295836866004329
sexual,27,3.295836866004329
speech,27,3.295836866004329
facing,27,3.295836866004329
actively,27,3.295836866004329
cascade,27,3.295836866004329
donor,27,3.295836866004329
amongst,27,3.295836866004329
electrocardiograms,27,3.295836866004329
triggering,27,3.295836866004329
non,27,3.295836866004329
Low,27,3.295836866004329
tracking,27,3.295836866004329
comorbidity,27,3.295836866004329
tree,27,3.295836866004329
absent,27,3.295836866004329
03,27,3.295836866004329
ensuring,27,3.295836866004329
modifiable,27,3.295836866004329
sufficiently,27,3.295836866004329
stroke-related,27,3.295836866004329
real-world,27,3.295836866004329
echo,27,3.295836866004329
pilot,27,3.295836866004329
enabled,27,3.295836866004329
fibrinolysis,27,3.295836866004329
Hypertension,27,3.295836866004329
California,27,3.295836866004329
fractional,27,3.295836866004329
anteroseptal,27,3.295836866004329
Delta,27,3.295836866004329
autophagy,27,3.295836866004329
stenoses,27,3.295836866004329
Long-term,27,3.295836866004329
prove,27,3.295836866004329
author,27,3.295836866004329
solid,27,3.295836866004329
transcranial,27,3.295836866004329
Exercise,27,3.295836866004329
0002,27,3.295836866004329
victims,27,3.295836866004329
long-acting,27,3.295836866004329
member,27,3.295836866004329
103,27,3.295836866004329
ESUS,27,3.295836866004329
publication,27,3.295836866004329
trained,27,3.295836866004329
preexisting,27,3.295836866004329
Infection,27,3.295836866004329
ocular,27,3.295836866004329
mammalian,27,3.295836866004329
endocarditis,27,3.295836866004329
places,27,3.295836866004329
offspring,27,3.295836866004329
extracellular,27,3.295836866004329
Oseltamivir,27,3.295836866004329
mucosa,27,3.295836866004329
mixing,27,3.295836866004329
identical,27,3.295836866004329
comprised,27,3.295836866004329
1994,27,3.295836866004329
utilizing,27,3.295836866004329
Total,27,3.295836866004329
College,27,3.295836866004329
elective,27,3.295836866004329
Classification,27,3.295836866004329
Real-time,27,3.295836866004329
dispersion,27,3.295836866004329
H1N1pdm09,27,3.295836866004329
intra-arterial,27,3.295836866004329
Black,27,3.295836866004329
ideas,27,3.295836866004329
CD8,27,3.295836866004329
irrespective,27,3.295836866004329
bicycle,27,3.295836866004329
medically,27,3.295836866004329
anatomic,27,3.295836866004329
pathogenetic,27,3.295836866004329
track,27,3.295836866004329
organized,27,3.295836866004329
DM,27,3.295836866004329
tuberculosis,27,3.295836866004329
western,27,3.295836866004329
artificial,27,3.295836866004329
limb,27,3.295836866004329
elucidated,27,3.295836866004329
112,27,3.295836866004329
mediastinal,27,3.295836866004329
vast,27,3.295836866004329
interesting,27,3.295836866004329
views,26,3.258096538021482
sense,26,3.258096538021482
hemodynamics,26,3.258096538021482
Netherlands,26,3.258096538021482
computational,26,3.258096538021482
non-Q-wave,26,3.258096538021482
societal,26,3.258096538021482
preceding,26,3.258096538021482
cutoff,26,3.258096538021482
classic,26,3.258096538021482
acquisition,26,3.258096538021482
HIV,26,3.258096538021482
sparse,26,3.258096538021482
180,26,3.258096538021482
seeking,26,3.258096538021482
German,26,3.258096538021482
consciousness,26,3.258096538021482
V,26,3.258096538021482
AD,26,3.258096538021482
rat,26,3.258096538021482
designated,26,3.258096538021482
140,26,3.258096538021482
subcortical,26,3.258096538021482
avoiding,26,3.258096538021482
pre-,26,3.258096538021482
P0001,26,3.258096538021482
emphasized,26,3.258096538021482
Additional,26,3.258096538021482
Hispanic,26,3.258096538021482
SS,26,3.258096538021482
accelerate,26,3.258096538021482
1990,26,3.258096538021482
scope,26,3.258096538021482
ID,26,3.258096538021482
seropositivity,26,3.258096538021482
pneumothorax,26,3.258096538021482
dramatically,26,3.258096538021482
racial,26,3.258096538021482
IL-6,26,3.258096538021482
weak,26,3.258096538021482
fractions,26,3.258096538021482
ICD,26,3.258096538021482
accounting,26,3.258096538021482
thalamic,26,3.258096538021482
capability,26,3.258096538021482
neck,26,3.258096538021482
rRT-PCR,26,3.258096538021482
naturally,26,3.258096538021482
short-,26,3.258096538021482
Nine,26,3.258096538021482
Positive,26,3.258096538021482
pivotal,26,3.258096538021482
prescribing,26,3.258096538021482
coordination,26,3.258096538021482
visited,26,3.258096538021482
Factors,26,3.258096538021482
amplitude,26,3.258096538021482
diameter,26,3.258096538021482
OSA,26,3.258096538021482
Once,26,3.258096538021482
behavioural,26,3.258096538021482
Sensitivity,26,3.258096538021482
considerably,26,3.258096538021482
optical,26,3.258096538021482
controversy,26,3.258096538021482
detrimental,26,3.258096538021482
time-dependent,26,3.258096538021482
sigma,26,3.258096538021482
Different,26,3.258096538021482
Airway,26,3.258096538021482
outlined,26,3.258096538021482
So,26,3.258096538021482
Limited,26,3.258096538021482
manifested,26,3.258096538021482
109,26,3.258096538021482
removed,26,3.258096538021482
connection,26,3.258096538021482
inconsistent,26,3.258096538021482
machine,26,3.258096538021482
metabolites,26,3.258096538021482
marrow,26,3.258096538021482
concordance,26,3.258096538021482
expand,26,3.258096538021482
angiogenesis,26,3.258096538021482
glucocorticoid,26,3.258096538021482
weighted,26,3.258096538021482
tone,26,3.258096538021482
suppression,26,3.258096538021482
1978,26,3.258096538021482
fat,26,3.258096538021482
inhibited,26,3.258096538021482
HCW,26,3.258096538021482
Consequently,26,3.258096538021482
translational,26,3.258096538021482
hearts,26,3.258096538021482
confined,25,3.2188758248682006
one-third,25,3.2188758248682006
coughing,25,3.2188758248682006
conflicting,25,3.2188758248682006
Interestingly,25,3.2188758248682006
responsibility,25,3.2188758248682006
statement,25,3.2188758248682006
conduction,25,3.2188758248682006
121,25,3.2188758248682006
red,25,3.2188758248682006
bat,25,3.2188758248682006
deliver,25,3.2188758248682006
genotype,25,3.2188758248682006
AAR,25,3.2188758248682006
residence,25,3.2188758248682006
fatalities,25,3.2188758248682006
Vietnam,25,3.2188758248682006
Immunization,25,3.2188758248682006
belonging,25,3.2188758248682006
rhinosinusitis,25,3.2188758248682006
clot,25,3.2188758248682006
dysregulation,25,3.2188758248682006
Carotid,25,3.2188758248682006
empirical,25,3.2188758248682006
SARS-CoV2,25,3.2188758248682006
sporadic,25,3.2188758248682006
thallium,25,3.2188758248682006
Serum,25,3.2188758248682006
aggregation,25,3.2188758248682006
Cardiogenic,25,3.2188758248682006
realistic,25,3.2188758248682006
agreed,25,3.2188758248682006
organic,25,3.2188758248682006
autumn,25,3.2188758248682006
insulin,25,3.2188758248682006
150,25,3.2188758248682006
Chest,25,3.2188758248682006
histories,25,3.2188758248682006
precautions,25,3.2188758248682006
PSF,25,3.2188758248682006
protected,25,3.2188758248682006
Diseases,25,3.2188758248682006
132,25,3.2188758248682006
residues,25,3.2188758248682006
extract,25,3.2188758248682006
workup,25,3.2188758248682006
107,25,3.2188758248682006
pig,25,3.2188758248682006
similarity,25,3.2188758248682006
1995,25,3.2188758248682006
academic,25,3.2188758248682006
look,25,3.2188758248682006
assumption,25,3.2188758248682006
H,25,3.2188758248682006
characterised,25,3.2188758248682006
nonfatal,25,3.2188758248682006
restoration,25,3.2188758248682006
myoglobin,25,3.2188758248682006
correction,25,3.2188758248682006
shorter,25,3.2188758248682006
reversal,25,3.2188758248682006
resting,25,3.2188758248682006
monthly,25,3.2188758248682006
visualization,25,3.2188758248682006
hypotheses,25,3.2188758248682006
droplet,25,3.2188758248682006
incubation,25,3.2188758248682006
collagen,25,3.2188758248682006
acceptability,25,3.2188758248682006
Cardiovascular,25,3.2188758248682006
consists,25,3.2188758248682006
dobutamine,25,3.2188758248682006
dilation,25,3.2188758248682006
code,25,3.2188758248682006
Inhaled,25,3.2188758248682006
codes,25,3.2188758248682006
108,25,3.2188758248682006
105,25,3.2188758248682006
dilatation,25,3.2188758248682006
imported,25,3.2188758248682006
MT,25,3.2188758248682006
fungal,25,3.2188758248682006
ECR,25,3.2188758248682006
recognizing,25,3.2188758248682006
pulse,25,3.2188758248682006
cope,25,3.2188758248682006
indirectly,25,3.2188758248682006
hemagglutination,25,3.2188758248682006
British,25,3.2188758248682006
QT,25,3.2188758248682006
provinces,25,3.2188758248682006
molecule,25,3.2188758248682006
inappropriate,25,3.2188758248682006
answer,25,3.2188758248682006
creatinine,25,3.2188758248682006
transcription-polymerase,25,3.2188758248682006
dataset,25,3.2188758248682006
pumping,24,3.1780538303479458
diffusion-weighted,24,3.1780538303479458
distributions,24,3.1780538303479458
Life,24,3.1780538303479458
P1,24,3.1780538303479458
intubation,24,3.1780538303479458
COVID‐19,24,3.1780538303479458
contexts,24,3.1780538303479458
stochastic,24,3.1780538303479458
Antigen,24,3.1780538303479458
separately,24,3.1780538303479458
market,24,3.1780538303479458
R0,24,3.1780538303479458
diarrhea,24,3.1780538303479458
updates,24,3.1780538303479458
keep,24,3.1780538303479458
predictions,24,3.1780538303479458
hazards,24,3.1780538303479458
CFR,24,3.1780538303479458
occlusions,24,3.1780538303479458
antioxidants,24,3.1780538303479458
dependence,24,3.1780538303479458
insurance,24,3.1780538303479458
initiate,24,3.1780538303479458
nerve,24,3.1780538303479458
courses,24,3.1780538303479458
first-line,24,3.1780538303479458
injected,24,3.1780538303479458
methodological,24,3.1780538303479458
beats,24,3.1780538303479458
ethnicity,24,3.1780538303479458
similarly,24,3.1780538303479458
Indian,24,3.1780538303479458
Twenty,24,3.1780538303479458
played,24,3.1780538303479458
BBB,24,3.1780538303479458
district,24,3.1780538303479458
pathologies,24,3.1780538303479458
ARD,24,3.1780538303479458
stakeholders,24,3.1780538303479458
cervical,24,3.1780538303479458
governments,24,3.1780538303479458
manuscript,24,3.1780538303479458
manufacturing,24,3.1780538303479458
sepsis,24,3.1780538303479458
initiating,24,3.1780538303479458
subsets,24,3.1780538303479458
p005,24,3.1780538303479458
exception,24,3.1780538303479458
integration,24,3.1780538303479458
histological,24,3.1780538303479458
written,24,3.1780538303479458
constitutes,24,3.1780538303479458
PPCI,24,3.1780538303479458
depressed,24,3.1780538303479458
priorities,24,3.1780538303479458
Increasing,24,3.1780538303479458
outline,24,3.1780538303479458
chosen,24,3.1780538303479458
Web,24,3.1780538303479458
evolve,24,3.1780538303479458
SCD,24,3.1780538303479458
virulent,24,3.1780538303479458
familial,24,3.1780538303479458
differs,24,3.1780538303479458
docking,24,3.1780538303479458
stents,24,3.1780538303479458
paid,24,3.1780538303479458
kind,24,3.1780538303479458
1996,24,3.1780538303479458
false-negative,24,3.1780538303479458
girl,24,3.1780538303479458
preceded,24,3.1780538303479458
appendage,24,3.1780538303479458
deployment,24,3.1780538303479458
wild-type,24,3.1780538303479458
radiation,24,3.1780538303479458
sent,24,3.1780538303479458
hospitalised,24,3.1780538303479458
minute,24,3.1780538303479458
prick,24,3.1780538303479458
writing,24,3.1780538303479458
Neurological,24,3.1780538303479458
predisposing,24,3.1780538303479458
reassortment,24,3.1780538303479458
modulate,24,3.1780538303479458
radiography,24,3.1780538303479458
inhabitants,24,3.1780538303479458
hundreds,24,3.1780538303479458
135,24,3.1780538303479458
develops,24,3.1780538303479458
ascertain,24,3.1780538303479458
dedicated,24,3.1780538303479458
mutants,24,3.1780538303479458
channel,24,3.1780538303479458
1st,24,3.1780538303479458
mentioned,24,3.1780538303479458
posterolateral,24,3.1780538303479458
oropharyngeal,24,3.1780538303479458
takes,24,3.1780538303479458
combating,24,3.1780538303479458
t-PA,24,3.1780538303479458
cardiomyopathy,24,3.1780538303479458
mimics,24,3.1780538303479458
wider,24,3.1780538303479458
Second,24,3.1780538303479458
incorporating,24,3.1780538303479458
thresholds,24,3.1780538303479458
Wales,24,3.1780538303479458
1983,24,3.1780538303479458
co-infection,24,3.1780538303479458
repetitive,24,3.1780538303479458
modest,24,3.1780538303479458
consultation,24,3.1780538303479458
handling,24,3.1780538303479458
alveolar,24,3.1780538303479458
enormous,24,3.1780538303479458
postural,24,3.1780538303479458
responded,24,3.1780538303479458
s,23,3.1354942159291497
az,23,3.1354942159291497
T2,23,3.1354942159291497
joint,23,3.1354942159291497
heightened,23,3.1354942159291497
slight,23,3.1354942159291497
subclinical,23,3.1354942159291497
dehydrogenase,23,3.1354942159291497
away,23,3.1354942159291497
consequently,23,3.1354942159291497
verified,23,3.1354942159291497
frequencies,23,3.1354942159291497
infrastructure,23,3.1354942159291497
Higher,23,3.1354942159291497
mammals,23,3.1354942159291497
optimizing,23,3.1354942159291497
Diagnostic,23,3.1354942159291497
autologous,23,3.1354942159291497
incorporate,23,3.1354942159291497
modify,23,3.1354942159291497
SARS-CoV-2-specific,23,3.1354942159291497
revised,23,3.1354942159291497
trunk,23,3.1354942159291497
milk,23,3.1354942159291497
caregiver,23,3.1354942159291497
integrity,23,3.1354942159291497
regulated,23,3.1354942159291497
requirement,23,3.1354942159291497
foreign,23,3.1354942159291497
06,23,3.1354942159291497
blunt,23,3.1354942159291497
ECGs,23,3.1354942159291497
gamma,23,3.1354942159291497
feeding,23,3.1354942159291497
came,23,3.1354942159291497
H1N1pdm,23,3.1354942159291497
so-called,23,3.1354942159291497
confounding,23,3.1354942159291497
hyperacute,23,3.1354942159291497
inexpensive,23,3.1354942159291497
AC,23,3.1354942159291497
confirms,23,3.1354942159291497
necessarily,23,3.1354942159291497
monotherapy,23,3.1354942159291497
advent,23,3.1354942159291497
Specific,23,3.1354942159291497
items,23,3.1354942159291497
PI,23,3.1354942159291497
Before,23,3.1354942159291497
yearly,23,3.1354942159291497
error,23,3.1354942159291497
provider,23,3.1354942159291497
Review,23,3.1354942159291497
societies,23,3.1354942159291497
deterministic,23,3.1354942159291497
sequential,23,3.1354942159291497
relations,23,3.1354942159291497
progenitor,23,3.1354942159291497
licensed,23,3.1354942159291497
construct,23,3.1354942159291497
absenteeism,23,3.1354942159291497
122,23,3.1354942159291497
tolerated,23,3.1354942159291497
lesser,23,3.1354942159291497
1-2,23,3.1354942159291497
neuropsychological,23,3.1354942159291497
experiment,23,3.1354942159291497
Seven,23,3.1354942159291497
Ag,23,3.1354942159291497
imbalance,23,3.1354942159291497
unfavorable,23,3.1354942159291497
fields,23,3.1354942159291497
permeability,23,3.1354942159291497
DC,23,3.1354942159291497
beta-blockers,23,3.1354942159291497
expertise,23,3.1354942159291497
aiming,23,3.1354942159291497
commercially,23,3.1354942159291497
turnaround,23,3.1354942159291497
extreme,23,3.1354942159291497
Novel,23,3.1354942159291497
spontaneously,23,3.1354942159291497
Childhood,23,3.1354942159291497
creating,23,3.1354942159291497
compromised,23,3.1354942159291497
haemodynamic,23,3.1354942159291497
contraindications,23,3.1354942159291497
geometric,23,3.1354942159291497
unable,23,3.1354942159291497
Identification,23,3.1354942159291497
PC20,23,3.1354942159291497
relatives,23,3.1354942159291497
1981,23,3.1354942159291497
undiagnosed,23,3.1354942159291497
drawn,23,3.1354942159291497
thallium-201,23,3.1354942159291497
g,23,3.1354942159291497
demands,23,3.1354942159291497
BMI,23,3.1354942159291497
infective,23,3.1354942159291497
sessions,23,3.1354942159291497
paired,23,3.1354942159291497
breast,23,3.1354942159291497
descriptive,23,3.1354942159291497
errors,23,3.1354942159291497
medicines,23,3.1354942159291497
Bayesian,23,3.1354942159291497
WUS,23,3.1354942159291497
pre-hospital,23,3.1354942159291497
capacities,23,3.1354942159291497
S2,23,3.1354942159291497
notably,23,3.1354942159291497
go,23,3.1354942159291497
considers,23,3.1354942159291497
116,23,3.1354942159291497
3rd,23,3.1354942159291497
desirable,23,3.1354942159291497
English,23,3.1354942159291497
Hubei,23,3.1354942159291497
evidenced,23,3.1354942159291497
apnea,23,3.1354942159291497
precisely,23,3.1354942159291497
produces,23,3.1354942159291497
spreads,23,3.1354942159291497
preference,23,3.1354942159291497
SARS-CoV-1,23,3.1354942159291497
financial,23,3.1354942159291497
Iran,23,3.1354942159291497
prompted,23,3.1354942159291497
Switzerland,23,3.1354942159291497
VOCs,23,3.1354942159291497
proportions,23,3.1354942159291497
cultures,23,3.1354942159291497
unmet,23,3.1354942159291497
accordance,23,3.1354942159291497
vulnerability,23,3.1354942159291497
spasm,23,3.1354942159291497
cardiomyocytes,23,3.1354942159291497
transported,23,3.1354942159291497
inoculation,23,3.1354942159291497
whites,23,3.1354942159291497
aorta,23,3.1354942159291497
L,23,3.1354942159291497
tend,22,3.091042453358316
surge,22,3.091042453358316
reflected,22,3.091042453358316
middle-income,22,3.091042453358316
actually,22,3.091042453358316
messages,22,3.091042453358316
Cochrane,22,3.091042453358316
és,22,3.091042453358316
plasticity,22,3.091042453358316
MVO,22,3.091042453358316
unnecessary,22,3.091042453358316
elicit,22,3.091042453358316
interventricular,22,3.091042453358316
raising,22,3.091042453358316
gave,22,3.091042453358316
Organisation,22,3.091042453358316
AUC,22,3.091042453358316
exclusively,22,3.091042453358316
continents,22,3.091042453358316
responsive,22,3.091042453358316
HRQoL,22,3.091042453358316
normalized,22,3.091042453358316
manufacturers,22,3.091042453358316
recall,22,3.091042453358316
Results-,22,3.091042453358316
reliably,22,3.091042453358316
regeneration,22,3.091042453358316
sampled,22,3.091042453358316
recover,22,3.091042453358316
2001,22,3.091042453358316
FENO,22,3.091042453358316
2009-2010,22,3.091042453358316
Conclusions-,22,3.091042453358316
cross-reactivity,22,3.091042453358316
determines,22,3.091042453358316
interference,22,3.091042453358316
NVAF,22,3.091042453358316
Beijing,22,3.091042453358316
Successful,22,3.091042453358316
signature,22,3.091042453358316
corrected,22,3.091042453358316
expanded,22,3.091042453358316
Ten,22,3.091042453358316
excluding,22,3.091042453358316
visible,22,3.091042453358316
intestinal,22,3.091042453358316
kept,22,3.091042453358316
neglect,22,3.091042453358316
indexes,22,3.091042453358316
pace,22,3.091042453358316
clustering,22,3.091042453358316
explanations,22,3.091042453358316
apical,22,3.091042453358316
Cerebrovascular,22,3.091042453358316
lobe,22,3.091042453358316
ASM,22,3.091042453358316
emotions,22,3.091042453358316
reading,22,3.091042453358316
ipsilateral,22,3.091042453358316
emboli,22,3.091042453358316
endpoint,22,3.091042453358316
incomplete,22,3.091042453358316
broad-spectrum,22,3.091042453358316
overlapping,22,3.091042453358316
GP,22,3.091042453358316
chance,22,3.091042453358316
vomiting,22,3.091042453358316
encoding,22,3.091042453358316
TCD,22,3.091042453358316
tremendous,22,3.091042453358316
everyday,22,3.091042453358316
storage,22,3.091042453358316
instrumental,22,3.091042453358316
Large,22,3.091042453358316
modules,22,3.091042453358316
submitted,22,3.091042453358316
gradual,22,3.091042453358316
tried,22,3.091042453358316
connected,22,3.091042453358316
recordings,22,3.091042453358316
rely,22,3.091042453358316
modulation,22,3.091042453358316
documentation,22,3.091042453358316
origins,22,3.091042453358316
nontransmural,22,3.091042453358316
agonist,22,3.091042453358316
spectrometry,22,3.091042453358316
interview,22,3.091042453358316
transferred,22,3.091042453358316
H5,22,3.091042453358316
albumin,22,3.091042453358316
companies,22,3.091042453358316
athletes,22,3.091042453358316
130,22,3.091042453358316
Project,22,3.091042453358316
ER,22,3.091042453358316
shortening,22,3.091042453358316
exploring,22,3.091042453358316
nanoparticles,22,3.091042453358316
Effective,22,3.091042453358316
Experimental,22,3.091042453358316
diseased,22,3.091042453358316
inconclusive,22,3.091042453358316
preoperative,22,3.091042453358316
VSR,22,3.091042453358316
ease,22,3.091042453358316
adhesion,22,3.091042453358316
angiogram,22,3.091042453358316
stored,22,3.091042453358316
contracting,22,3.091042453358316
probe,22,3.091042453358316
ml,22,3.091042453358316
obese,22,3.091042453358316
bridging,22,3.091042453358316
Apart,22,3.091042453358316
sensors,22,3.091042453358316
Infectious,22,3.091042453358316
LA,22,3.091042453358316
signals,22,3.091042453358316
G,22,3.091042453358316
inhibitory,22,3.091042453358316
underway,22,3.091042453358316
Knowledge,22,3.091042453358316
asthma-like,22,3.091042453358316
injured,22,3.091042453358316
Annual,22,3.091042453358316
test-negative,22,3.091042453358316
themes,22,3.091042453358316
represented,22,3.091042453358316
progressed,22,3.091042453358316
regulating,22,3.091042453358316
acting,22,3.091042453358316
distinguishing,22,3.091042453358316
high-dose,22,3.091042453358316
primer,22,3.091042453358316
minimizing,22,3.091042453358316
Purpose-,22,3.091042453358316
wearing,22,3.091042453358316
contributor,22,3.091042453358316
Methods-,22,3.091042453358316
Environmental,22,3.091042453358316
hospitalisations,22,3.091042453358316
attractive,22,3.091042453358316
analyzing,22,3.091042453358316
asynergy,22,3.091042453358316
Roche,22,3.091042453358316
experimentally,22,3.091042453358316
phenomena,22,3.091042453358316
AH1N1v,22,3.091042453358316
10000,22,3.091042453358316
Indonesia,22,3.091042453358316
supplies,21,3.044522437723423
add,21,3.044522437723423
accident,21,3.044522437723423
manifest,21,3.044522437723423
paramount,21,3.044522437723423
uniform,21,3.044522437723423
mitigating,21,3.044522437723423
bronchiectasis,21,3.044522437723423
low-dose,21,3.044522437723423
Out,21,3.044522437723423
adult-onset,21,3.044522437723423
post-infarction,21,3.044522437723423
exert,21,3.044522437723423
unpredictable,21,3.044522437723423
AR,21,3.044522437723423
documents,21,3.044522437723423
office,21,3.044522437723423
Xpress,21,3.044522437723423
1985,21,3.044522437723423
readmission,21,3.044522437723423
FG,21,3.044522437723423
reveals,21,3.044522437723423
Republic,21,3.044522437723423
strongest,21,3.044522437723423
sialic,21,3.044522437723423
J,21,3.044522437723423
Hz,21,3.044522437723423
generic,21,3.044522437723423
pneumococcal,21,3.044522437723423
nutritional,21,3.044522437723423
throughput,21,3.044522437723423
nose,21,3.044522437723423
capabilities,21,3.044522437723423
utilize,21,3.044522437723423
cell-based,21,3.044522437723423
incremental,21,3.044522437723423
assumptions,21,3.044522437723423
staining,21,3.044522437723423
c,21,3.044522437723423
compound,21,3.044522437723423
youth,21,3.044522437723423
paroxysmal,21,3.044522437723423
Thoracic,21,3.044522437723423
non-fatal,21,3.044522437723423
brainstem,21,3.044522437723423
Q-wave,21,3.044522437723423
Through,21,3.044522437723423
angiographically,21,3.044522437723423
People,21,3.044522437723423
fatty,21,3.044522437723423
Endovascular,21,3.044522437723423
1984,21,3.044522437723423
reinfection,21,3.044522437723423
hematopoietic,21,3.044522437723423
Follow-up,21,3.044522437723423
Outcome,21,3.044522437723423
CoVs,21,3.044522437723423
sensitized,21,3.044522437723423
TIV,21,3.044522437723423
exchange,21,3.044522437723423
narrow,21,3.044522437723423
SES,21,3.044522437723423
equine,21,3.044522437723423
Coronaviruses,21,3.044522437723423
Council,21,3.044522437723423
blockade,21,3.044522437723423
neonates,21,3.044522437723423
Direct,21,3.044522437723423
eliminate,21,3.044522437723423
hormone,21,3.044522437723423
sore,21,3.044522437723423
operated,21,3.044522437723423
HRV,21,3.044522437723423
Prior,21,3.044522437723423
Intravenous,21,3.044522437723423
proposes,21,3.044522437723423
asthmaticus,21,3.044522437723423
RCTs,21,3.044522437723423
downstream,21,3.044522437723423
fibers,21,3.044522437723423
translate,21,3.044522437723423
Findings,21,3.044522437723423
IL-10,21,3.044522437723423
no-reflow,21,3.044522437723423
consisting,21,3.044522437723423
supportive,21,3.044522437723423
tube,21,3.044522437723423
movements,21,3.044522437723423
QoL,21,3.044522437723423
guiding,21,3.044522437723423
immunisation,21,3.044522437723423
ventricles,21,3.044522437723423
cross,21,3.044522437723423
concerned,21,3.044522437723423
defense,21,3.044522437723423
map,21,3.044522437723423
expanding,21,3.044522437723423
sound,21,3.044522437723423
immunodeficiency,21,3.044522437723423
proteases,21,3.044522437723423
1918-1919,21,3.044522437723423
breathlessness,21,3.044522437723423
sensitivities,21,3.044522437723423
neurons,21,3.044522437723423
PA,21,3.044522437723423
Symptoms,21,3.044522437723423
Eastern,21,3.044522437723423
instance,21,3.044522437723423
contributions,21,3.044522437723423
Expert,21,3.044522437723423
papers,21,3.044522437723423
capture,21,3.044522437723423
unexpected,21,3.044522437723423
conference,21,3.044522437723423
rose,21,3.044522437723423
weakness,21,3.044522437723423
seizure,21,3.044522437723423
Emerging,21,3.044522437723423
enter,21,3.044522437723423
potency,21,3.044522437723423
reproducible,21,3.044522437723423
effector,21,3.044522437723423
adjunct,21,3.044522437723423
vaccinating,21,3.044522437723423
Considering,21,3.044522437723423
LAMP,21,3.044522437723423
figures,21,3.044522437723423
County,21,3.044522437723423
ChAdOx1,21,3.044522437723423
biosensor,21,3.044522437723423
Peak,21,3.044522437723423
ascertained,21,3.044522437723423
procedural,21,3.044522437723423
PPE,20,2.995732273553991
adolescent,20,2.995732273553991
Key,20,2.995732273553991
swine-origin,20,2.995732273553991
leukotriene,20,2.995732273553991
160,20,2.995732273553991
landscape,20,2.995732273553991
Physicians,20,2.995732273553991
assesses,20,2.995732273553991
links,20,2.995732273553991
inversely,20,2.995732273553991
dying,20,2.995732273553991
Clinicians,20,2.995732273553991
dangerous,20,2.995732273553991
inhibiting,20,2.995732273553991
weather,20,2.995732273553991
occasional,20,2.995732273553991
sick,20,2.995732273553991
optimally,20,2.995732273553991
argue,20,2.995732273553991
urinary,20,2.995732273553991
ASA,20,2.995732273553991
profiling,20,2.995732273553991
HS,20,2.995732273553991
mind,20,2.995732273553991
PBC,20,2.995732273553991
CBF,20,2.995732273553991
fracture,20,2.995732273553991
operational,20,2.995732273553991
boy,20,2.995732273553991
London,20,2.995732273553991
deleterious,20,2.995732273553991
simulated,20,2.995732273553991
complaints,20,2.995732273553991
anemia,20,2.995732273553991
IFN-γ,20,2.995732273553991
steady,20,2.995732273553991
epilepsy,20,2.995732273553991
restriction,20,2.995732273553991
Much,20,2.995732273553991
PB2,20,2.995732273553991
supplement,20,2.995732273553991
inversion,20,2.995732273553991
enabling,20,2.995732273553991
begin,20,2.995732273553991
modeled,20,2.995732273553991
atrium,20,2.995732273553991
lasting,20,2.995732273553991
immunofluorescence,20,2.995732273553991
convenient,20,2.995732273553991
Taken,20,2.995732273553991
adjuvants,20,2.995732273553991
depth,20,2.995732273553991
Saudi,20,2.995732273553991
threatening,20,2.995732273553991
carrying,20,2.995732273553991
phenotypic,20,2.995732273553991
particle,20,2.995732273553991
probes,20,2.995732273553991
interquartile,20,2.995732273553991
myositis,20,2.995732273553991
Besides,20,2.995732273553991
accidents,20,2.995732273553991
intercostal,20,2.995732273553991
contamination,20,2.995732273553991
applicability,20,2.995732273553991
nations,20,2.995732273553991
mutated,20,2.995732273553991
fibrinogen,20,2.995732273553991
ARI,20,2.995732273553991
recognised,20,2.995732273553991
suggestions,20,2.995732273553991
wk,20,2.995732273553991
lactate,20,2.995732273553991
RNAs,20,2.995732273553991
bridge,20,2.995732273553991
LOS,20,2.995732273553991
Imaging,20,2.995732273553991
Register,20,2.995732273553991
shares,20,2.995732273553991
mixture,20,2.995732273553991
occasionally,20,2.995732273553991
claims,20,2.995732273553991
elimination,20,2.995732273553991
alternatives,20,2.995732273553991
inequities,20,2.995732273553991
transthoracic,20,2.995732273553991
In-hospital,20,2.995732273553991
lymphatic,20,2.995732273553991
Sweden,20,2.995732273553991
unless,20,2.995732273553991
habits,20,2.995732273553991
Age,20,2.995732273553991
relapse,20,2.995732273553991
endogenous,20,2.995732273553991
software,20,2.995732273553991
cerebellar,20,2.995732273553991
alive,20,2.995732273553991
closures,20,2.995732273553991
sections,20,2.995732273553991
junction,20,2.995732273553991
hyperintensity,20,2.995732273553991
contralateral,20,2.995732273553991
Women,20,2.995732273553991
reaching,20,2.995732273553991
rigorous,20,2.995732273553991
166,20,2.995732273553991
stop,20,2.995732273553991
drainage,20,2.995732273553991
RIDT,20,2.995732273553991
SA,20,2.995732273553991
methodologies,20,2.995732273553991
makers,20,2.995732273553991
Conclusion,20,2.995732273553991
collaterals,20,2.995732273553991
composed,20,2.995732273553991
Rationale,20,2.995732273553991
informative,20,2.995732273553991
retrieved,20,2.995732273553991
HRQL,20,2.995732273553991
CAS,20,2.995732273553991
today,20,2.995732273553991
CHF,20,2.995732273553991
Specifically,20,2.995732273553991
gut,20,2.995732273553991
personalized,20,2.995732273553991
nonatopic,20,2.995732273553991
preserved,20,2.995732273553991
acquire,20,2.995732273553991
mediator,20,2.995732273553991
character,20,2.995732273553991
preservation,20,2.995732273553991
mobilization,20,2.995732273553991
Thrombolytic,20,2.995732273553991
module,20,2.995732273553991
propagation,20,2.995732273553991
regards,20,2.995732273553991
Comparison,20,2.995732273553991
Though,20,2.995732273553991
normally,20,2.995732273553991
transmit,20,2.995732273553991
mites,20,2.995732273553991
engagement,20,2.995732273553991
neurovascular,20,2.995732273553991
presently,20,2.995732273553991
Advisory,20,2.995732273553991
viewed,20,2.995732273553991
sexes,20,2.995732273553991
inspiratory,20,2.995732273553991
personality,20,2.995732273553991
turned,20,2.995732273553991
post-myocardial,20,2.995732273553991
soluble,20,2.995732273553991
uncertainties,19,2.9444389791664403
confounders,19,2.9444389791664403
IL-13,19,2.9444389791664403
conjunctivitis,19,2.9444389791664403
Clinically,19,2.9444389791664403
collapse,19,2.9444389791664403
T2-weighted,19,2.9444389791664403
NS1,19,2.9444389791664403
cultural,19,2.9444389791664403
AHong,19,2.9444389791664403
conceptual,19,2.9444389791664403
migraine,19,2.9444389791664403
tropical,19,2.9444389791664403
126,19,2.9444389791664403
panic,19,2.9444389791664403
meta-analyses,19,2.9444389791664403
Testing,19,2.9444389791664403
hydroxychloroquine,19,2.9444389791664403
wedge,19,2.9444389791664403
replicate,19,2.9444389791664403
228,19,2.9444389791664403
alpha,19,2.9444389791664403
0003,19,2.9444389791664403
recruitment,19,2.9444389791664403
initiatives,19,2.9444389791664403
issued,19,2.9444389791664403
formulated,19,2.9444389791664403
parenchymal,19,2.9444389791664403
p00001,19,2.9444389791664403
interpret,19,2.9444389791664403
fell,19,2.9444389791664403
calculate,19,2.9444389791664403
encouraged,19,2.9444389791664403
thereafter,19,2.9444389791664403
caution,19,2.9444389791664403
interface,19,2.9444389791664403
authorization,19,2.9444389791664403
worsen,19,2.9444389791664403
COVID‑19,19,2.9444389791664403
LAR,19,2.9444389791664403
favor,19,2.9444389791664403
Case,19,2.9444389791664403
cardiology,19,2.9444389791664403
Similar,19,2.9444389791664403
chapter,19,2.9444389791664403
entered,19,2.9444389791664403
frame,19,2.9444389791664403
Nurses,19,2.9444389791664403
X,19,2.9444389791664403
HF,19,2.9444389791664403
TDI,19,2.9444389791664403
extracranial,19,2.9444389791664403
composite,19,2.9444389791664403
meaningful,19,2.9444389791664403
necrotic,19,2.9444389791664403
adding,19,2.9444389791664403
injections,19,2.9444389791664403
prevents,19,2.9444389791664403
metoprolol,19,2.9444389791664403
angiograms,19,2.9444389791664403
sympathetic,19,2.9444389791664403
nodes,19,2.9444389791664403
iii,19,2.9444389791664403
Preliminary,19,2.9444389791664403
progressively,19,2.9444389791664403
08,19,2.9444389791664403
124,19,2.9444389791664403
traditionally,19,2.9444389791664403
exploration,19,2.9444389791664403
demonstration,19,2.9444389791664403
explains,19,2.9444389791664403
128,19,2.9444389791664403
CCP,19,2.9444389791664403
MC,19,2.9444389791664403
influenzae,19,2.9444389791664403
raises,19,2.9444389791664403
Nineteen,19,2.9444389791664403
left-ventricular,19,2.9444389791664403
daytime,19,2.9444389791664403
Oral,19,2.9444389791664403
West,19,2.9444389791664403
disturbance,19,2.9444389791664403
20th,19,2.9444389791664403
Moderna,19,2.9444389791664403
disabilities,19,2.9444389791664403
1976,19,2.9444389791664403
exam,19,2.9444389791664403
EEG,19,2.9444389791664403
interfere,19,2.9444389791664403
microcirculation,19,2.9444389791664403
stimulated,19,2.9444389791664403
SE,19,2.9444389791664403
substitutions,19,2.9444389791664403
Therapeutic,19,2.9444389791664403
075,19,2.9444389791664403
false-positive,19,2.9444389791664403
glucocorticoids,19,2.9444389791664403
N501Y,19,2.9444389791664403
Cognitive,19,2.9444389791664403
adjacent,19,2.9444389791664403
intravascular,19,2.9444389791664403
crises,19,2.9444389791664403
worlds,19,2.9444389791664403
controller,19,2.9444389791664403
drop,19,2.9444389791664403
reflecting,19,2.9444389791664403
high-frequency,19,2.9444389791664403
evaluates,19,2.9444389791664403
stimulate,19,2.9444389791664403
faced,19,2.9444389791664403
inside,19,2.9444389791664403
time-consuming,19,2.9444389791664403
P2,19,2.9444389791664403
natriuretic,19,2.9444389791664403
prescriptions,19,2.9444389791664403
qualified,19,2.9444389791664403
1977,19,2.9444389791664403
Cancer,19,2.9444389791664403
triple,19,2.9444389791664403
worsened,19,2.9444389791664403
LVO,19,2.9444389791664403
newborn,19,2.9444389791664403
remarkably,19,2.9444389791664403
diabetics,19,2.9444389791664403
adjunctive,19,2.9444389791664403
distinguished,19,2.9444389791664403
Accurate,19,2.9444389791664403
characterizing,19,2.9444389791664403
spectral,19,2.9444389791664403
carbon,19,2.9444389791664403
stopped,19,2.9444389791664403
CXR,19,2.9444389791664403
dengue,19,2.9444389791664403
Then,19,2.9444389791664403
one-year,19,2.9444389791664403
murine,19,2.9444389791664403
sharing,19,2.9444389791664403
adenovirus,19,2.9444389791664403
endothelium,19,2.9444389791664403
array,19,2.9444389791664403
revision,19,2.9444389791664403
arm,19,2.9444389791664403
neuroprotection,19,2.9444389791664403
stockpiling,19,2.9444389791664403
cardiologists,19,2.9444389791664403
119,19,2.9444389791664403
Centre,19,2.9444389791664403
entering,19,2.9444389791664403
A2,19,2.9444389791664403
vaccinees,19,2.9444389791664403
Thailand,19,2.9444389791664403
reverse-transcription,19,2.9444389791664403
About,19,2.9444389791664403
1975,19,2.9444389791664403
shape,19,2.9444389791664403
hemispheres,19,2.9444389791664403
blocking,19,2.9444389791664403
amounts,19,2.9444389791664403
174,19,2.9444389791664403
restore,19,2.9444389791664403
subcutaneous,19,2.9444389791664403
m,19,2.9444389791664403
sequenced,19,2.9444389791664403
outlines,19,2.9444389791664403
stepwise,19,2.9444389791664403
seasonality,18,2.8903717578961645
shunt,18,2.8903717578961645
tumors,18,2.8903717578961645
infecting,18,2.8903717578961645
supplementation,18,2.8903717578961645
preventative,18,2.8903717578961645
exosomes,18,2.8903717578961645
bats,18,2.8903717578961645
tackle,18,2.8903717578961645
chemokines,18,2.8903717578961645
Southeast,18,2.8903717578961645
demographics,18,2.8903717578961645
yield,18,2.8903717578961645
computerized,18,2.8903717578961645
Fourteen,18,2.8903717578961645
1992,18,2.8903717578961645
capillary,18,2.8903717578961645
reproducibility,18,2.8903717578961645
activate,18,2.8903717578961645
pacing,18,2.8903717578961645
vertebral,18,2.8903717578961645
propensity,18,2.8903717578961645
case-fatality,18,2.8903717578961645
NPIs,18,2.8903717578961645
extrinsic,18,2.8903717578961645
authorized,18,2.8903717578961645
ACQ,18,2.8903717578961645
end-systolic,18,2.8903717578961645
morphological,18,2.8903717578961645
Xpert,18,2.8903717578961645
MINOCA,18,2.8903717578961645
differing,18,2.8903717578961645
breastfeeding,18,2.8903717578961645
grouped,18,2.8903717578961645
disabling,18,2.8903717578961645
Antiviral,18,2.8903717578961645
Physical,18,2.8903717578961645
fifth,18,2.8903717578961645
Every,18,2.8903717578961645
underestimated,18,2.8903717578961645
hormones,18,2.8903717578961645
nonasthmatic,18,2.8903717578961645
Score,18,2.8903717578961645
091,18,2.8903717578961645
latent,18,2.8903717578961645
lipids,18,2.8903717578961645
extra,18,2.8903717578961645
shortcomings,18,2.8903717578961645
wood,18,2.8903717578961645
creation,18,2.8903717578961645
rooms,18,2.8903717578961645
hold,18,2.8903717578961645
clopidogrel,18,2.8903717578961645
Journal,18,2.8903717578961645
safer,18,2.8903717578961645
adversely,18,2.8903717578961645
monovalent,18,2.8903717578961645
acupuncture,18,2.8903717578961645
comes,18,2.8903717578961645
gathered,18,2.8903717578961645
zones,18,2.8903717578961645
pertinent,18,2.8903717578961645
198,18,2.8903717578961645
solely,18,2.8903717578961645
principle,18,2.8903717578961645
Echocardiography,18,2.8903717578961645
Holter,18,2.8903717578961645
revealing,18,2.8903717578961645
Improved,18,2.8903717578961645
supplements,18,2.8903717578961645
Common,18,2.8903717578961645
Context,18,2.8903717578961645
transcriptase,18,2.8903717578961645
valvular,18,2.8903717578961645
MCAO,18,2.8903717578961645
Spike,18,2.8903717578961645
consolidation,18,2.8903717578961645
etiologic,18,2.8903717578961645
142,18,2.8903717578961645
girls,18,2.8903717578961645
preparations,18,2.8903717578961645
129,18,2.8903717578961645
Antibody,18,2.8903717578961645
disseminated,18,2.8903717578961645
hyper-responsiveness,18,2.8903717578961645
111,18,2.8903717578961645
UL,18,2.8903717578961645
1979,18,2.8903717578961645
cystic,18,2.8903717578961645
preschool,18,2.8903717578961645
sports,18,2.8903717578961645
primers,18,2.8903717578961645
in-depth,18,2.8903717578961645
contraceptives,18,2.8903717578961645
shortages,18,2.8903717578961645
CP,18,2.8903717578961645
substrate,18,2.8903717578961645
P005,18,2.8903717578961645
U,18,2.8903717578961645
certification,18,2.8903717578961645
Molecular,18,2.8903717578961645
non-asthmatic,18,2.8903717578961645
hemiparesis,18,2.8903717578961645
°C,18,2.8903717578961645
parenteral,18,2.8903717578961645
143,18,2.8903717578961645
inactivation,18,2.8903717578961645
unexplained,18,2.8903717578961645
ventilatory,18,2.8903717578961645
LAA,18,2.8903717578961645
214,18,2.8903717578961645
allele,18,2.8903717578961645
walls,18,2.8903717578961645
worked,18,2.8903717578961645
carriers,18,2.8903717578961645
crude,18,2.8903717578961645
chemokine,18,2.8903717578961645
decided,18,2.8903717578961645
maximize,18,2.8903717578961645
immunosorbent,18,2.8903717578961645
degradation,18,2.8903717578961645
differentiated,18,2.8903717578961645
Regarding,18,2.8903717578961645
substance,18,2.8903717578961645
indicative,18,2.8903717578961645
built,18,2.8903717578961645
antiinflammatory,18,2.8903717578961645
114,18,2.8903717578961645
performances,18,2.8903717578961645
ICA,18,2.8903717578961645
build,18,2.8903717578961645
holistic,18,2.8903717578961645
Model,18,2.8903717578961645
low-risk,18,2.8903717578961645
predisposition,18,2.8903717578961645
inoculated,18,2.8903717578961645
10-year,18,2.8903717578961645
predispose,18,2.8903717578961645
GI,18,2.8903717578961645
237,18,2.8903717578961645
2D,18,2.8903717578961645
converting,18,2.8903717578961645
promoted,18,2.8903717578961645
illustrated,18,2.8903717578961645
rTMS,18,2.8903717578961645
127,18,2.8903717578961645
cocaine,18,2.8903717578961645
vaccine-induced,18,2.8903717578961645
Importance,18,2.8903717578961645
text,18,2.8903717578961645
permits,18,2.8903717578961645
Complications,18,2.8903717578961645
corona,18,2.8903717578961645
temperate,18,2.8903717578961645
problematic,18,2.8903717578961645
enrollment,18,2.8903717578961645
extend,18,2.8903717578961645
Special,18,2.8903717578961645
emphasizing,18,2.8903717578961645
IR,18,2.8903717578961645
rhinovirus,18,2.8903717578961645
official,18,2.8903717578961645
CVA,18,2.8903717578961645
gastroesophageal,18,2.8903717578961645
165,18,2.8903717578961645
mesenchymal,18,2.8903717578961645
anti-viral,18,2.8903717578961645
recovering,18,2.8903717578961645
antiarrhythmic,18,2.8903717578961645
till,18,2.8903717578961645
Diabetes,18,2.8903717578961645
optimum,18,2.8903717578961645
HPAI,18,2.8903717578961645
suppress,18,2.8903717578961645
aeroallergens,18,2.8903717578961645
trimester,18,2.8903717578961645
vestibular,18,2.8903717578961645
159,18,2.8903717578961645
translated,18,2.8903717578961645
heavily,18,2.8903717578961645
consecutively,18,2.8903717578961645
partnership,18,2.8903717578961645
flu-like,18,2.8903717578961645
HRQOL,18,2.8903717578961645
variance,18,2.8903717578961645
accomplished,18,2.8903717578961645
encephalitis,18,2.8903717578961645
attachment,18,2.8903717578961645
Exposure,18,2.8903717578961645
saving,18,2.8903717578961645
anticipated,18,2.8903717578961645
Recommendations,18,2.8903717578961645
reviewing,17,2.833213344056216
comprising,17,2.833213344056216
expressing,17,2.833213344056216
passage,17,2.833213344056216
judged,17,2.833213344056216
Thirty,17,2.833213344056216
Union,17,2.833213344056216
118,17,2.833213344056216
preferences,17,2.833213344056216
Killip,17,2.833213344056216
treatable,17,2.833213344056216
predominance,17,2.833213344056216
message,17,2.833213344056216
compatible,17,2.833213344056216
student,17,2.833213344056216
right-sided,17,2.833213344056216
Monitoring,17,2.833213344056216
instituted,17,2.833213344056216
residential,17,2.833213344056216
compares,17,2.833213344056216
college,17,2.833213344056216
HDM,17,2.833213344056216
unsuccessful,17,2.833213344056216
responding,17,2.833213344056216
selecting,17,2.833213344056216
delivering,17,2.833213344056216
Pfizer-BioNTech,17,2.833213344056216
151,17,2.833213344056216
constructed,17,2.833213344056216
carries,17,2.833213344056216
Brain,17,2.833213344056216
obtaining,17,2.833213344056216
Academy,17,2.833213344056216
vasospasm,17,2.833213344056216
ECP,17,2.833213344056216
21st,17,2.833213344056216
trajectory,17,2.833213344056216
State,17,2.833213344056216
residue,17,2.833213344056216
ranges,17,2.833213344056216
T1,17,2.833213344056216
beds,17,2.833213344056216
1957,17,2.833213344056216
145,17,2.833213344056216
sizes,17,2.833213344056216
political,17,2.833213344056216
pH,17,2.833213344056216
renewed,17,2.833213344056216
CSC,17,2.833213344056216
Computed,17,2.833213344056216
hit,17,2.833213344056216
5-year,17,2.833213344056216
completion,17,2.833213344056216
damages,17,2.833213344056216
self-efficacy,17,2.833213344056216
TMPRSS2,17,2.833213344056216
exhibits,17,2.833213344056216
discriminate,17,2.833213344056216
PM,17,2.833213344056216
CCU,17,2.833213344056216
enzyme-linked,17,2.833213344056216
lies,17,2.833213344056216
processed,17,2.833213344056216
177,17,2.833213344056216
motivation,17,2.833213344056216
whilst,17,2.833213344056216
isoenzyme,17,2.833213344056216
nonvalvular,17,2.833213344056216
Part,17,2.833213344056216
pass,17,2.833213344056216
disinfection,17,2.833213344056216
door-to-balloon,17,2.833213344056216
Prehospital,17,2.833213344056216
astrocytes,17,2.833213344056216
adolescence,17,2.833213344056216
hematologic,17,2.833213344056216
employing,17,2.833213344056216
Recognition,17,2.833213344056216
mediating,17,2.833213344056216
ICD-9,17,2.833213344056216
summarise,17,2.833213344056216
derive,17,2.833213344056216
ecological,17,2.833213344056216
thyroid,17,2.833213344056216
case-patients,17,2.833213344056216
putative,17,2.833213344056216
5-10,17,2.833213344056216
subarachnoid,17,2.833213344056216
secretions,17,2.833213344056216
forming,17,2.833213344056216
Cardiology,17,2.833213344056216
confirming,17,2.833213344056216
drinking,17,2.833213344056216
ambient,17,2.833213344056216
201112,17,2.833213344056216
withdrawal,17,2.833213344056216
formulation,17,2.833213344056216
Th2,17,2.833213344056216
sclerosis,17,2.833213344056216
Measurement,17,2.833213344056216
echocardiogram,17,2.833213344056216
feelings,17,2.833213344056216
pointed,17,2.833213344056216
Intensive,17,2.833213344056216
parainfluenza,17,2.833213344056216
successive,17,2.833213344056216
covariates,17,2.833213344056216
favour,17,2.833213344056216
mononuclear,17,2.833213344056216
V4R,17,2.833213344056216
SCA,17,2.833213344056216
Animal,17,2.833213344056216
lab,17,2.833213344056216
0004,17,2.833213344056216
upregulated,17,2.833213344056216
sport,17,2.833213344056216
try,17,2.833213344056216
symptomatology,17,2.833213344056216
aspergillosis,17,2.833213344056216
unanswered,17,2.833213344056216
hepatitis,17,2.833213344056216
discriminant,17,2.833213344056216
reserve,17,2.833213344056216
collaborative,17,2.833213344056216
hereditary,17,2.833213344056216
vectorcardiography,17,2.833213344056216
traffic,17,2.833213344056216
fluids,17,2.833213344056216
hypothesize,17,2.833213344056216
normalization,17,2.833213344056216
funding,17,2.833213344056216
self,17,2.833213344056216
newborns,17,2.833213344056216
trajectories,17,2.833213344056216
cornerstone,17,2.833213344056216
H1,17,2.833213344056216
Region,17,2.833213344056216
facilitates,17,2.833213344056216
state-of-the-art,17,2.833213344056216
meter,17,2.833213344056216
idea,17,2.833213344056216
strengthen,17,2.833213344056216
formal,17,2.833213344056216
Almost,17,2.833213344056216
toxic,17,2.833213344056216
costly,17,2.833213344056216
modulating,17,2.833213344056216
high-quality,17,2.833213344056216
tomographic,17,2.833213344056216
Hemisphere,17,2.833213344056216
progressing,17,2.833213344056216
contaminated,17,2.833213344056216
Southern,17,2.833213344056216
pyrophosphate,17,2.833213344056216
besides,17,2.833213344056216
pregnancies,17,2.833213344056216
RVMI,17,2.833213344056216
RdRp,17,2.833213344056216
Under,17,2.833213344056216
adulthood,17,2.833213344056216
dexamethasone,17,2.833213344056216
proinflammatory,17,2.833213344056216
isoproterenol,17,2.833213344056216
outdoor,17,2.833213344056216
prioritized,17,2.833213344056216
qRT-PCR,17,2.833213344056216
Safety,17,2.833213344056216
Kit,17,2.833213344056216
section,17,2.833213344056216
139,17,2.833213344056216
3D,17,2.833213344056216
lipoprotein,17,2.833213344056216
Eighteen,17,2.833213344056216
reocclusion,17,2.833213344056216
malignancies,17,2.833213344056216
stockpile,17,2.833213344056216
microscopy,17,2.833213344056216
incorporated,17,2.833213344056216
QOL,17,2.833213344056216
co-morbidities,17,2.833213344056216
manual,17,2.833213344056216
hemoglobin,17,2.833213344056216
emphasizes,17,2.833213344056216
Late,17,2.833213344056216
asthma-specific,17,2.833213344056216
radiographic,17,2.833213344056216
big,17,2.833213344056216
self-administered,17,2.833213344056216
ORF1ab,17,2.833213344056216
SNP,17,2.833213344056216
beta-blocker,16,2.772588722239781
curative,16,2.772588722239781
non-pharmaceutical,16,2.772588722239781
electrochemical,16,2.772588722239781
farms,16,2.772588722239781
oncology,16,2.772588722239781
Median,16,2.772588722239781
pharmacy,16,2.772588722239781
1991,16,2.772588722239781
invasion,16,2.772588722239781
placement,16,2.772588722239781
intranasal,16,2.772588722239781
belief,16,2.772588722239781
receipt,16,2.772588722239781
high-resolution,16,2.772588722239781
compensatory,16,2.772588722239781
coded,16,2.772588722239781
beta2-agonists,16,2.772588722239781
quantitatively,16,2.772588722239781
integrating,16,2.772588722239781
confirmatory,16,2.772588722239781
heat,16,2.772588722239781
drawing,16,2.772588722239781
Individuals,16,2.772588722239781
cooperation,16,2.772588722239781
acts,16,2.772588722239781
overwhelming,16,2.772588722239781
confer,16,2.772588722239781
ACS,16,2.772588722239781
leukoaraiosis,16,2.772588722239781
apart,16,2.772588722239781
catastrophic,16,2.772588722239781
dead,16,2.772588722239781
perfect,16,2.772588722239781
007,16,2.772588722239781
Adult,16,2.772588722239781
county,16,2.772588722239781
engaged,16,2.772588722239781
immunosuppressive,16,2.772588722239781
cytotoxic,16,2.772588722239781
filter,16,2.772588722239781
electric,16,2.772588722239781
AKI,16,2.772588722239781
IRA,16,2.772588722239781
counties,16,2.772588722239781
renin-angiotensin,16,2.772588722239781
dioxide,16,2.772588722239781
cycles,16,2.772588722239781
building,16,2.772588722239781
CAD,16,2.772588722239781
2010-11,16,2.772588722239781
guided,16,2.772588722239781
industrial,16,2.772588722239781
3-month,16,2.772588722239781
policymakers,16,2.772588722239781
Polish,16,2.772588722239781
correspond,16,2.772588722239781
unrelated,16,2.772588722239781
Minnesota,16,2.772588722239781
additive,16,2.772588722239781
binds,16,2.772588722239781
quadrivalent,16,2.772588722239781
bring,16,2.772588722239781
urgency,16,2.772588722239781
introducing,16,2.772588722239781
Turkish,16,2.772588722239781
virtual,16,2.772588722239781
thrombin,16,2.772588722239781
endocardial,16,2.772588722239781
vasculature,16,2.772588722239781
visualized,16,2.772588722239781
TEE,16,2.772588722239781
hormonal,16,2.772588722239781
homocysteine,16,2.772588722239781
immunomodulatory,16,2.772588722239781
Optimal,16,2.772588722239781
Serological,16,2.772588722239781
acquiring,16,2.772588722239781
Randomized,16,2.772588722239781
conversion,16,2.772588722239781
inherent,16,2.772588722239781
ipsilesional,16,2.772588722239781
Veterans,16,2.772588722239781
ST-T,16,2.772588722239781
Conversely,16,2.772588722239781
Depression,16,2.772588722239781
school-aged,16,2.772588722239781
resultant,16,2.772588722239781
CHADS2,16,2.772588722239781
repolarization,16,2.772588722239781
Quantitative,16,2.772588722239781
serves,16,2.772588722239781
debated,16,2.772588722239781
Ab,16,2.772588722239781
I2,16,2.772588722239781
histopathological,16,2.772588722239781
doing,16,2.772588722239781
deletion,16,2.772588722239781
Reverse,16,2.772588722239781
justify,16,2.772588722239781
registers,16,2.772588722239781
hypoxic,16,2.772588722239781
surviving,16,2.772588722239781
publicly,16,2.772588722239781
sum,16,2.772588722239781
shifts,16,2.772588722239781
hyperventilation,16,2.772588722239781
NGS,16,2.772588722239781
responders,16,2.772588722239781
investigates,16,2.772588722239781
T-wave,16,2.772588722239781
restenosis,16,2.772588722239781
encounters,16,2.772588722239781
particulate,16,2.772588722239781
IHD,16,2.772588722239781
Norway,16,2.772588722239781
nCoV-19,16,2.772588722239781
MCE,16,2.772588722239781
AIV,16,2.772588722239781
Exhaled,16,2.772588722239781
microbiota,16,2.772588722239781
GPs,16,2.772588722239781
Victoria,16,2.772588722239781
immunogenic,16,2.772588722239781
cut-off,16,2.772588722239781
possess,16,2.772588722239781
interdisciplinary,16,2.772588722239781
formulations,16,2.772588722239781
voluntary,16,2.772588722239781
pharyngeal,16,2.772588722239781
mainland,16,2.772588722239781
comprise,16,2.772588722239781
notable,16,2.772588722239781
Practices,16,2.772588722239781
ferret,16,2.772588722239781
permit,16,2.772588722239781
fluorescent,16,2.772588722239781
ultrasonography,16,2.772588722239781
aetiological,16,2.772588722239781
hyperglycemia,16,2.772588722239781
salivary,16,2.772588722239781
electron,16,2.772588722239781
begun,16,2.772588722239781
msec,16,2.772588722239781
choices,16,2.772588722239781
084,16,2.772588722239781
individualized,16,2.772588722239781
high-income,16,2.772588722239781
well-known,16,2.772588722239781
parent,16,2.772588722239781
intelligence,16,2.772588722239781
hard,16,2.772588722239781
lethality,16,2.772588722239781
returning,16,2.772588722239781
arch,16,2.772588722239781
oseltamivir-resistant,16,2.772588722239781
mediate,16,2.772588722239781
lived,16,2.772588722239781
Major,16,2.772588722239781
offering,16,2.772588722239781
short-acting,16,2.772588722239781
tidal,16,2.772588722239781
opposed,16,2.772588722239781
trace,16,2.772588722239781
save,16,2.772588722239781
traits,16,2.772588722239781
TAVR,16,2.772588722239781
AND,16,2.772588722239781
work-up,16,2.772588722239781
leave,16,2.772588722239781
OCS,16,2.772588722239781
141,16,2.772588722239781
Identifying,16,2.772588722239781
moment,16,2.772588722239781
disciplines,16,2.772588722239781
lot,16,2.772588722239781
nighttime,16,2.772588722239781
layer,16,2.772588722239781
impending,16,2.772588722239781
clade,16,2.772588722239781
113,16,2.772588722239781
pools,16,2.772588722239781
exceeding,16,2.772588722239781
myalgia,16,2.772588722239781
confusion,16,2.772588722239781
phosphokinase,16,2.772588722239781
individually,16,2.772588722239781
reassortant,16,2.772588722239781
arising,16,2.772588722239781
biomedical,16,2.772588722239781
White,16,2.772588722239781
radical,16,2.772588722239781
opinions,16,2.772588722239781
chemiluminescence,16,2.772588722239781
low-cost,16,2.772588722239781
postdischarge,16,2.772588722239781
siRNA,16,2.772588722239781
compression,16,2.772588722239781
N-terminal,16,2.772588722239781
supplied,16,2.772588722239781
Panel,16,2.772588722239781
ROS,16,2.772588722239781
HCoVs,16,2.772588722239781
stimulating,16,2.772588722239781
Up,16,2.772588722239781
1968,16,2.772588722239781
inference,16,2.772588722239781
RA,16,2.772588722239781
register,16,2.772588722239781
advocated,16,2.772588722239781
9-1-1,15,2.70805020110221
arrhythmic,15,2.70805020110221
PCR-based,15,2.70805020110221
neurologists,15,2.70805020110221
IT,15,2.70805020110221
stratify,15,2.70805020110221
overlooked,15,2.70805020110221
SNPs,15,2.70805020110221
voltage,15,2.70805020110221
counterparts,15,2.70805020110221
regenerative,15,2.70805020110221
abciximab,15,2.70805020110221
antimicrobial,15,2.70805020110221
resolve,15,2.70805020110221
CR,15,2.70805020110221
discomfort,15,2.70805020110221
reorganization,15,2.70805020110221
leukocytes,15,2.70805020110221
leaders,15,2.70805020110221
disparity,15,2.70805020110221
enhances,15,2.70805020110221
behaviours,15,2.70805020110221
skilled,15,2.70805020110221
discover,15,2.70805020110221
dilution,15,2.70805020110221
beings,15,2.70805020110221
exertion,15,2.70805020110221
embolization,15,2.70805020110221
Trials,15,2.70805020110221
remainder,15,2.70805020110221
independence,15,2.70805020110221
117,15,2.70805020110221
bronchi,15,2.70805020110221
deceased,15,2.70805020110221
veterinary,15,2.70805020110221
misdiagnosed,15,2.70805020110221
nuclear,15,2.70805020110221
cut,15,2.70805020110221
culturally,15,2.70805020110221
greenhouse,15,2.70805020110221
in-house,15,2.70805020110221
011,15,2.70805020110221
markets,15,2.70805020110221
hoped,15,2.70805020110221
proteomics,15,2.70805020110221
Medline,15,2.70805020110221
convincing,15,2.70805020110221
glial,15,2.70805020110221
episodic,15,2.70805020110221
zero,15,2.70805020110221
mL,15,2.70805020110221
univariate,15,2.70805020110221
eligibility,15,2.70805020110221
discoveries,15,2.70805020110221
133,15,2.70805020110221
institutional,15,2.70805020110221
recipient,15,2.70805020110221
genotypes,15,2.70805020110221
1980,15,2.70805020110221
immunology,15,2.70805020110221
IMT,15,2.70805020110221
Greece,15,2.70805020110221
Detection,15,2.70805020110221
progresses,15,2.70805020110221
non-valvular,15,2.70805020110221
Potential,15,2.70805020110221
coordinated,15,2.70805020110221
Rehabilitation,15,2.70805020110221
encounter,15,2.70805020110221
IFA,15,2.70805020110221
vagal,15,2.70805020110221
Family,15,2.70805020110221
replaced,15,2.70805020110221
Whereas,15,2.70805020110221
preparing,15,2.70805020110221
Authorization,15,2.70805020110221
MRA,15,2.70805020110221
Female,15,2.70805020110221
avenues,15,2.70805020110221
constantly,15,2.70805020110221
height,15,2.70805020110221
09,15,2.70805020110221
EDs,15,2.70805020110221
colleagues,15,2.70805020110221
clades,15,2.70805020110221
observers,15,2.70805020110221
interim,15,2.70805020110221
frontline,15,2.70805020110221
wound,15,2.70805020110221
Egypt,15,2.70805020110221
intraaortic,15,2.70805020110221
microbial,15,2.70805020110221
acceleration,15,2.70805020110221
shorten,15,2.70805020110221
existed,15,2.70805020110221
Nepal,15,2.70805020110221
IVT,15,2.70805020110221
025,15,2.70805020110221
Better,15,2.70805020110221
cerebrospinal,15,2.70805020110221
BNP,15,2.70805020110221
prioritization,15,2.70805020110221
ribavirin,15,2.70805020110221
HWs,15,2.70805020110221
MIF,15,2.70805020110221
Social,15,2.70805020110221
12-month,15,2.70805020110221
paradoxical,15,2.70805020110221
Cerebral,15,2.70805020110221
prerequisite,15,2.70805020110221
panels,15,2.70805020110221
phosphate,15,2.70805020110221
District,15,2.70805020110221
Strategies,15,2.70805020110221
adenosine,15,2.70805020110221
sinusitis,15,2.70805020110221
burdens,15,2.70805020110221
Cases,15,2.70805020110221
tracts,15,2.70805020110221
Pulmonary,15,2.70805020110221
homology,15,2.70805020110221
provoke,15,2.70805020110221
Childrens,15,2.70805020110221
colorimetric,15,2.70805020110221
His,15,2.70805020110221
CHA2DS2-VASc,15,2.70805020110221
mgml,15,2.70805020110221
cardioprotective,15,2.70805020110221
note,15,2.70805020110221
Now,15,2.70805020110221
allogeneic,15,2.70805020110221
H3N2v,15,2.70805020110221
Swine,15,2.70805020110221
receiver,15,2.70805020110221
assembly,15,2.70805020110221
anaphylactic,15,2.70805020110221
kinds,15,2.70805020110221
Plasma,15,2.70805020110221
Toronto,15,2.70805020110221
thoroughly,15,2.70805020110221
multi-organ,15,2.70805020110221
omalizumab,15,2.70805020110221
island,15,2.70805020110221
collective,15,2.70805020110221
dominated,15,2.70805020110221
well-defined,15,2.70805020110221
workflow,15,2.70805020110221
cromoglycate,15,2.70805020110221
Time,15,2.70805020110221
Fifteen,15,2.70805020110221
Class,15,2.70805020110221
persists,15,2.70805020110221
proximity,15,2.70805020110221
vision,15,2.70805020110221
flexible,15,2.70805020110221
nitrate,15,2.70805020110221
operative,15,2.70805020110221
sub-Saharan,15,2.70805020110221
prototype,15,2.70805020110221
stresses,15,2.70805020110221
vaccine-related,15,2.70805020110221
2-agonists,15,2.70805020110221
quantities,15,2.70805020110221
ahead,15,2.70805020110221
basilar,15,2.70805020110221
Google,15,2.70805020110221
diuretics,15,2.70805020110221
blue,15,2.70805020110221
strengthening,15,2.70805020110221
seriously,15,2.70805020110221
telestroke,15,2.70805020110221
biologics,15,2.70805020110221
stimulus,15,2.70805020110221
deployed,15,2.70805020110221
161,15,2.70805020110221
atherothrombotic,15,2.70805020110221
histologic,15,2.70805020110221
pitfalls,15,2.70805020110221
Arabia,15,2.70805020110221
positron,15,2.70805020110221
nausea,15,2.70805020110221
workshop,15,2.70805020110221
school-based,15,2.70805020110221
B-cell,15,2.70805020110221
dyslipidemia,15,2.70805020110221
131,15,2.70805020110221
rheumatic,15,2.70805020110221
titre,15,2.70805020110221
Possible,15,2.70805020110221
dosing,15,2.70805020110221
LUS,15,2.70805020110221
ganglia,15,2.70805020110221
flexibility,15,2.70805020110221
Serial,15,2.70805020110221
201Tl,15,2.70805020110221
1990s,15,2.70805020110221
preinfarction,15,2.70805020110221
reservoirs,15,2.70805020110221
milder,15,2.70805020110221
jurisdictions,15,2.70805020110221
elsewhere,15,2.70805020110221
Immunology,15,2.70805020110221
Report,15,2.70805020110221
PI3K,15,2.70805020110221
rimantadine,15,2.70805020110221
federal,15,2.70805020110221
climatic,15,2.70805020110221
answers,15,2.70805020110221
registries,15,2.70805020110221
Lack,15,2.70805020110221
loop-mediated,15,2.70805020110221
constraints,15,2.70805020110221
potassium,15,2.70805020110221
V1,15,2.70805020110221
radiologic,15,2.70805020110221
simulate,14,2.6390573296152584
Mathematical,14,2.6390573296152584
apex,14,2.6390573296152584
Tomography,14,2.6390573296152584
hybrid,14,2.6390573296152584
attendance,14,2.6390573296152584
utmost,14,2.6390573296152584
stool,14,2.6390573296152584
hemiblock,14,2.6390573296152584
isocyanate,14,2.6390573296152584
sublingual,14,2.6390573296152584
RH,14,2.6390573296152584
Surgical,14,2.6390573296152584
endpoints,14,2.6390573296152584
misery,14,2.6390573296152584
RCT,14,2.6390573296152584
secure,14,2.6390573296152584
works,14,2.6390573296152584
qualitatively,14,2.6390573296152584
Having,14,2.6390573296152584
codon,14,2.6390573296152584
PC,14,2.6390573296152584
convalescents,14,2.6390573296152584
inotropic,14,2.6390573296152584
desired,14,2.6390573296152584
node,14,2.6390573296152584
capital,14,2.6390573296152584
forecasts,14,2.6390573296152584
AstraZeneca,14,2.6390573296152584
accessory,14,2.6390573296152584
6-month,14,2.6390573296152584
accept,14,2.6390573296152584
well-established,14,2.6390573296152584
contralesional,14,2.6390573296152584
stated,14,2.6390573296152584
element,14,2.6390573296152584
organisms,14,2.6390573296152584
labeled,14,2.6390573296152584
electrophysiological,14,2.6390573296152584
originating,14,2.6390573296152584
virtually,14,2.6390573296152584
emergencies,14,2.6390573296152584
distinction,14,2.6390573296152584
Fortunately,14,2.6390573296152584
prime,14,2.6390573296152584
discussing,14,2.6390573296152584
calculation,14,2.6390573296152584
90-day,14,2.6390573296152584
hypersensitivity,14,2.6390573296152584
metropolitan,14,2.6390573296152584
surgically,14,2.6390573296152584
extends,14,2.6390573296152584
cardiological,14,2.6390573296152584
theories,14,2.6390573296152584
circulated,14,2.6390573296152584
fibrous,14,2.6390573296152584
Initial,14,2.6390573296152584
said,14,2.6390573296152584
session,14,2.6390573296152584
truly,14,2.6390573296152584
age-matched,14,2.6390573296152584
quarter,14,2.6390573296152584
333,14,2.6390573296152584
person-years,14,2.6390573296152584
compensation,14,2.6390573296152584
PPV,14,2.6390573296152584
upcoming,14,2.6390573296152584
201,14,2.6390573296152584
mlm2,14,2.6390573296152584
Chain,14,2.6390573296152584
Nonetheless,14,2.6390573296152584
Air,14,2.6390573296152584
microarray,14,2.6390573296152584
striking,14,2.6390573296152584
anomalies,14,2.6390573296152584
hypoperfusion,14,2.6390573296152584
Less,14,2.6390573296152584
engineering,14,2.6390573296152584
relieve,14,2.6390573296152584
messenger,14,2.6390573296152584
AA,14,2.6390573296152584
stringent,14,2.6390573296152584
aerobic,14,2.6390573296152584
SARS‐CoV‐2,14,2.6390573296152584
syndromic,14,2.6390573296152584
AS,14,2.6390573296152584
sole,14,2.6390573296152584
possesses,14,2.6390573296152584
biosafety,14,2.6390573296152584
Scientific,14,2.6390573296152584
immunosuppression,14,2.6390573296152584
identifiable,14,2.6390573296152584
Interventions,14,2.6390573296152584
multicentre,14,2.6390573296152584
verify,14,2.6390573296152584
sanitation,14,2.6390573296152584
IgE-mediated,14,2.6390573296152584
non-structural,14,2.6390573296152584
ground,14,2.6390573296152584
scheduled,14,2.6390573296152584
competition,14,2.6390573296152584
Blacks,14,2.6390573296152584
deemed,14,2.6390573296152584
074,14,2.6390573296152584
bed,14,2.6390573296152584
uniquely,14,2.6390573296152584
procurement,14,2.6390573296152584
NAEPP,14,2.6390573296152584
epigenetic,14,2.6390573296152584
fungi,14,2.6390573296152584
classifications,14,2.6390573296152584
weaknesses,14,2.6390573296152584
analogue,14,2.6390573296152584
illustrates,14,2.6390573296152584
1987,14,2.6390573296152584
anomaly,14,2.6390573296152584
trachea,14,2.6390573296152584
savings,14,2.6390573296152584
check,14,2.6390573296152584
mgkg,14,2.6390573296152584
indeed,14,2.6390573296152584
SF-36,14,2.6390573296152584
gatherings,14,2.6390573296152584
peoples,14,2.6390573296152584
Therapy,14,2.6390573296152584
plants,14,2.6390573296152584
lumen,14,2.6390573296152584
IIbIIIa,14,2.6390573296152584
MAPK,14,2.6390573296152584
orders,14,2.6390573296152584
Recurrent,14,2.6390573296152584
puberty,14,2.6390573296152584
satisfaction,14,2.6390573296152584
qPCR,14,2.6390573296152584
cross-reactive,14,2.6390573296152584
recommends,14,2.6390573296152584
conformation,14,2.6390573296152584
helper,14,2.6390573296152584
vasoconstriction,14,2.6390573296152584
203,14,2.6390573296152584
administrative,14,2.6390573296152584
differently,14,2.6390573296152584
Pacific,14,2.6390573296152584
210,14,2.6390573296152584
questioned,14,2.6390573296152584
abilities,14,2.6390573296152584
virology,14,2.6390573296152584
MD,14,2.6390573296152584
engineered,14,2.6390573296152584
MCA,14,2.6390573296152584
averted,14,2.6390573296152584
low-,14,2.6390573296152584
anticipate,14,2.6390573296152584
digestive,14,2.6390573296152584
exhaustion,14,2.6390573296152584
advancements,14,2.6390573296152584
Antiplatelet,14,2.6390573296152584
mRNA-1273,14,2.6390573296152584
instructions,14,2.6390573296152584
classify,14,2.6390573296152584
oil,14,2.6390573296152584
input,14,2.6390573296152584
Infections,14,2.6390573296152584
interleukin,14,2.6390573296152584
radiographs,14,2.6390573296152584
template,14,2.6390573296152584
dependency,14,2.6390573296152584
principally,14,2.6390573296152584
switch,14,2.6390573296152584
P001,14,2.6390573296152584
hemorrhages,14,2.6390573296152584
scalable,14,2.6390573296152584
144,14,2.6390573296152584
blinded,14,2.6390573296152584
plant,14,2.6390573296152584
DEFUSE,14,2.6390573296152584
176,14,2.6390573296152584
exceeded,14,2.6390573296152584
telephone,14,2.6390573296152584
Young,14,2.6390573296152584
grafts,14,2.6390573296152584
impossible,14,2.6390573296152584
bodies,14,2.6390573296152584
whereby,14,2.6390573296152584
PCR-confirmed,14,2.6390573296152584
pathobiology,14,2.6390573296152584
preconditioning,14,2.6390573296152584
066,14,2.6390573296152584
COVID-19-related,14,2.6390573296152584
prospects,14,2.6390573296152584
developmental,14,2.6390573296152584
community-acquired,14,2.6390573296152584
reality,14,2.6390573296152584
H275Y,14,2.6390573296152584
Important,14,2.6390573296152584
1989,14,2.6390573296152584
240,14,2.6390573296152584
connectivity,14,2.6390573296152584
masking,14,2.6390573296152584
transcatheter,14,2.6390573296152584
declines,14,2.6390573296152584
223,14,2.6390573296152584
respirators,14,2.6390573296152584
Prevalence,14,2.6390573296152584
sustainable,14,2.6390573296152584
incidences,14,2.6390573296152584
beta2-agonist,14,2.6390573296152584
dysphagia,14,2.6390573296152584
dose-response,14,2.6390573296152584
NAAT,14,2.6390573296152584
sensing,14,2.6390573296152584
prolongation,14,2.6390573296152584
large-vessel,14,2.6390573296152584
Genetic,14,2.6390573296152584
TAVI,14,2.6390573296152584
tension,14,2.6390573296152584
difficult-to-treat,14,2.6390573296152584
LAIV,14,2.6390573296152584
162,14,2.6390573296152584
shortage,14,2.6390573296152584
meteorological,14,2.6390573296152584
familiar,14,2.6390573296152584
pets,14,2.6390573296152584
latex,14,2.6390573296152584
212,14,2.6390573296152584
197,14,2.6390573296152584
certainly,14,2.6390573296152584
verapamil,14,2.6390573296152584
233,14,2.6390573296152584
suddenly,14,2.6390573296152584
anomalous,14,2.6390573296152584
defines,14,2.6390573296152584
transesophageal,14,2.6390573296152584
draw,14,2.6390573296152584
pdm09,14,2.6390573296152584
disappeared,14,2.6390573296152584
band,14,2.6390573296152584
medicinal,14,2.6390573296152584
CRP,14,2.6390573296152584
Pregnant,14,2.6390573296152584
disadvantages,14,2.6390573296152584
simply,14,2.6390573296152584
alarming,14,2.6390573296152584
linkage,14,2.6390573296152584
inner-city,14,2.6390573296152584
photon,14,2.6390573296152584
flows,14,2.6390573296152584
clarified,14,2.6390573296152584
format,14,2.6390573296152584
vasculopathy,14,2.6390573296152584
Traditional,14,2.6390573296152584
color,14,2.6390573296152584
disabled,14,2.6390573296152584
long-lasting,14,2.6390573296152584
multiorgan,14,2.6390573296152584
allocated,14,2.6390573296152584
Korean,14,2.6390573296152584
full-length,14,2.6390573296152584
accessibility,14,2.6390573296152584
intrathoracic,14,2.6390573296152584
Dermatophagoides,14,2.6390573296152584
slowly,14,2.6390573296152584
summarises,14,2.6390573296152584
137,14,2.6390573296152584
β,14,2.6390573296152584
pteronyssinus,14,2.6390573296152584
consent,14,2.6390573296152584
hallmark,14,2.6390573296152584
delineate,14,2.6390573296152584
industrialized,14,2.6390573296152584
2010-2011,14,2.6390573296152584
S-T,14,2.6390573296152584
RAS,14,2.6390573296152584
eliminating,14,2.6390573296152584
overt,14,2.6390573296152584
perennial,14,2.6390573296152584
repeatedly,14,2.6390573296152584
inability,14,2.6390573296152584
registration,14,2.6390573296152584
hypothetical,14,2.6390573296152584
Prompt,14,2.6390573296152584
exacerbated,14,2.6390573296152584
ventilated,14,2.6390573296152584
chemotherapy,14,2.6390573296152584
nitrates,14,2.6390573296152584
self-care,14,2.6390573296152584
Ventricular,14,2.6390573296152584
Researchers,13,2.5649493574615367
BT,13,2.5649493574615367
ground-glass,13,2.5649493574615367
pursued,13,2.5649493574615367
LVAD,13,2.5649493574615367
otitis,13,2.5649493574615367
disappointing,13,2.5649493574615367
minorities,13,2.5649493574615367
Oxford,13,2.5649493574615367
altitude,13,2.5649493574615367
Post-stroke,13,2.5649493574615367
prothrombotic,13,2.5649493574615367
153,13,2.5649493574615367
heterologous,13,2.5649493574615367
initiative,13,2.5649493574615367
Functional,13,2.5649493574615367
narratives,13,2.5649493574615367
meningococcal,13,2.5649493574615367
bowel,13,2.5649493574615367
declining,13,2.5649493574615367
Appropriate,13,2.5649493574615367
miRNA,13,2.5649493574615367
disaster,13,2.5649493574615367
diminished,13,2.5649493574615367
Meanwhile,13,2.5649493574615367
holds,13,2.5649493574615367
urokinase,13,2.5649493574615367
Spontaneous,13,2.5649493574615367
explaining,13,2.5649493574615367
peers,13,2.5649493574615367
educate,13,2.5649493574615367
instruction,13,2.5649493574615367
implies,13,2.5649493574615367
interactive,13,2.5649493574615367
deciding,13,2.5649493574615367
CSOE,13,2.5649493574615367
MS,13,2.5649493574615367
helping,13,2.5649493574615367
DSE,13,2.5649493574615367
045,13,2.5649493574615367
170,13,2.5649493574615367
HCT,13,2.5649493574615367
playing,13,2.5649493574615367
telemedicine,13,2.5649493574615367
PD,13,2.5649493574615367
branches,13,2.5649493574615367
IL-4,13,2.5649493574615367
confers,13,2.5649493574615367
2016-2017,13,2.5649493574615367
NAbs,13,2.5649493574615367
opening,13,2.5649493574615367
ligands,13,2.5649493574615367
eczema,13,2.5649493574615367
PCS,13,2.5649493574615367
dermatitis,13,2.5649493574615367
Sciences,13,2.5649493574615367
redistribution,13,2.5649493574615367
spray,13,2.5649493574615367
Statins,13,2.5649493574615367
transmissions,13,2.5649493574615367
analyzes,13,2.5649493574615367
amenable,13,2.5649493574615367
proof,13,2.5649493574615367
insertion,13,2.5649493574615367
mRNA-based,13,2.5649493574615367
neuroplasticity,13,2.5649493574615367
extracts,13,2.5649493574615367
connections,13,2.5649493574615367
μM,13,2.5649493574615367
209,13,2.5649493574615367
LGE,13,2.5649493574615367
youngest,13,2.5649493574615367
meters,13,2.5649493574615367
evidences,13,2.5649493574615367
excursion,13,2.5649493574615367
functionally,13,2.5649493574615367
expressions,13,2.5649493574615367
metrics,13,2.5649493574615367
bronchopulmonary,13,2.5649493574615367
keywords,13,2.5649493574615367
automatically,13,2.5649493574615367
complicate,13,2.5649493574615367
010,13,2.5649493574615367
incorrect,13,2.5649493574615367
lysis,13,2.5649493574615367
Failure,13,2.5649493574615367
246,13,2.5649493574615367
unselected,13,2.5649493574615367
217,13,2.5649493574615367
Index,13,2.5649493574615367
genesis,13,2.5649493574615367
pacemaker,13,2.5649493574615367
combines,13,2.5649493574615367
co-infections,13,2.5649493574615367
glutathione,13,2.5649493574615367
African-American,13,2.5649493574615367
signatures,13,2.5649493574615367
QS,13,2.5649493574615367
belongs,13,2.5649493574615367
homeostasis,13,2.5649493574615367
implication,13,2.5649493574615367
vectorcardiographic,13,2.5649493574615367
BALBc,13,2.5649493574615367
literacy,13,2.5649493574615367
FVC,13,2.5649493574615367
farmers,13,2.5649493574615367
counter,13,2.5649493574615367
Neuraminidase,13,2.5649493574615367
security,13,2.5649493574615367
standardization,13,2.5649493574615367
vigilant,13,2.5649493574615367
clues,13,2.5649493574615367
work-related,13,2.5649493574615367
nifedipine,13,2.5649493574615367
stressed,13,2.5649493574615367
easier,13,2.5649493574615367
cm,13,2.5649493574615367
single-stranded,13,2.5649493574615367
7th,13,2.5649493574615367
feeling,13,2.5649493574615367
boost,13,2.5649493574615367
width,13,2.5649493574615367
Medicare,13,2.5649493574615367
overweight,13,2.5649493574615367
Next,13,2.5649493574615367
multidimensional,13,2.5649493574615367
differentiating,13,2.5649493574615367
saturation,13,2.5649493574615367
24-hour,13,2.5649493574615367
tocilizumab,13,2.5649493574615367
Poor,13,2.5649493574615367
neglected,13,2.5649493574615367
Conventional,13,2.5649493574615367
infectiousness,13,2.5649493574615367
worst,13,2.5649493574615367
attributes,13,2.5649493574615367
arrived,13,2.5649493574615367
TLRs,13,2.5649493574615367
functionality,13,2.5649493574615367
creates,13,2.5649493574615367
extending,13,2.5649493574615367
bearing,13,2.5649493574615367
M1,13,2.5649493574615367
tissue-type,13,2.5649493574615367
IBV,13,2.5649493574615367
schemes,13,2.5649493574615367
187,13,2.5649493574615367
156,13,2.5649493574615367
neutralize,13,2.5649493574615367
parenchyma,13,2.5649493574615367
biopsies,13,2.5649493574615367
Any,13,2.5649493574615367
provoked,13,2.5649493574615367
216,13,2.5649493574615367
Inc,13,2.5649493574615367
subtle,13,2.5649493574615367
purified,13,2.5649493574615367
foremen,13,2.5649493574615367
TOAST,13,2.5649493574615367
postpartum,13,2.5649493574615367
ectopic,13,2.5649493574615367
affordable,13,2.5649493574615367
trying,13,2.5649493574615367
hypothermia,13,2.5649493574615367
225,13,2.5649493574615367
thousand,13,2.5649493574615367
cell-mediated,13,2.5649493574615367
unfavourable,13,2.5649493574615367
inner,13,2.5649493574615367
claimed,13,2.5649493574615367
conformational,13,2.5649493574615367
urine,13,2.5649493574615367
Lower,13,2.5649493574615367
biases,13,2.5649493574615367
in-person,13,2.5649493574615367
revascularisation,13,2.5649493574615367
coagulopathy,13,2.5649493574615367
Groups,13,2.5649493574615367
RVI,13,2.5649493574615367
transcriptase-polymerase,13,2.5649493574615367
insult,13,2.5649493574615367
inevitable,13,2.5649493574615367
tandem,13,2.5649493574615367
1988,13,2.5649493574615367
EIB,13,2.5649493574615367
liquid,13,2.5649493574615367
contrary,13,2.5649493574615367
unlike,13,2.5649493574615367
yrs,13,2.5649493574615367
Cell,13,2.5649493574615367
169,13,2.5649493574615367
lasted,13,2.5649493574615367
circulate,13,2.5649493574615367
alteplase,13,2.5649493574615367
non-ST,13,2.5649493574615367
forecast,13,2.5649493574615367
cysteine,13,2.5649493574615367
Ontario,13,2.5649493574615367
stiffness,13,2.5649493574615367
neuromuscular,13,2.5649493574615367
linking,13,2.5649493574615367
099,13,2.5649493574615367
Protein,13,2.5649493574615367
NCP,13,2.5649493574615367
cromolyn,13,2.5649493574615367
loop,13,2.5649493574615367
carrier,13,2.5649493574615367
devoted,13,2.5649493574615367
pure,13,2.5649493574615367
invaluable,13,2.5649493574615367
surprising,13,2.5649493574615367
facial,13,2.5649493574615367
CBT,13,2.5649493574615367
arguments,13,2.5649493574615367
preferable,13,2.5649493574615367
CST,13,2.5649493574615367
interested,13,2.5649493574615367
WM,13,2.5649493574615367
malignancy,13,2.5649493574615367
quantity,13,2.5649493574615367
EUA,13,2.5649493574615367
organizational,13,2.5649493574615367
promotion,13,2.5649493574615367
SI,13,2.5649493574615367
simplicity,13,2.5649493574615367
discussions,13,2.5649493574615367
advocate,13,2.5649493574615367
felt,13,2.5649493574615367
constriction,13,2.5649493574615367
RBBB,13,2.5649493574615367
promotes,13,2.5649493574615367
Older,13,2.5649493574615367
assume,13,2.5649493574615367
blind,13,2.5649493574615367
anginal,13,2.5649493574615367
S-OIV,13,2.5649493574615367
175,13,2.5649493574615367
H2N2,13,2.5649493574615367
Outcomes,13,2.5649493574615367
intervene,13,2.5649493574615367
171,13,2.5649493574615367
IDV,13,2.5649493574615367
occasions,13,2.5649493574615367
NAIs,13,2.5649493574615367
guinea,13,2.5649493574615367
resection,13,2.5649493574615367
entirely,13,2.5649493574615367
up-to-date,13,2.5649493574615367
separated,13,2.5649493574615367
Silent,13,2.5649493574615367
positions,13,2.5649493574615367
Available,13,2.5649493574615367
doubt,13,2.5649493574615367
congestion,13,2.5649493574615367
determinations,13,2.5649493574615367
lay,13,2.5649493574615367
Aspirin,13,2.5649493574615367
035,13,2.5649493574615367
inferred,13,2.5649493574615367
powder,13,2.5649493574615367
Phylogenetic,13,2.5649493574615367
circuit,13,2.5649493574615367
plausible,13,2.5649493574615367
coexisting,13,2.5649493574615367
hematoma,13,2.5649493574615367
Reaction,13,2.5649493574615367
OMI,13,2.5649493574615367
chemoprophylaxis,13,2.5649493574615367
cat,13,2.5649493574615367
imply,13,2.5649493574615367
alignment,13,2.5649493574615367
begins,13,2.5649493574615367
Agency,13,2.5649493574615367
Protection,13,2.5649493574615367
gated,13,2.5649493574615367
VL,13,2.5649493574615367
009,13,2.5649493574615367
tamponade,13,2.5649493574615367
delaying,13,2.5649493574615367
swallowing,13,2.5649493574615367
147,13,2.5649493574615367
atrioventricular,13,2.5649493574615367
SC,13,2.5649493574615367
antiphospholipid,13,2.5649493574615367
quantifying,13,2.5649493574615367
poverty,13,2.5649493574615367
Subsequently,13,2.5649493574615367
sociodemographic,13,2.5649493574615367
incorporates,13,2.5649493574615367
amplified,13,2.5649493574615367
mannitol,13,2.5649493574615367
Baseline,13,2.5649493574615367
243,13,2.5649493574615367
enrichment,13,2.5649493574615367
cardioembolism,13,2.5649493574615367
Not,13,2.5649493574615367
Clinic,13,2.5649493574615367
egg,13,2.5649493574615367
unusually,13,2.5649493574615367
malaise,13,2.5649493574615367
War,12,2.4849066497880004
first-time,12,2.4849066497880004
ruled,12,2.4849066497880004
sex-specific,12,2.4849066497880004
A549,12,2.4849066497880004
Cepheid,12,2.4849066497880004
preterm,12,2.4849066497880004
atheromatous,12,2.4849066497880004
undoubtedly,12,2.4849066497880004
Unlike,12,2.4849066497880004
commonest,12,2.4849066497880004
172,12,2.4849066497880004
expectations,12,2.4849066497880004
Efforts,12,2.4849066497880004
Basic,12,2.4849066497880004
reacted,12,2.4849066497880004
Samples,12,2.4849066497880004
needing,12,2.4849066497880004
reductase,12,2.4849066497880004
opacities,12,2.4849066497880004
Polymerase,12,2.4849066497880004
economical,12,2.4849066497880004
183,12,2.4849066497880004
195,12,2.4849066497880004
Scopus,12,2.4849066497880004
Death,12,2.4849066497880004
fighting,12,2.4849066497880004
antiplatelets,12,2.4849066497880004
HT,12,2.4849066497880004
covers,12,2.4849066497880004
vertigo,12,2.4849066497880004
post-acute,12,2.4849066497880004
user,12,2.4849066497880004
minimally,12,2.4849066497880004
pre-pandemic,12,2.4849066497880004
134,12,2.4849066497880004
resident,12,2.4849066497880004
IFN,12,2.4849066497880004
protects,12,2.4849066497880004
non-pharmacological,12,2.4849066497880004
inverse,12,2.4849066497880004
waiting,12,2.4849066497880004
fiber,12,2.4849066497880004
femoral,12,2.4849066497880004
advised,12,2.4849066497880004
Kong68,12,2.4849066497880004
homologous,12,2.4849066497880004
genome-wide,12,2.4849066497880004
hip,12,2.4849066497880004
discrete,12,2.4849066497880004
complained,12,2.4849066497880004
IACP,12,2.4849066497880004
nucleoprotein,12,2.4849066497880004
intra-hospital,12,2.4849066497880004
choose,12,2.4849066497880004
exerts,12,2.4849066497880004
misinformation,12,2.4849066497880004
149,12,2.4849066497880004
backgrounds,12,2.4849066497880004
falls,12,2.4849066497880004
ascending,12,2.4849066497880004
Notably,12,2.4849066497880004
temporary,12,2.4849066497880004
concentrated,12,2.4849066497880004
derivatives,12,2.4849066497880004
222,12,2.4849066497880004
humanity,12,2.4849066497880004
appearing,12,2.4849066497880004
N2,12,2.4849066497880004
three-dimensional,12,2.4849066497880004
post-vaccination,12,2.4849066497880004
UEMI,12,2.4849066497880004
Extensive,12,2.4849066497880004
RI,12,2.4849066497880004
somewhat,12,2.4849066497880004
ozone,12,2.4849066497880004
implanted,12,2.4849066497880004
Argentina,12,2.4849066497880004
labs,12,2.4849066497880004
productivity,12,2.4849066497880004
Nigeria,12,2.4849066497880004
preserve,12,2.4849066497880004
arises,12,2.4849066497880004
evasion,12,2.4849066497880004
hamsters,12,2.4849066497880004
earliest,12,2.4849066497880004
GGOs,12,2.4849066497880004
latency,12,2.4849066497880004
ACO,12,2.4849066497880004
pertaining,12,2.4849066497880004
neuropsychiatric,12,2.4849066497880004
MIS,12,2.4849066497880004
Auckland,12,2.4849066497880004
RaTG13,12,2.4849066497880004
pipeline,12,2.4849066497880004
Investigation,12,2.4849066497880004
Mb,12,2.4849066497880004
traumatic,12,2.4849066497880004
meaning,12,2.4849066497880004
Assay,12,2.4849066497880004
non-diabetic,12,2.4849066497880004
Dutch,12,2.4849066497880004
E484K,12,2.4849066497880004
Sv-O2,12,2.4849066497880004
dealt,12,2.4849066497880004
one-step,12,2.4849066497880004
single-dose,12,2.4849066497880004
RT,12,2.4849066497880004
virus-specific,12,2.4849066497880004
GER,12,2.4849066497880004
noticed,12,2.4849066497880004
266,12,2.4849066497880004
hot,12,2.4849066497880004
Plan,12,2.4849066497880004
suppressing,12,2.4849066497880004
chronically,12,2.4849066497880004
speculated,12,2.4849066497880004
aggravation,12,2.4849066497880004
expect,12,2.4849066497880004
hemodialysis,12,2.4849066497880004
stroke-induced,12,2.4849066497880004
PAI-1,12,2.4849066497880004
rtPA,12,2.4849066497880004
implantable,12,2.4849066497880004
on-site,12,2.4849066497880004
croup,12,2.4849066497880004
Eleven,12,2.4849066497880004
labor,12,2.4849066497880004
web,12,2.4849066497880004
ngmL,12,2.4849066497880004
NI,12,2.4849066497880004
Improvements,12,2.4849066497880004
fate,12,2.4849066497880004
VF,12,2.4849066497880004
Sera,12,2.4849066497880004
Guideline,12,2.4849066497880004
aureus,12,2.4849066497880004
ABCD2,12,2.4849066497880004
detects,12,2.4849066497880004
microorganisms,12,2.4849066497880004
hyperplasia,12,2.4849066497880004
exercises,12,2.4849066497880004
buffer,12,2.4849066497880004
tightness,12,2.4849066497880004
gestational,12,2.4849066497880004
Streptococcus,12,2.4849066497880004
fulfilled,12,2.4849066497880004
productive,12,2.4849066497880004
age-specific,12,2.4849066497880004
drivers,12,2.4849066497880004
compelling,12,2.4849066497880004
CAP,12,2.4849066497880004
sST2,12,2.4849066497880004
whole-genome,12,2.4849066497880004
chemicals,12,2.4849066497880004
equitable,12,2.4849066497880004
Greater,12,2.4849066497880004
adrenal,12,2.4849066497880004
predominated,12,2.4849066497880004
eleven,12,2.4849066497880004
sectors,12,2.4849066497880004
meant,12,2.4849066497880004
Impella,12,2.4849066497880004
microenvironment,12,2.4849066497880004
219,12,2.4849066497880004
canine,12,2.4849066497880004
charts,12,2.4849066497880004
add-on,12,2.4849066497880004
235,12,2.4849066497880004
bad,12,2.4849066497880004
anterolateral,12,2.4849066497880004
sharp,12,2.4849066497880004
naïve,12,2.4849066497880004
185,12,2.4849066497880004
transduction,12,2.4849066497880004
bound,12,2.4849066497880004
town,12,2.4849066497880004
Flow,12,2.4849066497880004
exponential,12,2.4849066497880004
tight,12,2.4849066497880004
distinctive,12,2.4849066497880004
rollout,12,2.4849066497880004
Scholar,12,2.4849066497880004
HIT,12,2.4849066497880004
retrieval,12,2.4849066497880004
percentages,12,2.4849066497880004
MEDLINE,12,2.4849066497880004
mutational,12,2.4849066497880004
lacks,12,2.4849066497880004
Magnetic,12,2.4849066497880004
graded,12,2.4849066497880004
undertreatment,12,2.4849066497880004
sustain,12,2.4849066497880004
146,12,2.4849066497880004
PFR,12,2.4849066497880004
disease-19,12,2.4849066497880004
span,12,2.4849066497880004
underscore,12,2.4849066497880004
discontinued,12,2.4849066497880004
precipitating,12,2.4849066497880004
wheezers,12,2.4849066497880004
2-year,12,2.4849066497880004
suspect,12,2.4849066497880004
intensified,12,2.4849066497880004
synthesized,12,2.4849066497880004
201213,12,2.4849066497880004
eastern,12,2.4849066497880004
Agreement,12,2.4849066497880004
Statistical,12,2.4849066497880004
long-standing,12,2.4849066497880004
interacting,12,2.4849066497880004
e,12,2.4849066497880004
vertebrobasilar,12,2.4849066497880004
fibrin,12,2.4849066497880004
specified,12,2.4849066497880004
Lombardy,12,2.4849066497880004
malnutrition,12,2.4849066497880004
dye,12,2.4849066497880004
foundation,12,2.4849066497880004
chances,12,2.4849066497880004
restored,12,2.4849066497880004
consequent,12,2.4849066497880004
elusive,12,2.4849066497880004
07,12,2.4849066497880004
orientation,12,2.4849066497880004
NOACs,12,2.4849066497880004
disposable,12,2.4849066497880004
Advances,12,2.4849066497880004
cavitations,12,2.4849066497880004
suppressed,12,2.4849066497880004
Services,12,2.4849066497880004
synergistic,12,2.4849066497880004
mgdl,12,2.4849066497880004
monocyte,12,2.4849066497880004
thinking,12,2.4849066497880004
necessitates,12,2.4849066497880004
situ,12,2.4849066497880004
workplaces,12,2.4849066497880004
enriched,12,2.4849066497880004
herald,12,2.4849066497880004
thinning,12,2.4849066497880004
breakthrough,12,2.4849066497880004
Incidence,12,2.4849066497880004
San,12,2.4849066497880004
IA,12,2.4849066497880004
182,12,2.4849066497880004
abundant,12,2.4849066497880004
Finland,12,2.4849066497880004
Bangladesh,12,2.4849066497880004
motivated,12,2.4849066497880004
pneumomediastinum,12,2.4849066497880004
rises,12,2.4849066497880004
EC50,12,2.4849066497880004
partners,12,2.4849066497880004
closer,12,2.4849066497880004
History,12,2.4849066497880004
conjunctival,12,2.4849066497880004
AQLQ,12,2.4849066497880004
serine,12,2.4849066497880004
agricultural,12,2.4849066497880004
189,12,2.4849066497880004
alongside,12,2.4849066497880004
year-old,12,2.4849066497880004
intractable,12,2.4849066497880004
immunopathology,12,2.4849066497880004
RCA,12,2.4849066497880004
conservatively,12,2.4849066497880004
PTCR,12,2.4849066497880004
nutrition,12,2.4849066497880004
depletion,12,2.4849066497880004
Main,12,2.4849066497880004
subdivided,12,2.4849066497880004
laboratory-based,12,2.4849066497880004
microscopic,12,2.4849066497880004
158,12,2.4849066497880004
allergenic,12,2.4849066497880004
stunning,12,2.4849066497880004
microg,12,2.4849066497880004
socio-demographic,12,2.4849066497880004
luminal,12,2.4849066497880004
predictable,12,2.4849066497880004
ns,12,2.4849066497880004
gastric,12,2.4849066497880004
HDAC1,12,2.4849066497880004
employment,12,2.4849066497880004
endocrine,12,2.4849066497880004
underlie,12,2.4849066497880004
school-age,12,2.4849066497880004
native,12,2.4849066497880004
Brazilian,12,2.4849066497880004
static,12,2.4849066497880004
Angioplasty,12,2.4849066497880004
conferred,12,2.4849066497880004
glycoproteins,12,2.4849066497880004
systole,12,2.4849066497880004
Is,12,2.4849066497880004
HRCT,12,2.4849066497880004
arithmetic,12,2.4849066497880004
Swedish,12,2.4849066497880004
obstetric,12,2.4849066497880004
mutate,12,2.4849066497880004
Working,12,2.4849066497880004
mAbs,12,2.4849066497880004
ACP,12,2.4849066497880004
methylation,12,2.4849066497880004
B16172,12,2.4849066497880004
sham,12,2.4849066497880004
SARS-Cov-2,12,2.4849066497880004
destructive,12,2.4849066497880004
0000,12,2.4849066497880004
personalised,12,2.4849066497880004
MCDA,12,2.4849066497880004
beclomethasone,12,2.4849066497880004
log10,12,2.4849066497880004
words,12,2.4849066497880004
SP,12,2.4849066497880004
Survival,12,2.4849066497880004
measles,12,2.4849066497880004
noncardiac,12,2.4849066497880004
architecture,12,2.4849066497880004
ORs,12,2.4849066497880004
Adverse,12,2.4849066497880004
v,12,2.4849066497880004
dimension,12,2.4849066497880004
keeping,12,2.4849066497880004
age-adjusted,12,2.4849066497880004
Systematic,12,2.4849066497880004
Database,12,2.4849066497880004
moving,12,2.4849066497880004
refers,12,2.4849066497880004
IBD,12,2.4849066497880004
capillaries,12,2.4849066497880004
specificities,12,2.4849066497880004
contraindicated,12,2.4849066497880004
O,12,2.4849066497880004
dipyridamole,12,2.4849066497880004
distances,12,2.4849066497880004
districts,12,2.4849066497880004
filtration,12,2.4849066497880004
NIH,12,2.4849066497880004
warrants,12,2.4849066497880004
POC,12,2.4849066497880004
whenever,12,2.4849066497880004
regurgitation,12,2.4849066497880004
strengths,12,2.4849066497880004
Improvement,12,2.4849066497880004
expiration,12,2.4849066497880004
163,12,2.4849066497880004
comprehensively,12,2.4849066497880004
going,12,2.4849066497880004
hypersecretion,12,2.4849066497880004
envelope,12,2.4849066497880004
RNA-dependent,12,2.4849066497880004
Swiss,12,2.4849066497880004
zip,12,2.4849066497880004
non-ST-elevation,12,2.4849066497880004
discrimination,12,2.4849066497880004
uneventful,12,2.4849066497880004
adjust,12,2.4849066497880004
saved,12,2.4849066497880004
pts,12,2.4849066497880004
universally,12,2.4849066497880004
sector,12,2.4849066497880004
blood-brain,12,2.4849066497880004
Authors,11,2.3978952727983707
LDH,11,2.3978952727983707
hyperlipidemia,11,2.3978952727983707
MBG,11,2.3978952727983707
adopt,11,2.3978952727983707
failures,11,2.3978952727983707
012,11,2.3978952727983707
Arterial,11,2.3978952727983707
ICSs,11,2.3978952727983707
figure,11,2.3978952727983707
went,11,2.3978952727983707
cleared,11,2.3978952727983707
224,11,2.3978952727983707
locally,11,2.3978952727983707
G-CSF,11,2.3978952727983707
monocytes,11,2.3978952727983707
1-3,11,2.3978952727983707
twofold,11,2.3978952727983707
Alberta,11,2.3978952727983707
corresponded,11,2.3978952727983707
interfering,11,2.3978952727983707
elementary,11,2.3978952727983707
040,11,2.3978952727983707
immunizations,11,2.3978952727983707
stressors,11,2.3978952727983707
pericardium,11,2.3978952727983707
siRNAs,11,2.3978952727983707
indispensable,11,2.3978952727983707
deteriorated,11,2.3978952727983707
Internal,11,2.3978952727983707
afford,11,2.3978952727983707
Service,11,2.3978952727983707
raceethnicity,11,2.3978952727983707
automatic,11,2.3978952727983707
connective,11,2.3978952727983707
psychologic,11,2.3978952727983707
persisting,11,2.3978952727983707
Standard,11,2.3978952727983707
eliminated,11,2.3978952727983707
p001,11,2.3978952727983707
CSF,11,2.3978952727983707
234,11,2.3978952727983707
Outbreaks,11,2.3978952727983707
accelerating,11,2.3978952727983707
proteomic,11,2.3978952727983707
impair,11,2.3978952727983707
M2,11,2.3978952727983707
parasympathetic,11,2.3978952727983707
execution,11,2.3978952727983707
pilgrims,11,2.3978952727983707
serving,11,2.3978952727983707
rating,11,2.3978952727983707
fistula,11,2.3978952727983707
dimensions,11,2.3978952727983707
pharmacists,11,2.3978952727983707
muscular,11,2.3978952727983707
faces,11,2.3978952727983707
complexities,11,2.3978952727983707
aVL,11,2.3978952727983707
eliciting,11,2.3978952727983707
Hispanics,11,2.3978952727983707
cited,11,2.3978952727983707
AEFI,11,2.3978952727983707
265,11,2.3978952727983707
hazardous,11,2.3978952727983707
advancing,11,2.3978952727983707
Skin,11,2.3978952727983707
physically,11,2.3978952727983707
hinder,11,2.3978952727983707
geriatric,11,2.3978952727983707
186,11,2.3978952727983707
bioinformatics,11,2.3978952727983707
doubled,11,2.3978952727983707
148,11,2.3978952727983707
forces,11,2.3978952727983707
Staphylococcus,11,2.3978952727983707
088,11,2.3978952727983707
oedema,11,2.3978952727983707
ET,11,2.3978952727983707
continent,11,2.3978952727983707
stabilize,11,2.3978952727983707
physiotherapy,11,2.3978952727983707
von,11,2.3978952727983707
outreach,11,2.3978952727983707
readings,11,2.3978952727983707
homogeneous,11,2.3978952727983707
admitting,11,2.3978952727983707
cover,11,2.3978952727983707
202,11,2.3978952727983707
schedule,11,2.3978952727983707
Multivariable,11,2.3978952727983707
aptamer,11,2.3978952727983707
probabilities,11,2.3978952727983707
virions,11,2.3978952727983707
Hospitals,11,2.3978952727983707
Together,11,2.3978952727983707
expectancy,11,2.3978952727983707
136,11,2.3978952727983707
094,11,2.3978952727983707
deeper,11,2.3978952727983707
continuation,11,2.3978952727983707
167,11,2.3978952727983707
curb,11,2.3978952727983707
Sixteen,11,2.3978952727983707
out-of-hospital,11,2.3978952727983707
endoscopy,11,2.3978952727983707
stabilized,11,2.3978952727983707
RIDTs,11,2.3978952727983707
divergence,11,2.3978952727983707
Negative,11,2.3978952727983707
necessitating,11,2.3978952727983707
attenuate,11,2.3978952727983707
non-Hispanic,11,2.3978952727983707
atrophy,11,2.3978952727983707
deals,11,2.3978952727983707
classifier,11,2.3978952727983707
polyps,11,2.3978952727983707
late-onset,11,2.3978952727983707
suggestion,11,2.3978952727983707
disrupted,11,2.3978952727983707
Upon,11,2.3978952727983707
remedies,11,2.3978952727983707
ergometry,11,2.3978952727983707
155,11,2.3978952727983707
PT,11,2.3978952727983707
immunomodulation,11,2.3978952727983707
hierarchical,11,2.3978952727983707
popular,11,2.3978952727983707
252,11,2.3978952727983707
reconstruction,11,2.3978952727983707
positives,11,2.3978952727983707
irritant,11,2.3978952727983707
diaries,11,2.3978952727983707
dispensing,11,2.3978952727983707
comprises,11,2.3978952727983707
014,11,2.3978952727983707
schedules,11,2.3978952727983707
065,11,2.3978952727983707
Twelve,11,2.3978952727983707
AZD1222,11,2.3978952727983707
washing,11,2.3978952727983707
Anxiety,11,2.3978952727983707
00002,11,2.3978952727983707
extrapolated,11,2.3978952727983707
gaining,11,2.3978952727983707
neurology,11,2.3978952727983707
leukotrienes,11,2.3978952727983707
INDICAID,11,2.3978952727983707
informal,11,2.3978952727983707
Haemophilus,11,2.3978952727983707
pre-stroke,11,2.3978952727983707
underused,11,2.3978952727983707
hemostatic,11,2.3978952727983707
neurogenesis,11,2.3978952727983707
ablation,11,2.3978952727983707
Especially,11,2.3978952727983707
destruction,11,2.3978952727983707
Ebola,11,2.3978952727983707
H3,11,2.3978952727983707
hematological,11,2.3978952727983707
inhibits,11,2.3978952727983707
prodromal,11,2.3978952727983707
round,11,2.3978952727983707
populated,11,2.3978952727983707
miRs,11,2.3978952727983707
quintiles,11,2.3978952727983707
constructs,11,2.3978952727983707
123,11,2.3978952727983707
albeit,11,2.3978952727983707
relates,11,2.3978952727983707
Relative,11,2.3978952727983707
spatiotemporal,11,2.3978952727983707
1986,11,2.3978952727983707
motif,11,2.3978952727983707
players,11,2.3978952727983707
recesses,11,2.3978952727983707
MA,11,2.3978952727983707
puncture,11,2.3978952727983707
copper,11,2.3978952727983707
person-to-person,11,2.3978952727983707
separation,11,2.3978952727983707
RAD,11,2.3978952727983707
identity,11,2.3978952727983707
031,11,2.3978952727983707
infects,11,2.3978952727983707
frontal,11,2.3978952727983707
immunosuppressed,11,2.3978952727983707
Aspergillus,11,2.3978952727983707
strategic,11,2.3978952727983707
administering,11,2.3978952727983707
suspended,11,2.3978952727983707
anosmia,11,2.3978952727983707
chloride,11,2.3978952727983707
FA,11,2.3978952727983707
Elderly,11,2.3978952727983707
compiled,11,2.3978952727983707
postmenopausal,11,2.3978952727983707
4-year,11,2.3978952727983707
aggregated,11,2.3978952727983707
layers,11,2.3978952727983707
MV,11,2.3978952727983707
website,11,2.3978952727983707
drug-resistant,11,2.3978952727983707
mapped,11,2.3978952727983707
196,11,2.3978952727983707
Independent,11,2.3978952727983707
173,11,2.3978952727983707
Prospective,11,2.3978952727983707
elapsed,11,2.3978952727983707
RD,11,2.3978952727983707
aggravate,11,2.3978952727983707
web-based,11,2.3978952727983707
provocative,11,2.3978952727983707
376,11,2.3978952727983707
visiting,11,2.3978952727983707
pneumonias,11,2.3978952727983707
unresolved,11,2.3978952727983707
logistical,11,2.3978952727983707
achievement,11,2.3978952727983707
technological,11,2.3978952727983707
relying,11,2.3978952727983707
SOT,11,2.3978952727983707
ascertainment,11,2.3978952727983707
PAF,11,2.3978952727983707
delineated,11,2.3978952727983707
originally,11,2.3978952727983707
scored,11,2.3978952727983707
515,11,2.3978952727983707
transgenic,11,2.3978952727983707
Anticoagulation,11,2.3978952727983707
Asthmatic,11,2.3978952727983707
VTM,11,2.3978952727983707
decompressive,11,2.3978952727983707
obstacles,11,2.3978952727983707
temperatures,11,2.3978952727983707
Single,11,2.3978952727983707
belonged,11,2.3978952727983707
375,11,2.3978952727983707
blocked,11,2.3978952727983707
Immune,11,2.3978952727983707
resource-limited,11,2.3978952727983707
192,11,2.3978952727983707
salbutamol,11,2.3978952727983707
remove,11,2.3978952727983707
inducible,11,2.3978952727983707
rhinoviruses,11,2.3978952727983707
standardised,11,2.3978952727983707
ingestion,11,2.3978952727983707
intracardiac,11,2.3978952727983707
trade,11,2.3978952727983707
157,11,2.3978952727983707
longevity,11,2.3978952727983707
Vascular,11,2.3978952727983707
primates,11,2.3978952727983707
excretion,11,2.3978952727983707
Latino,11,2.3978952727983707
arteriopathy,11,2.3978952727983707
angiopathy,11,2.3978952727983707
bolus,11,2.3978952727983707
Surprisingly,11,2.3978952727983707
drops,11,2.3978952727983707
staging,11,2.3978952727983707
strictly,11,2.3978952727983707
physician-diagnosed,11,2.3978952727983707
DOAC,11,2.3978952727983707
preserving,11,2.3978952727983707
durations,11,2.3978952727983707
discrepancies,11,2.3978952727983707
framing,11,2.3978952727983707
migratory,11,2.3978952727983707
nonischemic,11,2.3978952727983707
tilt,11,2.3978952727983707
readers,11,2.3978952727983707
longer-term,11,2.3978952727983707
accordingly,11,2.3978952727983707
IU,11,2.3978952727983707
economies,11,2.3978952727983707
bioactive,11,2.3978952727983707
Ang,11,2.3978952727983707
render,11,2.3978952727983707
IgMIgG,11,2.3978952727983707
borderline,11,2.3978952727983707
Kaplan-Meier,11,2.3978952727983707
segmentation,11,2.3978952727983707
bundle-branch,11,2.3978952727983707
evolves,11,2.3978952727983707
sensorimotor,11,2.3978952727983707
extremity,11,2.3978952727983707
argues,11,2.3978952727983707
NQMI,11,2.3978952727983707
equipped,11,2.3978952727983707
deficient,11,2.3978952727983707
ETT,11,2.3978952727983707
EMBASE,11,2.3978952727983707
t,11,2.3978952727983707
colds,11,2.3978952727983707
205,11,2.3978952727983707
cranial,11,2.3978952727983707
AV,11,2.3978952727983707
lifetime,11,2.3978952727983707
library,11,2.3978952727983707
modifying,11,2.3978952727983707
chains,11,2.3978952727983707
centralized,11,2.3978952727983707
displaying,11,2.3978952727983707
compartments,11,2.3978952727983707
intensively,11,2.3978952727983707
accumulated,11,2.3978952727983707
ACIP,11,2.3978952727983707
signal-averaged,11,2.3978952727983707
demanding,11,2.3978952727983707
new-onset,11,2.3978952727983707
campus,11,2.3978952727983707
rank,11,2.3978952727983707
Texas,11,2.3978952727983707
ST-segment-elevation,11,2.3978952727983707
imminent,11,2.3978952727983707
referring,11,2.3978952727983707
213,11,2.3978952727983707
posing,11,2.3978952727983707
LR,11,2.3978952727983707
Taking,11,2.3978952727983707
foods,11,2.3978952727983707
ready,11,2.3978952727983707
investigational,11,2.3978952727983707
138,11,2.3978952727983707
winters,11,2.3978952727983707
reinforce,11,2.3978952727983707
projected,11,2.3978952727983707
preferentially,11,2.3978952727983707
diary,11,2.3978952727983707
kinases,11,2.3978952727983707
sparing,11,2.3978952727983707
MDCK,11,2.3978952727983707
healed,11,2.3978952727983707
geographically,11,2.3978952727983707
opposite,11,2.3978952727983707
IVE,11,2.3978952727983707
condensate,11,2.3978952727983707
margin,11,2.3978952727983707
beta-agonists,11,2.3978952727983707
losses,11,2.3978952727983707
transfusions,11,2.3978952727983707
Half,11,2.3978952727983707
ADE,11,2.3978952727983707
spatio-temporal,11,2.3978952727983707
chicken,11,2.3978952727983707
aligned,11,2.3978952727983707
Certain,11,2.3978952727983707
infiltrate,11,2.3978952727983707
launched,11,2.3978952727983707
Measure,11,2.3978952727983707
administer,11,2.3978952727983707
counseling,11,2.3978952727983707
justified,11,2.3978952727983707
Ethiopia,11,2.3978952727983707
Coronaviridae,11,2.3978952727983707
skill,11,2.3978952727983707
negatives,11,2.3978952727983707
subunits,11,2.3978952727983707
submaximal,11,2.3978952727983707
kappa,11,2.3978952727983707
≤,11,2.3978952727983707
loci,11,2.3978952727983707
phenotyping,11,2.3978952727983707
two-thirds,11,2.3978952727983707
precipitate,11,2.3978952727983707
near-fatal,11,2.3978952727983707
Child,11,2.3978952727983707
CA,11,2.3978952727983707
fold,11,2.3978952727983707
esophageal,11,2.3978952727983707
dog,11,2.3978952727983707
stabilization,11,2.3978952727983707
spots,11,2.3978952727983707
steadily,11,2.3978952727983707
reciprocal,11,2.3978952727983707
cleaning,11,2.3978952727983707
real-life,11,2.3978952727983707
Reperfusion,11,2.3978952727983707
Differences,11,2.3978952727983707
credible,10,2.302585092994046
isoenzymes,10,2.302585092994046
notes,10,2.302585092994046
employ,10,2.302585092994046
macaques,10,2.302585092994046
mitochondrial,10,2.302585092994046
HLA,10,2.302585092994046
yielding,10,2.302585092994046
plastic,10,2.302585092994046
irregular,10,2.302585092994046
Echocardiographic,10,2.302585092994046
journals,10,2.302585092994046
MoCA,10,2.302585092994046
Consensus,10,2.302585092994046
workload,10,2.302585092994046
seldom,10,2.302585092994046
Day,10,2.302585092994046
passengers,10,2.302585092994046
tropism,10,2.302585092994046
068,10,2.302585092994046
marginal,10,2.302585092994046
immunologically,10,2.302585092994046
dinitrate,10,2.302585092994046
negligible,10,2.302585092994046
neighboring,10,2.302585092994046
reversed,10,2.302585092994046
inherited,10,2.302585092994046
220,10,2.302585092994046
Lacunar,10,2.302585092994046
hourly,10,2.302585092994046
styles,10,2.302585092994046
carers,10,2.302585092994046
082,10,2.302585092994046
imposed,10,2.302585092994046
PLR,10,2.302585092994046
refer,10,2.302585092994046
distant,10,2.302585092994046
projections,10,2.302585092994046
BCG,10,2.302585092994046
Whilst,10,2.302585092994046
persistently,10,2.302585092994046
peripartum,10,2.302585092994046
DA,10,2.302585092994046
references,10,2.302585092994046
LOD,10,2.302585092994046
matching,10,2.302585092994046
rhesus,10,2.302585092994046
willing,10,2.302585092994046
intramuscular,10,2.302585092994046
researches,10,2.302585092994046
tea,10,2.302585092994046
244,10,2.302585092994046
SSA,10,2.302585092994046
supplemented,10,2.302585092994046
Georgia,10,2.302585092994046
reaches,10,2.302585092994046
sneezing,10,2.302585092994046
313,10,2.302585092994046
HA1,10,2.302585092994046
Univariate,10,2.302585092994046
Area,10,2.302585092994046
CpG,10,2.302585092994046
additionally,10,2.302585092994046
Ohio,10,2.302585092994046
C-STAT,10,2.302585092994046
afferent,10,2.302585092994046
625,10,2.302585092994046
regulators,10,2.302585092994046
biggest,10,2.302585092994046
tends,10,2.302585092994046
grow,10,2.302585092994046
fairly,10,2.302585092994046
disturbed,10,2.302585092994046
non-smokers,10,2.302585092994046
subendocardial,10,2.302585092994046
reminders,10,2.302585092994046
microRNAs,10,2.302585092994046
Viruses,10,2.302585092994046
exaggerated,10,2.302585092994046
imagery,10,2.302585092994046
pseudotyped,10,2.302585092994046
mechanics,10,2.302585092994046
visualize,10,2.302585092994046
expenditure,10,2.302585092994046
waking,10,2.302585092994046
contradictory,10,2.302585092994046
218,10,2.302585092994046
temporally,10,2.302585092994046
IM,10,2.302585092994046
forcing,10,2.302585092994046
antecedent,10,2.302585092994046
Anti-SARS-CoV-2,10,2.302585092994046
superimposed,10,2.302585092994046
Sex,10,2.302585092994046
QTc,10,2.302585092994046
ANew,10,2.302585092994046
6th,10,2.302585092994046
fifty,10,2.302585092994046
revolutionized,10,2.302585092994046
CIs,10,2.302585092994046
table,10,2.302585092994046
BM,10,2.302585092994046
208,10,2.302585092994046
recurring,10,2.302585092994046
fair,10,2.302585092994046
Effectiveness,10,2.302585092994046
V3,10,2.302585092994046
mink,10,2.302585092994046
IAM,10,2.302585092994046
tailoring,10,2.302585092994046
supplementary,10,2.302585092994046
survivor,10,2.302585092994046
situated,10,2.302585092994046
Cambodia,10,2.302585092994046
024,10,2.302585092994046
fitting,10,2.302585092994046
channels,10,2.302585092994046
enlargement,10,2.302585092994046
se,10,2.302585092994046
Embase,10,2.302585092994046
sixth,10,2.302585092994046
logistics,10,2.302585092994046
gadolinium,10,2.302585092994046
Ireland,10,2.302585092994046
attenuation,10,2.302585092994046
190,10,2.302585092994046
autonomy,10,2.302585092994046
Russia,10,2.302585092994046
008,10,2.302585092994046
prednisolone,10,2.302585092994046
partnerships,10,2.302585092994046
asthmas,10,2.302585092994046
FDA-approved,10,2.302585092994046
longitudinally,10,2.302585092994046
shortened,10,2.302585092994046
listed,10,2.302585092994046
ordinary,10,2.302585092994046
radial,10,2.302585092994046
312,10,2.302585092994046
restrictive,10,2.302585092994046
convenience,10,2.302585092994046
notified,10,2.302585092994046
Sequencing,10,2.302585092994046
KO,10,2.302585092994046
Thirty-five,10,2.302585092994046
virion,10,2.302585092994046
HCTs,10,2.302585092994046
Systems,10,2.302585092994046
227,10,2.302585092994046
IL-5,10,2.302585092994046
tracer,10,2.302585092994046
tracheal,10,2.302585092994046
universities,10,2.302585092994046
Vero,10,2.302585092994046
interrupt,10,2.302585092994046
RNAi,10,2.302585092994046
TB,10,2.302585092994046
006,10,2.302585092994046
073,10,2.302585092994046
debilitating,10,2.302585092994046
intensities,10,2.302585092994046
endothelin-1,10,2.302585092994046
gestation,10,2.302585092994046
nested,10,2.302585092994046
SIV,10,2.302585092994046
019,10,2.302585092994046
macrofocal,10,2.302585092994046
Seventeen,10,2.302585092994046
HCoV-229E,10,2.302585092994046
feline,10,2.302585092994046
haemagglutination,10,2.302585092994046
hybridization,10,2.302585092994046
consist,10,2.302585092994046
predictability,10,2.302585092994046
Access,10,2.302585092994046
fractures,10,2.302585092994046
nonstructural,10,2.302585092994046
estrogen,10,2.302585092994046
affection,10,2.302585092994046
diaphragm,10,2.302585092994046
30th,10,2.302585092994046
intravenously,10,2.302585092994046
STAT3,10,2.302585092994046
mistrust,10,2.302585092994046
bronchoprovocation,10,2.302585092994046
Demographic,10,2.302585092994046
10-fold,10,2.302585092994046
disappearance,10,2.302585092994046
286,10,2.302585092994046
blocks,10,2.302585092994046
SRA,10,2.302585092994046
pseudovirus,10,2.302585092994046
impression,10,2.302585092994046
366,10,2.302585092994046
504,10,2.302585092994046
activating,10,2.302585092994046
successes,10,2.302585092994046
nevertheless,10,2.302585092994046
306,10,2.302585092994046
ultimate,10,2.302585092994046
multifaceted,10,2.302585092994046
CF,10,2.302585092994046
DD,10,2.302585092994046
cross-protective,10,2.302585092994046
phospholipase,10,2.302585092994046
framed,10,2.302585092994046
monogenic,10,2.302585092994046
intraoperative,10,2.302585092994046
exploratory,10,2.302585092994046
filled,10,2.302585092994046
corticospinal,10,2.302585092994046
expose,10,2.302585092994046
Systemic,10,2.302585092994046
stressful,10,2.302585092994046
PC-ASPECTS,10,2.302585092994046
battery,10,2.302585092994046
valves,10,2.302585092994046
Vitamin,10,2.302585092994046
deficiencies,10,2.302585092994046
Tamiflu,10,2.302585092994046
womens,10,2.302585092994046
inactivity,10,2.302585092994046
exacerbate,10,2.302585092994046
danger,10,2.302585092994046
periprocedural,10,2.302585092994046
dysfunctional,10,2.302585092994046
donation,10,2.302585092994046
Method,10,2.302585092994046
Corona,10,2.302585092994046
020,10,2.302585092994046
Small,10,2.302585092994046
reagent,10,2.302585092994046
acknowledged,10,2.302585092994046
innovations,10,2.302585092994046
AP,10,2.302585092994046
Patent,10,2.302585092994046
histopathology,10,2.302585092994046
permanently,10,2.302585092994046
Antigenic,10,2.302585092994046
ORF,10,2.302585092994046
Without,10,2.302585092994046
balanced,10,2.302585092994046
manufacture,10,2.302585092994046
post-pandemic,10,2.302585092994046
repurposed,10,2.302585092994046
collecting,10,2.302585092994046
reasoning,10,2.302585092994046
shot,10,2.302585092994046
pediatricians,10,2.302585092994046
ameliorate,10,2.302585092994046
fails,10,2.302585092994046
analysing,10,2.302585092994046
kinase-MB,10,2.302585092994046
291,10,2.302585092994046
novo,10,2.302585092994046
dealing,10,2.302585092994046
093,10,2.302585092994046
precipitated,10,2.302585092994046
pupils,10,2.302585092994046
cured,10,2.302585092994046
Caucasian,10,2.302585092994046
well-designed,10,2.302585092994046
reassortants,10,2.302585092994046
stigma,10,2.302585092994046
Amantadine,10,2.302585092994046
outweigh,10,2.302585092994046
Thirteen,10,2.302585092994046
comparatively,10,2.302585092994046
forecasting,10,2.302585092994046
inserted,10,2.302585092994046
arachidonic,10,2.302585092994046
Ministry,10,2.302585092994046
coherence,10,2.302585092994046
N1,10,2.302585092994046
upregulation,10,2.302585092994046
Commission,10,2.302585092994046
combine,10,2.302585092994046
interstitial,10,2.302585092994046
completeness,10,2.302585092994046
atheroma,10,2.302585092994046
timeliness,10,2.302585092994046
085,10,2.302585092994046
GPX-1,10,2.302585092994046
Maternal,10,2.302585092994046
adenoviral,10,2.302585092994046
serologically,10,2.302585092994046
discordance,10,2.302585092994046
COVID-19-associated,10,2.302585092994046
copiesmL,10,2.302585092994046
Recovery,10,2.302585092994046
Smoking,10,2.302585092994046
answered,10,2.302585092994046
diaphragmatic,10,2.302585092994046
purification,10,2.302585092994046
averaged,10,2.302585092994046
neurosurgical,10,2.302585092994046
age-related,10,2.302585092994046
lifelong,10,2.302585092994046
GISAID,10,2.302585092994046
Routine,10,2.302585092994046
anti-RBD,10,2.302585092994046
NSSTTAs,10,2.302585092994046
velocities,10,2.302585092994046
diurnal,10,2.302585092994046
184,10,2.302585092994046
εs,10,2.302585092994046
news,10,2.302585092994046
offending,10,2.302585092994046
contagion,10,2.302585092994046
loading,10,2.302585092994046
Chicago,10,2.302585092994046
mmoll,10,2.302585092994046
microbleeds,10,2.302585092994046
CADASIL,10,2.302585092994046
biomaterials,10,2.302585092994046
desensitization,10,2.302585092994046
dendritic,10,2.302585092994046
atmospheric,10,2.302585092994046
dysregulated,10,2.302585092994046
conditioning,10,2.302585092994046
operators,10,2.302585092994046
concordant,10,2.302585092994046
1974,10,2.302585092994046
APN,10,2.302585092994046
MACE,10,2.302585092994046
lowered,10,2.302585092994046
extraordinary,10,2.302585092994046
mouth,10,2.302585092994046
Peoples,10,2.302585092994046
peramivir,10,2.302585092994046
reporter,10,2.302585092994046
convalescence,10,2.302585092994046
continually,10,2.302585092994046
underestimate,10,2.302585092994046
OD,10,2.302585092994046
fasting,10,2.302585092994046
Cape,10,2.302585092994046
Ongoing,10,2.302585092994046
gait,10,2.302585092994046
Zhejiang,10,2.302585092994046
Continuous,10,2.302585092994046
non-ST-segment,10,2.302585092994046
exciting,10,2.302585092994046
presumably,10,2.302585092994046
CPAP,10,2.302585092994046
Decreased,10,2.302585092994046
sVNT,10,2.302585092994046
199,10,2.302585092994046
Isolated,10,2.302585092994046
Nasopharyngeal,10,2.302585092994046
4th,10,2.302585092994046
Daily,10,2.302585092994046
Colorado,10,2.302585092994046
Large-scale,10,2.302585092994046
biosensing,10,2.302585092994046
communicate,10,2.302585092994046
immunohistochemistry,10,2.302585092994046
biologically,10,2.302585092994046
sludge,10,2.302585092994046
alleviate,10,2.302585092994046
masses,10,2.302585092994046
Amongst,10,2.302585092994046
resistive,10,2.302585092994046
080,10,2.302585092994046
gains,10,2.302585092994046
replace,10,2.302585092994046
239,10,2.302585092994046
gross,10,2.302585092994046
thin,10,2.302585092994046
formerly,10,2.302585092994046
recurrences,10,2.302585092994046
spent,10,2.302585092994046
seemingly,10,2.302585092994046
ILS,10,2.302585092994046
break,10,2.302585092994046
evening,10,2.302585092994046
hypercoagulable,10,2.302585092994046
V2,10,2.302585092994046
dysarthria,10,2.302585092994046
substrates,10,2.302585092994046
travelers,10,2.302585092994046
exactly,10,2.302585092994046
displacement,10,2.302585092994046
placenta,10,2.302585092994046
charge,10,2.302585092994046
alike,10,2.302585092994046
seeks,10,2.302585092994046
practically,10,2.302585092994046
VITT,10,2.302585092994046
internationally,10,2.302585092994046
incompletely,10,2.302585092994046
virus-induced,10,2.302585092994046
path,10,2.302585092994046
0007,10,2.302585092994046
pranlukast,10,2.302585092994046
age-,10,2.302585092994046
Anterior,10,2.302585092994046
Frequent,10,2.302585092994046
cautious,10,2.302585092994046
mgday,10,2.302585092994046
grounds,10,2.302585092994046
paracrine,10,2.302585092994046
soldiers,10,2.302585092994046
seemed,10,2.302585092994046
Tissue,10,2.302585092994046
PR,10,2.302585092994046
Willebrand,10,2.302585092994046
quarantined,10,2.302585092994046
Latin,10,2.302585092994046
SGaw,10,2.302585092994046
zinc,10,2.302585092994046
disposition,10,2.302585092994046
pave,10,2.302585092994046
cockroach,10,2.302585092994046
ovalbumin,10,2.302585092994046
098,10,2.302585092994046
waning,10,2.302585092994046
warrant,10,2.302585092994046
two-dose,10,2.302585092994046
schizophrenia,10,2.302585092994046
peroxidation,10,2.302585092994046
wake-up,10,2.302585092994046
2-3,10,2.302585092994046
favipiravir,10,2.302585092994046
PB1,10,2.302585092994046
hydrochloride,10,2.302585092994046
integrate,10,2.302585092994046
supervised,10,2.302585092994046
transmembrane,10,2.302585092994046
diminish,10,2.302585092994046
Figure,10,2.302585092994046
herbal,10,2.302585092994046
storms,10,2.302585092994046
dynamically,10,2.302585092994046
express,10,2.302585092994046
labelled,10,2.302585092994046
stockpiled,10,2.302585092994046
IgGIgM,10,2.302585092994046
cardiomyocyte,10,2.302585092994046
suicidal,10,2.302585092994046
Repeated,10,2.302585092994046
295,10,2.302585092994046
≥65,10,2.302585092994046
ACE-2,10,2.302585092994046
underpinning,10,2.302585092994046
ICUs,10,2.302585092994046
next-generation,10,2.302585092994046
alleviation,10,2.302585092994046
MHC,10,2.302585092994046
attained,10,2.302585092994046
154,10,2.302585092994046
therapeutical,10,2.302585092994046
SPMA,10,2.302585092994046
housing,10,2.302585092994046
brings,10,2.302585092994046
spaces,10,2.302585092994046
alleles,10,2.302585092994046
Insurance,10,2.302585092994046
selectivity,10,2.302585092994046
Morbidity,10,2.302585092994046
recreational,9,2.1972245773362196
formulate,9,2.1972245773362196
Asymptomatic,9,2.1972245773362196
prioritize,9,2.1972245773362196
Melbourne,9,2.1972245773362196
294,9,2.1972245773362196
bringing,9,2.1972245773362196
superoxide,9,2.1972245773362196
accompanying,9,2.1972245773362196
intima-media,9,2.1972245773362196
notion,9,2.1972245773362196
microglia,9,2.1972245773362196
Highly,9,2.1972245773362196
347,9,2.1972245773362196
eyes,9,2.1972245773362196
halt,9,2.1972245773362196
favored,9,2.1972245773362196
215,9,2.1972245773362196
reasonably,9,2.1972245773362196
film,9,2.1972245773362196
moral,9,2.1972245773362196
endurance,9,2.1972245773362196
Utah,9,2.1972245773362196
St,9,2.1972245773362196
crossed,9,2.1972245773362196
CV,9,2.1972245773362196
wanted,9,2.1972245773362196
Criteria,9,2.1972245773362196
as-needed,9,2.1972245773362196
Complete,9,2.1972245773362196
reconstructed,9,2.1972245773362196
NAT,9,2.1972245773362196
lacked,9,2.1972245773362196
aeroallergen,9,2.1972245773362196
respiration,9,2.1972245773362196
cutaneous,9,2.1972245773362196
incidentally,9,2.1972245773362196
fulminant,9,2.1972245773362196
necrotizing,9,2.1972245773362196
resumption,9,2.1972245773362196
mechanically,9,2.1972245773362196
skeletal,9,2.1972245773362196
chemically,9,2.1972245773362196
1960s,9,2.1972245773362196
seventh,9,2.1972245773362196
fMRI,9,2.1972245773362196
decompensation,9,2.1972245773362196
cohorting,9,2.1972245773362196
Epidemiologic,9,2.1972245773362196
sophisticated,9,2.1972245773362196
4-6,9,2.1972245773362196
Guinea,9,2.1972245773362196
METHODS,9,2.1972245773362196
Comprehensive,9,2.1972245773362196
underscores,9,2.1972245773362196
laboratory-developed,9,2.1972245773362196
informing,9,2.1972245773362196
longest,9,2.1972245773362196
grass,9,2.1972245773362196
DBS,9,2.1972245773362196
15th,9,2.1972245773362196
covalent,9,2.1972245773362196
notification,9,2.1972245773362196
Adherence,9,2.1972245773362196
Reliable,9,2.1972245773362196
MCs,9,2.1972245773362196
Cohort,9,2.1972245773362196
obstructed,9,2.1972245773362196
insular,9,2.1972245773362196
antibody-dependent,9,2.1972245773362196
278,9,2.1972245773362196
trait,9,2.1972245773362196
cautiously,9,2.1972245773362196
Nucleocapsid,9,2.1972245773362196
depicted,9,2.1972245773362196
physiologically,9,2.1972245773362196
VT,9,2.1972245773362196
Developing,9,2.1972245773362196
periodic,9,2.1972245773362196
immunoglobulins,9,2.1972245773362196
DTI,9,2.1972245773362196
tyrosine,9,2.1972245773362196
spatially,9,2.1972245773362196
threatened,9,2.1972245773362196
Grade,9,2.1972245773362196
ion,9,2.1972245773362196
modulators,9,2.1972245773362196
CONCLUSIONS,9,2.1972245773362196
nanoparticle,9,2.1972245773362196
Average,9,2.1972245773362196
204,9,2.1972245773362196
conventionally,9,2.1972245773362196
inferoposterior,9,2.1972245773362196
infiltrates,9,2.1972245773362196
wealth,9,2.1972245773362196
unified,9,2.1972245773362196
harm,9,2.1972245773362196
frail,9,2.1972245773362196
predisposed,9,2.1972245773362196
CRS,9,2.1972245773362196
within-host,9,2.1972245773362196
194,9,2.1972245773362196
Nasal,9,2.1972245773362196
correlating,9,2.1972245773362196
explicit,9,2.1972245773362196
transcription-PCR,9,2.1972245773362196
preclude,9,2.1972245773362196
non-influenza,9,2.1972245773362196
institute,9,2.1972245773362196
And,9,2.1972245773362196
side-effects,9,2.1972245773362196
1969,9,2.1972245773362196
war,9,2.1972245773362196
forefront,9,2.1972245773362196
0008,9,2.1972245773362196
calculating,9,2.1972245773362196
inspired,9,2.1972245773362196
H1N12009,9,2.1972245773362196
207,9,2.1972245773362196
Consecutive,9,2.1972245773362196
Investigations,9,2.1972245773362196
dismutase,9,2.1972245773362196
hepatic,9,2.1972245773362196
ELISAs,9,2.1972245773362196
Local,9,2.1972245773362196
ventriculograms,9,2.1972245773362196
nuclei,9,2.1972245773362196
evacuation,9,2.1972245773362196
idiopathic,9,2.1972245773362196
think,9,2.1972245773362196
mistaken,9,2.1972245773362196
vocal,9,2.1972245773362196
asthma-COPD,9,2.1972245773362196
sporadically,9,2.1972245773362196
net,9,2.1972245773362196
260,9,2.1972245773362196
Her,9,2.1972245773362196
deserves,9,2.1972245773362196
radiograph,9,2.1972245773362196
inactivate,9,2.1972245773362196
rated,9,2.1972245773362196
merits,9,2.1972245773362196
H7,9,2.1972245773362196
senescence,9,2.1972245773362196
devised,9,2.1972245773362196
theoretically,9,2.1972245773362196
Preparedness,9,2.1972245773362196
LDL-cholesterol,9,2.1972245773362196
raw,9,2.1972245773362196
house-dust,9,2.1972245773362196
macrophage,9,2.1972245773362196
Combined,9,2.1972245773362196
WT,9,2.1972245773362196
laser,9,2.1972245773362196
paretic,9,2.1972245773362196
reactogenicity,9,2.1972245773362196
gradient,9,2.1972245773362196
036,9,2.1972245773362196
population-level,9,2.1972245773362196
neurodevelopmental,9,2.1972245773362196
citizens,9,2.1972245773362196
neutralising,9,2.1972245773362196
misclassification,9,2.1972245773362196
papillary,9,2.1972245773362196
Elevated,9,2.1972245773362196
conclusive,9,2.1972245773362196
anaerobic,9,2.1972245773362196
cognition,9,2.1972245773362196
Antibodies,9,2.1972245773362196
prepandemic,9,2.1972245773362196
bidirectional,9,2.1972245773362196
262,9,2.1972245773362196
cleaved,9,2.1972245773362196
strokeTIA,9,2.1972245773362196
concludes,9,2.1972245773362196
epileptic,9,2.1972245773362196
Saliva,9,2.1972245773362196
osteoporosis,9,2.1972245773362196
proteolytic,9,2.1972245773362196
alters,9,2.1972245773362196
CAO,9,2.1972245773362196
nonpregnant,9,2.1972245773362196
beatsmin,9,2.1972245773362196
Serology,9,2.1972245773362196
RS,9,2.1972245773362196
overnight,9,2.1972245773362196
multisystem,9,2.1972245773362196
Posterior,9,2.1972245773362196
Genome,9,2.1972245773362196
SaO2,9,2.1972245773362196
consuming,9,2.1972245773362196
Complementary,9,2.1972245773362196
sitting,9,2.1972245773362196
downregulated,9,2.1972245773362196
Plaque,9,2.1972245773362196
neuroinflammation,9,2.1972245773362196
dynamical,9,2.1972245773362196
periodically,9,2.1972245773362196
BVictoria,9,2.1972245773362196
hypoxemia,9,2.1972245773362196
Fever,9,2.1972245773362196
arthritis,9,2.1972245773362196
086,9,2.1972245773362196
teach,9,2.1972245773362196
manufactured,9,2.1972245773362196
influenzas,9,2.1972245773362196
320,9,2.1972245773362196
realized,9,2.1972245773362196
want,9,2.1972245773362196
076,9,2.1972245773362196
operate,9,2.1972245773362196
RAT,9,2.1972245773362196
Chile,9,2.1972245773362196
interferons,9,2.1972245773362196
wellbeing,9,2.1972245773362196
assisted,9,2.1972245773362196
suited,9,2.1972245773362196
proposal,9,2.1972245773362196
hMPV,9,2.1972245773362196
rendered,9,2.1972245773362196
ESD,9,2.1972245773362196
impressive,9,2.1972245773362196
GMT,9,2.1972245773362196
END,9,2.1972245773362196
putting,9,2.1972245773362196
intrauterine,9,2.1972245773362196
2nd,9,2.1972245773362196
reviewers,9,2.1972245773362196
Indians,9,2.1972245773362196
Mechanical,9,2.1972245773362196
genus,9,2.1972245773362196
virus-host,9,2.1972245773362196
Exercise-induced,9,2.1972245773362196
sp,9,2.1972245773362196
A1,9,2.1972245773362196
advantageous,9,2.1972245773362196
Ad26,9,2.1972245773362196
thoracotomy,9,2.1972245773362196
cavities,9,2.1972245773362196
875,9,2.1972245773362196
violence,9,2.1972245773362196
dabigatran,9,2.1972245773362196
somatic,9,2.1972245773362196
shifted,9,2.1972245773362196
hesitant,9,2.1972245773362196
attribute,9,2.1972245773362196
DBP,9,2.1972245773362196
284,9,2.1972245773362196
wash,9,2.1972245773362196
exponentially,9,2.1972245773362196
H6,9,2.1972245773362196
477,9,2.1972245773362196
infrequently,9,2.1972245773362196
Tl-201,9,2.1972245773362196
•,9,2.1972245773362196
audit,9,2.1972245773362196
emotion,9,2.1972245773362196
Impact,9,2.1972245773362196
000001,9,2.1972245773362196
Owing,9,2.1972245773362196
witnessed,9,2.1972245773362196
circuits,9,2.1972245773362196
H7N7,9,2.1972245773362196
move,9,2.1972245773362196
Kawasaki,9,2.1972245773362196
259,9,2.1972245773362196
impede,9,2.1972245773362196
confronted,9,2.1972245773362196
climates,9,2.1972245773362196
Lastly,9,2.1972245773362196
Paediatric,9,2.1972245773362196
152,9,2.1972245773362196
PAD,9,2.1972245773362196
coefficients,9,2.1972245773362196
325,9,2.1972245773362196
controllers,9,2.1972245773362196
documenting,9,2.1972245773362196
mimicking,9,2.1972245773362196
afforded,9,2.1972245773362196
unidentified,9,2.1972245773362196
indigenous,9,2.1972245773362196
antibody-based,9,2.1972245773362196
2004-2005,9,2.1972245773362196
calculations,9,2.1972245773362196
augmented,9,2.1972245773362196
501YV2,9,2.1972245773362196
resembled,9,2.1972245773362196
boarding,9,2.1972245773362196
suitability,9,2.1972245773362196
agenda,9,2.1972245773362196
observer,9,2.1972245773362196
competing,9,2.1972245773362196
232,9,2.1972245773362196
Still,9,2.1972245773362196
anti-NP,9,2.1972245773362196
searching,9,2.1972245773362196
in-patient,9,2.1972245773362196
proposals,9,2.1972245773362196
ventral,9,2.1972245773362196
Tokyo,9,2.1972245773362196
thalamus,9,2.1972245773362196
Performance,9,2.1972245773362196
integrins,9,2.1972245773362196
bronchoscopy,9,2.1972245773362196
metric,9,2.1972245773362196
updating,9,2.1972245773362196
nebulized,9,2.1972245773362196
OS,9,2.1972245773362196
favorably,9,2.1972245773362196
cardioplegic,9,2.1972245773362196
overseas,9,2.1972245773362196
thirds,9,2.1972245773362196
mo,9,2.1972245773362196
spirometric,9,2.1972245773362196
altering,9,2.1972245773362196
Learning,9,2.1972245773362196
battle,9,2.1972245773362196
descriptions,9,2.1972245773362196
durable,9,2.1972245773362196
mural,9,2.1972245773362196
forensic,9,2.1972245773362196
asynergic,9,2.1972245773362196
Present,9,2.1972245773362196
lupus,9,2.1972245773362196
022,9,2.1972245773362196
anecdotal,9,2.1972245773362196
SARS‑CoV‑2,9,2.1972245773362196
serotonin,9,2.1972245773362196
leaves,9,2.1972245773362196
selenium,9,2.1972245773362196
tolerability,9,2.1972245773362196
item,9,2.1972245773362196
Alternative,9,2.1972245773362196
Moyamoya,9,2.1972245773362196
thorax,9,2.1972245773362196
totally,9,2.1972245773362196
vasoactive,9,2.1972245773362196
conferring,9,2.1972245773362196
genomics,9,2.1972245773362196
leukocytosis,9,2.1972245773362196
pharmacies,9,2.1972245773362196
integrative,9,2.1972245773362196
uncover,9,2.1972245773362196
proteome,9,2.1972245773362196
agree,9,2.1972245773362196
Emergent,9,2.1972245773362196
denial,9,2.1972245773362196
pre-clinical,9,2.1972245773362196
unavailable,9,2.1972245773362196
durability,9,2.1972245773362196
Scotland,9,2.1972245773362196
surgeons,9,2.1972245773362196
Biomarkers,9,2.1972245773362196
11th,9,2.1972245773362196
Screening,9,2.1972245773362196
PICU,9,2.1972245773362196
home-based,9,2.1972245773362196
elaborate,9,2.1972245773362196
readmissions,9,2.1972245773362196
flocking,9,2.1972245773362196
headaches,9,2.1972245773362196
539,9,2.1972245773362196
Florida,9,2.1972245773362196
Examination,9,2.1972245773362196
Work-related,9,2.1972245773362196
Xpert®,9,2.1972245773362196
presymptomatic,9,2.1972245773362196
pgml,9,2.1972245773362196
yogurt,9,2.1972245773362196
Short-term,9,2.1972245773362196
dose-dependent,9,2.1972245773362196
Hemodynamic,9,2.1972245773362196
hub,9,2.1972245773362196
272,9,2.1972245773362196
reversing,9,2.1972245773362196
theme,9,2.1972245773362196
Preventive,9,2.1972245773362196
penetration,9,2.1972245773362196
Stent,9,2.1972245773362196
ostium,9,2.1972245773362196
Complex,9,2.1972245773362196
ROC,9,2.1972245773362196
IAV-infected,9,2.1972245773362196
overexpression,9,2.1972245773362196
drastically,9,2.1972245773362196
anesthetic,9,2.1972245773362196
modifiers,9,2.1972245773362196
low-molecular-weight,9,2.1972245773362196
claim,9,2.1972245773362196
Action,9,2.1972245773362196
Comparisons,9,2.1972245773362196
087,9,2.1972245773362196
noise,9,2.1972245773362196
digitalis,9,2.1972245773362196
aggressively,9,2.1972245773362196
digoxin,9,2.1972245773362196
aberrant,9,2.1972245773362196
hemodialyzed,9,2.1972245773362196
015,9,2.1972245773362196
yields,9,2.1972245773362196
nationally,9,2.1972245773362196
inception,9,2.1972245773362196
Literature,9,2.1972245773362196
chimeric,9,2.1972245773362196
scintigraphic,9,2.1972245773362196
opened,9,2.1972245773362196
258,9,2.1972245773362196
aggravated,9,2.1972245773362196
LDT,9,2.1972245773362196
Abs,9,2.1972245773362196
450,9,2.1972245773362196
temporarily,9,2.1972245773362196
249,9,2.1972245773362196
transcripts,9,2.1972245773362196
SEM,9,2.1972245773362196
IL-1β,9,2.1972245773362196
enters,9,2.1972245773362196
RAST,9,2.1972245773362196
anticancer,9,2.1972245773362196
histology,9,2.1972245773362196
IAE,9,2.1972245773362196
MW06,9,2.1972245773362196
leaving,9,2.1972245773362196
hemiplegia,9,2.1972245773362196
occurrences,9,2.1972245773362196
097,9,2.1972245773362196
eggs,9,2.1972245773362196
underdiagnosis,9,2.1972245773362196
chart,9,2.1972245773362196
PCT,9,2.1972245773362196
Psychological,9,2.1972245773362196
choosing,9,2.1972245773362196
rivaroxaban,9,2.1972245773362196
closest,9,2.1972245773362196
pressing,9,2.1972245773362196
SLE,9,2.1972245773362196
flutter,9,2.1972245773362196
property,9,2.1972245773362196
EX,9,2.1972245773362196
Czech,9,2.1972245773362196
undetectable,9,2.1972245773362196
high-sensitivity,9,2.1972245773362196
master,9,2.1972245773362196
intricate,9,2.1972245773362196
GM-CSF,9,2.1972245773362196
conjugate,9,2.1972245773362196
deposited,9,2.1972245773362196
chromatography,9,2.1972245773362196
TTS,9,2.1972245773362196
Two-dimensional,9,2.1972245773362196
anti-ischemic,9,2.1972245773362196
Areas,9,2.1972245773362196
falling,9,2.1972245773362196
limbs,9,2.1972245773362196
smoked,9,2.1972245773362196
≥4,9,2.1972245773362196
swelling,9,2.1972245773362196
Nursing,9,2.1972245773362196
placental,9,2.1972245773362196
Army,9,2.1972245773362196
LVOT,9,2.1972245773362196
encodes,9,2.1972245773362196
regulator,9,2.1972245773362196
mediates,9,2.1972245773362196
camps,9,2.1972245773362196
contractions,9,2.1972245773362196
endorsed,9,2.1972245773362196
Persistent,9,2.1972245773362196
complicates,9,2.1972245773362196
olfactory,9,2.1972245773362196
N95,9,2.1972245773362196
Symptom,9,2.1972245773362196
FIA,9,2.1972245773362196
unaffected,9,2.1972245773362196
k,9,2.1972245773362196
distortion,9,2.1972245773362196
Persons,9,2.1972245773362196
GLS,9,2.1972245773362196
anti-CD20,9,2.1972245773362196
Motor,9,2.1972245773362196
representation,9,2.1972245773362196
respirator,9,2.1972245773362196
continuum,9,2.1972245773362196
unloading,9,2.1972245773362196
contributors,9,2.1972245773362196
precursors,9,2.1972245773362196
hyperkinetic,9,2.1972245773362196
doubts,9,2.1972245773362196
201011,9,2.1972245773362196
transplanted,9,2.1972245773362196
IL-17,9,2.1972245773362196
mildmoderate,9,2.1972245773362196
Previously,9,2.1972245773362196
2019-nCOV,9,2.1972245773362196
hospital-acquired,9,2.1972245773362196
activates,9,2.1972245773362196
NK,9,2.1972245773362196
lens,9,2.1972245773362196
nitrogen,9,2.1972245773362196
vigorous,9,2.1972245773362196
propranolol,9,2.1972245773362196
awakening,9,2.1972245773362196
chemistry,9,2.1972245773362196
785,9,2.1972245773362196
publics,9,2.1972245773362196
aura,9,2.1972245773362196
IL-18,9,2.1972245773362196
penetrating,9,2.1972245773362196
causality,9,2.1972245773362196
densely,9,2.1972245773362196
1919,9,2.1972245773362196
conception,9,2.1972245773362196
contents,9,2.1972245773362196
Portugal,9,2.1972245773362196
PACs,9,2.1972245773362196
entropy,9,2.1972245773362196
transitory,9,2.1972245773362196
cytotoxicity,9,2.1972245773362196
INCS,9,2.1972245773362196
square,9,2.1972245773362196
reteplase,9,2.1972245773362196
dander,9,2.1972245773362196
switching,9,2.1972245773362196
Affairs,9,2.1972245773362196
banding,9,2.1972245773362196
rules,9,2.1972245773362196
553,9,2.1972245773362196
attempting,9,2.1972245773362196
Existing,9,2.1972245773362196
feces,9,2.1972245773362196
Mexican,9,2.1972245773362196
RT-ddPCR,9,2.1972245773362196
254,9,2.1972245773362196
IIV,9,2.1972245773362196
quality-of-life,9,2.1972245773362196
tailor,9,2.1972245773362196
GCR,9,2.1972245773362196
CE,9,2.1972245773362196
nonpharmaceutical,9,2.1972245773362196
VO2,9,2.1972245773362196
cAMP,9,2.1972245773362196
escalating,9,2.1972245773362196
AAEMI,9,2.1972245773362196
Presence,9,2.1972245773362196
root,9,2.1972245773362196
synonymous,9,2.1972245773362196
Ischaemic,9,2.1972245773362196
Transient,9,2.1972245773362196
executive,9,2.1972245773362196
hs-cTnI,9,2.1972245773362196
cortisol,9,2.1972245773362196
versions,9,2.1972245773362196
modulated,9,2.1972245773362196
eNO,9,2.1972245773362196
Treating,9,2.1972245773362196
ENO,9,2.1972245773362196
HCoV,9,2.1972245773362196
constrained,9,2.1972245773362196
030,9,2.1972245773362196
postmyocardial,9,2.1972245773362196
Sequence,9,2.1972245773362196
CD66c,9,2.1972245773362196
card,9,2.1972245773362196
dysplasia,9,2.1972245773362196
numerical,9,2.1972245773362196
unravel,9,2.1972245773362196
neighborhoods,8,2.0794415416798357
umbilical,8,2.0794415416798357
PSO,8,2.0794415416798357
seroprotection,8,2.0794415416798357
retinopathy,8,2.0794415416798357
iron,8,2.0794415416798357
Collectively,8,2.0794415416798357
Experts,8,2.0794415416798357
cruise,8,2.0794415416798357
ship,8,2.0794415416798357
therapeutically,8,2.0794415416798357
fibroblasts,8,2.0794415416798357
Covid,8,2.0794415416798357
ideally,8,2.0794415416798357
606,8,2.0794415416798357
EIAs,8,2.0794415416798357
blacks,8,2.0794415416798357
nAbs,8,2.0794415416798357
atelectasis,8,2.0794415416798357
acidosis,8,2.0794415416798357
intolerance,8,2.0794415416798357
misdiagnosis,8,2.0794415416798357
GISSI,8,2.0794415416798357
vials,8,2.0794415416798357
abundance,8,2.0794415416798357
worry,8,2.0794415416798357
Nearly,8,2.0794415416798357
Europeans,8,2.0794415416798357
OC43,8,2.0794415416798357
Pooled,8,2.0794415416798357
HC,8,2.0794415416798357
virus-infected,8,2.0794415416798357
Reported,8,2.0794415416798357
DES,8,2.0794415416798357
gel,8,2.0794415416798357
Statistics,8,2.0794415416798357
BB536,8,2.0794415416798357
modelled,8,2.0794415416798357
CFAF,8,2.0794415416798357
supine,8,2.0794415416798357
vaccinology,8,2.0794415416798357
PRISMA,8,2.0794415416798357
043,8,2.0794415416798357
phagocytic,8,2.0794415416798357
epinephrine,8,2.0794415416798357
rejection,8,2.0794415416798357
interspecies,8,2.0794415416798357
Subgroup,8,2.0794415416798357
irritants,8,2.0794415416798357
characterizes,8,2.0794415416798357
oxidation,8,2.0794415416798357
aids,8,2.0794415416798357
video,8,2.0794415416798357
lymphoid,8,2.0794415416798357
sciences,8,2.0794415416798357
incorporation,8,2.0794415416798357
regimes,8,2.0794415416798357
allograft,8,2.0794415416798357
attracted,8,2.0794415416798357
bronchiolitis,8,2.0794415416798357
erythematosus,8,2.0794415416798357
Controlled,8,2.0794415416798357
disclosed,8,2.0794415416798357
37-year-old,8,2.0794415416798357
exceptional,8,2.0794415416798357
secreted,8,2.0794415416798357
abuse,8,2.0794415416798357
gene-environment,8,2.0794415416798357
waterfowl,8,2.0794415416798357
POCT,8,2.0794415416798357
nutrients,8,2.0794415416798357
Mediterranean,8,2.0794415416798357
SARS-CoV-2-infected,8,2.0794415416798357
ducks,8,2.0794415416798357
reserved,8,2.0794415416798357
Yamagata,8,2.0794415416798357
285,8,2.0794415416798357
Rwanda,8,2.0794415416798357
abrupt,8,2.0794415416798357
jobs,8,2.0794415416798357
sugar,8,2.0794415416798357
QP2,8,2.0794415416798357
Personal,8,2.0794415416798357
contract,8,2.0794415416798357
resilience,8,2.0794415416798357
biosecurity,8,2.0794415416798357
stented,8,2.0794415416798357
Cardioembolic,8,2.0794415416798357
PCM,8,2.0794415416798357
Med,8,2.0794415416798357
419,8,2.0794415416798357
impulse,8,2.0794415416798357
Joint,8,2.0794415416798357
pragmatic,8,2.0794415416798357
UV,8,2.0794415416798357
adjuvanted,8,2.0794415416798357
racialethnic,8,2.0794415416798357
secretory,8,2.0794415416798357
99mTc-sestamibi,8,2.0794415416798357
minimise,8,2.0794415416798357
857,8,2.0794415416798357
freely,8,2.0794415416798357
constituted,8,2.0794415416798357
underline,8,2.0794415416798357
face-to-face,8,2.0794415416798357
plasmapheresis,8,2.0794415416798357
towns,8,2.0794415416798357
editorial,8,2.0794415416798357
yoga,8,2.0794415416798357
TW,8,2.0794415416798357
0006,8,2.0794415416798357
prevalences,8,2.0794415416798357
claudication,8,2.0794415416798357
moderate-to-severe,8,2.0794415416798357
adopting,8,2.0794415416798357
backward,8,2.0794415416798357
164,8,2.0794415416798357
769,8,2.0794415416798357
lessen,8,2.0794415416798357
captured,8,2.0794415416798357
NAIS,8,2.0794415416798357
cheap,8,2.0794415416798357
residing,8,2.0794415416798357
475,8,2.0794415416798357
worthwhile,8,2.0794415416798357
comply,8,2.0794415416798357
ruptured,8,2.0794415416798357
thrombophilia,8,2.0794415416798357
perfusion-weighted,8,2.0794415416798357
restrict,8,2.0794415416798357
thick,8,2.0794415416798357
ordinal,8,2.0794415416798357
inactive,8,2.0794415416798357
evoked,8,2.0794415416798357
regenerating,8,2.0794415416798357
solve,8,2.0794415416798357
assuming,8,2.0794415416798357
Respondents,8,2.0794415416798357
classifying,8,2.0794415416798357
noninfarcted,8,2.0794415416798357
self-collected,8,2.0794415416798357
porcine,8,2.0794415416798357
HSAP-NP,8,2.0794415416798357
friends,8,2.0794415416798357
tensor,8,2.0794415416798357
company,8,2.0794415416798357
post-PCI,8,2.0794415416798357
IVIG,8,2.0794415416798357
adamantanes,8,2.0794415416798357
regulates,8,2.0794415416798357
termination,8,2.0794415416798357
leakage,8,2.0794415416798357
overlay,8,2.0794415416798357
circle,8,2.0794415416798357
NLR,8,2.0794415416798357
502,8,2.0794415416798357
extinction,8,2.0794415416798357
30-40,8,2.0794415416798357
≥1,8,2.0794415416798357
NSBH,8,2.0794415416798357
oscillation,8,2.0794415416798357
VA,8,2.0794415416798357
road,8,2.0794415416798357
applies,8,2.0794415416798357
augment,8,2.0794415416798357
participatory,8,2.0794415416798357
Cerebrolysin,8,2.0794415416798357
Implementation,8,2.0794415416798357
hopefully,8,2.0794415416798357
188,8,2.0794415416798357
puzzling,8,2.0794415416798357
Very,8,2.0794415416798357
introductions,8,2.0794415416798357
patient-reported,8,2.0794415416798357
intimal,8,2.0794415416798357
perforating,8,2.0794415416798357
contraindication,8,2.0794415416798357
representatives,8,2.0794415416798357
HCPs,8,2.0794415416798357
devise,8,2.0794415416798357
end-stage,8,2.0794415416798357
decide,8,2.0794415416798357
chiefly,8,2.0794415416798357
anti-platelet,8,2.0794415416798357
Retrospective,8,2.0794415416798357
TH,8,2.0794415416798357
cared,8,2.0794415416798357
Cost,8,2.0794415416798357
Angiographic,8,2.0794415416798357
ash,8,2.0794415416798357
pursuit,8,2.0794415416798357
entitled,8,2.0794415416798357
prototypes,8,2.0794415416798357
innovation,8,2.0794415416798357
ergometer,8,2.0794415416798357
peer,8,2.0794415416798357
DAWN,8,2.0794415416798357
observable,8,2.0794415416798357
chromosome,8,2.0794415416798357
Histological,8,2.0794415416798357
fluctuations,8,2.0794415416798357
restoring,8,2.0794415416798357
doubling,8,2.0794415416798357
arrive,8,2.0794415416798357
Sleep,8,2.0794415416798357
cultured,8,2.0794415416798357
316,8,2.0794415416798357
prophylactically,8,2.0794415416798357
siblings,8,2.0794415416798357
influenzalike,8,2.0794415416798357
HBV,8,2.0794415416798357
assurance,8,2.0794415416798357
characterise,8,2.0794415416798357
carcinoma,8,2.0794415416798357
non-cardiac,8,2.0794415416798357
priming,8,2.0794415416798357
quality-adjusted,8,2.0794415416798357
realize,8,2.0794415416798357
economics,8,2.0794415416798357
pay,8,2.0794415416798357
differentially,8,2.0794415416798357
rotation,8,2.0794415416798357
Implications,8,2.0794415416798357
endobronchial,8,2.0794415416798357
Zika,8,2.0794415416798357
cascades,8,2.0794415416798357
382,8,2.0794415416798357
290,8,2.0794415416798357
intubated,8,2.0794415416798357
budget,8,2.0794415416798357
BMC,8,2.0794415416798357
NO2,8,2.0794415416798357
thermal,8,2.0794415416798357
Pregnancy,8,2.0794415416798357
VN,8,2.0794415416798357
edition,8,2.0794415416798357
aerosol-generating,8,2.0794415416798357
CCC,8,2.0794415416798357
dangers,8,2.0794415416798357
eventual,8,2.0794415416798357
plethora,8,2.0794415416798357
postprocedural,8,2.0794415416798357
Inventory,8,2.0794415416798357
319,8,2.0794415416798357
olds,8,2.0794415416798357
IST-3,8,2.0794415416798357
self-limited,8,2.0794415416798357
VWF,8,2.0794415416798357
immunochromatographic,8,2.0794415416798357
Poisson,8,2.0794415416798357
mgdL,8,2.0794415416798357
336,8,2.0794415416798357
southeastern,8,2.0794415416798357
borders,8,2.0794415416798357
HSCT,8,2.0794415416798357
relied,8,2.0794415416798357
consults,8,2.0794415416798357
orally,8,2.0794415416798357
7-10,8,2.0794415416798357
psychometric,8,2.0794415416798357
implicate,8,2.0794415416798357
Lmin,8,2.0794415416798357
peroxidase,8,2.0794415416798357
sickness,8,2.0794415416798357
style,8,2.0794415416798357
Island,8,2.0794415416798357
lobes,8,2.0794415416798357
patch,8,2.0794415416798357
Knowing,8,2.0794415416798357
manually,8,2.0794415416798357
elaborated,8,2.0794415416798357
radicals,8,2.0794415416798357
Act,8,2.0794415416798357
worth,8,2.0794415416798357
indeterminate,8,2.0794415416798357
marital,8,2.0794415416798357
LFIA,8,2.0794415416798357
HIV-infected,8,2.0794415416798357
virome,8,2.0794415416798357
3-5,8,2.0794415416798357
exposing,8,2.0794415416798357
NTD,8,2.0794415416798357
bronchodilation,8,2.0794415416798357
Depending,8,2.0794415416798357
antibacterial,8,2.0794415416798357
NOW,8,2.0794415416798357
Initially,8,2.0794415416798357
SM,8,2.0794415416798357
transmitral,8,2.0794415416798357
Arab,8,2.0794415416798357
occasion,8,2.0794415416798357
pharmacology,8,2.0794415416798357
awake,8,2.0794415416798357
practicing,8,2.0794415416798357
ISAAC,8,2.0794415416798357
low-frequency,8,2.0794415416798357
Today,8,2.0794415416798357
NF,8,2.0794415416798357
census,8,2.0794415416798357
193,8,2.0794415416798357
conscious,8,2.0794415416798357
pre-COVID-19,8,2.0794415416798357
1980s,8,2.0794415416798357
SAH,8,2.0794415416798357
NSP6,8,2.0794415416798357
Activation,8,2.0794415416798357
Prolonged,8,2.0794415416798357
releasing,8,2.0794415416798357
distribute,8,2.0794415416798357
synthesize,8,2.0794415416798357
hyperinflation,8,2.0794415416798357
Immunotherapy,8,2.0794415416798357
announced,8,2.0794415416798357
996,8,2.0794415416798357
370,8,2.0794415416798357
Associations,8,2.0794415416798357
wear,8,2.0794415416798357
front,8,2.0794415416798357
occupation,8,2.0794415416798357
ophthalmological,8,2.0794415416798357
VCG,8,2.0794415416798357
lymph,8,2.0794415416798357
Significantly,8,2.0794415416798357
RNase,8,2.0794415416798357
analytic,8,2.0794415416798357
allergen-induced,8,2.0794415416798357
IFVA,8,2.0794415416798357
lists,8,2.0794415416798357
syndrome-coronavirus-2,8,2.0794415416798357
Particularly,8,2.0794415416798357
competence,8,2.0794415416798357
Individual,8,2.0794415416798357
179,8,2.0794415416798357
depended,8,2.0794415416798357
wake,8,2.0794415416798357
disasters,8,2.0794415416798357
PV,8,2.0794415416798357
mitigated,8,2.0794415416798357
uric,8,2.0794415416798357
QIV,8,2.0794415416798357
outer,8,2.0794415416798357
myriad,8,2.0794415416798357
notifications,8,2.0794415416798357
Nucleic,8,2.0794415416798357
MN,8,2.0794415416798357
Illness,8,2.0794415416798357
Altogether,8,2.0794415416798357
laryngeal,8,2.0794415416798357
Congress,8,2.0794415416798357
supratentorial,8,2.0794415416798357
haemodynamics,8,2.0794415416798357
Sixty,8,2.0794415416798357
appreciate,8,2.0794415416798357
Across,8,2.0794415416798357
dilated,8,2.0794415416798357
monkey,8,2.0794415416798357
PSA,8,2.0794415416798357
350,8,2.0794415416798357
life-saving,8,2.0794415416798357
omics,8,2.0794415416798357
equations,8,2.0794415416798357
triad,8,2.0794415416798357
Mental,8,2.0794415416798357
Hygiene,8,2.0794415416798357
700,8,2.0794415416798357
covert,8,2.0794415416798357
confused,8,2.0794415416798357
permitted,8,2.0794415416798357
Johnson,8,2.0794415416798357
occupying,8,2.0794415416798357
interpreting,8,2.0794415416798357
fine,8,2.0794415416798357
camp,8,2.0794415416798357
marketed,8,2.0794415416798357
neurodegenerative,8,2.0794415416798357
multimodal,8,2.0794415416798357
discrepancy,8,2.0794415416798357
335,8,2.0794415416798357
092,8,2.0794415416798357
quintile,8,2.0794415416798357
cooling,8,2.0794415416798357
slower,8,2.0794415416798357
178,8,2.0794415416798357
intriguing,8,2.0794415416798357
Virginia,8,2.0794415416798357
giant,8,2.0794415416798357
Romania,8,2.0794415416798357
histopathologic,8,2.0794415416798357
Experience,8,2.0794415416798357
intranasally,8,2.0794415416798357
W,8,2.0794415416798357
That,8,2.0794415416798357
biased,8,2.0794415416798357
4-week,8,2.0794415416798357
germ,8,2.0794415416798357
317,8,2.0794415416798357
Alternaria,8,2.0794415416798357
Neutralizing,8,2.0794415416798357
rendering,8,2.0794415416798357
methylene,8,2.0794415416798357
Progress,8,2.0794415416798357
ML,8,2.0794415416798357
tetrazolium,8,2.0794415416798357
Allplex,8,2.0794415416798357
pair,8,2.0794415416798357
rescued,8,2.0794415416798357
exploiting,8,2.0794415416798357
organism,8,2.0794415416798357
virologically,8,2.0794415416798357
resemble,8,2.0794415416798357
workforce,8,2.0794415416798357
counting,8,2.0794415416798357
clustered,8,2.0794415416798357
serially,8,2.0794415416798357
Forty-three,8,2.0794415416798357
plotted,8,2.0794415416798357
20-30,8,2.0794415416798357
green,8,2.0794415416798357
antisera,8,2.0794415416798357
contributory,8,2.0794415416798357
struggle,8,2.0794415416798357
depolarization,8,2.0794415416798357
comparator,8,2.0794415416798357
Logistic,8,2.0794415416798357
single-center,8,2.0794415416798357
leukemia,8,2.0794415416798357
prioritizing,8,2.0794415416798357
KD,8,2.0794415416798357
hypokinetic,8,2.0794415416798357
Genes,8,2.0794415416798357
Presently,8,2.0794415416798357
father,8,2.0794415416798357
Thirty-one,8,2.0794415416798357
probabilistic,8,2.0794415416798357
spasticity,8,2.0794415416798357
Proper,8,2.0794415416798357
overload,8,2.0794415416798357
communications,8,2.0794415416798357
low-density,8,2.0794415416798357
Inflammatory,8,2.0794415416798357
RDT,8,2.0794415416798357
Educational,8,2.0794415416798357
Adjusted,8,2.0794415416798357
Worldwide,8,2.0794415416798357
looking,8,2.0794415416798357
conservation,8,2.0794415416798357
Accumulating,8,2.0794415416798357
DEGs,8,2.0794415416798357
scholars,8,2.0794415416798357
HAs,8,2.0794415416798357
exceeds,8,2.0794415416798357
institutes,8,2.0794415416798357
burst,8,2.0794415416798357
IFNγ,8,2.0794415416798357
TA,8,2.0794415416798357
pathomechanism,8,2.0794415416798357
STING,8,2.0794415416798357
repositioning,8,2.0794415416798357
invited,8,2.0794415416798357
generates,8,2.0794415416798357
Mass,8,2.0794415416798357
evade,8,2.0794415416798357
AIA,8,2.0794415416798357
elicits,8,2.0794415416798357
underdiagnosed,8,2.0794415416798357
my,8,2.0794415416798357
Intervention,8,2.0794415416798357
compromising,8,2.0794415416798357
hACE2,8,2.0794415416798357
Office,8,2.0794415416798357
Instead,8,2.0794415416798357
summed,8,2.0794415416798357
HFQE,8,2.0794415416798357
CD163,8,2.0794415416798357
ancestral,8,2.0794415416798357
objects,8,2.0794415416798357
Exacerbations,8,2.0794415416798357
adds,8,2.0794415416798357
Hospitalized,8,2.0794415416798357
Excessive,8,2.0794415416798357
elucidating,8,2.0794415416798357
Atherosclerosis,8,2.0794415416798357
CO2,8,2.0794415416798357
Hemorrhagic,8,2.0794415416798357
thrombolytics,8,2.0794415416798357
nm,8,2.0794415416798357
229,8,2.0794415416798357
1970s,8,2.0794415416798357
soy,8,2.0794415416798357
entrance,8,2.0794415416798357
frames,8,2.0794415416798357
anti-asthma,8,2.0794415416798357
Denmark,8,2.0794415416798357
SWT,8,2.0794415416798357
3-4,8,2.0794415416798357
countermeasures,8,2.0794415416798357
engage,8,2.0794415416798357
granzyme,8,2.0794415416798357
myeloma,8,2.0794415416798357
calcification,8,2.0794415416798357
clue,8,2.0794415416798357
elastic,8,2.0794415416798357
autopsies,8,2.0794415416798357
WMSI,8,2.0794415416798357
executed,8,2.0794415416798357
naive,8,2.0794415416798357
hidden,8,2.0794415416798357
dominance,8,2.0794415416798357
517,8,2.0794415416798357
inferences,8,2.0794415416798357
displays,8,2.0794415416798357
countrys,8,2.0794415416798357
tubes,8,2.0794415416798357
onto,8,2.0794415416798357
231,8,2.0794415416798357
catecholamines,8,2.0794415416798357
motivational,8,2.0794415416798357
enteral,8,2.0794415416798357
supplemental,8,2.0794415416798357
isosorbide,8,2.0794415416798357
Barthel,8,2.0794415416798357
bases,8,2.0794415416798357
premorbid,8,2.0794415416798357
echocardiograms,8,2.0794415416798357
easy-to-use,8,2.0794415416798357
2-D,8,2.0794415416798357
elders,8,2.0794415416798357
employee,8,2.0794415416798357
covid-19,8,2.0794415416798357
am,8,2.0794415416798357
nonhuman,8,2.0794415416798357
274,8,2.0794415416798357
neutrophilic,8,2.0794415416798357
proxy,8,2.0794415416798357
anti-vaccine,8,2.0794415416798357
SNFs,8,2.0794415416798357
Specificity,8,2.0794415416798357
Odds,8,2.0794415416798357
Lab,8,2.0794415416798357
export,8,2.0794415416798357
X-rays,8,2.0794415416798357
SMS,8,2.0794415416798357
earthquake,8,2.0794415416798357
DDAH1,8,2.0794415416798357
socially,8,2.0794415416798357
volatile,8,2.0794415416798357
NAWM,8,2.0794415416798357
progeny,8,2.0794415416798357
judicious,8,2.0794415416798357
glands,8,2.0794415416798357
exceed,8,2.0794415416798357
Gadolinium-DTPA,8,2.0794415416798357
associate,8,2.0794415416798357
kidneys,8,2.0794415416798357
SVD,8,2.0794415416798357
NLRP3,8,2.0794415416798357
three-vessel,8,2.0794415416798357
advise,8,2.0794415416798357
TLR4,8,2.0794415416798357
reliever,8,2.0794415416798357
immense,8,2.0794415416798357
DS,8,2.0794415416798357
P-RDT,8,2.0794415416798357
read,8,2.0794415416798357
BB-EPI,8,2.0794415416798357
435,8,2.0794415416798357
amiodarone,8,2.0794415416798357
reverse-transcriptase,8,2.0794415416798357
interleukin-6,8,2.0794415416798357
relieved,8,2.0794415416798357
750,8,2.0794415416798357
ignored,8,2.0794415416798357
38-year-old,8,2.0794415416798357
transit,8,2.0794415416798357
questionable,8,2.0794415416798357
frusemide,8,2.0794415416798357
seronegative,8,2.0794415416798357
seroconverted,8,2.0794415416798357
z-score,8,2.0794415416798357
C1,8,2.0794415416798357
propagate,8,2.0794415416798357
600,8,2.0794415416798357
ICCI,8,2.0794415416798357
Prophylactic,8,2.0794415416798357
2003-2004,8,2.0794415416798357
448,8,2.0794415416798357
isocyanates,8,2.0794415416798357
BALF,8,2.0794415416798357
062,8,2.0794415416798357
busy,8,2.0794415416798357
TAT,8,2.0794415416798357
crossover,8,2.0794415416798357
Medicines,8,2.0794415416798357
1918-19,8,2.0794415416798357
small-vessel,8,2.0794415416798357
advisable,8,2.0794415416798357
Correlation,8,2.0794415416798357
centuries,8,2.0794415416798357
portions,8,2.0794415416798357
shelters,8,2.0794415416798357
Soon,8,2.0794415416798357
046,8,2.0794415416798357
1951,8,2.0794415416798357
302,8,2.0794415416798357
discharges,8,2.0794415416798357
MIS-C,8,2.0794415416798357
mepolizumab,8,2.0794415416798357
column,8,2.0794415416798357
rales,8,2.0794415416798357
consumables,8,2.0794415416798357
encompassing,8,2.0794415416798357
438,8,2.0794415416798357
S128P,8,2.0794415416798357
representations,8,2.0794415416798357
walk,8,2.0794415416798357
833,8,2.0794415416798357
structurally,8,2.0794415416798357
364,8,2.0794415416798357
Paulo,8,2.0794415416798357
intent,8,2.0794415416798357
crowded,8,2.0794415416798357
AIT,8,2.0794415416798357
DI,8,2.0794415416798357
destabilization,8,2.0794415416798357
racing,8,2.0794415416798357
verification,8,2.0794415416798357
Comparing,8,2.0794415416798357
extrasystoles,8,2.0794415416798357
AH1N12009,8,2.0794415416798357
oldest,8,2.0794415416798357
disproportionate,8,2.0794415416798357
TPP,8,2.0794415416798357
telocytes,8,2.0794415416798357
ultraviolet,8,2.0794415416798357
influx,8,2.0794415416798357
subepithelial,8,2.0794415416798357
ITP,8,2.0794415416798357
mm2,8,2.0794415416798357
Pfizer,8,2.0794415416798357
midbrain,8,2.0794415416798357
inaccurate,8,2.0794415416798357
edge,8,2.0794415416798357
FLU-v,8,2.0794415416798357
Third,8,2.0794415416798357
tears,8,2.0794415416798357
misleading,8,2.0794415416798357
occipital,8,2.0794415416798357
positioning,8,2.0794415416798357
269,8,2.0794415416798357
079,8,2.0794415416798357
GC,8,2.0794415416798357
unspecific,8,2.0794415416798357
IEI,8,2.0794415416798357
ventriculographic,8,2.0794415416798357
Universal,8,2.0794415416798357
shaped,8,2.0794415416798357
basement,8,2.0794415416798357
493,8,2.0794415416798357
roughly,8,2.0794415416798357
arrhythmogenic,8,2.0794415416798357
prescribe,8,2.0794415416798357
Gene,8,2.0794415416798357
industries,8,2.0794415416798357
309,8,2.0794415416798357
coincided,8,2.0794415416798357
401,8,2.0794415416798357
leg,8,2.0794415416798357
overcoming,8,2.0794415416798357
slices,8,2.0794415416798357
neutral,7,1.9459101490553132
NRL,7,1.9459101490553132
dehydration,7,1.9459101490553132
Sprague-Dawley,7,1.9459101490553132
MCP-1,7,1.9459101490553132
DEP,7,1.9459101490553132
demonstrable,7,1.9459101490553132
Frequency,7,1.9459101490553132
infer,7,1.9459101490553132
synthase,7,1.9459101490553132
TMA,7,1.9459101490553132
disseminate,7,1.9459101490553132
Observational,7,1.9459101490553132
Factor,7,1.9459101490553132
early-stage,7,1.9459101490553132
growers,7,1.9459101490553132
planar,7,1.9459101490553132
Markov,7,1.9459101490553132
037,7,1.9459101490553132
Sheva,7,1.9459101490553132
mineralizing,7,1.9459101490553132
900,7,1.9459101490553132
natto,7,1.9459101490553132
geometry,7,1.9459101490553132
recombination,7,1.9459101490553132
CdM,7,1.9459101490553132
officially,7,1.9459101490553132
acuteness,7,1.9459101490553132
intensive-care,7,1.9459101490553132
Year,7,1.9459101490553132
empiric,7,1.9459101490553132
Beer,7,1.9459101490553132
C4,7,1.9459101490553132
undifferentiated,7,1.9459101490553132
starts,7,1.9459101490553132
BACKGROUND,7,1.9459101490553132
passed,7,1.9459101490553132
HPA,7,1.9459101490553132
predominate,7,1.9459101490553132
year-round,7,1.9459101490553132
typing,7,1.9459101490553132
Along,7,1.9459101490553132
transformed,7,1.9459101490553132
prolong,7,1.9459101490553132
scanner,7,1.9459101490553132
RESULTS,7,1.9459101490553132
cholinergic,7,1.9459101490553132
upward,7,1.9459101490553132
cyst,7,1.9459101490553132
aneurysmal,7,1.9459101490553132
FEV1FVC,7,1.9459101490553132
depressions,7,1.9459101490553132
afterwards,7,1.9459101490553132
RdRP,7,1.9459101490553132
Published,7,1.9459101490553132
handicap,7,1.9459101490553132
Likewise,7,1.9459101490553132
2012-2013,7,1.9459101490553132
viperin,7,1.9459101490553132
ended,7,1.9459101490553132
NK-cells,7,1.9459101490553132
ruptures,7,1.9459101490553132
cardiothoracic,7,1.9459101490553132
pending,7,1.9459101490553132
gray,7,1.9459101490553132
radiologists,7,1.9459101490553132
Hajj,7,1.9459101490553132
SEIR,7,1.9459101490553132
supraventricular,7,1.9459101490553132
34-year-old,7,1.9459101490553132
funded,7,1.9459101490553132
FT,7,1.9459101490553132
rash,7,1.9459101490553132
hay,7,1.9459101490553132
skewed,7,1.9459101490553132
contracted,7,1.9459101490553132
fulfilling,7,1.9459101490553132
Attack,7,1.9459101490553132
visceral,7,1.9459101490553132
AH,7,1.9459101490553132
infratentorial,7,1.9459101490553132
vesicles,7,1.9459101490553132
EDVI,7,1.9459101490553132
Shanghai,7,1.9459101490553132
postoperatively,7,1.9459101490553132
Autophagy,7,1.9459101490553132
specially,7,1.9459101490553132
circumferential,7,1.9459101490553132
multiplication,7,1.9459101490553132
accumulate,7,1.9459101490553132
plethysmography,7,1.9459101490553132
reproduce,7,1.9459101490553132
cytoplasmic,7,1.9459101490553132
formula,7,1.9459101490553132
multifocal,7,1.9459101490553132
282,7,1.9459101490553132
ataxia,7,1.9459101490553132
drain,7,1.9459101490553132
researcher,7,1.9459101490553132
083,7,1.9459101490553132
influenzavirus,7,1.9459101490553132
unfractionated,7,1.9459101490553132
purely,7,1.9459101490553132
Influenza-associated,7,1.9459101490553132
preferably,7,1.9459101490553132
biosolids,7,1.9459101490553132
establishes,7,1.9459101490553132
killing,7,1.9459101490553132
IPC,7,1.9459101490553132
CARAT10,7,1.9459101490553132
Barcelona,7,1.9459101490553132
988,7,1.9459101490553132
SAQ,7,1.9459101490553132
191,7,1.9459101490553132
at-home,7,1.9459101490553132
Postmortem,7,1.9459101490553132
Columbia,7,1.9459101490553132
Standardized,7,1.9459101490553132
alleviating,7,1.9459101490553132
109l,7,1.9459101490553132
fabricated,7,1.9459101490553132
low-resource,7,1.9459101490553132
Ds,7,1.9459101490553132
investment,7,1.9459101490553132
307,7,1.9459101490553132
Perhaps,7,1.9459101490553132
RWM,7,1.9459101490553132
CypA,7,1.9459101490553132
synchronous,7,1.9459101490553132
preferential,7,1.9459101490553132
curcumin,7,1.9459101490553132
reelevation,7,1.9459101490553132
Electrocardiographic,7,1.9459101490553132
Manitoba,7,1.9459101490553132
Telemedicine,7,1.9459101490553132
NOS,7,1.9459101490553132
incision,7,1.9459101490553132
neutralized,7,1.9459101490553132
explicitly,7,1.9459101490553132
risk-benefit,7,1.9459101490553132
IL-2,7,1.9459101490553132
equity,7,1.9459101490553132
amplify,7,1.9459101490553132
OCSP,7,1.9459101490553132
partner,7,1.9459101490553132
obviously,7,1.9459101490553132
far-reaching,7,1.9459101490553132
definitely,7,1.9459101490553132
TIAs,7,1.9459101490553132
Urgent,7,1.9459101490553132
elaboration,7,1.9459101490553132
amounted,7,1.9459101490553132
078,7,1.9459101490553132
linearity,7,1.9459101490553132
non-allergic,7,1.9459101490553132
aVF,7,1.9459101490553132
contusion,7,1.9459101490553132
P00001,7,1.9459101490553132
V4,7,1.9459101490553132
Sample,7,1.9459101490553132
Inpatient,7,1.9459101490553132
amlodipine,7,1.9459101490553132
virologic,7,1.9459101490553132
DTEC,7,1.9459101490553132
Stenting,7,1.9459101490553132
Arteries,7,1.9459101490553132
inequalities,7,1.9459101490553132
Occluded,7,1.9459101490553132
933,7,1.9459101490553132
fears,7,1.9459101490553132
explanatory,7,1.9459101490553132
Indoor,7,1.9459101490553132
tricuspid,7,1.9459101490553132
ADs,7,1.9459101490553132
knee,7,1.9459101490553132
undertook,7,1.9459101490553132
immigrants,7,1.9459101490553132
medial,7,1.9459101490553132
339,7,1.9459101490553132
speaking,7,1.9459101490553132
jump,7,1.9459101490553132
transplants,7,1.9459101490553132
PWI,7,1.9459101490553132
Perth,7,1.9459101490553132
Pakistan,7,1.9459101490553132
424,7,1.9459101490553132
peanut,7,1.9459101490553132
Twenty-three,7,1.9459101490553132
Cumulative,7,1.9459101490553132
1972,7,1.9459101490553132
251,7,1.9459101490553132
spores,7,1.9459101490553132
citicoline,7,1.9459101490553132
community-dwelling,7,1.9459101490553132
technicians,7,1.9459101490553132
teens,7,1.9459101490553132
breadth,7,1.9459101490553132
spleen,7,1.9459101490553132
terminology,7,1.9459101490553132
paraplegia,7,1.9459101490553132
AWM,7,1.9459101490553132
Events,7,1.9459101490553132
378,7,1.9459101490553132
1973,7,1.9459101490553132
NBTE,7,1.9459101490553132
Epidemiology,7,1.9459101490553132
belong,7,1.9459101490553132
FTN,7,1.9459101490553132
reimbursement,7,1.9459101490553132
tracks,7,1.9459101490553132
sleepiness,7,1.9459101490553132
spanning,7,1.9459101490553132
segmented,7,1.9459101490553132
605,7,1.9459101490553132
thanks,7,1.9459101490553132
380,7,1.9459101490553132
ensuing,7,1.9459101490553132
segmentations,7,1.9459101490553132
contiguous,7,1.9459101490553132
calendar,7,1.9459101490553132
multilevel,7,1.9459101490553132
perturbations,7,1.9459101490553132
reliance,7,1.9459101490553132
DM2,7,1.9459101490553132
law,7,1.9459101490553132
6800,7,1.9459101490553132
mRNAs,7,1.9459101490553132
neurotrophins,7,1.9459101490553132
noteworthy,7,1.9459101490553132
land,7,1.9459101490553132
precedes,7,1.9459101490553132
thyroiditis,7,1.9459101490553132
S-100β,7,1.9459101490553132
800,7,1.9459101490553132
subgenomic,7,1.9459101490553132
058,7,1.9459101490553132
discriminative,7,1.9459101490553132
moyamoya,7,1.9459101490553132
coordinate,7,1.9459101490553132
intramural,7,1.9459101490553132
projection,7,1.9459101490553132
underutilization,7,1.9459101490553132
ACCP,7,1.9459101490553132
nucleus,7,1.9459101490553132
wildfire,7,1.9459101490553132
attenuating,7,1.9459101490553132
360,7,1.9459101490553132
exerted,7,1.9459101490553132
retained,7,1.9459101490553132
head-to-head,7,1.9459101490553132
microangiopathy,7,1.9459101490553132
hamper,7,1.9459101490553132
Achieving,7,1.9459101490553132
deletions,7,1.9459101490553132
Subsequent,7,1.9459101490553132
reinfarctions,7,1.9459101490553132
biologicals,7,1.9459101490553132
tens,7,1.9459101490553132
agency,7,1.9459101490553132
commuting,7,1.9459101490553132
Framingham,7,1.9459101490553132
Good,7,1.9459101490553132
co-circulation,7,1.9459101490553132
insults,7,1.9459101490553132
κ,7,1.9459101490553132
deeply,7,1.9459101490553132
536,7,1.9459101490553132
2500,7,1.9459101490553132
lifesaving,7,1.9459101490553132
Toll-like,7,1.9459101490553132
mix,7,1.9459101490553132
310,7,1.9459101490553132
TNF-α,7,1.9459101490553132
non-adherence,7,1.9459101490553132
Predictors,7,1.9459101490553132
rhythms,7,1.9459101490553132
lymphopenia,7,1.9459101490553132
Library,7,1.9459101490553132
sec,7,1.9459101490553132
microfocal,7,1.9459101490553132
protein-based,7,1.9459101490553132
BYamagata,7,1.9459101490553132
myofibroblasts,7,1.9459101490553132
hyperintensities,7,1.9459101490553132
syndrome-related,7,1.9459101490553132
lipoproteina,7,1.9459101490553132
Practice,7,1.9459101490553132
refined,7,1.9459101490553132
hypercholesterolaemia,7,1.9459101490553132
PPARgamma,7,1.9459101490553132
thirty,7,1.9459101490553132
427,7,1.9459101490553132
hemicraniectomy,7,1.9459101490553132
enveloped,7,1.9459101490553132
lengths,7,1.9459101490553132
2-5,7,1.9459101490553132
416,7,1.9459101490553132
runs,7,1.9459101490553132
unacceptable,7,1.9459101490553132
HeLa,7,1.9459101490553132
standardize,7,1.9459101490553132
cigarettes,7,1.9459101490553132
Ltd,7,1.9459101490553132
symptom-free,7,1.9459101490553132
blood-based,7,1.9459101490553132
ensures,7,1.9459101490553132
anticoagulated,7,1.9459101490553132
TH2,7,1.9459101490553132
ranked,7,1.9459101490553132
072,7,1.9459101490553132
forest,7,1.9459101490553132
Statement,7,1.9459101490553132
shoulder,7,1.9459101490553132
Thereafter,7,1.9459101490553132
possessing,7,1.9459101490553132
cedar,7,1.9459101490553132
dosages,7,1.9459101490553132
partitioning,7,1.9459101490553132
perceptual,7,1.9459101490553132
Gastroesophageal,7,1.9459101490553132
diltiazem,7,1.9459101490553132
297,7,1.9459101490553132
Severity,7,1.9459101490553132
pleura,7,1.9459101490553132
antiasthmatic,7,1.9459101490553132
immunopathogenesis,7,1.9459101490553132
retardation,7,1.9459101490553132
alternatively,7,1.9459101490553132
MRs,7,1.9459101490553132
escalation,7,1.9459101490553132
Abstract,7,1.9459101490553132
developers,7,1.9459101490553132
MACEs,7,1.9459101490553132
postulate,7,1.9459101490553132
outgrown,7,1.9459101490553132
mucous,7,1.9459101490553132
impairs,7,1.9459101490553132
manifests,7,1.9459101490553132
AF-related,7,1.9459101490553132
prospect,7,1.9459101490553132
r2,7,1.9459101490553132
Whole,7,1.9459101490553132
farm,7,1.9459101490553132
hyperinflammatory,7,1.9459101490553132
ferritin,7,1.9459101490553132
infusions,7,1.9459101490553132
prostate,7,1.9459101490553132
TFC,7,1.9459101490553132
T2-high,7,1.9459101490553132
reactivation,7,1.9459101490553132
posts,7,1.9459101490553132
anisotropy,7,1.9459101490553132
Mycoplasma,7,1.9459101490553132
contacted,7,1.9459101490553132
perforator,7,1.9459101490553132
pontine,7,1.9459101490553132
Siriraj,7,1.9459101490553132
Allen,7,1.9459101490553132
invading,7,1.9459101490553132
adipose,7,1.9459101490553132
indium-111,7,1.9459101490553132
Britain,7,1.9459101490553132
correspondence,7,1.9459101490553132
2017-2018,7,1.9459101490553132
submucosal,7,1.9459101490553132
convulsion,7,1.9459101490553132
Queensland,7,1.9459101490553132
honey,7,1.9459101490553132
Fractional,7,1.9459101490553132
hypercholesterolemia,7,1.9459101490553132
modulates,7,1.9459101490553132
2-4,7,1.9459101490553132
mTOR,7,1.9459101490553132
Substantial,7,1.9459101490553132
alternate,7,1.9459101490553132
NSW,7,1.9459101490553132
stopping,7,1.9459101490553132
ANS,7,1.9459101490553132
Reasons,7,1.9459101490553132
effectors,7,1.9459101490553132
smoker,7,1.9459101490553132
Government,7,1.9459101490553132
encompasses,7,1.9459101490553132
apathy,7,1.9459101490553132
protein-protein,7,1.9459101490553132
047,7,1.9459101490553132
Mpro,7,1.9459101490553132
064,7,1.9459101490553132
audience,7,1.9459101490553132
equivocal,7,1.9459101490553132
AUml,7,1.9459101490553132
Hetil,7,1.9459101490553132
Materials,7,1.9459101490553132
SR,7,1.9459101490553132
Pearsons,7,1.9459101490553132
attribution,7,1.9459101490553132
inflation,7,1.9459101490553132
humanized,7,1.9459101490553132
proactive,7,1.9459101490553132
impedance,7,1.9459101490553132
bands,7,1.9459101490553132
assembled,7,1.9459101490553132
S1S2,7,1.9459101490553132
conditional,7,1.9459101490553132
furin,7,1.9459101490553132
cell-cell,7,1.9459101490553132
Sensitization,7,1.9459101490553132
Orv,7,1.9459101490553132
syncope,7,1.9459101490553132
Hospitalization,7,1.9459101490553132
microgramsl,7,1.9459101490553132
Controversy,7,1.9459101490553132
Nationwide,7,1.9459101490553132
duck,7,1.9459101490553132
308,7,1.9459101490553132
830,7,1.9459101490553132
PAM,7,1.9459101490553132
255,7,1.9459101490553132
373,7,1.9459101490553132
Mild,7,1.9459101490553132
Parental,7,1.9459101490553132
348,7,1.9459101490553132
habit,7,1.9459101490553132
patient-centered,7,1.9459101490553132
veins,7,1.9459101490553132
hyperglycemic,7,1.9459101490553132
CES,7,1.9459101490553132
fill,7,1.9459101490553132
SVS,7,1.9459101490553132
Multiplex,7,1.9459101490553132
Economic,7,1.9459101490553132
twelve,7,1.9459101490553132
esophagus,7,1.9459101490553132
troponins,7,1.9459101490553132
Rats,7,1.9459101490553132
Inclusion,7,1.9459101490553132
245,7,1.9459101490553132
ingredients,7,1.9459101490553132
hemostasis,7,1.9459101490553132
killer,7,1.9459101490553132
endoscopic,7,1.9459101490553132
2001-2002,7,1.9459101490553132
discarded,7,1.9459101490553132
open-label,7,1.9459101490553132
football,7,1.9459101490553132
grading,7,1.9459101490553132
unbiased,7,1.9459101490553132
Prefecture,7,1.9459101490553132
afterload,7,1.9459101490553132
nearest,7,1.9459101490553132
N-acetyl,7,1.9459101490553132
self-monitoring,7,1.9459101490553132
Vaxzevria,7,1.9459101490553132
Whites,7,1.9459101490553132
essentially,7,1.9459101490553132
IZ,7,1.9459101490553132
replacing,7,1.9459101490553132
AS-STEMI,7,1.9459101490553132
reader,7,1.9459101490553132
tertile,7,1.9459101490553132
Federation,7,1.9459101490553132
CDT,7,1.9459101490553132
340,7,1.9459101490553132
Neurology,7,1.9459101490553132
perforation,7,1.9459101490553132
absolutely,7,1.9459101490553132
gravity,7,1.9459101490553132
LVD,7,1.9459101490553132
Sputum,7,1.9459101490553132
sulfate,7,1.9459101490553132
country-specific,7,1.9459101490553132
polygenic,7,1.9459101490553132
cross-protection,7,1.9459101490553132
AUD,7,1.9459101490553132
monkeys,7,1.9459101490553132
Oxfordshire,7,1.9459101490553132
Disability,7,1.9459101490553132
commitment,7,1.9459101490553132
3-6,7,1.9459101490553132
protracted,7,1.9459101490553132
Mgl,7,1.9459101490553132
anti-IgE,7,1.9459101490553132
erroneously,7,1.9459101490553132
18F-FDG,7,1.9459101490553132
public-health,7,1.9459101490553132
Jersey,7,1.9459101490553132
TENS,7,1.9459101490553132
glucose-lowering,7,1.9459101490553132
equivalents,7,1.9459101490553132
distrust,7,1.9459101490553132
resumed,7,1.9459101490553132
exhibiting,7,1.9459101490553132
20102011,7,1.9459101490553132
weakly,7,1.9459101490553132
chronicity,7,1.9459101490553132
saw,7,1.9459101490553132
individualised,7,1.9459101490553132
surgeon,7,1.9459101490553132
dysbiosis,7,1.9459101490553132
vera,7,1.9459101490553132
post-AMI,7,1.9459101490553132
Twenty-nine,7,1.9459101490553132
matrices,7,1.9459101490553132
stations,7,1.9459101490553132
post-infection,7,1.9459101490553132
swimmers,7,1.9459101490553132
evoke,7,1.9459101490553132
226,7,1.9459101490553132
201516,7,1.9459101490553132
Sentinel,7,1.9459101490553132
leukoencephalopathy,7,1.9459101490553132
autosomal,7,1.9459101490553132
OEF,7,1.9459101490553132
NYHA,7,1.9459101490553132
morphologic,7,1.9459101490553132
221,7,1.9459101490553132
affective,7,1.9459101490553132
drawbacks,7,1.9459101490553132
intradermal,7,1.9459101490553132
DNT,7,1.9459101490553132
279,7,1.9459101490553132
antidiabetic,7,1.9459101490553132
Digital,7,1.9459101490553132
decisive,7,1.9459101490553132
solved,7,1.9459101490553132
352,7,1.9459101490553132
Response,7,1.9459101490553132
Regular,7,1.9459101490553132
Interview,7,1.9459101490553132
skin-prick,7,1.9459101490553132
Twenty-four,7,1.9459101490553132
063,7,1.9459101490553132
interpandemic,7,1.9459101490553132
surprisingly,7,1.9459101490553132
096,7,1.9459101490553132
SOD,7,1.9459101490553132
door-to-needle,7,1.9459101490553132
IC,7,1.9459101490553132
dentists,7,1.9459101490553132
excised,7,1.9459101490553132
bottleneck,7,1.9459101490553132
rests,7,1.9459101490553132
Controls,7,1.9459101490553132
wait,7,1.9459101490553132
mount,7,1.9459101490553132
manipulation,7,1.9459101490553132
Y,7,1.9459101490553132
0025,7,1.9459101490553132
antigenicity,7,1.9459101490553132
accompany,7,1.9459101490553132
categorical,7,1.9459101490553132
formally,7,1.9459101490553132
ascribed,7,1.9459101490553132
sporting,7,1.9459101490553132
hypokinesia,7,1.9459101490553132
anaemia,7,1.9459101490553132
advancement,7,1.9459101490553132
10-15,7,1.9459101490553132
on-line,7,1.9459101490553132
single-vessel,7,1.9459101490553132
cTnI,7,1.9459101490553132
Cobas,7,1.9459101490553132
postponed,7,1.9459101490553132
east,7,1.9459101490553132
clarification,7,1.9459101490553132
retinal,7,1.9459101490553132
subpopulation,7,1.9459101490553132
NMDs,7,1.9459101490553132
immunocompetent,7,1.9459101490553132
NIOX,7,1.9459101490553132
visitors,7,1.9459101490553132
049,7,1.9459101490553132
Simple,7,1.9459101490553132
027,7,1.9459101490553132
quinapril,7,1.9459101490553132
on-going,7,1.9459101490553132
HCoV-OC43,7,1.9459101490553132
GWAS,7,1.9459101490553132
scant,7,1.9459101490553132
permission,7,1.9459101490553132
Avoidance,7,1.9459101490553132
worsens,7,1.9459101490553132
Natural,7,1.9459101490553132
symptom-limited,7,1.9459101490553132
nedocromil,7,1.9459101490553132
Federal,7,1.9459101490553132
insignificant,7,1.9459101490553132
Malaysia,7,1.9459101490553132
C-ACT,7,1.9459101490553132
EBC,7,1.9459101490553132
Being,7,1.9459101490553132
20000,7,1.9459101490553132
RPD,7,1.9459101490553132
IWMI,7,1.9459101490553132
Excess,7,1.9459101490553132
filtered,7,1.9459101490553132
hotspot,7,1.9459101490553132
Great,7,1.9459101490553132
maximizing,7,1.9459101490553132
HU,7,1.9459101490553132
transcribed,7,1.9459101490553132
exogenous,7,1.9459101490553132
PD20,7,1.9459101490553132
Surgery,7,1.9459101490553132
AN,7,1.9459101490553132
Angina,7,1.9459101490553132
Centres,7,1.9459101490553132
V5,7,1.9459101490553132
SDIA,7,1.9459101490553132
Carolina,7,1.9459101490553132
BinaxNOW,7,1.9459101490553132
proof-of-concept,7,1.9459101490553132
disadvantage,7,1.9459101490553132
journal,7,1.9459101490553132
umbrella,7,1.9459101490553132
spectra,7,1.9459101490553132
requested,7,1.9459101490553132
profession,7,1.9459101490553132
managers,7,1.9459101490553132
Heterogeneity,7,1.9459101490553132
PAQLQ,7,1.9459101490553132
Critical,7,1.9459101490553132
continuity,7,1.9459101490553132
LAIV4,7,1.9459101490553132
optimise,7,1.9459101490553132
Forced,7,1.9459101490553132
Reducing,7,1.9459101490553132
unsuitable,7,1.9459101490553132
asymmetric,7,1.9459101490553132
discrepant,7,1.9459101490553132
NSM,7,1.9459101490553132
visually,7,1.9459101490553132
Obesity,7,1.9459101490553132
chi-square,7,1.9459101490553132
S3,7,1.9459101490553132
recommending,7,1.9459101490553132
rodents,7,1.9459101490553132
rationing,7,1.9459101490553132
Syrian,7,1.9459101490553132
facts,7,1.9459101490553132
superiority,7,1.9459101490553132
Beyond,7,1.9459101490553132
rheumatoid,7,1.9459101490553132
marrow-derived,7,1.9459101490553132
perceive,7,1.9459101490553132
anamnestic,7,1.9459101490553132
simpler,7,1.9459101490553132
354,7,1.9459101490553132
fragments,7,1.9459101490553132
viewpoint,7,1.9459101490553132
disease-specific,7,1.9459101490553132
risen,7,1.9459101490553132
Reduced,7,1.9459101490553132
restricting,7,1.9459101490553132
antihypertensives,7,1.9459101490553132
transverse,7,1.9459101490553132
TPA,7,1.9459101490553132
myelitis,7,1.9459101490553132
anxious,7,1.9459101490553132
Globally,7,1.9459101490553132
avoidable,7,1.9459101490553132
single-nucleotide,7,1.9459101490553132
faecal-oral,7,1.9459101490553132
job,7,1.9459101490553132
Longitudinal,7,1.9459101490553132
283,7,1.9459101490553132
AM,7,1.9459101490553132
twenty,7,1.9459101490553132
topical,7,1.9459101490553132
396,7,1.9459101490553132
diuretic,7,1.9459101490553132
Wheezing,7,1.9459101490553132
meningitis,7,1.9459101490553132
AMIs,7,1.9459101490553132
Board,7,1.9459101490553132
unscheduled,7,1.9459101490553132
168,7,1.9459101490553132
090,7,1.9459101490553132
2011-2012,7,1.9459101490553132
dizziness,7,1.9459101490553132
1982,7,1.9459101490553132
arisen,7,1.9459101490553132
AHA,7,1.9459101490553132
viruss,7,1.9459101490553132
Neither,7,1.9459101490553132
Gastrointestinal,7,1.9459101490553132
Reporting,7,1.9459101490553132
PG,7,1.9459101490553132
Guangdong,7,1.9459101490553132
unequivocally,7,1.9459101490553132
Force,7,1.9459101490553132
epidemiologists,7,1.9459101490553132
FHMI,7,1.9459101490553132
Surveys,7,1.9459101490553132
undertreated,7,1.9459101490553132
Mutations,7,1.9459101490553132
Serious,7,1.9459101490553132
BHong,7,1.9459101490553132
circumference,7,1.9459101490553132
readiness,7,1.9459101490553132
programming,7,1.9459101490553132
humid,7,1.9459101490553132
progenitors,7,1.9459101490553132
9th,7,1.9459101490553132
ACOS,7,1.9459101490553132
PM25,7,1.9459101490553132
kg,7,1.9459101490553132
ethically,7,1.9459101490553132
utilizes,7,1.9459101490553132
post-infarct,7,1.9459101490553132
expired,7,1.9459101490553132
difficult-to-control,7,1.9459101490553132
roll-out,7,1.9459101490553132
pet,7,1.9459101490553132
aspergillus,7,1.9459101490553132
viscosity,7,1.9459101490553132
dates,7,1.9459101490553132
0012,7,1.9459101490553132
SARS-CoV-2-positive,7,1.9459101490553132
Croatia,7,1.9459101490553132
883,7,1.9459101490553132
technetium,7,1.9459101490553132
cycling,7,1.9459101490553132
HADS,7,1.9459101490553132
competitive,7,1.9459101490553132
Survivors,7,1.9459101490553132
rehabilitative,7,1.9459101490553132
retention,7,1.9459101490553132
metasurface,7,1.9459101490553132
syringe,7,1.9459101490553132
apo,7,1.9459101490553132
Alaska,7,1.9459101490553132
Beta,7,1.9459101490553132
Stockholm,7,1.9459101490553132
hrs,7,1.9459101490553132
credit,7,1.9459101490553132
checked,7,1.9459101490553132
0-4,7,1.9459101490553132
leukocyte,7,1.9459101490553132
mounting,7,1.9459101490553132
embolisation,7,1.9459101490553132
TTE,7,1.9459101490553132
certificates,7,1.9459101490553132
nitrite,7,1.9459101490553132
RVEF,7,1.9459101490553132
druggable,7,1.9459101490553132
stakeholder,7,1.9459101490553132
GRADE,7,1.9459101490553132
bank,7,1.9459101490553132
938,7,1.9459101490553132
competent,7,1.9459101490553132
entails,7,1.9459101490553132
portal,7,1.9459101490553132
minimized,7,1.9459101490553132
NF-κB,7,1.9459101490553132
swabbing,7,1.9459101490553132
interrupted,7,1.9459101490553132
milieu,7,1.9459101490553132
230,7,1.9459101490553132
273,7,1.9459101490553132
Rt,7,1.9459101490553132
MTHFR,7,1.9459101490553132
committee,7,1.9459101490553132
CCIS,7,1.9459101490553132
implicating,7,1.9459101490553132
hoc,7,1.9459101490553132
T-helper,7,1.9459101490553132
Psychosocial,7,1.9459101490553132
appreciable,7,1.9459101490553132
opacity,7,1.9459101490553132
Mg,7,1.9459101490553132
WBE,7,1.9459101490553132
km,7,1.9459101490553132
Philippines,7,1.9459101490553132
gland,7,1.9459101490553132
Full,7,1.9459101490553132
Cohens,7,1.9459101490553132
heme,7,1.9459101490553132
tear,7,1.9459101490553132
nonallergic,7,1.9459101490553132
soil,7,1.9459101490553132
disrupt,7,1.9459101490553132
intra-,7,1.9459101490553132
Majority,7,1.9459101490553132
Zn,7,1.9459101490553132
leak,7,1.9459101490553132
spared,7,1.9459101490553132
lymphocytopenia,7,1.9459101490553132
signalling,7,1.9459101490553132
CRISPR-Cas,7,1.9459101490553132
cheaper,7,1.9459101490553132
077,7,1.9459101490553132
Expiratory,7,1.9459101490553132
needle,7,1.9459101490553132
SMC,6,1.791759469228055
WMH,6,1.791759469228055
FRPs,6,1.791759469228055
767,6,1.791759469228055
unavoidable,6,1.791759469228055
Forty-eight,6,1.791759469228055
315,6,1.791759469228055
farinae,6,1.791759469228055
patchy,6,1.791759469228055
attentional,6,1.791759469228055
low-level,6,1.791759469228055
Sequential,6,1.791759469228055
multi-faceted,6,1.791759469228055
CD4CD8,6,1.791759469228055
religious,6,1.791759469228055
Native,6,1.791759469228055
Analyses,6,1.791759469228055
paraclinical,6,1.791759469228055
DLV,6,1.791759469228055
cytometry,6,1.791759469228055
misuse,6,1.791759469228055
backyard,6,1.791759469228055
181,6,1.791759469228055
NHS,6,1.791759469228055
analytically,6,1.791759469228055
randomization,6,1.791759469228055
robustness,6,1.791759469228055
ngml,6,1.791759469228055
lateralization,6,1.791759469228055
PVS,6,1.791759469228055
--,6,1.791759469228055
-19,6,1.791759469228055
CoronaVac,6,1.791759469228055
centered,6,1.791759469228055
nut,6,1.791759469228055
expectoration,6,1.791759469228055
surfactant,6,1.791759469228055
Twitter,6,1.791759469228055
Core,6,1.791759469228055
frictional,6,1.791759469228055
rabbits,6,1.791759469228055
Intracoronary,6,1.791759469228055
Repeat,6,1.791759469228055
inevitably,6,1.791759469228055
sway,6,1.791759469228055
Resistance,6,1.791759469228055
long-time,6,1.791759469228055
corpus,6,1.791759469228055
supposed,6,1.791759469228055
achievements,6,1.791759469228055
you,6,1.791759469228055
grouping,6,1.791759469228055
Cuba,6,1.791759469228055
spike-specific,6,1.791759469228055
URTI,6,1.791759469228055
334,6,1.791759469228055
Belt,6,1.791759469228055
curated,6,1.791759469228055
concomitantly,6,1.791759469228055
co-circulating,6,1.791759469228055
Wide,6,1.791759469228055
EIPH,6,1.791759469228055
suspicious,6,1.791759469228055
CC,6,1.791759469228055
causation,6,1.791759469228055
743,6,1.791759469228055
CAB,6,1.791759469228055
atherothrombosis,6,1.791759469228055
surpassed,6,1.791759469228055
authority,6,1.791759469228055
QMI,6,1.791759469228055
SCT,6,1.791759469228055
succeeded,6,1.791759469228055
discourse,6,1.791759469228055
argument,6,1.791759469228055
work-exacerbated,6,1.791759469228055
044,6,1.791759469228055
Estimates,6,1.791759469228055
struck,6,1.791759469228055
max,6,1.791759469228055
0048,6,1.791759469228055
CRISPR,6,1.791759469228055
urbanization,6,1.791759469228055
sunlight,6,1.791759469228055
967,6,1.791759469228055
AGPs,6,1.791759469228055
Laboratories,6,1.791759469228055
CDCs,6,1.791759469228055
bloodstream,6,1.791759469228055
SDB,6,1.791759469228055
antithrombotics,6,1.791759469228055
appreciation,6,1.791759469228055
387,6,1.791759469228055
318,6,1.791759469228055
decontamination,6,1.791759469228055
dorsal,6,1.791759469228055
sub-strains,6,1.791759469228055
bACE2-Rm,6,1.791759469228055
isolating,6,1.791759469228055
444,6,1.791759469228055
tumour,6,1.791759469228055
stockpiles,6,1.791759469228055
yellow,6,1.791759469228055
thunderstorm,6,1.791759469228055
declaration,6,1.791759469228055
Th2-type,6,1.791759469228055
THC-MIST,6,1.791759469228055
Egyptian,6,1.791759469228055
Organizations,6,1.791759469228055
fossa,6,1.791759469228055
A-V,6,1.791759469228055
ratings,6,1.791759469228055
206,6,1.791759469228055
post-COVID,6,1.791759469228055
DALYs,6,1.791759469228055
lymphoma,6,1.791759469228055
lncRNAs,6,1.791759469228055
co-occurrence,6,1.791759469228055
non-EVT,6,1.791759469228055
encourages,6,1.791759469228055
cytopathic,6,1.791759469228055
017,6,1.791759469228055
MVD,6,1.791759469228055
Gamma,6,1.791759469228055
Dr,6,1.791759469228055
tercile,6,1.791759469228055
concentrate,6,1.791759469228055
WRA,6,1.791759469228055
pre-treatment,6,1.791759469228055
frameworks,6,1.791759469228055
well-controlled,6,1.791759469228055
1918-1920,6,1.791759469228055
non-human,6,1.791759469228055
NY,6,1.791759469228055
ischemia-reperfusion,6,1.791759469228055
clarifying,6,1.791759469228055
Atypical,6,1.791759469228055
RIPerC,6,1.791759469228055
1950s,6,1.791759469228055
prerequisites,6,1.791759469228055
Recanalization,6,1.791759469228055
Dynamic,6,1.791759469228055
T2WI,6,1.791759469228055
labeling,6,1.791759469228055
dictate,6,1.791759469228055
blot,6,1.791759469228055
drawback,6,1.791759469228055
Remdesivir,6,1.791759469228055
©,6,1.791759469228055
VLM,6,1.791759469228055
branching,6,1.791759469228055
NOS1,6,1.791759469228055
extracurricular,6,1.791759469228055
haloperidol,6,1.791759469228055
Forty,6,1.791759469228055
non-infectious,6,1.791759469228055
Host,6,1.791759469228055
314,6,1.791759469228055
appreciated,6,1.791759469228055
syndrome-coronavirus,6,1.791759469228055
plot,6,1.791759469228055
traced,6,1.791759469228055
MEF50,6,1.791759469228055
grams,6,1.791759469228055
non-linear,6,1.791759469228055
4-5,6,1.791759469228055
SCS,6,1.791759469228055
CH,6,1.791759469228055
AYA,6,1.791759469228055
Ghana,6,1.791759469228055
programmed,6,1.791759469228055
grown,6,1.791759469228055
kindergarten,6,1.791759469228055
sided,6,1.791759469228055
953,6,1.791759469228055
lytic,6,1.791759469228055
Foundation,6,1.791759469228055
Belgium,6,1.791759469228055
UMCs,6,1.791759469228055
boosting,6,1.791759469228055
answering,6,1.791759469228055
PMCT,6,1.791759469228055
Sixty-seven,6,1.791759469228055
irritability,6,1.791759469228055
alternating,6,1.791759469228055
unremarkable,6,1.791759469228055
238,6,1.791759469228055
bypassing,6,1.791759469228055
Continued,6,1.791759469228055
world-wide,6,1.791759469228055
stasis-dissolving,6,1.791759469228055
moved,6,1.791759469228055
congregate,6,1.791759469228055
622,6,1.791759469228055
nonobstructive,6,1.791759469228055
actuarial,6,1.791759469228055
assignment,6,1.791759469228055
expense,6,1.791759469228055
mailed,6,1.791759469228055
CD147,6,1.791759469228055
underscoring,6,1.791759469228055
erythropoietin,6,1.791759469228055
Generally,6,1.791759469228055
cockroaches,6,1.791759469228055
Streptokinase,6,1.791759469228055
historically,6,1.791759469228055
bivalirudin,6,1.791759469228055
hands,6,1.791759469228055
harmless,6,1.791759469228055
Intracerebral,6,1.791759469228055
Asthmatics,6,1.791759469228055
NRP-1,6,1.791759469228055
river,6,1.791759469228055
dalteparin,6,1.791759469228055
Olomouc,6,1.791759469228055
10th,6,1.791759469228055
seriousness,6,1.791759469228055
insect,6,1.791759469228055
influent,6,1.791759469228055
Scientists,6,1.791759469228055
Ch,6,1.791759469228055
tachyarrhythmias,6,1.791759469228055
bronchoconstrictor,6,1.791759469228055
y,6,1.791759469228055
threaten,6,1.791759469228055
infantile,6,1.791759469228055
invade,6,1.791759469228055
atlas,6,1.791759469228055
speak,6,1.791759469228055
chromosomal,6,1.791759469228055
TIS,6,1.791759469228055
left-sided,6,1.791759469228055
DE-MRI,6,1.791759469228055
neutralisation,6,1.791759469228055
rt-PCR,6,1.791759469228055
volt,6,1.791759469228055
Uncontrolled,6,1.791759469228055
563,6,1.791759469228055
introduces,6,1.791759469228055
45-6h,6,1.791759469228055
Countries,6,1.791759469228055
vaccine-preventable,6,1.791759469228055
ARIC,6,1.791759469228055
Cough,6,1.791759469228055
hyperactivity,6,1.791759469228055
467,6,1.791759469228055
performs,6,1.791759469228055
2DE,6,1.791759469228055
Vero-CCL81,6,1.791759469228055
kinetic,6,1.791759469228055
Calcium,6,1.791759469228055
hemagglutinins,6,1.791759469228055
MM,6,1.791759469228055
hypothyroidism,6,1.791759469228055
dollars,6,1.791759469228055
threatens,6,1.791759469228055
nystagmus,6,1.791759469228055
PPI,6,1.791759469228055
hardly,6,1.791759469228055
Allergies,6,1.791759469228055
eradicate,6,1.791759469228055
aqueous,6,1.791759469228055
5000,6,1.791759469228055
Abnormal,6,1.791759469228055
fomite,6,1.791759469228055
arms,6,1.791759469228055
snakebite,6,1.791759469228055
cross-validation,6,1.791759469228055
symmetrical,6,1.791759469228055
peer-reviewed,6,1.791759469228055
remind,6,1.791759469228055
boundaries,6,1.791759469228055
Fifty-two,6,1.791759469228055
fluctuation,6,1.791759469228055
Careful,6,1.791759469228055
vitamins,6,1.791759469228055
962,6,1.791759469228055
ostial,6,1.791759469228055
recursive,6,1.791759469228055
handle,6,1.791759469228055
SERS,6,1.791759469228055
GR,6,1.791759469228055
myxoma,6,1.791759469228055
postconditioning,6,1.791759469228055
empirically,6,1.791759469228055
eighth,6,1.791759469228055
anastomoses,6,1.791759469228055
onwards,6,1.791759469228055
noninvasively,6,1.791759469228055
normotensive,6,1.791759469228055
conceivable,6,1.791759469228055
Asian-Indian,6,1.791759469228055
renin-angiotensin-aldosterone,6,1.791759469228055
404,6,1.791759469228055
cancers,6,1.791759469228055
Questions,6,1.791759469228055
paralysis,6,1.791759469228055
cerebellum,6,1.791759469228055
forthcoming,6,1.791759469228055
immunotherapeutics,6,1.791759469228055
queried,6,1.791759469228055
201415,6,1.791759469228055
insensitive,6,1.791759469228055
I-MOVE,6,1.791759469228055
fibrotic,6,1.791759469228055
optimism,6,1.791759469228055
damaging,6,1.791759469228055
hypertonic,6,1.791759469228055
readout,6,1.791759469228055
grades,6,1.791759469228055
disease-related,6,1.791759469228055
localisation,6,1.791759469228055
obscure,6,1.791759469228055
mortalities,6,1.791759469228055
Transcranial,6,1.791759469228055
confusing,6,1.791759469228055
non-stroke,6,1.791759469228055
Examples,6,1.791759469228055
touched,6,1.791759469228055
SIR,6,1.791759469228055
consulted,6,1.791759469228055
prognoses,6,1.791759469228055
organisation,6,1.791759469228055
electrodes,6,1.791759469228055
342,6,1.791759469228055
HAI,6,1.791759469228055
short-axis,6,1.791759469228055
specify,6,1.791759469228055
meets,6,1.791759469228055
Applying,6,1.791759469228055
dual-use,6,1.791759469228055
hyperkalemia,6,1.791759469228055
classically,6,1.791759469228055
24-48,6,1.791759469228055
NHP,6,1.791759469228055
corresponds,6,1.791759469228055
bilirubin,6,1.791759469228055
plasmonic,6,1.791759469228055
village,6,1.791759469228055
298,6,1.791759469228055
alarm,6,1.791759469228055
incriminated,6,1.791759469228055
Transcription,6,1.791759469228055
horizon,6,1.791759469228055
isotope,6,1.791759469228055
molecularly,6,1.791759469228055
medullary,6,1.791759469228055
muscles,6,1.791759469228055
auditory,6,1.791759469228055
Week,6,1.791759469228055
slope,6,1.791759469228055
unexplored,6,1.791759469228055
conflicts,6,1.791759469228055
handgrip,6,1.791759469228055
Inactivated,6,1.791759469228055
vitreous,6,1.791759469228055
deduced,6,1.791759469228055
20-HETE,6,1.791759469228055
3000,6,1.791759469228055
prognostically,6,1.791759469228055
NPA,6,1.791759469228055
exclusive,6,1.791759469228055
exploited,6,1.791759469228055
PPA,6,1.791759469228055
Combination,6,1.791759469228055
or65,6,1.791759469228055
LTCFs,6,1.791759469228055
reflex,6,1.791759469228055
hypoxaemia,6,1.791759469228055
ventilator,6,1.791759469228055
counselling,6,1.791759469228055
Alcohol,6,1.791759469228055
STRE,6,1.791759469228055
983,6,1.791759469228055
thrombocythemia,6,1.791759469228055
replicated,6,1.791759469228055
Sansure,6,1.791759469228055
30-50,6,1.791759469228055
non-cardioembolic,6,1.791759469228055
chambers,6,1.791759469228055
seeding,6,1.791759469228055
arteriovenous,6,1.791759469228055
968,6,1.791759469228055
unsatisfactory,6,1.791759469228055
Long-acting,6,1.791759469228055
PP,6,1.791759469228055
2005-2006,6,1.791759469228055
compromises,6,1.791759469228055
tactics,6,1.791759469228055
beta-2,6,1.791759469228055
Pneumonia,6,1.791759469228055
PMI,6,1.791759469228055
metagenomic,6,1.791759469228055
021,6,1.791759469228055
FIM,6,1.791759469228055
Tfh,6,1.791759469228055
removing,6,1.791759469228055
polymeric,6,1.791759469228055
subtyping,6,1.791759469228055
Stem,6,1.791759469228055
approximate,6,1.791759469228055
disposal,6,1.791759469228055
Reference,6,1.791759469228055
happen,6,1.791759469228055
2030,6,1.791759469228055
UDA,6,1.791759469228055
501,6,1.791759469228055
PF4,6,1.791759469228055
inhalations,6,1.791759469228055
career,6,1.791759469228055
hindered,6,1.791759469228055
Changing,6,1.791759469228055
AEs,6,1.791759469228055
rigid,6,1.791759469228055
lowers,6,1.791759469228055
Perinatal,6,1.791759469228055
GFAP,6,1.791759469228055
pharmacokinetics,6,1.791759469228055
specialty,6,1.791759469228055
recanalisation,6,1.791759469228055
foster,6,1.791759469228055
shaping,6,1.791759469228055
Male,6,1.791759469228055
digestion,6,1.791759469228055
OSAS,6,1.791759469228055
septic,6,1.791759469228055
PBM,6,1.791759469228055
602,6,1.791759469228055
Detailed,6,1.791759469228055
Red,6,1.791759469228055
non-COVID-19,6,1.791759469228055
normative,6,1.791759469228055
repertoire,6,1.791759469228055
intoxication,6,1.791759469228055
multi-center,6,1.791759469228055
nearby,6,1.791759469228055
akinetic,6,1.791759469228055
catchment,6,1.791759469228055
Resonance,6,1.791759469228055
adequacy,6,1.791759469228055
mutual,6,1.791759469228055
aerosolized,6,1.791759469228055
Mac1,6,1.791759469228055
imaging-based,6,1.791759469228055
ophthalmology,6,1.791759469228055
PMN,6,1.791759469228055
searches,6,1.791759469228055
Pennsylvania,6,1.791759469228055
Göteborg,6,1.791759469228055
nudges,6,1.791759469228055
standing,6,1.791759469228055
Artemisia,6,1.791759469228055
electrode,6,1.791759469228055
financing,6,1.791759469228055
shelter,6,1.791759469228055
cytoplasm,6,1.791759469228055
physiopathological,6,1.791759469228055
IIV4s,6,1.791759469228055
COVID-19-like,6,1.791759469228055
underuse,6,1.791759469228055
akinesis,6,1.791759469228055
resurgence,6,1.791759469228055
vehicle,6,1.791759469228055
São,6,1.791759469228055
fathers,6,1.791759469228055
sequentially,6,1.791759469228055
symbolic,6,1.791759469228055
reflection,6,1.791759469228055
microchips,6,1.791759469228055
VTE,6,1.791759469228055
bivariate,6,1.791759469228055
LFA,6,1.791759469228055
5-7,6,1.791759469228055
1-4,6,1.791759469228055
253,6,1.791759469228055
narrowed,6,1.791759469228055
817,6,1.791759469228055
practiced,6,1.791759469228055
microbes,6,1.791759469228055
925,6,1.791759469228055
ends,6,1.791759469228055
023,6,1.791759469228055
gracile,6,1.791759469228055
paced,6,1.791759469228055
Mobile,6,1.791759469228055
horizontal,6,1.791759469228055
post-treatment,6,1.791759469228055
SAP,6,1.791759469228055
inaccuracy,6,1.791759469228055
routines,6,1.791759469228055
betacoronavirus,6,1.791759469228055
aluminum,6,1.791759469228055
DHC,6,1.791759469228055
Virocult,6,1.791759469228055
three-year,6,1.791759469228055
jugular,6,1.791759469228055
Traditionally,6,1.791759469228055
Euroimmun,6,1.791759469228055
stunned,6,1.791759469228055
aiding,6,1.791759469228055
Triage,6,1.791759469228055
divergent,6,1.791759469228055
fresh,6,1.791759469228055
nail,6,1.791759469228055
885,6,1.791759469228055
moderate-severe,6,1.791759469228055
RRT,6,1.791759469228055
logical,6,1.791759469228055
flocked,6,1.791759469228055
callosum,6,1.791759469228055
timeline,6,1.791759469228055
Australians,6,1.791759469228055
user-friendly,6,1.791759469228055
EL,6,1.791759469228055
Notch3,6,1.791759469228055
383,6,1.791759469228055
00005,6,1.791759469228055
304,6,1.791759469228055
validating,6,1.791759469228055
granted,6,1.791759469228055
suppresses,6,1.791759469228055
underserved,6,1.791759469228055
261,6,1.791759469228055
kill,6,1.791759469228055
Nanopore,6,1.791759469228055
BMD,6,1.791759469228055
Long,6,1.791759469228055
periostin,6,1.791759469228055
drug-eluting,6,1.791759469228055
imperfect,6,1.791759469228055
neonate,6,1.791759469228055
deteriorating,6,1.791759469228055
409,6,1.791759469228055
postinfection,6,1.791759469228055
straightforward,6,1.791759469228055
PD15,6,1.791759469228055
NAATs,6,1.791759469228055
STRA,6,1.791759469228055
menopause,6,1.791759469228055
PSCI,6,1.791759469228055
biomass,6,1.791759469228055
premenstrual,6,1.791759469228055
beta-agonist,6,1.791759469228055
step-up,6,1.791759469228055
anticholinergic,6,1.791759469228055
mmolL,6,1.791759469228055
6-12,6,1.791759469228055
POD,6,1.791759469228055
Gender,6,1.791759469228055
periphery,6,1.791759469228055
verbal,6,1.791759469228055
GCS,6,1.791759469228055
GO,6,1.791759469228055
hs-CRP,6,1.791759469228055
postulated,6,1.791759469228055
Qualitative,6,1.791759469228055
junior,6,1.791759469228055
perfectly,6,1.791759469228055
pocket,6,1.791759469228055
plausibility,6,1.791759469228055
DRUL,6,1.791759469228055
civilian,6,1.791759469228055
rigor,6,1.791759469228055
abstinence,6,1.791759469228055
40000,6,1.791759469228055
MSC,6,1.791759469228055
868,6,1.791759469228055
Emotional,6,1.791759469228055
uninsured,6,1.791759469228055
ADCC,6,1.791759469228055
outlook,6,1.791759469228055
AH1N2,6,1.791759469228055
Papua,6,1.791759469228055
clotting,6,1.791759469228055
786,6,1.791759469228055
outweighs,6,1.791759469228055
hypoglycemia,6,1.791759469228055
HLH,6,1.791759469228055
post-mortem,6,1.791759469228055
noticeable,6,1.791759469228055
Reports,6,1.791759469228055
stroke-like,6,1.791759469228055
non-coding,6,1.791759469228055
327,6,1.791759469228055
senior,6,1.791759469228055
selectively,6,1.791759469228055
Disturbances,6,1.791759469228055
211,6,1.791759469228055
miR‑125a,6,1.791759469228055
transform,6,1.791759469228055
thymic,6,1.791759469228055
metaplasia,6,1.791759469228055
sternum,6,1.791759469228055
069,6,1.791759469228055
256,6,1.791759469228055
solids,6,1.791759469228055
548,6,1.791759469228055
demyelination,6,1.791759469228055
bronchus,6,1.791759469228055
Assessing,6,1.791759469228055
interacts,6,1.791759469228055
tumours,6,1.791759469228055
stock,6,1.791759469228055
non-atopic,6,1.791759469228055
structure-based,6,1.791759469228055
P50,6,1.791759469228055
soft,6,1.791759469228055
Matrix,6,1.791759469228055
opens,6,1.791759469228055
SCAD,6,1.791759469228055
empyema,6,1.791759469228055
Where,6,1.791759469228055
fomites,6,1.791759469228055
dentist,6,1.791759469228055
eNOS,6,1.791759469228055
MMP-9,6,1.791759469228055
dipropionate,6,1.791759469228055
maturation,6,1.791759469228055
steady-state,6,1.791759469228055
meetings,6,1.791759469228055
bottom,6,1.791759469228055
stimulates,6,1.791759469228055
seed,6,1.791759469228055
assisting,6,1.791759469228055
Functioning,6,1.791759469228055
IST,6,1.791759469228055
roadmap,6,1.791759469228055
municipality,6,1.791759469228055
Twenty-two,6,1.791759469228055
migrating,6,1.791759469228055
subendocardium,6,1.791759469228055
Reversible,6,1.791759469228055
confident,6,1.791759469228055
cardiologic,6,1.791759469228055
acted,6,1.791759469228055
subsided,6,1.791759469228055
PRV,6,1.791759469228055
miR-1,6,1.791759469228055
harboring,6,1.791759469228055
Regardless,6,1.791759469228055
infarctionaortic,6,1.791759469228055
Intraoperative,6,1.791759469228055
Caucasians,6,1.791759469228055
BBS,6,1.791759469228055
downregulation,6,1.791759469228055
fitted,6,1.791759469228055
countermeasure,6,1.791759469228055
sinovenous,6,1.791759469228055
IVS,6,1.791759469228055
extremities,6,1.791759469228055
42-year-old,6,1.791759469228055
wildlife,6,1.791759469228055
label,6,1.791759469228055
AH1pdm09,6,1.791759469228055
Transmission,6,1.791759469228055
polymorphic,6,1.791759469228055
Lessons,6,1.791759469228055
Americas,6,1.791759469228055
Aboriginal,6,1.791759469228055
CLD,6,1.791759469228055
ESA,6,1.791759469228055
blocker,6,1.791759469228055
grandparents,6,1.791759469228055
precautionary,6,1.791759469228055
522,6,1.791759469228055
WASH,6,1.791759469228055
coffee,6,1.791759469228055
Considerable,6,1.791759469228055
dysgraphia,6,1.791759469228055
timesday,6,1.791759469228055
precursor,6,1.791759469228055
288,6,1.791759469228055
authentic,6,1.791759469228055
CardiologyAmerican,6,1.791759469228055
Jiangsu,6,1.791759469228055
564,6,1.791759469228055
unparalleled,6,1.791759469228055
apoptotic,6,1.791759469228055
diminishing,6,1.791759469228055
late-phase,6,1.791759469228055
bereavement,6,1.791759469228055
ISAR,6,1.791759469228055
discordant,6,1.791759469228055
NMR,6,1.791759469228055
meta-population,6,1.791759469228055
prosocial,6,1.791759469228055
diagram,6,1.791759469228055
ERM,6,1.791759469228055
nation,6,1.791759469228055
diarrhoea,6,1.791759469228055
convened,6,1.791759469228055
Noninvasive,6,1.791759469228055
uncovered,6,1.791759469228055
ions,6,1.791759469228055
423,6,1.791759469228055
tremendously,6,1.791759469228055
MHz,6,1.791759469228055
TDC,6,1.791759469228055
275,6,1.791759469228055
thermoplasty,6,1.791759469228055
adaptations,6,1.791759469228055
EVLW,6,1.791759469228055
061,6,1.791759469228055
makeup,6,1.791759469228055
armamentarium,6,1.791759469228055
Either,6,1.791759469228055
wintertime,6,1.791759469228055
neurohumoral,6,1.791759469228055
cocktail,6,1.791759469228055
029,6,1.791759469228055
large-artery,6,1.791759469228055
malformations,6,1.791759469228055
blush,6,1.791759469228055
package,6,1.791759469228055
381,6,1.791759469228055
chloroquine,6,1.791759469228055
expressive,6,1.791759469228055
ownership,6,1.791759469228055
retrievers,6,1.791759469228055
Mx1,6,1.791759469228055
PFA,6,1.791759469228055
six-month,6,1.791759469228055
ultrasonic,6,1.791759469228055
ICF,6,1.791759469228055
Concerns,6,1.791759469228055
cardiorespiratory,6,1.791759469228055
followed-up,6,1.791759469228055
salvageable,6,1.791759469228055
Alpha,6,1.791759469228055
clinic-based,6,1.791759469228055
excitability,6,1.791759469228055
biocides,6,1.791759469228055
insensitivity,6,1.791759469228055
TE,6,1.791759469228055
statements,6,1.791759469228055
Uganda,6,1.791759469228055
KAESP,6,1.791759469228055
ban,6,1.791759469228055
regressions,6,1.791759469228055
AMPs,6,1.791759469228055
subtraction,6,1.791759469228055
071,6,1.791759469228055
modestly,6,1.791759469228055
Chinas,6,1.791759469228055
suture,6,1.791759469228055
relieving,6,1.791759469228055
inconsistency,6,1.791759469228055
VKA,6,1.791759469228055
lymphocytic,6,1.791759469228055
await,6,1.791759469228055
neutropenia,6,1.791759469228055
appropriateness,6,1.791759469228055
objectively,6,1.791759469228055
HKU1,6,1.791759469228055
SC75741,6,1.791759469228055
myeloid,6,1.791759469228055
biventricular,6,1.791759469228055
random-effects,6,1.791759469228055
extrapolate,6,1.791759469228055
Like,6,1.791759469228055
draws,6,1.791759469228055
untranslated,6,1.791759469228055
sides,6,1.791759469228055
PBMC,6,1.791759469228055
AMs,6,1.791759469228055
swift,6,1.791759469228055
BECH,6,1.791759469228055
Eurasian,6,1.791759469228055
Strategy,6,1.791759469228055
excreted,6,1.791759469228055
Emergence,6,1.791759469228055
597,6,1.791759469228055
neurorehabilitation,6,1.791759469228055
SACE2,6,1.791759469228055
outperformed,6,1.791759469228055
Pattern,6,1.791759469228055
STE,6,1.791759469228055
pushing,6,1.791759469228055
noradrenaline,6,1.791759469228055
influential,6,1.791759469228055
Measuring,6,1.791759469228055
525,6,1.791759469228055
ORF3a,6,1.791759469228055
door,6,1.791759469228055
SBR,6,1.791759469228055
simvastatin,6,1.791759469228055
AS-IV,6,1.791759469228055
hydrogel,6,1.791759469228055
gold-standard,6,1.791759469228055
dissociation,6,1.791759469228055
patches,6,1.791759469228055
aOR,6,1.791759469228055
co-morbidity,6,1.791759469228055
electrocardiographically,6,1.791759469228055
beneficiaries,6,1.791759469228055
402,6,1.791759469228055
Nocturnal,6,1.791759469228055
MDCT,6,1.791759469228055
proposing,6,1.791759469228055
specifications,6,1.791759469228055
Code,6,1.791759469228055
self-report,6,1.791759469228055
encompass,6,1.791759469228055
governmental,6,1.791759469228055
STEP,6,1.791759469228055
Training,6,1.791759469228055
demanded,6,1.791759469228055
setup,6,1.791759469228055
inferolateral,6,1.791759469228055
Caledonia2099,6,1.791759469228055
embedded,6,1.791759469228055
LP,6,1.791759469228055
PMM,6,1.791759469228055
Oxy,6,1.791759469228055
yen,6,1.791759469228055
MCCD,6,1.791759469228055
H3N2-like,6,1.791759469228055
pituitary,6,1.791759469228055
489,6,1.791759469228055
PCA,6,1.791759469228055
Assuming,6,1.791759469228055
higher-risk,6,1.791759469228055
rehospitalization,6,1.791759469228055
Tests,6,1.791759469228055
apico-septo-lateral,6,1.791759469228055
mandates,6,1.791759469228055
successively,6,1.791759469228055
hampered,6,1.791759469228055
sustaining,6,1.791759469228055
nephrotic,6,1.791759469228055
occluding,6,1.791759469228055
FS,6,1.791759469228055
expedite,6,1.791759469228055
cyanosis,6,1.791759469228055
perfume,6,1.791759469228055
DiaSorin,6,1.791759469228055
kin,6,1.791759469228055
horse,6,1.791759469228055
TKA,6,1.791759469228055
transcriptional,6,1.791759469228055
vehicles,6,1.791759469228055
radiomics,6,1.791759469228055
SARI,6,1.791759469228055
chronological,6,1.791759469228055
NOAC,6,1.791759469228055
Neovastat,6,1.791759469228055
mandate,6,1.791759469228055
IFN-β,6,1.791759469228055
Convalescent,6,1.791759469228055
Biotech,6,1.791759469228055
sales,6,1.791759469228055
vigilance,6,1.791759469228055
inspection,6,1.791759469228055
reinforces,6,1.791759469228055
municipal,6,1.791759469228055
MMD,6,1.791759469228055
todays,6,1.791759469228055
influenzaviruses,6,1.791759469228055
NAT2,6,1.791759469228055
supervision,6,1.791759469228055
mumps,6,1.791759469228055
Autopsy,6,1.791759469228055
looks,6,1.791759469228055
Advanced,6,1.791759469228055
debris,6,1.791759469228055
opportunistic,6,1.791759469228055
hypercoagulability,6,1.791759469228055
hyperinflammation,6,1.791759469228055
erosion,6,1.791759469228055
cryo-EM,6,1.791759469228055
Stress,6,1.791759469228055
goblet,6,1.791759469228055
bradycardia,6,1.791759469228055
Reduction,6,1.791759469228055
mildly,6,1.791759469228055
IABC,6,1.791759469228055
445,6,1.791759469228055
helium-oxygen,6,1.791759469228055
immune-mediated,6,1.791759469228055
staffing,6,1.791759469228055
necropsy,6,1.791759469228055
denied,6,1.791759469228055
Cefuroxime,6,1.791759469228055
Kaunas,6,1.791759469228055
ICIs,6,1.791759469228055
Obstructive,6,1.791759469228055
Lesions,6,1.791759469228055
axial,6,1.791759469228055
peaking,6,1.791759469228055
Town,6,1.791759469228055
profoundly,6,1.791759469228055
navigate,6,1.791759469228055
non-significant,6,1.791759469228055
Symptomatic,6,1.791759469228055
accumulating,6,1.791759469228055
null,6,1.791759469228055
clean,6,1.791759469228055
CM,6,1.791759469228055
disappear,6,1.791759469228055
Twenty-five,6,1.791759469228055
averaging,6,1.791759469228055
263,6,1.791759469228055
MESs,6,1.791759469228055
hemodynamically,6,1.791759469228055
nephropathy,6,1.791759469228055
SLIT,6,1.791759469228055
IFITM3,6,1.791759469228055
acetylcholine,6,1.791759469228055
2009-10,6,1.791759469228055
transcriptome,6,1.791759469228055
MSU,6,1.791759469228055
capturing,6,1.791759469228055
teenagers,6,1.791759469228055
GORD,6,1.791759469228055
well-recognized,6,1.791759469228055
NPV,6,1.791759469228055
prenatal,6,1.791759469228055
preventer,6,1.791759469228055
437,6,1.791759469228055
data-driven,6,1.791759469228055
crossing,6,1.791759469228055
AHT,6,1.791759469228055
Forty-six,6,1.791759469228055
Newer,6,1.791759469228055
antihistamines,6,1.791759469228055
transducer,6,1.791759469228055
looming,6,1.791759469228055
AspAT,6,1.791759469228055
CIN,6,1.791759469228055
irradiation,6,1.791759469228055
456,6,1.791759469228055
ineligible,6,1.791759469228055
art,6,1.791759469228055
SAVR,6,1.791759469228055
Atopy,6,1.791759469228055
TNF,6,1.791759469228055
Slovakia,6,1.791759469228055
rich,6,1.791759469228055
co-morbid,6,1.791759469228055
humanistic,6,1.791759469228055
autophagosomes,6,1.791759469228055
pPCI,6,1.791759469228055
forth,6,1.791759469228055
cross-immunity,6,1.791759469228055
necessitate,6,1.791759469228055
unremitting,6,1.791759469228055
failing,6,1.791759469228055
inadequately,6,1.791759469228055
advocates,6,1.791759469228055
viz,6,1.791759469228055
Technology,6,1.791759469228055
cardinal,6,1.791759469228055
CysLT1,6,1.791759469228055
bronchiale,6,1.791759469228055
cutting,6,1.791759469228055
Selected,6,1.791759469228055
featured,6,1.791759469228055
computerised,6,1.791759469228055
biobanks,6,1.791759469228055
synergism,6,1.791759469228055
charges,6,1.791759469228055
Sofia,6,1.791759469228055
brittle,6,1.791759469228055
foci,6,1.791759469228055
hyperglycaemia,6,1.791759469228055
pi,6,1.791759469228055
ligand,6,1.791759469228055
Electrical,6,1.791759469228055
765,6,1.791759469228055
Adolescents,6,1.791759469228055
Best,6,1.791759469228055
behalf,6,1.791759469228055
cardiomegaly,6,1.791759469228055
carbohydrate,6,1.791759469228055
well-characterized,6,1.791759469228055
Differential,6,1.791759469228055
conspiracy,6,1.791759469228055
Cellular,6,1.791759469228055
AII,6,1.791759469228055
Combining,6,1.791759469228055
transitional,6,1.791759469228055
stays,6,1.791759469228055
word,6,1.791759469228055
inheritance,6,1.791759469228055
Rhinitis,6,1.791759469228055
Summary,6,1.791759469228055
fixation,6,1.791759469228055
completing,6,1.791759469228055
dilemmas,6,1.791759469228055
beta-adrenergic,6,1.791759469228055
15-30,6,1.791759469228055
300000,6,1.791759469228055
chose,6,1.791759469228055
allergologic,6,1.791759469228055
RAAS,6,1.791759469228055
201Tl-defect,6,1.791759469228055
myocytes,6,1.791759469228055
apnoea,6,1.791759469228055
180-day,6,1.791759469228055
homozygous,6,1.791759469228055
296,6,1.791759469228055
505,6,1.791759469228055
nights,6,1.791759469228055
endomyocardial,6,1.791759469228055
dysfunctions,6,1.791759469228055
vasculitis,6,1.791759469228055
fragment,6,1.791759469228055
Coalition,6,1.791759469228055
splenial,6,1.791759469228055
Elecsys,6,1.791759469228055
reinforced,6,1.791759469228055
up-regulated,6,1.791759469228055
counterpart,6,1.791759469228055
MxA,6,1.791759469228055
Angiotensin-converting,6,1.791759469228055
palliative,6,1.791759469228055
concurrently,6,1.791759469228055
employer,6,1.791759469228055
pollens,6,1.791759469228055
GA,6,1.791759469228055
1977-1978,6,1.791759469228055
Coronavirus-2,6,1.791759469228055
pulsed,6,1.791759469228055
RIG-I,6,1.791759469228055
Responses,6,1.791759469228055
vegetations,6,1.791759469228055
exacerbating,6,1.791759469228055
overwhelmed,6,1.791759469228055
neuroscience,6,1.791759469228055
mid,6,1.791759469228055
graph,6,1.791759469228055
sixty,6,1.791759469228055
post-influenza,6,1.791759469228055
metered-dose,6,1.791759469228055
390,6,1.791759469228055
neighborhood,6,1.791759469228055
microfluidic,6,1.791759469228055
coil,6,1.791759469228055
SIC,6,1.791759469228055
herpes,6,1.791759469228055
Drugs,6,1.791759469228055
resume,6,1.791759469228055
impacting,6,1.791759469228055
SOFIA,6,1.791759469228055
SAECG,6,1.791759469228055
Royal,6,1.791759469228055
Ischemia,6,1.791759469228055
basically,6,1.791759469228055
morbid,6,1.791759469228055
247,6,1.791759469228055
Device,6,1.791759469228055
BMS,6,1.791759469228055
refractoriness,6,1.791759469228055
Memorial,6,1.791759469228055
Diagnostics,6,1.791759469228055
neutrophilia,6,1.791759469228055
aforementioned,6,1.791759469228055
PH,6,1.791759469228055
407,6,1.791759469228055
Adults,6,1.791759469228055
interpretations,6,1.791759469228055
485,6,1.791759469228055
coinfections,6,1.791759469228055
356,6,1.791759469228055
coma,6,1.791759469228055
323,6,1.791759469228055
post-operative,6,1.791759469228055
Reviews,6,1.791759469228055
onset-to-balloon,6,1.791759469228055
augmentation,6,1.791759469228055
six-year,6,1.791759469228055
Rates,5,1.6094379124341003
methodologically,5,1.6094379124341003
scintigrams,5,1.6094379124341003
twentieth,5,1.6094379124341003
presenters,5,1.6094379124341003
ncovNP,5,1.6094379124341003
replicative,5,1.6094379124341003
Nosocomial,5,1.6094379124341003
LBBB,5,1.6094379124341003
p0008,5,1.6094379124341003
severities,5,1.6094379124341003
translating,5,1.6094379124341003
attend,5,1.6094379124341003
62-year-old,5,1.6094379124341003
seroprotective,5,1.6094379124341003
dire,5,1.6094379124341003
evolutive,5,1.6094379124341003
unemployed,5,1.6094379124341003
bamlanivimab,5,1.6094379124341003
Concerning,5,1.6094379124341003
autoregulation,5,1.6094379124341003
abroad,5,1.6094379124341003
aptamer-nucleoprotein,5,1.6094379124341003
live-attenuated,5,1.6094379124341003
AQLQ-S,5,1.6094379124341003
YGW,5,1.6094379124341003
English-language,5,1.6094379124341003
scoping,5,1.6094379124341003
defence,5,1.6094379124341003
Neurologic,5,1.6094379124341003
Artery,5,1.6094379124341003
ACTIV,5,1.6094379124341003
untoward,5,1.6094379124341003
communicating,5,1.6094379124341003
COVID19,5,1.6094379124341003
APPROACH-score,5,1.6094379124341003
CART,5,1.6094379124341003
postal,5,1.6094379124341003
DH,5,1.6094379124341003
Evaluating,5,1.6094379124341003
Guillain-Barré,5,1.6094379124341003
ovarian,5,1.6094379124341003
397,5,1.6094379124341003
practise,5,1.6094379124341003
grafted,5,1.6094379124341003
mention,5,1.6094379124341003
ICC,5,1.6094379124341003
hurdles,5,1.6094379124341003
frozen,5,1.6094379124341003
ICI,5,1.6094379124341003
awaited,5,1.6094379124341003
nonetheless,5,1.6094379124341003
merit,5,1.6094379124341003
reconstruct,5,1.6094379124341003
981,5,1.6094379124341003
miss,5,1.6094379124341003
2014-2015,5,1.6094379124341003
AC-EIA,5,1.6094379124341003
Ramaswamy,5,1.6094379124341003
bead,5,1.6094379124341003
aspartate,5,1.6094379124341003
tweets,5,1.6094379124341003
Inf,5,1.6094379124341003
Students,5,1.6094379124341003
set-up,5,1.6094379124341003
microscopes,5,1.6094379124341003
Communities,5,1.6094379124341003
evacuees,5,1.6094379124341003
NoV,5,1.6094379124341003
scaled,5,1.6094379124341003
DNARNA,5,1.6094379124341003
shall,5,1.6094379124341003
Reactive,5,1.6094379124341003
unaware,5,1.6094379124341003
facepiece,5,1.6094379124341003
motives,5,1.6094379124341003
insufficiently,5,1.6094379124341003
fM,5,1.6094379124341003
Reinfarction,5,1.6094379124341003
co-pathogens,5,1.6094379124341003
obstacle,5,1.6094379124341003
unavailability,5,1.6094379124341003
693,5,1.6094379124341003
Grading,5,1.6094379124341003
occult,5,1.6094379124341003
provoking,5,1.6094379124341003
MIBI,5,1.6094379124341003
substitute,5,1.6094379124341003
AVictoria375,5,1.6094379124341003
scarcity,5,1.6094379124341003
essentials,5,1.6094379124341003
unreported,5,1.6094379124341003
trimeric,5,1.6094379124341003
capsules,5,1.6094379124341003
JAGL,5,1.6094379124341003
collectively,5,1.6094379124341003
commented,5,1.6094379124341003
prudent,5,1.6094379124341003
mutates,5,1.6094379124341003
codons,5,1.6094379124341003
self-isolation,5,1.6094379124341003
Language,5,1.6094379124341003
decoy,5,1.6094379124341003
30-minute,5,1.6094379124341003
exploit,5,1.6094379124341003
judge,5,1.6094379124341003
386,5,1.6094379124341003
bovine,5,1.6094379124341003
FSO,5,1.6094379124341003
MTT,5,1.6094379124341003
roll,5,1.6094379124341003
cows,5,1.6094379124341003
0013,5,1.6094379124341003
hypothesised,5,1.6094379124341003
intuitive,5,1.6094379124341003
lactating,5,1.6094379124341003
N-glycosylation,5,1.6094379124341003
6-8,5,1.6094379124341003
constituting,5,1.6094379124341003
regionally,5,1.6094379124341003
semi-structured,5,1.6094379124341003
intraclass,5,1.6094379124341003
Biology,5,1.6094379124341003
Occlusion,5,1.6094379124341003
resembling,5,1.6094379124341003
percentile,5,1.6094379124341003
neuron,5,1.6094379124341003
slowed,5,1.6094379124341003
step-wise,5,1.6094379124341003
Maximum,5,1.6094379124341003
Around,5,1.6094379124341003
IL-1,5,1.6094379124341003
Chlamydia,5,1.6094379124341003
participant,5,1.6094379124341003
Confidence,5,1.6094379124341003
NAFLD,5,1.6094379124341003
chickens,5,1.6094379124341003
Finding,5,1.6094379124341003
ose-R,5,1.6094379124341003
placing,5,1.6094379124341003
docked,5,1.6094379124341003
mets,5,1.6094379124341003
reinforcing,5,1.6094379124341003
050,5,1.6094379124341003
re-evaluation,5,1.6094379124341003
Malays,5,1.6094379124341003
QuickVue,5,1.6094379124341003
SAC,5,1.6094379124341003
PE,5,1.6094379124341003
SAB,5,1.6094379124341003
Improving,5,1.6094379124341003
betablockers,5,1.6094379124341003
SAA,5,1.6094379124341003
7-year,5,1.6094379124341003
FFO,5,1.6094379124341003
purpura,5,1.6094379124341003
offices,5,1.6094379124341003
0-1,5,1.6094379124341003
admittance,5,1.6094379124341003
neurocognitive,5,1.6094379124341003
EPR-3,5,1.6094379124341003
occlude,5,1.6094379124341003
lifestyles,5,1.6094379124341003
histologically,5,1.6094379124341003
posttreatment,5,1.6094379124341003
apps,5,1.6094379124341003
Thirty-two,5,1.6094379124341003
Younger,5,1.6094379124341003
Asians,5,1.6094379124341003
bedding,5,1.6094379124341003
P0DTC4,5,1.6094379124341003
gathering,5,1.6094379124341003
diagnostically,5,1.6094379124341003
MI-NCA,5,1.6094379124341003
radioactive,5,1.6094379124341003
understandings,5,1.6094379124341003
Ros,5,1.6094379124341003
Rescue,5,1.6094379124341003
Real,5,1.6094379124341003
thrombogenic,5,1.6094379124341003
cataract,5,1.6094379124341003
AIM-BP,5,1.6094379124341003
56°C,5,1.6094379124341003
quartile,5,1.6094379124341003
Evans,5,1.6094379124341003
Planning,5,1.6094379124341003
AH3,5,1.6094379124341003
N-protein,5,1.6094379124341003
en,5,1.6094379124341003
Later,5,1.6094379124341003
58-year-old,5,1.6094379124341003
neurologist,5,1.6094379124341003
tertiary-care,5,1.6094379124341003
case-based,5,1.6094379124341003
dispatchers,5,1.6094379124341003
micro,5,1.6094379124341003
periodicity-2,5,1.6094379124341003
558,5,1.6094379124341003
Disorders,5,1.6094379124341003
pharmacokinetic,5,1.6094379124341003
Against,5,1.6094379124341003
RAPID,5,1.6094379124341003
catheter-based,5,1.6094379124341003
lying,5,1.6094379124341003
dreams,5,1.6094379124341003
twenty-nine,5,1.6094379124341003
non-invasively,5,1.6094379124341003
semi-quantitative,5,1.6094379124341003
Cross,5,1.6094379124341003
neurobehavioral,5,1.6094379124341003
non-obstructive,5,1.6094379124341003
SAR-CoV-2,5,1.6094379124341003
colony,5,1.6094379124341003
sensitizations,5,1.6094379124341003
prevail,5,1.6094379124341003
993,5,1.6094379124341003
Nations,5,1.6094379124341003
single-photon,5,1.6094379124341003
foreseeable,5,1.6094379124341003
specialised,5,1.6094379124341003
Programme,5,1.6094379124341003
phenytoin,5,1.6094379124341003
Receiver,5,1.6094379124341003
factor-α,5,1.6094379124341003
dream,5,1.6094379124341003
nonatherosclerotic,5,1.6094379124341003
influenzal,5,1.6094379124341003
MMR,5,1.6094379124341003
refine,5,1.6094379124341003
30-year-old,5,1.6094379124341003
overrepresented,5,1.6094379124341003
stemprogenitor,5,1.6094379124341003
synopsis,5,1.6094379124341003
longterm,5,1.6094379124341003
Danish,5,1.6094379124341003
10-20,5,1.6094379124341003
RPA-LF,5,1.6094379124341003
Circulating,5,1.6094379124341003
PROGRESS,5,1.6094379124341003
repairing,5,1.6094379124341003
NET,5,1.6094379124341003
antispike,5,1.6094379124341003
pharmacologically,5,1.6094379124341003
contraceptive,5,1.6094379124341003
mixtures,5,1.6094379124341003
Document,5,1.6094379124341003
thoracoscopy,5,1.6094379124341003
stroke-specific,5,1.6094379124341003
TI,5,1.6094379124341003
manipulated,5,1.6094379124341003
watershed,5,1.6094379124341003
airports,5,1.6094379124341003
noncardioembolic,5,1.6094379124341003
permissive,5,1.6094379124341003
dialogue,5,1.6094379124341003
GSTTF,5,1.6094379124341003
virus-associated,5,1.6094379124341003
Step,5,1.6094379124341003
528,5,1.6094379124341003
mortem,5,1.6094379124341003
470,5,1.6094379124341003
Evaluations,5,1.6094379124341003
finite,5,1.6094379124341003
react,5,1.6094379124341003
hyperlipidaemia,5,1.6094379124341003
templates,5,1.6094379124341003
0009,5,1.6094379124341003
outperform,5,1.6094379124341003
anthrax,5,1.6094379124341003
coronarography,5,1.6094379124341003
converted,5,1.6094379124341003
HCTCAR-T,5,1.6094379124341003
auxiliary,5,1.6094379124341003
Cincinnati,5,1.6094379124341003
Included,5,1.6094379124341003
apixaban,5,1.6094379124341003
Saint,5,1.6094379124341003
learnt,5,1.6094379124341003
15-20,5,1.6094379124341003
arginine,5,1.6094379124341003
strata,5,1.6094379124341003
UTM,5,1.6094379124341003
Colombia,5,1.6094379124341003
diminution,5,1.6094379124341003
ROI,5,1.6094379124341003
Cladosporium,5,1.6094379124341003
Indirect,5,1.6094379124341003
BSL-2,5,1.6094379124341003
promises,5,1.6094379124341003
shortest,5,1.6094379124341003
EUROIMMUN,5,1.6094379124341003
Fisher,5,1.6094379124341003
nSTEMI,5,1.6094379124341003
copiesμL,5,1.6094379124341003
satisfy,5,1.6094379124341003
089,5,1.6094379124341003
transmittable,5,1.6094379124341003
Pharmacologic,5,1.6094379124341003
FLAIR,5,1.6094379124341003
régióban,5,1.6094379124341003
ear,5,1.6094379124341003
your,5,1.6094379124341003
non-MVO,5,1.6094379124341003
Questionnaires,5,1.6094379124341003
Montreal,5,1.6094379124341003
ADMA,5,1.6094379124341003
Az,5,1.6094379124341003
Ml,5,1.6094379124341003
ROIs,5,1.6094379124341003
között,5,1.6094379124341003
Russian,5,1.6094379124341003
ACalifornia72009,5,1.6094379124341003
presumptive,5,1.6094379124341003
malaria,5,1.6094379124341003
afflicted,5,1.6094379124341003
f,5,1.6094379124341003
enrolling,5,1.6094379124341003
gases,5,1.6094379124341003
Opinion,5,1.6094379124341003
TAb,5,1.6094379124341003
SNAb,5,1.6094379124341003
200910,5,1.6094379124341003
suffers,5,1.6094379124341003
rho,5,1.6094379124341003
weights,5,1.6094379124341003
Eighty,5,1.6094379124341003
twin,5,1.6094379124341003
Georges,5,1.6094379124341003
multitude,5,1.6094379124341003
confront,5,1.6094379124341003
Health-related,5,1.6094379124341003
orthogonal,5,1.6094379124341003
blood-pressure,5,1.6094379124341003
EDP,5,1.6094379124341003
Content,5,1.6094379124341003
Islands,5,1.6094379124341003
south,5,1.6094379124341003
utilised,5,1.6094379124341003
food-induced,5,1.6094379124341003
switched,5,1.6094379124341003
Thirty-eight,5,1.6094379124341003
summarizing,5,1.6094379124341003
FENO₀₀₅,5,1.6094379124341003
sting,5,1.6094379124341003
pre-epidemic,5,1.6094379124341003
nRIC,5,1.6094379124341003
B-type,5,1.6094379124341003
pneumonectomy,5,1.6094379124341003
gemcitabine,5,1.6094379124341003
stromal,5,1.6094379124341003
Seegene,5,1.6094379124341003
benchmark,5,1.6094379124341003
disinfecting,5,1.6094379124341003
vRNA,5,1.6094379124341003
200405,5,1.6094379124341003
Mounting,5,1.6094379124341003
032,5,1.6094379124341003
≥3,5,1.6094379124341003
7500,5,1.6094379124341003
C3,5,1.6094379124341003
5th,5,1.6094379124341003
nonalcoholic,5,1.6094379124341003
Olympics,5,1.6094379124341003
Der,5,1.6094379124341003
CKmax,5,1.6094379124341003
repercussions,5,1.6094379124341003
proliferative,5,1.6094379124341003
Siemens,5,1.6094379124341003
SDN,5,1.6094379124341003
Exacerbation,5,1.6094379124341003
calibrated,5,1.6094379124341003
C2,5,1.6094379124341003
high-grade,5,1.6094379124341003
H1N1-induced,5,1.6094379124341003
coupling,5,1.6094379124341003
IMD,5,1.6094379124341003
firmly,5,1.6094379124341003
Nrf2,5,1.6094379124341003
paralleled,5,1.6094379124341003
AOA,5,1.6094379124341003
OEFR,5,1.6094379124341003
sensitizers,5,1.6094379124341003
BEpCs,5,1.6094379124341003
Dental,5,1.6094379124341003
refute,5,1.6094379124341003
ANFIS,5,1.6094379124341003
Strikingly,5,1.6094379124341003
microcatheter,5,1.6094379124341003
decision-makers,5,1.6094379124341003
BioGerm,5,1.6094379124341003
exhibitors,5,1.6094379124341003
Practitioner,5,1.6094379124341003
SPSN,5,1.6094379124341003
Angiography,5,1.6094379124341003
School-based,5,1.6094379124341003
years-old,5,1.6094379124341003
Alere,5,1.6094379124341003
struggling,5,1.6094379124341003
V6,5,1.6094379124341003
conducts,5,1.6094379124341003
Establishing,5,1.6094379124341003
PLS,5,1.6094379124341003
FAK,5,1.6094379124341003
pasture,5,1.6094379124341003
therapists,5,1.6094379124341003
RMSV,5,1.6094379124341003
ultraorthodox,5,1.6094379124341003
lenses,5,1.6094379124341003
1084,5,1.6094379124341003
consumers,5,1.6094379124341003
NR,5,1.6094379124341003
TSA,5,1.6094379124341003
IAV-induced,5,1.6094379124341003
10172,5,1.6094379124341003
Jewish,5,1.6094379124341003
AHAASA,5,1.6094379124341003
BAPE,5,1.6094379124341003
915,5,1.6094379124341003
vegetative,5,1.6094379124341003
Known,5,1.6094379124341003
Minority,5,1.6094379124341003
practising,5,1.6094379124341003
LTB4,5,1.6094379124341003
581,5,1.6094379124341003
Sydney,5,1.6094379124341003
copiesµl,5,1.6094379124341003
406,5,1.6094379124341003
cysts,5,1.6094379124341003
toluene,5,1.6094379124341003
TV,5,1.6094379124341003
strain-specific,5,1.6094379124341003
arrangements,5,1.6094379124341003
neuroradiological,5,1.6094379124341003
derivative,5,1.6094379124341003
salient,5,1.6094379124341003
money,5,1.6094379124341003
Th1,5,1.6094379124341003
DW,5,1.6094379124341003
EA-STEMI,5,1.6094379124341003
516,5,1.6094379124341003
generalization,5,1.6094379124341003
system-wide,5,1.6094379124341003
Takotsubo,5,1.6094379124341003
booster,5,1.6094379124341003
disadvantaged,5,1.6094379124341003
Prognosis,5,1.6094379124341003
strengthened,5,1.6094379124341003
oximetry,5,1.6094379124341003
SMASH-U,5,1.6094379124341003
subtropical,5,1.6094379124341003
ODT,5,1.6094379124341003
auscultation,5,1.6094379124341003
Santa,5,1.6094379124341003
8-12,5,1.6094379124341003
30-min,5,1.6094379124341003
Michigan,5,1.6094379124341003
431,5,1.6094379124341003
wavefront,5,1.6094379124341003
Tecumseh,5,1.6094379124341003
angle,5,1.6094379124341003
Site,5,1.6094379124341003
caudispina,5,1.6094379124341003
GERD,5,1.6094379124341003
inspiration,5,1.6094379124341003
Ejection,5,1.6094379124341003
fluctuating,5,1.6094379124341003
constituents,5,1.6094379124341003
exotic,5,1.6094379124341003
sex-related,5,1.6094379124341003
prominently,5,1.6094379124341003
lifespan,5,1.6094379124341003
amelioration,5,1.6094379124341003
division,5,1.6094379124341003
positioned,5,1.6094379124341003
FP,5,1.6094379124341003
re-emergent,5,1.6094379124341003
civil,5,1.6094379124341003
Myocarditis,5,1.6094379124341003
non-medical,5,1.6094379124341003
toco,5,1.6094379124341003
antiepileptic,5,1.6094379124341003
Wall,5,1.6094379124341003
neurotropic,5,1.6094379124341003
catecholamine,5,1.6094379124341003
Diffusion,5,1.6094379124341003
8th,5,1.6094379124341003
walled,5,1.6094379124341003
age-standardized,5,1.6094379124341003
SiNW,5,1.6094379124341003
dollar,5,1.6094379124341003
duty,5,1.6094379124341003
adhere,5,1.6094379124341003
interviewing,5,1.6094379124341003
flipping,5,1.6094379124341003
RKI,5,1.6094379124341003
6-fold,5,1.6094379124341003
disrupting,5,1.6094379124341003
subepicardial,5,1.6094379124341003
discovering,5,1.6094379124341003
NhPV,5,1.6094379124341003
Ecuador,5,1.6094379124341003
Timely,5,1.6094379124341003
immunostimulatory,5,1.6094379124341003
divers,5,1.6094379124341003
Essential,5,1.6094379124341003
culminating,5,1.6094379124341003
unexposed,5,1.6094379124341003
bipolar,5,1.6094379124341003
OSCN-,5,1.6094379124341003
NST,5,1.6094379124341003
hyponatremia,5,1.6094379124341003
perturbation,5,1.6094379124341003
446-480,5,1.6094379124341003
influenza-infected,5,1.6094379124341003
1-month,5,1.6094379124341003
VOP,5,1.6094379124341003
predefined,5,1.6094379124341003
essence,5,1.6094379124341003
immunopathological,5,1.6094379124341003
clots,5,1.6094379124341003
slice,5,1.6094379124341003
TCID50,5,1.6094379124341003
dyskinesis,5,1.6094379124341003
firefighters,5,1.6094379124341003
occured,5,1.6094379124341003
rehabilitants,5,1.6094379124341003
CMIRLV,5,1.6094379124341003
costing,5,1.6094379124341003
Seroprevalence,5,1.6094379124341003
Ad26-based,5,1.6094379124341003
rectal,5,1.6094379124341003
Reductions,5,1.6094379124341003
FunCoup,5,1.6094379124341003
dyssynergy,5,1.6094379124341003
over-the-counter,5,1.6094379124341003
SLI,5,1.6094379124341003
BioFire,5,1.6094379124341003
LRE,5,1.6094379124341003
358,5,1.6094379124341003
Twenty-six,5,1.6094379124341003
collaborations,5,1.6094379124341003
powered,5,1.6094379124341003
Measures,5,1.6094379124341003
happened,5,1.6094379124341003
non-DAWN,5,1.6094379124341003
iso,5,1.6094379124341003
SUVmax,5,1.6094379124341003
minus,5,1.6094379124341003
VPR,5,1.6094379124341003
Impaired,5,1.6094379124341003
operates,5,1.6094379124341003
abnormally,5,1.6094379124341003
coumarin,5,1.6094379124341003
argued,5,1.6094379124341003
STR,5,1.6094379124341003
999,5,1.6094379124341003
BMP-7,5,1.6094379124341003
cDNA,5,1.6094379124341003
SHOCK,5,1.6094379124341003
mineral,5,1.6094379124341003
port,5,1.6094379124341003
236,5,1.6094379124341003
pBECs,5,1.6094379124341003
Sigma,5,1.6094379124341003
extra-cardiac,5,1.6094379124341003
LMICs,5,1.6094379124341003
reopening,5,1.6094379124341003
Cross-sectional,5,1.6094379124341003
firstly,5,1.6094379124341003
341,5,1.6094379124341003
VC,5,1.6094379124341003
Simultaneous,5,1.6094379124341003
TNP,5,1.6094379124341003
353,5,1.6094379124341003
028,5,1.6094379124341003
metformin,5,1.6094379124341003
057,5,1.6094379124341003
reception,5,1.6094379124341003
displaced,5,1.6094379124341003
pneumococci,5,1.6094379124341003
Fast,5,1.6094379124341003
collaborating,5,1.6094379124341003
draft,5,1.6094379124341003
well-tolerated,5,1.6094379124341003
glycan-based,5,1.6094379124341003
F,5,1.6094379124341003
Diabetic,5,1.6094379124341003
CD,5,1.6094379124341003
energies,5,1.6094379124341003
292,5,1.6094379124341003
CAG,5,1.6094379124341003
sternotomy,5,1.6094379124341003
charged,5,1.6094379124341003
commenced,5,1.6094379124341003
fueled,5,1.6094379124341003
camera,5,1.6094379124341003
Postoperative,5,1.6094379124341003
ERV,5,1.6094379124341003
T-cells,5,1.6094379124341003
pulmonologists,5,1.6094379124341003
allergists,5,1.6094379124341003
≥12,5,1.6094379124341003
antenatal,5,1.6094379124341003
toddlers,5,1.6094379124341003
capsule,5,1.6094379124341003
apico-septal,5,1.6094379124341003
sensitisation,5,1.6094379124341003
statistic,5,1.6094379124341003
shapes,5,1.6094379124341003
Kentucky,5,1.6094379124341003
GST,5,1.6094379124341003
A-S-C-O,5,1.6094379124341003
coordinating,5,1.6094379124341003
impedes,5,1.6094379124341003
cytological,5,1.6094379124341003
Eosinophilia,5,1.6094379124341003
coexistence,5,1.6094379124341003
anticholinergics,5,1.6094379124341003
game,5,1.6094379124341003
post-bypass,5,1.6094379124341003
CAFO,5,1.6094379124341003
CRISPR-based,5,1.6094379124341003
pseudoviruses,5,1.6094379124341003
054,5,1.6094379124341003
affliction,5,1.6094379124341003
pandemia,5,1.6094379124341003
pro-BNP,5,1.6094379124341003
Function,5,1.6094379124341003
appearances,5,1.6094379124341003
continual,5,1.6094379124341003
transparent,5,1.6094379124341003
analgesic,5,1.6094379124341003
basics,5,1.6094379124341003
229E,5,1.6094379124341003
Guangzhou,5,1.6094379124341003
officers,5,1.6094379124341003
Features,5,1.6094379124341003
oscillations,5,1.6094379124341003
acetylcholinesterase,5,1.6094379124341003
genotyping,5,1.6094379124341003
tilts,5,1.6094379124341003
somatosensory,5,1.6094379124341003
inactivating,5,1.6094379124341003
heat-inactivated,5,1.6094379124341003
consolidated,5,1.6094379124341003
entailed,5,1.6094379124341003
EZ,5,1.6094379124341003
glycemic,5,1.6094379124341003
multicentric,5,1.6094379124341003
lymphoblastic,5,1.6094379124341003
BD,5,1.6094379124341003
sufferers,5,1.6094379124341003
Practitioners,5,1.6094379124341003
well-documented,5,1.6094379124341003
FLUA,5,1.6094379124341003
incompetence,5,1.6094379124341003
relapsed,5,1.6094379124341003
arteritis,5,1.6094379124341003
Schools,5,1.6094379124341003
≥60,5,1.6094379124341003
farming,5,1.6094379124341003
haptic,5,1.6094379124341003
Indigenous,5,1.6094379124341003
egg-allergic,5,1.6094379124341003
Discharge,5,1.6094379124341003
creative,5,1.6094379124341003
explosion,5,1.6094379124341003
certainty,5,1.6094379124341003
interrogate,5,1.6094379124341003
CAC,5,1.6094379124341003
sensitizing,5,1.6094379124341003
simplify,5,1.6094379124341003
blockage,5,1.6094379124341003
dispersal,5,1.6094379124341003
painless,5,1.6094379124341003
trialled,5,1.6094379124341003
Massachusetts,5,1.6094379124341003
14-day,5,1.6094379124341003
day-to-day,5,1.6094379124341003
L452R,5,1.6094379124341003
historic,5,1.6094379124341003
CAVB,5,1.6094379124341003
noncompliance,5,1.6094379124341003
ring,5,1.6094379124341003
plateau,5,1.6094379124341003
Senegal,5,1.6094379124341003
PFV,5,1.6094379124341003
latitude,5,1.6094379124341003
P-R,5,1.6094379124341003
widened,5,1.6094379124341003
neuropathy,5,1.6094379124341003
labetalol,5,1.6094379124341003
293,5,1.6094379124341003
incentives,5,1.6094379124341003
metapneumovirus,5,1.6094379124341003
scale-up,5,1.6094379124341003
bottlenecks,5,1.6094379124341003
MBF,5,1.6094379124341003
CRRT,5,1.6094379124341003
EZ-SARS-CoV-2,5,1.6094379124341003
4-weekly,5,1.6094379124341003
copy,5,1.6094379124341003
441,5,1.6094379124341003
disability-adjusted,5,1.6094379124341003
antiarrhythmics,5,1.6094379124341003
SPSS,5,1.6094379124341003
EA,5,1.6094379124341003
favoured,5,1.6094379124341003
SVA,5,1.6094379124341003
gallopamil,5,1.6094379124341003
Associated,5,1.6094379124341003
goes,5,1.6094379124341003
APS,5,1.6094379124341003
533,5,1.6094379124341003
planners,5,1.6094379124341003
FLU,5,1.6094379124341003
transforming,5,1.6094379124341003
Experiments,5,1.6094379124341003
autoantibodies,5,1.6094379124341003
memo,5,1.6094379124341003
trans-system,5,1.6094379124341003
counteract,5,1.6094379124341003
CDGSF,5,1.6094379124341003
provisions,5,1.6094379124341003
mediation,5,1.6094379124341003
MAQLQ-M,5,1.6094379124341003
0017,5,1.6094379124341003
localize,5,1.6094379124341003
CovTI,5,1.6094379124341003
cineangiography,5,1.6094379124341003
catheterisation,5,1.6094379124341003
microvasculature,5,1.6094379124341003
937,5,1.6094379124341003
repression,5,1.6094379124341003
aspirates,5,1.6094379124341003
Finnish,5,1.6094379124341003
macroscopic,5,1.6094379124341003
Rhode,5,1.6094379124341003
micrograms,5,1.6094379124341003
irritant-induced,5,1.6094379124341003
Twenty-eight,5,1.6094379124341003
distinctly,5,1.6094379124341003
CPR,5,1.6094379124341003
precipitation,5,1.6094379124341003
wind,5,1.6094379124341003
something,5,1.6094379124341003
hypertensives,5,1.6094379124341003
breaks,5,1.6094379124341003
417,5,1.6094379124341003
appraisal,5,1.6094379124341003
MVO2,5,1.6094379124341003
Latinos,5,1.6094379124341003
2008-2009,5,1.6094379124341003
Caco-2,5,1.6094379124341003
Calu-3,5,1.6094379124341003
perfused,5,1.6094379124341003
adenocarcinoma,5,1.6094379124341003
aspirate,5,1.6094379124341003
Last,5,1.6094379124341003
RAO,5,1.6094379124341003
389,5,1.6094379124341003
344,5,1.6094379124341003
Characterization,5,1.6094379124341003
non-synonymous,5,1.6094379124341003
nonsurvivors,5,1.6094379124341003
truncated,5,1.6094379124341003
T3,5,1.6094379124341003
responder,5,1.6094379124341003
recalled,5,1.6094379124341003
Twenty-one,5,1.6094379124341003
Nowadays,5,1.6094379124341003
JMI,5,1.6094379124341003
Plus,5,1.6094379124341003
millennium,5,1.6094379124341003
Investigational,5,1.6094379124341003
Men,5,1.6094379124341003
Islanders,5,1.6094379124341003
collector,5,1.6094379124341003
epidemiologically,5,1.6094379124341003
Norwegian,5,1.6094379124341003
substudy,5,1.6094379124341003
reproduced,5,1.6094379124341003
facilitys,5,1.6094379124341003
undertake,5,1.6094379124341003
tackling,5,1.6094379124341003
relievers,5,1.6094379124341003
concrete,5,1.6094379124341003
837,5,1.6094379124341003
Electronic,5,1.6094379124341003
rarity,5,1.6094379124341003
visualizing,5,1.6094379124341003
GBS,5,1.6094379124341003
computation,5,1.6094379124341003
cava,5,1.6094379124341003
diastole,5,1.6094379124341003
subjectively,5,1.6094379124341003
Protocol,5,1.6094379124341003
COVID-19-positive,5,1.6094379124341003
aortocoronary,5,1.6094379124341003
BR,5,1.6094379124341003
cesarean,5,1.6094379124341003
technically,5,1.6094379124341003
399,5,1.6094379124341003
Regulation,5,1.6094379124341003
mankind,5,1.6094379124341003
synergy,5,1.6094379124341003
anti-flu,5,1.6094379124341003
Hopkins,5,1.6094379124341003
preservative,5,1.6094379124341003
Wiley,5,1.6094379124341003
weekends,5,1.6094379124341003
Population,5,1.6094379124341003
R₀,5,1.6094379124341003
Collaborating,5,1.6094379124341003
mHla-RBD,5,1.6094379124341003
riskbenefit,5,1.6094379124341003
exerting,5,1.6094379124341003
parasitic,5,1.6094379124341003
fecal-oral,5,1.6094379124341003
wives,5,1.6094379124341003
Covasim,5,1.6094379124341003
cold-adapted,5,1.6094379124341003
Intraaortic,5,1.6094379124341003
merely,5,1.6094379124341003
Cities,5,1.6094379124341003
Serologic,5,1.6094379124341003
allergen-specific,5,1.6094379124341003
Why,5,1.6094379124341003
customized,5,1.6094379124341003
phased,5,1.6094379124341003
endotracheal,5,1.6094379124341003
anaesthetic,5,1.6094379124341003
normal-weight,5,1.6094379124341003
AOP,5,1.6094379124341003
IFNs,5,1.6094379124341003
Integrated,5,1.6094379124341003
drives,5,1.6094379124341003
Transesophageal,5,1.6094379124341003
610,5,1.6094379124341003
prevailing,5,1.6094379124341003
Anti-inflammatory,5,1.6094379124341003
tachyarrhythmia,5,1.6094379124341003
Magnesium,5,1.6094379124341003
leverage,5,1.6094379124341003
psychophysiological,5,1.6094379124341003
MZ,5,1.6094379124341003
tobacco-related,5,1.6094379124341003
usefully,5,1.6094379124341003
Quadrivalent,5,1.6094379124341003
ILIs,5,1.6094379124341003
Backgroundaim,5,1.6094379124341003
outstanding,5,1.6094379124341003
midst,5,1.6094379124341003
Contact,5,1.6094379124341003
Prediction,5,1.6094379124341003
LPL,5,1.6094379124341003
Online,5,1.6094379124341003
εa,5,1.6094379124341003
enlarged,5,1.6094379124341003
niche,5,1.6094379124341003
4°C,5,1.6094379124341003
withdrawn,5,1.6094379124341003
Pharmacological,5,1.6094379124341003
conveyed,5,1.6094379124341003
289,5,1.6094379124341003
barotrauma,5,1.6094379124341003
unexpectedly,5,1.6094379124341003
038,5,1.6094379124341003
056,5,1.6094379124341003
Utilization,5,1.6094379124341003
jointly,5,1.6094379124341003
diving,5,1.6094379124341003
unacceptably,5,1.6094379124341003
reluctant,5,1.6094379124341003
059,5,1.6094379124341003
GAP,5,1.6094379124341003
curriculum,5,1.6094379124341003
Cytokine,5,1.6094379124341003
procoagulant,5,1.6094379124341003
EGFR,5,1.6094379124341003
ubiquitous,5,1.6094379124341003
adrenergic,5,1.6094379124341003
12000,5,1.6094379124341003
coenzyme,5,1.6094379124341003
SHR-A3,5,1.6094379124341003
dissecting,5,1.6094379124341003
Units,5,1.6094379124341003
swimming,5,1.6094379124341003
Quick,5,1.6094379124341003
penetrate,5,1.6094379124341003
Capilia,5,1.6094379124341003
devastated,5,1.6094379124341003
untrained,5,1.6094379124341003
immunochromatography,5,1.6094379124341003
sedentary,5,1.6094379124341003
miniaturized,5,1.6094379124341003
Structural,5,1.6094379124341003
equation,5,1.6094379124341003
undergraduate,5,1.6094379124341003
proteinuria,5,1.6094379124341003
QTcd,5,1.6094379124341003
QTd,5,1.6094379124341003
predisposes,5,1.6094379124341003
SCID,5,1.6094379124341003
delivers,5,1.6094379124341003
24-h,5,1.6094379124341003
evenly,5,1.6094379124341003
vasodilator,5,1.6094379124341003
boosted,5,1.6094379124341003
WTP,5,1.6094379124341003
Dox,5,1.6094379124341003
antecedents,5,1.6094379124341003
426,5,1.6094379124341003
embryonic,5,1.6094379124341003
amyloid,5,1.6094379124341003
specialties,5,1.6094379124341003
contrasted,5,1.6094379124341003
positional,5,1.6094379124341003
Pediatricians,5,1.6094379124341003
unsolved,5,1.6094379124341003
Hsp90,5,1.6094379124341003
flight,5,1.6094379124341003
dipole,5,1.6094379124341003
sialidase,5,1.6094379124341003
stores,5,1.6094379124341003
relapses,5,1.6094379124341003
ambiguous,5,1.6094379124341003
1989-90,5,1.6094379124341003
lose,5,1.6094379124341003
microbiome,5,1.6094379124341003
FSM,5,1.6094379124341003
Oxidative,5,1.6094379124341003
isoprenaline,5,1.6094379124341003
0035,5,1.6094379124341003
Amr,5,1.6094379124341003
emerges,5,1.6094379124341003
bodys,5,1.6094379124341003
bar,5,1.6094379124341003
really,5,1.6094379124341003
craniectomy,5,1.6094379124341003
1-10,5,1.6094379124341003
event-free,5,1.6094379124341003
2-adrenergic,5,1.6094379124341003
patient-based,5,1.6094379124341003
inconsistently,5,1.6094379124341003
stress-induced,5,1.6094379124341003
PAMI,5,1.6094379124341003
GUSTO,5,1.6094379124341003
Consideration,5,1.6094379124341003
subscale,5,1.6094379124341003
686,5,1.6094379124341003
100-fold,5,1.6094379124341003
accepting,5,1.6094379124341003
disseminating,5,1.6094379124341003
parotitis,5,1.6094379124341003
childhood-onset,5,1.6094379124341003
leisure,5,1.6094379124341003
scientifically,5,1.6094379124341003
Bacterial,5,1.6094379124341003
bronchiolar,5,1.6094379124341003
single-cell,5,1.6094379124341003
R-wave,5,1.6094379124341003
Selvester,5,1.6094379124341003
age-dependent,5,1.6094379124341003
Promising,5,1.6094379124341003
geography,5,1.6094379124341003
retain,5,1.6094379124341003
moreover,5,1.6094379124341003
bullous,5,1.6094379124341003
matches,5,1.6094379124341003
OPHL,5,1.6094379124341003
under-diagnosed,5,1.6094379124341003
DP,5,1.6094379124341003
phylogeny,5,1.6094379124341003
conditioned,5,1.6094379124341003
STOP,5,1.6094379124341003
haematological,5,1.6094379124341003
hyposensitization,5,1.6094379124341003
Sharing,5,1.6094379124341003
mild-to-moderate,5,1.6094379124341003
travelling,5,1.6094379124341003
Statin,5,1.6094379124341003
nAb,5,1.6094379124341003
II-IV,5,1.6094379124341003
subtotal,5,1.6094379124341003
fastest,5,1.6094379124341003
readmitted,5,1.6094379124341003
exercising,5,1.6094379124341003
Alternatively,5,1.6094379124341003
metastatic,5,1.6094379124341003
mL-1,5,1.6094379124341003
bioaerosols,5,1.6094379124341003
leadership,5,1.6094379124341003
aptamers,5,1.6094379124341003
insects,5,1.6094379124341003
chamber,5,1.6094379124341003
654,5,1.6094379124341003
bioanalytical,5,1.6094379124341003
consultant,5,1.6094379124341003
beads,5,1.6094379124341003
orthognathic,5,1.6094379124341003
2015-2016,5,1.6094379124341003
fixed-axis,5,1.6094379124341003
everyone,5,1.6094379124341003
steroid-dependent,5,1.6094379124341003
wearable,5,1.6094379124341003
Osaka,5,1.6094379124341003
recanalized,5,1.6094379124341003
Maoris,5,1.6094379124341003
LIS,5,1.6094379124341003
utilisation,5,1.6094379124341003
460,5,1.6094379124341003
angiogenic,5,1.6094379124341003
align,5,1.6094379124341003
childcare,5,1.6094379124341003
OVA,5,1.6094379124341003
fQRS,5,1.6094379124341003
Typical,5,1.6094379124341003
Distribution,5,1.6094379124341003
E-selectin,5,1.6094379124341003
AIM,5,1.6094379124341003
Taiwanese,5,1.6094379124341003
Bilateral,5,1.6094379124341003
high-altitude,5,1.6094379124341003
radiologist,5,1.6094379124341003
effusions,5,1.6094379124341003
Behavioral,5,1.6094379124341003
distressing,5,1.6094379124341003
708,5,1.6094379124341003
heaves,5,1.6094379124341003
generations,5,1.6094379124341003
fragile,5,1.6094379124341003
Mini,5,1.6094379124341003
restricts,5,1.6094379124341003
00,5,1.6094379124341003
Changsha,5,1.6094379124341003
Sixty-three,5,1.6094379124341003
Simultaneously,5,1.6094379124341003
harbor,5,1.6094379124341003
MCS,5,1.6094379124341003
waned,5,1.6094379124341003
cirrhosis,5,1.6094379124341003
abscess,5,1.6094379124341003
haplotypes,5,1.6094379124341003
influenza-specific,5,1.6094379124341003
Particular,5,1.6094379124341003
sternal,5,1.6094379124341003
onward,5,1.6094379124341003
Frequently,5,1.6094379124341003
Bedside,5,1.6094379124341003
rapidity,5,1.6094379124341003
cost-benefit,5,1.6094379124341003
windows,5,1.6094379124341003
⩾,5,1.6094379124341003
2-7,5,1.6094379124341003
hypotensive,5,1.6094379124341003
angular,5,1.6094379124341003
chick,5,1.6094379124341003
spacers,5,1.6094379124341003
330,5,1.6094379124341003
ABO,5,1.6094379124341003
hydrogen,5,1.6094379124341003
April-June,5,1.6094379124341003
accessed,5,1.6094379124341003
islands,5,1.6094379124341003
LVT,5,1.6094379124341003
ADAMTS13,5,1.6094379124341003
embolus,5,1.6094379124341003
recycling,5,1.6094379124341003
age-structured,5,1.6094379124341003
obligations,5,1.6094379124341003
emphasised,5,1.6094379124341003
ascorbic,5,1.6094379124341003
plane,5,1.6094379124341003
EU,5,1.6094379124341003
affluent,5,1.6094379124341003
2-week,5,1.6094379124341003
971,5,1.6094379124341003
dearth,5,1.6094379124341003
CIB,5,1.6094379124341003
co-infected,5,1.6094379124341003
disagreement,5,1.6094379124341003
duplex,5,1.6094379124341003
337,5,1.6094379124341003
disclose,5,1.6094379124341003
screens,5,1.6094379124341003
plague,5,1.6094379124341003
incurred,5,1.6094379124341003
herb,5,1.6094379124341003
parietal,5,1.6094379124341003
non-occupational,5,1.6094379124341003
HM3,5,1.6094379124341003
HVAD,5,1.6094379124341003
venom,5,1.6094379124341003
305,5,1.6094379124341003
participates,5,1.6094379124341003
convey,5,1.6094379124341003
3CLpro,5,1.6094379124341003
houses,5,1.6094379124341003
Conference,5,1.6094379124341003
anti-S,5,1.6094379124341003
Visual,5,1.6094379124341003
happens,5,1.6094379124341003
5-9,5,1.6094379124341003
intensifying,5,1.6094379124341003
Treatments,5,1.6094379124341003
583,5,1.6094379124341003
1950,5,1.6094379124341003
fulfill,5,1.6094379124341003
Tianjin,5,1.6094379124341003
undue,5,1.6094379124341003
inhalant,5,1.6094379124341003
322,5,1.6094379124341003
414,5,1.6094379124341003
LLEx,5,1.6094379124341003
upright,5,1.6094379124341003
PAI-2,5,1.6094379124341003
flowers,5,1.6094379124341003
421,5,1.6094379124341003
in-vitro,5,1.6094379124341003
RNEF,5,1.6094379124341003
antidepressant,5,1.6094379124341003
BMCs,5,1.6094379124341003
hub-and-spoke,5,1.6094379124341003
small-molecule,5,1.6094379124341003
crucially,5,1.6094379124341003
strip,5,1.6094379124341003
bimodal,5,1.6094379124341003
re-infarction,5,1.6094379124341003
economically,5,1.6094379124341003
reuteri,5,1.6094379124341003
acetaminophen,5,1.6094379124341003
resuming,5,1.6094379124341003
Effects,5,1.6094379124341003
epizootic,5,1.6094379124341003
expenses,5,1.6094379124341003
unfolding,5,1.6094379124341003
Facing,5,1.6094379124341003
down-regulated,5,1.6094379124341003
MH,5,1.6094379124341003
opted,5,1.6094379124341003
accommodation,5,1.6094379124341003
venue,5,1.6094379124341003
hyperthyroidism,5,1.6094379124341003
accommodated,5,1.6094379124341003
ordered,5,1.6094379124341003
community-wide,5,1.6094379124341003
immunosenescence,5,1.6094379124341003
dPdt,5,1.6094379124341003
perforators,5,1.6094379124341003
speculate,5,1.6094379124341003
ECT,5,1.6094379124341003
influenza-positive,5,1.6094379124341003
essay,5,1.6094379124341003
SUA,5,1.6094379124341003
transcriptomic,5,1.6094379124341003
immunosensor,5,1.6094379124341003
redesign,5,1.6094379124341003
gather,5,1.6094379124341003
CTP,5,1.6094379124341003
depict,5,1.6094379124341003
cationic,5,1.6094379124341003
thromboprophylaxis,5,1.6094379124341003
fourteen,5,1.6094379124341003
neuropeptides,5,1.6094379124341003
CPSS,5,1.6094379124341003
mining,5,1.6094379124341003
influenza-attributable,5,1.6094379124341003
Spatial,5,1.6094379124341003
14000,5,1.6094379124341003
CoVdb,5,1.6094379124341003
subpopulations,5,1.6094379124341003
Suggestions,5,1.6094379124341003
838,5,1.6094379124341003
neurologically,5,1.6094379124341003
interconnected,5,1.6094379124341003
760,5,1.6094379124341003
2-dimensional,5,1.6094379124341003
cobas®,5,1.6094379124341003
victim,5,1.6094379124341003
cardiomyoplasty,5,1.6094379124341003
intraluminal,5,1.6094379124341003
Division,5,1.6094379124341003
bear,5,1.6094379124341003
concentrating,5,1.6094379124341003
three-fold,5,1.6094379124341003
482,5,1.6094379124341003
0047,5,1.6094379124341003
asystole,5,1.6094379124341003
24-year-old,5,1.6094379124341003
Pediatrics,5,1.6094379124341003
projects,5,1.6094379124341003
818,5,1.6094379124341003
electively,5,1.6094379124341003
accelerates,5,1.6094379124341003
oblique,5,1.6094379124341003
GFP,5,1.6094379124341003
adaptable,5,1.6094379124341003
Infected,5,1.6094379124341003
press,5,1.6094379124341003
coworkers,5,1.6094379124341003
additives,5,1.6094379124341003
exhaustive,5,1.6094379124341003
ARBs,5,1.6094379124341003
tiredness,5,1.6094379124341003
ambulant,5,1.6094379124341003
cell-derived,5,1.6094379124341003
OPCAB,5,1.6094379124341003
electrolyte,5,1.6094379124341003
co-circulated,5,1.6094379124341003
Internet-based,5,1.6094379124341003
ancestor,5,1.6094379124341003
Metabolic,5,1.6094379124341003
comprehension,5,1.6094379124341003
configurations,5,1.6094379124341003
membranes,5,1.6094379124341003
laninamivir,5,1.6094379124341003
educated,5,1.6094379124341003
cardiologist,5,1.6094379124341003
attracting,5,1.6094379124341003
inclusive,5,1.6094379124341003
OF,5,1.6094379124341003
peptide-based,5,1.6094379124341003
Venous,5,1.6094379124341003
BMJ,5,1.6094379124341003
contrasts,5,1.6094379124341003
rhinorrhea,5,1.6094379124341003
five-year,5,1.6094379124341003
nasopharynx,5,1.6094379124341003
PS,5,1.6094379124341003
Tl-ECT,5,1.6094379124341003
Open,5,1.6094379124341003
Inadequate,5,1.6094379124341003
Sarbecoviruses,5,1.6094379124341003
Determining,5,1.6094379124341003
heating,5,1.6094379124341003
assets,5,1.6094379124341003
Innate,5,1.6094379124341003
postexposure,5,1.6094379124341003
12th,5,1.6094379124341003
construction,5,1.6094379124341003
reflow,5,1.6094379124341003
occupationally,5,1.6094379124341003
Cigarette,5,1.6094379124341003
Protective,5,1.6094379124341003
antagonism,5,1.6094379124341003
polar,5,1.6094379124341003
Premature,5,1.6094379124341003
attainment,5,1.6094379124341003
proceed,5,1.6094379124341003
libraries,5,1.6094379124341003
ml-1,5,1.6094379124341003
bronchospastic,5,1.6094379124341003
postero-inferior,5,1.6094379124341003
VAs,5,1.6094379124341003
706,5,1.6094379124341003
high-volume,5,1.6094379124341003
autonomous,5,1.6094379124341003
erythrocyte,5,1.6094379124341003
ADP-ribose,5,1.6094379124341003
nanoagent,5,1.6094379124341003
poly,5,1.6094379124341003
394,5,1.6094379124341003
UPE,5,1.6094379124341003
442,5,1.6094379124341003
fibroblast,5,1.6094379124341003
phagocytosis,5,1.6094379124341003
importations,5,1.6094379124341003
auricle,5,1.6094379124341003
assayed,5,1.6094379124341003
uniformly,5,1.6094379124341003
Delaware,5,1.6094379124341003
municipalities,5,1.6094379124341003
860,5,1.6094379124341003
smell,5,1.6094379124341003
rhinoconjunctivitis,5,1.6094379124341003
IVUS-VH,5,1.6094379124341003
Delayed,5,1.6094379124341003
1966,5,1.6094379124341003
734,5,1.6094379124341003
originate,5,1.6094379124341003
667,5,1.6094379124341003
prompting,5,1.6094379124341003
ventilators,5,1.6094379124341003
Iranian,5,1.6094379124341003
Z,5,1.6094379124341003
013,5,1.6094379124341003
mobilize,5,1.6094379124341003
configuration,5,1.6094379124341003
H9,5,1.6094379124341003
Bonferroni,5,1.6094379124341003
hemagglutination-inhibition,5,1.6094379124341003
co-ordinated,5,1.6094379124341003
enquiry,5,1.6094379124341003
T1-weighted,5,1.6094379124341003
feared,5,1.6094379124341003
ischemiareperfusion,5,1.6094379124341003
016,5,1.6094379124341003
DL,5,1.6094379124341003
Injury,5,1.6094379124341003
Biochemical,5,1.6094379124341003
q,5,1.6094379124341003
retriever,5,1.6094379124341003
Image,5,1.6094379124341003
Communication,5,1.6094379124341003
CSR,5,1.6094379124341003
microm,5,1.6094379124341003
398,5,1.6094379124341003
321,5,1.6094379124341003
Suppression,5,1.6094379124341003
discern,5,1.6094379124341003
underutilized,5,1.6094379124341003
hitherto,5,1.6094379124341003
metabolite,5,1.6094379124341003
p-values,5,1.6094379124341003
priori,5,1.6094379124341003
TNFA,5,1.6094379124341003
0018,5,1.6094379124341003
trigeminal,5,1.6094379124341003
anti-human,5,1.6094379124341003
Estimating,5,1.6094379124341003
661,5,1.6094379124341003
necessitated,5,1.6094379124341003
incidents,5,1.6094379124341003
COVID-19-recovered,5,1.6094379124341003
films,5,1.6094379124341003
defective,5,1.6094379124341003
19th,5,1.6094379124341003
IgMIgA,5,1.6094379124341003
absences,5,1.6094379124341003
AMP,5,1.6094379124341003
Zanamivir,5,1.6094379124341003
Zambia,5,1.6094379124341003
spending,5,1.6094379124341003
dichotomized,5,1.6094379124341003
nothing,5,1.6094379124341003
overuse,5,1.6094379124341003
consumed,5,1.6094379124341003
directional,5,1.6094379124341003
claiming,5,1.6094379124341003
Immediate,5,1.6094379124341003
328,5,1.6094379124341003
RAGE,5,1.6094379124341003
community-level,5,1.6094379124341003
palsy,5,1.6094379124341003
733,5,1.6094379124341003
Percent,5,1.6094379124341003
normothermic,5,1.6094379124341003
PCG,5,1.6094379124341003
non-SARS-CoV-2,5,1.6094379124341003
machines,5,1.6094379124341003
topographical,5,1.6094379124341003
LE,5,1.6094379124341003
chills,5,1.6094379124341003
2019-nCov,5,1.6094379124341003
RGD,5,1.6094379124341003
incidental,5,1.6094379124341003
0011,5,1.6094379124341003
stains,5,1.6094379124341003
aggravating,5,1.6094379124341003
corroborated,5,1.6094379124341003
anaesthesia,5,1.6094379124341003
amplifying,5,1.6094379124341003
coronaviral,5,1.6094379124341003
mfEMT,5,1.6094379124341003
insomnia,5,1.6094379124341003
puerperium,5,1.6094379124341003
59-year-old,5,1.6094379124341003
one-half,5,1.6094379124341003
consulting,5,1.6094379124341003
masked,5,1.6094379124341003
HCs,5,1.6094379124341003
IDNOW,5,1.6094379124341003
expedited,5,1.6094379124341003
TISMO,5,1.6094379124341003
sewage,5,1.6094379124341003
grew,5,1.6094379124341003
interrelation,5,1.6094379124341003
DDSP,5,1.6094379124341003
weekdays,5,1.6094379124341003
LCX,5,1.6094379124341003
monitors,5,1.6094379124341003
glycemia,5,1.6094379124341003
Peripheral,5,1.6094379124341003
decentralized,5,1.6094379124341003
CVR,5,1.6094379124341003
gm,5,1.6094379124341003
ppb,5,1.6094379124341003
beta2,5,1.6094379124341003
hyper-reactivity,5,1.6094379124341003
Sickle,5,1.6094379124341003
ergometric,5,1.6094379124341003
Marked,5,1.6094379124341003
questioning,5,1.6094379124341003
Ultimately,5,1.6094379124341003
IP,5,1.6094379124341003
returns,5,1.6094379124341003
Caribbean,5,1.6094379124341003
2006-2007,5,1.6094379124341003
immunodominant,5,1.6094379124341003
up-regulation,5,1.6094379124341003
DO2,5,1.6094379124341003
Multisystem,5,1.6094379124341003
Delay,5,1.6094379124341003
non-vaccinated,5,1.6094379124341003
12-15,5,1.6094379124341003
lockdowns,5,1.6094379124341003
dPCR,5,1.6094379124341003
delirium,5,1.6094379124341003
non-infarcted,5,1.6094379124341003
servers,5,1.6094379124341003
978,5,1.6094379124341003
multiplicity,5,1.6094379124341003
taping,4,1.3862943611198906
MOLLI,4,1.3862943611198906
SVT,4,1.3862943611198906
nonagenarian,4,1.3862943611198906
kinesio,4,1.3862943611198906
astrocyte,4,1.3862943611198906
acute-onset,4,1.3862943611198906
snoring,4,1.3862943611198906
Lpa,4,1.3862943611198906
tolls,4,1.3862943611198906
synd4,4,1.3862943611198906
Electrocardiogram,4,1.3862943611198906
949,4,1.3862943611198906
millió,4,1.3862943611198906
relaxed,4,1.3862943611198906
optic,4,1.3862943611198906
night-time,4,1.3862943611198906
NAs,4,1.3862943611198906
977,4,1.3862943611198906
MIC,4,1.3862943611198906
cardiopathy,4,1.3862943611198906
predetermined,4,1.3862943611198906
defensive,4,1.3862943611198906
ELVs,4,1.3862943611198906
Analytical,4,1.3862943611198906
inflow,4,1.3862943611198906
biosynthesis,4,1.3862943611198906
plates,4,1.3862943611198906
545,4,1.3862943611198906
downregulate,4,1.3862943611198906
hindering,4,1.3862943611198906
BEAS-2B,4,1.3862943611198906
3WJ,4,1.3862943611198906
reassuring,4,1.3862943611198906
epicenter,4,1.3862943611198906
NIBS,4,1.3862943611198906
names,4,1.3862943611198906
Liat®,4,1.3862943611198906
paratracheal,4,1.3862943611198906
Parkinsons,4,1.3862943611198906
stripe,4,1.3862943611198906
haematopoietic,4,1.3862943611198906
Industry,4,1.3862943611198906
Reinfection,4,1.3862943611198906
SBO,4,1.3862943611198906
nonallergenic,4,1.3862943611198906
spurred,4,1.3862943611198906
Repetitive,4,1.3862943611198906
remissions,4,1.3862943611198906
LCMV,4,1.3862943611198906
FFR,4,1.3862943611198906
CASP,4,1.3862943611198906
illegal,4,1.3862943611198906
QFP,4,1.3862943611198906
resp,4,1.3862943611198906
Tesla,4,1.3862943611198906
High-risk,4,1.3862943611198906
interindividual,4,1.3862943611198906
2-6,4,1.3862943611198906
electroencephalography,4,1.3862943611198906
pangolins,4,1.3862943611198906
weaken,4,1.3862943611198906
lateropulsion,4,1.3862943611198906
C57BL6,4,1.3862943611198906
nonculprit,4,1.3862943611198906
nonclinical,4,1.3862943611198906
canceling,4,1.3862943611198906
analogous,4,1.3862943611198906
472,4,1.3862943611198906
filtering,4,1.3862943611198906
strained,4,1.3862943611198906
verticality,4,1.3862943611198906
Quidel,4,1.3862943611198906
territorial,4,1.3862943611198906
Hb,4,1.3862943611198906
cancellation,4,1.3862943611198906
Applied,4,1.3862943611198906
CRPS,4,1.3862943611198906
pathologically,4,1.3862943611198906
eighteen,4,1.3862943611198906
573,4,1.3862943611198906
0043,4,1.3862943611198906
virtue,4,1.3862943611198906
HCR,4,1.3862943611198906
0023,4,1.3862943611198906
BTS,4,1.3862943611198906
unprotected,4,1.3862943611198906
calibre,4,1.3862943611198906
Immunisation,4,1.3862943611198906
grandchildren,4,1.3862943611198906
co-workers,4,1.3862943611198906
CZ-MD,4,1.3862943611198906
pseudoaneurysms,4,1.3862943611198906
toxin,4,1.3862943611198906
preserves,4,1.3862943611198906
interhospital,4,1.3862943611198906
seals,4,1.3862943611198906
OC,4,1.3862943611198906
ties,4,1.3862943611198906
vegetation,4,1.3862943611198906
AGP,4,1.3862943611198906
Authorities,4,1.3862943611198906
neuraminidases,4,1.3862943611198906
1020,4,1.3862943611198906
Dengue,4,1.3862943611198906
430,4,1.3862943611198906
watching,4,1.3862943611198906
touches,4,1.3862943611198906
TaqPath,4,1.3862943611198906
self-assessment,4,1.3862943611198906
correcting,4,1.3862943611198906
stems,4,1.3862943611198906
Relationships,4,1.3862943611198906
ARVI,4,1.3862943611198906
radiosurgery,4,1.3862943611198906
umifenovir,4,1.3862943611198906
upslope,4,1.3862943611198906
DRG,4,1.3862943611198906
Brown,4,1.3862943611198906
sea,4,1.3862943611198906
genotypic,4,1.3862943611198906
SMD,4,1.3862943611198906
unadjusted,4,1.3862943611198906
equator,4,1.3862943611198906
attack-rates,4,1.3862943611198906
passing,4,1.3862943611198906
engaging,4,1.3862943611198906
055,4,1.3862943611198906
casualties,4,1.3862943611198906
sprays,4,1.3862943611198906
280,4,1.3862943611198906
feel,4,1.3862943611198906
Pathway,4,1.3862943611198906
paradigms,4,1.3862943611198906
replicates,4,1.3862943611198906
RGGI,4,1.3862943611198906
Karachi,4,1.3862943611198906
sweating,4,1.3862943611198906
sounds,4,1.3862943611198906
partum,4,1.3862943611198906
affiliation,4,1.3862943611198906
host-virus,4,1.3862943611198906
non-approved,4,1.3862943611198906
juvenile,4,1.3862943611198906
travellers,4,1.3862943611198906
globulin,4,1.3862943611198906
epilepsies,4,1.3862943611198906
sulphites,4,1.3862943611198906
Cochran-Mantel-Haenszel,4,1.3862943611198906
noncoding,4,1.3862943611198906
El,4,1.3862943611198906
sulphite,4,1.3862943611198906
Studying,4,1.3862943611198906
Hgsec,4,1.3862943611198906
distinguishes,4,1.3862943611198906
maladaptive,4,1.3862943611198906
ponds,4,1.3862943611198906
MBS-Lab,4,1.3862943611198906
886,4,1.3862943611198906
ARIMA,4,1.3862943611198906
pictorial,4,1.3862943611198906
IPH,4,1.3862943611198906
arrhythmogenesis,4,1.3862943611198906
AVI,4,1.3862943611198906
Rural,4,1.3862943611198906
cms,4,1.3862943611198906
872,4,1.3862943611198906
radiotherapy,4,1.3862943611198906
bp,4,1.3862943611198906
Platelets,4,1.3862943611198906
amplicon,4,1.3862943611198906
18-49,4,1.3862943611198906
MBCS,4,1.3862943611198906
Historically,4,1.3862943611198906
inotropy,4,1.3862943611198906
orchestrate,4,1.3862943611198906
shear,4,1.3862943611198906
receives,4,1.3862943611198906
laterality,4,1.3862943611198906
hypothalamic,4,1.3862943611198906
electrophoresis,4,1.3862943611198906
colleges,4,1.3862943611198906
MSUs,4,1.3862943611198906
sparked,4,1.3862943611198906
50-64,4,1.3862943611198906
monoxide,4,1.3862943611198906
prefer,4,1.3862943611198906
653,4,1.3862943611198906
artery-to-artery,4,1.3862943611198906
spouses,4,1.3862943611198906
characters,4,1.3862943611198906
Californians,4,1.3862943611198906
Enzyme,4,1.3862943611198906
staying,4,1.3862943611198906
self-perceived,4,1.3862943611198906
KEGG,4,1.3862943611198906
H1N1-2009,4,1.3862943611198906
nonadherence,4,1.3862943611198906
life-style,4,1.3862943611198906
kD,4,1.3862943611198906
disruptions,4,1.3862943611198906
Collaboration,4,1.3862943611198906
consumer,4,1.3862943611198906
detections,4,1.3862943611198906
convergence,4,1.3862943611198906
intimate,4,1.3862943611198906
APTIMA,4,1.3862943611198906
Products,4,1.3862943611198906
Aspiration,4,1.3862943611198906
patient-level,4,1.3862943611198906
criticized,4,1.3862943611198906
non-parametric,4,1.3862943611198906
0019,4,1.3862943611198906
Forty-four,4,1.3862943611198906
spine,4,1.3862943611198906
531,4,1.3862943611198906
NSP3,4,1.3862943611198906
Brittle,4,1.3862943611198906
anger,4,1.3862943611198906
foundational,4,1.3862943611198906
donated,4,1.3862943611198906
sanitary,4,1.3862943611198906
PHI,4,1.3862943611198906
AuNPs,4,1.3862943611198906
68Ga-NODAGA-RGD,4,1.3862943611198906
RGS,4,1.3862943611198906
Rio,4,1.3862943611198906
cyclic,4,1.3862943611198906
adenoviruses,4,1.3862943611198906
toucans,4,1.3862943611198906
557,4,1.3862943611198906
multinational,4,1.3862943611198906
425,4,1.3862943611198906
Strong,4,1.3862943611198906
plasmid,4,1.3862943611198906
99m,4,1.3862943611198906
IMI,4,1.3862943611198906
fermented,4,1.3862943611198906
LSA,4,1.3862943611198906
K627E,4,1.3862943611198906
APort,4,1.3862943611198906
ORF1a,4,1.3862943611198906
laughter,4,1.3862943611198906
cross-over,4,1.3862943611198906
OLL1073R-1,4,1.3862943611198906
CBDM,4,1.3862943611198906
neuroendocrine,4,1.3862943611198906
prefectures,4,1.3862943611198906
Pune,4,1.3862943611198906
year-olds,4,1.3862943611198906
tortuosity,4,1.3862943611198906
0-2,4,1.3862943611198906
Nifedipine,4,1.3862943611198906
psychogenic,4,1.3862943611198906
IUliter,4,1.3862943611198906
ictus,4,1.3862943611198906
633,4,1.3862943611198906
PaO2FiO2,4,1.3862943611198906
PBMCs,4,1.3862943611198906
LQC,4,1.3862943611198906
legal,4,1.3862943611198906
Perfusion,4,1.3862943611198906
sIgE,4,1.3862943611198906
Variations,4,1.3862943611198906
isometric,4,1.3862943611198906
RP21,4,1.3862943611198906
manifesting,4,1.3862943611198906
AH1,4,1.3862943611198906
scattered,4,1.3862943611198906
crystal,4,1.3862943611198906
Multicenter,4,1.3862943611198906
Twenty-seven,4,1.3862943611198906
elemental,4,1.3862943611198906
fabrication,4,1.3862943611198906
meningitidis,4,1.3862943611198906
Milan,4,1.3862943611198906
NL63,4,1.3862943611198906
MPV,4,1.3862943611198906
intellectual,4,1.3862943611198906
hUC-MSCs,4,1.3862943611198906
cardioversion,4,1.3862943611198906
20-40,4,1.3862943611198906
assure,4,1.3862943611198906
Mechanisms,4,1.3862943611198906
B19,4,1.3862943611198906
Volunteers,4,1.3862943611198906
BPV,4,1.3862943611198906
NOx,4,1.3862943611198906
Dpt,4,1.3862943611198906
suppressant,4,1.3862943611198906
weaker,4,1.3862943611198906
transplacental,4,1.3862943611198906
Intra-arterial,4,1.3862943611198906
Efficacy,4,1.3862943611198906
Antivirals,4,1.3862943611198906
LFAs,4,1.3862943611198906
lopinavirritonavir,4,1.3862943611198906
bond,4,1.3862943611198906
terminals,4,1.3862943611198906
CAPA,4,1.3862943611198906
KIV-2,4,1.3862943611198906
LPA,4,1.3862943611198906
Theoretically,4,1.3862943611198906
gdL,4,1.3862943611198906
hyperimmune,4,1.3862943611198906
Ningbo,4,1.3862943611198906
ASI,4,1.3862943611198906
pursuing,4,1.3862943611198906
interrelated,4,1.3862943611198906
uninfected,4,1.3862943611198906
PTF,4,1.3862943611198906
00035,4,1.3862943611198906
isoprostanes,4,1.3862943611198906
F₂-isoP,4,1.3862943611198906
Thrombus,4,1.3862943611198906
Bax,4,1.3862943611198906
Bcl-2,4,1.3862943611198906
271,4,1.3862943611198906
abstract,4,1.3862943611198906
label-free,4,1.3862943611198906
page,4,1.3862943611198906
myeloproliferative,4,1.3862943611198906
spectroscopy,4,1.3862943611198906
prefecture,4,1.3862943611198906
enteric,4,1.3862943611198906
well-studied,4,1.3862943611198906
sequel,4,1.3862943611198906
singing,4,1.3862943611198906
repeating,4,1.3862943611198906
credibility,4,1.3862943611198906
GOF,4,1.3862943611198906
multi-vessel,4,1.3862943611198906
fortunately,4,1.3862943611198906
benefit-risk,4,1.3862943611198906
inquiries,4,1.3862943611198906
49-year-old,4,1.3862943611198906
627,4,1.3862943611198906
CMN,4,1.3862943611198906
Corticosteroids,4,1.3862943611198906
SU,4,1.3862943611198906
UAE,4,1.3862943611198906
ambitious,4,1.3862943611198906
electronically,4,1.3862943611198906
Cw,4,1.3862943611198906
0020,4,1.3862943611198906
enactment,4,1.3862943611198906
Physiological,4,1.3862943611198906
ragweed,4,1.3862943611198906
552,4,1.3862943611198906
Wilcoxon,4,1.3862943611198906
592,4,1.3862943611198906
deliberate,4,1.3862943611198906
1200,4,1.3862943611198906
coexist,4,1.3862943611198906
BGI,4,1.3862943611198906
tracings,4,1.3862943611198906
371,4,1.3862943611198906
endotyping,4,1.3862943611198906
IPS,4,1.3862943611198906
host-cell,4,1.3862943611198906
alkaline,4,1.3862943611198906
GVHD,4,1.3862943611198906
ACE2h,4,1.3862943611198906
MEM,4,1.3862943611198906
endoplasmic,4,1.3862943611198906
calcified,4,1.3862943611198906
southwestern,4,1.3862943611198906
languages,4,1.3862943611198906
Military,4,1.3862943611198906
CYP4F2,4,1.3862943611198906
Population-based,4,1.3862943611198906
Absolute,4,1.3862943611198906
Cryptogenic,4,1.3862943611198906
α-23-,4,1.3862943611198906
cc,4,1.3862943611198906
Physiologic,4,1.3862943611198906
endangered,4,1.3862943611198906
μV,4,1.3862943611198906
Neuroprotection,4,1.3862943611198906
Accuracy,4,1.3862943611198906
THPA,4,1.3862943611198906
Which,4,1.3862943611198906
cross-react,4,1.3862943611198906
NICU,4,1.3862943611198906
litre,4,1.3862943611198906
HeartMate,4,1.3862943611198906
wild-silk,4,1.3862943611198906
struggled,4,1.3862943611198906
A-20,4,1.3862943611198906
sub-acute,4,1.3862943611198906
derangements,4,1.3862943611198906
corrections,4,1.3862943611198906
aches,4,1.3862943611198906
H5N6,4,1.3862943611198906
Building,4,1.3862943611198906
host-pathogen,4,1.3862943611198906
Seroconversion,4,1.3862943611198906
18-64,4,1.3862943611198906
thickened,4,1.3862943611198906
HLP,4,1.3862943611198906
HTN,4,1.3862943611198906
proceeds,4,1.3862943611198906
islanders,4,1.3862943611198906
magnitudes,4,1.3862943611198906
dot,4,1.3862943611198906
spices,4,1.3862943611198906
thoracoscopic,4,1.3862943611198906
prestroke,4,1.3862943611198906
GDR,4,1.3862943611198906
anamnesis,4,1.3862943611198906
Utilizing,4,1.3862943611198906
Histologic,4,1.3862943611198906
hypokalemia,4,1.3862943611198906
8-week,4,1.3862943611198906
879,4,1.3862943611198906
bronchogenic,4,1.3862943611198906
excitation,4,1.3862943611198906
PRES,4,1.3862943611198906
hisher,4,1.3862943611198906
attract,4,1.3862943611198906
Navarre,4,1.3862943611198906
Fatigue,4,1.3862943611198906
polyvalent,4,1.3862943611198906
RMS,4,1.3862943611198906
hand-washing,4,1.3862943611198906
incontinence,4,1.3862943611198906
immunopathologic,4,1.3862943611198906
leptin,4,1.3862943611198906
PAC,4,1.3862943611198906
COVID-19-specific,4,1.3862943611198906
gamma-globulin,4,1.3862943611198906
47-year-old,4,1.3862943611198906
Janssen,4,1.3862943611198906
innocuous,4,1.3862943611198906
Contemporary,4,1.3862943611198906
65°C,4,1.3862943611198906
ageing,4,1.3862943611198906
rigorously,4,1.3862943611198906
thirteen,4,1.3862943611198906
ecologic,4,1.3862943611198906
DCI,4,1.3862943611198906
speeds,4,1.3862943611198906
contextual,4,1.3862943611198906
MAC,4,1.3862943611198906
functionalized,4,1.3862943611198906
NF-kappaB,4,1.3862943611198906
symptom-based,4,1.3862943611198906
birthweight,4,1.3862943611198906
WEA,4,1.3862943611198906
electromagnetic,4,1.3862943611198906
swabbed,4,1.3862943611198906
Quebec,4,1.3862943611198906
CPF,4,1.3862943611198906
Collective,4,1.3862943611198906
Fig,4,1.3862943611198906
026,4,1.3862943611198906
closing,4,1.3862943611198906
trapped,4,1.3862943611198906
modulator,4,1.3862943611198906
harbors,4,1.3862943611198906
toroidal,4,1.3862943611198906
513,4,1.3862943611198906
deciphering,4,1.3862943611198906
Israeli,4,1.3862943611198906
peroxide,4,1.3862943611198906
385,4,1.3862943611198906
Partial,4,1.3862943611198906
AE,4,1.3862943611198906
regulations,4,1.3862943611198906
antidepressants,4,1.3862943611198906
alkaloid,4,1.3862943611198906
preoperatively,4,1.3862943611198906
I-TVR,4,1.3862943611198906
microbiological,4,1.3862943611198906
post-traumatic,4,1.3862943611198906
molds,4,1.3862943611198906
PESs,4,1.3862943611198906
fills,4,1.3862943611198906
One-Pot,4,1.3862943611198906
SESs,4,1.3862943611198906
e-Nose,4,1.3862943611198906
EpiRank,4,1.3862943611198906
linguistic,4,1.3862943611198906
logic,4,1.3862943611198906
568,4,1.3862943611198906
looked,4,1.3862943611198906
unplanned,4,1.3862943611198906
descent,4,1.3862943611198906
Ski,4,1.3862943611198906
labels,4,1.3862943611198906
Ad-synd4,4,1.3862943611198906
contaminants,4,1.3862943611198906
CP-based,4,1.3862943611198906
overwhelmingly,4,1.3862943611198906
FlOPs,4,1.3862943611198906
1600,4,1.3862943611198906
inquiry,4,1.3862943611198906
PVADs,4,1.3862943611198906
Referral,4,1.3862943611198906
Fluorescent,4,1.3862943611198906
SHA,4,1.3862943611198906
655,4,1.3862943611198906
case-patient,4,1.3862943611198906
sharply,4,1.3862943611198906
increment,4,1.3862943611198906
cite,4,1.3862943611198906
cine,4,1.3862943611198906
Tl,4,1.3862943611198906
bioavailability,4,1.3862943611198906
1-11,4,1.3862943611198906
fill-in,4,1.3862943611198906
TIAminor,4,1.3862943611198906
RSI,4,1.3862943611198906
MK,4,1.3862943611198906
EI,4,1.3862943611198906
draining,4,1.3862943611198906
corroborate,4,1.3862943611198906
succumbed,4,1.3862943611198906
NSBR,4,1.3862943611198906
lowest-income,4,1.3862943611198906
Telestroke,4,1.3862943611198906
diagonal,4,1.3862943611198906
guarantee,4,1.3862943611198906
1958,4,1.3862943611198906
says,4,1.3862943611198906
haplotype,4,1.3862943611198906
0-5,4,1.3862943611198906
polysomnography,4,1.3862943611198906
tonsils,4,1.3862943611198906
095,4,1.3862943611198906
passages,4,1.3862943611198906
Diffusion-weighted,4,1.3862943611198906
locomotor,4,1.3862943611198906
682,4,1.3862943611198906
frustration,4,1.3862943611198906
HTR,4,1.3862943611198906
thoughts,4,1.3862943611198906
ECHO-LVEF,4,1.3862943611198906
denominator,4,1.3862943611198906
object,4,1.3862943611198906
maintains,4,1.3862943611198906
governance,4,1.3862943611198906
alerts,4,1.3862943611198906
MPro,4,1.3862943611198906
Disparities,4,1.3862943611198906
non-TCM,4,1.3862943611198906
pork,4,1.3862943611198906
BDI,4,1.3862943611198906
interdependence,4,1.3862943611198906
quest,4,1.3862943611198906
SN,4,1.3862943611198906
Lipid,4,1.3862943611198906
HRs,4,1.3862943611198906
low-grade,4,1.3862943611198906
collaboratively,4,1.3862943611198906
519,4,1.3862943611198906
promoter,4,1.3862943611198906
O-deacylated,4,1.3862943611198906
6-year,4,1.3862943611198906
patient-related,4,1.3862943611198906
proficiency,4,1.3862943611198906
SARS-related,4,1.3862943611198906
Humans,4,1.3862943611198906
bibliometric,4,1.3862943611198906
editing,4,1.3862943611198906
ISTIA,4,1.3862943611198906
neurotrophin,4,1.3862943611198906
schema,4,1.3862943611198906
479,4,1.3862943611198906
AMICS,4,1.3862943611198906
substituted,4,1.3862943611198906
Design,4,1.3862943611198906
267,4,1.3862943611198906
volumetric,4,1.3862943611198906
serous,4,1.3862943611198906
SGs,4,1.3862943611198906
Responsibility,4,1.3862943611198906
refinement,4,1.3862943611198906
36-year-old,4,1.3862943611198906
HL,4,1.3862943611198906
serotonergic,4,1.3862943611198906
allergy-related,4,1.3862943611198906
sympathomimetic,4,1.3862943611198906
seasonally,4,1.3862943611198906
favourably,4,1.3862943611198906
washout,4,1.3862943611198906
Spanish-speaking,4,1.3862943611198906
attached,4,1.3862943611198906
TMPG,4,1.3862943611198906
Acid,4,1.3862943611198906
phylodynamic,4,1.3862943611198906
PK,4,1.3862943611198906
dominate,4,1.3862943611198906
Excellence,4,1.3862943611198906
p300,4,1.3862943611198906
GK-7,4,1.3862943611198906
IAS,4,1.3862943611198906
allergological,4,1.3862943611198906
heterosubtypic,4,1.3862943611198906
Ideally,4,1.3862943611198906
prosody,4,1.3862943611198906
Sixty-five,4,1.3862943611198906
CCAAP,4,1.3862943611198906
507,4,1.3862943611198906
SK,4,1.3862943611198906
unobserved,4,1.3862943611198906
prednisone,4,1.3862943611198906
neuroimmunological,4,1.3862943611198906
remedy,4,1.3862943611198906
Two-thirds,4,1.3862943611198906
diphosphonate,4,1.3862943611198906
MCD,4,1.3862943611198906
687,4,1.3862943611198906
RMD,4,1.3862943611198906
marginally,4,1.3862943611198906
IUL,4,1.3862943611198906
carnosine,4,1.3862943611198906
vWD,4,1.3862943611198906
nearing,4,1.3862943611198906
condition-specific,4,1.3862943611198906
488,4,1.3862943611198906
methylated,4,1.3862943611198906
lipomatous,4,1.3862943611198906
alleviated,4,1.3862943611198906
POEMS,4,1.3862943611198906
acidic,4,1.3862943611198906
Lp-PLA2,4,1.3862943611198906
turn-around-time,4,1.3862943611198906
HD,4,1.3862943611198906
consolidate,4,1.3862943611198906
neuroinvasive,4,1.3862943611198906
programmatic,4,1.3862943611198906
Swan-Ganz,4,1.3862943611198906
ICCU,4,1.3862943611198906
BDNF,4,1.3862943611198906
99th,4,1.3862943611198906
workplace-related,4,1.3862943611198906
ORF8,4,1.3862943611198906
ORF6,4,1.3862943611198906
CHA2DS2-VASc-CF,4,1.3862943611198906
anonymous,4,1.3862943611198906
intensify,4,1.3862943611198906
conductance,4,1.3862943611198906
Status,4,1.3862943611198906
implicates,4,1.3862943611198906
perimeter,4,1.3862943611198906
promoters,4,1.3862943611198906
Congenital,4,1.3862943611198906
motifs,4,1.3862943611198906
stops,4,1.3862943611198906
extubated,4,1.3862943611198906
Causes,4,1.3862943611198906
favors,4,1.3862943611198906
elucidation,4,1.3862943611198906
BHV-1,4,1.3862943611198906
high-density,4,1.3862943611198906
methotrexate,4,1.3862943611198906
mitochondria,4,1.3862943611198906
defibrillation,4,1.3862943611198906
MMWR,4,1.3862943611198906
Post,4,1.3862943611198906
oxidants,4,1.3862943611198906
Precision,4,1.3862943611198906
Biomeme,4,1.3862943611198906
planimetry,4,1.3862943611198906
twenty-first,4,1.3862943611198906
332,4,1.3862943611198906
practolol,4,1.3862943611198906
Highlights,4,1.3862943611198906
20-year,4,1.3862943611198906
healers,4,1.3862943611198906
Microvascular,4,1.3862943611198906
RSV-associated,4,1.3862943611198906
slowing,4,1.3862943611198906
SEOS,4,1.3862943611198906
microbiology,4,1.3862943611198906
leukopenia,4,1.3862943611198906
ASMareaPBM,4,1.3862943611198906
Roosevelt,4,1.3862943611198906
acoustic,4,1.3862943611198906
nuanced,4,1.3862943611198906
statutory,4,1.3862943611198906
microneutralisation,4,1.3862943611198906
ImunoAce,4,1.3862943611198906
Nitroglycerin,4,1.3862943611198906
subgenomes,4,1.3862943611198906
postischemic,4,1.3862943611198906
integrates,4,1.3862943611198906
Mucosal,4,1.3862943611198906
exudation,4,1.3862943611198906
RNA-seq,4,1.3862943611198906
Transfer,4,1.3862943611198906
nondiagnostic,4,1.3862943611198906
-308,4,1.3862943611198906
Uncertainty,4,1.3862943611198906
dopamine,4,1.3862943611198906
Home,4,1.3862943611198906
absorption,4,1.3862943611198906
Developed,4,1.3862943611198906
H1N1v,4,1.3862943611198906
short-lived,4,1.3862943611198906
repeatability,4,1.3862943611198906
immature,4,1.3862943611198906
Necropsy,4,1.3862943611198906
painful,4,1.3862943611198906
917,4,1.3862943611198906
WMFT-IT,4,1.3862943611198906
stochasticity,4,1.3862943611198906
Volume,4,1.3862943611198906
QR,4,1.3862943611198906
Cq,4,1.3862943611198906
hierarchy,4,1.3862943611198906
box,4,1.3862943611198906
CRTH2,4,1.3862943611198906
maximally,4,1.3862943611198906
mathematically,4,1.3862943611198906
norovirus,4,1.3862943611198906
926,4,1.3862943611198906
cannabis,4,1.3862943611198906
non-atherosclerotic,4,1.3862943611198906
junctions,4,1.3862943611198906
practicable,4,1.3862943611198906
exhaust,4,1.3862943611198906
nonocclusive,4,1.3862943611198906
one-day,4,1.3862943611198906
Monoclonal,4,1.3862943611198906
303,4,1.3862943611198906
EV,4,1.3862943611198906
heterogenous,4,1.3862943611198906
biofeedback,4,1.3862943611198906
Headache,4,1.3862943611198906
bronchopneumonia,4,1.3862943611198906
strikingly,4,1.3862943611198906
diesel,4,1.3862943611198906
vasodilatation,4,1.3862943611198906
Eurasia,4,1.3862943611198906
silica,4,1.3862943611198906
impoverished,4,1.3862943611198906
stands,4,1.3862943611198906
mid-November,4,1.3862943611198906
facilitators,4,1.3862943611198906
refuse,4,1.3862943611198906
1-5,4,1.3862943611198906
chemotaxis,4,1.3862943611198906
AIDS,4,1.3862943611198906
T-lymphocytes,4,1.3862943611198906
0029,4,1.3862943611198906
early-onset,4,1.3862943611198906
Cys145,4,1.3862943611198906
GFT,4,1.3862943611198906
vena,4,1.3862943611198906
Written,4,1.3862943611198906
researched,4,1.3862943611198906
RMSD,4,1.3862943611198906
Ninety-eight,4,1.3862943611198906
hydrochlorothiazide,4,1.3862943611198906
advising,4,1.3862943611198906
dimensionality,4,1.3862943611198906
P003,4,1.3862943611198906
T0,4,1.3862943611198906
ITZs,4,1.3862943611198906
holidays,4,1.3862943611198906
nonresponders,4,1.3862943611198906
transparency,4,1.3862943611198906
SPM,4,1.3862943611198906
Assays,4,1.3862943611198906
α,4,1.3862943611198906
junctional,4,1.3862943611198906
ICHD,4,1.3862943611198906
Systolic,4,1.3862943611198906
nonreperfused,4,1.3862943611198906
Siberia,4,1.3862943611198906
Hand,4,1.3862943611198906
simplified,4,1.3862943611198906
Computerized,4,1.3862943611198906
AW,4,1.3862943611198906
sibling,4,1.3862943611198906
confinement,4,1.3862943611198906
catheterizations,4,1.3862943611198906
west,4,1.3862943611198906
flooding,4,1.3862943611198906
ethics,4,1.3862943611198906
mini-review,4,1.3862943611198906
Poststroke,4,1.3862943611198906
nightly,4,1.3862943611198906
psychical,4,1.3862943611198906
laparoscopic,4,1.3862943611198906
soccer,4,1.3862943611198906
phosphatidylserine,4,1.3862943611198906
peri-infarct,4,1.3862943611198906
helpers,4,1.3862943611198906
20-25,4,1.3862943611198906
Cluster,4,1.3862943611198906
electrophilic,4,1.3862943611198906
liposomes,4,1.3862943611198906
accrued,4,1.3862943611198906
1809,4,1.3862943611198906
re-purposed,4,1.3862943611198906
thematic,4,1.3862943611198906
Olympic,4,1.3862943611198906
self-limiting,4,1.3862943611198906
serumplasma,4,1.3862943611198906
exposes,4,1.3862943611198906
commencement,4,1.3862943611198906
OCD,4,1.3862943611198906
mongrel,4,1.3862943611198906
roentgenogram,4,1.3862943611198906
socioprofessional,4,1.3862943611198906
CHA,4,1.3862943611198906
re-emerging,4,1.3862943611198906
clock,4,1.3862943611198906
Trends,4,1.3862943611198906
63-year-old,4,1.3862943611198906
901,4,1.3862943611198906
gain-of-function,4,1.3862943611198906
20022003,4,1.3862943611198906
sH1N1,4,1.3862943611198906
Compliance,4,1.3862943611198906
Health-care,4,1.3862943611198906
1920s,4,1.3862943611198906
day-care,4,1.3862943611198906
secondary-treated,4,1.3862943611198906
Dhaka,4,1.3862943611198906
Intra-aortic,4,1.3862943611198906
hypercytokinaemia,4,1.3862943611198906
kindergartens,4,1.3862943611198906
CPB,4,1.3862943611198906
proportionally,4,1.3862943611198906
intuitively,4,1.3862943611198906
conduit,4,1.3862943611198906
EH,4,1.3862943611198906
cross-species,4,1.3862943611198906
superfamily,4,1.3862943611198906
multigated,4,1.3862943611198906
Austin,4,1.3862943611198906
mould,4,1.3862943611198906
Seeking,4,1.3862943611198906
duties,4,1.3862943611198906
Field,4,1.3862943611198906
alpine,4,1.3862943611198906
569,4,1.3862943611198906
purchasing,4,1.3862943611198906
basing,4,1.3862943611198906
enalapril,4,1.3862943611198906
Hologic,4,1.3862943611198906
impart,4,1.3862943611198906
scars,4,1.3862943611198906
backbone,4,1.3862943611198906
645,4,1.3862943611198906
underestimation,4,1.3862943611198906
NL602,4,1.3862943611198906
NL2631-R223,4,1.3862943611198906
retrosternal,4,1.3862943611198906
Muscle,4,1.3862943611198906
Teaching,4,1.3862943611198906
w,4,1.3862943611198906
haemagglutination-inhibition,4,1.3862943611198906
seroepidemiological,4,1.3862943611198906
diluted,4,1.3862943611198906
SRD,4,1.3862943611198906
flu-related,4,1.3862943611198906
991,4,1.3862943611198906
neurotrophic,4,1.3862943611198906
humankind,4,1.3862943611198906
equilibrium,4,1.3862943611198906
excreta,4,1.3862943611198906
compensate,4,1.3862943611198906
ambulances,4,1.3862943611198906
factor-alpha,4,1.3862943611198906
flour,4,1.3862943611198906
pregnancy-related,4,1.3862943611198906
zoonosis,4,1.3862943611198906
CICU,4,1.3862943611198906
concerted,4,1.3862943611198906
replicating,4,1.3862943611198906
bailout,4,1.3862943611198906
postulates,4,1.3862943611198906
NVU,4,1.3862943611198906
invades,4,1.3862943611198906
SORP,4,1.3862943611198906
Deaths,4,1.3862943611198906
anterograde,4,1.3862943611198906
tip,4,1.3862943611198906
AH1N1pdm,4,1.3862943611198906
accidentally,4,1.3862943611198906
NQO1,4,1.3862943611198906
deviations,4,1.3862943611198906
WBC,4,1.3862943611198906
bars,4,1.3862943611198906
Sinovac,4,1.3862943611198906
Words,4,1.3862943611198906
misplacement,4,1.3862943611198906
vaccine-resistant,4,1.3862943611198906
deprivation,4,1.3862943611198906
detoxification,4,1.3862943611198906
planetary,4,1.3862943611198906
Nuss,4,1.3862943611198906
meningoencephalitis,4,1.3862943611198906
yes,4,1.3862943611198906
chemiluminescent,4,1.3862943611198906
EIT,4,1.3862943611198906
solitary,4,1.3862943611198906
757,4,1.3862943611198906
ADC,4,1.3862943611198906
optional,4,1.3862943611198906
1970,4,1.3862943611198906
thunderstorms,4,1.3862943611198906
Assess,4,1.3862943611198906
Leningrad,4,1.3862943611198906
Animals,4,1.3862943611198906
grains,4,1.3862943611198906
vorapaxar,4,1.3862943611198906
anti-asthmatic,4,1.3862943611198906
n8,4,1.3862943611198906
6h,4,1.3862943611198906
Birmingham,4,1.3862943611198906
6-23,4,1.3862943611198906
neoplasms,4,1.3862943611198906
Glasgow,4,1.3862943611198906
GFR,4,1.3862943611198906
268,4,1.3862943611198906
microfiber,4,1.3862943611198906
SSMI,4,1.3862943611198906
PMNs,4,1.3862943611198906
m-2,4,1.3862943611198906
LVR,4,1.3862943611198906
Active,4,1.3862943611198906
Statistically,4,1.3862943611198906
Wistar,4,1.3862943611198906
non-ischaemic,4,1.3862943611198906
ultrasensitive,4,1.3862943611198906
transmitting,4,1.3862943611198906
Discriminant,4,1.3862943611198906
Cadm2,4,1.3862943611198906
mgL,4,1.3862943611198906
sagittal,4,1.3862943611198906
comment,4,1.3862943611198906
Outbreak,4,1.3862943611198906
cues,4,1.3862943611198906
DREP,4,1.3862943611198906
aggregate,4,1.3862943611198906
debridement,4,1.3862943611198906
non-severe,4,1.3862943611198906
glycans,4,1.3862943611198906
lectin,4,1.3862943611198906
777,4,1.3862943611198906
high-priority,4,1.3862943611198906
miR-101,4,1.3862943611198906
Fatal,4,1.3862943611198906
H2,4,1.3862943611198906
MCCU,4,1.3862943611198906
mid-term,4,1.3862943611198906
PECAM-1,4,1.3862943611198906
845,4,1.3862943611198906
transitions,4,1.3862943611198906
labelling,4,1.3862943611198906
psychic,4,1.3862943611198906
Mesenchymal,4,1.3862943611198906
828,4,1.3862943611198906
µENIA,4,1.3862943611198906
compartmental,4,1.3862943611198906
dreadful,4,1.3862943611198906
microchip,4,1.3862943611198906
believes,4,1.3862943611198906
intramyocardial,4,1.3862943611198906
PDMS,4,1.3862943611198906
ophthalmic,4,1.3862943611198906
Copenhagen,4,1.3862943611198906
FPA,4,1.3862943611198906
Allergen,4,1.3862943611198906
PPAR-γ,4,1.3862943611198906
H10,4,1.3862943611198906
fiberoptic,4,1.3862943611198906
zoster,4,1.3862943611198906
non-STEMI,4,1.3862943611198906
Maximal,4,1.3862943611198906
inducer,4,1.3862943611198906
p-value,4,1.3862943611198906
overlapped,4,1.3862943611198906
PVC,4,1.3862943611198906
n60,4,1.3862943611198906
M40,4,1.3862943611198906
Compliant,4,1.3862943611198906
Predicting,4,1.3862943611198906
recognizes,4,1.3862943611198906
troponin-I,4,1.3862943611198906
lasts,4,1.3862943611198906
reevaluated,4,1.3862943611198906
nerves,4,1.3862943611198906
wherein,4,1.3862943611198906
underrepresented,4,1.3862943611198906
rationally,4,1.3862943611198906
biotechnology,4,1.3862943611198906
Cooperative,4,1.3862943611198906
Contrast,4,1.3862943611198906
optimistic,4,1.3862943611198906
prosthesis,4,1.3862943611198906
Seattle,4,1.3862943611198906
DCVMN,4,1.3862943611198906
piglets,4,1.3862943611198906
IIV3s,4,1.3862943611198906
TD,4,1.3862943611198906
hopes,4,1.3862943611198906
nanobodies,4,1.3862943611198906
melanoma,4,1.3862943611198906
disregarded,4,1.3862943611198906
ERPs,4,1.3862943611198906
hydroxyurea,4,1.3862943611198906
871,4,1.3862943611198906
beat,4,1.3862943611198906
Ad26COV2S,4,1.3862943611198906
sociological,4,1.3862943611198906
versa,4,1.3862943611198906
loaded,4,1.3862943611198906
straight,4,1.3862943611198906
intertwined,4,1.3862943611198906
deteriorate,4,1.3862943611198906
Sarma,4,1.3862943611198906
prolonging,4,1.3862943611198906
BioNTech,4,1.3862943611198906
vice,4,1.3862943611198906
ClinicalTrialsgov,4,1.3862943611198906
metabolomics,4,1.3862943611198906
above-mentioned,4,1.3862943611198906
SARP,4,1.3862943611198906
wildland,4,1.3862943611198906
594,4,1.3862943611198906
578,4,1.3862943611198906
burning,4,1.3862943611198906
isopotential,4,1.3862943611198906
Growth,4,1.3862943611198906
Latinx,4,1.3862943611198906
IVUS,4,1.3862943611198906
468,4,1.3862943611198906
granules,4,1.3862943611198906
respirable,4,1.3862943611198906
stratifying,4,1.3862943611198906
Ninety-four,4,1.3862943611198906
Emphasis,4,1.3862943611198906
preload,4,1.3862943611198906
apoplexy,4,1.3862943611198906
petroleum,4,1.3862943611198906
tragic,4,1.3862943611198906
exceedingly,4,1.3862943611198906
616,4,1.3862943611198906
interepidemic,4,1.3862943611198906
tonsil,4,1.3862943611198906
STANDARD,4,1.3862943611198906
tonsillectomy,4,1.3862943611198906
inter-pandemic,4,1.3862943611198906
PVCs,4,1.3862943611198906
Sudden,4,1.3862943611198906
malformation,4,1.3862943611198906
graft-versus-host,4,1.3862943611198906
ribs,4,1.3862943611198906
Essen,4,1.3862943611198906
Items,4,1.3862943611198906
norm,4,1.3862943611198906
gloves,4,1.3862943611198906
repeatable,4,1.3862943611198906
Subjective,4,1.3862943611198906
adjustments,4,1.3862943611198906
Hungarian,4,1.3862943611198906
sublineages,4,1.3862943611198906
Work,4,1.3862943611198906
AIS-LVO,4,1.3862943611198906
anti-S1RBD,4,1.3862943611198906
LS,4,1.3862943611198906
TPB,4,1.3862943611198906
C-acetate,4,1.3862943611198906
blood-activating,4,1.3862943611198906
Microbiology,4,1.3862943611198906
iterative,4,1.3862943611198906
ICUS,4,1.3862943611198906
subphenotypes,4,1.3862943611198906
norms,4,1.3862943611198906
Bronchoalveolar,4,1.3862943611198906
two-step,4,1.3862943611198906
bronchodilating,4,1.3862943611198906
subarachnoidal,4,1.3862943611198906
35°C,4,1.3862943611198906
estimator,4,1.3862943611198906
Resuscitation,4,1.3862943611198906
clot-busting,4,1.3862943611198906
curbing,4,1.3862943611198906
fermentation,4,1.3862943611198906
psychosomatic,4,1.3862943611198906
disruptive,4,1.3862943611198906
LitCovid,4,1.3862943611198906
deploy,4,1.3862943611198906
upstream,4,1.3862943611198906
RBD219-N1C1,4,1.3862943611198906
topology,4,1.3862943611198906
ATF6,4,1.3862943611198906
rCBV,4,1.3862943611198906
BOLD,4,1.3862943611198906
moderator,4,1.3862943611198906
coincidence,4,1.3862943611198906
TG,4,1.3862943611198906
820,4,1.3862943611198906
Females,4,1.3862943611198906
721,4,1.3862943611198906
405,4,1.3862943611198906
395,4,1.3862943611198906
Postinfarction,4,1.3862943611198906
arteriogram,4,1.3862943611198906
sp-A,4,1.3862943611198906
27-year-old,4,1.3862943611198906
moderating,4,1.3862943611198906
P18,4,1.3862943611198906
fruit,4,1.3862943611198906
RHD,4,1.3862943611198906
Lake,4,1.3862943611198906
halting,4,1.3862943611198906
hits,4,1.3862943611198906
bioassays,4,1.3862943611198906
incubated,4,1.3862943611198906
freeze-thawing,4,1.3862943611198906
acetylsalicylic,4,1.3862943611198906
Caregivers,4,1.3862943611198906
Ribavirin,4,1.3862943611198906
BMPAQ,4,1.3862943611198906
547,4,1.3862943611198906
Pre-hospital,4,1.3862943611198906
Comirnaty,4,1.3862943611198906
270,4,1.3862943611198906
myxomas,4,1.3862943611198906
stand,4,1.3862943611198906
IRME,4,1.3862943611198906
withholding,4,1.3862943611198906
neoplastic,4,1.3862943611198906
PAGs,4,1.3862943611198906
440,4,1.3862943611198906
bleedings,4,1.3862943611198906
non-ischemia,4,1.3862943611198906
transferring,4,1.3862943611198906
εe,4,1.3862943611198906
PTFE,4,1.3862943611198906
Suramin,4,1.3862943611198906
filters,4,1.3862943611198906
4-11,4,1.3862943611198906
12-14,4,1.3862943611198906
ecg,4,1.3862943611198906
Meta-analysis,4,1.3862943611198906
haematoma,4,1.3862943611198906
Protease,4,1.3862943611198906
disparate,4,1.3862943611198906
Phosphatase,4,1.3862943611198906
Methyltransferase,4,1.3862943611198906
mutagenesis,4,1.3862943611198906
funds,4,1.3862943611198906
n16,4,1.3862943611198906
20-OH-LTB4,4,1.3862943611198906
LoD,4,1.3862943611198906
41071,4,1.3862943611198906
Embolic,4,1.3862943611198906
extremes,4,1.3862943611198906
rib,4,1.3862943611198906
Diagnosing,4,1.3862943611198906
amounting,4,1.3862943611198906
dominating,4,1.3862943611198906
MP,4,1.3862943611198906
retrieve,4,1.3862943611198906
givers,4,1.3862943611198906
β2-agonists,4,1.3862943611198906
BioNTechPfizer,4,1.3862943611198906
Tozinameran,4,1.3862943611198906
pharynx,4,1.3862943611198906
extracting,4,1.3862943611198906
polyphenols,4,1.3862943611198906
TM,4,1.3862943611198906
formulating,4,1.3862943611198906
DST,4,1.3862943611198906
communitys,4,1.3862943611198906
withdrawing,4,1.3862943611198906
bridges,4,1.3862943611198906
Hypothesis,4,1.3862943611198906
dried,4,1.3862943611198906
glycosite,4,1.3862943611198906
Air-MSU,4,1.3862943611198906
Diltiazem,4,1.3862943611198906
glomerular,4,1.3862943611198906
fish,4,1.3862943611198906
preprocedural,4,1.3862943611198906
antioxidative,4,1.3862943611198906
dreaded,4,1.3862943611198906
Geneva,4,1.3862943611198906
localities,4,1.3862943611198906
least-squares,4,1.3862943611198906
Documents,4,1.3862943611198906
or380,4,1.3862943611198906
platoons,4,1.3862943611198906
Attitudes,4,1.3862943611198906
reverse-genetics,4,1.3862943611198906
discriminating,4,1.3862943611198906
contend,4,1.3862943611198906
Oceania,4,1.3862943611198906
Innovative,4,1.3862943611198906
Immediately,4,1.3862943611198906
DB,4,1.3862943611198906
one-way,4,1.3862943611198906
Carlo,4,1.3862943611198906
Cocaine,4,1.3862943611198906
Willis,4,1.3862943611198906
relatedness,4,1.3862943611198906
exhausted,4,1.3862943611198906
metapopulation,4,1.3862943611198906
β-blockers,4,1.3862943611198906
imposes,4,1.3862943611198906
antero-septal,4,1.3862943611198906
anticipation,4,1.3862943611198906
Fourth,4,1.3862943611198906
Warsaw,4,1.3862943611198906
immunodepression,4,1.3862943611198906
indistinguishable,4,1.3862943611198906
Age-specific,4,1.3862943611198906
IFN-λ2,4,1.3862943611198906
ordering,4,1.3862943611198906
recruiting,4,1.3862943611198906
IQ,4,1.3862943611198906
soap,4,1.3862943611198906
Tanzania,4,1.3862943611198906
sanitiser,4,1.3862943611198906
multi-factorial,4,1.3862943611198906
Pathologic,4,1.3862943611198906
recognising,4,1.3862943611198906
nCoV,4,1.3862943611198906
HSAP,4,1.3862943611198906
dormitory,4,1.3862943611198906
glass,4,1.3862943611198906
splenic,4,1.3862943611198906
orthodontic,4,1.3862943611198906
tropics,4,1.3862943611198906
methylprednisolone,4,1.3862943611198906
Atlanta,4,1.3862943611198906
worried,4,1.3862943611198906
rCBF,4,1.3862943611198906
premise,4,1.3862943611198906
CFD,4,1.3862943611198906
polymers,4,1.3862943611198906
Increases,4,1.3862943611198906
long-range,4,1.3862943611198906
postvaccination,4,1.3862943611198906
SVR,4,1.3862943611198906
411,4,1.3862943611198906
lesson,4,1.3862943611198906
cynomolgus,4,1.3862943611198906
FD,4,1.3862943611198906
sub-types,4,1.3862943611198906
transfection,4,1.3862943611198906
Staff,4,1.3862943611198906
aortal,4,1.3862943611198906
IFN-stimulated,4,1.3862943611198906
LH,4,1.3862943611198906
Novosibirsk,4,1.3862943611198906
BPL,4,1.3862943611198906
Boston,4,1.3862943611198906
recognise,4,1.3862943611198906
ARC,4,1.3862943611198906
IFN-λ3,4,1.3862943611198906
pre-discharge,4,1.3862943611198906
842,4,1.3862943611198906
allocate,4,1.3862943611198906
telehealth,4,1.3862943611198906
Spirometric,4,1.3862943611198906
MCP,4,1.3862943611198906
post-discharge,4,1.3862943611198906
1014,4,1.3862943611198906
Leukoaraiosis,4,1.3862943611198906
SARS-CoV-2COVID-19,4,1.3862943611198906
LVS,4,1.3862943611198906
mediastinoscopy,4,1.3862943611198906
rodent,4,1.3862943611198906
stained,4,1.3862943611198906
NPOP,4,1.3862943611198906
fluticasone,4,1.3862943611198906
Ninety,4,1.3862943611198906
maximise,4,1.3862943611198906
pial,4,1.3862943611198906
Nyugat-Magyarország,4,1.3862943611198906
Nature,4,1.3862943611198906
Keywords,4,1.3862943611198906
eradication,4,1.3862943611198906
stomach,4,1.3862943611198906
GIS,4,1.3862943611198906
cathepsins,4,1.3862943611198906
µg,4,1.3862943611198906
ex,4,1.3862943611198906
conductivity,4,1.3862943611198906
Are,4,1.3862943611198906
amplifies,4,1.3862943611198906
migrainous,4,1.3862943611198906
ensue,4,1.3862943611198906
institutionalized,4,1.3862943611198906
vegetables,4,1.3862943611198906
finger,4,1.3862943611198906
ranks,4,1.3862943611198906
AZ,4,1.3862943611198906
Favipiravir,4,1.3862943611198906
Feb,4,1.3862943611198906
trypsin,4,1.3862943611198906
ρ,4,1.3862943611198906
centred,4,1.3862943611198906
Alternate,4,1.3862943611198906
industrialised,4,1.3862943611198906
CrCl,4,1.3862943611198906
irregularity,4,1.3862943611198906
standardisation,4,1.3862943611198906
beteg,4,1.3862943611198906
births,4,1.3862943611198906
age-group,4,1.3862943611198906
PTSD,4,1.3862943611198906
acetazolamide,4,1.3862943611198906
rhinomanometry,4,1.3862943611198906
fetuses,4,1.3862943611198906
endeavors,4,1.3862943611198906
ASTER,4,1.3862943611198906
OAS,4,1.3862943611198906
unsupervised,4,1.3862943611198906
polio,4,1.3862943611198906
zoonoses,4,1.3862943611198906
Final,4,1.3862943611198906
AcHERV-VLP,4,1.3862943611198906
interests,4,1.3862943611198906
interobserver,4,1.3862943611198906
Leiden,4,1.3862943611198906
occluder,4,1.3862943611198906
phylogenies,4,1.3862943611198906
Spearman,4,1.3862943611198906
celiac,4,1.3862943611198906
deficiency，,4,1.3862943611198906
FluRSV,4,1.3862943611198906
rights,4,1.3862943611198906
s-1,4,1.3862943611198906
041,4,1.3862943611198906
Table,4,1.3862943611198906
transcutaneous,4,1.3862943611198906
biliary,4,1.3862943611198906
1889,4,1.3862943611198906
Buenos,4,1.3862943611198906
Aires,4,1.3862943611198906
AVS,4,1.3862943611198906
éves,4,1.3862943611198906
lability,4,1.3862943611198906
betegek,4,1.3862943611198906
externally,4,1.3862943611198906
newspapers,4,1.3862943611198906
speckle,4,1.3862943611198906
reinjection,4,1.3862943611198906
catheterized,4,1.3862943611198906
redirected,4,1.3862943611198906
ultrafast,4,1.3862943611198906
diameters,4,1.3862943611198906
1918-like,4,1.3862943611198906
Supplemental,4,1.3862943611198906
neuroendovascular,4,1.3862943611198906
TLTs,4,1.3862943611198906
PAMBA,4,1.3862943611198906
adjudication,4,1.3862943611198906
invalid,4,1.3862943611198906
Hurricane,4,1.3862943611198906
ACOV,4,1.3862943611198906
eating,4,1.3862943611198906
abbreviated,4,1.3862943611198906
skiers,4,1.3862943611198906
VAS,4,1.3862943611198906
pterostilbene,4,1.3862943611198906
simulating,4,1.3862943611198906
baby,4,1.3862943611198906
Tobacco,4,1.3862943611198906
labour,4,1.3862943611198906
chief,4,1.3862943611198906
Intracranial,4,1.3862943611198906
switches,4,1.3862943611198906
Awareness,4,1.3862943611198906
Fall,4,1.3862943611198906
CCR5-Δ32,4,1.3862943611198906
Widespread,4,1.3862943611198906
stepping,4,1.3862943611198906
lag,4,1.3862943611198906
betacoronaviruses,4,1.3862943611198906
underlined,4,1.3862943611198906
staffs,4,1.3862943611198906
Internet,4,1.3862943611198906
cooperative,4,1.3862943611198906
BIPQ,4,1.3862943611198906
misconceptions,4,1.3862943611198906
enroll,4,1.3862943611198906
non-vitamin,4,1.3862943611198906
EE,4,1.3862943611198906
Jima,4,1.3862943611198906
IFN-I,4,1.3862943611198906
attain,4,1.3862943611198906
NHPs,4,1.3862943611198906
antiasthma,4,1.3862943611198906
scrutiny,4,1.3862943611198906
Randomised,4,1.3862943611198906
Iscomatrix,4,1.3862943611198906
732,4,1.3862943611198906
MIP,4,1.3862943611198906
Monday,4,1.3862943611198906
resveratrol,4,1.3862943611198906
oxygenase,4,1.3862943611198906
metacholine,4,1.3862943611198906
titration,4,1.3862943611198906
caliber,4,1.3862943611198906
ticlopidine,4,1.3862943611198906
retired,4,1.3862943611198906
Rotterdam,4,1.3862943611198906
ASCO,4,1.3862943611198906
acutesubacute,4,1.3862943611198906
RT-PCR-based,4,1.3862943611198906
founded,4,1.3862943611198906
hematology,4,1.3862943611198906
non-communicable,4,1.3862943611198906
MicroRNAs,4,1.3862943611198906
stools,4,1.3862943611198906
RTMM,4,1.3862943611198906
Transplant,4,1.3862943611198906
vWF,4,1.3862943611198906
Peru,4,1.3862943611198906
SARS-CoV-2-laden,4,1.3862943611198906
Restoration,4,1.3862943611198906
Earlier,4,1.3862943611198906
lncRNA,4,1.3862943611198906
3-year,4,1.3862943611198906
preeclampsia,4,1.3862943611198906
Epidemic,4,1.3862943611198906
FC-SBL,4,1.3862943611198906
pangolin,4,1.3862943611198906
Historical,4,1.3862943611198906
non-complicated,4,1.3862943611198906
diffusivity,4,1.3862943611198906
characterisation,4,1.3862943611198906
culling,4,1.3862943611198906
emptying,4,1.3862943611198906
Leukotrienes,4,1.3862943611198906
anorexia,4,1.3862943611198906
Arizona,4,1.3862943611198906
immunofluorescent,4,1.3862943611198906
051,4,1.3862943611198906
495,4,1.3862943611198906
384,4,1.3862943611198906
commencing,4,1.3862943611198906
SEC,4,1.3862943611198906
Vienna,4,1.3862943611198906
AEM,4,1.3862943611198906
extubation,4,1.3862943611198906
846,4,1.3862943611198906
instrumentation,4,1.3862943611198906
MTS,4,1.3862943611198906
biosurfactants,4,1.3862943611198906
Paul,4,1.3862943611198906
licorice,4,1.3862943611198906
Support,4,1.3862943611198906
inorganic,4,1.3862943611198906
deliveries,4,1.3862943611198906
Jones,4,1.3862943611198906
Types,4,1.3862943611198906
prognostication,4,1.3862943611198906
bears,4,1.3862943611198906
arthralgia,4,1.3862943611198906
Symposium,4,1.3862943611198906
≥40,4,1.3862943611198906
organised,4,1.3862943611198906
070,4,1.3862943611198906
Abundant,4,1.3862943611198906
Mice,4,1.3862943611198906
hypercapnia,4,1.3862943611198906
right-hemisphere,4,1.3862943611198906
paradox,4,1.3862943611198906
VS,4,1.3862943611198906
suite,4,1.3862943611198906
computationally,4,1.3862943611198906
Rate,4,1.3862943611198906
NYC,4,1.3862943611198906
bilaterally,4,1.3862943611198906
843,4,1.3862943611198906
north,4,1.3862943611198906
immunised,4,1.3862943611198906
Penicillium,4,1.3862943611198906
metal,4,1.3862943611198906
Preclinical,4,1.3862943611198906
Upper,4,1.3862943611198906
healthier,4,1.3862943611198906
43-year-old,4,1.3862943611198906
sex-based,4,1.3862943611198906
viremia,4,1.3862943611198906
electrochemiluminescence,4,1.3862943611198906
Arbidol,4,1.3862943611198906
grippe,4,1.3862943611198906
cardioverter-defibrillator,4,1.3862943611198906
degeneration,4,1.3862943611198906
Enzymatic,4,1.3862943611198906
leukosis,4,1.3862943611198906
914,4,1.3862943611198906
files,4,1.3862943611198906
perindopril,4,1.3862943611198906
WHAT,4,1.3862943611198906
synergistically,4,1.3862943611198906
Racial,4,1.3862943611198906
sedimentation,4,1.3862943611198906
metered,4,1.3862943611198906
EM,4,1.3862943611198906
excitement,4,1.3862943611198906
recapitulates,4,1.3862943611198906
359,4,1.3862943611198906
TO,4,1.3862943611198906
stricter,4,1.3862943611198906
BID,4,1.3862943611198906
post-PET,4,1.3862943611198906
train,4,1.3862943611198906
convolutional,4,1.3862943611198906
CNN,4,1.3862943611198906
cusp,4,1.3862943611198906
overlaps,4,1.3862943611198906
aldosterone,4,1.3862943611198906
contacting,4,1.3862943611198906
WE,4,1.3862943611198906
coronarosclerosis,4,1.3862943611198906
La,4,1.3862943611198906
LTRAs,4,1.3862943611198906
Inflammation,4,1.3862943611198906
naso-pharyngeal,4,1.3862943611198906
unequivocal,4,1.3862943611198906
248,4,1.3862943611198906
MSI,4,1.3862943611198906
amniotic,4,1.3862943611198906
281,4,1.3862943611198906
NEED,4,1.3862943611198906
mg100,4,1.3862943611198906
nebulizers,4,1.3862943611198906
recruits,4,1.3862943611198906
pretreated,4,1.3862943611198906
alveoli,4,1.3862943611198906
positive-sense,4,1.3862943611198906
parishes,4,1.3862943611198906
degraded,4,1.3862943611198906
tenth,4,1.3862943611198906
ABPA,4,1.3862943611198906
nonsynonymous,4,1.3862943611198906
Effect,4,1.3862943611198906
Difficulties,4,1.3862943611198906
immunize,4,1.3862943611198906
Enhanced,4,1.3862943611198906
off-pump,4,1.3862943611198906
legacy,4,1.3862943611198906
dense,4,1.3862943611198906
Consistent,4,1.3862943611198906
importation,4,1.3862943611198906
nsp1,4,1.3862943611198906
CTA,4,1.3862943611198906
blood-pool,4,1.3862943611198906
Radionuclide,4,1.3862943611198906
time-of-flight,4,1.3862943611198906
ruling,4,1.3862943611198906
illuminate,4,1.3862943611198906
reevaluation,4,1.3862943611198906
sparsely,4,1.3862943611198906
4-fold,4,1.3862943611198906
Measurements,4,1.3862943611198906
linearly,4,1.3862943611198906
fairs,4,1.3862943611198906
892,4,1.3862943611198906
proxies,4,1.3862943611198906
EVT-access,4,1.3862943611198906
TLR,4,1.3862943611198906
Co,4,1.3862943611198906
age-appropriate,4,1.3862943611198906
wheezy,4,1.3862943611198906
individualize,4,1.3862943611198906
swallow,4,1.3862943611198906
bioscience,4,1.3862943611198906
461,4,1.3862943611198906
orthopedic,4,1.3862943611198906
conducive,4,1.3862943611198906
Permanent,4,1.3862943611198906
Markers,4,1.3862943611198906
isolations,4,1.3862943611198906
turmoil,4,1.3862943611198906
paramagnetic,4,1.3862943611198906
full-term,4,1.3862943611198906
Interleukin,4,1.3862943611198906
endotoxin,4,1.3862943611198906
implied,4,1.3862943611198906
Sixty-two,4,1.3862943611198906
seventy,4,1.3862943611198906
sociocultural,4,1.3862943611198906
invariably,4,1.3862943611198906
atherogenic,4,1.3862943611198906
Histopathological,4,1.3862943611198906
Pretreatment,4,1.3862943611198906
haemoglobin,4,1.3862943611198906
RBD-specific,4,1.3862943611198906
0046,4,1.3862943611198906
sanatorium,4,1.3862943611198906
fractured,4,1.3862943611198906
Extracorporeal,4,1.3862943611198906
foam,4,1.3862943611198906
indoors,4,1.3862943611198906
undetected,4,1.3862943611198906
1-7,4,1.3862943611198906
AGT,4,1.3862943611198906
postnatal,4,1.3862943611198906
External,4,1.3862943611198906
908,4,1.3862943611198906
lymphadenopathy,4,1.3862943611198906
fragmented,4,1.3862943611198906
Sustained,4,1.3862943611198906
Francisco,4,1.3862943611198906
obtainable,4,1.3862943611198906
Excluding,4,1.3862943611198906
Notch,4,1.3862943611198906
ulceration,4,1.3862943611198906
covariance,4,1.3862943611198906
parsimonious,4,1.3862943611198906
marmosets,4,1.3862943611198906
alertness,4,1.3862943611198906
lipoproteins,4,1.3862943611198906
Adequate,4,1.3862943611198906
Bay,4,1.3862943611198906
Hopefully,4,1.3862943611198906
two-vessel,4,1.3862943611198906
exudate,4,1.3862943611198906
sooner,4,1.3862943611198906
fourfold,4,1.3862943611198906
referrals,4,1.3862943611198906
analyzer,4,1.3862943611198906
911,4,1.3862943611198906
flying,4,1.3862943611198906
unspecified,4,1.3862943611198906
311,4,1.3862943611198906
Perioperative,4,1.3862943611198906
NJ,4,1.3862943611198906
hsCRP,4,1.3862943611198906
cobas,4,1.3862943611198906
discount,4,1.3862943611198906
basigin,4,1.3862943611198906
cardio-embolic,4,1.3862943611198906
relax,4,1.3862943611198906
974,4,1.3862943611198906
sure,4,1.3862943611198906
catalytic,4,1.3862943611198906
Alinity,4,1.3862943611198906
apparatus,4,1.3862943611198906
rationales,4,1.3862943611198906
stretching,4,1.3862943611198906
calling,4,1.3862943611198906
population-scale,4,1.3862943611198906
939,4,1.3862943611198906
arteriographic,4,1.3862943611198906
1900,4,1.3862943611198906
quantitated,4,1.3862943611198906
deacetylase,4,1.3862943611198906
parkinsonism,4,1.3862943611198906
interruption,4,1.3862943611198906
histone,4,1.3862943611198906
re-infection,4,1.3862943611198906
summarised,4,1.3862943611198906
permitting,4,1.3862943611198906
flux,4,1.3862943611198906
plasmon,4,1.3862943611198906
Fifty-three,4,1.3862943611198906
False,4,1.3862943611198906
weaned,4,1.3862943611198906
secondly,4,1.3862943611198906
≥160,4,1.3862943611198906
eliminates,4,1.3862943611198906
definitively,4,1.3862943611198906
catalyze,4,1.3862943611198906
Cronbachs,4,1.3862943611198906
proceeded,4,1.3862943611198906
indexed,4,1.3862943611198906
614,4,1.3862943611198906
preconditioned,4,1.3862943611198906
cell-specific,4,1.3862943611198906
reprogramming,4,1.3862943611198906
vague,4,1.3862943611198906
hydrophobic,4,1.3862943611198906
979,4,1.3862943611198906
normalcy,4,1.3862943611198906
Adelaide,4,1.3862943611198906
atmosphere,4,1.3862943611198906
bee,4,1.3862943611198906
optimisation,4,1.3862943611198906
compact,4,1.3862943611198906
launch,4,1.3862943611198906
Paired,4,1.3862943611198906
975,4,1.3862943611198906
ensemble,4,1.3862943611198906
conceptions,4,1.3862943611198906
multiply,4,1.3862943611198906
Computational,4,1.3862943611198906
cathepsin,4,1.3862943611198906
normalisation,4,1.3862943611198906
4G4G,4,1.3862943611198906
academia,4,1.3862943611198906
recur,4,1.3862943611198906
Inconsistent,4,1.3862943611198906
erythrocytes,4,1.3862943611198906
Tuberculosis,4,1.3862943611198906
Acupuncture,4,1.3862943611198906
immunocompetence,4,1.3862943611198906
employs,4,1.3862943611198906
say,4,1.3862943611198906
neurosurgery,4,1.3862943611198906
mature,4,1.3862943611198906
messaging,4,1.3862943611198906
D614,4,1.3862943611198906
Technological,4,1.3862943611198906
t-test,4,1.3862943611198906
USSR,4,1.3862943611198906
764,4,1.3862943611198906
0026,4,1.3862943611198906
wished,4,1.3862943611198906
disturbing,4,1.3862943611198906
Gross,4,1.3862943611198906
defenses,4,1.3862943611198906
1890,4,1.3862943611198906
remedial,4,1.3862943611198906
taught,4,1.3862943611198906
clearer,4,1.3862943611198906
infarctionABSTRACT,4,1.3862943611198906
BH,4,1.3862943611198906
electrographic,4,1.3862943611198906
Pharmacists,4,1.3862943611198906
motivate,4,1.3862943611198906
degenerative,4,1.3862943611198906
satisfactorily,4,1.3862943611198906
weapon,4,1.3862943611198906
Close,4,1.3862943611198906
earthquakes,4,1.3862943611198906
Rh,4,1.3862943611198906
650,4,1.3862943611198906
Usually,4,1.3862943611198906
Afterwards,4,1.3862943611198906
588,4,1.3862943611198906
plugging,4,1.3862943611198906
chromatin,4,1.3862943611198906
time-course,4,1.3862943611198906
post-exposure,4,1.3862943611198906
tendencies,4,1.3862943611198906
difficult-to-manage,4,1.3862943611198906
486,4,1.3862943611198906
Barriers,4,1.3862943611198906
sphincter,4,1.3862943611198906
interatrial,4,1.3862943611198906
liberation,4,1.3862943611198906
543,4,1.3862943611198906
Valsalva,4,1.3862943611198906
quarantining,4,1.3862943611198906
363,4,1.3862943611198906
sinuses,4,1.3862943611198906
remembered,4,1.3862943611198906
electroencephalogram,4,1.3862943611198906
VOI,4,1.3862943611198906
MHV,4,1.3862943611198906
200000,4,1.3862943611198906
two-stage,4,1.3862943611198906
multistage,4,1.3862943611198906
restorative,4,1.3862943611198906
nucleoside,4,1.3862943611198906
Salt,4,1.3862943611198906
precede,4,1.3862943611198906
443,4,1.3862943611198906
IMPORTANCE,4,1.3862943611198906
post-symptom,4,1.3862943611198906
subtended,4,1.3862943611198906
discounted,4,1.3862943611198906
615,4,1.3862943611198906
swept,4,1.3862943611198906
Influenza-like,4,1.3862943611198906
bench,4,1.3862943611198906
teasoda,4,1.3862943611198906
contemporaneous,4,1.3862943611198906
weapons,4,1.3862943611198906
chemotactic,4,1.3862943611198906
TNG,4,1.3862943611198906
slopes,4,1.3862943611198906
dispersed,4,1.3862943611198906
azithromycin,4,1.3862943611198906
large-focal,4,1.3862943611198906
nonlinear,4,1.3862943611198906
renin,4,1.3862943611198906
unfortunately,4,1.3862943611198906
purchase,4,1.3862943611198906
convincingly,4,1.3862943611198906
purchased,4,1.3862943611198906
beta-blockade,4,1.3862943611198906
papain-like,4,1.3862943611198906
manuscripts,4,1.3862943611198906
referent,4,1.3862943611198906
atenolol,4,1.3862943611198906
MBTE,4,1.3862943611198906
Pooling,4,1.3862943611198906
329,4,1.3862943611198906
coronal,4,1.3862943611198906
428,4,1.3862943611198906
840,4,1.3862943611198906
tetrapolar,4,1.3862943611198906
TWN,4,1.3862943611198906
retrograde,4,1.3862943611198906
neurohormonal,4,1.3862943611198906
AHMPPI,4,1.3862943611198906
053,4,1.3862943611198906
ample,4,1.3862943611198906
NPs,4,1.3862943611198906
front-line,4,1.3862943611198906
Src,4,1.3862943611198906
635,4,1.3862943611198906
occupations,4,1.3862943611198906
AdC68-19S,4,1.3862943611198906
educating,4,1.3862943611198906
non-responders,4,1.3862943611198906
distilled,4,1.3862943611198906
Parents,4,1.3862943611198906
ANE,4,1.3862943611198906
eucapnic,4,1.3862943611198906
immigration,4,1.3862943611198906
captopril,4,1.3862943611198906
confound,4,1.3862943611198906
vicious,4,1.3862943611198906
Normal,4,1.3862943611198906
smallpox,4,1.3862943611198906
Tertiary,4,1.3862943611198906
IF,4,1.3862943611198906
urge,4,1.3862943611198906
abrogated,4,1.3862943611198906
gets,4,1.3862943611198906
name,4,1.3862943611198906
specifying,4,1.3862943611198906
overestimate,4,1.3862943611198906
Bahia,4,1.3862943611198906
728,4,1.3862943611198906
letter,4,1.3862943611198906
misinterpretation,4,1.3862943611198906
centrifugal,4,1.3862943611198906
transporters,4,1.3862943611198906
granulocytes,4,1.3862943611198906
989,4,1.3862943611198906
deploying,4,1.3862943611198906
1971,4,1.3862943611198906
506,4,1.3862943611198906
shunting,4,1.3862943611198906
high-,4,1.3862943611198906
companion,4,1.3862943611198906
Immunological,4,1.3862943611198906
690,4,1.3862943611198906
sixteen,4,1.3862943611198906
asphyxia,4,1.3862943611198906
Canadians,4,1.3862943611198906
chromatographic,4,1.3862943611198906
leukaemia,4,1.3862943611198906
computer-aided,4,1.3862943611198906
wish,4,1.3862943611198906
correlational,4,1.3862943611198906
mediastinitis,4,1.3862943611198906
Invasive,4,1.3862943611198906
10-12,4,1.3862943611198906
extrapulmonary,4,1.3862943611198906
pollutant,4,1.3862943611198906
generalizable,4,1.3862943611198906
S-protein,4,1.3862943611198906
wet,4,1.3862943611198906
case-finding,4,1.3862943611198906
Vaccinated,4,1.3862943611198906
72-year-old,4,1.3862943611198906
Secondly,4,1.3862943611198906
oxidized,4,1.3862943611198906
Admission,4,1.3862943611198906
081,4,1.3862943611198906
420,4,1.3862943611198906
z,4,1.3862943611198906
sub-group,4,1.3862943611198906
proceeding,4,1.3862943611198906
golden,4,1.3862943611198906
guardians,4,1.3862943611198906
Collaborative,4,1.3862943611198906
Generalized,4,1.3862943611198906
CMILRV,4,1.3862943611198906
SCPS,4,1.3862943611198906
571,4,1.3862943611198906
dyspneic,4,1.3862943611198906
driver,4,1.3862943611198906
hypoperfused,4,1.3862943611198906
716,4,1.3862943611198906
tracked,4,1.3862943611198906
fecal,4,1.3862943611198906
Rapidly,4,1.3862943611198906
IVA,4,1.3862943611198906
Cairo,4,1.3862943611198906
NT-proBNP,4,1.3862943611198906
appreciably,4,1.3862943611198906
choroidal,4,1.3862943611198906
realizing,4,1.3862943611198906
engraftment,4,1.3862943611198906
vial,4,1.3862943611198906
≥50,4,1.3862943611198906
restructuring,4,1.3862943611198906
exceptionally,4,1.3862943611198906
57-year-old,4,1.3862943611198906
346,4,1.3862943611198906
RBD-conjugated,4,1.3862943611198906
Evidence-based,4,1.3862943611198906
legs,4,1.3862943611198906
gaseous,4,1.3862943611198906
nonepidemic,4,1.3862943611198906
four-fold,4,1.3862943611198906
Making,4,1.3862943611198906
mandated,4,1.3862943611198906
Performing,4,1.3862943611198906
regained,4,1.3862943611198906
convulsions,4,1.3862943611198906
nonoccupational,4,1.3862943611198906
asymmetrical,4,1.3862943611198906
0-3,4,1.3862943611198906
unextracted,4,1.3862943611198906
452,4,1.3862943611198906
LTC4,4,1.3862943611198906
-3,4,1.3862943611198906
Equine,4,1.3862943611198906
parasite,4,1.3862943611198906
HeO2,4,1.3862943611198906
cytology,4,1.3862943611198906
mark,4,1.3862943611198906
895,4,1.3862943611198906
labored,4,1.3862943611198906
ill-defined,4,1.3862943611198906
Diego,4,1.3862943611198906
466,4,1.3862943611198906
Spirometry,4,1.3862943611198906
55-year-old,4,1.3862943611198906
458,4,1.3862943611198906
Abciximab,4,1.3862943611198906
enzymatically,4,1.3862943611198906
dropped,4,1.3862943611198906
368,4,1.3862943611198906
FDG,4,1.3862943611198906
two-year,4,1.3862943611198906
orand,4,1.3862943611198906
spin,4,1.3862943611198906
defend,4,1.3862943611198906
certified,4,1.3862943611198906
intramyocardially,4,1.3862943611198906
Maori,4,1.3862943611198906
Insight,4,1.3862943611198906
Past,4,1.3862943611198906
Virology,4,1.3862943611198906
Burden,4,1.3862943611198906
1-6,4,1.3862943611198906
abortion,4,1.3862943611198906
outperforms,4,1.3862943611198906
Thirty-three,4,1.3862943611198906
doubles,4,1.3862943611198906
arriving,4,1.3862943611198906
knowledgeable,4,1.3862943611198906
destination,4,1.3862943611198906
Mixed,4,1.3862943611198906
NIs,4,1.3862943611198906
phynoptin,4,1.3862943611198906
nascent,4,1.3862943611198906
broke,4,1.3862943611198906
1232,4,1.3862943611198906
Thirty-six,4,1.3862943611198906
SVC,4,1.3862943611198906
complements,4,1.3862943611198906
791,4,1.3862943611198906
preponderance,4,1.3862943611198906
46-year-old,4,1.3862943611198906
mirror,4,1.3862943611198906
Fishers,4,1.3862943611198906
workdays,4,1.3862943611198906
consult,4,1.3862943611198906
exemplify,4,1.3862943611198906
northeast,4,1.3862943611198906
epidermal,4,1.3862943611198906
FSMs,4,1.3862943611198906
Inhalation,4,1.3862943611198906
work-aggravated,4,1.3862943611198906
cough-variant,4,1.3862943611198906
cattle,4,1.3862943611198906
042,4,1.3862943611198906
peak-flow,4,1.3862943611198906
wall-motion,4,1.3862943611198906
stepped,4,1.3862943611198906
computer-based,4,1.3862943611198906
V3R,4,1.3862943611198906
hypokinesis,4,1.3862943611198906
1a,4,1.3862943611198906
Think,4,1.3862943611198906
N3,4,1.3862943611198906
713,4,1.3862943611198906
seconds,4,1.3862943611198906
irritation,4,1.3862943611198906
60-year-old,4,1.3862943611198906
got,4,1.3862943611198906
200809,4,1.3862943611198906
Recognizing,4,1.3862943611198906
surprised,4,1.3862943611198906
midlife,4,1.3862943611198906
acid-based,4,1.3862943611198906
packaging,4,1.3862943611198906
isocyanate-induced,4,1.3862943611198906
expenditures,4,1.3862943611198906
proliferate,4,1.3862943611198906
P0003,4,1.3862943611198906
amplicons,4,1.3862943611198906
IL,4,1.3862943611198906
hinders,4,1.3862943611198906
018,4,1.3862943611198906
660,4,1.3862943611198906
nucleotides,4,1.3862943611198906
nonsteroidal,4,1.3862943611198906
Addressing,4,1.3862943611198906
adaptability,4,1.3862943611198906
nonsevere,4,1.3862943611198906
gustatory,4,1.3862943611198906
peculiar,4,1.3862943611198906
343,4,1.3862943611198906
ontology,4,1.3862943611198906
Asia-Pacific,4,1.3862943611198906
mitogen,4,1.3862943611198906
Anesthesia,4,1.3862943611198906
RP,4,1.3862943611198906
injectable,4,1.3862943611198906
Bivariate,4,1.3862943611198906
blunted,4,1.3862943611198906
intraocular,4,1.3862943611198906
myofibroblast,4,1.3862943611198906
cause-specific,4,1.3862943611198906
immunosuppressants,4,1.3862943611198906
rs1800896,4,1.3862943611198906
judgment,4,1.3862943611198906
transcriptomics,4,1.3862943611198906
totaling,4,1.3862943611198906
mutism,4,1.3862943611198906
humor,4,1.3862943611198906
conclusively,4,1.3862943611198906
Costs,4,1.3862943611198906
fits,4,1.3862943611198906
ecosystem,4,1.3862943611198906
paramedics,4,1.3862943611198906
half-maximal,4,1.3862943611198906
USD,4,1.3862943611198906
Aortic,4,1.3862943611198906
hotspots,4,1.3862943611198906
topography,4,1.3862943611198906
754,4,1.3862943611198906
worthy,4,1.3862943611198906
neurogenic,4,1.3862943611198906
pseudoviral,4,1.3862943611198906
binomial,4,1.3862943611198906
underpin,4,1.3862943611198906
antipsychotic,4,1.3862943611198906
Damage,4,1.3862943611198906
Bronchoconstriction,4,1.3862943611198906
milliliter,3,1.0986122886681098
Handgrip,3,1.0986122886681098
BAU,3,1.0986122886681098
archives,3,1.0986122886681098
Academic,3,1.0986122886681098
Will,3,1.0986122886681098
suit,3,1.0986122886681098
health-economic,3,1.0986122886681098
NC,3,1.0986122886681098
climatotherapy,3,1.0986122886681098
nonsignificant,3,1.0986122886681098
drifted,3,1.0986122886681098
rifampicin,3,1.0986122886681098
coalescent,3,1.0986122886681098
biomolecules,3,1.0986122886681098
651,3,1.0986122886681098
Wake-up,3,1.0986122886681098
SXscore,3,1.0986122886681098
altogether,3,1.0986122886681098
pre-school,3,1.0986122886681098
meta-regression,3,1.0986122886681098
JMB2002,3,1.0986122886681098
acute-phase,3,1.0986122886681098
diagrams,3,1.0986122886681098
Syncope,3,1.0986122886681098
Bacillus,3,1.0986122886681098
CTR,3,1.0986122886681098
nonmedical,3,1.0986122886681098
columns,3,1.0986122886681098
Vircell,3,1.0986122886681098
within-week,3,1.0986122886681098
etiopathogenetic,3,1.0986122886681098
inter-assay,3,1.0986122886681098
enrich,3,1.0986122886681098
valuations,3,1.0986122886681098
824,3,1.0986122886681098
hyaline,3,1.0986122886681098
NDT,3,1.0986122886681098
timescale,3,1.0986122886681098
taxonomic,3,1.0986122886681098
Providing,3,1.0986122886681098
CYamagata2681,3,1.0986122886681098
NAION,3,1.0986122886681098
intestine,3,1.0986122886681098
Dysphagia,3,1.0986122886681098
Accident,3,1.0986122886681098
contrasting,3,1.0986122886681098
ab,3,1.0986122886681098
epizootics,3,1.0986122886681098
SCoV-2,3,1.0986122886681098
Methylene,3,1.0986122886681098
subway,3,1.0986122886681098
STAIR,3,1.0986122886681098
heredity,3,1.0986122886681098
reappearance,3,1.0986122886681098
dividing,3,1.0986122886681098
photodynamic,3,1.0986122886681098
Healthy,3,1.0986122886681098
NSP-RDT,3,1.0986122886681098
lining,3,1.0986122886681098
arteriopathies,3,1.0986122886681098
Get,3,1.0986122886681098
reportedly,3,1.0986122886681098
restarting,3,1.0986122886681098
Motivated,3,1.0986122886681098
JPGL,3,1.0986122886681098
XeCT,3,1.0986122886681098
midwives,3,1.0986122886681098
compile,3,1.0986122886681098
convex,3,1.0986122886681098
Excellent,3,1.0986122886681098
parallels,3,1.0986122886681098
mLmin,3,1.0986122886681098
bottle,3,1.0986122886681098
trimer,3,1.0986122886681098
asynchronous,3,1.0986122886681098
Warfarin,3,1.0986122886681098
meditation,3,1.0986122886681098
reperfusionABSTRACT,3,1.0986122886681098
herniation,3,1.0986122886681098
vegetable,3,1.0986122886681098
Austrian,3,1.0986122886681098
mammal,3,1.0986122886681098
well-developed,3,1.0986122886681098
benefiting,3,1.0986122886681098
inhalative,3,1.0986122886681098
HITT,3,1.0986122886681098
CDC-based,3,1.0986122886681098
phagocytes,3,1.0986122886681098
Ninety-six,3,1.0986122886681098
constructive,3,1.0986122886681098
reinfections,3,1.0986122886681098
Genomic,3,1.0986122886681098
t-tests,3,1.0986122886681098
palate,3,1.0986122886681098
organizing,3,1.0986122886681098
semaphorin3E,3,1.0986122886681098
Community-acquired,3,1.0986122886681098
marine,3,1.0986122886681098
underpinned,3,1.0986122886681098
Hungary,3,1.0986122886681098
Decision,3,1.0986122886681098
Point-of-care,3,1.0986122886681098
POCTs,3,1.0986122886681098
shifting,3,1.0986122886681098
I223R,3,1.0986122886681098
Clin,3,1.0986122886681098
Guidelines-Stroke,3,1.0986122886681098
11-16,3,1.0986122886681098
repository,3,1.0986122886681098
mid-January,3,1.0986122886681098
intermediate-term,3,1.0986122886681098
sphingolipid,3,1.0986122886681098
arrangement,3,1.0986122886681098
spirometer,3,1.0986122886681098
instigated,3,1.0986122886681098
asymptomatics,3,1.0986122886681098
Betacoronavirus,3,1.0986122886681098
Kong3302001-like,3,1.0986122886681098
bid,3,1.0986122886681098
pulsus,3,1.0986122886681098
anosognosia,3,1.0986122886681098
Rituximab,3,1.0986122886681098
obstructions,3,1.0986122886681098
Moscow,3,1.0986122886681098
TVs,3,1.0986122886681098
disclosure,3,1.0986122886681098
TPE,3,1.0986122886681098
margins,3,1.0986122886681098
WWTP,3,1.0986122886681098
arsenal,3,1.0986122886681098
A2Hong,3,1.0986122886681098
neighbouring,3,1.0986122886681098
paradoxus,3,1.0986122886681098
neuropathological,3,1.0986122886681098
TPE-TR,3,1.0986122886681098
CNSLD,3,1.0986122886681098
ribonucleoprotein,3,1.0986122886681098
Reviewing,3,1.0986122886681098
palmitoleic,3,1.0986122886681098
Edward,3,1.0986122886681098
segregation,3,1.0986122886681098
flora,3,1.0986122886681098
50000,3,1.0986122886681098
ninth,3,1.0986122886681098
351,3,1.0986122886681098
FV,3,1.0986122886681098
Monte,3,1.0986122886681098
coinciding,3,1.0986122886681098
Bank,3,1.0986122886681098
dandruff,3,1.0986122886681098
Anticoagulants,3,1.0986122886681098
Antithrombotic,3,1.0986122886681098
2-3rd,3,1.0986122886681098
cilazapril,3,1.0986122886681098
25-hydroxyvitamin,3,1.0986122886681098
contraception,3,1.0986122886681098
Country,3,1.0986122886681098
explosive,3,1.0986122886681098
Tibet,3,1.0986122886681098
twenty-one,3,1.0986122886681098
trainees,3,1.0986122886681098
AF-unrelated,3,1.0986122886681098
EXE,3,1.0986122886681098
cocktails,3,1.0986122886681098
inter-,3,1.0986122886681098
infarcting,3,1.0986122886681098
reinfected,3,1.0986122886681098
antibody-mediated,3,1.0986122886681098
intensification,3,1.0986122886681098
overcomes,3,1.0986122886681098
metalloproteins,3,1.0986122886681098
eradicating,3,1.0986122886681098
agreements,3,1.0986122886681098
otolaryngologists,3,1.0986122886681098
investigative,3,1.0986122886681098
Clusters,3,1.0986122886681098
MBBA,3,1.0986122886681098
sterile,3,1.0986122886681098
ancillary,3,1.0986122886681098
Member,3,1.0986122886681098
pro-,3,1.0986122886681098
hypernatremia,3,1.0986122886681098
cross-talk,3,1.0986122886681098
non-immune,3,1.0986122886681098
Bland-Altman,3,1.0986122886681098
constituent,3,1.0986122886681098
polyprotein,3,1.0986122886681098
n19,3,1.0986122886681098
stringency,3,1.0986122886681098
prisons,3,1.0986122886681098
Hyperglycemia,3,1.0986122886681098
Gy,3,1.0986122886681098
milestones,3,1.0986122886681098
dissect,3,1.0986122886681098
ASCOD,3,1.0986122886681098
batch,3,1.0986122886681098
stretched,3,1.0986122886681098
WMI,3,1.0986122886681098
60-80,3,1.0986122886681098
Wake-Up,3,1.0986122886681098
mAb,3,1.0986122886681098
organisations,3,1.0986122886681098
post-conditioning,3,1.0986122886681098
Asian-Pacific,3,1.0986122886681098
infection-control,3,1.0986122886681098
dissected,3,1.0986122886681098
RBM,3,1.0986122886681098
Caledonia2099-like,3,1.0986122886681098
9-11,3,1.0986122886681098
initiates,3,1.0986122886681098
736,3,1.0986122886681098
inflammasome,3,1.0986122886681098
instructed,3,1.0986122886681098
systematized,3,1.0986122886681098
del,3,1.0986122886681098
Guidance,3,1.0986122886681098
peri-procedural,3,1.0986122886681098
hypopituitarism,3,1.0986122886681098
TN,3,1.0986122886681098
expectation,3,1.0986122886681098
wounds,3,1.0986122886681098
cp,3,1.0986122886681098
Munich,3,1.0986122886681098
GenBank,3,1.0986122886681098
Thirty-seven,3,1.0986122886681098
antiparasitic,3,1.0986122886681098
renders,3,1.0986122886681098
miR-488,3,1.0986122886681098
Useful,3,1.0986122886681098
supplying,3,1.0986122886681098
EC90,3,1.0986122886681098
stepped-wedge,3,1.0986122886681098
Refractory,3,1.0986122886681098
Encephalitis,3,1.0986122886681098
educators,3,1.0986122886681098
computer-assisted,3,1.0986122886681098
ImpellaCP,3,1.0986122886681098
grant,3,1.0986122886681098
IUml,3,1.0986122886681098
GOT,3,1.0986122886681098
oblongata,3,1.0986122886681098
barrel,3,1.0986122886681098
Kong168,3,1.0986122886681098
surrounds,3,1.0986122886681098
PSC,3,1.0986122886681098
endothelin,3,1.0986122886681098
Hyperacute,3,1.0986122886681098
Preventing,3,1.0986122886681098
Predictive,3,1.0986122886681098
licensure,3,1.0986122886681098
carnitine,3,1.0986122886681098
rs1800871,3,1.0986122886681098
Syndromes,3,1.0986122886681098
clinicopathological,3,1.0986122886681098
inoculum,3,1.0986122886681098
Standardised,3,1.0986122886681098
m2,3,1.0986122886681098
≥15,3,1.0986122886681098
standpoint,3,1.0986122886681098
medium-sized,3,1.0986122886681098
splanchnic,3,1.0986122886681098
albicans,3,1.0986122886681098
19181919,3,1.0986122886681098
H7N2,3,1.0986122886681098
seamlessly,3,1.0986122886681098
allopurinol,3,1.0986122886681098
radiology,3,1.0986122886681098
Voluntary,3,1.0986122886681098
amplitudes,3,1.0986122886681098
pathomechanisms,3,1.0986122886681098
naturopathy,3,1.0986122886681098
gonadotrophin-releasing,3,1.0986122886681098
garnered,3,1.0986122886681098
excessively,3,1.0986122886681098
cancerous,3,1.0986122886681098
anti-spike,3,1.0986122886681098
epicentre,3,1.0986122886681098
microarrays,3,1.0986122886681098
Australias,3,1.0986122886681098
1979-1980,3,1.0986122886681098
TX,3,1.0986122886681098
committees,3,1.0986122886681098
business,3,1.0986122886681098
signify,3,1.0986122886681098
professions,3,1.0986122886681098
ought,3,1.0986122886681098
276,3,1.0986122886681098
usable,3,1.0986122886681098
Candida,3,1.0986122886681098
IH,3,1.0986122886681098
Weighted,3,1.0986122886681098
Humoral,3,1.0986122886681098
Africans,3,1.0986122886681098
psychotherapy,3,1.0986122886681098
198990,3,1.0986122886681098
NaCl,3,1.0986122886681098
capsular,3,1.0986122886681098
paternal,3,1.0986122886681098
hypoparathyroidism,3,1.0986122886681098
Chi-square,3,1.0986122886681098
μgmL,3,1.0986122886681098
IPV,3,1.0986122886681098
embryonated,3,1.0986122886681098
penalty,3,1.0986122886681098
B-cells,3,1.0986122886681098
accompanies,3,1.0986122886681098
Families,3,1.0986122886681098
sulfonylurea,3,1.0986122886681098
Peter,3,1.0986122886681098
physiopathology,3,1.0986122886681098
242,3,1.0986122886681098
spot,3,1.0986122886681098
Span,3,1.0986122886681098
Intense,3,1.0986122886681098
ESC,3,1.0986122886681098
Laboratory-based,3,1.0986122886681098
Digit,3,1.0986122886681098
solar,3,1.0986122886681098
polymer,3,1.0986122886681098
esophagectomy,3,1.0986122886681098
intermingled,3,1.0986122886681098
papaverine,3,1.0986122886681098
707,3,1.0986122886681098
1964,3,1.0986122886681098
Exploration,3,1.0986122886681098
PImax,3,1.0986122886681098
067,3,1.0986122886681098
PEmax,3,1.0986122886681098
mimetics,3,1.0986122886681098
BMP,3,1.0986122886681098
paracetamol,3,1.0986122886681098
PIRA,3,1.0986122886681098
CIIS,3,1.0986122886681098
Antihypertensive,3,1.0986122886681098
enforced,3,1.0986122886681098
interferon-induced,3,1.0986122886681098
Problem,3,1.0986122886681098
oligonucleotide,3,1.0986122886681098
Syndromic,3,1.0986122886681098
BCAA,3,1.0986122886681098
particulates,3,1.0986122886681098
emissions,3,1.0986122886681098
SAT,3,1.0986122886681098
crepitations,3,1.0986122886681098
ataxic,3,1.0986122886681098
Tmprss2--,3,1.0986122886681098
nonpathogenic,3,1.0986122886681098
SGOT,3,1.0986122886681098
uninterpretable,3,1.0986122886681098
Carney,3,1.0986122886681098
convergent,3,1.0986122886681098
RAP,3,1.0986122886681098
human-to-animal,3,1.0986122886681098
pays,3,1.0986122886681098
A3,3,1.0986122886681098
AMoscow1099,3,1.0986122886681098
unstudied,3,1.0986122886681098
ICAS,3,1.0986122886681098
measurable,3,1.0986122886681098
obstetrical,3,1.0986122886681098
atomic,3,1.0986122886681098
glycan,3,1.0986122886681098
Stimulation,3,1.0986122886681098
enteroviruses,3,1.0986122886681098
influenza-like-illness,3,1.0986122886681098
JAKSTAT,3,1.0986122886681098
contention,3,1.0986122886681098
SHERLOCK,3,1.0986122886681098
murmur,3,1.0986122886681098
inadvertently,3,1.0986122886681098
ecology,3,1.0986122886681098
amp,3,1.0986122886681098
entail,3,1.0986122886681098
Sixty-nine,3,1.0986122886681098
Asthma-related,3,1.0986122886681098
1-,3,1.0986122886681098
RMZ,3,1.0986122886681098
quarters,3,1.0986122886681098
512,3,1.0986122886681098
abdomen,3,1.0986122886681098
fires,3,1.0986122886681098
nanobiosensors,3,1.0986122886681098
GSPECT,3,1.0986122886681098
bedroom,3,1.0986122886681098
remantadin,3,1.0986122886681098
Virological,3,1.0986122886681098
vaccae,3,1.0986122886681098
PCTs,3,1.0986122886681098
o,3,1.0986122886681098
nebulization,3,1.0986122886681098
occupy,3,1.0986122886681098
685,3,1.0986122886681098
overloading,3,1.0986122886681098
Severodvinsk,3,1.0986122886681098
appointments,3,1.0986122886681098
2012-2014,3,1.0986122886681098
PD35SGaw,3,1.0986122886681098
reemergence,3,1.0986122886681098
privileged,3,1.0986122886681098
Sacks,3,1.0986122886681098
neurodegeneration,3,1.0986122886681098
subsectors,3,1.0986122886681098
Involvement,3,1.0986122886681098
converge,3,1.0986122886681098
time-point,3,1.0986122886681098
NOD2,3,1.0986122886681098
missions,3,1.0986122886681098
systems-level,3,1.0986122886681098
Clara,3,1.0986122886681098
LKN,3,1.0986122886681098
unwitnessed,3,1.0986122886681098
responsibilities,3,1.0986122886681098
Susceptibility,3,1.0986122886681098
lagged,3,1.0986122886681098
PROM,3,1.0986122886681098
1996-1997,3,1.0986122886681098
induced-sputum,3,1.0986122886681098
MMF,3,1.0986122886681098
ray,3,1.0986122886681098
25-64,3,1.0986122886681098
oesophageal,3,1.0986122886681098
714,3,1.0986122886681098
FLU-v-specific,3,1.0986122886681098
EPA,3,1.0986122886681098
reminiscent,3,1.0986122886681098
goods,3,1.0986122886681098
sensation,3,1.0986122886681098
2-12,3,1.0986122886681098
CBV,3,1.0986122886681098
ice,3,1.0986122886681098
pons,3,1.0986122886681098
TLT,3,1.0986122886681098
subcostal,3,1.0986122886681098
seroreactivity,3,1.0986122886681098
aPL,3,1.0986122886681098
cryoinjury,3,1.0986122886681098
encapsulated,3,1.0986122886681098
campers,3,1.0986122886681098
teamwork,3,1.0986122886681098
two-component,3,1.0986122886681098
early-warning,3,1.0986122886681098
1ab,3,1.0986122886681098
sol-gel,3,1.0986122886681098
Forest,3,1.0986122886681098
metalloproteinase,3,1.0986122886681098
MRI-FT,3,1.0986122886681098
ICAD,3,1.0986122886681098
Triazavirin,3,1.0986122886681098
Years,3,1.0986122886681098
graduated,3,1.0986122886681098
lie,3,1.0986122886681098
8-11,3,1.0986122886681098
cross-reacting,3,1.0986122886681098
two-period,3,1.0986122886681098
12-18,3,1.0986122886681098
etiopathogenesis,3,1.0986122886681098
SCC,3,1.0986122886681098
psycho-social,3,1.0986122886681098
continuous-time,3,1.0986122886681098
pediatrician,3,1.0986122886681098
Coma,3,1.0986122886681098
desire,3,1.0986122886681098
fiscal,3,1.0986122886681098
bulk,3,1.0986122886681098
nitroblue,3,1.0986122886681098
A57,3,1.0986122886681098
TestNorm,3,1.0986122886681098
noisy,3,1.0986122886681098
mint,3,1.0986122886681098
paroxystic,3,1.0986122886681098
BoNTA,3,1.0986122886681098
LC,3,1.0986122886681098
e-learning,3,1.0986122886681098
EHRs,3,1.0986122886681098
T2-MAP,3,1.0986122886681098
signal-to-noise,3,1.0986122886681098
foremost,3,1.0986122886681098
16S,3,1.0986122886681098
MEF,3,1.0986122886681098
pulmonologist,3,1.0986122886681098
PFTs,3,1.0986122886681098
Energy,3,1.0986122886681098
596,3,1.0986122886681098
min-1,3,1.0986122886681098
GIST,3,1.0986122886681098
p0004,3,1.0986122886681098
Ref,3,1.0986122886681098
ADL,3,1.0986122886681098
spend,3,1.0986122886681098
T2-mapping,3,1.0986122886681098
T1-mapping,3,1.0986122886681098
futile,3,1.0986122886681098
responsivness,3,1.0986122886681098
Catalonia,3,1.0986122886681098
journey,3,1.0986122886681098
coast,3,1.0986122886681098
M-mode,3,1.0986122886681098
Clopidogrel,3,1.0986122886681098
dextromethorphan,3,1.0986122886681098
034,3,1.0986122886681098
Demographics,3,1.0986122886681098
terns,3,1.0986122886681098
docking-based,3,1.0986122886681098
Consider,3,1.0986122886681098
electroporation,3,1.0986122886681098
frustrations,3,1.0986122886681098
587,3,1.0986122886681098
EUSI,3,1.0986122886681098
audible,3,1.0986122886681098
Observation,3,1.0986122886681098
Bengal,3,1.0986122886681098
Societies,3,1.0986122886681098
Vitros,3,1.0986122886681098
intersex,3,1.0986122886681098
Plans,3,1.0986122886681098
Efficiency,3,1.0986122886681098
visualisation,3,1.0986122886681098
cholera,3,1.0986122886681098
SGM,3,1.0986122886681098
INSIGHT,3,1.0986122886681098
safeguard,3,1.0986122886681098
sample-specific,3,1.0986122886681098
CRVs,3,1.0986122886681098
suicide,3,1.0986122886681098
gender-specific,3,1.0986122886681098
Attention,3,1.0986122886681098
tDCS,3,1.0986122886681098
14-year-old,3,1.0986122886681098
tonsillitis,3,1.0986122886681098
unsuccessfully,3,1.0986122886681098
ankle,3,1.0986122886681098
gastrocnemius,3,1.0986122886681098
≥18,3,1.0986122886681098
epistemological,3,1.0986122886681098
player,3,1.0986122886681098
481,3,1.0986122886681098
manipulations,3,1.0986122886681098
placebo-TENS,3,1.0986122886681098
FL,3,1.0986122886681098
generalize,3,1.0986122886681098
450000,3,1.0986122886681098
incapable,3,1.0986122886681098
AH3N2v,3,1.0986122886681098
circulations,3,1.0986122886681098
H1N2,3,1.0986122886681098
478,3,1.0986122886681098
campuses,3,1.0986122886681098
Nitric,3,1.0986122886681098
transaminase,3,1.0986122886681098
tHcy,3,1.0986122886681098
goodness,3,1.0986122886681098
epi-aortic,3,1.0986122886681098
ageusia,3,1.0986122886681098
MTM,3,1.0986122886681098
peri-operative,3,1.0986122886681098
K18-hACE2,3,1.0986122886681098
326,3,1.0986122886681098
brains,3,1.0986122886681098
grave,3,1.0986122886681098
beneficially,3,1.0986122886681098
multiplexed,3,1.0986122886681098
popularity,3,1.0986122886681098
near-patient,3,1.0986122886681098
cytoprotective,3,1.0986122886681098
orthomyxoviruses,3,1.0986122886681098
trans-complementation,3,1.0986122886681098
EC,3,1.0986122886681098
matters,3,1.0986122886681098
operator,3,1.0986122886681098
homogeneity,3,1.0986122886681098
complement-fixation,3,1.0986122886681098
Biomonitoring,3,1.0986122886681098
TripleLock,3,1.0986122886681098
752,3,1.0986122886681098
Pleural,3,1.0986122886681098
anti-ischaemic,3,1.0986122886681098
Variation,3,1.0986122886681098
harder,3,1.0986122886681098
avert,3,1.0986122886681098
MFEIT,3,1.0986122886681098
isoproterenol-induced,3,1.0986122886681098
Yearly,3,1.0986122886681098
Verbal,3,1.0986122886681098
streamline,3,1.0986122886681098
UCB,3,1.0986122886681098
pertain,3,1.0986122886681098
586,3,1.0986122886681098
authorisation,3,1.0986122886681098
vehicle-treated,3,1.0986122886681098
ports,3,1.0986122886681098
flap,3,1.0986122886681098
allergist,3,1.0986122886681098
Tropical,3,1.0986122886681098
ASD,3,1.0986122886681098
exertional,3,1.0986122886681098
constrictive,3,1.0986122886681098
broadening,3,1.0986122886681098
poisoning,3,1.0986122886681098
obscured,3,1.0986122886681098
JNK,3,1.0986122886681098
30-69,3,1.0986122886681098
Towards,3,1.0986122886681098
ellátási,3,1.0986122886681098
aktívfekvőbeteg-szakellátás,3,1.0986122886681098
Dox-,3,1.0986122886681098
adenoma,3,1.0986122886681098
p38,3,1.0986122886681098
heath,3,1.0986122886681098
Modification,3,1.0986122886681098
weighed,3,1.0986122886681098
Concern,3,1.0986122886681098
JAK,3,1.0986122886681098
hemiplegic,3,1.0986122886681098
salvianolic,3,1.0986122886681098
sectioned,3,1.0986122886681098
medulla,3,1.0986122886681098
frightening,3,1.0986122886681098
EDL,3,1.0986122886681098
astounding,3,1.0986122886681098
telemetry,3,1.0986122886681098
revising,3,1.0986122886681098
pharmacotherapies,3,1.0986122886681098
compassionate,3,1.0986122886681098
crosses,3,1.0986122886681098
Parallel,3,1.0986122886681098
mutagenic,3,1.0986122886681098
NSA,3,1.0986122886681098
annotation,3,1.0986122886681098
frustrating,3,1.0986122886681098
Passive,3,1.0986122886681098
Immunosenescence,3,1.0986122886681098
immunogen,3,1.0986122886681098
correctable,3,1.0986122886681098
musculoskeletal,3,1.0986122886681098
OTV-resistant,3,1.0986122886681098
heveny,3,1.0986122886681098
orchestrated,3,1.0986122886681098
categorization,3,1.0986122886681098
valamint,3,1.0986122886681098
informational,3,1.0986122886681098
conserving,3,1.0986122886681098
high-level,3,1.0986122886681098
posttraumatic,3,1.0986122886681098
0015,3,1.0986122886681098
banks,3,1.0986122886681098
GPIIbIIIa,3,1.0986122886681098
mid-,3,1.0986122886681098
sacrifice,3,1.0986122886681098
three-month,3,1.0986122886681098
COLD,3,1.0986122886681098
keystone,3,1.0986122886681098
races,3,1.0986122886681098
200001,3,1.0986122886681098
RBP4,3,1.0986122886681098
abruptly,3,1.0986122886681098
biphasic,3,1.0986122886681098
Preventions,3,1.0986122886681098
reappraisal,3,1.0986122886681098
HDM-driven,3,1.0986122886681098
0125,3,1.0986122886681098
psychosis,3,1.0986122886681098
374,3,1.0986122886681098
tissue-derived,3,1.0986122886681098
pros,3,1.0986122886681098
cons,3,1.0986122886681098
Pool,3,1.0986122886681098
youngster,3,1.0986122886681098
fibrofatty,3,1.0986122886681098
LTA,3,1.0986122886681098
Harvard,3,1.0986122886681098
friend,3,1.0986122886681098
trinitrate,3,1.0986122886681098
degranulation,3,1.0986122886681098
glyceryl,3,1.0986122886681098
LHospitalet,3,1.0986122886681098
921,3,1.0986122886681098
Onset,3,1.0986122886681098
hippocampal,3,1.0986122886681098
synthesised,3,1.0986122886681098
ECRHS,3,1.0986122886681098
YHPG,3,1.0986122886681098
Medication,3,1.0986122886681098
granule,3,1.0986122886681098
Glial,3,1.0986122886681098
affiliated,3,1.0986122886681098
fruits,3,1.0986122886681098
MMF-treated,3,1.0986122886681098
SGTF,3,1.0986122886681098
youngsters,3,1.0986122886681098
studys,3,1.0986122886681098
story,3,1.0986122886681098
Pigs,3,1.0986122886681098
Abstracts,3,1.0986122886681098
repurpose,3,1.0986122886681098
Facilities,3,1.0986122886681098
Maintenance,3,1.0986122886681098
853,3,1.0986122886681098
griffithsin,3,1.0986122886681098
dilemma,3,1.0986122886681098
Typically,3,1.0986122886681098
cut-offs,3,1.0986122886681098
impaction,3,1.0986122886681098
Organ,3,1.0986122886681098
philosophy,3,1.0986122886681098
passenger,3,1.0986122886681098
362,3,1.0986122886681098
Policies,3,1.0986122886681098
SalivaAll,3,1.0986122886681098
XS,3,1.0986122886681098
airline,3,1.0986122886681098
erythroid,3,1.0986122886681098
family-centered,3,1.0986122886681098
collections,3,1.0986122886681098
homogenization,3,1.0986122886681098
superficial,3,1.0986122886681098
hemosorption,3,1.0986122886681098
Betacoronaviruses,3,1.0986122886681098
eminent,3,1.0986122886681098
ranking,3,1.0986122886681098
streams,3,1.0986122886681098
focussing,3,1.0986122886681098
-1,3,1.0986122886681098
bronchoscopic,3,1.0986122886681098
Swabs,3,1.0986122886681098
Tulsa,3,1.0986122886681098
lateralized,3,1.0986122886681098
revascularized,3,1.0986122886681098
standardizing,3,1.0986122886681098
FluNet,3,1.0986122886681098
checking,3,1.0986122886681098
PMT,3,1.0986122886681098
727,3,1.0986122886681098
2000s,3,1.0986122886681098
tape,3,1.0986122886681098
nigra,3,1.0986122886681098
counted,3,1.0986122886681098
abstracts,3,1.0986122886681098
Renal,3,1.0986122886681098
torso,3,1.0986122886681098
stroke-unit,3,1.0986122886681098
909,3,1.0986122886681098
Binding,3,1.0986122886681098
pneumocytes,3,1.0986122886681098
extra-pulmonary,3,1.0986122886681098
cell-surface,3,1.0986122886681098
26-year-old,3,1.0986122886681098
satisfied,3,1.0986122886681098
flaws,3,1.0986122886681098
μm,3,1.0986122886681098
Arrhythmias,3,1.0986122886681098
1010,3,1.0986122886681098
Hospital-based,3,1.0986122886681098
fluorescence-based,3,1.0986122886681098
non-eosinophilic,3,1.0986122886681098
Circadian,3,1.0986122886681098
hAOs,3,1.0986122886681098
BVictoria287,3,1.0986122886681098
caspase,3,1.0986122886681098
incur,3,1.0986122886681098
rinses,3,1.0986122886681098
Balloon,3,1.0986122886681098
owners,3,1.0986122886681098
562,3,1.0986122886681098
832,3,1.0986122886681098
losartan,3,1.0986122886681098
Shock,3,1.0986122886681098
likewise,3,1.0986122886681098
RBC,3,1.0986122886681098
questionnaire-based,3,1.0986122886681098
TRPM2,3,1.0986122886681098
RRs,3,1.0986122886681098
2001-02,3,1.0986122886681098
speculation,3,1.0986122886681098
Procedural,3,1.0986122886681098
942,3,1.0986122886681098
PARG,3,1.0986122886681098
AOntario12522007,3,1.0986122886681098
Meta-analyses,3,1.0986122886681098
intakes,3,1.0986122886681098
629,3,1.0986122886681098
placebo-treated,3,1.0986122886681098
cumulated,3,1.0986122886681098
missense,3,1.0986122886681098
Minor,3,1.0986122886681098
taxonomy,3,1.0986122886681098
Elevation,3,1.0986122886681098
EDCs,3,1.0986122886681098
CT6,3,1.0986122886681098
genotypephenotype,3,1.0986122886681098
connect,3,1.0986122886681098
ECG-gated,3,1.0986122886681098
open-source,3,1.0986122886681098
profiled,3,1.0986122886681098
V-lineage,3,1.0986122886681098
retina,3,1.0986122886681098
replacements,3,1.0986122886681098
norepinephrine,3,1.0986122886681098
CT17,3,1.0986122886681098
chips,3,1.0986122886681098
IFR,3,1.0986122886681098
NDs,3,1.0986122886681098
hamster,3,1.0986122886681098
homing,3,1.0986122886681098
uncomfortable,3,1.0986122886681098
perpetuate,3,1.0986122886681098
self-collection,3,1.0986122886681098
comfortable,3,1.0986122886681098
down-regulation,3,1.0986122886681098
vacuum,3,1.0986122886681098
fascicular,3,1.0986122886681098
resting-state,3,1.0986122886681098
super,3,1.0986122886681098
ciliary,3,1.0986122886681098
pneumonitis,3,1.0986122886681098
PRNT90,3,1.0986122886681098
loose,3,1.0986122886681098
secular,3,1.0986122886681098
pan-coronavirus,3,1.0986122886681098
abstracted,3,1.0986122886681098
low-amplitude,3,1.0986122886681098
sneeze,3,1.0986122886681098
PAGER-CoV,3,1.0986122886681098
fountains,3,1.0986122886681098
Chief,3,1.0986122886681098
90000,3,1.0986122886681098
spectrometer,3,1.0986122886681098
mins,3,1.0986122886681098
urea,3,1.0986122886681098
hand-held,3,1.0986122886681098
ADCD-P,3,1.0986122886681098
abrogate,3,1.0986122886681098
Ipratropium,3,1.0986122886681098
Cromolyn,3,1.0986122886681098
Broad,3,1.0986122886681098
AST,3,1.0986122886681098
genuine,3,1.0986122886681098
Match,3,1.0986122886681098
POPs,3,1.0986122886681098
builds,3,1.0986122886681098
DNB,3,1.0986122886681098
bore,3,1.0986122886681098
polycythaemia,3,1.0986122886681098
predisease,3,1.0986122886681098
ACE-inhibitors,3,1.0986122886681098
Immunity,3,1.0986122886681098
tubular,3,1.0986122886681098
VITROS,3,1.0986122886681098
mid-February,3,1.0986122886681098
supposedly,3,1.0986122886681098
Seoul,3,1.0986122886681098
injury-induced,3,1.0986122886681098
103-122,3,1.0986122886681098
listening,3,1.0986122886681098
test-positive,3,1.0986122886681098
compensated,3,1.0986122886681098
bursts,3,1.0986122886681098
virus-like,3,1.0986122886681098
cast,3,1.0986122886681098
Theory,3,1.0986122886681098
Low-income,3,1.0986122886681098
1968-69,3,1.0986122886681098
aeruginosa,3,1.0986122886681098
vagus,3,1.0986122886681098
mildest,3,1.0986122886681098
890,3,1.0986122886681098
spectrogram,3,1.0986122886681098
1349,3,1.0986122886681098
constitutional,3,1.0986122886681098
superinfection,3,1.0986122886681098
tracheas,3,1.0986122886681098
luciferase,3,1.0986122886681098
improper,3,1.0986122886681098
1972-73,3,1.0986122886681098
self-control,3,1.0986122886681098
intrahospital,3,1.0986122886681098
curricula,3,1.0986122886681098
Prognostic,3,1.0986122886681098
Angiotensin,3,1.0986122886681098
DEI,3,1.0986122886681098
Dobutamine,3,1.0986122886681098
vizsgált,3,1.0986122886681098
Tsp45I,3,1.0986122886681098
Notice,3,1.0986122886681098
Winter,3,1.0986122886681098
1788,3,1.0986122886681098
Cath,3,1.0986122886681098
time-sensitive,3,1.0986122886681098
PHAC,3,1.0986122886681098
T‑cell,3,1.0986122886681098
LTs,3,1.0986122886681098
intermediates,3,1.0986122886681098
cysteinyl,3,1.0986122886681098
CysLTs,3,1.0986122886681098
683,3,1.0986122886681098
Predominant,3,1.0986122886681098
G9,3,1.0986122886681098
End,3,1.0986122886681098
Taxonomy,3,1.0986122886681098
entailing,3,1.0986122886681098
dimethylarginine,3,1.0986122886681098
YouTube,3,1.0986122886681098
Disease-19,3,1.0986122886681098
demographically,3,1.0986122886681098
Danshen,3,1.0986122886681098
RFN,3,1.0986122886681098
Wild,3,1.0986122886681098
repolarisation,3,1.0986122886681098
colonization,3,1.0986122886681098
Head,3,1.0986122886681098
ceased,3,1.0986122886681098
wheezed,3,1.0986122886681098
CTs,3,1.0986122886681098
acidification,3,1.0986122886681098
time-related,3,1.0986122886681098
unrealistic,3,1.0986122886681098
Infants,3,1.0986122886681098
sanitizing,3,1.0986122886681098
sedation,3,1.0986122886681098
localised,3,1.0986122886681098
Integrative,3,1.0986122886681098
culminated,3,1.0986122886681098
ambivalence,3,1.0986122886681098
query,3,1.0986122886681098
kUL,3,1.0986122886681098
Hypotension,3,1.0986122886681098
cleaners,3,1.0986122886681098
HEPA,3,1.0986122886681098
mLh,3,1.0986122886681098
coagulative,3,1.0986122886681098
venovenous,3,1.0986122886681098
KAMIR,3,1.0986122886681098
oppression,3,1.0986122886681098
mentoring,3,1.0986122886681098
communicators,3,1.0986122886681098
Bangladeshi,3,1.0986122886681098
violations,3,1.0986122886681098
MS023,3,1.0986122886681098
intelligent,3,1.0986122886681098
physicochemical,3,1.0986122886681098
bacteriology,3,1.0986122886681098
momentary,3,1.0986122886681098
stemming,3,1.0986122886681098
domain-containing,3,1.0986122886681098
late-type,3,1.0986122886681098
wheal,3,1.0986122886681098
bacillus,3,1.0986122886681098
613,3,1.0986122886681098
one-vessel,3,1.0986122886681098
genders,3,1.0986122886681098
PRMT,3,1.0986122886681098
wastes,3,1.0986122886681098
cytokine-mediated,3,1.0986122886681098
1918-20,3,1.0986122886681098
Manual,3,1.0986122886681098
horizons,3,1.0986122886681098
intimately,3,1.0986122886681098
weekend,3,1.0986122886681098
R95,3,1.0986122886681098
CrI,3,1.0986122886681098
plenty,3,1.0986122886681098
795,3,1.0986122886681098
Targeting,3,1.0986122886681098
arteriosclerotic,3,1.0986122886681098
sterilization,3,1.0986122886681098
haploidentical,3,1.0986122886681098
incorrectly,3,1.0986122886681098
2014-15,3,1.0986122886681098
gone,3,1.0986122886681098
stenosed,3,1.0986122886681098
CAR-T,3,1.0986122886681098
saphenous,3,1.0986122886681098
thiobarbituric,3,1.0986122886681098
conjugation,3,1.0986122886681098
octogenarians,3,1.0986122886681098
informatics,3,1.0986122886681098
Modeling,3,1.0986122886681098
QIVs,3,1.0986122886681098
96-well,3,1.0986122886681098
Updated,3,1.0986122886681098
NCIT,3,1.0986122886681098
third-party,3,1.0986122886681098
Set,3,1.0986122886681098
politicians,3,1.0986122886681098
861,3,1.0986122886681098
reuse,3,1.0986122886681098
FFRs,3,1.0986122886681098
Biosafety,3,1.0986122886681098
Level,3,1.0986122886681098
LEAD,3,1.0986122886681098
or1,3,1.0986122886681098
deposits,3,1.0986122886681098
retraining,3,1.0986122886681098
permeation,3,1.0986122886681098
Zagreb,3,1.0986122886681098
Otitis,3,1.0986122886681098
Loop,3,1.0986122886681098
RT-fLAMP,3,1.0986122886681098
Connections,3,1.0986122886681098
REGEN-COV,3,1.0986122886681098
201TI,3,1.0986122886681098
99mTc-glucarate,3,1.0986122886681098
safest,3,1.0986122886681098
1962,3,1.0986122886681098
da,3,1.0986122886681098
Targets,3,1.0986122886681098
Cessation,3,1.0986122886681098
amnesia,3,1.0986122886681098
POBA,3,1.0986122886681098
provincial,3,1.0986122886681098
primersprobe,3,1.0986122886681098
Harlem,3,1.0986122886681098
Ninth,3,1.0986122886681098
bounds,3,1.0986122886681098
followup,3,1.0986122886681098
433,3,1.0986122886681098
compounded,3,1.0986122886681098
1142,3,1.0986122886681098
Leukotriene,3,1.0986122886681098
B4,3,1.0986122886681098
asbestos,3,1.0986122886681098
Caspian,3,1.0986122886681098
quantitation,3,1.0986122886681098
sub-score,3,1.0986122886681098
Collateral,3,1.0986122886681098
transitioning,3,1.0986122886681098
constellation,3,1.0986122886681098
930,3,1.0986122886681098
early-,3,1.0986122886681098
0800,3,1.0986122886681098
PFT,3,1.0986122886681098
pc-ASPECTS,3,1.0986122886681098
lymphadenectomy,3,1.0986122886681098
radiofrequency,3,1.0986122886681098
first-onset,3,1.0986122886681098
IVs,3,1.0986122886681098
mm3,3,1.0986122886681098
Sandy,3,1.0986122886681098
retains,3,1.0986122886681098
sonography,3,1.0986122886681098
μL,3,1.0986122886681098
810,3,1.0986122886681098
elite,3,1.0986122886681098
4-8,3,1.0986122886681098
eGLIA,3,1.0986122886681098
48h,3,1.0986122886681098
attaining,3,1.0986122886681098
dating,3,1.0986122886681098
parturients,3,1.0986122886681098
Fecal,3,1.0986122886681098
stenotic,3,1.0986122886681098
Conservative,3,1.0986122886681098
ESO,3,1.0986122886681098
contrast-enhanced,3,1.0986122886681098
473,3,1.0986122886681098
SARS-like,3,1.0986122886681098
648,3,1.0986122886681098
Age-adjusted,3,1.0986122886681098
immigrant,3,1.0986122886681098
Lodz,3,1.0986122886681098
consumable,3,1.0986122886681098
drip,3,1.0986122886681098
Characteristic,3,1.0986122886681098
TND-IVE,3,1.0986122886681098
sustainability,3,1.0986122886681098
overstated,3,1.0986122886681098
964,3,1.0986122886681098
719,3,1.0986122886681098
Neurosurgery,3,1.0986122886681098
submit,3,1.0986122886681098
Value,3,1.0986122886681098
16-year-old,3,1.0986122886681098
Kuwait,3,1.0986122886681098
Wastewater-based,3,1.0986122886681098
COVID-,3,1.0986122886681098
loratadine,3,1.0986122886681098
TTP,3,1.0986122886681098
chlorination,3,1.0986122886681098
PGD2,3,1.0986122886681098
RADS,3,1.0986122886681098
EMV,3,1.0986122886681098
Cyprus,3,1.0986122886681098
nem,3,1.0986122886681098
copiesL,3,1.0986122886681098
multilayer,3,1.0986122886681098
Regiszter,3,1.0986122886681098
spikes,3,1.0986122886681098
18-month,3,1.0986122886681098
underappreciated,3,1.0986122886681098
chord,3,1.0986122886681098
K417N,3,1.0986122886681098
pemphigoid,3,1.0986122886681098
abolish,3,1.0986122886681098
hemichorea-hemiballism,3,1.0986122886681098
supersite,3,1.0986122886681098
postinfectious,3,1.0986122886681098
coincide,3,1.0986122886681098
túlélés,3,1.0986122886681098
microspheres,3,1.0986122886681098
transmodal,3,1.0986122886681098
277,3,1.0986122886681098
multipurpose,3,1.0986122886681098
asthma-predictive,3,1.0986122886681098
Nutrition,3,1.0986122886681098
glycogen,3,1.0986122886681098
KNa,3,1.0986122886681098
trade-offs,3,1.0986122886681098
OACs,3,1.0986122886681098
glycosides,3,1.0986122886681098
Å,3,1.0986122886681098
THE,3,1.0986122886681098
sample-to-answer,3,1.0986122886681098
µgmL,3,1.0986122886681098
990,3,1.0986122886681098
personally,3,1.0986122886681098
45th,3,1.0986122886681098
≥14,3,1.0986122886681098
solicited,3,1.0986122886681098
pneumophila,3,1.0986122886681098
united,3,1.0986122886681098
SARS-CoV-,3,1.0986122886681098
etexilate,3,1.0986122886681098
α-26-sialic,3,1.0986122886681098
643,3,1.0986122886681098
anti-IV,3,1.0986122886681098
WAPs,3,1.0986122886681098
systemically,3,1.0986122886681098
Berardinelli-Seip,3,1.0986122886681098
lipodystrophy,3,1.0986122886681098
Legionella,3,1.0986122886681098
iatrogenic,3,1.0986122886681098
Midwest,3,1.0986122886681098
influenza-negative,3,1.0986122886681098
Connecticut,3,1.0986122886681098
EQA,3,1.0986122886681098
semiquantitative,3,1.0986122886681098
stressor,3,1.0986122886681098
payer,3,1.0986122886681098
Chimeric,3,1.0986122886681098
6-7,3,1.0986122886681098
Összefoglaló,3,1.0986122886681098
ose-S,3,1.0986122886681098
919,3,1.0986122886681098
payment,3,1.0986122886681098
receptivity,3,1.0986122886681098
CIND,3,1.0986122886681098
preschoolers,3,1.0986122886681098
endoscopically,3,1.0986122886681098
mold,3,1.0986122886681098
brain-damaged,3,1.0986122886681098
co-occur,3,1.0986122886681098
DSC-PWI,3,1.0986122886681098
487,3,1.0986122886681098
turkeys,3,1.0986122886681098
MgSO4,3,1.0986122886681098
sweeping,3,1.0986122886681098
unconcentrated,3,1.0986122886681098
antileukotriene,3,1.0986122886681098
ad,3,1.0986122886681098
Informed,3,1.0986122886681098
tetanus,3,1.0986122886681098
non-response,3,1.0986122886681098
CD163high,3,1.0986122886681098
paths,3,1.0986122886681098
Neuroimaging,3,1.0986122886681098
revisited,3,1.0986122886681098
within-,3,1.0986122886681098
Pandemics,3,1.0986122886681098
inefficient,3,1.0986122886681098
microgL,3,1.0986122886681098
accumulates,3,1.0986122886681098
Valencia,3,1.0986122886681098
Acinetobacter,3,1.0986122886681098
four-month,3,1.0986122886681098
neuroradiology,3,1.0986122886681098
phone,3,1.0986122886681098
912,3,1.0986122886681098
POS,3,1.0986122886681098
station,3,1.0986122886681098
PERC6,3,1.0986122886681098
TDM,3,1.0986122886681098
DWI-FLAIR,3,1.0986122886681098
POMS,3,1.0986122886681098
multiplexing,3,1.0986122886681098
Beside,3,1.0986122886681098
ANOVA,3,1.0986122886681098
CRISPR-augmented,3,1.0986122886681098
sensitively,3,1.0986122886681098
Biosensor,3,1.0986122886681098
992,3,1.0986122886681098
HispanicsLatinos,3,1.0986122886681098
anticytokine,3,1.0986122886681098
experimentation,3,1.0986122886681098
1005,3,1.0986122886681098
Resources,3,1.0986122886681098
preprint,3,1.0986122886681098
BI,3,1.0986122886681098
Immunoglobulin,3,1.0986122886681098
dysphagic,3,1.0986122886681098
L194P,3,1.0986122886681098
swab-negative,3,1.0986122886681098
endocytosis,3,1.0986122886681098
à,3,1.0986122886681098
AmericansBlacks,3,1.0986122886681098
high-use,3,1.0986122886681098
Orthomyxoviridae,3,1.0986122886681098
496,3,1.0986122886681098
in-silico,3,1.0986122886681098
treatment-subgroup,3,1.0986122886681098
dysphasia,3,1.0986122886681098
scarring,3,1.0986122886681098
open-ended,3,1.0986122886681098
≥10,3,1.0986122886681098
surface-enhanced,3,1.0986122886681098
Raman,3,1.0986122886681098
underdeveloped,3,1.0986122886681098
reflective,3,1.0986122886681098
expCFR,3,1.0986122886681098
enjoyed,3,1.0986122886681098
534,3,1.0986122886681098
characteristically,3,1.0986122886681098
PFUmL,3,1.0986122886681098
self-expanding,3,1.0986122886681098
Suspected,3,1.0986122886681098
FURIN,3,1.0986122886681098
infarct-avid,3,1.0986122886681098
coronaries,3,1.0986122886681098
fetuin,3,1.0986122886681098
preoccupation,3,1.0986122886681098
metadata,3,1.0986122886681098
high-prevalence,3,1.0986122886681098
Mood,3,1.0986122886681098
IBAE,3,1.0986122886681098
31-year-old,3,1.0986122886681098
caesarean,3,1.0986122886681098
passes,3,1.0986122886681098
wheezes,3,1.0986122886681098
casualty,3,1.0986122886681098
inaugural,3,1.0986122886681098
8-14,3,1.0986122886681098
betablocker,3,1.0986122886681098
nonparticipation,3,1.0986122886681098
Paso,3,1.0986122886681098
Focusing,3,1.0986122886681098
diuresis,3,1.0986122886681098
76-year-old,3,1.0986122886681098
5-8,3,1.0986122886681098
nonstenotic,3,1.0986122886681098
leverages,3,1.0986122886681098
gadolinium-DTPA,3,1.0986122886681098
montelukast,3,1.0986122886681098
English-speaking,3,1.0986122886681098
Meteorological,3,1.0986122886681098
nomogram,3,1.0986122886681098
bed-1,3,1.0986122886681098
encephalomyelitis,3,1.0986122886681098
morphine,3,1.0986122886681098
day-1,3,1.0986122886681098
approaching,3,1.0986122886681098
mid-March,3,1.0986122886681098
industrialization,3,1.0986122886681098
≤5,3,1.0986122886681098
LoS,3,1.0986122886681098
3200,3,1.0986122886681098
rashes,3,1.0986122886681098
serotype,3,1.0986122886681098
mid-expiratory,3,1.0986122886681098
curtail,3,1.0986122886681098
underscored,3,1.0986122886681098
Isothermal,3,1.0986122886681098
recessive,3,1.0986122886681098
triaged,3,1.0986122886681098
inappropriately,3,1.0986122886681098
maybe,3,1.0986122886681098
tablets,3,1.0986122886681098
telemonitoring,3,1.0986122886681098
nondiabetic,3,1.0986122886681098
CVC,3,1.0986122886681098
Indiana,3,1.0986122886681098
microgramsmin,3,1.0986122886681098
noninfectious,3,1.0986122886681098
triglycerides,3,1.0986122886681098
491,3,1.0986122886681098
syndrome，,3,1.0986122886681098
urged,3,1.0986122886681098
Dysregulation,3,1.0986122886681098
comparability,3,1.0986122886681098
Southeastern,3,1.0986122886681098
untimely,3,1.0986122886681098
businesses,3,1.0986122886681098
fluorogenic,3,1.0986122886681098
non-receptor,3,1.0986122886681098
Qi,3,1.0986122886681098
Jordan,3,1.0986122886681098
peer-led,3,1.0986122886681098
uLTE4,3,1.0986122886681098
ASMarea,3,1.0986122886681098
PaO2,3,1.0986122886681098
mild-moderate,3,1.0986122886681098
aminotransferase,3,1.0986122886681098
772,3,1.0986122886681098
things,3,1.0986122886681098
orofacial,3,1.0986122886681098
scale-free,3,1.0986122886681098
hypochrloridemia,3,1.0986122886681098
Dubai,3,1.0986122886681098
hyperchrloridemia,3,1.0986122886681098
intend,3,1.0986122886681098
Framework,3,1.0986122886681098
14th,3,1.0986122886681098
Plasmapheresis,3,1.0986122886681098
averting,3,1.0986122886681098
irreversibly,3,1.0986122886681098
Consortium,3,1.0986122886681098
LAVs,3,1.0986122886681098
Deployment,3,1.0986122886681098
Insufficient,3,1.0986122886681098
washings,3,1.0986122886681098
certificate,3,1.0986122886681098
Faculty,3,1.0986122886681098
Fabry,3,1.0986122886681098
n23,3,1.0986122886681098
Histamine,3,1.0986122886681098
pill,3,1.0986122886681098
365,3,1.0986122886681098
ivermectin,3,1.0986122886681098
756,3,1.0986122886681098
ISDs,3,1.0986122886681098
vertebrates,3,1.0986122886681098
request,3,1.0986122886681098
assuring,3,1.0986122886681098
accentuated,3,1.0986122886681098
Sodium,3,1.0986122886681098
reformulated,3,1.0986122886681098
200506,3,1.0986122886681098
cPass,3,1.0986122886681098
proton,3,1.0986122886681098
EtOH,3,1.0986122886681098
Daylight,3,1.0986122886681098
undernutrition,3,1.0986122886681098
tetravalent,3,1.0986122886681098
Problems,3,1.0986122886681098
wearers,3,1.0986122886681098
accrue,3,1.0986122886681098
platelet-rich,3,1.0986122886681098
respects,3,1.0986122886681098
Urinary,3,1.0986122886681098
CRPs,3,1.0986122886681098
Defense,3,1.0986122886681098
CNPs,3,1.0986122886681098
Muslim,3,1.0986122886681098
CLIA,3,1.0986122886681098
unopsonized,3,1.0986122886681098
urogenital,3,1.0986122886681098
LABA,3,1.0986122886681098
hospital-related,3,1.0986122886681098
cross-country,3,1.0986122886681098
nowadays,3,1.0986122886681098
arose,3,1.0986122886681098
Starting,3,1.0986122886681098
CHC,3,1.0986122886681098
hHIT,3,1.0986122886681098
voivodeship,3,1.0986122886681098
CoVID-19,3,1.0986122886681098
post-training,3,1.0986122886681098
hyperemia,3,1.0986122886681098
brachial,3,1.0986122886681098
866,3,1.0986122886681098
someone,3,1.0986122886681098
Subclinical,3,1.0986122886681098
Yazd,3,1.0986122886681098
357,3,1.0986122886681098
nonselective,3,1.0986122886681098
meaningfully,3,1.0986122886681098
Multicentre,3,1.0986122886681098
arena,3,1.0986122886681098
twenty-eight,3,1.0986122886681098
hsa-miR-1307-3p,3,1.0986122886681098
echo-planar,3,1.0986122886681098
predecessors,3,1.0986122886681098
Undergoing,3,1.0986122886681098
Adolescent,3,1.0986122886681098
machinery,3,1.0986122886681098
Spinal,3,1.0986122886681098
coexistent,3,1.0986122886681098
741,3,1.0986122886681098
Psychogenic,3,1.0986122886681098
second-generation,3,1.0986122886681098
impetus,3,1.0986122886681098
breastfeed,3,1.0986122886681098
milestone,3,1.0986122886681098
n5,3,1.0986122886681098
flights,3,1.0986122886681098
436,3,1.0986122886681098
self-esteem,3,1.0986122886681098
athletic,3,1.0986122886681098
VKAs,3,1.0986122886681098
Gansu,3,1.0986122886681098
Midwestern,3,1.0986122886681098
15-year-old,3,1.0986122886681098
crew,3,1.0986122886681098
drug-delivery,3,1.0986122886681098
jaw,3,1.0986122886681098
collagenous,3,1.0986122886681098
RE-LY,3,1.0986122886681098
Anticoagulant,3,1.0986122886681098
halogenated,3,1.0986122886681098
benzoyl,3,1.0986122886681098
cMCAO,3,1.0986122886681098
Dabigatran,3,1.0986122886681098
n10,3,1.0986122886681098
motivates,3,1.0986122886681098
acenocoumarol,3,1.0986122886681098
pre-determined,3,1.0986122886681098
CCS,3,1.0986122886681098
TLR6,3,1.0986122886681098
perturbance,3,1.0986122886681098
Coupled,3,1.0986122886681098
Provocation,3,1.0986122886681098
organizes,3,1.0986122886681098
privacy,3,1.0986122886681098
intratracheal,3,1.0986122886681098
Omnibus,3,1.0986122886681098
unfamiliar,3,1.0986122886681098
Spring,3,1.0986122886681098
cerebrum,3,1.0986122886681098
Arabian,3,1.0986122886681098
homolog,3,1.0986122886681098
Amazon,3,1.0986122886681098
HE,3,1.0986122886681098
rhetorics,3,1.0986122886681098
valuation,3,1.0986122886681098
life-years,3,1.0986122886681098
mobilized,3,1.0986122886681098
pristimerin,3,1.0986122886681098
INO-4800,3,1.0986122886681098
coli,3,1.0986122886681098
pull,3,1.0986122886681098
sleeping,3,1.0986122886681098
684,3,1.0986122886681098
LVFP,3,1.0986122886681098
671,3,1.0986122886681098
membrane-bound,3,1.0986122886681098
8-9,3,1.0986122886681098
stridor,3,1.0986122886681098
781,3,1.0986122886681098
in-group,3,1.0986122886681098
polyclinical,3,1.0986122886681098
imprecise,3,1.0986122886681098
halted,3,1.0986122886681098
time-varying,3,1.0986122886681098
Grippovak,3,1.0986122886681098
Basigin,3,1.0986122886681098
646,3,1.0986122886681098
r-TPA,3,1.0986122886681098
coreceptor,3,1.0986122886681098
μ,3,1.0986122886681098
re-emergence,3,1.0986122886681098
othering,3,1.0986122886681098
CD14,3,1.0986122886681098
AcHERV-HA,3,1.0986122886681098
group-specific,3,1.0986122886681098
AMCAS,3,1.0986122886681098
MCAS,3,1.0986122886681098
vaccinee,3,1.0986122886681098
interferon-γ,3,1.0986122886681098
Pulsed,3,1.0986122886681098
integrin,3,1.0986122886681098
steroid-resistant,3,1.0986122886681098
549,3,1.0986122886681098
morbidities,3,1.0986122886681098
tracheobronchial,3,1.0986122886681098
77-year-old,3,1.0986122886681098
recapitulate,3,1.0986122886681098
ILK-MSCs,3,1.0986122886681098
ΔNIHSS,3,1.0986122886681098
222GN,3,1.0986122886681098
RBB,3,1.0986122886681098
asymmetry,3,1.0986122886681098
NHLBI,3,1.0986122886681098
Sinus,3,1.0986122886681098
redundant,3,1.0986122886681098
SARS-coronavirus,3,1.0986122886681098
Fluzone,3,1.0986122886681098
portability,3,1.0986122886681098
enormously,3,1.0986122886681098
disinfectants,3,1.0986122886681098
STEMI-betegek,3,1.0986122886681098
osmotic,3,1.0986122886681098
Policy,3,1.0986122886681098
radioactivity,3,1.0986122886681098
Dublin,3,1.0986122886681098
Kelet-Magyarország,3,1.0986122886681098
Dakar,3,1.0986122886681098
splitting,3,1.0986122886681098
mid-October,3,1.0986122886681098
upto,3,1.0986122886681098
ICP,3,1.0986122886681098
spirit,3,1.0986122886681098
hypertrophic,3,1.0986122886681098
AH1N109,3,1.0986122886681098
GSTs,3,1.0986122886681098
IVNC,3,1.0986122886681098
plateaued,3,1.0986122886681098
epicardium,3,1.0986122886681098
cation,3,1.0986122886681098
0042,3,1.0986122886681098
colitis,3,1.0986122886681098
Loefflers,3,1.0986122886681098
HES,3,1.0986122886681098
probiotics,3,1.0986122886681098
hypomagnesemia,3,1.0986122886681098
Seropositivity,3,1.0986122886681098
OSEs,3,1.0986122886681098
laws,3,1.0986122886681098
push,3,1.0986122886681098
excavatum,3,1.0986122886681098
ECI,3,1.0986122886681098
devising,3,1.0986122886681098
cage,3,1.0986122886681098
ISIS,3,1.0986122886681098
warm,3,1.0986122886681098
sarcoidosis,3,1.0986122886681098
stereotypes,3,1.0986122886681098
disturb,3,1.0986122886681098
colder,3,1.0986122886681098
Transcatheter,3,1.0986122886681098
accredited,3,1.0986122886681098
surely,3,1.0986122886681098
Binfluenza,3,1.0986122886681098
SPME,3,1.0986122886681098
bladder,3,1.0986122886681098
self-stereotypes,3,1.0986122886681098
KEY,3,1.0986122886681098
AssociationAmerican,3,1.0986122886681098
purity,3,1.0986122886681098
peribronchiolar,3,1.0986122886681098
high-intensity,3,1.0986122886681098
LLC,3,1.0986122886681098
scratch,3,1.0986122886681098
post-COVID-19,3,1.0986122886681098
subtype-specific,3,1.0986122886681098
pelvic,3,1.0986122886681098
attractor,3,1.0986122886681098
conceived,3,1.0986122886681098
6-year-old,3,1.0986122886681098
city-level,3,1.0986122886681098
outflow,3,1.0986122886681098
roots,3,1.0986122886681098
intervening,3,1.0986122886681098
cytopathology,3,1.0986122886681098
offline,3,1.0986122886681098
Alzheimers,3,1.0986122886681098
hydroxyl,3,1.0986122886681098
DFSA,3,1.0986122886681098
5-,3,1.0986122886681098
0022,3,1.0986122886681098
three-quarters,3,1.0986122886681098
hypnotic,3,1.0986122886681098
elasticity,3,1.0986122886681098
exhalation,3,1.0986122886681098
endorsing,3,1.0986122886681098
antisense,3,1.0986122886681098
pharma,3,1.0986122886681098
post-menopausal,3,1.0986122886681098
Perceived,3,1.0986122886681098
everything,3,1.0986122886681098
avian-like,3,1.0986122886681098
peritoneal,3,1.0986122886681098
preclinically,3,1.0986122886681098
classrooms,3,1.0986122886681098
257,3,1.0986122886681098
periodontal,3,1.0986122886681098
time-efficient,3,1.0986122886681098
ebony,3,1.0986122886681098
Intradermal,3,1.0986122886681098
Clear,3,1.0986122886681098
treatment-related,3,1.0986122886681098
species-specific,3,1.0986122886681098
paramedical,3,1.0986122886681098
retail,3,1.0986122886681098
undocumented,3,1.0986122886681098
CFRs,3,1.0986122886681098
800000,3,1.0986122886681098
MONICA,3,1.0986122886681098
aminophylline,3,1.0986122886681098
hibernating,3,1.0986122886681098
chi,3,1.0986122886681098
insurers,3,1.0986122886681098
heterogeneities,3,1.0986122886681098
6-15,3,1.0986122886681098
x-ray,3,1.0986122886681098
lecture,3,1.0986122886681098
deferred,3,1.0986122886681098
spiked,3,1.0986122886681098
House,3,1.0986122886681098
Governments,3,1.0986122886681098
tenfold,3,1.0986122886681098
rough,3,1.0986122886681098
338,3,1.0986122886681098
RBCs,3,1.0986122886681098
B6-CH1-RBD,3,1.0986122886681098
dichotomous,3,1.0986122886681098
intraventricular,3,1.0986122886681098
coaching,3,1.0986122886681098
Games,3,1.0986122886681098
inanimate,3,1.0986122886681098
806,3,1.0986122886681098
CINAHL,3,1.0986122886681098
intracutaneous,3,1.0986122886681098
1100,3,1.0986122886681098
myeloperoxidase,3,1.0986122886681098
BDP,3,1.0986122886681098
784,3,1.0986122886681098
neurotoxin,3,1.0986122886681098
526,3,1.0986122886681098
proximate,3,1.0986122886681098
yeast,3,1.0986122886681098
Confirmatory,3,1.0986122886681098
coastal,3,1.0986122886681098
Belief,3,1.0986122886681098
pre-exercise,3,1.0986122886681098
reparative,3,1.0986122886681098
March-June,3,1.0986122886681098
COVID-19s,3,1.0986122886681098
férfiak,3,1.0986122886681098
immunoregulatory,3,1.0986122886681098
graphical,3,1.0986122886681098
smallest,3,1.0986122886681098
S-myoglobin,3,1.0986122886681098
normalize,3,1.0986122886681098
log,3,1.0986122886681098
discontinuation,3,1.0986122886681098
meantime,3,1.0986122886681098
probit,3,1.0986122886681098
Ul,3,1.0986122886681098
1322,3,1.0986122886681098
amphetamine,3,1.0986122886681098
coldflu,3,1.0986122886681098
Diet,3,1.0986122886681098
Application,3,1.0986122886681098
18-59,3,1.0986122886681098
Bird,3,1.0986122886681098
disequilibrium,3,1.0986122886681098
Doctors,3,1.0986122886681098
immunizing,3,1.0986122886681098
download,3,1.0986122886681098
protein-ligand,3,1.0986122886681098
prostaglandins,3,1.0986122886681098
succumb,3,1.0986122886681098
allosteric,3,1.0986122886681098
primed,3,1.0986122886681098
thrombocytopaenia,3,1.0986122886681098
VMX,3,1.0986122886681098
harsh,3,1.0986122886681098
gauge,3,1.0986122886681098
emergently,3,1.0986122886681098
gateway,3,1.0986122886681098
Allplex™,3,1.0986122886681098
swH1N1,3,1.0986122886681098
rubber,3,1.0986122886681098
burials,3,1.0986122886681098
inaccuracies,3,1.0986122886681098
actin,3,1.0986122886681098
Variable,3,1.0986122886681098
reflexes,3,1.0986122886681098
CHQ,3,1.0986122886681098
constraint,3,1.0986122886681098
B1617,3,1.0986122886681098
RdRPE,3,1.0986122886681098
exams,3,1.0986122886681098
gram,3,1.0986122886681098
conflict,3,1.0986122886681098
Porto,3,1.0986122886681098
Update,3,1.0986122886681098
OBJECTIVE,3,1.0986122886681098
toxicants,3,1.0986122886681098
thrombolitic,3,1.0986122886681098
akinetic-dyskinetic,3,1.0986122886681098
IL-22,3,1.0986122886681098
consensus-negative,3,1.0986122886681098
infero-posterior,3,1.0986122886681098
EPCs,3,1.0986122886681098
resolves,3,1.0986122886681098
fungus,3,1.0986122886681098
Ratchaburi,3,1.0986122886681098
insolation,3,1.0986122886681098
spinothalamic,3,1.0986122886681098
Oasys,3,1.0986122886681098
heterosexual,3,1.0986122886681098
transventricular,3,1.0986122886681098
Days,3,1.0986122886681098
flawed,3,1.0986122886681098
overarching,3,1.0986122886681098
epitope-based,3,1.0986122886681098
hsTn,3,1.0986122886681098
MCOs,3,1.0986122886681098
Borg,3,1.0986122886681098
hydrochloric,3,1.0986122886681098
utero,3,1.0986122886681098
1998-1999,3,1.0986122886681098
345,3,1.0986122886681098
lavages,3,1.0986122886681098
LVEDV,3,1.0986122886681098
Janeiro,3,1.0986122886681098
neurotic,3,1.0986122886681098
≥70,3,1.0986122886681098
Yalta,3,1.0986122886681098
embodied,3,1.0986122886681098
falsely,3,1.0986122886681098
unhoused,3,1.0986122886681098
him,3,1.0986122886681098
linkages,3,1.0986122886681098
Paramedics,3,1.0986122886681098
Induced,3,1.0986122886681098
449,3,1.0986122886681098
Montelukast,3,1.0986122886681098
2-agonist,3,1.0986122886681098
Bindu,3,1.0986122886681098
reintegration,3,1.0986122886681098
ethanol,3,1.0986122886681098
Amrita,3,1.0986122886681098
silver,3,1.0986122886681098
Prime,3,1.0986122886681098
Plasminogen,3,1.0986122886681098
pink,3,1.0986122886681098
excitotoxicity,3,1.0986122886681098
smear,3,1.0986122886681098
439,3,1.0986122886681098
Stalin,3,1.0986122886681098
Just,3,1.0986122886681098
astrogliosis,3,1.0986122886681098
638,3,1.0986122886681098
Orange,3,1.0986122886681098
Ninety-five,3,1.0986122886681098
hypodensity,3,1.0986122886681098
phytochemicals,3,1.0986122886681098
1980-1981,3,1.0986122886681098
IRR,3,1.0986122886681098
Living,3,1.0986122886681098
post-first,3,1.0986122886681098
IRAT,3,1.0986122886681098
COV,3,1.0986122886681098
jail,3,1.0986122886681098
Tool,3,1.0986122886681098
sticker,3,1.0986122886681098
insecticides,3,1.0986122886681098
264,3,1.0986122886681098
835,3,1.0986122886681098
22-month-old,3,1.0986122886681098
coating,3,1.0986122886681098
mismanagement,3,1.0986122886681098
Meeting,3,1.0986122886681098
primate,3,1.0986122886681098
Shortening,3,1.0986122886681098
Thai,3,1.0986122886681098
Washington,3,1.0986122886681098
82-year-old,3,1.0986122886681098
notching,3,1.0986122886681098
dark,3,1.0986122886681098
internet-based,3,1.0986122886681098
departure,3,1.0986122886681098
immune-related,3,1.0986122886681098
planes,3,1.0986122886681098
polypeptide,3,1.0986122886681098
stabilizing,3,1.0986122886681098
Fosun,3,1.0986122886681098
WGS,3,1.0986122886681098
conspicuous,3,1.0986122886681098
couples,3,1.0986122886681098
repositories,3,1.0986122886681098
subfertile,3,1.0986122886681098
RNAi-based,3,1.0986122886681098
636,3,1.0986122886681098
Containing,3,1.0986122886681098
MCVs,3,1.0986122886681098
non-sentinel,3,1.0986122886681098
wastewater-based,3,1.0986122886681098
virus-laden,3,1.0986122886681098
discernible,3,1.0986122886681098
TATs,3,1.0986122886681098
toll-like,3,1.0986122886681098
Issues,3,1.0986122886681098
TRUPCR,3,1.0986122886681098
reformulation,3,1.0986122886681098
crosstalk,3,1.0986122886681098
congress,3,1.0986122886681098
00007,3,1.0986122886681098
Rather,3,1.0986122886681098
neuroinvasion,3,1.0986122886681098
pH1N12009,3,1.0986122886681098
hygiene-related,3,1.0986122886681098
unsafe,3,1.0986122886681098
woods,3,1.0986122886681098
Umbria,3,1.0986122886681098
Employers,3,1.0986122886681098
heritable,3,1.0986122886681098
fulfil,3,1.0986122886681098
fragmentation,3,1.0986122886681098
coincident,3,1.0986122886681098
Robust,3,1.0986122886681098
autophagic,3,1.0986122886681098
sacs,3,1.0986122886681098
nadir,3,1.0986122886681098
Sputnik,3,1.0986122886681098
attitudinal,3,1.0986122886681098
FOV,3,1.0986122886681098
transiently,3,1.0986122886681098
thrombocytopenic,3,1.0986122886681098
Robert,3,1.0986122886681098
Neonatal,3,1.0986122886681098
observing,3,1.0986122886681098
Needs,3,1.0986122886681098
reshaping,3,1.0986122886681098
24h,3,1.0986122886681098
20192020,3,1.0986122886681098
OCT,3,1.0986122886681098
Frankfurt,3,1.0986122886681098
cloning,3,1.0986122886681098
Virtual,3,1.0986122886681098
Koch,3,1.0986122886681098
infero-apico-septal,3,1.0986122886681098
BCI,3,1.0986122886681098
artifacts,3,1.0986122886681098
board,3,1.0986122886681098
minigenome,3,1.0986122886681098
483,3,1.0986122886681098
DOE,3,1.0986122886681098
Sexual,3,1.0986122886681098
solid-liquid,3,1.0986122886681098
Intrinsic,3,1.0986122886681098
tb,3,1.0986122886681098
FAST,3,1.0986122886681098
TT,3,1.0986122886681098
KTA,3,1.0986122886681098
INR,3,1.0986122886681098
MarchApril,3,1.0986122886681098
Luminex,3,1.0986122886681098
aquatic,3,1.0986122886681098
Number,3,1.0986122886681098
appraise,3,1.0986122886681098
infero-apical,3,1.0986122886681098
4-year-old,3,1.0986122886681098
DIT,3,1.0986122886681098
Growing,3,1.0986122886681098
560,3,1.0986122886681098
RT-PCR-confirmed,3,1.0986122886681098
618,3,1.0986122886681098
Arrhythmia,3,1.0986122886681098
514,3,1.0986122886681098
antigen-specific,3,1.0986122886681098
DPSO,3,1.0986122886681098
Concurrent,3,1.0986122886681098
TGF-b,3,1.0986122886681098
25HC,3,1.0986122886681098
976,3,1.0986122886681098
hypovolemia,3,1.0986122886681098
CRISPR-Cas12aCrRNA,3,1.0986122886681098
debatable,3,1.0986122886681098
Brugada,3,1.0986122886681098
joints,3,1.0986122886681098
probiotic,3,1.0986122886681098
seeded,3,1.0986122886681098
erythrocytic,3,1.0986122886681098
Trunk,3,1.0986122886681098
Pseudomonas,3,1.0986122886681098
Glutathione,3,1.0986122886681098
premenopausal,3,1.0986122886681098
1422,3,1.0986122886681098
volunteer,3,1.0986122886681098
reopened,3,1.0986122886681098
6-14,3,1.0986122886681098
Sources,3,1.0986122886681098
dreaming,3,1.0986122886681098
perceivers,3,1.0986122886681098
iAVS,3,1.0986122886681098
sampler,3,1.0986122886681098
TOP,3,1.0986122886681098
749,3,1.0986122886681098
Islander,3,1.0986122886681098
COVID-19-infected,3,1.0986122886681098
G1,3,1.0986122886681098
Validation,3,1.0986122886681098
Klebsiella,3,1.0986122886681098
XX,3,1.0986122886681098
RT-MCDA,3,1.0986122886681098
meanwhile,3,1.0986122886681098
menstruation,3,1.0986122886681098
≥75,3,1.0986122886681098
deciphered,3,1.0986122886681098
substantiated,3,1.0986122886681098
electrophysiology,3,1.0986122886681098
multimodality,3,1.0986122886681098
lipid-lowering,3,1.0986122886681098
platelet-activating,3,1.0986122886681098
863,3,1.0986122886681098
455,3,1.0986122886681098
semester,3,1.0986122886681098
uncommonly,3,1.0986122886681098
GSK,3,1.0986122886681098
524,3,1.0986122886681098
remediation,3,1.0986122886681098
reticulum,3,1.0986122886681098
Austria,3,1.0986122886681098
SCI,3,1.0986122886681098
lithium,3,1.0986122886681098
dyes,3,1.0986122886681098
mesothelial,3,1.0986122886681098
-7,3,1.0986122886681098
Romed,3,1.0986122886681098
counteracting,3,1.0986122886681098
hygienic,3,1.0986122886681098
caudal,3,1.0986122886681098
reclassification,3,1.0986122886681098
carbachol,3,1.0986122886681098
Capoten,3,1.0986122886681098
RPS3,3,1.0986122886681098
CC16,3,1.0986122886681098
colon,3,1.0986122886681098
Ad-null,3,1.0986122886681098
Portuguese,3,1.0986122886681098
tegmentum,3,1.0986122886681098
decompression,3,1.0986122886681098
vison,3,1.0986122886681098
Neutrophil,3,1.0986122886681098
non-corticosteroids,3,1.0986122886681098
multiple-organ,3,1.0986122886681098
B1128,3,1.0986122886681098
1920,3,1.0986122886681098
rotational,3,1.0986122886681098
nomenclature,3,1.0986122886681098
neovascularization,3,1.0986122886681098
Manaus,3,1.0986122886681098
workshops,3,1.0986122886681098
intraplaque,3,1.0986122886681098
928,3,1.0986122886681098
LDG,3,1.0986122886681098
LHI,3,1.0986122886681098
cadavers,3,1.0986122886681098
fasciitis,3,1.0986122886681098
Maintaining,3,1.0986122886681098
hamming,3,1.0986122886681098
Eligible,3,1.0986122886681098
illustrating,3,1.0986122886681098
Trivalent,3,1.0986122886681098
inert,3,1.0986122886681098
Metoprolol,3,1.0986122886681098
HMO,3,1.0986122886681098
R-R,3,1.0986122886681098
PACS,3,1.0986122886681098
nonsustained,3,1.0986122886681098
Eosinophils,3,1.0986122886681098
Saxony,3,1.0986122886681098
AIMI,3,1.0986122886681098
mean-field,3,1.0986122886681098
429,3,1.0986122886681098
transyears,3,1.0986122886681098
embryos,3,1.0986122886681098
bizarre,3,1.0986122886681098
mycosis,3,1.0986122886681098
thromboses,3,1.0986122886681098
urticariaangioedema,3,1.0986122886681098
RBD-hFc,3,1.0986122886681098
non-paretic,3,1.0986122886681098
Limitations,3,1.0986122886681098
troublesome,3,1.0986122886681098
567,3,1.0986122886681098
oligosaccharides,3,1.0986122886681098
Sex-specific,3,1.0986122886681098
922,3,1.0986122886681098
hydrolysis,3,1.0986122886681098
concise,3,1.0986122886681098
under-treated,3,1.0986122886681098
Behavioural,3,1.0986122886681098
Pharmaceutical,3,1.0986122886681098
Neutralization,3,1.0986122886681098
Blue,3,1.0986122886681098
Wseg,3,1.0986122886681098
transferrin,3,1.0986122886681098
RM,3,1.0986122886681098
N-methyl-D-aspartate,3,1.0986122886681098
glycine,3,1.0986122886681098
NCDs,3,1.0986122886681098
0400,3,1.0986122886681098
realities,3,1.0986122886681098
solving,3,1.0986122886681098
403,3,1.0986122886681098
556,3,1.0986122886681098
Coverdell,3,1.0986122886681098
place-based,3,1.0986122886681098
vapor,3,1.0986122886681098
Mex09-S,3,1.0986122886681098
fibrates,3,1.0986122886681098
shell,3,1.0986122886681098
DOACs,3,1.0986122886681098
galactose,3,1.0986122886681098
Advice,3,1.0986122886681098
pharmacogenomics,3,1.0986122886681098
overlying,3,1.0986122886681098
long-distance,3,1.0986122886681098
480,3,1.0986122886681098
trading,3,1.0986122886681098
Rigorous,3,1.0986122886681098
bipartite,3,1.0986122886681098
interactome,3,1.0986122886681098
IHS,3,1.0986122886681098
centrally,3,1.0986122886681098
20092010,3,1.0986122886681098
710,3,1.0986122886681098
Uptake,3,1.0986122886681098
interactors,3,1.0986122886681098
approached,3,1.0986122886681098
cellsml,3,1.0986122886681098
obstetricians,3,1.0986122886681098
cholecystectomy,3,1.0986122886681098
pneumologists,3,1.0986122886681098
vectorcardiograms,3,1.0986122886681098
tablet,3,1.0986122886681098
PI3Ks,3,1.0986122886681098
64-year-old,3,1.0986122886681098
auspices,3,1.0986122886681098
nanomedicine,3,1.0986122886681098
NAC,3,1.0986122886681098
peptidase,3,1.0986122886681098
distantly,3,1.0986122886681098
frailty,3,1.0986122886681098
proprietary,3,1.0986122886681098
near-real-time,3,1.0986122886681098
PHOFS,3,1.0986122886681098
non-PHOFS,3,1.0986122886681098
prostanoid,3,1.0986122886681098
≥6,3,1.0986122886681098
ambivalent,3,1.0986122886681098
CEAs,3,1.0986122886681098
1752,3,1.0986122886681098
polytetrafluoroethylene,3,1.0986122886681098
anesthesiologists,3,1.0986122886681098
catheters,3,1.0986122886681098
topographic,3,1.0986122886681098
bloods,3,1.0986122886681098
PQ,3,1.0986122886681098
housed,3,1.0986122886681098
antispastic,3,1.0986122886681098
700000,3,1.0986122886681098
IC50,3,1.0986122886681098
unfolds,3,1.0986122886681098
polyethylene,3,1.0986122886681098
left-side,3,1.0986122886681098
flowmetry,3,1.0986122886681098
shadow,3,1.0986122886681098
prethrombolytic,3,1.0986122886681098
sE-selectin,3,1.0986122886681098
6-week,3,1.0986122886681098
bradyarrhythmia,3,1.0986122886681098
strenuous,3,1.0986122886681098
Others,3,1.0986122886681098
Extending,3,1.0986122886681098
envisioned,3,1.0986122886681098
January-March,3,1.0986122886681098
Thirty-day,3,1.0986122886681098
oligosaccharide,3,1.0986122886681098
nCOV-19,3,1.0986122886681098
pointing,3,1.0986122886681098
dysgeusia,3,1.0986122886681098
Age-matched,3,1.0986122886681098
tMCAO,3,1.0986122886681098
DPS,3,1.0986122886681098
subsamples,3,1.0986122886681098
484,3,1.0986122886681098
Moderate,3,1.0986122886681098
BS,3,1.0986122886681098
Fc,3,1.0986122886681098
talking,3,1.0986122886681098
pertains,3,1.0986122886681098
antiischemic,3,1.0986122886681098
Inferior,3,1.0986122886681098
posted,3,1.0986122886681098
Overlap,3,1.0986122886681098
GPIbalpha,3,1.0986122886681098
bout,3,1.0986122886681098
ES,3,1.0986122886681098
intersection,3,1.0986122886681098
Balance,3,1.0986122886681098
assortativity,3,1.0986122886681098
checkpoint,3,1.0986122886681098
pheochromocytoma,3,1.0986122886681098
silencing,3,1.0986122886681098
Houston,3,1.0986122886681098
PCRs,3,1.0986122886681098
suspension,3,1.0986122886681098
chemoprophylactic,3,1.0986122886681098
987,3,1.0986122886681098
J-point,3,1.0986122886681098
EBV,3,1.0986122886681098
post-contrast,3,1.0986122886681098
691,3,1.0986122886681098
457,3,1.0986122886681098
non-hemodialyzed,3,1.0986122886681098
subgenome,3,1.0986122886681098
Beginning,3,1.0986122886681098
breastmilk,3,1.0986122886681098
sIgA,3,1.0986122886681098
proving,3,1.0986122886681098
SIA,3,1.0986122886681098
wildfires,3,1.0986122886681098
Thirty-nine,3,1.0986122886681098
constitution,3,1.0986122886681098
confabulation,3,1.0986122886681098
pairing,3,1.0986122886681098
Mechanistically,3,1.0986122886681098
osmolality,3,1.0986122886681098
cytomegalovirus,3,1.0986122886681098
flower,3,1.0986122886681098
formazan,3,1.0986122886681098
SNAP1,3,1.0986122886681098
FH,3,1.0986122886681098
Low-level,3,1.0986122886681098
SIVs,3,1.0986122886681098
5C,3,1.0986122886681098
Preschool,3,1.0986122886681098
DPOS,3,1.0986122886681098
sub-optimal,3,1.0986122886681098
fees,3,1.0986122886681098
antero-lateral,3,1.0986122886681098
Parent,3,1.0986122886681098
rescinding,3,1.0986122886681098
peribronchial,3,1.0986122886681098
Zymo,3,1.0986122886681098
10-4,3,1.0986122886681098
streamlined,3,1.0986122886681098
decipher,3,1.0986122886681098
triglyceride,3,1.0986122886681098
drug-drug,3,1.0986122886681098
periodontitis,3,1.0986122886681098
gL,3,1.0986122886681098
Closure,3,1.0986122886681098
O3,3,1.0986122886681098
Samsun,3,1.0986122886681098
Sea,3,1.0986122886681098
pages,3,1.0986122886681098
upregulating,3,1.0986122886681098
commonalities,3,1.0986122886681098
sex-ratio,3,1.0986122886681098
2007-2008,3,1.0986122886681098
molecular-based,3,1.0986122886681098
TNFα,3,1.0986122886681098
FCFA,3,1.0986122886681098
cohesion,3,1.0986122886681098
macrolide,3,1.0986122886681098
Tl201,3,1.0986122886681098
EUROS,3,1.0986122886681098
la,3,1.0986122886681098
obliterans,3,1.0986122886681098
counter-pulsation,3,1.0986122886681098
Krasnodar,3,1.0986122886681098
Thermo,3,1.0986122886681098
cancelled,3,1.0986122886681098
kcalmol,3,1.0986122886681098
RDTs,3,1.0986122886681098
739,3,1.0986122886681098
recoil,3,1.0986122886681098
multiplied,3,1.0986122886681098
antimicrobials,3,1.0986122886681098
CP®,3,1.0986122886681098
hypothermic,3,1.0986122886681098
542,3,1.0986122886681098
dermatomyositis,3,1.0986122886681098
time-lags,3,1.0986122886681098
Thallium,3,1.0986122886681098
extinct,3,1.0986122886681098
Signs,3,1.0986122886681098
30000,3,1.0986122886681098
hardship,3,1.0986122886681098
designation,3,1.0986122886681098
van,3,1.0986122886681098
gastro-esophageal,3,1.0986122886681098
355,3,1.0986122886681098
Change,3,1.0986122886681098
unpublished,3,1.0986122886681098
penumbral,3,1.0986122886681098
cup,3,1.0986122886681098
ultra-early,3,1.0986122886681098
holding,3,1.0986122886681098
509,3,1.0986122886681098
december,3,1.0986122886681098
2053,3,1.0986122886681098
unveil,3,1.0986122886681098
Madagascar,3,1.0986122886681098
restores,3,1.0986122886681098
scarcely,3,1.0986122886681098
survivability,3,1.0986122886681098
broadband,3,1.0986122886681098
ref,3,1.0986122886681098
vesicular,3,1.0986122886681098
CCBs,3,1.0986122886681098
pedagogical,3,1.0986122886681098
709,3,1.0986122886681098
unclassified,3,1.0986122886681098
8-10,3,1.0986122886681098
neuritis,3,1.0986122886681098
vaccine-associated,3,1.0986122886681098
1931,3,1.0986122886681098
appetite,3,1.0986122886681098
Innovations,3,1.0986122886681098
prothrombin,3,1.0986122886681098
Urban,3,1.0986122886681098
subscales,3,1.0986122886681098
percentiles,3,1.0986122886681098
evidenced-based,3,1.0986122886681098
Palermo,3,1.0986122886681098
NIRS,3,1.0986122886681098
extensions,3,1.0986122886681098
nodule,3,1.0986122886681098
Denver,3,1.0986122886681098
gastroenteritis,3,1.0986122886681098
Cx,3,1.0986122886681098
IRDTs,3,1.0986122886681098
Corticosteroid,3,1.0986122886681098
circulates,3,1.0986122886681098
dual-track,3,1.0986122886681098
pursue,3,1.0986122886681098
A-H3N2,3,1.0986122886681098
posttransplant,3,1.0986122886681098
GMTs,3,1.0986122886681098
ALMS1,3,1.0986122886681098
32-year-old,3,1.0986122886681098
human-human,3,1.0986122886681098
PRP,3,1.0986122886681098
0-14,3,1.0986122886681098
coffeegreen,3,1.0986122886681098
ball,3,1.0986122886681098
aerodynamic,3,1.0986122886681098
enthusiasm,3,1.0986122886681098
analyzers,3,1.0986122886681098
dietdietary,3,1.0986122886681098
2005-2008,3,1.0986122886681098
551,3,1.0986122886681098
maxima,3,1.0986122886681098
287,3,1.0986122886681098
201617,3,1.0986122886681098
drank,3,1.0986122886681098
nNOS,3,1.0986122886681098
reproductive-aged,3,1.0986122886681098
MMP9,3,1.0986122886681098
Totally,3,1.0986122886681098
alternation,3,1.0986122886681098
680,3,1.0986122886681098
80-90,3,1.0986122886681098
resected,3,1.0986122886681098
Object,3,1.0986122886681098
hampers,3,1.0986122886681098
676,3,1.0986122886681098
rarer,3,1.0986122886681098
Larger,3,1.0986122886681098
non-corticosteroid,3,1.0986122886681098
P002,3,1.0986122886681098
by-pass,3,1.0986122886681098
antianginal,3,1.0986122886681098
unwilling,3,1.0986122886681098
non-diabetics,3,1.0986122886681098
post-MCAo,3,1.0986122886681098
RAC1,3,1.0986122886681098
CCR1,3,1.0986122886681098
Northeast,3,1.0986122886681098
CCR10,3,1.0986122886681098
non-hospitalized,3,1.0986122886681098
CSF3R,3,1.0986122886681098
prohibition,3,1.0986122886681098
WIR,3,1.0986122886681098
Corresponding,3,1.0986122886681098
Antiarrhythmic,3,1.0986122886681098
compulsory,3,1.0986122886681098
non-compliance,3,1.0986122886681098
schooling,3,1.0986122886681098
guideline-recommended,3,1.0986122886681098
overtreatment,3,1.0986122886681098
purines,3,1.0986122886681098
angiotensin-converting-enzyme,3,1.0986122886681098
bodyweight,3,1.0986122886681098
FVH,3,1.0986122886681098
Increase,3,1.0986122886681098
VO2max,3,1.0986122886681098
1035,3,1.0986122886681098
self-sampling,3,1.0986122886681098
judgement,3,1.0986122886681098
achievable,3,1.0986122886681098
reassure,3,1.0986122886681098
cardioprotection,3,1.0986122886681098
Basel,3,1.0986122886681098
histochemical,3,1.0986122886681098
E-gene,3,1.0986122886681098
microaspiration,3,1.0986122886681098
ATP,3,1.0986122886681098
foregoing,3,1.0986122886681098
Exclusion,3,1.0986122886681098
TH1,3,1.0986122886681098
HCoV-NL63,3,1.0986122886681098
nineteen,3,1.0986122886681098
Mouse,3,1.0986122886681098
cardio-respiratory,3,1.0986122886681098
urges,3,1.0986122886681098
avenue,3,1.0986122886681098
cardioverted,3,1.0986122886681098
MLS,3,1.0986122886681098
exit,3,1.0986122886681098
in-stent,3,1.0986122886681098
Sub-Saharan,3,1.0986122886681098
non-governmental,3,1.0986122886681098
URI,3,1.0986122886681098
grass-pollen,3,1.0986122886681098
transcendental,3,1.0986122886681098
decompensated,3,1.0986122886681098
Anaphylaxis,3,1.0986122886681098
non-experimental,3,1.0986122886681098
EDI,3,1.0986122886681098
Section,3,1.0986122886681098
NFA,3,1.0986122886681098
VIII,3,1.0986122886681098
non-pregnant,3,1.0986122886681098
symptom-to-door,3,1.0986122886681098
November-December,3,1.0986122886681098
fifteen,3,1.0986122886681098
imposing,3,1.0986122886681098
Biological,3,1.0986122886681098
3-7,3,1.0986122886681098
havoc,3,1.0986122886681098
hematocrit,3,1.0986122886681098
AVictoria75,3,1.0986122886681098
co‐infections,3,1.0986122886681098
organelles,3,1.0986122886681098
staged,3,1.0986122886681098
P05,3,1.0986122886681098
worrying,3,1.0986122886681098
GSH,3,1.0986122886681098
stimulants,3,1.0986122886681098
2002-2003,3,1.0986122886681098
haemolysis,3,1.0986122886681098
factorial,3,1.0986122886681098
coated,3,1.0986122886681098
652,3,1.0986122886681098
Length,3,1.0986122886681098
Salvador,3,1.0986122886681098
AURSS9077,3,1.0986122886681098
Equity,3,1.0986122886681098
mass-vaccination,3,1.0986122886681098
AL-Flu,3,1.0986122886681098
HMW,3,1.0986122886681098
ESVI,3,1.0986122886681098
antidysrhythmic,3,1.0986122886681098
small-artery,3,1.0986122886681098
BBrisbane602008-like,3,1.0986122886681098
Preferred,3,1.0986122886681098
Discordance,3,1.0986122886681098
Airborne,3,1.0986122886681098
cross-reaction,3,1.0986122886681098
muscle-specific,3,1.0986122886681098
Kappa,3,1.0986122886681098
rotating,3,1.0986122886681098
Wolf,3,1.0986122886681098
Crl,3,1.0986122886681098
unconventional,3,1.0986122886681098
-0009,3,1.0986122886681098
pillars,3,1.0986122886681098
PsycINFO,3,1.0986122886681098
SPX,3,1.0986122886681098
otolith,3,1.0986122886681098
Basilar,3,1.0986122886681098
RTW,3,1.0986122886681098
hypereosinophilia,3,1.0986122886681098
DSMI,3,1.0986122886681098
mismatches,3,1.0986122886681098
Arm,3,1.0986122886681098
725,3,1.0986122886681098
ultrastructural,3,1.0986122886681098
neurosyphilis,3,1.0986122886681098
theatre,3,1.0986122886681098
echinococcosis,3,1.0986122886681098
982-100,3,1.0986122886681098
smartphones,3,1.0986122886681098
15-44,3,1.0986122886681098
spasms,3,1.0986122886681098
sub-haplotypes,3,1.0986122886681098
dozens,3,1.0986122886681098
novelty,3,1.0986122886681098
traveling,3,1.0986122886681098
H5N8,3,1.0986122886681098
warranting,3,1.0986122886681098
OZG-38613,3,1.0986122886681098
atherectomy,3,1.0986122886681098
Orf1ab,3,1.0986122886681098
dampness,3,1.0986122886681098
JJ,3,1.0986122886681098
PMA,3,1.0986122886681098
pluripotent,3,1.0986122886681098
Turku,3,1.0986122886681098
Penh,3,1.0986122886681098
two-week,3,1.0986122886681098
fare,3,1.0986122886681098
administrated,3,1.0986122886681098
menstrual,3,1.0986122886681098
15-2,3,1.0986122886681098
-2,3,1.0986122886681098
adapting,3,1.0986122886681098
COVID-2019,3,1.0986122886681098
accountable,3,1.0986122886681098
Remarkably,3,1.0986122886681098
99mTc-PPi,3,1.0986122886681098
rESV,3,1.0986122886681098
Including,3,1.0986122886681098
edges,3,1.0986122886681098
NGNN,3,1.0986122886681098
covid19,3,1.0986122886681098
GTNN,3,1.0986122886681098
stoke,3,1.0986122886681098
tightly,3,1.0986122886681098
Throat,3,1.0986122886681098
rooted,3,1.0986122886681098
T2-type,3,1.0986122886681098
109L,3,1.0986122886681098
maxillofacial,3,1.0986122886681098
Commercial,3,1.0986122886681098
PPH,3,1.0986122886681098
exploits,3,1.0986122886681098
-001,3,1.0986122886681098
logarithmic,3,1.0986122886681098
unmodified,3,1.0986122886681098
Solitaire,3,1.0986122886681098
divide,3,1.0986122886681098
Fugl-Meyer,3,1.0986122886681098
underrecognized,3,1.0986122886681098
touching,3,1.0986122886681098
Remantadin,3,1.0986122886681098
Targeted,3,1.0986122886681098
Fund,3,1.0986122886681098
exported,3,1.0986122886681098
Ca,3,1.0986122886681098
cleaned,3,1.0986122886681098
hemophagocytic,3,1.0986122886681098
Workers,3,1.0986122886681098
grass-treated,3,1.0986122886681098
drastic,3,1.0986122886681098
ingredient,3,1.0986122886681098
Throughout,3,1.0986122886681098
twins,3,1.0986122886681098
virus-positive,3,1.0986122886681098
neglecting,3,1.0986122886681098
microneutralization,3,1.0986122886681098
assured,3,1.0986122886681098
Return,3,1.0986122886681098
post-inoculation,3,1.0986122886681098
Amino,3,1.0986122886681098
arenavirus,3,1.0986122886681098
salt,3,1.0986122886681098
Old,3,1.0986122886681098
married,3,1.0986122886681098
FEV,3,1.0986122886681098
Ingavirin,3,1.0986122886681098
benidipine,3,1.0986122886681098
conjugated,3,1.0986122886681098
663,3,1.0986122886681098
ICD-10,3,1.0986122886681098
extrapolation,3,1.0986122886681098
Akita,3,1.0986122886681098
babies,3,1.0986122886681098
intra-arrest,3,1.0986122886681098
Re,3,1.0986122886681098
GOLD,3,1.0986122886681098
albino,3,1.0986122886681098
singleton,3,1.0986122886681098
analogues,3,1.0986122886681098
Ninety-nine,3,1.0986122886681098
31st,3,1.0986122886681098
well-matched,3,1.0986122886681098
SCIT,3,1.0986122886681098
Experimentally,3,1.0986122886681098
12-year-old,3,1.0986122886681098
DECREASE,3,1.0986122886681098
undefined,3,1.0986122886681098
classroom,3,1.0986122886681098
caregiving,3,1.0986122886681098
plicatic,3,1.0986122886681098
dusts,3,1.0986122886681098
ESCAPE,3,1.0986122886681098
transposition,3,1.0986122886681098
PD40,3,1.0986122886681098
T478K,3,1.0986122886681098
sawmill,3,1.0986122886681098
redox,3,1.0986122886681098
ammonia,3,1.0986122886681098
non-ST-segment-elevation,3,1.0986122886681098
896,3,1.0986122886681098
antiallergic,3,1.0986122886681098
metabolomic,3,1.0986122886681098
1400,3,1.0986122886681098
facets,3,1.0986122886681098
urban-rural,3,1.0986122886681098
Retriever,3,1.0986122886681098
SNF,3,1.0986122886681098
standalone,3,1.0986122886681098
phylogeography,3,1.0986122886681098
rheography,3,1.0986122886681098
non-surgical,3,1.0986122886681098
AMI-CS,3,1.0986122886681098
ailments,3,1.0986122886681098
Tea,3,1.0986122886681098
Sicily,3,1.0986122886681098
paramedic,3,1.0986122886681098
weaning,3,1.0986122886681098
population-wide,3,1.0986122886681098
Platelet,3,1.0986122886681098
Preoperative,3,1.0986122886681098
R2,3,1.0986122886681098
M2-3,3,1.0986122886681098
3T,3,1.0986122886681098
935,3,1.0986122886681098
Iceland,3,1.0986122886681098
thermostable,3,1.0986122886681098
906,3,1.0986122886681098
ensured,3,1.0986122886681098
Telecommunications,3,1.0986122886681098
669,3,1.0986122886681098
Eighty-one,3,1.0986122886681098
Hunan,3,1.0986122886681098
guides,3,1.0986122886681098
fumes,3,1.0986122886681098
inferring,3,1.0986122886681098
uterine,3,1.0986122886681098
Steroids,3,1.0986122886681098
Selecting,3,1.0986122886681098
rhabdomyolysis,3,1.0986122886681098
annotated,3,1.0986122886681098
outburst,3,1.0986122886681098
superinfections,3,1.0986122886681098
chi2,3,1.0986122886681098
unfounded,3,1.0986122886681098
defences,3,1.0986122886681098
EMA,3,1.0986122886681098
Interferons,3,1.0986122886681098
N-13,3,1.0986122886681098
T-,3,1.0986122886681098
AT2,3,1.0986122886681098
Lipoprotein-associated,3,1.0986122886681098
responds,3,1.0986122886681098
Receptor,3,1.0986122886681098
oriented,3,1.0986122886681098
microgramskg,3,1.0986122886681098
smears,3,1.0986122886681098
freezing,3,1.0986122886681098
columnar,3,1.0986122886681098
colour,3,1.0986122886681098
pieces,3,1.0986122886681098
Saturdays,3,1.0986122886681098
intrafamilial,3,1.0986122886681098
oncologist,3,1.0986122886681098
15100,3,1.0986122886681098
Kenya,3,1.0986122886681098
human-type,3,1.0986122886681098
polyposis,3,1.0986122886681098
micronutrients,3,1.0986122886681098
effected,3,1.0986122886681098
AUDIT-positive,3,1.0986122886681098
p002,3,1.0986122886681098
CVST,3,1.0986122886681098
devoid,3,1.0986122886681098
nation-wide,3,1.0986122886681098
contemplated,3,1.0986122886681098
HP,3,1.0986122886681098
standstill,3,1.0986122886681098
Task,3,1.0986122886681098
Archive,3,1.0986122886681098
cadets,3,1.0986122886681098
drinkers,3,1.0986122886681098
3-hydroxy-3-methylglutaryl,3,1.0986122886681098
January-February,3,1.0986122886681098
impeding,3,1.0986122886681098
reinfect,3,1.0986122886681098
reappeared,3,1.0986122886681098
slow-flow,3,1.0986122886681098
discretion,3,1.0986122886681098
HL-1,3,1.0986122886681098
r-LVR,3,1.0986122886681098
semi-automated,3,1.0986122886681098
p0002,3,1.0986122886681098
Cameroon,3,1.0986122886681098
obliged,3,1.0986122886681098
intercurrent,3,1.0986122886681098
Achievement,3,1.0986122886681098
BSS,3,1.0986122886681098
nonagenarians,3,1.0986122886681098
multiform,3,1.0986122886681098
literatures,3,1.0986122886681098
WeChat,3,1.0986122886681098
precipitants,3,1.0986122886681098
nontraditional,3,1.0986122886681098
laceration,3,1.0986122886681098
Rome,3,1.0986122886681098
exercised,3,1.0986122886681098
sticking,3,1.0986122886681098
awakened,3,1.0986122886681098
vaginal,3,1.0986122886681098
0016,3,1.0986122886681098
Linear,3,1.0986122886681098
northeastern,3,1.0986122886681098
TSoccupational,3,1.0986122886681098
324,3,1.0986122886681098
bradykinin,3,1.0986122886681098
hairdressers,3,1.0986122886681098
RmYN02,3,1.0986122886681098
agitated,3,1.0986122886681098
ICTG,3,1.0986122886681098
QuantStudio,3,1.0986122886681098
medRxiv,3,1.0986122886681098
IAT,3,1.0986122886681098
pathomorphological,3,1.0986122886681098
seroepidemiologic,3,1.0986122886681098
gelatin,3,1.0986122886681098
IL-8,3,1.0986122886681098
venepuncture,3,1.0986122886681098
EDTA,3,1.0986122886681098
Hypercholesterolaemia,3,1.0986122886681098
timeframe,3,1.0986122886681098
inter-individual,3,1.0986122886681098
Oropharyngeal,3,1.0986122886681098
undertaking,3,1.0986122886681098
0037,3,1.0986122886681098
atorvastatin,3,1.0986122886681098
Gloucestershire,3,1.0986122886681098
PoC,3,1.0986122886681098
non-narrative,3,1.0986122886681098
salicylate,3,1.0986122886681098
non-high-risk,3,1.0986122886681098
collects,3,1.0986122886681098
confluent,3,1.0986122886681098
urticaria,3,1.0986122886681098
metasensors,3,1.0986122886681098
aside,3,1.0986122886681098
Pakistani,3,1.0986122886681098
TGF-β1,3,1.0986122886681098
IVF,3,1.0986122886681098
low-molecular,3,1.0986122886681098
politics,3,1.0986122886681098
anti-COVID-19,3,1.0986122886681098
epigenome,3,1.0986122886681098
locus,3,1.0986122886681098
H5N1-negative,3,1.0986122886681098
bACE2,3,1.0986122886681098
H5N1-positive,3,1.0986122886681098
monomer,3,1.0986122886681098
notions,3,1.0986122886681098
glucocorticoid-dependent,3,1.0986122886681098
time-series,3,1.0986122886681098
procalcitonin,3,1.0986122886681098
Hepatitis,3,1.0986122886681098
aroused,3,1.0986122886681098
Strains,3,1.0986122886681098
thalassaemia,3,1.0986122886681098
laminar,3,1.0986122886681098
human-animal,3,1.0986122886681098
Cu,3,1.0986122886681098
anserine,3,1.0986122886681098
H10N8,3,1.0986122886681098
associating,3,1.0986122886681098
aetiologies,3,1.0986122886681098
glomangiosarcoma,3,1.0986122886681098
Ann,3,1.0986122886681098
cytoskeleton,3,1.0986122886681098
varieties,3,1.0986122886681098
Synthetic,3,1.0986122886681098
casirivimab,3,1.0986122886681098
periinfarct,3,1.0986122886681098
moments,3,1.0986122886681098
glomus,3,1.0986122886681098
hemispatial,3,1.0986122886681098
Bone,3,1.0986122886681098
une,3,1.0986122886681098
parasitosis,3,1.0986122886681098
conjunctiva,3,1.0986122886681098
conductive,3,1.0986122886681098
trophic,3,1.0986122886681098
Standards,3,1.0986122886681098
interviewees,3,1.0986122886681098
Matching,3,1.0986122886681098
GRACE,3,1.0986122886681098
floors,3,1.0986122886681098
Size,3,1.0986122886681098
048,3,1.0986122886681098
453,3,1.0986122886681098
Ventilation,3,1.0986122886681098
propelled,3,1.0986122886681098
pH1N1-related,3,1.0986122886681098
Contamination,3,1.0986122886681098
palpable,3,1.0986122886681098
SEAS,3,1.0986122886681098
OM,3,1.0986122886681098
361,3,1.0986122886681098
67-year-old,3,1.0986122886681098
Northeastern,3,1.0986122886681098
446,3,1.0986122886681098
50-year-old,3,1.0986122886681098
Fifty-seven,3,1.0986122886681098
periodicity,3,1.0986122886681098
overestimation,3,1.0986122886681098
karyotype,3,1.0986122886681098
MDI,3,1.0986122886681098
resuscitated,3,1.0986122886681098
adopts,3,1.0986122886681098
Affected,3,1.0986122886681098
residuals,3,1.0986122886681098
Strongyloides,3,1.0986122886681098
PCR-positive,3,1.0986122886681098
antibody-positive,3,1.0986122886681098
folk,3,1.0986122886681098
lifting,3,1.0986122886681098
neurilemmoma,3,1.0986122886681098
579,3,1.0986122886681098
pericardiocentesis,3,1.0986122886681098
descriptors,3,1.0986122886681098
Programs,3,1.0986122886681098
SITS,3,1.0986122886681098
301,3,1.0986122886681098
Ever,3,1.0986122886681098
injecting,3,1.0986122886681098
VAMLA,3,1.0986122886681098
stabilisation,3,1.0986122886681098
s-IGF-I,3,1.0986122886681098
905,3,1.0986122886681098
474,3,1.0986122886681098
leaks,3,1.0986122886681098
lobectomy,3,1.0986122886681098
20122013,3,1.0986122886681098
SARS-CoV-2s,3,1.0986122886681098
osteopathic,3,1.0986122886681098
multifunctional,3,1.0986122886681098
Th1Th2,3,1.0986122886681098
polluted,3,1.0986122886681098
pneumoallergens,3,1.0986122886681098
FN,3,1.0986122886681098
LDTs,3,1.0986122886681098
OAT,3,1.0986122886681098
proceedings,3,1.0986122886681098
frontier,3,1.0986122886681098
RNaseP,3,1.0986122886681098
497,3,1.0986122886681098
Fragile,3,1.0986122886681098
hs,3,1.0986122886681098
Thousands,3,1.0986122886681098
T-group,3,1.0986122886681098
S-group,3,1.0986122886681098
Devices,3,1.0986122886681098
point-of-use,3,1.0986122886681098
on-road,3,1.0986122886681098
Gated,3,1.0986122886681098
Ambulatory,3,1.0986122886681098
Greek,3,1.0986122886681098
BTT,3,1.0986122886681098
July-August,3,1.0986122886681098
diversification,3,1.0986122886681098
chromosomes,3,1.0986122886681098
Regression,3,1.0986122886681098
posthospital,3,1.0986122886681098
refusal,3,1.0986122886681098
pro,3,1.0986122886681098
Lazio,3,1.0986122886681098
Security,3,1.0986122886681098
circular,3,1.0986122886681098
proves,3,1.0986122886681098
pictures,3,1.0986122886681098
mitotic,3,1.0986122886681098
terminated,3,1.0986122886681098
runny,3,1.0986122886681098
excludes,3,1.0986122886681098
discriminatory,3,1.0986122886681098
THD,3,1.0986122886681098
stem-cell,3,1.0986122886681098
RCM,3,1.0986122886681098
effluents,3,1.0986122886681098
≤40,3,1.0986122886681098
cTnT,3,1.0986122886681098
sentiment,3,1.0986122886681098
multi-ethnic,3,1.0986122886681098
medium-,3,1.0986122886681098
refused,3,1.0986122886681098
tissuesorgans,3,1.0986122886681098
reminder,3,1.0986122886681098
allocating,3,1.0986122886681098
double-blinded,3,1.0986122886681098
insertions,3,1.0986122886681098
9000,3,1.0986122886681098
longstanding,3,1.0986122886681098
asses,3,1.0986122886681098
predominately,3,1.0986122886681098
estimations,3,1.0986122886681098
one-,3,1.0986122886681098
AVR,3,1.0986122886681098
low-intensity,3,1.0986122886681098
remember,3,1.0986122886681098
awaiting,3,1.0986122886681098
colors,3,1.0986122886681098
excursions,3,1.0986122886681098
IBM-Bonner,3,1.0986122886681098
influenza-B,3,1.0986122886681098
unsuppressed,3,1.0986122886681098
complementing,3,1.0986122886681098
end-to-end,3,1.0986122886681098
conduction-heterogeneity,3,1.0986122886681098
anal,3,1.0986122886681098
Definition,3,1.0986122886681098
satisfies,3,1.0986122886681098
echocardiograph,3,1.0986122886681098
Proposed,3,1.0986122886681098
SAD,3,1.0986122886681098
allergenicity,3,1.0986122886681098
CTL,3,1.0986122886681098
relaxin,3,1.0986122886681098
factor-beta,3,1.0986122886681098
-omics,3,1.0986122886681098
autoinflammatory,3,1.0986122886681098
scanners,3,1.0986122886681098
EULAR,3,1.0986122886681098
pediatrics,3,1.0986122886681098
Alert,3,1.0986122886681098
arrives,3,1.0986122886681098
U-BIOPRED,3,1.0986122886681098
websites,3,1.0986122886681098
formulas,3,1.0986122886681098
Chemoprophylaxis,3,1.0986122886681098
Ethnopharmacological,3,1.0986122886681098
ionic,3,1.0986122886681098
guideline-based,3,1.0986122886681098
miltiorrhiza,3,1.0986122886681098
Salvia,3,1.0986122886681098
fed,3,1.0986122886681098
n9,3,1.0986122886681098
grows,3,1.0986122886681098
overcrowding,3,1.0986122886681098
speaker,3,1.0986122886681098
first-aid,3,1.0986122886681098
attaching,3,1.0986122886681098
Surface,3,1.0986122886681098
elderberry,3,1.0986122886681098
redefinition,3,1.0986122886681098
ribonucleic,3,1.0986122886681098
CPs,3,1.0986122886681098
hyaluronic,3,1.0986122886681098
1999-2000,3,1.0986122886681098
20142015,3,1.0986122886681098
microglial,3,1.0986122886681098
See,3,1.0986122886681098
NMDA,3,1.0986122886681098
man-made,3,1.0986122886681098
Tongji,3,1.0986122886681098
farmed,3,1.0986122886681098
TMGW,3,1.0986122886681098
128x,3,1.0986122886681098
inferoapical,3,1.0986122886681098
Hcy,3,1.0986122886681098
MAPCs,3,1.0986122886681098
firm,3,1.0986122886681098
stacked,3,1.0986122886681098
550,3,1.0986122886681098
Selective,3,1.0986122886681098
Safe,3,1.0986122886681098
ETS,3,1.0986122886681098
delineation,3,1.0986122886681098
conjugates,3,1.0986122886681098
mucolytic,3,1.0986122886681098
aided,3,1.0986122886681098
trees,3,1.0986122886681098
535,3,1.0986122886681098
P0024,3,1.0986122886681098
out-patient,3,1.0986122886681098
out-patients,3,1.0986122886681098
angles,3,1.0986122886681098
H5N1-infected,3,1.0986122886681098
echocardiographically,3,1.0986122886681098
debates,3,1.0986122886681098
single-strand,3,1.0986122886681098
EIATS,3,1.0986122886681098
Curcumin,3,1.0986122886681098
disarray,3,1.0986122886681098
PolyVD,3,1.0986122886681098
stroketransient,3,1.0986122886681098
traffic-related,3,1.0986122886681098
Zymosan,3,1.0986122886681098
stocks,3,1.0986122886681098
986,3,1.0986122886681098
freitasi,3,1.0986122886681098
17000,3,1.0986122886681098
albuterol,3,1.0986122886681098
2009H1N1,3,1.0986122886681098
Interim,3,1.0986122886681098
SPETT,3,1.0986122886681098
NSP,3,1.0986122886681098
glucocorticosteroids,3,1.0986122886681098
Panic-Fear,3,1.0986122886681098
980,3,1.0986122886681098
EAR,3,1.0986122886681098
potentiation,3,1.0986122886681098
Degree,3,1.0986122886681098
Random,3,1.0986122886681098
histocompatibility,3,1.0986122886681098
activity-related,3,1.0986122886681098
469,3,1.0986122886681098
nanobubbles,3,1.0986122886681098
1899,3,1.0986122886681098
commensal,3,1.0986122886681098
APOE,3,1.0986122886681098
349,3,1.0986122886681098
compendium,3,1.0986122886681098
Solid,3,1.0986122886681098
Supplement,3,1.0986122886681098
reassessed,3,1.0986122886681098
Live,3,1.0986122886681098
lipase,3,1.0986122886681098
Ca2,3,1.0986122886681098
knowing,3,1.0986122886681098
centerpiece,3,1.0986122886681098
SHEP,3,1.0986122886681098
1075,3,1.0986122886681098
influenza-,3,1.0986122886681098
COPDasthma,3,1.0986122886681098
cost-saving,3,1.0986122886681098
Org,3,1.0986122886681098
MFI-20,3,1.0986122886681098
geo-social,3,1.0986122886681098
Muslims,3,1.0986122886681098
electromechanical,3,1.0986122886681098
Ramadan,3,1.0986122886681098
Dipetalonema,3,1.0986122886681098
Detecting,3,1.0986122886681098
28-day,3,1.0986122886681098
archived,3,1.0986122886681098
HRI,3,1.0986122886681098
Comparative,3,1.0986122886681098
Module,3,1.0986122886681098
Australia-New,3,1.0986122886681098
singular,3,1.0986122886681098
Bleeding,3,1.0986122886681098
Side,3,1.0986122886681098
unambiguous,3,1.0986122886681098
EUROSTROKE,3,1.0986122886681098
Discussion,3,1.0986122886681098
approvals,3,1.0986122886681098
metalloproteinases,3,1.0986122886681098
IMS,3,1.0986122886681098
suburban,3,1.0986122886681098
secured,3,1.0986122886681098
rheolytic,3,1.0986122886681098
witnessing,3,1.0986122886681098
Corporation,3,1.0986122886681098
Instrumental,3,1.0986122886681098
SLS,3,1.0986122886681098
Identical,3,1.0986122886681098
meshwork,3,1.0986122886681098
Ischaemia,3,1.0986122886681098
SEE,3,1.0986122886681098
Duke,3,1.0986122886681098
415,3,1.0986122886681098
Loss,3,1.0986122886681098
AU,3,1.0986122886681098
smart,3,1.0986122886681098
CENTRAL,3,1.0986122886681098
cepheid®,3,1.0986122886681098
pioneered,3,1.0986122886681098
BPT,3,1.0986122886681098
non-bacterial,3,1.0986122886681098
phospholipids,3,1.0986122886681098
unwell,3,1.0986122886681098
704,3,1.0986122886681098
388,3,1.0986122886681098
glutamate,3,1.0986122886681098
generalist,3,1.0986122886681098
sinusoidal,3,1.0986122886681098
outlining,3,1.0986122886681098
REM,3,1.0986122886681098
Indias,3,1.0986122886681098
derivation,3,1.0986122886681098
awakenings,3,1.0986122886681098
LBD,3,1.0986122886681098
prefusion,3,1.0986122886681098
DhsLLL,3,1.0986122886681098
conversations,3,1.0986122886681098
904,3,1.0986122886681098
mainstays,3,1.0986122886681098
trended,3,1.0986122886681098
471,3,1.0986122886681098
Schrodinger,3,1.0986122886681098
2300,3,1.0986122886681098
pre-specified,3,1.0986122886681098
Frank,3,1.0986122886681098
JTotal,3,1.0986122886681098
paradoxic,3,1.0986122886681098
PCV7,3,1.0986122886681098
Values,3,1.0986122886681098
tracheostomy,3,1.0986122886681098
559,3,1.0986122886681098
self-medication,3,1.0986122886681098
sexuality,3,1.0986122886681098
BioSpeedia,3,1.0986122886681098
import,3,1.0986122886681098
triaging,3,1.0986122886681098
Paris,3,1.0986122886681098
2020-2021,3,1.0986122886681098
Berlin,3,1.0986122886681098
432,3,1.0986122886681098
constructing,3,1.0986122886681098
Investigators,3,1.0986122886681098
homeostatic,3,1.0986122886681098
fluctuation-very,3,1.0986122886681098
48-year-old,3,1.0986122886681098
408,3,1.0986122886681098
electrogram,3,1.0986122886681098
Patterns,3,1.0986122886681098
distributing,3,1.0986122886681098
salvaged,3,1.0986122886681098
synaptic,3,1.0986122886681098
dyskinesia,3,1.0986122886681098
car,3,1.0986122886681098
S1P1R,3,1.0986122886681098
Annually,3,1.0986122886681098
appeals,3,1.0986122886681098
Neuroscience,3,1.0986122886681098
13-14,3,1.0986122886681098
10-30,3,1.0986122886681098
Probably,3,1.0986122886681098
atlases,3,1.0986122886681098
sponsored,3,1.0986122886681098
tachypnea,3,1.0986122886681098
diminishes,3,1.0986122886681098
Genomics,3,1.0986122886681098
seminar,3,1.0986122886681098
leptinergic,3,1.0986122886681098
alanine,3,1.0986122886681098
Thrombectomy,3,1.0986122886681098
wrist,3,1.0986122886681098
transferase,3,1.0986122886681098
cards,3,1.0986122886681098
PEG,3,1.0986122886681098
10-day,3,1.0986122886681098
potentiate,3,1.0986122886681098
interrelationships,3,1.0986122886681098
·,3,1.0986122886681098
Lead,3,1.0986122886681098
Delays,3,1.0986122886681098
meanings,3,1.0986122886681098
1737,3,1.0986122886681098
pre-procedural,3,1.0986122886681098
41-year-old,3,1.0986122886681098
SARS-CoV-2-RdRp,3,1.0986122886681098
JNC,3,1.0986122886681098
703,3,1.0986122886681098
two-part,3,1.0986122886681098
noninfarct,3,1.0986122886681098
hypothalamic-pituitary-adrenal,3,1.0986122886681098
investments,3,1.0986122886681098
lobar,3,1.0986122886681098
believing,3,1.0986122886681098
3-week,3,1.0986122886681098
Smart,3,1.0986122886681098
chicks,3,1.0986122886681098
VI,3,1.0986122886681098
PRAMI,3,1.0986122886681098
891,3,1.0986122886681098
T2D,3,1.0986122886681098
entries,3,1.0986122886681098
symptomology,3,1.0986122886681098
G614,3,1.0986122886681098
Decades,3,1.0986122886681098
anOPCAB,3,1.0986122886681098
revise,3,1.0986122886681098
ICSLABA,3,1.0986122886681098
Cochran,3,1.0986122886681098
SAVE,3,1.0986122886681098
subtest,3,1.0986122886681098
2-,3,1.0986122886681098
obstructing,3,1.0986122886681098
impose,3,1.0986122886681098
judgments,3,1.0986122886681098
Item,3,1.0986122886681098
2019-2020,3,1.0986122886681098
anticipating,3,1.0986122886681098
structure-function,3,1.0986122886681098
daylight,3,1.0986122886681098
re-elevation,3,1.0986122886681098
SVO,3,1.0986122886681098
resided,3,1.0986122886681098
adiposity,3,1.0986122886681098
Breathing,3,1.0986122886681098
cohosh,3,1.0986122886681098
cornerstones,3,1.0986122886681098
unsure,3,1.0986122886681098
SHR,3,1.0986122886681098
Laos,3,1.0986122886681098
Periodic,3,1.0986122886681098
emphasises,3,1.0986122886681098
psychophysical,3,1.0986122886681098
cross-reacted,3,1.0986122886681098
CCR5,3,1.0986122886681098
happening,3,1.0986122886681098
MBs,3,1.0986122886681098
hypoalbuminemia,3,1.0986122886681098
Kong873,3,1.0986122886681098
AlPO4,3,1.0986122886681098
accreditation,3,1.0986122886681098
encoded,3,1.0986122886681098
self-regulation,3,1.0986122886681098
582,3,1.0986122886681098
ask,3,1.0986122886681098
transfemoral,3,1.0986122886681098
WHOs,3,1.0986122886681098
correlative,3,1.0986122886681098
1128,3,1.0986122886681098
River,3,1.0986122886681098
Nijmegen,3,1.0986122886681098
swiftly,3,1.0986122886681098
PM10,3,1.0986122886681098
705,3,1.0986122886681098
abolished,3,1.0986122886681098
TRA,3,1.0986122886681098
polarimetry,3,1.0986122886681098
Antibiotics,3,1.0986122886681098
LPVr,3,1.0986122886681098
whatever,3,1.0986122886681098
neurorestorative,3,1.0986122886681098
normality,3,1.0986122886681098
OXVASC,3,1.0986122886681098
fearing,3,1.0986122886681098
TFA,3,1.0986122886681098
575,3,1.0986122886681098
Benefit,3,1.0986122886681098
comprehensiveness,3,1.0986122886681098
-9,3,1.0986122886681098
2-dose,3,1.0986122886681098
shipment,3,1.0986122886681098
migrant,3,1.0986122886681098
MAP1LC3,3,1.0986122886681098
Oncology,3,1.0986122886681098
forty,3,1.0986122886681098
manufacturer,3,1.0986122886681098
extention,3,1.0986122886681098
OD450,3,1.0986122886681098
culmination,3,1.0986122886681098
subepicardium,3,1.0986122886681098
FNMI,3,1.0986122886681098
FDP,3,1.0986122886681098
individual-level,3,1.0986122886681098
licensing,3,1.0986122886681098
052,3,1.0986122886681098
pressure-volume,3,1.0986122886681098
MRIMRA,3,1.0986122886681098
focussed,3,1.0986122886681098
constants,3,1.0986122886681098
dictates,3,1.0986122886681098
Machine,3,1.0986122886681098
t-peak,3,1.0986122886681098
PfizerBioNTech,3,1.0986122886681098
elevate,3,1.0986122886681098
precludes,3,1.0986122886681098
unambiguously,3,1.0986122886681098
624,3,1.0986122886681098
Seventy-five,3,1.0986122886681098
NOLC1,3,1.0986122886681098
proteolysis,3,1.0986122886681098
subcutaneously,3,1.0986122886681098
interferes,3,1.0986122886681098
half-saturation,3,1.0986122886681098
preformed,3,1.0986122886681098
Fort,2,0.6931471805599453
non-ICU,2,0.6931471805599453
syrup,2,0.6931471805599453
trans,2,0.6931471805599453
re-opening,2,0.6931471805599453
2025,2,0.6931471805599453
alpha-MHC,2,0.6931471805599453
Properly,2,0.6931471805599453
Ligation,2,0.6931471805599453
alpha-actin,2,0.6931471805599453
hemangioendothelioma,2,0.6931471805599453
MCAo,2,0.6931471805599453
IV-tPA,2,0.6931471805599453
Kounis,2,0.6931471805599453
patents,2,0.6931471805599453
735,2,0.6931471805599453
Furanthril,2,0.6931471805599453
remits,2,0.6931471805599453
instrumented,2,0.6931471805599453
currents,2,0.6931471805599453
Dijon,2,0.6931471805599453
weigh,2,0.6931471805599453
Defence,2,0.6931471805599453
legally,2,0.6931471805599453
SkMs,2,0.6931471805599453
piperine,2,0.6931471805599453
Entry,2,0.6931471805599453
precarious,2,0.6931471805599453
OCR,2,0.6931471805599453
anterior-posterior,2,0.6931471805599453
carotid-related,2,0.6931471805599453
clamp,2,0.6931471805599453
optimizations,2,0.6931471805599453
webcast,2,0.6931471805599453
hemichorea-hemiballismus,2,0.6931471805599453
amnesic,2,0.6931471805599453
deliberations,2,0.6931471805599453
derangement,2,0.6931471805599453
counteracted,2,0.6931471805599453
mlminm2,2,0.6931471805599453
Medications,2,0.6931471805599453
TS,2,0.6931471805599453
816,2,0.6931471805599453
endings,2,0.6931471805599453
toxicologic,2,0.6931471805599453
Postpartum,2,0.6931471805599453
taste,2,0.6931471805599453
eager,2,0.6931471805599453
side‑effects,2,0.6931471805599453
-074,2,0.6931471805599453
referenced,2,0.6931471805599453
dangerously,2,0.6931471805599453
Too,2,0.6931471805599453
hyperkinesia,2,0.6931471805599453
marijuana,2,0.6931471805599453
disrupts,2,0.6931471805599453
ACE-inhibitor,2,0.6931471805599453
UE,2,0.6931471805599453
n22,2,0.6931471805599453
593,2,0.6931471805599453
frontosubcortical,2,0.6931471805599453
music,2,0.6931471805599453
-25,2,0.6931471805599453
Latinao,2,0.6931471805599453
EIC,2,0.6931471805599453
Expanded,2,0.6931471805599453
LSCI,2,0.6931471805599453
IgG1,2,0.6931471805599453
non-exposed,2,0.6931471805599453
-009,2,0.6931471805599453
REGN10933,2,0.6931471805599453
REGN10987,2,0.6931471805599453
Elderberry,2,0.6931471805599453
133xenon,2,0.6931471805599453
non-reperfusion,2,0.6931471805599453
takotsubo,2,0.6931471805599453
Wntβ-catenin,2,0.6931471805599453
work-place,2,0.6931471805599453
30days,2,0.6931471805599453
cuff,2,0.6931471805599453
membrane-derived,2,0.6931471805599453
Eighty-five,2,0.6931471805599453
TAS2Rs,2,0.6931471805599453
TAMI-6,2,0.6931471805599453
arterioles,2,0.6931471805599453
Neutrophils,2,0.6931471805599453
shaking,2,0.6931471805599453
DAD,2,0.6931471805599453
TPLSM,2,0.6931471805599453
tilted,2,0.6931471805599453
biopsied,2,0.6931471805599453
drug-induced,2,0.6931471805599453
supply-chain,2,0.6931471805599453
Mask,2,0.6931471805599453
interwoven,2,0.6931471805599453
Physiologically,2,0.6931471805599453
stopgap,2,0.6931471805599453
hydroxymethylglutaryl,2,0.6931471805599453
monomeric,2,0.6931471805599453
sin,2,0.6931471805599453
HRVs,2,0.6931471805599453
transmitters,2,0.6931471805599453
aorto-coronary,2,0.6931471805599453
hemothorax,2,0.6931471805599453
roundtable,2,0.6931471805599453
unsettling,2,0.6931471805599453
biosciences,2,0.6931471805599453
8-,2,0.6931471805599453
midline,2,0.6931471805599453
alkaloids,2,0.6931471805599453
transgenes,2,0.6931471805599453
1265,2,0.6931471805599453
822,2,0.6931471805599453
887,2,0.6931471805599453
caffeine,2,0.6931471805599453
747,2,0.6931471805599453
WMLs,2,0.6931471805599453
LT,2,0.6931471805599453
infiltrative,2,0.6931471805599453
calf,2,0.6931471805599453
RIDT-positive,2,0.6931471805599453
scalar,2,0.6931471805599453
1396,2,0.6931471805599453
Relying,2,0.6931471805599453
19971998,2,0.6931471805599453
syncytia,2,0.6931471805599453
201314,2,0.6931471805599453
Blocking,2,0.6931471805599453
nitrate-enhanced,2,0.6931471805599453
Quarantine,2,0.6931471805599453
RTI,2,0.6931471805599453
tracheobronchitis,2,0.6931471805599453
Process,2,0.6931471805599453
diffusely,2,0.6931471805599453
Priming,2,0.6931471805599453
subconjunctival,2,0.6931471805599453
adultchild,2,0.6931471805599453
2-related,2,0.6931471805599453
PANAS,2,0.6931471805599453
Ukg,2,0.6931471805599453
post-ischemic,2,0.6931471805599453
destroy,2,0.6931471805599453
coronary-arterial,2,0.6931471805599453
transgene,2,0.6931471805599453
Short,2,0.6931471805599453
MEA,2,0.6931471805599453
Correction,2,0.6931471805599453
Healths,2,0.6931471805599453
substantiate,2,0.6931471805599453
CH25H,2,0.6931471805599453
Schedule,2,0.6931471805599453
cloned,2,0.6931471805599453
stomatitis,2,0.6931471805599453
characterising,2,0.6931471805599453
climatological,2,0.6931471805599453
897,2,0.6931471805599453
Cas,2,0.6931471805599453
367,2,0.6931471805599453
789,2,0.6931471805599453
Uliter,2,0.6931471805599453
PICTs,2,0.6931471805599453
CMIA,2,0.6931471805599453
Households,2,0.6931471805599453
HCl,2,0.6931471805599453
Fe,2,0.6931471805599453
28th,2,0.6931471805599453
mouthwashes,2,0.6931471805599453
NSCs,2,0.6931471805599453
CRISPR-Cas-based,2,0.6931471805599453
squared,2,0.6931471805599453
acquaintances,2,0.6931471805599453
2012-13,2,0.6931471805599453
viewer,2,0.6931471805599453
1082,2,0.6931471805599453
Brief,2,0.6931471805599453
prioritising,2,0.6931471805599453
transdisciplinary,2,0.6931471805599453
Fatality,2,0.6931471805599453
obviate,2,0.6931471805599453
cellscollagen,2,0.6931471805599453
faculties,2,0.6931471805599453
Monogenic,2,0.6931471805599453
TEE-detected,2,0.6931471805599453
thrombosed,2,0.6931471805599453
sixty-four,2,0.6931471805599453
LC-MRM-MS,2,0.6931471805599453
Users,2,0.6931471805599453
pre-PTCA,2,0.6931471805599453
Neuroendocrine,2,0.6931471805599453
MMP,2,0.6931471805599453
PAG-to-PAG,2,0.6931471805599453
reassort,2,0.6931471805599453
pmoll,2,0.6931471805599453
MDCK-2,2,0.6931471805599453
Next-generation,2,0.6931471805599453
triphosphate,2,0.6931471805599453
mentality,2,0.6931471805599453
inviting,2,0.6931471805599453
neurophysiological,2,0.6931471805599453
balances,2,0.6931471805599453
692,2,0.6931471805599453
T-and,2,0.6931471805599453
MDCK-H,2,0.6931471805599453
Restenosis,2,0.6931471805599453
Translating,2,0.6931471805599453
high-energy,2,0.6931471805599453
implying,2,0.6931471805599453
105th,2,0.6931471805599453
ft,2,0.6931471805599453
-005,2,0.6931471805599453
Comparatively,2,0.6931471805599453
recorder,2,0.6931471805599453
IAP,2,0.6931471805599453
systematize,2,0.6931471805599453
Sensory,2,0.6931471805599453
mentors,2,0.6931471805599453
Pathways,2,0.6931471805599453
498,2,0.6931471805599453
Transthoracic,2,0.6931471805599453
AUSSR,2,0.6931471805599453
Maryland,2,0.6931471805599453
hymenoptera,2,0.6931471805599453
envenomation,2,0.6931471805599453
observance,2,0.6931471805599453
post-PTCA,2,0.6931471805599453
diets,2,0.6931471805599453
inversions,2,0.6931471805599453
chloramine-T,2,0.6931471805599453
OMT,2,0.6931471805599453
radiolabelled,2,0.6931471805599453
bone-marrow-derived,2,0.6931471805599453
depleted,2,0.6931471805599453
rhinovirusenterovirus,2,0.6931471805599453
cryoablation,2,0.6931471805599453
Babol,2,0.6931471805599453
701,2,0.6931471805599453
lipoprotein-associated,2,0.6931471805599453
Backgroundpurpose,2,0.6931471805599453
manifold,2,0.6931471805599453
illuminating,2,0.6931471805599453
baumannii,2,0.6931471805599453
PCPS,2,0.6931471805599453
Activator,2,0.6931471805599453
65-year-old,2,0.6931471805599453
valued,2,0.6931471805599453
left-ventricular-assist,2,0.6931471805599453
confounded,2,0.6931471805599453
dissimilarities,2,0.6931471805599453
concert,2,0.6931471805599453
V7,2,0.6931471805599453
0032,2,0.6931471805599453
UDOs,2,0.6931471805599453
time-resolved,2,0.6931471805599453
customize,2,0.6931471805599453
24-mer,2,0.6931471805599453
854,2,0.6931471805599453
non-Type,2,0.6931471805599453
pre-Delta,2,0.6931471805599453
H4,2,0.6931471805599453
Grant,2,0.6931471805599453
Expression,2,0.6931471805599453
Newly,2,0.6931471805599453
obturation,2,0.6931471805599453
stone,2,0.6931471805599453
morphometric,2,0.6931471805599453
V9,2,0.6931471805599453
investigator,2,0.6931471805599453
DMP,2,0.6931471805599453
BSL3,2,0.6931471805599453
De,2,0.6931471805599453
FGF-2,2,0.6931471805599453
wise,2,0.6931471805599453
EMH,2,0.6931471805599453
Minimal,2,0.6931471805599453
insulin-like,2,0.6931471805599453
third-degree,2,0.6931471805599453
FNAB,2,0.6931471805599453
thermometer,2,0.6931471805599453
inaccessible,2,0.6931471805599453
cytologic,2,0.6931471805599453
940,2,0.6931471805599453
Neotropical,2,0.6931471805599453
liquid-based,2,0.6931471805599453
voice,2,0.6931471805599453
ILVNC,2,0.6931471805599453
plexus,2,0.6931471805599453
biplane,2,0.6931471805599453
harmonization,2,0.6931471805599453
overactivity,2,0.6931471805599453
ASIA,2,0.6931471805599453
over-mortality,2,0.6931471805599453
bigger,2,0.6931471805599453
risk-stratification,2,0.6931471805599453
antifibrillatory,2,0.6931471805599453
cleft,2,0.6931471805599453
pathognomonic,2,0.6931471805599453
EPM,2,0.6931471805599453
publishes,2,0.6931471805599453
monachus,2,0.6931471805599453
lends,2,0.6931471805599453
dislocation,2,0.6931471805599453
worms,2,0.6931471805599453
intimacy,2,0.6931471805599453
articular,2,0.6931471805599453
Peruvian,2,0.6931471805599453
VEM,2,0.6931471805599453
Intra-observer,2,0.6931471805599453
Rudolphi,2,0.6931471805599453
headgroups,2,0.6931471805599453
autoimmuneinflammatory,2,0.6931471805599453
intertrabecular,2,0.6931471805599453
dispensable,2,0.6931471805599453
cross-city,2,0.6931471805599453
granulation,2,0.6931471805599453
Guiana,2,0.6931471805599453
Impedance,2,0.6931471805599453
nucleoside-modified,2,0.6931471805599453
Tetanus,2,0.6931471805599453
homogeneously,2,0.6931471805599453
make-up,2,0.6931471805599453
infectors,2,0.6931471805599453
Result,2,0.6931471805599453
herhis,2,0.6931471805599453
Reagent,2,0.6931471805599453
Paecilomyces,2,0.6931471805599453
envision,2,0.6931471805599453
burnout,2,0.6931471805599453
EPICES,2,0.6931471805599453
nontraining,2,0.6931471805599453
zymography,2,0.6931471805599453
vasodilatory,2,0.6931471805599453
analgesia,2,0.6931471805599453
l-isoproterenol,2,0.6931471805599453
bioanalysis,2,0.6931471805599453
Resting,2,0.6931471805599453
rhinorrhoea,2,0.6931471805599453
bead-based,2,0.6931471805599453
correctional,2,0.6931471805599453
motive,2,0.6931471805599453
Delhi,2,0.6931471805599453
pinpoint,2,0.6931471805599453
semi-automatic,2,0.6931471805599453
genera,2,0.6931471805599453
RdRpHel,2,0.6931471805599453
abstain,2,0.6931471805599453
Onchocercidae,2,0.6931471805599453
James,2,0.6931471805599453
nematodes,2,0.6931471805599453
CD68,2,0.6931471805599453
cisgender,2,0.6931471805599453
dragon,2,0.6931471805599453
streptokinase-treated,2,0.6931471805599453
Fetour,2,0.6931471805599453
reflections,2,0.6931471805599453
intrinsically,2,0.6931471805599453
closings,2,0.6931471805599453
upgrade,2,0.6931471805599453
continence,2,0.6931471805599453
filarial,2,0.6931471805599453
B1429,2,0.6931471805599453
jeopardized,2,0.6931471805599453
002-005,2,0.6931471805599453
post-procedural,2,0.6931471805599453
VPW,2,0.6931471805599453
LF,2,0.6931471805599453
overmortality,2,0.6931471805599453
Methotrexate,2,0.6931471805599453
orthostatic,2,0.6931471805599453
unleashed,2,0.6931471805599453
unwarranted,2,0.6931471805599453
basin,2,0.6931471805599453
stay-at-home,2,0.6931471805599453
diving-related,2,0.6931471805599453
NABL,2,0.6931471805599453
compressed,2,0.6931471805599453
mmsec,2,0.6931471805599453
sleep-wake,2,0.6931471805599453
641,2,0.6931471805599453
RB,2,0.6931471805599453
HF-rTMS,2,0.6931471805599453
asthma-associated,2,0.6931471805599453
non-LVO,2,0.6931471805599453
compliant,2,0.6931471805599453
beta2-adrenoceptor,2,0.6931471805599453
vRNPs,2,0.6931471805599453
invalidity,2,0.6931471805599453
unreliable,2,0.6931471805599453
WWTPs,2,0.6931471805599453
neurofibromatosis,2,0.6931471805599453
borne,2,0.6931471805599453
outset,2,0.6931471805599453
compilation,2,0.6931471805599453
ACORN,2,0.6931471805599453
locate,2,0.6931471805599453
prazosin,2,0.6931471805599453
post-hospital,2,0.6931471805599453
par,2,0.6931471805599453
rituximab,2,0.6931471805599453
purposive,2,0.6931471805599453
underlining,2,0.6931471805599453
Estimated,2,0.6931471805599453
Bach2,2,0.6931471805599453
stature,2,0.6931471805599453
24000,2,0.6931471805599453
1486,2,0.6931471805599453
trough,2,0.6931471805599453
929,2,0.6931471805599453
Primates,2,0.6931471805599453
non-,2,0.6931471805599453
LVED,2,0.6931471805599453
0010,2,0.6931471805599453
Thomas,2,0.6931471805599453
elude,2,0.6931471805599453
non-inferiority,2,0.6931471805599453
L5,2,0.6931471805599453
35-year-old,2,0.6931471805599453
re-entry,2,0.6931471805599453
drowsiness,2,0.6931471805599453
-15,2,0.6931471805599453
PU1,2,0.6931471805599453
PPARγ,2,0.6931471805599453
flu-associated,2,0.6931471805599453
inventory,2,0.6931471805599453
aborted,2,0.6931471805599453
paediatricians,2,0.6931471805599453
sustained-release,2,0.6931471805599453
Disease-modifying,2,0.6931471805599453
1324,2,0.6931471805599453
laid,2,0.6931471805599453
Institutional,2,0.6931471805599453
vectormRNA,2,0.6931471805599453
Biotechnology,2,0.6931471805599453
Recipients,2,0.6931471805599453
serum-ECP,2,0.6931471805599453
1922,2,0.6931471805599453
venues,2,0.6931471805599453
Spike-specific,2,0.6931471805599453
sibs,2,0.6931471805599453
premedication,2,0.6931471805599453
preexistent,2,0.6931471805599453
Artery-to-artery,2,0.6931471805599453
MMM,2,0.6931471805599453
re-evaluate,2,0.6931471805599453
mgkgday,2,0.6931471805599453
Yorkshire,2,0.6931471805599453
deadliest,2,0.6931471805599453
P681H,2,0.6931471805599453
lesioned,2,0.6931471805599453
1148,2,0.6931471805599453
Influ,2,0.6931471805599453
Bronchiectasis,2,0.6931471805599453
interpersonal,2,0.6931471805599453
14-44,2,0.6931471805599453
outcompeted,2,0.6931471805599453
misnomer,2,0.6931471805599453
antigenemiaviremia,2,0.6931471805599453
GUSTO-I,2,0.6931471805599453
2312,2,0.6931471805599453
nodosome,2,0.6931471805599453
cellulo,2,0.6931471805599453
Lebanon,2,0.6931471805599453
Behcets,2,0.6931471805599453
resonances,2,0.6931471805599453
Receiving,2,0.6931471805599453
middle-age,2,0.6931471805599453
Containment,2,0.6931471805599453
commitments,2,0.6931471805599453
Delivery,2,0.6931471805599453
embraces,2,0.6931471805599453
multilayered,2,0.6931471805599453
angiographical,2,0.6931471805599453
vRNAs,2,0.6931471805599453
tissueorgan,2,0.6931471805599453
812,2,0.6931471805599453
end-organ,2,0.6931471805599453
NTZ,2,0.6931471805599453
boundary,2,0.6931471805599453
IVSPW,2,0.6931471805599453
Bunge,2,0.6931471805599453
Zone,2,0.6931471805599453
LVOS,2,0.6931471805599453
SDH,2,0.6931471805599453
bony,2,0.6931471805599453
ZIKV,2,0.6931471805599453
post-exercise,2,0.6931471805599453
995,2,0.6931471805599453
anti-PF4,2,0.6931471805599453
standard-of-care,2,0.6931471805599453
PEGs,2,0.6931471805599453
SCN-,2,0.6931471805599453
SARS-COV2,2,0.6931471805599453
allergologists,2,0.6931471805599453
cavernous,2,0.6931471805599453
Vaccinations,2,0.6931471805599453
insist,2,0.6931471805599453
cytogenetic,2,0.6931471805599453
Horners,2,0.6931471805599453
outbreak-associated,2,0.6931471805599453
cobalt,2,0.6931471805599453
Remission,2,0.6931471805599453
5-day,2,0.6931471805599453
10-16,2,0.6931471805599453
Mycobacterium,2,0.6931471805599453
Volunteer,2,0.6931471805599453
hyper-immune,2,0.6931471805599453
snuff,2,0.6931471805599453
698,2,0.6931471805599453
mistake,2,0.6931471805599453
Ivano-Frankivsk,2,0.6931471805599453
precocious,2,0.6931471805599453
Transluminal,2,0.6931471805599453
process-of-care,2,0.6931471805599453
antithyroid,2,0.6931471805599453
tide,2,0.6931471805599453
scaling,2,0.6931471805599453
inimitable,2,0.6931471805599453
local-level,2,0.6931471805599453
Emission,2,0.6931471805599453
delineating,2,0.6931471805599453
Home-based,2,0.6931471805599453
Biomedical,2,0.6931471805599453
acrocentral,2,0.6931471805599453
extra-respiratory,2,0.6931471805599453
13-15,2,0.6931471805599453
21-22,2,0.6931471805599453
surging,2,0.6931471805599453
3-24,2,0.6931471805599453
cadaveric,2,0.6931471805599453
marboxil,2,0.6931471805599453
Womens,2,0.6931471805599453
plateau-like,2,0.6931471805599453
right-to-left,2,0.6931471805599453
Pro-ANP,2,0.6931471805599453
pro-ANP,2,0.6931471805599453
baloxavir,2,0.6931471805599453
simplest,2,0.6931471805599453
Highlands,2,0.6931471805599453
Fore,2,0.6931471805599453
revolutionize,2,0.6931471805599453
autoantigens,2,0.6931471805599453
decrements,2,0.6931471805599453
Sao,2,0.6931471805599453
negotiation,2,0.6931471805599453
ventriculogram,2,0.6931471805599453
densities,2,0.6931471805599453
premier,2,0.6931471805599453
anti-IL-4,2,0.6931471805599453
WHI,2,0.6931471805599453
intrapulmonary,2,0.6931471805599453
Abdominal,2,0.6931471805599453
progestin,2,0.6931471805599453
KDPH,2,0.6931471805599453
970,2,0.6931471805599453
corneal,2,0.6931471805599453
balancing,2,0.6931471805599453
pecilomycosis,2,0.6931471805599453
upwards,2,0.6931471805599453
nonselected,2,0.6931471805599453
desserts,2,0.6931471805599453
ofpecilomycotic,2,0.6931471805599453
11-19,2,0.6931471805599453
EIW,2,0.6931471805599453
SAHPRA,2,0.6931471805599453
FKN,2,0.6931471805599453
Naples,2,0.6931471805599453
catechin,2,0.6931471805599453
enddiastolic,2,0.6931471805599453
ASDs,2,0.6931471805599453
PRN,2,0.6931471805599453
helicopter,2,0.6931471805599453
coughs,2,0.6931471805599453
TNFi,2,0.6931471805599453
Cutaneous,2,0.6931471805599453
H7N9-related,2,0.6931471805599453
exanthem,2,0.6931471805599453
Readiness,2,0.6931471805599453
batteries,2,0.6931471805599453
defibrillator,2,0.6931471805599453
binge,2,0.6931471805599453
5-17,2,0.6931471805599453
3-45,2,0.6931471805599453
robustly,2,0.6931471805599453
under-vaccinated,2,0.6931471805599453
Travellers,2,0.6931471805599453
Residual,2,0.6931471805599453
Everest,2,0.6931471805599453
Mondays,2,0.6931471805599453
postsymptom,2,0.6931471805599453
AUDIT-negative,2,0.6931471805599453
1213,2,0.6931471805599453
nursing-home,2,0.6931471805599453
Characterizing,2,0.6931471805599453
sciatica,2,0.6931471805599453
19992000,2,0.6931471805599453
Binge,2,0.6931471805599453
PD35,2,0.6931471805599453
Inhibition,2,0.6931471805599453
bisoprolol,2,0.6931471805599453
perturbed,2,0.6931471805599453
judiciously,2,0.6931471805599453
3884,2,0.6931471805599453
envisage,2,0.6931471805599453
nonmechanical,2,0.6931471805599453
Nairobi,2,0.6931471805599453
Muranga,2,0.6931471805599453
hypereosinophilic,2,0.6931471805599453
603,2,0.6931471805599453
prespecified,2,0.6931471805599453
holiday,2,0.6931471805599453
Christmas,2,0.6931471805599453
discouraging,2,0.6931471805599453
Adamantanes,2,0.6931471805599453
aHR,2,0.6931471805599453
releases,2,0.6931471805599453
mgkg-1,2,0.6931471805599453
Zero,2,0.6931471805599453
ameliorating,2,0.6931471805599453
sink,2,0.6931471805599453
Near,2,0.6931471805599453
recourse,2,0.6931471805599453
hypnosis,2,0.6931471805599453
TNE,2,0.6931471805599453
870,2,0.6931471805599453
chiropractic,2,0.6931471805599453
ectodomain,2,0.6931471805599453
EET,2,0.6931471805599453
ASLR,2,0.6931471805599453
Residents,2,0.6931471805599453
organize,2,0.6931471805599453
sonographic,2,0.6931471805599453
patterned,2,0.6931471805599453
Illumina,2,0.6931471805599453
clinicopathologic,2,0.6931471805599453
inhibitor-1,2,0.6931471805599453
lapses,2,0.6931471805599453
Sensitive,2,0.6931471805599453
gamma-irradiated,2,0.6931471805599453
edvs,2,0.6931471805599453
infarctionIn,2,0.6931471805599453
autoencoder,2,0.6931471805599453
SSAE,2,0.6931471805599453
LD,2,0.6931471805599453
1343,2,0.6931471805599453
SNF-associated,2,0.6931471805599453
ORMDL3,2,0.6931471805599453
Procedures,2,0.6931471805599453
anginous,2,0.6931471805599453
4G,2,0.6931471805599453
worn,2,0.6931471805599453
IL-2R,2,0.6931471805599453
guideline-directed,2,0.6931471805599453
Facility-wide,2,0.6931471805599453
diisocyanate,2,0.6931471805599453
hypnotherapy,2,0.6931471805599453
marginalized,2,0.6931471805599453
causally,2,0.6931471805599453
hand-crafted,2,0.6931471805599453
deregulated,2,0.6931471805599453
NFkB,2,0.6931471805599453
cmH2O,2,0.6931471805599453
Inspiratory,2,0.6931471805599453
2-Hi,2,0.6931471805599453
K-dependent,2,0.6931471805599453
exemption,2,0.6931471805599453
Meta-Analyses,2,0.6931471805599453
mimicked,2,0.6931471805599453
co-existing,2,0.6931471805599453
Far,2,0.6931471805599453
post-transcriptional,2,0.6931471805599453
logistically,2,0.6931471805599453
392,2,0.6931471805599453
malondialdehyde,2,0.6931471805599453
≥140,2,0.6931471805599453
vitamin-D-mediated,2,0.6931471805599453
CoviVac,2,0.6931471805599453
governing,2,0.6931471805599453
BC,2,0.6931471805599453
Y15,2,0.6931471805599453
VCI,2,0.6931471805599453
Articles,2,0.6931471805599453
sort,2,0.6931471805599453
dysfunctioning,2,0.6931471805599453
finds,2,0.6931471805599453
contaminate,2,0.6931471805599453
Tracking,2,0.6931471805599453
breakdown,2,0.6931471805599453
IL-13-dependent,2,0.6931471805599453
biliverdin,2,0.6931471805599453
paradoxically,2,0.6931471805599453
CCCs,2,0.6931471805599453
risk-reducing,2,0.6931471805599453
glycol,2,0.6931471805599453
stroke-risk-reduction,2,0.6931471805599453
distillation,2,0.6931471805599453
Pheochromocytomas,2,0.6931471805599453
receiptnon-receipt,2,0.6931471805599453
FAK-KD,2,0.6931471805599453
provisional,2,0.6931471805599453
locating,2,0.6931471805599453
PBV,2,0.6931471805599453
hurdle,2,0.6931471805599453
Linjudge,2,0.6931471805599453
contradictions,2,0.6931471805599453
subcategories,2,0.6931471805599453
warmer,2,0.6931471805599453
mutually,2,0.6931471805599453
atheroembolic,2,0.6931471805599453
silicon,2,0.6931471805599453
Th,2,0.6931471805599453
nonsmoking,2,0.6931471805599453
president,2,0.6931471805599453
1525,2,0.6931471805599453
user-generated,2,0.6931471805599453
1425,2,0.6931471805599453
ILI-related,2,0.6931471805599453
Qatar,2,0.6931471805599453
uniqueness,2,0.6931471805599453
PGF,2,0.6931471805599453
biogenesis,2,0.6931471805599453
Predominantly,2,0.6931471805599453
FluApdm,2,0.6931471805599453
Oslo,2,0.6931471805599453
Migrainous,2,0.6931471805599453
interrelations,2,0.6931471805599453
television,2,0.6931471805599453
Preference,2,0.6931471805599453
sewersheds,2,0.6931471805599453
FACS,2,0.6931471805599453
CD19,2,0.6931471805599453
ISIS-2,2,0.6931471805599453
KwaZulu-Natal,2,0.6931471805599453
0600,2,0.6931471805599453
Checklist,2,0.6931471805599453
1800,2,0.6931471805599453
MHT,2,0.6931471805599453
rhythmic,2,0.6931471805599453
anti-inflammation,2,0.6931471805599453
duo,2,0.6931471805599453
scatter,2,0.6931471805599453
january,2,0.6931471805599453
post-vaccine,2,0.6931471805599453
2a,2,0.6931471805599453
774,2,0.6931471805599453
50-60,2,0.6931471805599453
Beta-blocking,2,0.6931471805599453
John,2,0.6931471805599453
sur,2,0.6931471805599453
HA-pseudoviruses,2,0.6931471805599453
cross-neutralizing,2,0.6931471805599453
Multimodal,2,0.6931471805599453
owned,2,0.6931471805599453
POINTS,2,0.6931471805599453
2443,2,0.6931471805599453
201718,2,0.6931471805599453
Combo,2,0.6931471805599453
tell,2,0.6931471805599453
lysosomes,2,0.6931471805599453
hydrochlorotiazide,2,0.6931471805599453
persuasive,2,0.6931471805599453
Altered,2,0.6931471805599453
1986-1987,2,0.6931471805599453
component-gene,2,0.6931471805599453
7-15,2,0.6931471805599453
0-6,2,0.6931471805599453
Titers,2,0.6931471805599453
appealing,2,0.6931471805599453
One-hundred,2,0.6931471805599453
Varenicline,2,0.6931471805599453
CTLs,2,0.6931471805599453
relapsing,2,0.6931471805599453
short-read,2,0.6931471805599453
landscapes,2,0.6931471805599453
gram-negative,2,0.6931471805599453
imagined,2,0.6931471805599453
2125,2,0.6931471805599453
rounds,2,0.6931471805599453
subsample,2,0.6931471805599453
Interferon,2,0.6931471805599453
Adenosine,2,0.6931471805599453
13-24,2,0.6931471805599453
16-64,2,0.6931471805599453
Amplification,2,0.6931471805599453
expert-reviewed,2,0.6931471805599453
Th-2,2,0.6931471805599453
groundwater,2,0.6931471805599453
coronavirus-related,2,0.6931471805599453
001The,2,0.6931471805599453
Anti,2,0.6931471805599453
96-98,2,0.6931471805599453
subcommittees,2,0.6931471805599453
Disaster,2,0.6931471805599453
36-48,2,0.6931471805599453
3-terminal,2,0.6931471805599453
Beckman,2,0.6931471805599453
Poludanum,2,0.6931471805599453
LVES,2,0.6931471805599453
amplicon-based,2,0.6931471805599453
furthermore,2,0.6931471805599453
HIV-1-based,2,0.6931471805599453
Tennessee,2,0.6931471805599453
Technetium,2,0.6931471805599453
prodromi,2,0.6931471805599453
hydrolyze,2,0.6931471805599453
R203KG204R,2,0.6931471805599453
TCC,2,0.6931471805599453
15-25,2,0.6931471805599453
instigate,2,0.6931471805599453
Related,2,0.6931471805599453
329-473,2,0.6931471805599453
reflectance,2,0.6931471805599453
Thrombocytopenia,2,0.6931471805599453
topological,2,0.6931471805599453
analgesics,2,0.6931471805599453
neuroadrenergic,2,0.6931471805599453
1982-1983,2,0.6931471805599453
Two-hundred,2,0.6931471805599453
antiretroviral,2,0.6931471805599453
free-ranging,2,0.6931471805599453
Alma-Ata,2,0.6931471805599453
etiologically,2,0.6931471805599453
affinities,2,0.6931471805599453
Subgroups,2,0.6931471805599453
HPAIV,2,0.6931471805599453
core-too-large,2,0.6931471805599453
AUCs,2,0.6931471805599453
hydroxide,2,0.6931471805599453
673,2,0.6931471805599453
immunoblotting,2,0.6931471805599453
Electrocardiography,2,0.6931471805599453
H5N1AV,2,0.6931471805599453
aggression,2,0.6931471805599453
enterprises,2,0.6931471805599453
chylothorax,2,0.6931471805599453
aeromedical,2,0.6931471805599453
Inner-City,2,0.6931471805599453
HINTS-plus,2,0.6931471805599453
Goal,2,0.6931471805599453
mobilisation,2,0.6931471805599453
Hill,2,0.6931471805599453
2018-2019,2,0.6931471805599453
CVRF,2,0.6931471805599453
Portal,2,0.6931471805599453
n50,2,0.6931471805599453
Progressive,2,0.6931471805599453
Platform,2,0.6931471805599453
p00005,2,0.6931471805599453
nonasthmatics,2,0.6931471805599453
Mast,2,0.6931471805599453
divisions,2,0.6931471805599453
stroke-prone,2,0.6931471805599453
age-associated,2,0.6931471805599453
200304,2,0.6931471805599453
TOE,2,0.6931471805599453
purify,2,0.6931471805599453
hesitancyresistance,2,0.6931471805599453
purported,2,0.6931471805599453
H7N3,2,0.6931471805599453
TTETOE,2,0.6931471805599453
Counselling,2,0.6931471805599453
approximation,2,0.6931471805599453
1684,2,0.6931471805599453
CPT,2,0.6931471805599453
agarose,2,0.6931471805599453
pharmacotherapeutic,2,0.6931471805599453
Eosinophil,2,0.6931471805599453
presenceabsence,2,0.6931471805599453
teenage,2,0.6931471805599453
bactericidal,2,0.6931471805599453
manipulate,2,0.6931471805599453
irreversibility,2,0.6931471805599453
overestimated,2,0.6931471805599453
high-sensitive,2,0.6931471805599453
PAedP,2,0.6931471805599453
separating,2,0.6931471805599453
deiodinase,2,0.6931471805599453
non-hypertensive,2,0.6931471805599453
distally,2,0.6931471805599453
individualization,2,0.6931471805599453
watt,2,0.6931471805599453
gonadal,2,0.6931471805599453
Underlying,2,0.6931471805599453
XY,2,0.6931471805599453
dyskinetic,2,0.6931471805599453
expresses,2,0.6931471805599453
phenotyped,2,0.6931471805599453
PHIs,2,0.6931471805599453
NPI,2,0.6931471805599453
ECHO,2,0.6931471805599453
genetical,2,0.6931471805599453
24-72,2,0.6931471805599453
sELISA,2,0.6931471805599453
post-IAV,2,0.6931471805599453
Xinfadi,2,0.6931471805599453
XFD,2,0.6931471805599453
Black-blood,2,0.6931471805599453
authorize,2,0.6931471805599453
infarct-like,2,0.6931471805599453
Sanitation,2,0.6931471805599453
antiaggregant,2,0.6931471805599453
hasten,2,0.6931471805599453
door-to-imaging,2,0.6931471805599453
4-16,2,0.6931471805599453
proliferator-activated,2,0.6931471805599453
Geyer,2,0.6931471805599453
peroxisome,2,0.6931471805599453
talk,2,0.6931471805599453
propagated,2,0.6931471805599453
poised,2,0.6931471805599453
Diamond,2,0.6931471805599453
n30,2,0.6931471805599453
Princess,2,0.6931471805599453
45h,2,0.6931471805599453
FCG,2,0.6931471805599453
High-frequency,2,0.6931471805599453
abundantly,2,0.6931471805599453
swineIowa1530,2,0.6931471805599453
neutropenic,2,0.6931471805599453
CTPA,2,0.6931471805599453
Seventy-two,2,0.6931471805599453
spiral,2,0.6931471805599453
19-fold,2,0.6931471805599453
β-agonists,2,0.6931471805599453
dilatations,2,0.6931471805599453
exhibition,2,0.6931471805599453
523,2,0.6931471805599453
PEF-guided,2,0.6931471805599453
745,2,0.6931471805599453
nonvaccinated,2,0.6931471805599453
3-day,2,0.6931471805599453
coroners,2,0.6931471805599453
n35,2,0.6931471805599453
certifying,2,0.6931471805599453
crRNAs,2,0.6931471805599453
swineTaiwan69,2,0.6931471805599453
unquestioned,2,0.6931471805599453
transdermal,2,0.6931471805599453
cancer-specific,2,0.6931471805599453
13-18,2,0.6931471805599453
490,2,0.6931471805599453
OLT,2,0.6931471805599453
liver-related,2,0.6931471805599453
hepatocellular,2,0.6931471805599453
XXF,2,0.6931471805599453
Paediatricians,2,0.6931471805599453
maternal-fetal,2,0.6931471805599453
XXM,2,0.6931471805599453
XYF,2,0.6931471805599453
XYM,2,0.6931471805599453
Multivessel,2,0.6931471805599453
notice,2,0.6931471805599453
IAVs,2,0.6931471805599453
Jude,2,0.6931471805599453
sMCAO,2,0.6931471805599453
nylon,2,0.6931471805599453
Disease-2019,2,0.6931471805599453
nonmodifiable,2,0.6931471805599453
northwestern,2,0.6931471805599453
waist,2,0.6931471805599453
ORF14,2,0.6931471805599453
ACSS,2,0.6931471805599453
Scoring,2,0.6931471805599453
two-fold,2,0.6931471805599453
9b,2,0.6931471805599453
encode,2,0.6931471805599453
ORFs,2,0.6931471805599453
suppurative,2,0.6931471805599453
intermittently,2,0.6931471805599453
BFMI,2,0.6931471805599453
FFMI,2,0.6931471805599453
nanotechnology,2,0.6931471805599453
Nanomaterials,2,0.6931471805599453
1880,2,0.6931471805599453
reusable,2,0.6931471805599453
p65,2,0.6931471805599453
mutating,2,0.6931471805599453
DPP4,2,0.6931471805599453
NSP13,2,0.6931471805599453
underestimates,2,0.6931471805599453
craniocerebral,2,0.6931471805599453
senile,2,0.6931471805599453
lambda-like,2,0.6931471805599453
ever-increasing,2,0.6931471805599453
veloergometry,2,0.6931471805599453
feet,2,0.6931471805599453
salvaging,2,0.6931471805599453
Neuroprotective,2,0.6931471805599453
GICA,2,0.6931471805599453
deformation,2,0.6931471805599453
Challenges,2,0.6931471805599453
initio,2,0.6931471805599453
single-tube,2,0.6931471805599453
vaccine2,2,0.6931471805599453
inadequacies,2,0.6931471805599453
anxiolytic,2,0.6931471805599453
intuition,2,0.6931471805599453
inotropes,2,0.6931471805599453
VSDs,2,0.6931471805599453
997,2,0.6931471805599453
867,2,0.6931471805599453
endeavor,2,0.6931471805599453
hemopneumothorax,2,0.6931471805599453
Quito,2,0.6931471805599453
HGSQ,2,0.6931471805599453
uraemia,2,0.6931471805599453
AAP,2,0.6931471805599453
AI-assisted,2,0.6931471805599453
biannual,2,0.6931471805599453
rostral,2,0.6931471805599453
microV,2,0.6931471805599453
H1N1pdm09-like,2,0.6931471805599453
Kong48012014,2,0.6931471805599453
protuberance,2,0.6931471805599453
traumatism,2,0.6931471805599453
Vertebral,2,0.6931471805599453
pair-approximation,2,0.6931471805599453
BPhuket30732013-like,2,0.6931471805599453
lineage3,2,0.6931471805599453
1638,2,0.6931471805599453
care-associated,2,0.6931471805599453
head-velocity,2,0.6931471805599453
4-10,2,0.6931471805599453
ribosomal,2,0.6931471805599453
allergen-SIT,2,0.6931471805599453
macro-economic,2,0.6931471805599453
effluent,2,0.6931471805599453
PFC,2,0.6931471805599453
globular,2,0.6931471805599453
helices,2,0.6931471805599453
Panbio,2,0.6931471805599453
mutability,2,0.6931471805599453
Dyspnea,2,0.6931471805599453
non-black,2,0.6931471805599453
severefatal,2,0.6931471805599453
virulence-conferring,2,0.6931471805599453
obliteration,2,0.6931471805599453
misperceptions,2,0.6931471805599453
treatment-seeking,2,0.6931471805599453
Household,2,0.6931471805599453
PubMedMEDLINE,2,0.6931471805599453
Islamic,2,0.6931471805599453
day-time,2,0.6931471805599453
1-8,2,0.6931471805599453
Integration,2,0.6931471805599453
malpractice,2,0.6931471805599453
dies,2,0.6931471805599453
hierarchically,2,0.6931471805599453
Neuroplasticity,2,0.6931471805599453
gradients,2,0.6931471805599453
apolipoprotein,2,0.6931471805599453
multisystemic,2,0.6931471805599453
Dietary,2,0.6931471805599453
helix,2,0.6931471805599453
2-family,2,0.6931471805599453
coverings,2,0.6931471805599453
bilayer,2,0.6931471805599453
corporations,2,0.6931471805599453
NOEs,2,0.6931471805599453
mentioning,2,0.6931471805599453
disorientation,2,0.6931471805599453
cerebro-vascular,2,0.6931471805599453
CT-based,2,0.6931471805599453
pasteurization,2,0.6931471805599453
remit,2,0.6931471805599453
hydraulic,2,0.6931471805599453
constricted,2,0.6931471805599453
acronym,2,0.6931471805599453
DF,2,0.6931471805599453
Doubled,2,0.6931471805599453
ICHs,2,0.6931471805599453
00009,2,0.6931471805599453
hypogammaglobulinemia,2,0.6931471805599453
LPs,2,0.6931471805599453
rearrange,2,0.6931471805599453
pancreas,2,0.6931471805599453
metabolizes,2,0.6931471805599453
preservatives,2,0.6931471805599453
sulfites,2,0.6931471805599453
phosphorylation,2,0.6931471805599453
clamping,2,0.6931471805599453
empty,2,0.6931471805599453
cannulation,2,0.6931471805599453
stressing,2,0.6931471805599453
underassessed,2,0.6931471805599453
angioplasties,2,0.6931471805599453
wedge-shaped,2,0.6931471805599453
Preventative,2,0.6931471805599453
early-phase,2,0.6931471805599453
Placing,2,0.6931471805599453
Dramatic,2,0.6931471805599453
run-in,2,0.6931471805599453
rheumatologic,2,0.6931471805599453
antipyretic,2,0.6931471805599453
filariae,2,0.6931471805599453
hastens,2,0.6931471805599453
hopeful,2,0.6931471805599453
Nitrite,2,0.6931471805599453
0-17,2,0.6931471805599453
TaqPathTM,2,0.6931471805599453
B1133,2,0.6931471805599453
Whole-genome,2,0.6931471805599453
macrocephalus,2,0.6931471805599453
persuasiveness,2,0.6931471805599453
LAP,2,0.6931471805599453
not-well,2,0.6931471805599453
epidrugs,2,0.6931471805599453
Anhui,2,0.6931471805599453
Inner,2,0.6931471805599453
collated,2,0.6931471805599453
President,2,0.6931471805599453
billing,2,0.6931471805599453
year-to-year,2,0.6931471805599453
richness,2,0.6931471805599453
Crisis,2,0.6931471805599453
lately,2,0.6931471805599453
unfolded,2,0.6931471805599453
telephoning,2,0.6931471805599453
dusty,2,0.6931471805599453
enclosed,2,0.6931471805599453
S4,2,0.6931471805599453
Churchill,2,0.6931471805599453
reticulum-associated,2,0.6931471805599453
Minister,2,0.6931471805599453
Premier,2,0.6931471805599453
hSAR,2,0.6931471805599453
Household-based,2,0.6931471805599453
coryza,2,0.6931471805599453
forceps,2,0.6931471805599453
empowering,2,0.6931471805599453
replication-incompetent,2,0.6931471805599453
CPLNI,2,0.6931471805599453
RNP,2,0.6931471805599453
biobanking,2,0.6931471805599453
Nagasaki,2,0.6931471805599453
768,2,0.6931471805599453
Nation,2,0.6931471805599453
Environment,2,0.6931471805599453
14-yr-old,2,0.6931471805599453
13-,2,0.6931471805599453
LIMS,2,0.6931471805599453
Well-Integrated,2,0.6931471805599453
HSES,2,0.6931471805599453
admit,2,0.6931471805599453
3-fold,2,0.6931471805599453
intentionally,2,0.6931471805599453
equivalence,2,0.6931471805599453
enzyme-2,2,0.6931471805599453
ingested,2,0.6931471805599453
Proelmed,2,0.6931471805599453
2-fold,2,0.6931471805599453
paramivir,2,0.6931471805599453
ambiguity,2,0.6931471805599453
2-low,2,0.6931471805599453
broken,2,0.6931471805599453
niches,2,0.6931471805599453
Self-reported,2,0.6931471805599453
5862,2,0.6931471805599453
Soviet,2,0.6931471805599453
affordability,2,0.6931471805599453
whole-body,2,0.6931471805599453
alignments,2,0.6931471805599453
reoccurrence,2,0.6931471805599453
endemically,2,0.6931471805599453
Zidovudine,2,0.6931471805599453
Delphi,2,0.6931471805599453
Earthing,2,0.6931471805599453
drinks,2,0.6931471805599453
ΔG,2,0.6931471805599453
Probiotics,2,0.6931471805599453
cryptic,2,0.6931471805599453
GC-MSMS,2,0.6931471805599453
alternans,2,0.6931471805599453
colloidal,2,0.6931471805599453
pleurodesis,2,0.6931471805599453
pleurectomy,2,0.6931471805599453
Often,2,0.6931471805599453
Immunogenicity,2,0.6931471805599453
nobody,2,0.6931471805599453
catamenial,2,0.6931471805599453
PubChem,2,0.6931471805599453
Asinex,2,0.6931471805599453
inositol,2,0.6931471805599453
East-Southeast,2,0.6931471805599453
extravasation,2,0.6931471805599453
prolongs,2,0.6931471805599453
pyruvate,2,0.6931471805599453
Non-invasive,2,0.6931471805599453
mountain,2,0.6931471805599453
70-year-old,2,0.6931471805599453
SNAP,2,0.6931471805599453
defects--VSDs,2,0.6931471805599453
salmeterol,2,0.6931471805599453
Recorded,2,0.6931471805599453
EXTEND,2,0.6931471805599453
GISSI-2,2,0.6931471805599453
subsidence,2,0.6931471805599453
colonies,2,0.6931471805599453
neurointerventional,2,0.6931471805599453
Stingray™,2,0.6931471805599453
mainstream,2,0.6931471805599453
LT-alpha,2,0.6931471805599453
Heterogeneous,2,0.6931471805599453
IAR,2,0.6931471805599453
debilitated,2,0.6931471805599453
Receipt,2,0.6931471805599453
grim,2,0.6931471805599453
non-COVID,2,0.6931471805599453
Gensini,2,0.6931471805599453
anxieties,2,0.6931471805599453
pushed,2,0.6931471805599453
lower-limb,2,0.6931471805599453
BCoM,2,0.6931471805599453
TnI,2,0.6931471805599453
locomotion,2,0.6931471805599453
self-confidence,2,0.6931471805599453
5-years,2,0.6931471805599453
unpartnered,2,0.6931471805599453
Relevant,2,0.6931471805599453
Provision,2,0.6931471805599453
Consolidated,2,0.6931471805599453
membrane-engineered,2,0.6931471805599453
73·8,2,0.6931471805599453
63·3,2,0.6931471805599453
stationary,2,0.6931471805599453
Propofol,2,0.6931471805599453
thiopental,2,0.6931471805599453
eukaryotic,2,0.6931471805599453
Veritor™,2,0.6931471805599453
EIATS-GP,2,0.6931471805599453
nonurban,2,0.6931471805599453
conversions,2,0.6931471805599453
1816,2,0.6931471805599453
whole-virion,2,0.6931471805599453
subtypical,2,0.6931471805599453
N95s,2,0.6931471805599453
severity-of-asthma,2,0.6931471805599453
ramipril,2,0.6931471805599453
plasma-fibrinogen,2,0.6931471805599453
zofenopril,2,0.6931471805599453
five-fold,2,0.6931471805599453
Brewers,2,0.6931471805599453
Vocal,2,0.6931471805599453
SPR,2,0.6931471805599453
Allergists,2,0.6931471805599453
analytes,2,0.6931471805599453
Biosensors,2,0.6931471805599453
Binax,2,0.6931471805599453
parasternal,2,0.6931471805599453
1490,2,0.6931471805599453
SM1,2,0.6931471805599453
bihemispheric,2,0.6931471805599453
non-modifiable,2,0.6931471805599453
standby,2,0.6931471805599453
bullet,2,0.6931471805599453
antithrombin,2,0.6931471805599453
restart,2,0.6931471805599453
multispecialty,2,0.6931471805599453
5-34,2,0.6931471805599453
EIATS-WV,2,0.6931471805599453
royalblue,2,0.6931471805599453
greenyellow,2,0.6931471805599453
Arteriosclerosis,2,0.6931471805599453
CHA₂DS₂VASC,2,0.6931471805599453
CIMT,2,0.6931471805599453
L-arginine,2,0.6931471805599453
SDMA,2,0.6931471805599453
A549-IFN-λ2,2,0.6931471805599453
vaccination-related,2,0.6931471805599453
Pap,2,0.6931471805599453
0014,2,0.6931471805599453
Epitope,2,0.6931471805599453
1987-99,2,0.6931471805599453
819,2,0.6931471805599453
small-airway,2,0.6931471805599453
restrain,2,0.6931471805599453
prostatectomy,2,0.6931471805599453
dispatches,2,0.6931471805599453
cubic,2,0.6931471805599453
Comorbidity,2,0.6931471805599453
Charlson,2,0.6931471805599453
Humphreys,2,0.6931471805599453
army,2,0.6931471805599453
shadows,2,0.6931471805599453
nonhealthcare,2,0.6931471805599453
informants,2,0.6931471805599453
1000000,2,0.6931471805599453
anywhere,2,0.6931471805599453
HFAV,2,0.6931471805599453
anastomosis,2,0.6931471805599453
re-established,2,0.6931471805599453
subclavian,2,0.6931471805599453
7-14,2,0.6931471805599453
Apparently,2,0.6931471805599453
ACC,2,0.6931471805599453
HPB,2,0.6931471805599453
Alzheimer,2,0.6931471805599453
Context—,2,0.6931471805599453
olive,2,0.6931471805599453
scoliosis,2,0.6931471805599453
visit-to-visit,2,0.6931471805599453
spirometers,2,0.6931471805599453
OTCA,2,0.6931471805599453
non-effective,2,0.6931471805599453
Acetylcholinesterase,2,0.6931471805599453
PRAM,2,0.6931471805599453
3400,2,0.6931471805599453
PHC,2,0.6931471805599453
Steps,2,0.6931471805599453
Emirates,2,0.6931471805599453
coiling,2,0.6931471805599453
justifies,2,0.6931471805599453
brushing,2,0.6931471805599453
converging,2,0.6931471805599453
Epidemiol,2,0.6931471805599453
overactivation,2,0.6931471805599453
Evolving,2,0.6931471805599453
PercuSurge,2,0.6931471805599453
A23403G,2,0.6931471805599453
myocardiac,2,0.6931471805599453
ligated,2,0.6931471805599453
1017,2,0.6931471805599453
776,2,0.6931471805599453
arranged,2,0.6931471805599453
sprouting,2,0.6931471805599453
time-points,2,0.6931471805599453
Atmospheric,2,0.6931471805599453
recruit,2,0.6931471805599453
co-factor,2,0.6931471805599453
distinctions,2,0.6931471805599453
pejorative,2,0.6931471805599453
B-C,2,0.6931471805599453
mcg,2,0.6931471805599453
FEF25-75,2,0.6931471805599453
Fifty-four,2,0.6931471805599453
AG,2,0.6931471805599453
LVEDP,2,0.6931471805599453
floor,2,0.6931471805599453
MISs,2,0.6931471805599453
potently,2,0.6931471805599453
3D-STE,2,0.6931471805599453
supply-demand,2,0.6931471805599453
typified,2,0.6931471805599453
high-molecular-weight,2,0.6931471805599453
non-contrast,2,0.6931471805599453
Murmansk,2,0.6931471805599453
Ninety-seven,2,0.6931471805599453
1933,2,0.6931471805599453
prematurely,2,0.6931471805599453
breaking,2,0.6931471805599453
nonpandemic,2,0.6931471805599453
self-identity,2,0.6931471805599453
Sc,2,0.6931471805599453
antemortem,2,0.6931471805599453
AMI-BTT,2,0.6931471805599453
Short-Form,2,0.6931471805599453
36-Item,2,0.6931471805599453
10-14,2,0.6931471805599453
semen,2,0.6931471805599453
CSCs,2,0.6931471805599453
Sustainable,2,0.6931471805599453
STAT1,2,0.6931471805599453
knockdown,2,0.6931471805599453
sIgG4,2,0.6931471805599453
SQ,2,0.6931471805599453
nonpharmacologic,2,0.6931471805599453
AWAD,2,0.6931471805599453
infectious-related,2,0.6931471805599453
UD,2,0.6931471805599453
resolving,2,0.6931471805599453
Bangkok,2,0.6931471805599453
H1N1-infected,2,0.6931471805599453
King,2,0.6931471805599453
hemiballismus,2,0.6931471805599453
High-dose,2,0.6931471805599453
IIV-HD,2,0.6931471805599453
IIV-SD,2,0.6931471805599453
MP789,2,0.6931471805599453
Genomes,2,0.6931471805599453
peculiarities,2,0.6931471805599453
CpGs,2,0.6931471805599453
clinical-epidemiological,2,0.6931471805599453
ascendant,2,0.6931471805599453
rolled,2,0.6931471805599453
gait-training,2,0.6931471805599453
pharmaceuticals,2,0.6931471805599453
impeded,2,0.6931471805599453
autoimmunity,2,0.6931471805599453
artificially,2,0.6931471805599453
colourful,2,0.6931471805599453
conversely,2,0.6931471805599453
C677T,2,0.6931471805599453
citations,2,0.6931471805599453
8-30,2,0.6931471805599453
AOR,2,0.6931471805599453
Ag-RDT,2,0.6931471805599453
eustachian,2,0.6931471805599453
LCSC,2,0.6931471805599453
struggles,2,0.6931471805599453
hampering,2,0.6931471805599453
eighty,2,0.6931471805599453
booth,2,0.6931471805599453
non-respiratory,2,0.6931471805599453
paraffin-embedded,2,0.6931471805599453
pharmacogenetics,2,0.6931471805599453
1990-91,2,0.6931471805599453
DAO,2,0.6931471805599453
Pharmacogenomics,2,0.6931471805599453
ROM,2,0.6931471805599453
619,2,0.6931471805599453
furosemide,2,0.6931471805599453
1995-1996,2,0.6931471805599453
Pharmacogenetic,2,0.6931471805599453
full-growns,2,0.6931471805599453
nonhospitalized,2,0.6931471805599453
off-campus,2,0.6931471805599453
undergraduates,2,0.6931471805599453
graduate,2,0.6931471805599453
AOT,2,0.6931471805599453
CRV,2,0.6931471805599453
polarization,2,0.6931471805599453
Optical,2,0.6931471805599453
10W,2,0.6931471805599453
Ground-glass,2,0.6931471805599453
telemedically,2,0.6931471805599453
orchestrating,2,0.6931471805599453
ambulate,2,0.6931471805599453
Encyclopedia,2,0.6931471805599453
execute,2,0.6931471805599453
99mTc-gated,2,0.6931471805599453
cath-lab,2,0.6931471805599453
scaffolds,2,0.6931471805599453
unload,2,0.6931471805599453
kDa,2,0.6931471805599453
infestation,2,0.6931471805599453
585,2,0.6931471805599453
1823,2,0.6931471805599453
1540,2,0.6931471805599453
narrowings,2,0.6931471805599453
binders,2,0.6931471805599453
MM4,2,0.6931471805599453
oligopeptides,2,0.6931471805599453
electrostimulation,2,0.6931471805599453
regress,2,0.6931471805599453
201Tl-scintigraphy,2,0.6931471805599453
Kyoto,2,0.6931471805599453
Teen-caregiver,2,0.6931471805599453
teen,2,0.6931471805599453
Nor,2,0.6931471805599453
1992-1993,2,0.6931471805599453
Trevo,2,0.6931471805599453
thermophilus,2,0.6931471805599453
811,2,0.6931471805599453
50min,2,0.6931471805599453
atypia,2,0.6931471805599453
retinoic,2,0.6931471805599453
non-paced,2,0.6931471805599453
non-asthmatics,2,0.6931471805599453
discriminated,2,0.6931471805599453
Manufacturers,2,0.6931471805599453
Faced,2,0.6931471805599453
recent-phase,2,0.6931471805599453
FGF-23,2,0.6931471805599453
toolbox,2,0.6931471805599453
DEPs,2,0.6931471805599453
Nanyang,2,0.6931471805599453
heartbeat,2,0.6931471805599453
susceptibles,2,0.6931471805599453
build-up,2,0.6931471805599453
understudied,2,0.6931471805599453
monoform,2,0.6931471805599453
seeing,2,0.6931471805599453
n70,2,0.6931471805599453
RWA,2,0.6931471805599453
Coxs,2,0.6931471805599453
sideways,2,0.6931471805599453
lidocaine,2,0.6931471805599453
isointegral,2,0.6931471805599453
Lymphocyte,2,0.6931471805599453
moesin,2,0.6931471805599453
stretch,2,0.6931471805599453
ezrin,2,0.6931471805599453
nt,2,0.6931471805599453
sibutramine,2,0.6931471805599453
IUmlh,2,0.6931471805599453
TIVs,2,0.6931471805599453
life-year,2,0.6931471805599453
MAP,2,0.6931471805599453
Contributors,2,0.6931471805599453
H5N1-induced,2,0.6931471805599453
alum,2,0.6931471805599453
n25,2,0.6931471805599453
non-pulmonary,2,0.6931471805599453
MS2,2,0.6931471805599453
Loop-mediated,2,0.6931471805599453
22-year-old,2,0.6931471805599453
methodologic,2,0.6931471805599453
vanished,2,0.6931471805599453
prepares,2,0.6931471805599453
Serine128Arginine,2,0.6931471805599453
extramural,2,0.6931471805599453
microsphere,2,0.6931471805599453
raceethnic,2,0.6931471805599453
microgramsday,2,0.6931471805599453
onset-to-door,2,0.6931471805599453
stimulant,2,0.6931471805599453
NOMAS,2,0.6931471805599453
absorbance,2,0.6931471805599453
naked-eye,2,0.6931471805599453
Employees,2,0.6931471805599453
Practical,2,0.6931471805599453
Unique,2,0.6931471805599453
athlete,2,0.6931471805599453
943,2,0.6931471805599453
mid-September,2,0.6931471805599453
psychogenias,2,0.6931471805599453
bioterrorism,2,0.6931471805599453
CVDs,2,0.6931471805599453
CB1,2,0.6931471805599453
CB2,2,0.6931471805599453
dinucleotides,2,0.6931471805599453
photothrombotic,2,0.6931471805599453
chemoreflex,2,0.6931471805599453
FHMC,2,0.6931471805599453
cardiocirculatory,2,0.6931471805599453
garlic,2,0.6931471805599453
plain,2,0.6931471805599453
civets,2,0.6931471805599453
Azygos,2,0.6931471805599453
cross-recognition,2,0.6931471805599453
Józef,2,0.6931471805599453
revisit,2,0.6931471805599453
forelimb,2,0.6931471805599453
Distal,2,0.6931471805599453
cores,2,0.6931471805599453
recalls,2,0.6931471805599453
clear-cut,2,0.6931471805599453
breathe,2,0.6931471805599453
adrenaline,2,0.6931471805599453
gEq,2,0.6931471805599453
Cybulski,2,0.6931471805599453
dissolve,2,0.6931471805599453
plasmin,2,0.6931471805599453
Mönkemüller,2,0.6931471805599453
AEngland4272,2,0.6931471805599453
SAR,2,0.6931471805599453
carriage,2,0.6931471805599453
Władysław,2,0.6931471805599453
Chalmers173,2,0.6931471805599453
vectorcardiogram,2,0.6931471805599453
Korczyński,2,0.6931471805599453
RealTime,2,0.6931471805599453
modifier,2,0.6931471805599453
intra-assay,2,0.6931471805599453
apnoeas,2,0.6931471805599453
ADRs,2,0.6931471805599453
subnational,2,0.6931471805599453
hyperdense,2,0.6931471805599453
anteriorly,2,0.6931471805599453
esophageal-pleural,2,0.6931471805599453
i2000,2,0.6931471805599453
catalase,2,0.6931471805599453
anti-N,2,0.6931471805599453
occupant,2,0.6931471805599453
SOFA,2,0.6931471805599453
unused,2,0.6931471805599453
mists,2,0.6931471805599453
momentum,2,0.6931471805599453
2344,2,0.6931471805599453
webservers,2,0.6931471805599453
Jan,2,0.6931471805599453
OverCOVID,2,0.6931471805599453
needling,2,0.6931471805599453
2050,2,0.6931471805599453
fix,2,0.6931471805599453
scientist,2,0.6931471805599453
Non-vitamin,2,0.6931471805599453
handwashing,2,0.6931471805599453
PNI,2,0.6931471805599453
SAPS,2,0.6931471805599453
Agents,2,0.6931471805599453
Apache,2,0.6931471805599453
41-year,2,0.6931471805599453
dysregulate,2,0.6931471805599453
2006-2014,2,0.6931471805599453
checklist,2,0.6931471805599453
Again,2,0.6931471805599453
phosphoprotein,2,0.6931471805599453
backed,2,0.6931471805599453
Diarrhea,2,0.6931471805599453
sulfinpyrazone,2,0.6931471805599453
hide,2,0.6931471805599453
52-year-old,2,0.6931471805599453
Jaccard,2,0.6931471805599453
model-free,2,0.6931471805599453
interpretable,2,0.6931471805599453
MLP,2,0.6931471805599453
Richard,2,0.6931471805599453
LDF,2,0.6931471805599453
Stepwise,2,0.6931471805599453
Modernas,2,0.6931471805599453
23-71,2,0.6931471805599453
20-37,2,0.6931471805599453
undecided,2,0.6931471805599453
architectural,2,0.6931471805599453
Modifiable,2,0.6931471805599453
cromones,2,0.6931471805599453
Murine,2,0.6931471805599453
grossly,2,0.6931471805599453
indefinitely,2,0.6931471805599453
Gram,2,0.6931471805599453
Intermittent,2,0.6931471805599453
corpuscular,2,0.6931471805599453
702,2,0.6931471805599453
hematologic-metabolic,2,0.6931471805599453
noninfarction,2,0.6931471805599453
951,2,0.6931471805599453
paresthesias,2,0.6931471805599453
achieves,2,0.6931471805599453
≤6,2,0.6931471805599453
incubating,2,0.6931471805599453
surrogates,2,0.6931471805599453
parathyroid,2,0.6931471805599453
15-mer,2,0.6931471805599453
innervation,2,0.6931471805599453
rearrangement,2,0.6931471805599453
minimised,2,0.6931471805599453
NFZ,2,0.6931471805599453
caps,2,0.6931471805599453
non-transplant,2,0.6931471805599453
N-terminus,2,0.6931471805599453
Underuse,2,0.6931471805599453
LIFE,2,0.6931471805599453
1707,2,0.6931471805599453
28-year-old,2,0.6931471805599453
cerebroprotection,2,0.6931471805599453
immunocomplexes,2,0.6931471805599453
ARB,2,0.6931471805599453
Colleges,2,0.6931471805599453
lactose,2,0.6931471805599453
massively,2,0.6931471805599453
springboard,2,0.6931471805599453
moulds,2,0.6931471805599453
piloted,2,0.6931471805599453
factory,2,0.6931471805599453
realist,2,0.6931471805599453
emotionally,2,0.6931471805599453
Classifying,2,0.6931471805599453
hospital-level,2,0.6931471805599453
musculature,2,0.6931471805599453
livelihoods,2,0.6931471805599453
ticagrelor,2,0.6931471805599453
≥2,2,0.6931471805599453
Topical,2,0.6931471805599453
flushing,2,0.6931471805599453
≥90,2,0.6931471805599453
fertility,2,0.6931471805599453
Lancet,2,0.6931471805599453
liquids,2,0.6931471805599453
3-10,2,0.6931471805599453
tht,2,0.6931471805599453
804,2,0.6931471805599453
hday,2,0.6931471805599453
activation-recovery,2,0.6931471805599453
Aerocrine,2,0.6931471805599453
ion-channel,2,0.6931471805599453
preadmission,2,0.6931471805599453
USEPA,2,0.6931471805599453
fluency,2,0.6931471805599453
tentative,2,0.6931471805599453
Brocas,2,0.6931471805599453
non-FN,2,0.6931471805599453
warn,2,0.6931471805599453
refusing,2,0.6931471805599453
reliabilities,2,0.6931471805599453
residency,2,0.6931471805599453
aligns,2,0.6931471805599453
Walker,2,0.6931471805599453
reopen,2,0.6931471805599453
protections,2,0.6931471805599453
EPRR,2,0.6931471805599453
printed,2,0.6931471805599453
rest-injected,2,0.6931471805599453
Adding,2,0.6931471805599453
C57BL6J,2,0.6931471805599453
demented,2,0.6931471805599453
verbatim,2,0.6931471805599453
Dispersion,2,0.6931471805599453
1911,2,0.6931471805599453
Ninety-day,2,0.6931471805599453
sewing,2,0.6931471805599453
arthroplasty,2,0.6931471805599453
activators,2,0.6931471805599453
0-22,2,0.6931471805599453
captures,2,0.6931471805599453
non-transmural,2,0.6931471805599453
RT-qPCR-based,2,0.6931471805599453
terrestrial,2,0.6931471805599453
theophyllines,2,0.6931471805599453
apathetic,2,0.6931471805599453
pressure-lowering,2,0.6931471805599453
watery,2,0.6931471805599453
nicotine,2,0.6931471805599453
dissatisfaction,2,0.6931471805599453
Sp,2,0.6931471805599453
20-minute,2,0.6931471805599453
WBCs,2,0.6931471805599453
turns,2,0.6931471805599453
pioneers,2,0.6931471805599453
orderly,2,0.6931471805599453
Olten,2,0.6931471805599453
armed,2,0.6931471805599453
No-reflow,2,0.6931471805599453
fostering,2,0.6931471805599453
plasmids,2,0.6931471805599453
respiratory-related,2,0.6931471805599453
knowledge-sharing,2,0.6931471805599453
imagine,2,0.6931471805599453
Influenza-related,2,0.6931471805599453
subpleural,2,0.6931471805599453
virgin,2,0.6931471805599453
neurotherapeutic,2,0.6931471805599453
Company,2,0.6931471805599453
ophthalmologists,2,0.6931471805599453
migrations,2,0.6931471805599453
mw,2,0.6931471805599453
Defect,2,0.6931471805599453
Aq,2,0.6931471805599453
colored,2,0.6931471805599453
NBT,2,0.6931471805599453
atraumatic,2,0.6931471805599453
socio-economically,2,0.6931471805599453
RNV,2,0.6931471805599453
EUA-approved,2,0.6931471805599453
transfers,2,0.6931471805599453
neutrality,2,0.6931471805599453
tocolytic,2,0.6931471805599453
Wright,2,0.6931471805599453
radiomics-based,2,0.6931471805599453
BIOSYNEX®,2,0.6931471805599453
Immunocompromised,2,0.6931471805599453
exacts,2,0.6931471805599453
antiinfluenza,2,0.6931471805599453
β-weights,2,0.6931471805599453
Youdens,2,0.6931471805599453
14-fold,2,0.6931471805599453
reuptake,2,0.6931471805599453
texture-related,2,0.6931471805599453
cytometry-based,2,0.6931471805599453
Adjustment,2,0.6931471805599453
HPG,2,0.6931471805599453
TGFβ1,2,0.6931471805599453
internet,2,0.6931471805599453
nonteaching,2,0.6931471805599453
1120,2,0.6931471805599453
PGE2,2,0.6931471805599453
Admissions,2,0.6931471805599453
fixing,2,0.6931471805599453
disulfide,2,0.6931471805599453
unjammed,2,0.6931471805599453
inventory-20,2,0.6931471805599453
assists,2,0.6931471805599453
Tel,2,0.6931471805599453
Aviv,2,0.6931471805599453
severer,2,0.6931471805599453
Pontryagins,2,0.6931471805599453
rainy,2,0.6931471805599453
pectoral,2,0.6931471805599453
truth,2,0.6931471805599453
under-estimation,2,0.6931471805599453
Croatian,2,0.6931471805599453
IV3,2,0.6931471805599453
sphingosine-1-phosphate,2,0.6931471805599453
-2SD,2,0.6931471805599453
WMAS,2,0.6931471805599453
PLpro,2,0.6931471805599453
centerline,2,0.6931471805599453
6-19,2,0.6931471805599453
20-39,2,0.6931471805599453
preschool-age,2,0.6931471805599453
ICDs,2,0.6931471805599453
collateralization,2,0.6931471805599453
glycomics,2,0.6931471805599453
ninety-seven,2,0.6931471805599453
9-month,2,0.6931471805599453
Near-fatal,2,0.6931471805599453
veritable,2,0.6931471805599453
deepening,2,0.6931471805599453
bare,2,0.6931471805599453
kills,2,0.6931471805599453
logically,2,0.6931471805599453
myotubes,2,0.6931471805599453
myoblasts,2,0.6931471805599453
collaborated,2,0.6931471805599453
coordinator,2,0.6931471805599453
Lightmix®,2,0.6931471805599453
LMCA,2,0.6931471805599453
pregnancy-induced,2,0.6931471805599453
hospital-wide,2,0.6931471805599453
bystander,2,0.6931471805599453
biophysical,2,0.6931471805599453
paying,2,0.6931471805599453
price,2,0.6931471805599453
heparins,2,0.6931471805599453
LSTM,2,0.6931471805599453
annulus,2,0.6931471805599453
CCAM,2,0.6931471805599453
ambition,2,0.6931471805599453
narrated,2,0.6931471805599453
forestall,2,0.6931471805599453
contigs,2,0.6931471805599453
Toward,2,0.6931471805599453
glioma,2,0.6931471805599453
flourishing,2,0.6931471805599453
Keeping,2,0.6931471805599453
avian-origin,2,0.6931471805599453
ISRO,2,0.6931471805599453
prostaglandin,2,0.6931471805599453
paraffin,2,0.6931471805599453
Enigma,2,0.6931471805599453
adult-specific,2,0.6931471805599453
Generation,2,0.6931471805599453
Worse,2,0.6931471805599453
detritus,2,0.6931471805599453
subnormal,2,0.6931471805599453
quantum,2,0.6931471805599453
84-year-old,2,0.6931471805599453
Preventable,2,0.6931471805599453
Potentially,2,0.6931471805599453
Angiotensin-converting-enzyme,2,0.6931471805599453
ml3,2,0.6931471805599453
antioxidation,2,0.6931471805599453
rRBD,2,0.6931471805599453
perceptible,2,0.6931471805599453
CCL-81,2,0.6931471805599453
Wise,2,0.6931471805599453
BE,2,0.6931471805599453
529,2,0.6931471805599453
PhT,2,0.6931471805599453
Antioxidants,2,0.6931471805599453
clinical-anamnestic,2,0.6931471805599453
fundamentally,2,0.6931471805599453
HArS,2,0.6931471805599453
symmetry,2,0.6931471805599453
predominating,2,0.6931471805599453
powers,2,0.6931471805599453
Be,2,0.6931471805599453
LDL-C,2,0.6931471805599453
cofactor,2,0.6931471805599453
Rising,2,0.6931471805599453
contemplating,2,0.6931471805599453
minireplicon,2,0.6931471805599453
Th17,2,0.6931471805599453
host-gene,2,0.6931471805599453
Relatively,2,0.6931471805599453
SDchord,2,0.6931471805599453
five-week,2,0.6931471805599453
history-taking,2,0.6931471805599453
one-month,2,0.6931471805599453
V1-V6,2,0.6931471805599453
Perspectives,2,0.6931471805599453
birthplace,2,0.6931471805599453
heterotypic,2,0.6931471805599453
panzootic,2,0.6931471805599453
nebulisation,2,0.6931471805599453
2FdC,2,0.6931471805599453
bites,2,0.6931471805599453
379,2,0.6931471805599453
budding,2,0.6931471805599453
30-339,2,0.6931471805599453
announcements,2,0.6931471805599453
US-licensed,2,0.6931471805599453
standard-dose,2,0.6931471805599453
dysregulates,2,0.6931471805599453
confounds,2,0.6931471805599453
non-gated,2,0.6931471805599453
hemadsorption,2,0.6931471805599453
200958No,2,0.6931471805599453
incongruence,2,0.6931471805599453
BAO,2,0.6931471805599453
Concordance,2,0.6931471805599453
skin-test,2,0.6931471805599453
Familial,2,0.6931471805599453
vaccine-mediated,2,0.6931471805599453
rPCI,2,0.6931471805599453
961,2,0.6931471805599453
enduring,2,0.6931471805599453
non-CIB,2,0.6931471805599453
xanthines,2,0.6931471805599453
Geriatric,2,0.6931471805599453
aVR,2,0.6931471805599453
dairy,2,0.6931471805599453
ketamine,2,0.6931471805599453
Spearman-rho,2,0.6931471805599453
Depressed,2,0.6931471805599453
opposes,2,0.6931471805599453
defeat,2,0.6931471805599453
environment-,2,0.6931471805599453
medicolegal,2,0.6931471805599453
regularity,2,0.6931471805599453
NOTEWORTHY,2,0.6931471805599453
NEW,2,0.6931471805599453
sensory-motor,2,0.6931471805599453
Controversies,2,0.6931471805599453
Favara,2,0.6931471805599453
steadier,2,0.6931471805599453
Favignana,2,0.6931471805599453
H1N1-associated,2,0.6931471805599453
Correct,2,0.6931471805599453
MVC,2,0.6931471805599453
torque,2,0.6931471805599453
transpulmonary,2,0.6931471805599453
memory-guided,2,0.6931471805599453
eviction,2,0.6931471805599453
bereaved,2,0.6931471805599453
Person-to-person,2,0.6931471805599453
reticular,2,0.6931471805599453
NeuroAiD,2,0.6931471805599453
case-crossover,2,0.6931471805599453
Bullous,2,0.6931471805599453
elastance,2,0.6931471805599453
atlantoaxial,2,0.6931471805599453
accession,2,0.6931471805599453
GSE97320,2,0.6931471805599453
Hormonal,2,0.6931471805599453
exquisitely,2,0.6931471805599453
heated,2,0.6931471805599453
Eskimo,2,0.6931471805599453
Annotation,2,0.6931471805599453
tortuous,2,0.6931471805599453
HHS,2,0.6931471805599453
649,2,0.6931471805599453
2011-12,2,0.6931471805599453
33-year-old,2,0.6931471805599453
bifrontal,2,0.6931471805599453
generalised,2,0.6931471805599453
parties,2,0.6931471805599453
NICE,2,0.6931471805599453
rainfall,2,0.6931471805599453
Ambient,2,0.6931471805599453
heaviest,2,0.6931471805599453
Biffl,2,0.6931471805599453
endotype,2,0.6931471805599453
1661,2,0.6931471805599453
graphene,2,0.6931471805599453
LSG-based,2,0.6931471805599453
Sensation,2,0.6931471805599453
Impulsive,2,0.6931471805599453
Activity,2,0.6931471805599453
Recommended,2,0.6931471805599453
ketotifene,2,0.6931471805599453
diproprionate,2,0.6931471805599453
microbiomes,2,0.6931471805599453
characterizations,2,0.6931471805599453
rapid-eye-movement,2,0.6931471805599453
custom,2,0.6931471805599453
smartphone,2,0.6931471805599453
mUml,2,0.6931471805599453
noncore,2,0.6931471805599453
Documentation,2,0.6931471805599453
EMR,2,0.6931471805599453
fishbone,2,0.6931471805599453
PDCA,2,0.6931471805599453
MTA,2,0.6931471805599453
p0018,2,0.6931471805599453
heredity-related,2,0.6931471805599453
mid-August,2,0.6931471805599453
badly,2,0.6931471805599453
purview,2,0.6931471805599453
380°C,2,0.6931471805599453
nursery,2,0.6931471805599453
arteriosclerosis,2,0.6931471805599453
CAA,2,0.6931471805599453
resampling,2,0.6931471805599453
Focus,2,0.6931471805599453
plateletpheresis,2,0.6931471805599453
MPS,2,0.6931471805599453
Personality,2,0.6931471805599453
ECGraphic,2,0.6931471805599453
VPB,2,0.6931471805599453
Expectations,2,0.6931471805599453
cannula,2,0.6931471805599453
baseball,2,0.6931471805599453
AML,2,0.6931471805599453
open-reading,2,0.6931471805599453
9999,2,0.6931471805599453
BMC-derived,2,0.6931471805599453
knock-out,2,0.6931471805599453
non-progressive,2,0.6931471805599453
MMSE,2,0.6931471805599453
realtime,2,0.6931471805599453
instillation,2,0.6931471805599453
constitutive,2,0.6931471805599453
740,2,0.6931471805599453
infarct100,2,0.6931471805599453
599,2,0.6931471805599453
mucociliary,2,0.6931471805599453
TH2-type,2,0.6931471805599453
COX-1,2,0.6931471805599453
countryside,2,0.6931471805599453
390°C,2,0.6931471805599453
single-blind,2,0.6931471805599453
3068,2,0.6931471805599453
tennis,2,0.6931471805599453
games,2,0.6931471805599453
HTRA1,2,0.6931471805599453
5-month,2,0.6931471805599453
trunks,2,0.6931471805599453
concordantly,2,0.6931471805599453
room-visiting,2,0.6931471805599453
room-based,2,0.6931471805599453
organ-specific,2,0.6931471805599453
10-25,2,0.6931471805599453
one-fourth,2,0.6931471805599453
free-running,2,0.6931471805599453
Slovenian,2,0.6931471805599453
non-serious,2,0.6931471805599453
H1v,2,0.6931471805599453
crops,2,0.6931471805599453
1030,2,0.6931471805599453
half-life,2,0.6931471805599453
ornamental,2,0.6931471805599453
Slovenia,2,0.6931471805599453
C-D-T,2,0.6931471805599453
LAIVs,2,0.6931471805599453
617,2,0.6931471805599453
Target,2,0.6931471805599453
ELISpot,2,0.6931471805599453
Haemagglutination,2,0.6931471805599453
934,2,0.6931471805599453
defer,2,0.6931471805599453
kgm2,2,0.6931471805599453
Mini-Log,2,0.6931471805599453
MODS,2,0.6931471805599453
heal,2,0.6931471805599453
pseudoaneurysm,2,0.6931471805599453
Medtronic,2,0.6931471805599453
Escherichia,2,0.6931471805599453
1500,2,0.6931471805599453
polyclonal,2,0.6931471805599453
15-day,2,0.6931471805599453
vector-MSCs,2,0.6931471805599453
PLL,2,0.6931471805599453
arbitrary,2,0.6931471805599453
ferumoxytol,2,0.6931471805599453
Latency,2,0.6931471805599453
779,2,0.6931471805599453
tries,2,0.6931471805599453
disordered,2,0.6931471805599453
pfu,2,0.6931471805599453
sex-standardized,2,0.6931471805599453
microbiologist,2,0.6931471805599453
heroic,2,0.6931471805599453
BCE,2,0.6931471805599453
pre,2,0.6931471805599453
1993-1994,2,0.6931471805599453
Athens,2,0.6931471805599453
seeds,2,0.6931471805599453
Movement,2,0.6931471805599453
IUC,2,0.6931471805599453
solid-phase,2,0.6931471805599453
GC×GC-HRTOF-MS,2,0.6931471805599453
thrombin-antithrombin,2,0.6931471805599453
minimally-invasive,2,0.6931471805599453
1313,2,0.6931471805599453
Th2-driven,2,0.6931471805599453
NeuroIntervent,2,0.6931471805599453
rubella,2,0.6931471805599453
Cic2,2,0.6931471805599453
biopsychosocial,2,0.6931471805599453
infection-related,2,0.6931471805599453
close-contact,2,0.6931471805599453
repress,2,0.6931471805599453
SMI,2,0.6931471805599453
complemented,2,0.6931471805599453
Babies,2,0.6931471805599453
Preservation,2,0.6931471805599453
Clearly,2,0.6931471805599453
drainer,2,0.6931471805599453
bioinformatic,2,0.6931471805599453
Benchmarking,2,0.6931471805599453
traveled,2,0.6931471805599453
commissioned,2,0.6931471805599453
parasites,2,0.6931471805599453
baboons,2,0.6931471805599453
Human-to-human,2,0.6931471805599453
joining,2,0.6931471805599453
unpredictability,2,0.6931471805599453
faulty,2,0.6931471805599453
tissue-plasminogen,2,0.6931471805599453
keys,2,0.6931471805599453
housekeeping,2,0.6931471805599453
splenocytes,2,0.6931471805599453
954,2,0.6931471805599453
VLP-forming,2,0.6931471805599453
identities,2,0.6931471805599453
In-depth,2,0.6931471805599453
egg-based,2,0.6931471805599453
Strategic,2,0.6931471805599453
Attacks,2,0.6931471805599453
undermined,2,0.6931471805599453
3-D,2,0.6931471805599453
queries,2,0.6931471805599453
univariates,2,0.6931471805599453
playground,2,0.6931471805599453
high-touch,2,0.6931471805599453
playgrounds,2,0.6931471805599453
on-call,2,0.6931471805599453
Clot,2,0.6931471805599453
Tracker,2,0.6931471805599453
51-year-old,2,0.6931471805599453
self-grounding,2,0.6931471805599453
aircrews,2,0.6931471805599453
corporate,2,0.6931471805599453
risk-based,2,0.6931471805599453
eco-friendly,2,0.6931471805599453
598,2,0.6931471805599453
vagotomized,2,0.6931471805599453
definable,2,0.6931471805599453
pleural-space-fluid,2,0.6931471805599453
544,2,0.6931471805599453
Electrocardiograms,2,0.6931471805599453
ballooning,2,0.6931471805599453
EAACI,2,0.6931471805599453
pyrin,2,0.6931471805599453
pulseless,2,0.6931471805599453
maneuvers,2,0.6931471805599453
beagles,2,0.6931471805599453
vectorial,2,0.6931471805599453
718,2,0.6931471805599453
well-calibrated,2,0.6931471805599453
724,2,0.6931471805599453
Q-,2,0.6931471805599453
traumas,2,0.6931471805599453
bacterium,2,0.6931471805599453
adhered,2,0.6931471805599453
Municipal,2,0.6931471805599453
requests,2,0.6931471805599453
culminate,2,0.6931471805599453
pro-oxidant,2,0.6931471805599453
paradoxes,2,0.6931471805599453
rs12252-C,2,0.6931471805599453
split,2,0.6931471805599453
microgramsdl,2,0.6931471805599453
nickel,2,0.6931471805599453
launching,2,0.6931471805599453
DOR,2,0.6931471805599453
Prominent,2,0.6931471805599453
implicitly,2,0.6931471805599453
deviate,2,0.6931471805599453
inferior-posterior,2,0.6931471805599453
Dose-response,2,0.6931471805599453
employers,2,0.6931471805599453
60-70,2,0.6931471805599453
AfSD,2,0.6931471805599453
BDT,2,0.6931471805599453
after-care,2,0.6931471805599453
Perugia,2,0.6931471805599453
VNS,2,0.6931471805599453
WMCs,2,0.6931471805599453
Orthopedics,2,0.6931471805599453
717,2,0.6931471805599453
Trauma,2,0.6931471805599453
Sam,2,0.6931471805599453
-16,2,0.6931471805599453
ciclesonide,2,0.6931471805599453
nonimmunological,2,0.6931471805599453
mastocytes,2,0.6931471805599453
neuroradiologist,2,0.6931471805599453
rivaroxabanASA,2,0.6931471805599453
Nitrates,2,0.6931471805599453
prescription，,2,0.6931471805599453
ATM,2,0.6931471805599453
thereof,2,0.6931471805599453
phlegm，,2,0.6931471805599453
wind，,2,0.6931471805599453
Yin,2,0.6931471805599453
civic,2,0.6931471805599453
assigns,2,0.6931471805599453
Isoproterenol,2,0.6931471805599453
Age-related,2,0.6931471805599453
Yang，,2,0.6931471805599453
liver，,2,0.6931471805599453
Apgar,2,0.6931471805599453
Formal,2,0.6931471805599453
Endothelial,2,0.6931471805599453
malnourishment,2,0.6931471805599453
Classically,2,0.6931471805599453
individualism,2,0.6931471805599453
0992,2,0.6931471805599453
culture-based,2,0.6931471805599453
circulation-improving,2,0.6931471805599453
Nonstenotic,2,0.6931471805599453
medicineor,2,0.6931471805599453
anti-fibrinogen,2,0.6931471805599453
n3,2,0.6931471805599453
drug，,2,0.6931471805599453
splenium,2,0.6931471805599453
CDS,2,0.6931471805599453
MMEF,2,0.6931471805599453
Maine,2,0.6931471805599453
biomolecular,2,0.6931471805599453
Concomitant,2,0.6931471805599453
noninflammatory,2,0.6931471805599453
Surg,2,0.6931471805599453
unrecognised,2,0.6931471805599453
Aspergillosis,2,0.6931471805599453
ELISA-based,2,0.6931471805599453
allied,2,0.6931471805599453
HDT,2,0.6931471805599453
Mann-Whitney,2,0.6931471805599453
Ce,2,0.6931471805599453
771,2,0.6931471805599453
patient’s,2,0.6931471805599453
des,2,0.6931471805599453
CoronaVac®,2,0.6931471805599453
1109,2,0.6931471805599453
00041,2,0.6931471805599453
human-pig,2,0.6931471805599453
AZD1222-dependent,2,0.6931471805599453
atresia,2,0.6931471805599453
aspecific,2,0.6931471805599453
methyl,2,0.6931471805599453
rationality,2,0.6931471805599453
deserve,2,0.6931471805599453
predilection,2,0.6931471805599453
miners,2,0.6931471805599453
non-dentist,2,0.6931471805599453
tasked,2,0.6931471805599453
solidarity,2,0.6931471805599453
Paroxysmal,2,0.6931471805599453
dismissal,2,0.6931471805599453
phlegm-reducing,2,0.6931471805599453
ITF-1697,2,0.6931471805599453
competitions,2,0.6931471805599453
neutrophil-to-lymphocyte,2,0.6931471805599453
Galway,2,0.6931471805599453
UPR,2,0.6931471805599453
synergize,2,0.6931471805599453
hypercontractility,2,0.6931471805599453
untypical,2,0.6931471805599453
GxE,2,0.6931471805599453
true-positives,2,0.6931471805599453
Refinement,2,0.6931471805599453
guano,2,0.6931471805599453
virus-neutralisation,2,0.6931471805599453
tigers,2,0.6931471805599453
GeneScriptcPass,2,0.6931471805599453
angiographies,2,0.6931471805599453
LVI,2,0.6931471805599453
optimised,2,0.6931471805599453
complain,2,0.6931471805599453
Sophisticated,2,0.6931471805599453
Euroimmun-anti-S1-IgA,2,0.6931471805599453
cancer-related,2,0.6931471805599453
AMEI,2,0.6931471805599453
Roche-anti-N,2,0.6931471805599453
2743,2,0.6931471805599453
carpets,2,0.6931471805599453
13NH3-PET,2,0.6931471805599453
strengthens,2,0.6931471805599453
SI-upslope,2,0.6931471805599453
3090,2,0.6931471805599453
single-chain,2,0.6931471805599453
RBD-2E8,2,0.6931471805599453
trocar,2,0.6931471805599453
3C2a,2,0.6931471805599453
neuroprotectants,2,0.6931471805599453
omission,2,0.6931471805599453
3434,2,0.6931471805599453
tetrapeptide,2,0.6931471805599453
SCDs,2,0.6931471805599453
antiquity,2,0.6931471805599453
Behaviour,2,0.6931471805599453
Coronary-prone,2,0.6931471805599453
sleep-disordered,2,0.6931471805599453
demarcation,2,0.6931471805599453
BOP,2,0.6931471805599453
PBI,2,0.6931471805599453
Age-standardized,2,0.6931471805599453
CAL,2,0.6931471805599453
nebuliser,2,0.6931471805599453
intensely,2,0.6931471805599453
Acting,2,0.6931471805599453
reorganize,2,0.6931471805599453
radically,2,0.6931471805599453
Ninety-two,2,0.6931471805599453
1671,2,0.6931471805599453
haemagglutination-inhibiting,2,0.6931471805599453
poorest,2,0.6931471805599453
-27,2,0.6931471805599453
-57,2,0.6931471805599453
-12,2,0.6931471805599453
mysterious,2,0.6931471805599453
-50,2,0.6931471805599453
Institutions,2,0.6931471805599453
SARS-Cov-1,2,0.6931471805599453
2167,2,0.6931471805599453
369,2,0.6931471805599453
heterotopic,2,0.6931471805599453
SARS-2-CoV,2,0.6931471805599453
AluI,2,0.6931471805599453
Acetylsalicylic,2,0.6931471805599453
tourism,2,0.6931471805599453
rebound,2,0.6931471805599453
Fibrinogen,2,0.6931471805599453
historians,2,0.6931471805599453
helium,2,0.6931471805599453
miR-132,2,0.6931471805599453
PKR,2,0.6931471805599453
13685,2,0.6931471805599453
neurorestoration,2,0.6931471805599453
Aeroallergen,2,0.6931471805599453
Pressure,2,0.6931471805599453
oesophagus,2,0.6931471805599453
AVs,2,0.6931471805599453
Therapies,2,0.6931471805599453
prethrombolysis,2,0.6931471805599453
drug-likeness,2,0.6931471805599453
radiographically,2,0.6931471805599453
averages,2,0.6931471805599453
significances,2,0.6931471805599453
convert,2,0.6931471805599453
robot,2,0.6931471805599453
hypersensitive,2,0.6931471805599453
90-95,2,0.6931471805599453
moist,2,0.6931471805599453
biocidal,2,0.6931471805599453
decontaminate,2,0.6931471805599453
bronchodilatory,2,0.6931471805599453
hypocapnia,2,0.6931471805599453
bronchoconstrictive,2,0.6931471805599453
IPA,2,0.6931471805599453
Fei,2,0.6931471805599453
Shen,2,0.6931471805599453
17-year-old,2,0.6931471805599453
Microalbuminuria,2,0.6931471805599453
compressive,2,0.6931471805599453
write,2,0.6931471805599453
handwriting,2,0.6931471805599453
transendothelial,2,0.6931471805599453
VTM-3840,2,0.6931471805599453
bromide,2,0.6931471805599453
letters,2,0.6931471805599453
scavenger,2,0.6931471805599453
reperfuse,2,0.6931471805599453
-cells,2,0.6931471805599453
affords,2,0.6931471805599453
juncture,2,0.6931471805599453
FRISC,2,0.6931471805599453
collaborate,2,0.6931471805599453
metabolically,2,0.6931471805599453
IL10,2,0.6931471805599453
embryogenesis,2,0.6931471805599453
CD163-macrophages,2,0.6931471805599453
ailment,2,0.6931471805599453
ERIS,2,0.6931471805599453
neferine,2,0.6931471805599453
open-chest,2,0.6931471805599453
Neferine,2,0.6931471805599453
18-year-old,2,0.6931471805599453
501YV1,2,0.6931471805599453
UL-VWFM,2,0.6931471805599453
sheds,2,0.6931471805599453
RATs,2,0.6931471805599453
Invalidism,2,0.6931471805599453
Weight,2,0.6931471805599453
Dissimilar,2,0.6931471805599453
VBDE,2,0.6931471805599453
near-deaths,2,0.6931471805599453
78-year-old,2,0.6931471805599453
Endoribonuclease,2,0.6931471805599453
Pain,2,0.6931471805599453
plastics,2,0.6931471805599453
monocentric,2,0.6931471805599453
subfamily,2,0.6931471805599453
P450,2,0.6931471805599453
non-Caucasians,2,0.6931471805599453
Mount,2,0.6931471805599453
Sinai,2,0.6931471805599453
cytochrome,2,0.6931471805599453
nucleoproteins,2,0.6931471805599453
squares,2,0.6931471805599453
Trail,2,0.6931471805599453
Cunha,2,0.6931471805599453
ribose,2,0.6931471805599453
Tristan,2,0.6931471805599453
Iraq,2,0.6931471805599453
nodal,2,0.6931471805599453
N1N2N3,2,0.6931471805599453
á-2,2,0.6931471805599453
multi-target,2,0.6931471805599453
16-year,2,0.6931471805599453
VHH,2,0.6931471805599453
Vmax,2,0.6931471805599453
Vaccinating,2,0.6931471805599453
communicable,2,0.6931471805599453
AQLQS,2,0.6931471805599453
7-16,2,0.6931471805599453
work-relatedness,2,0.6931471805599453
neuropathic,2,0.6931471805599453
Rhinomanometry,2,0.6931471805599453
-900,2,0.6931471805599453
Sepsis,2,0.6931471805599453
ADP,2,0.6931471805599453
15-120,2,0.6931471805599453
EndoribonucleaseendoU,2,0.6931471805599453
pericytes,2,0.6931471805599453
MTase,2,0.6931471805599453
MM-GBSA,2,0.6931471805599453
lysine,2,0.6931471805599453
RGGRG,2,0.6931471805599453
R177,2,0.6931471805599453
PRMT1,2,0.6931471805599453
ADME,2,0.6931471805599453
Calculation,2,0.6931471805599453
liability,2,0.6931471805599453
DRR,2,0.6931471805599453
oclock,2,0.6931471805599453
Diurnal,2,0.6931471805599453
Communicated,2,0.6931471805599453
Minimum,2,0.6931471805599453
-601,2,0.6931471805599453
irrigated,2,0.6931471805599453
-730,2,0.6931471805599453
-748,2,0.6931471805599453
decongestants,2,0.6931471805599453
-863,2,0.6931471805599453
-680,2,0.6931471805599453
basophils,2,0.6931471805599453
-842,2,0.6931471805599453
Thresholds,2,0.6931471805599453
-797,2,0.6931471805599453
Non-atopic,2,0.6931471805599453
Prescription,2,0.6931471805599453
EcoRI,2,0.6931471805599453
scanty,2,0.6931471805599453
CLOCK,2,0.6931471805599453
endotheliopathy,2,0.6931471805599453
pathologists,2,0.6931471805599453
nSES,2,0.6931471805599453
HAM,2,0.6931471805599453
phosphokinase-MB,2,0.6931471805599453
supernatants,2,0.6931471805599453
indiscriminately,2,0.6931471805599453
Hematology,2,0.6931471805599453
AIEOP,2,0.6931471805599453
inclusivity,2,0.6931471805599453
cyclosporin,2,0.6931471805599453
THC,2,0.6931471805599453
haphazard,2,0.6931471805599453
Collecting,2,0.6931471805599453
contingency,2,0.6931471805599453
Populations,2,0.6931471805599453
opacification,2,0.6931471805599453
Y-lineage,2,0.6931471805599453
Multidisciplinary,2,0.6931471805599453
anti-allergy,2,0.6931471805599453
amodiaquine,2,0.6931471805599453
1517,2,0.6931471805599453
planimetric,2,0.6931471805599453
Lifestyle,2,0.6931471805599453
pipe,2,0.6931471805599453
25-year-old,2,0.6931471805599453
unintentional,2,0.6931471805599453
refrain,2,0.6931471805599453
Anesthetized,2,0.6931471805599453
2016-17,2,0.6931471805599453
923,2,0.6931471805599453
1016,2,0.6931471805599453
bath,2,0.6931471805599453
maturity,2,0.6931471805599453
0036,2,0.6931471805599453
triennium,2,0.6931471805599453
attracts,2,0.6931471805599453
warnings,2,0.6931471805599453
spongiosis,2,0.6931471805599453
collaborators,2,0.6931471805599453
ameliorated,2,0.6931471805599453
semblance,2,0.6931471805599453
non-motor,2,0.6931471805599453
concur,2,0.6931471805599453
neuroinflammatory,2,0.6931471805599453
Ray,2,0.6931471805599453
α-SYN,2,0.6931471805599453
biocontainment,2,0.6931471805599453
Myanmar,2,0.6931471805599453
non-dominant,2,0.6931471805599453
acetylators,2,0.6931471805599453
substantia,2,0.6931471805599453
actor,2,0.6931471805599453
US-based,2,0.6931471805599453
cholesterol-lowering,2,0.6931471805599453
integrin-mediated,2,0.6931471805599453
Definitive,2,0.6931471805599453
fumigatus,2,0.6931471805599453
BMAL1,2,0.6931471805599453
sexually,2,0.6931471805599453
qualities,2,0.6931471805599453
ILO,2,0.6931471805599453
inflamed,2,0.6931471805599453
SLIR,2,0.6931471805599453
disodium,2,0.6931471805599453
SARS-,2,0.6931471805599453
HDLs,2,0.6931471805599453
Sinopharm,2,0.6931471805599453
beta2-adrenergic,2,0.6931471805599453
germane,2,0.6931471805599453
Dalbergia,2,0.6931471805599453
palisander,2,0.6931471805599453
first-of-its-kind,2,0.6931471805599453
850,2,0.6931471805599453
machine-learning,2,0.6931471805599453
long-chain,2,0.6931471805599453
6-10,2,0.6931471805599453
curation,2,0.6931471805599453
LMW,2,0.6931471805599453
extra-corporeal,2,0.6931471805599453
comments,2,0.6931471805599453
default,2,0.6931471805599453
dismissals,2,0.6931471805599453
kinin,2,0.6931471805599453
Australasia,2,0.6931471805599453
Established,2,0.6931471805599453
cholangitis,2,0.6931471805599453
S-proteins,2,0.6931471805599453
AOSC,2,0.6931471805599453
CD-sACE2,2,0.6931471805599453
ethnically,2,0.6931471805599453
AIRS,2,0.6931471805599453
IRs,2,0.6931471805599453
Vertebrobasilar,2,0.6931471805599453
INS,2,0.6931471805599453
BACM,2,0.6931471805599453
pleiotropic,2,0.6931471805599453
OxfordAstraZeneca,2,0.6931471805599453
compartment,2,0.6931471805599453
Gamaleya,2,0.6931471805599453
fronto-temporal,2,0.6931471805599453
Activities,2,0.6931471805599453
re-vaccination,2,0.6931471805599453
tempered,2,0.6931471805599453
neurotransmitter,2,0.6931471805599453
footprint,2,0.6931471805599453
Psoralen,2,0.6931471805599453
PUVA,2,0.6931471805599453
destined,2,0.6931471805599453
Wearing,2,0.6931471805599453
formidable,2,0.6931471805599453
non-viral,2,0.6931471805599453
asthmaallergy,2,0.6931471805599453
mefenamic,2,0.6931471805599453
D3,2,0.6931471805599453
PARP,2,0.6931471805599453
saliva-based,2,0.6931471805599453
repositioned,2,0.6931471805599453
DSA,2,0.6931471805599453
Viewing,2,0.6931471805599453
parenterally,2,0.6931471805599453
Novavax,2,0.6931471805599453
Cathepsin,2,0.6931471805599453
enhancers,2,0.6931471805599453
Insulin,2,0.6931471805599453
transcriptionally,2,0.6931471805599453
Fasting,2,0.6931471805599453
retrieving,2,0.6931471805599453
HDL,2,0.6931471805599453
cell-,2,0.6931471805599453
Fibromuscular,2,0.6931471805599453
alphacoronavirus,2,0.6931471805599453
1-December,2,0.6931471805599453
-308GA,2,0.6931471805599453
adenine,2,0.6931471805599453
összesen,2,0.6931471805599453
retards,2,0.6931471805599453
milliárd,2,0.6931471805599453
Ft,2,0.6931471805599453
unjustified,2,0.6931471805599453
EUR,2,0.6931471805599453
OVID,2,0.6931471805599453
ophthalmologist,2,0.6931471805599453
AMIS,2,0.6931471805599453
mobilizing,2,0.6931471805599453
rewarming,2,0.6931471805599453
VLAs,2,0.6931471805599453
decoction,2,0.6931471805599453
Syk,2,0.6931471805599453
artefactual,2,0.6931471805599453
nonarteriosclerotic,2,0.6931471805599453
castrated,2,0.6931471805599453
Infarcted,2,0.6931471805599453
strike,2,0.6931471805599453
budgets,2,0.6931471805599453
Free,2,0.6931471805599453
valamennyi,2,0.6931471805599453
castrates,2,0.6931471805599453
intervillositis,2,0.6931471805599453
villitis,2,0.6931471805599453
malperfusion,2,0.6931471805599453
sigma-1,2,0.6931471805599453
aktívfekvőbeteg-szakellátásban,2,0.6931471805599453
lymphotoxin-alpha,2,0.6931471805599453
Itk,2,0.6931471805599453
Can,2,0.6931471805599453
Flk-1,2,0.6931471805599453
tabulated,2,0.6931471805599453
OTV,2,0.6931471805599453
abreast,2,0.6931471805599453
epidemiológiai,2,0.6931471805599453
egészségbiztosítási,2,0.6931471805599453
274Y,2,0.6931471805599453
seventy-two,2,0.6931471805599453
anastomotic,2,0.6931471805599453
Switching,2,0.6931471805599453
NEAK,2,0.6931471805599453
Louisiana,2,0.6931471805599453
Split,2,0.6931471805599453
roommates,2,0.6931471805599453
1098,2,0.6931471805599453
neurobiological,2,0.6931471805599453
Immunohistochemistry,2,0.6931471805599453
vonatkozóan,2,0.6931471805599453
doxycycline,2,0.6931471805599453
internalizing,2,0.6931471805599453
benzene,2,0.6931471805599453
Ensuring,2,0.6931471805599453
BMT,2,0.6931471805599453
forma,2,0.6931471805599453
muscarinic,2,0.6931471805599453
EPR2,2,0.6931471805599453
abolition,2,0.6931471805599453
Post-infarction,2,0.6931471805599453
precedent,2,0.6931471805599453
nemenkénti,2,0.6931471805599453
serum-free,2,0.6931471805599453
Carbon,2,0.6931471805599453
mounted,2,0.6931471805599453
Zhu,2,0.6931471805599453
10664,2,0.6931471805599453
PEF-measurement,2,0.6931471805599453
dermal,2,0.6931471805599453
O2kg,2,0.6931471805599453
HSAP-NPpHO1,2,0.6931471805599453
cocaine-associated,2,0.6931471805599453
under-recognized,2,0.6931471805599453
RAGE-mediated,2,0.6931471805599453
harvested,2,0.6931471805599453
DP2k,2,0.6931471805599453
multijoint,2,0.6931471805599453
893,2,0.6931471805599453
pHO1,2,0.6931471805599453
29043,2,0.6931471805599453
onslaught,2,0.6931471805599453
hypoxia-specific,2,0.6931471805599453
electrograms,2,0.6931471805599453
Nucleotide,2,0.6931471805599453
Linkage,2,0.6931471805599453
865,2,0.6931471805599453
hypercontraction,2,0.6931471805599453
Ashworth,2,0.6931471805599453
concluding,2,0.6931471805599453
adhesive,2,0.6931471805599453
visualised,2,0.6931471805599453
consortium,2,0.6931471805599453
Modified,2,0.6931471805599453
neuropathies,2,0.6931471805599453
Forty-two,2,0.6931471805599453
ultra-low,2,0.6931471805599453
radioimmunoassay,2,0.6931471805599453
racemosa,2,0.6931471805599453
NO-parameters,2,0.6931471805599453
Multi-Tabs,2,0.6931471805599453
Ukraine,2,0.6931471805599453
carboxyhemoglobin,2,0.6931471805599453
limbic,2,0.6931471805599453
energetic,2,0.6931471805599453
top-ranked,2,0.6931471805599453
RBD-ACE2,2,0.6931471805599453
Insights,2,0.6931471805599453
Should,2,0.6931471805599453
perseveration,2,0.6931471805599453
end-of-life,2,0.6931471805599453
Saitama,2,0.6931471805599453
skull,2,0.6931471805599453
Vector,2,0.6931471805599453
NASBA,2,0.6931471805599453
sequence-based,2,0.6931471805599453
Sparse,2,0.6931471805599453
sequencing-based,2,0.6931471805599453
Distance,2,0.6931471805599453
DR,2,0.6931471805599453
mentions,2,0.6931471805599453
1-30,2,0.6931471805599453
spoke,2,0.6931471805599453
possessed,2,0.6931471805599453
IAB,2,0.6931471805599453
inter-hospital,2,0.6931471805599453
UTI,2,0.6931471805599453
agitation,2,0.6931471805599453
delicate,2,0.6931471805599453
large-core,2,0.6931471805599453
simulation-based,2,0.6931471805599453
Affiliated,2,0.6931471805599453
time-to-treatment,2,0.6931471805599453
coronavirus-induced,2,0.6931471805599453
Taipei,2,0.6931471805599453
Drawings,2,0.6931471805599453
repetition,2,0.6931471805599453
RSNA,2,0.6931471805599453
parent-child,2,0.6931471805599453
Taiwans,2,0.6931471805599453
disagreements,2,0.6931471805599453
Temple,2,0.6931471805599453
BSWH,2,0.6931471805599453
Scott,2,0.6931471805599453
autoregressive,2,0.6931471805599453
ablate,2,0.6931471805599453
intangible,2,0.6931471805599453
Individualized,2,0.6931471805599453
cures,2,0.6931471805599453
TTs,2,0.6931471805599453
start-up,2,0.6931471805599453
Minimizing,2,0.6931471805599453
clearing,2,0.6931471805599453
funnel,2,0.6931471805599453
plots,2,0.6931471805599453
Artificial,2,0.6931471805599453
Eggers,2,0.6931471805599453
Chi2,2,0.6931471805599453
Pardi,2,0.6931471805599453
ALL,2,0.6931471805599453
NEDS,2,0.6931471805599453
NRD,2,0.6931471805599453
bronchial-asthma,2,0.6931471805599453
Readmissions,2,0.6931471805599453
inundated,2,0.6931471805599453
Mepolizumab,2,0.6931471805599453
tailor-made,2,0.6931471805599453
insertable,2,0.6931471805599453
prohibitive,2,0.6931471805599453
animal-human,2,0.6931471805599453
long-axis,2,0.6931471805599453
HBP,2,0.6931471805599453
Preparation,2,0.6931471805599453
groin,2,0.6931471805599453
hypo-perfusion,2,0.6931471805599453
preintervention,2,0.6931471805599453
snow,2,0.6931471805599453
Woolhouse,2,0.6931471805599453
FIA-positive,2,0.6931471805599453
unintended,2,0.6931471805599453
parent-reported,2,0.6931471805599453
SO2,2,0.6931471805599453
heard,2,0.6931471805599453
prearrival,2,0.6931471805599453
transporter,2,0.6931471805599453
chaperone,2,0.6931471805599453
June-August,2,0.6931471805599453
ΔsirR,2,0.6931471805599453
SirRH,2,0.6931471805599453
coatingbonding,2,0.6931471805599453
membranous,2,0.6931471805599453
multicomponent,2,0.6931471805599453
hereafter,2,0.6931471805599453
rolling,2,0.6931471805599453
emotional-painful,2,0.6931471805599453
under-reporting,2,0.6931471805599453
ANanchang93395,2,0.6931471805599453
popularized,2,0.6931471805599453
Dendritic,2,0.6931471805599453
asserted,2,0.6931471805599453
Occurrence,2,0.6931471805599453
barracks,2,0.6931471805599453
Formulating,2,0.6931471805599453
beet,2,0.6931471805599453
heterozygote,2,0.6931471805599453
pharmacology-based,2,0.6931471805599453
Interventional,2,0.6931471805599453
leveraged,2,0.6931471805599453
H10-HA,2,0.6931471805599453
Relapse,2,0.6931471805599453
MDC,2,0.6931471805599453
DWIPWI,2,0.6931471805599453
787,2,0.6931471805599453
MDC80,2,0.6931471805599453
exposure-disease,2,0.6931471805599453
11-year-old,2,0.6931471805599453
16-fold,2,0.6931471805599453
affected-side,2,0.6931471805599453
sulfonylureas,2,0.6931471805599453
Viperin,2,0.6931471805599453
Wellbeing,2,0.6931471805599453
IFV,2,0.6931471805599453
logs,2,0.6931471805599453
WSN33,2,0.6931471805599453
adventitia,2,0.6931471805599453
tetracycline,2,0.6931471805599453
dysesthesia,2,0.6931471805599453
unpleasant,2,0.6931471805599453
frontoparietal,2,0.6931471805599453
pharmacodynamics,2,0.6931471805599453
antiseizure,2,0.6931471805599453
localizing,2,0.6931471805599453
hardness,2,0.6931471805599453
entirety,2,0.6931471805599453
Estimation,2,0.6931471805599453
sex-matched,2,0.6931471805599453
Prevent,2,0.6931471805599453
unaffected-side,2,0.6931471805599453
inland,2,0.6931471805599453
variablesConclusions,2,0.6931471805599453
WA,2,0.6931471805599453
Geographic,2,0.6931471805599453
endemicity,2,0.6931471805599453
flare,2,0.6931471805599453
Adjusting,2,0.6931471805599453
lethargica,2,0.6931471805599453
Memphis,2,0.6931471805599453
analysisABSTRACT,2,0.6931471805599453
opioids,2,0.6931471805599453
61-year-old,2,0.6931471805599453
1917,2,0.6931471805599453
50-,2,0.6931471805599453
ships,2,0.6931471805599453
Veracruz,2,0.6931471805599453
incongruent,2,0.6931471805599453
B-mode,2,0.6931471805599453
False-positive,2,0.6931471805599453
nebulised,2,0.6931471805599453
colony-stimulating,2,0.6931471805599453
IBS,2,0.6931471805599453
rs1800872,2,0.6931471805599453
logarithmically,2,0.6931471805599453
burdened,2,0.6931471805599453
substantiates,2,0.6931471805599453
Base,2,0.6931471805599453
FELUDA,2,0.6931471805599453
disconcerting,2,0.6931471805599453
overproduction,2,0.6931471805599453
Los,2,0.6931471805599453
cg05575921,2,0.6931471805599453
particularities,2,0.6931471805599453
hypomethylation,2,0.6931471805599453
rt-PA-treated,2,0.6931471805599453
within-subject,2,0.6931471805599453
Regionally,2,0.6931471805599453
Altman,2,0.6931471805599453
AHRR,2,0.6931471805599453
Ethiopias,2,0.6931471805599453
melatonin,2,0.6931471805599453
prompts,2,0.6931471805599453
anteroposterior,2,0.6931471805599453
selectin,2,0.6931471805599453
61-70,2,0.6931471805599453
Angeles,2,0.6931471805599453
Technologies,2,0.6931471805599453
droop,2,0.6931471805599453
Levels,2,0.6931471805599453
537,2,0.6931471805599453
MI-SVO,2,0.6931471805599453
hyperreactive,2,0.6931471805599453
VAL,2,0.6931471805599453
TCDI,2,0.6931471805599453
microgl,2,0.6931471805599453
MicroRNA,2,0.6931471805599453
corporation,2,0.6931471805599453
662,2,0.6931471805599453
small-world,2,0.6931471805599453
VUI-NP13L,2,0.6931471805599453
infinite,2,0.6931471805599453
miniaturization,2,0.6931471805599453
postinfluenzal,2,0.6931471805599453
Reversibility,2,0.6931471805599453
animal-derived,2,0.6931471805599453
MBBAs,2,0.6931471805599453
19911993,2,0.6931471805599453
larger-scale,2,0.6931471805599453
county-level,2,0.6931471805599453
time-frame,2,0.6931471805599453
RealOpt,2,0.6931471805599453
25OHD,2,0.6931471805599453
drill,2,0.6931471805599453
small-scale,2,0.6931471805599453
prosthetic,2,0.6931471805599453
intestines,2,0.6931471805599453
511,2,0.6931471805599453
marks,2,0.6931471805599453
ScienceDirect,2,0.6931471805599453
myelin,2,0.6931471805599453
Mazowieckie,2,0.6931471805599453
AGTP,2,0.6931471805599453
Interstitial,2,0.6931471805599453
objectified,2,0.6931471805599453
syringes,2,0.6931471805599453
patient-focused,2,0.6931471805599453
wastage,2,0.6931471805599453
under-diagnosis,2,0.6931471805599453
voluntarily,2,0.6931471805599453
Yijinjing,2,0.6931471805599453
nonmetropolitan,2,0.6931471805599453
QuickVue®,2,0.6931471805599453
Lepu,2,0.6931471805599453
influenzainfluenza-like,2,0.6931471805599453
do-it-yourself,2,0.6931471805599453
MRC,2,0.6931471805599453
P-value,2,0.6931471805599453
fragility,2,0.6931471805599453
antineoplastic,2,0.6931471805599453
immunostimulants,2,0.6931471805599453
under-,2,0.6931471805599453
vSP,2,0.6931471805599453
0-19,2,0.6931471805599453
cochleovestibular,2,0.6931471805599453
MAST-I,2,0.6931471805599453
Episodes,2,0.6931471805599453
psychotherapeutic,2,0.6931471805599453
Tocilizumab,2,0.6931471805599453
SOC,2,0.6931471805599453
audits,2,0.6931471805599453
welfare,2,0.6931471805599453
RNA-mediated,2,0.6931471805599453
bilingual,2,0.6931471805599453
dice,2,0.6931471805599453
25-50,2,0.6931471805599453
pretest,2,0.6931471805599453
consenting,2,0.6931471805599453
Transport,2,0.6931471805599453
CT-scanner,2,0.6931471805599453
Card,2,0.6931471805599453
radiographers,2,0.6931471805599453
competency,2,0.6931471805599453
signes,2,0.6931471805599453
qui,2,0.6931471805599453
Jordanian,2,0.6931471805599453
reexamined,2,0.6931471805599453
Dissection,2,0.6931471805599453
conceive,2,0.6931471805599453
HLA-identical,2,0.6931471805599453
litersmin,2,0.6931471805599453
para-clinical,2,0.6931471805599453
dwellers,2,0.6931471805599453
sparser,2,0.6931471805599453
Bagging,2,0.6931471805599453
check-ups,2,0.6931471805599453
baricitinib,2,0.6931471805599453
hernia,2,0.6931471805599453
pond,2,0.6931471805599453
granulocyte,2,0.6931471805599453
X-linked,2,0.6931471805599453
anorgasmia,2,0.6931471805599453
lysosomal,2,0.6931471805599453
glycaemic,2,0.6931471805599453
daunting,2,0.6931471805599453
perindopril-based,2,0.6931471805599453
Perindopril,2,0.6931471805599453
Belgian,2,0.6931471805599453
phosphatase,2,0.6931471805599453
Chilean,2,0.6931471805599453
wholly,2,0.6931471805599453
advises,2,0.6931471805599453
electrostatic,2,0.6931471805599453
whistling,2,0.6931471805599453
cross-linking,2,0.6931471805599453
single-domain,2,0.6931471805599453
les,2,0.6931471805599453
arrythmias,2,0.6931471805599453
2490,2,0.6931471805599453
tour,2,0.6931471805599453
slum,2,0.6931471805599453
land-based,2,0.6931471805599453
CYamagata1089,2,0.6931471805599453
phage,2,0.6931471805599453
AH1N2v,2,0.6931471805599453
analytics,2,0.6931471805599453
appraisals,2,0.6931471805599453
mPFC,2,0.6931471805599453
Zn-binding,2,0.6931471805599453
stroke-free,2,0.6931471805599453
Matsumoto,2,0.6931471805599453
sequestration,2,0.6931471805599453
∼30,2,0.6931471805599453
thoracoabdominal,2,0.6931471805599453
graver,2,0.6931471805599453
enumerated,2,0.6931471805599453
CCR5Δ32,2,0.6931471805599453
SARS‐COV‐2,2,0.6931471805599453
May-August,2,0.6931471805599453
wife,2,0.6931471805599453
Exercising,2,0.6931471805599453
Student,2,0.6931471805599453
autogenic,2,0.6931471805599453
sub-strain,2,0.6931471805599453
explainable,2,0.6931471805599453
exempt,2,0.6931471805599453
harvesting,2,0.6931471805599453
lyse,2,0.6931471805599453
Phenotypic,2,0.6931471805599453
emphasise,2,0.6931471805599453
non-infected,2,0.6931471805599453
Phenotypes,2,0.6931471805599453
AMayo,2,0.6931471805599453
Unbiased,2,0.6931471805599453
Hsw1N1,2,0.6931471805599453
Jersey76,2,0.6931471805599453
ArcGIS,2,0.6931471805599453
multi-drug,2,0.6931471805599453
maze,2,0.6931471805599453
joined,2,0.6931471805599453
Pranayama,2,0.6931471805599453
mJcm3,2,0.6931471805599453
cortisone,2,0.6931471805599453
Pittsburgh,2,0.6931471805599453
2057,2,0.6931471805599453
Rarely,2,0.6931471805599453
Immunol,2,0.6931471805599453
31172,2,0.6931471805599453
pressure-derived,2,0.6931471805599453
team-based,2,0.6931471805599453
multisite,2,0.6931471805599453
464,2,0.6931471805599453
Cardiologists,2,0.6931471805599453
RASi,2,0.6931471805599453
hypothetically,2,0.6931471805599453
Memorandum,2,0.6931471805599453
relegated,2,0.6931471805599453
OHNS,2,0.6931471805599453
superdiffusive,2,0.6931471805599453
perturb,2,0.6931471805599453
store,2,0.6931471805599453
unstructured,2,0.6931471805599453
coronary-care,2,0.6931471805599453
cross-referenced,2,0.6931471805599453
Papers,2,0.6931471805599453
diversify,2,0.6931471805599453
hallmarks,2,0.6931471805599453
AWenshan012009,2,0.6931471805599453
AWenshan,2,0.6931471805599453
tabulation,2,0.6931471805599453
aggregations,2,0.6931471805599453
1374,2,0.6931471805599453
GAPDH,2,0.6931471805599453
hemolysis,2,0.6931471805599453
pyrosequencing,2,0.6931471805599453
pacing-induced,2,0.6931471805599453
unanimous,2,0.6931471805599453
RCAP,2,0.6931471805599453
thrive,2,0.6931471805599453
alliance,2,0.6931471805599453
gene-gene,2,0.6931471805599453
peribronchovascular,2,0.6931471805599453
Unusual,2,0.6931471805599453
lake,2,0.6931471805599453
autopsied,2,0.6931471805599453
perpetuated,2,0.6931471805599453
Co-infection,2,0.6931471805599453
Ecological,2,0.6931471805599453
leukocyte-erythrocyte,2,0.6931471805599453
LCOS,2,0.6931471805599453
voles,2,0.6931471805599453
fibrillationflutter,2,0.6931471805599453
≈5,2,0.6931471805599453
interacted,2,0.6931471805599453
μgml,2,0.6931471805599453
BVF,2,0.6931471805599453
Madin-Darby,2,0.6931471805599453
exogenic,2,0.6931471805599453
cautioned,2,0.6931471805599453
Classical,2,0.6931471805599453
Myoglobin,2,0.6931471805599453
subtilis,2,0.6931471805599453
0056,2,0.6931471805599453
interchangeable,2,0.6931471805599453
isotype,2,0.6931471805599453
GenScript,2,0.6931471805599453
907,2,0.6931471805599453
74-year-old,2,0.6931471805599453
well-validated,2,0.6931471805599453
indapamide,2,0.6931471805599453
scavenging,2,0.6931471805599453
stent-assisted,2,0.6931471805599453
antifungal,2,0.6931471805599453
magnified,2,0.6931471805599453
autocorrelation,2,0.6931471805599453
George,2,0.6931471805599453
justice,2,0.6931471805599453
Attempts,2,0.6931471805599453
Problematic,2,0.6931471805599453
battling,2,0.6931471805599453
climbing,2,0.6931471805599453
XII,2,0.6931471805599453
sheets,2,0.6931471805599453
diary-card,2,0.6931471805599453
Unstable,2,0.6931471805599453
china,2,0.6931471805599453
FSRP,2,0.6931471805599453
micromolar,2,0.6931471805599453
Santiago,2,0.6931471805599453
reap,2,0.6931471805599453
scrambling,2,0.6931471805599453
summarising,2,0.6931471805599453
bruit,2,0.6931471805599453
case-by-case,2,0.6931471805599453
instructive,2,0.6931471805599453
community-onset,2,0.6931471805599453
Breastfeeding,2,0.6931471805599453
metabolome,2,0.6931471805599453
amoxicillin,2,0.6931471805599453
SDs,2,0.6931471805599453
Predictions,2,0.6931471805599453
Visits,2,0.6931471805599453
UVDR,2,0.6931471805599453
Co-Diagnostics,2,0.6931471805599453
anti-tuberculosis,2,0.6931471805599453
April-May,2,0.6931471805599453
Biomolecular,2,0.6931471805599453
controlquality,2,0.6931471805599453
Spearmans,2,0.6931471805599453
μl-1,2,0.6931471805599453
tapered,2,0.6931471805599453
interleukins,2,0.6931471805599453
suboptimally,2,0.6931471805599453
ILs,2,0.6931471805599453
1840,2,0.6931471805599453
wait-list,2,0.6931471805599453
CYP4A11,2,0.6931471805599453
potentiating,2,0.6931471805599453
substantiation,2,0.6931471805599453
ASPIRE,2,0.6931471805599453
penetrated,2,0.6931471805599453
orphanages,2,0.6931471805599453
inmates,2,0.6931471805599453
nsp7-10,2,0.6931471805599453
ACCESS,2,0.6931471805599453
evanescent,2,0.6931471805599453
stranded,2,0.6931471805599453
frontal-subcortical,2,0.6931471805599453
replicationtranscription,2,0.6931471805599453
CADILLAC,2,0.6931471805599453
open-platform,2,0.6931471805599453
ideation,2,0.6931471805599453
TVR,2,0.6931471805599453
enjoy,2,0.6931471805599453
tolerate,2,0.6931471805599453
Periplaneta,2,0.6931471805599453
americana,2,0.6931471805599453
subtyped,2,0.6931471805599453
precluded,2,0.6931471805599453
inadequacy,2,0.6931471805599453
79-year-old,2,0.6931471805599453
announcing,2,0.6931471805599453
thalamotomy,2,0.6931471805599453
interconnection,2,0.6931471805599453
Presented,2,0.6931471805599453
literature-based,2,0.6931471805599453
embarking,2,0.6931471805599453
Differentiation,2,0.6931471805599453
conferences,2,0.6931471805599453
9403,2,0.6931471805599453
conscripts,2,0.6931471805599453
NCF,2,0.6931471805599453
VDR,2,0.6931471805599453
β2,2,0.6931471805599453
destinations,2,0.6931471805599453
Passengers,2,0.6931471805599453
spacing,2,0.6931471805599453
beta-sympathomimetics,2,0.6931471805599453
isoniazid,2,0.6931471805599453
eventspatients,2,0.6931471805599453
823,2,0.6931471805599453
attack-related,2,0.6931471805599453
mania,2,0.6931471805599453
Cleavage,2,0.6931471805599453
Hokkaido,2,0.6931471805599453
deoxyribonucleic,2,0.6931471805599453
Ia,2,0.6931471805599453
Na3Ct,2,0.6931471805599453
citrate,2,0.6931471805599453
HAuCl4,2,0.6931471805599453
spp,2,0.6931471805599453
faecium,2,0.6931471805599453
Commentary,2,0.6931471805599453
oligodendrocytes,2,0.6931471805599453
≥8,2,0.6931471805599453
≤2,2,0.6931471805599453
unborn,2,0.6931471805599453
self-concept,2,0.6931471805599453
Non-Q-Wave,2,0.6931471805599453
diplopia,2,0.6931471805599453
macro-aggregation,2,0.6931471805599453
streptomycin,2,0.6931471805599453
Winnipeg,2,0.6931471805599453
Vancouver,2,0.6931471805599453
OHCA,2,0.6931471805599453
665,2,0.6931471805599453
Alliance,2,0.6931471805599453
impingers,2,0.6931471805599453
domesticated,2,0.6931471805599453
HNE,2,0.6931471805599453
Expanding,2,0.6931471805599453
mock,2,0.6931471805599453
probing,2,0.6931471805599453
trafficking,2,0.6931471805599453
-007,2,0.6931471805599453
nitrogenous,2,0.6931471805599453
Spikevax,2,0.6931471805599453
Cas13a,2,0.6931471805599453
VSV,2,0.6931471805599453
rabbit,2,0.6931471805599453
initiator,2,0.6931471805599453
hallucinations,2,0.6931471805599453
misidentification,2,0.6931471805599453
parent-adolescent,2,0.6931471805599453
neuropsychiatry,2,0.6931471805599453
SARS-CoV-2019,2,0.6931471805599453
herpesviruses,2,0.6931471805599453
herpesvirus,2,0.6931471805599453
non-PCM,2,0.6931471805599453
barricade,2,0.6931471805599453
SCOPUS,2,0.6931471805599453
high-yield,2,0.6931471805599453
archive,2,0.6931471805599453
NADPH,2,0.6931471805599453
Titres,2,0.6931471805599453
Fewer,2,0.6931471805599453
H1N1-positive,2,0.6931471805599453
Panther,2,0.6931471805599453
authorised,2,0.6931471805599453
cotton,2,0.6931471805599453
divisive,2,0.6931471805599453
fluid-attenuated,2,0.6931471805599453
instantaneous,2,0.6931471805599453
feather,2,0.6931471805599453
dyssynchrony,2,0.6931471805599453
urbanizing,2,0.6931471805599453
arrays,2,0.6931471805599453
axonal,2,0.6931471805599453
posttransplantation,2,0.6931471805599453
pinnipeds,2,0.6931471805599453
lions,2,0.6931471805599453
scattering,2,0.6931471805599453
confounder,2,0.6931471805599453
downward,2,0.6931471805599453
538,2,0.6931471805599453
Model-based,2,0.6931471805599453
contagiousness,2,0.6931471805599453
SERPINB2,2,0.6931471805599453
EMs,2,0.6931471805599453
αVβ3,2,0.6931471805599453
facility-wide,2,0.6931471805599453
infers,2,0.6931471805599453
interleukin-2,2,0.6931471805599453
nonrheumatic,2,0.6931471805599453
caloric,2,0.6931471805599453
Tailoring,2,0.6931471805599453
direct-acting,2,0.6931471805599453
Panbio™,2,0.6931471805599453
Challenge,2,0.6931471805599453
cease,2,0.6931471805599453
minimising,2,0.6931471805599453
Expressed,2,0.6931471805599453
endotheliocytes,2,0.6931471805599453
equipoise,2,0.6931471805599453
logo,2,0.6931471805599453
Differentially,2,0.6931471805599453
3-tier,2,0.6931471805599453
Chemical,2,0.6931471805599453
Anatomical,2,0.6931471805599453
DDDs,2,0.6931471805599453
multifarious,2,0.6931471805599453
3634,2,0.6931471805599453
aptasensor,2,0.6931471805599453
subsistence,2,0.6931471805599453
Forty-one,2,0.6931471805599453
VEMPs,2,0.6931471805599453
Antioxidant,2,0.6931471805599453
Prevaccination,2,0.6931471805599453
micronutrient,2,0.6931471805599453
-20,2,0.6931471805599453
assaying,2,0.6931471805599453
commoner,2,0.6931471805599453
nasalnasopharyngeal,2,0.6931471805599453
ETA,2,0.6931471805599453
congruence,2,0.6931471805599453
ETB,2,0.6931471805599453
prediagnosis,2,0.6931471805599453
singleplex,2,0.6931471805599453
ATG,2,0.6931471805599453
Lay,2,0.6931471805599453
clothes,2,0.6931471805599453
curvilinear,2,0.6931471805599453
glimpse,2,0.6931471805599453
haemodialysis,2,0.6931471805599453
RT-PCR-positive,2,0.6931471805599453
needless,2,0.6931471805599453
cardiospinal,2,0.6931471805599453
Odate,2,0.6931471805599453
LDL,2,0.6931471805599453
noticeably,2,0.6931471805599453
immunodiagnostic,2,0.6931471805599453
commercialized,2,0.6931471805599453
nanopopcorn,2,0.6931471805599453
Au,2,0.6931471805599453
Antibiotic,2,0.6931471805599453
SPAF,2,0.6931471805599453
drug-food,2,0.6931471805599453
non-PAF,2,0.6931471805599453
Bells,2,0.6931471805599453
STF,2,0.6931471805599453
LPG,2,0.6931471805599453
831,2,0.6931471805599453
1048,2,0.6931471805599453
Regulatory,2,0.6931471805599453
UKs,2,0.6931471805599453
selects,2,0.6931471805599453
Polycythaemia,2,0.6931471805599453
NEMSIS,2,0.6931471805599453
PRIMA,2,0.6931471805599453
pancreatitis,2,0.6931471805599453
SPS3,2,0.6931471805599453
Subcortical,2,0.6931471805599453
SPRINT,2,0.6931471805599453
Naval,2,0.6931471805599453
NAMRU-3,2,0.6931471805599453
underpinnings,2,0.6931471805599453
committed,2,0.6931471805599453
attach,2,0.6931471805599453
AlCl3,2,0.6931471805599453
HEDIS,2,0.6931471805599453
Worth,2,0.6931471805599453
DDC,2,0.6931471805599453
SMA,2,0.6931471805599453
Zn-SOD,2,0.6931471805599453
adrenals,2,0.6931471805599453
wayfinding,2,0.6931471805599453
apitherapy,2,0.6931471805599453
lips,2,0.6931471805599453
tongue,2,0.6931471805599453
millimetres,2,0.6931471805599453
Democratic,2,0.6931471805599453
Patient-Reported,2,0.6931471805599453
anti-H5N1,2,0.6931471805599453
gangrene,2,0.6931471805599453
dyspepsia,2,0.6931471805599453
mNIHSS,2,0.6931471805599453
Dosing,2,0.6931471805599453
faint,2,0.6931471805599453
spacer,2,0.6931471805599453
7-9,2,0.6931471805599453
Exaggerated,2,0.6931471805599453
2SARS-CoV-2,2,0.6931471805599453
Echocardiograms,2,0.6931471805599453
Sixty-four,2,0.6931471805599453
Brighton,2,0.6931471805599453
inconsistencies,2,0.6931471805599453
Cambodian,2,0.6931471805599453
Concentration,2,0.6931471805599453
oxidant,2,0.6931471805599453
666,2,0.6931471805599453
18th,2,0.6931471805599453
circumventricular,2,0.6931471805599453
Principles,2,0.6931471805599453
AAQOL,2,0.6931471805599453
Lithuanian,2,0.6931471805599453
nontotal,2,0.6931471805599453
AFC,2,0.6931471805599453
scepticism,2,0.6931471805599453
Valid,2,0.6931471805599453
glucocorticoid-resistant,2,0.6931471805599453
Mino,2,0.6931471805599453
isoleucine,2,0.6931471805599453
Atopic,2,0.6931471805599453
interregional,2,0.6931471805599453
spells,2,0.6931471805599453
9444,2,0.6931471805599453
0045,2,0.6931471805599453
PACSI,2,0.6931471805599453
Tabriz,2,0.6931471805599453
desaturation,2,0.6931471805599453
Subunit,2,0.6931471805599453
alveolar-arterial,2,0.6931471805599453
preeminent,2,0.6931471805599453
in-situ,2,0.6931471805599453
imprinted,2,0.6931471805599453
small-size,2,0.6931471805599453
realization,2,0.6931471805599453
O2,2,0.6931471805599453
chair,2,0.6931471805599453
VAT,2,0.6931471805599453
Directions,2,0.6931471805599453
mm-3,2,0.6931471805599453
steroid-phobia,2,0.6931471805599453
Fear,2,0.6931471805599453
potentiated,2,0.6931471805599453
orthopaedic,2,0.6931471805599453
phosphorothioate,2,0.6931471805599453
Seventy,2,0.6931471805599453
Eighty-four,2,0.6931471805599453
pressurized,2,0.6931471805599453
institutionalised,2,0.6931471805599453
God,2,0.6931471805599453
MB-CPK,2,0.6931471805599453
XXI,2,0.6931471805599453
chapters,2,0.6931471805599453
Gøtzsche,2,0.6931471805599453
reestablish,2,0.6931471805599453
finalized,2,0.6931471805599453
non-neutralizing,2,0.6931471805599453
Pericarditis,2,0.6931471805599453
constrictiva,2,0.6931471805599453
DESs,2,0.6931471805599453
enlisted,2,0.6931471805599453
light-to-moderate,2,0.6931471805599453
efficacies,2,0.6931471805599453
n21,2,0.6931471805599453
IMIs,2,0.6931471805599453
1140,2,0.6931471805599453
BYamagata1688,2,0.6931471805599453
41-50,2,0.6931471805599453
hyperresponsive,2,0.6931471805599453
fire,2,0.6931471805599453
70-90,2,0.6931471805599453
unlimited,2,0.6931471805599453
adrenalectomy,2,0.6931471805599453
Aphasia,2,0.6931471805599453
chromaffin,2,0.6931471805599453
Exogenous,2,0.6931471805599453
Art,2,0.6931471805599453
Johansen,2,0.6931471805599453
Record,2,0.6931471805599453
nonsurvivor,2,0.6931471805599453
1512,2,0.6931471805599453
likes,2,0.6931471805599453
scene,2,0.6931471805599453
Differentiating,2,0.6931471805599453
1205,2,0.6931471805599453
Post-MI,2,0.6931471805599453
invalidate,2,0.6931471805599453
in-,2,0.6931471805599453
antigen-capture,2,0.6931471805599453
steroidogenesis,2,0.6931471805599453
salutary,2,0.6931471805599453
Intra,2,0.6931471805599453
cell-survival,2,0.6931471805599453
postchallenge,2,0.6931471805599453
post-,2,0.6931471805599453
Liverpool,2,0.6931471805599453
negative-control,2,0.6931471805599453
P014,2,0.6931471805599453
HCRU,2,0.6931471805599453
P004,2,0.6931471805599453
noncirrhotic,2,0.6931471805599453
Neurol,2,0.6931471805599453
hyperosmolar,2,0.6931471805599453
craniocervical,2,0.6931471805599453
drying,2,0.6931471805599453
aPL-,2,0.6931471805599453
reserves,2,0.6931471805599453
rp,2,0.6931471805599453
hyperpnea,2,0.6931471805599453
UV-C,2,0.6931471805599453
re-randomized,2,0.6931471805599453
reinforcement,2,0.6931471805599453
mobilised,2,0.6931471805599453
encephalopathyencephalitis,2,0.6931471805599453
Léa,2,0.6931471805599453
foreseen,2,0.6931471805599453
Allopurinol,2,0.6931471805599453
12-13,2,0.6931471805599453
Capacity,2,0.6931471805599453
nonimmunologic,2,0.6931471805599453
inhaling,2,0.6931471805599453
503,2,0.6931471805599453
axes,2,0.6931471805599453
Macao,2,0.6931471805599453
cohesive,2,0.6931471805599453
Soldiers,2,0.6931471805599453
civilians,2,0.6931471805599453
conceptualized,2,0.6931471805599453
microelecrostimulation,2,0.6931471805599453
accountability,2,0.6931471805599453
pumps,2,0.6931471805599453
Wkg,2,0.6931471805599453
hypochlorite,2,0.6931471805599453
neuroregeneration,2,0.6931471805599453
superstandard,2,0.6931471805599453
accomplish,2,0.6931471805599453
welcome,2,0.6931471805599453
Positron,2,0.6931471805599453
tracers,2,0.6931471805599453
Atherosclerotic,2,0.6931471805599453
Mexican-Americans,2,0.6931471805599453
epilepticus,2,0.6931471805599453
Premenstrual,2,0.6931471805599453
patching,2,0.6931471805599453
told,2,0.6931471805599453
premenstrually,2,0.6931471805599453
casually,2,0.6931471805599453
Vital,2,0.6931471805599453
mini,2,0.6931471805599453
ache,2,0.6931471805599453
sinopulmonary,2,0.6931471805599453
Meningococcal,2,0.6931471805599453
abscesses,2,0.6931471805599453
serogroups,2,0.6931471805599453
odontogenic,2,0.6931471805599453
generalisability,2,0.6931471805599453
MobileNet,2,0.6931471805599453
PEDV,2,0.6931471805599453
ResNet,2,0.6931471805599453
vanishing,2,0.6931471805599453
UTR,2,0.6931471805599453
Franklin,2,0.6931471805599453
field-deployable,2,0.6931471805599453
EEG-pattern,2,0.6931471805599453
Psychiatric,2,0.6931471805599453
elaborates,2,0.6931471805599453
single-round,2,0.6931471805599453
1187,2,0.6931471805599453
Steroid,2,0.6931471805599453
dampen,2,0.6931471805599453
antigen-presenting,2,0.6931471805599453
16-34,2,0.6931471805599453
331,2,0.6931471805599453
Sublingual,2,0.6931471805599453
accessing,2,0.6931471805599453
SPEED,2,0.6931471805599453
bulb,2,0.6931471805599453
hypogeusia,2,0.6931471805599453
12-year,2,0.6931471805599453
ignoring,2,0.6931471805599453
Tc99m-sestamibi-SPECT,2,0.6931471805599453
formations,2,0.6931471805599453
pilgrimage,2,0.6931471805599453
centimeter,2,0.6931471805599453
LRTIs,2,0.6931471805599453
Journals,2,0.6931471805599453
Adalja,2,0.6931471805599453
Amesh,2,0.6931471805599453
editor,2,0.6931471805599453
Readers,2,0.6931471805599453
recNL602-I223R,2,0.6931471805599453
Policymakers,2,0.6931471805599453
alveolitis,2,0.6931471805599453
ST-SD,2,0.6931471805599453
immunogens,2,0.6931471805599453
16117,2,0.6931471805599453
spawning,2,0.6931471805599453
deceleration,2,0.6931471805599453
0-40,2,0.6931471805599453
NOW™,2,0.6931471805599453
-029,2,0.6931471805599453
coronavirus-19,2,0.6931471805599453
944,2,0.6931471805599453
ben,2,0.6931471805599453
excesses,2,0.6931471805599453
tail,2,0.6931471805599453
prepaid,2,0.6931471805599453
irritative,2,0.6931471805599453
phenotype-specific,2,0.6931471805599453
4200,2,0.6931471805599453
CFI,2,0.6931471805599453
magnifying,2,0.6931471805599453
low-age,2,0.6931471805599453
Inappropriate,2,0.6931471805599453
dimensional,2,0.6931471805599453
FRET-based,2,0.6931471805599453
pricing,2,0.6931471805599453
Fluorescence,2,0.6931471805599453
toxoid,2,0.6931471805599453
dpdt,2,0.6931471805599453
11-year,2,0.6931471805599453
cerebroprotective,2,0.6931471805599453
sleep-related,2,0.6931471805599453
UIIP,2,0.6931471805599453
notorious,2,0.6931471805599453
disastrous,2,0.6931471805599453
SWCM,2,0.6931471805599453
unloaded,2,0.6931471805599453
late-stage,2,0.6931471805599453
shrimp,2,0.6931471805599453
beta-sitosterol,2,0.6931471805599453
Dexamethasone,2,0.6931471805599453
U-shaped,2,0.6931471805599453
Counts,2,0.6931471805599453
viroporin,2,0.6931471805599453
antimalarial,2,0.6931471805599453
UVB,2,0.6931471805599453
Llobregat,2,0.6931471805599453
UVC,2,0.6931471805599453
10-19,2,0.6931471805599453
APP,2,0.6931471805599453
passport,2,0.6931471805599453
neuropathology,2,0.6931471805599453
recesses--behind,2,0.6931471805599453
manubrium,2,0.6931471805599453
resist,2,0.6931471805599453
Role,2,0.6931471805599453
inhaler-based,2,0.6931471805599453
conus,2,0.6931471805599453
shoulders,2,0.6931471805599453
reliant,2,0.6931471805599453
TSE,2,0.6931471805599453
vaso-occlusion,2,0.6931471805599453
impairing,2,0.6931471805599453
botulinum,2,0.6931471805599453
neurocritical,2,0.6931471805599453
post-coronary,2,0.6931471805599453
immunise,2,0.6931471805599453
non-alcoholic,2,0.6931471805599453
responsively,2,0.6931471805599453
pneumonia-causing,2,0.6931471805599453
hantavirus,2,0.6931471805599453
non-avian,2,0.6931471805599453
serum-based,2,0.6931471805599453
herds,2,0.6931471805599453
profit,2,0.6931471805599453
6B,2,0.6931471805599453
Soluble,2,0.6931471805599453
tumorigenicity,2,0.6931471805599453
interrelationship,2,0.6931471805599453
CMEAnswers,2,0.6931471805599453
Kolkata,2,0.6931471805599453
noninferior,2,0.6931471805599453
2017-18,2,0.6931471805599453
T200A,2,0.6931471805599453
D225N,2,0.6931471805599453
unit-level,2,0.6931471805599453
Regimen,2,0.6931471805599453
centimeters,2,0.6931471805599453
AGTs,2,0.6931471805599453
chi-squared,2,0.6931471805599453
full-time,2,0.6931471805599453
374-441,2,0.6931471805599453
anti-NTD,2,0.6931471805599453
242-244Δ,2,0.6931471805599453
operationally,2,0.6931471805599453
same-day,2,0.6931471805599453
RBD-subunit,2,0.6931471805599453
ZF2001,2,0.6931471805599453
ms2,2,0.6931471805599453
CD3CD1656,2,0.6931471805599453
HRCurrent,2,0.6931471805599453
CD3,2,0.6931471805599453
CLRD,2,0.6931471805599453
699,2,0.6931471805599453
Romanian,2,0.6931471805599453
suspicions,2,0.6931471805599453
2002-03,2,0.6931471805599453
afebrile,2,0.6931471805599453
disagreed,2,0.6931471805599453
Malawi,2,0.6931471805599453
engraft,2,0.6931471805599453
treatmentprophylaxis,2,0.6931471805599453
cumbersome,2,0.6931471805599453
myalgias,2,0.6931471805599453
Acutely,2,0.6931471805599453
DiI,2,0.6931471805599453
mitogen-activated,2,0.6931471805599453
hypoxic-ischemic,2,0.6931471805599453
NCT,2,0.6931471805599453
Shortness,2,0.6931471805599453
keeps,2,0.6931471805599453
MW05,2,0.6931471805599453
escaping,2,0.6931471805599453
PWV,2,0.6931471805599453
subclass,2,0.6931471805599453
15min,2,0.6931471805599453
chameleons,2,0.6931471805599453
DrugBank,2,0.6931471805599453
polysaccharides,2,0.6931471805599453
827,2,0.6931471805599453
GOS,2,0.6931471805599453
Hemorrhage,2,0.6931471805599453
SM-IVE,2,0.6931471805599453
-thickening,2,0.6931471805599453
Intra-operative,2,0.6931471805599453
dispensed,2,0.6931471805599453
anti-cancer,2,0.6931471805599453
perceptron,2,0.6931471805599453
RTK,2,0.6931471805599453
GPIbα,2,0.6931471805599453
throws,2,0.6931471805599453
imputing,2,0.6931471805599453
unimmunised,2,0.6931471805599453
TSCs,2,0.6931471805599453
lenvatinibremdesivir,2,0.6931471805599453
myofibrillar,2,0.6931471805599453
Infarcts,2,0.6931471805599453
GIK,2,0.6931471805599453
sham-operated,2,0.6931471805599453
gender-,2,0.6931471805599453
B16171,2,0.6931471805599453
1344,2,0.6931471805599453
2013-2014,2,0.6931471805599453
Ultrasound,2,0.6931471805599453
Pertinent,2,0.6931471805599453
gastrooesophageal,2,0.6931471805599453
Sri,2,0.6931471805599453
on-scene,2,0.6931471805599453
Revascularization,2,0.6931471805599453
640,2,0.6931471805599453
transcallosal,2,0.6931471805599453
EPHI,2,0.6931471805599453
fifty-six,2,0.6931471805599453
papilloma,2,0.6931471805599453
in-center,2,0.6931471805599453
PVAD,2,0.6931471805599453
Team,2,0.6931471805599453
Industrial,2,0.6931471805599453
ADAPT,2,0.6931471805599453
specification,2,0.6931471805599453
Helsinki,2,0.6931471805599453
clouds,2,0.6931471805599453
neurotransmitters,2,0.6931471805599453
academy,2,0.6931471805599453
ACTH,2,0.6931471805599453
dl-1,2,0.6931471805599453
Ophthalmology,2,0.6931471805599453
Adrenal,2,0.6931471805599453
tw,2,0.6931471805599453
aspirated,2,0.6931471805599453
IRF7,2,0.6931471805599453
IL6,2,0.6931471805599453
Motivation,2,0.6931471805599453
haemostatic,2,0.6931471805599453
bestowed,2,0.6931471805599453
Ophthalmol,2,0.6931471805599453
graphically,2,0.6931471805599453
end-tidal,2,0.6931471805599453
capita,2,0.6931471805599453
Walking,2,0.6931471805599453
Pubmed,2,0.6931471805599453
Hospital-acquired,2,0.6931471805599453
elapsing,2,0.6931471805599453
APC,2,0.6931471805599453
ANC,2,0.6931471805599453
FLPRSR,2,0.6931471805599453
CDTI,2,0.6931471805599453
goggles,2,0.6931471805599453
LCBIs,2,0.6931471805599453
datehourminute,2,0.6931471805599453
HBE,2,0.6931471805599453
LCBI,2,0.6931471805599453
Methodological,2,0.6931471805599453
sub-divided,2,0.6931471805599453
918,2,0.6931471805599453
isocapnic,2,0.6931471805599453
productions,2,0.6931471805599453
divisional,2,0.6931471805599453
IFVB,2,0.6931471805599453
wasp,2,0.6931471805599453
stings,2,0.6931471805599453
cognate,2,0.6931471805599453
single-chamber,2,0.6931471805599453
Ward,2,0.6931471805599453
hall,2,0.6931471805599453
Qinhuangdao,2,0.6931471805599453
patient-year,2,0.6931471805599453
compositions,2,0.6931471805599453
inferiority,2,0.6931471805599453
Yamanashi,2,0.6931471805599453
adsorption-direct,2,0.6931471805599453
CS-dependent,2,0.6931471805599453
Radiologic,2,0.6931471805599453
0-100,2,0.6931471805599453
High-throughput,2,0.6931471805599453
1-14,2,0.6931471805599453
Qiagen,2,0.6931471805599453
AWSN33,2,0.6931471805599453
Periodicals,2,0.6931471805599453
TNF-alpha,2,0.6931471805599453
unidirectional,2,0.6931471805599453
Intriguingly,2,0.6931471805599453
sterilants,2,0.6931471805599453
antigenantibody,2,0.6931471805599453
Johns,2,0.6931471805599453
Prophylaxis,2,0.6931471805599453
3702,2,0.6931471805599453
post-intervention,2,0.6931471805599453
CASE,2,0.6931471805599453
REPORT,2,0.6931471805599453
internally,2,0.6931471805599453
accidental,2,0.6931471805599453
Aggressive,2,0.6931471805599453
CEI,2,0.6931471805599453
946,2,0.6931471805599453
middle-,2,0.6931471805599453
discipline,2,0.6931471805599453
Edinburgh,2,0.6931471805599453
ignores,2,0.6931471805599453
nasopharyngealoropharyngeal,2,0.6931471805599453
monument,2,0.6931471805599453
1220,2,0.6931471805599453
nonreceipt,2,0.6931471805599453
reassessment,2,0.6931471805599453
9380,2,0.6931471805599453
invaded,2,0.6931471805599453
Balochistan,2,0.6931471805599453
anastomosing,2,0.6931471805599453
pubertal,2,0.6931471805599453
skiing,2,0.6931471805599453
vaccination-induced,2,0.6931471805599453
cold-weather,2,0.6931471805599453
3-month-old,2,0.6931471805599453
ce,2,0.6931471805599453
NF-kB,2,0.6931471805599453
European-wide,2,0.6931471805599453
publish,2,0.6931471805599453
CTACTP,2,0.6931471805599453
1886,2,0.6931471805599453
prematurity,2,0.6931471805599453
Create,2,0.6931471805599453
BYamanashi16698,2,0.6931471805599453
inter-hemispheric,2,0.6931471805599453
Utahs,2,0.6931471805599453
EPO,2,0.6931471805599453
BBeijing18493,2,0.6931471805599453
premotor,2,0.6931471805599453
Bayes,2,0.6931471805599453
parametric,2,0.6931471805599453
tuberculous,2,0.6931471805599453
non-endemic,2,0.6931471805599453
kinship,2,0.6931471805599453
EEG-fMRI,2,0.6931471805599453
invasions,2,0.6931471805599453
disease-associated,2,0.6931471805599453
2015-16,2,0.6931471805599453
foresee,2,0.6931471805599453
much-needed,2,0.6931471805599453
Calvados,2,0.6931471805599453
10-24,2,0.6931471805599453
④,2,0.6931471805599453
③,2,0.6931471805599453
trail,2,0.6931471805599453
Birds,2,0.6931471805599453
Hemagglutinin,2,0.6931471805599453
Autonomous,2,0.6931471805599453
multi-burden,2,0.6931471805599453
non-vaccine-controlled,2,0.6931471805599453
vaccine-controlled,2,0.6931471805599453
repositive,2,0.6931471805599453
②,2,0.6931471805599453
diphtheria,2,0.6931471805599453
pertussis,2,0.6931471805599453
vaccine-specific,2,0.6931471805599453
CPD,2,0.6931471805599453
Sakai,2,0.6931471805599453
arranging,2,0.6931471805599453
①,2,0.6931471805599453
tranexamic,2,0.6931471805599453
2019COVID-19,2,0.6931471805599453
packaged,2,0.6931471805599453
mentally,2,0.6931471805599453
capsid,2,0.6931471805599453
VLP-based,2,0.6931471805599453
Isahaya,2,0.6931471805599453
2-8,2,0.6931471805599453
baculovirus,2,0.6931471805599453
9753,2,0.6931471805599453
VPCs,2,0.6931471805599453
seaweed,2,0.6931471805599453
SBI,2,0.6931471805599453
CC50,2,0.6931471805599453
unwanted,2,0.6931471805599453
RHC,2,0.6931471805599453
vigorously,2,0.6931471805599453
endothelium-derived,2,0.6931471805599453
hyperpolarizing,2,0.6931471805599453
9-year,2,0.6931471805599453
cardioplegia,2,0.6931471805599453
instigating,2,0.6931471805599453
fibromuscular,2,0.6931471805599453
complementaryalternative,2,0.6931471805599453
insulting,2,0.6931471805599453
731,2,0.6931471805599453
530,2,0.6931471805599453
prayers,2,0.6931471805599453
-Örebro,2,0.6931471805599453
outliers,2,0.6931471805599453
932,2,0.6931471805599453
nongovernmental,2,0.6931471805599453
massage,2,0.6931471805599453
quantitate,2,0.6931471805599453
time-critical,2,0.6931471805599453
carbohydrates,2,0.6931471805599453
quotient,2,0.6931471805599453
ACCAHA,2,0.6931471805599453
provocations,2,0.6931471805599453
60-85,2,0.6931471805599453
CSVT,2,0.6931471805599453
sponsors,2,0.6931471805599453
immunomodulating,2,0.6931471805599453
doubtful,2,0.6931471805599453
weighting,2,0.6931471805599453
gastroenterology,2,0.6931471805599453
disagree,2,0.6931471805599453
oligomers,2,0.6931471805599453
withheld,2,0.6931471805599453
Swab,2,0.6931471805599453
off-target,2,0.6931471805599453
Ventriculography,2,0.6931471805599453
irregularities,2,0.6931471805599453
6799,2,0.6931471805599453
illness-related,2,0.6931471805599453
misclassifications,2,0.6931471805599453
RIA,2,0.6931471805599453
p-interaction,2,0.6931471805599453
step-down,2,0.6931471805599453
0081,2,0.6931471805599453
lend,2,0.6931471805599453
standpoints,2,0.6931471805599453
tragedy,2,0.6931471805599453
Adult-onset,2,0.6931471805599453
Thirty-four,2,0.6931471805599453
IL-33,2,0.6931471805599453
pinpointed,2,0.6931471805599453
sub-phenotypes,2,0.6931471805599453
eosin,2,0.6931471805599453
hematoxylin,2,0.6931471805599453
GlaxoSmithKline,2,0.6931471805599453
vírus,2,0.6931471805599453
catalyzed,2,0.6931471805599453
issuing,2,0.6931471805599453
spark,2,0.6931471805599453
Controlling,2,0.6931471805599453
Models,2,0.6931471805599453
ganglion,2,0.6931471805599453
Acquired,2,0.6931471805599453
myopathy,2,0.6931471805599453
hemithorax,2,0.6931471805599453
hierarchies,2,0.6931471805599453
insidious,2,0.6931471805599453
VRFs,2,0.6931471805599453
p00046,2,0.6931471805599453
graphs,2,0.6931471805599453
pyramidal,2,0.6931471805599453
destroys,2,0.6931471805599453
p00000001,2,0.6931471805599453
neurite,2,0.6931471805599453
IWMLs,2,0.6931471805599453
20-44,2,0.6931471805599453
enumerates,2,0.6931471805599453
socio-cultural,2,0.6931471805599453
Encouraging,2,0.6931471805599453
crying,2,0.6931471805599453
laughing,2,0.6931471805599453
3-chymotrypsin-like,2,0.6931471805599453
hepatotoxicity,2,0.6931471805599453
799,2,0.6931471805599453
MFS,2,0.6931471805599453
carcinogenicity,2,0.6931471805599453
oculomotor,2,0.6931471805599453
categorised,2,0.6931471805599453
non-mutagenic,2,0.6931471805599453
412,2,0.6931471805599453
myasthenia,2,0.6931471805599453
observant,2,0.6931471805599453
continental,2,0.6931471805599453
CMV,2,0.6931471805599453
bioaerosol,2,0.6931471805599453
Scales,2,0.6931471805599453
October-November,2,0.6931471805599453
IL-15,2,0.6931471805599453
hard-to-reach,2,0.6931471805599453
up-,2,0.6931471805599453
465,2,0.6931471805599453
pregnancy-associated,2,0.6931471805599453
tagging,2,0.6931471805599453
1260,2,0.6931471805599453
TMT-isobaric,2,0.6931471805599453
epidemicpandemic,2,0.6931471805599453
Taleum,2,0.6931471805599453
disentangle,2,0.6931471805599453
non-classical,2,0.6931471805599453
sham-controlled,2,0.6931471805599453
neuroplastic,2,0.6931471805599453
neuromodulatory,2,0.6931471805599453
networking,2,0.6931471805599453
self-controlled,2,0.6931471805599453
log-normal,2,0.6931471805599453
Telangana,2,0.6931471805599453
IAO,2,0.6931471805599453
allergy-immunology,2,0.6931471805599453
-the,2,0.6931471805599453
MX1,2,0.6931471805599453
extraction-free,2,0.6931471805599453
0539,2,0.6931471805599453
P0006,2,0.6931471805599453
amplification-based,2,0.6931471805599453
primigravida,2,0.6931471805599453
antigen-naive,2,0.6931471805599453
cytosolic,2,0.6931471805599453
mmolkg,2,0.6931471805599453
phospholipid,2,0.6931471805599453
D-VAMS,2,0.6931471805599453
p003,2,0.6931471805599453
nonverbal,2,0.6931471805599453
972,2,0.6931471805599453
Prima,2,0.6931471805599453
UT,2,0.6931471805599453
FLU-A,2,0.6931471805599453
Directigen,2,0.6931471805599453
Rwandas,2,0.6931471805599453
SEIT,2,0.6931471805599453
undamaged,2,0.6931471805599453
zymosan,2,0.6931471805599453
CCH,2,0.6931471805599453
phagocytosed,2,0.6931471805599453
ribosome,2,0.6931471805599453
discernment,2,0.6931471805599453
Addis,2,0.6931471805599453
Ababa,2,0.6931471805599453
retard,2,0.6931471805599453
16215,2,0.6931471805599453
563-570,2,0.6931471805599453
proponents,2,0.6931471805599453
Brunei,2,0.6931471805599453
robotic,2,0.6931471805599453
thrice,2,0.6931471805599453
ADEM,2,0.6931471805599453
pains,2,0.6931471805599453
spliceosome,2,0.6931471805599453
bronchoscope,2,0.6931471805599453
breaths,2,0.6931471805599453
subregions,2,0.6931471805599453
Malignant,2,0.6931471805599453
stand-alone,2,0.6931471805599453
biochemistry,2,0.6931471805599453
spherocytosis,2,0.6931471805599453
droppings,2,0.6931471805599453
swineTaiwan,2,0.6931471805599453
haematopoiesis,2,0.6931471805599453
abut,2,0.6931471805599453
abutting,2,0.6931471805599453
Publications,2,0.6931471805599453
High-level,2,0.6931471805599453
Extramedullary,2,0.6931471805599453
abolishing,2,0.6931471805599453
979-1000,2,0.6931471805599453
under-recognised,2,0.6931471805599453
planimetrically,2,0.6931471805599453
Hearts,2,0.6931471805599453
under-recognition,2,0.6931471805599453
paediatrician,2,0.6931471805599453
unregulated,2,0.6931471805599453
echo-cardiography,2,0.6931471805599453
biofluid,2,0.6931471805599453
cost-of-illness,2,0.6931471805599453
pneumococcus,2,0.6931471805599453
1071,2,0.6931471805599453
3611,2,0.6931471805599453
29000,2,0.6931471805599453
TCR-HA,2,0.6931471805599453
electroencephalographic,2,0.6931471805599453
1342,2,0.6931471805599453
MoH,2,0.6931471805599453
immortalized,2,0.6931471805599453
aviators,2,0.6931471805599453
AIIRD,2,0.6931471805599453
ungated,2,0.6931471805599453
Genesis,2,0.6931471805599453
FMA-UE,2,0.6931471805599453
1013,2,0.6931471805599453
SIS,2,0.6931471805599453
entrenched,2,0.6931471805599453
armhand,2,0.6931471805599453
summation,2,0.6931471805599453
16-segment,2,0.6931471805599453
microgkg,2,0.6931471805599453
anti‑PD‑1,2,0.6931471805599453
featuring,2,0.6931471805599453
Antarctica,2,0.6931471805599453
analyser,2,0.6931471805599453
hadnt,2,0.6931471805599453
1902,2,0.6931471805599453
Portable,2,0.6931471805599453
dupilumab,2,0.6931471805599453
VV-ECMO,2,0.6931471805599453
QUEST,2,0.6931471805599453
follicular,2,0.6931471805599453
acid-challenged,2,0.6931471805599453
APSAC,2,0.6931471805599453
Pairwise,2,0.6931471805599453
RNA-virus,2,0.6931471805599453
polyclinics,2,0.6931471805599453
transcriptomes,2,0.6931471805599453
treatment-resistant,2,0.6931471805599453
Smaller,2,0.6931471805599453
3481,2,0.6931471805599453
heparin-coated,2,0.6931471805599453
4122,2,0.6931471805599453
3991,2,0.6931471805599453
virologists,2,0.6931471805599453
609,2,0.6931471805599453
spherical,2,0.6931471805599453
concave,2,0.6931471805599453
raced,2,0.6931471805599453
introducer,2,0.6931471805599453
pectus,2,0.6931471805599453
patient-specific,2,0.6931471805599453
OSE,2,0.6931471805599453
openings,2,0.6931471805599453
Easy,2,0.6931471805599453
reocclusions,2,0.6931471805599453
myography,2,0.6931471805599453
ovales,2,0.6931471805599453
binary,2,0.6931471805599453
incompatible,2,0.6931471805599453
aviation,2,0.6931471805599453
di-isocyanate,2,0.6931471805599453
externalities,2,0.6931471805599453
1min,2,0.6931471805599453
commodity,2,0.6931471805599453
Firstly,2,0.6931471805599453
incapacitation,2,0.6931471805599453
tirofiban,2,0.6931471805599453
mgh,2,0.6931471805599453
work-induced,2,0.6931471805599453
dismal,2,0.6931471805599453
asthmogenic,2,0.6931471805599453
arbitrarily,2,0.6931471805599453
cross-section,2,0.6931471805599453
Witwatersrand,2,0.6931471805599453
stigmatized,2,0.6931471805599453
hml,2,0.6931471805599453
1356,2,0.6931471805599453
correspondingly,2,0.6931471805599453
coronavirus-like,2,0.6931471805599453
Cycle,2,0.6931471805599453
960,2,0.6931471805599453
encephalitisencephalopathy,2,0.6931471805599453
Undoubtedly,2,0.6931471805599453
LTE4,2,0.6931471805599453
ethnicities,2,0.6931471805599453
glitazones,2,0.6931471805599453
CRF,2,0.6931471805599453
492,2,0.6931471805599453
inspiring,2,0.6931471805599453
RHL,2,0.6931471805599453
polymorphonuclear,2,0.6931471805599453
RTT,2,0.6931471805599453
DCs,2,0.6931471805599453
antibody-binding,2,0.6931471805599453
pollinosis,2,0.6931471805599453
H1N109,2,0.6931471805599453
paucimicronic,2,0.6931471805599453
bradyarrhythmias,2,0.6931471805599453
1023,2,0.6931471805599453
Wagga,2,0.6931471805599453
clonal,2,0.6931471805599453
MIAMI,2,0.6931471805599453
anatomically,2,0.6931471805599453
endocardium,2,0.6931471805599453
NPEs,2,0.6931471805599453
webs,2,0.6931471805599453
Analyzing,2,0.6931471805599453
Mali,2,0.6931471805599453
rap,2,0.6931471805599453
polyunsaturated,2,0.6931471805599453
annum,2,0.6931471805599453
insecurity,2,0.6931471805599453
Fijians,2,0.6931471805599453
wrong,2,0.6931471805599453
bladeupper,2,0.6931471805599453
Sixty-eight,2,0.6931471805599453
Clade,2,0.6931471805599453
homeless,2,0.6931471805599453
multi-dimensional,2,0.6931471805599453
COVID-positive,2,0.6931471805599453
assortative,2,0.6931471805599453
inequality,2,0.6931471805599453
Marks,2,0.6931471805599453
AQLQ-M,2,0.6931471805599453
low-middle,2,0.6931471805599453
3492,2,0.6931471805599453
Likert,2,0.6931471805599453
cancel,2,0.6931471805599453
Test-retest,2,0.6931471805599453
Stronger,2,0.6931471805599453
destroyed,2,0.6931471805599453
Des,2,0.6931471805599453
unreasonable,2,0.6931471805599453
Plaines,2,0.6931471805599453
3444,2,0.6931471805599453
PAL,2,0.6931471805599453
sample-to-result,2,0.6931471805599453
ddPCR,2,0.6931471805599453
catch,2,0.6931471805599453
miR,2,0.6931471805599453
Embolism,2,0.6931471805599453
mycophenolic,2,0.6931471805599453
rationalization,2,0.6931471805599453
worksite,2,0.6931471805599453
nitrative,2,0.6931471805599453
individualizing,2,0.6931471805599453
fevers,2,0.6931471805599453
negative-strand,2,0.6931471805599453
imbalanced,2,0.6931471805599453
edoxaban,2,0.6931471805599453
autoptic,2,0.6931471805599453
exonuclease,2,0.6931471805599453
Congestive,2,0.6931471805599453
Q677H,2,0.6931471805599453
homotypic,2,0.6931471805599453
Undertreatment,2,0.6931471805599453
spike-based,2,0.6931471805599453
non-insulin-dependent,2,0.6931471805599453
hypercoagulation,2,0.6931471805599453
S-beta,2,0.6931471805599453
Citys,2,0.6931471805599453
Recurrence,2,0.6931471805599453
transfusionnal,2,0.6931471805599453
Procalcitonin,2,0.6931471805599453
facemasks,2,0.6931471805599453
577,2,0.6931471805599453
1106,2,0.6931471805599453
alexithymia,2,0.6931471805599453
catching,2,0.6931471805599453
unwillingness,2,0.6931471805599453
intercountry,2,0.6931471805599453
deregulation,2,0.6931471805599453
Inoculation,2,0.6931471805599453
aORs,2,0.6931471805599453
mgl,2,0.6931471805599453
12-month-old,2,0.6931471805599453
transcription-mediated,2,0.6931471805599453
omnipresent,2,0.6931471805599453
Reunion,2,0.6931471805599453
amantadine-treated,2,0.6931471805599453
Welfare,2,0.6931471805599453
atherogenesis,2,0.6931471805599453
upper-respiratory-tract,2,0.6931471805599453
re-tested,2,0.6931471805599453
micro-,2,0.6931471805599453
re-positive,2,0.6931471805599453
Wild-type,2,0.6931471805599453
WMFT,2,0.6931471805599453
WMD,2,0.6931471805599453
rethrombosis,2,0.6931471805599453
acetate,2,0.6931471805599453
ancestry,2,0.6931471805599453
Pharmacotherapy,2,0.6931471805599453
Correcting,2,0.6931471805599453
Disabilities,2,0.6931471805599453
Shoulder,2,0.6931471805599453
Adjunctive,2,0.6931471805599453
inflammation-related,2,0.6931471805599453
BIOVASC,2,0.6931471805599453
Vulnerable,2,0.6931471805599453
editors,2,0.6931471805599453
Opinions,2,0.6931471805599453
PFOs,2,0.6931471805599453
asthenia,2,0.6931471805599453
non-asthma,2,0.6931471805599453
2157,2,0.6931471805599453
POCS,2,0.6931471805599453
sequellae,2,0.6931471805599453
miR-145,2,0.6931471805599453
extraordinarily,2,0.6931471805599453
Going,2,0.6931471805599453
ethylene,2,0.6931471805599453
diamine,2,0.6931471805599453
age-demographic,2,0.6931471805599453
intolerable,2,0.6931471805599453
HPV,2,0.6931471805599453
portray,2,0.6931471805599453
45-year,2,0.6931471805599453
Co-infections,2,0.6931471805599453
916,2,0.6931471805599453
2007-8,2,0.6931471805599453
VPBs,2,0.6931471805599453
upper-limb,2,0.6931471805599453
413,2,0.6931471805599453
squirrels,2,0.6931471805599453
Angel,2,0.6931471805599453
1-59,2,0.6931471805599453
deer,2,0.6931471805599453
000µL,2,0.6931471805599453
wane,2,0.6931471805599453
pernio-like,2,0.6931471805599453
assign,2,0.6931471805599453
LACS,2,0.6931471805599453
Hazard,2,0.6931471805599453
Treated,2,0.6931471805599453
TACS,2,0.6931471805599453
clofazimine,2,0.6931471805599453
dabrafenib,2,0.6931471805599453
apatinib,2,0.6931471805599453
Form,2,0.6931471805599453
under-utilization,2,0.6931471805599453
inciting,2,0.6931471805599453
SRH,2,0.6931471805599453
eluate,2,0.6931471805599453
874,2,0.6931471805599453
confronting,2,0.6931471805599453
sperm,2,0.6931471805599453
dystonia,2,0.6931471805599453
limb-shaking,2,0.6931471805599453
540,2,0.6931471805599453
asterixis,2,0.6931471805599453
hyperstimulation-IVFICSI,2,0.6931471805599453
Concepts,2,0.6931471805599453
vertebra,2,0.6931471805599453
discharging,2,0.6931471805599453
bifid,2,0.6931471805599453
Self-management,2,0.6931471805599453
occupied,2,0.6931471805599453
syrinx,2,0.6931471805599453
restraint,2,0.6931471805599453
coelomic,2,0.6931471805599453
preventers,2,0.6931471805599453
Chalmers74,2,0.6931471805599453
NCBI,2,0.6931471805599453
FI,2,0.6931471805599453
calculates,2,0.6931471805599453
appointment,2,0.6931471805599453
shields,2,0.6931471805599453
finely,2,0.6931471805599453
follow-ups,2,0.6931471805599453
Files,2,0.6931471805599453
anti-LCMV,2,0.6931471805599453
plasmablasts,2,0.6931471805599453
surroundings,2,0.6931471805599453
Long-standing,2,0.6931471805599453
anti-virals,2,0.6931471805599453
Setting,2,0.6931471805599453
reluctance,2,0.6931471805599453
melting,2,0.6931471805599453
puts,2,0.6931471805599453
Capsule,2,0.6931471805599453
1617,2,0.6931471805599453
re-establish,2,0.6931471805599453
radio,2,0.6931471805599453
surges,2,0.6931471805599453
Cronbach,2,0.6931471805599453
Dongchang,2,0.6931471805599453
Thai-Myanmar,2,0.6931471805599453
tuberculin,2,0.6931471805599453
guaranteed,2,0.6931471805599453
brain-computer,2,0.6931471805599453
hypersecretory,2,0.6931471805599453
germs,2,0.6931471805599453
Lowering,2,0.6931471805599453
spillover,2,0.6931471805599453
RVLV,2,0.6931471805599453
arduous,2,0.6931471805599453
music-supported,2,0.6931471805599453
washed,2,0.6931471805599453
severity-based,2,0.6931471805599453
CAPS,2,0.6931471805599453
11-,2,0.6931471805599453
hypothalamus,2,0.6931471805599453
PNS,2,0.6931471805599453
pre-coating,2,0.6931471805599453
wells,2,0.6931471805599453
rigidity,2,0.6931471805599453
apt,2,0.6931471805599453
galvanic,2,0.6931471805599453
590,2,0.6931471805599453
Rotorod,2,0.6931471805599453
nurse-led,2,0.6931471805599453
LBMs,2,0.6931471805599453
LBM,2,0.6931471805599453
patinets,2,0.6931471805599453
125min,2,0.6931471805599453
Climatologic,2,0.6931471805599453
fenestration,2,0.6931471805599453
cases100,2,0.6931471805599453
GPC,2,0.6931471805599453
exceptions,2,0.6931471805599453
Room,2,0.6931471805599453
C5,2,0.6931471805599453
GSTP1,2,0.6931471805599453
BSichuan37999,2,0.6931471805599453
fluctuates,2,0.6931471805599453
coronavirus-specific,2,0.6931471805599453
IEDB,2,0.6931471805599453
Box,2,0.6931471805599453
electrolysis,2,0.6931471805599453
CPE,2,0.6931471805599453
undergoes,2,0.6931471805599453
infarct-healing,2,0.6931471805599453
Block,2,0.6931471805599453
antagonize,2,0.6931471805599453
SiO2AuQD,2,0.6931471805599453
autophagy-related,2,0.6931471805599453
hypothesis-driven,2,0.6931471805599453
environmentally,2,0.6931471805599453
039,2,0.6931471805599453
ICR,2,0.6931471805599453
short-sighted,2,0.6931471805599453
AScotland74,2,0.6931471805599453
extinguish,2,0.6931471805599453
physiopathologic,2,0.6931471805599453
Alere™,2,0.6931471805599453
chip,2,0.6931471805599453
batches,2,0.6931471805599453
suitably,2,0.6931471805599453
Investigating,2,0.6931471805599453
Pacing,2,0.6931471805599453
β-coronavirus,2,0.6931471805599453
Hyperhomocysteinemia,2,0.6931471805599453
Mechanistic,2,0.6931471805599453
fulfillment,2,0.6931471805599453
B6,2,0.6931471805599453
14-session,2,0.6931471805599453
Fifty,2,0.6931471805599453
RIC,2,0.6931471805599453
telithromycin,2,0.6931471805599453
MHV-A59,2,0.6931471805599453
three-part,2,0.6931471805599453
Barlows,2,0.6931471805599453
fusogenicity,2,0.6931471805599453
β-coronaviruses,2,0.6931471805599453
virophagy,2,0.6931471805599453
supra-aortic,2,0.6931471805599453
Lowen,2,0.6931471805599453
hottest,2,0.6931471805599453
prepublications,2,0.6931471805599453
hinges,2,0.6931471805599453
Subacute,2,0.6931471805599453
conceptualization,2,0.6931471805599453
CHAID,2,0.6931471805599453
SAPCReN-CPCSSN,2,0.6931471805599453
e-mail,2,0.6931471805599453
mucoid,2,0.6931471805599453
CPCSSN,2,0.6931471805599453
proteolytically,2,0.6931471805599453
expeditious,2,0.6931471805599453
double-membrane,2,0.6931471805599453
LCN2,2,0.6931471805599453
Triggering,2,0.6931471805599453
CCL20,2,0.6931471805599453
uPAR,2,0.6931471805599453
EGF,2,0.6931471805599453
SCF,2,0.6931471805599453
Aged,2,0.6931471805599453
HGF,2,0.6931471805599453
SCGF-β,2,0.6931471805599453
bachelor,2,0.6931471805599453
813,2,0.6931471805599453
Binary,2,0.6931471805599453
TFF3,2,0.6931471805599453
ATG5,2,0.6931471805599453
palsies,2,0.6931471805599453
antipyretics,2,0.6931471805599453
CXCL5,2,0.6931471805599453
View,2,0.6931471805599453
bioRxiv,2,0.6931471805599453
Automatic,2,0.6931471805599453
Recursive,2,0.6931471805599453
in-vivo,2,0.6931471805599453
helplessness,2,0.6931471805599453
July-1,2,0.6931471805599453
postinfarct,2,0.6931471805599453
provokes,2,0.6931471805599453
canton,2,0.6931471805599453
macro-,2,0.6931471805599453
myosin,2,0.6931471805599453
minks,2,0.6931471805599453
Neovison,2,0.6931471805599453
paraspinal,2,0.6931471805599453
supraazygos,2,0.6931471805599453
femalemale,2,0.6931471805599453
2013-2017,2,0.6931471805599453
ventriculotomy,2,0.6931471805599453
pleuro-esophageal,2,0.6931471805599453
practised,2,0.6931471805599453
Thematic,2,0.6931471805599453
oncologists,2,0.6931471805599453
391,2,0.6931471805599453
vignettes,2,0.6931471805599453
signssymptoms,2,0.6931471805599453
pluralism,2,0.6931471805599453
co-existence,2,0.6931471805599453
AutoDock,2,0.6931471805599453
folds,2,0.6931471805599453
heavier,2,0.6931471805599453
≤1,2,0.6931471805599453
NIV,2,0.6931471805599453
Johannesburg,2,0.6931471805599453
exaggeration,2,0.6931471805599453
Wanfang,2,0.6931471805599453
CNKI,2,0.6931471805599453
adiponectin,2,0.6931471805599453
harnessed,2,0.6931471805599453
SET,2,0.6931471805599453
chest-CT,2,0.6931471805599453
MADE-DBM,2,0.6931471805599453
transmits,2,0.6931471805599453
isozymes,2,0.6931471805599453
duct,2,0.6931471805599453
doctor-patient,2,0.6931471805599453
isozyme,2,0.6931471805599453
intra,2,0.6931471805599453
EAB,2,0.6931471805599453
longitude,2,0.6931471805599453
post-resuscitation,2,0.6931471805599453
CVIQ,2,0.6931471805599453
Vectorcardiographic,2,0.6931471805599453
201T1,2,0.6931471805599453
immunoinformatics,2,0.6931471805599453
nasaloropharyngeal,2,0.6931471805599453
atheromatosis,2,0.6931471805599453
amidst,2,0.6931471805599453
Intensified,2,0.6931471805599453
transcervical,2,0.6931471805599453
Keep,2,0.6931471805599453
obtuse,2,0.6931471805599453
tomorrow,2,0.6931471805599453
D-dimers,2,0.6931471805599453
traders,2,0.6931471805599453
manipulative,2,0.6931471805599453
Stanford,2,0.6931471805599453
2019-nCoV-infected,2,0.6931471805599453
hermetization,2,0.6931471805599453
1947--1956,2,0.6931471805599453
religiosity,2,0.6931471805599453
invasively,2,0.6931471805599453
CHI3L1,2,0.6931471805599453
CTS,2,0.6931471805599453
Assembly,2,0.6931471805599453
576,2,0.6931471805599453
Absence,2,0.6931471805599453
revival,2,0.6931471805599453
nervosa,2,0.6931471805599453
sponge,2,0.6931471805599453
447,2,0.6931471805599453
attributing,2,0.6931471805599453
rayon-bud,2,0.6931471805599453
Cytokines,2,0.6931471805599453
Viremia,2,0.6931471805599453
PSDapathy,2,0.6931471805599453
A177,2,0.6931471805599453
isnt,2,0.6931471805599453
insistence,2,0.6931471805599453
migrants,2,0.6931471805599453
predictably,2,0.6931471805599453
neuroanatomical,2,0.6931471805599453
DBM,2,0.6931471805599453
full-genome,2,0.6931471805599453
Blunt,2,0.6931471805599453
freedom,2,0.6931471805599453
snapshot,2,0.6931471805599453
S-specific,2,0.6931471805599453
broaden,2,0.6931471805599453
Adaptive,2,0.6931471805599453
SendSS,2,0.6931471805599453
inaccessibility,2,0.6931471805599453
OCSs,2,0.6931471805599453
early-differentiated,2,0.6931471805599453
nitroprusside,2,0.6931471805599453
26896,2,0.6931471805599453
tracheomalacia,2,0.6931471805599453
fundoplication,2,0.6931471805599453
Drs,2,0.6931471805599453
pancytopenia,2,0.6931471805599453
handled,2,0.6931471805599453
detergents,2,0.6931471805599453
titermL,2,0.6931471805599453
trimers,2,0.6931471805599453
MDA,2,0.6931471805599453
farmer,2,0.6931471805599453
lymphohistiocytosis,2,0.6931471805599453
vitally,2,0.6931471805599453
Philadelphia,2,0.6931471805599453
paramedian,2,0.6931471805599453
illustrative,2,0.6931471805599453
requesting,2,0.6931471805599453
Victoria-related,2,0.6931471805599453
hemisensory,2,0.6931471805599453
nucleotidessiteyear,2,0.6931471805599453
-015,2,0.6931471805599453
PCKC,2,0.6931471805599453
Difficult,2,0.6931471805599453
reconsidered,2,0.6931471805599453
PASC,2,0.6931471805599453
sequalae,2,0.6931471805599453
Sufficient,2,0.6931471805599453
wreak,2,0.6931471805599453
flow-volume,2,0.6931471805599453
halls,2,0.6931471805599453
Probit,2,0.6931471805599453
non-IHD,2,0.6931471805599453
Berg,2,0.6931471805599453
plume,2,0.6931471805599453
retirement,2,0.6931471805599453
11-45,2,0.6931471805599453
n52,2,0.6931471805599453
PCW,2,0.6931471805599453
NCAG,2,0.6931471805599453
Forresters,2,0.6931471805599453
pre-infarction,2,0.6931471805599453
Hematopoietic,2,0.6931471805599453
P0009,2,0.6931471805599453
controversies,2,0.6931471805599453
Standardization,2,0.6931471805599453
log-rank,2,0.6931471805599453
Epstein-Barr,2,0.6931471805599453
Backgroundobjectives,2,0.6931471805599453
club,2,0.6931471805599453
sport-specific,2,0.6931471805599453
6LU7,2,0.6931471805599453
∼99,2,0.6931471805599453
bronchiolo-alveolar,2,0.6931471805599453
His164,2,0.6931471805599453
Alongside,2,0.6931471805599453
mast-cells,2,0.6931471805599453
PIMICS,2,0.6931471805599453
phase-III,2,0.6931471805599453
prime-boost,2,0.6931471805599453
RMSF,2,0.6931471805599453
Domestic,2,0.6931471805599453
dcAMP,2,0.6931471805599453
eCO,2,0.6931471805599453
duplicate,2,0.6931471805599453
upscaling,2,0.6931471805599453
door-to-CT,2,0.6931471805599453
B1525,2,0.6931471805599453
antigen-based,2,0.6931471805599453
multivariant,2,0.6931471805599453
Inuit,2,0.6931471805599453
Métis,2,0.6931471805599453
Irrespective,2,0.6931471805599453
Liguria,2,0.6931471805599453
drew,2,0.6931471805599453
GAIN,2,0.6931471805599453
predicament,2,0.6931471805599453
Antagonist,2,0.6931471805599453
GV150526,2,0.6931471805599453
Gavestinel,2,0.6931471805599453
Light-to-moderate,2,0.6931471805599453
MI-associated,2,0.6931471805599453
bioactivation,2,0.6931471805599453
Uncertainties,2,0.6931471805599453
PMR,2,0.6931471805599453
elicitation,2,0.6931471805599453
VFWR,2,0.6931471805599453
testament,2,0.6931471805599453
AprilMay,2,0.6931471805599453
Nihon,2,0.6931471805599453
hosted,2,0.6931471805599453
webinar,2,0.6931471805599453
Louis,2,0.6931471805599453
super-infection,2,0.6931471805599453
Validated,2,0.6931471805599453
6-18,2,0.6931471805599453
P0039,2,0.6931471805599453
multiwave,2,0.6931471805599453
bacteriophages,2,0.6931471805599453
hindsight,2,0.6931471805599453
1066,2,0.6931471805599453
drawings,2,0.6931471805599453
abandoned,2,0.6931471805599453
misses,2,0.6931471805599453
584,2,0.6931471805599453
mid-May,2,0.6931471805599453
health-seeking,2,0.6931471805599453
anti-hemagglutinin,2,0.6931471805599453
Way,2,0.6931471805599453
Symphony,2,0.6931471805599453
crystallography,2,0.6931471805599453
Veneto,2,0.6931471805599453
Dialysis,2,0.6931471805599453
frequentist,2,0.6931471805599453
Nephrology,2,0.6931471805599453
ACE2-Fc-TD,2,0.6931471805599453
dimeric,2,0.6931471805599453
SARS‐CoV‐2‐specific,2,0.6931471805599453
Wastewater,2,0.6931471805599453
biomedicine,2,0.6931471805599453
saturations,2,0.6931471805599453
FiO2,2,0.6931471805599453
intra-cardiac,2,0.6931471805599453
pharmacodynamic,2,0.6931471805599453
bronchologic,2,0.6931471805599453
Gastroenterology,2,0.6931471805599453
lactic,2,0.6931471805599453
5719,2,0.6931471805599453
non-CIN,2,0.6931471805599453
VNT,2,0.6931471805599453
400000,2,0.6931471805599453
redness,2,0.6931471805599453
tenderness,2,0.6931471805599453
Residential,2,0.6931471805599453
eruptions,2,0.6931471805599453
pred,2,0.6931471805599453
stroke-prevention,2,0.6931471805599453
M4-5,2,0.6931471805599453
brother,2,0.6931471805599453
assistant,2,0.6931471805599453
M0,2,0.6931471805599453
899,2,0.6931471805599453
913,2,0.6931471805599453
locality,2,0.6931471805599453
compete,2,0.6931471805599453
bouts,2,0.6931471805599453
equals,2,0.6931471805599453
attenuates,2,0.6931471805599453
Y41,2,0.6931471805599453
non-infarct,2,0.6931471805599453
daughter,2,0.6931471805599453
SARSCoV-,2,0.6931471805599453
Smad,2,0.6931471805599453
Rhinolophus,2,0.6931471805599453
SARS-CoV-2-related,2,0.6931471805599453
Bed,2,0.6931471805599453
Censuses,2,0.6931471805599453
viral-bacterial,2,0.6931471805599453
PHLS,2,0.6931471805599453
Communicable,2,0.6931471805599453
dewfrost,2,0.6931471805599453
deconditioning,2,0.6931471805599453
MCAO-induced,2,0.6931471805599453
drafting,2,0.6931471805599453
offset,2,0.6931471805599453
personalize,2,0.6931471805599453
FluCAN,2,0.6931471805599453
631,2,0.6931471805599453
HTL,2,0.6931471805599453
1107,2,0.6931471805599453
1175,2,0.6931471805599453
plasma-phase,2,0.6931471805599453
occurence,2,0.6931471805599453
Sigma-Virocult,2,0.6931471805599453
EMEM,2,0.6931471805599453
stasis,2,0.6931471805599453
deposit,2,0.6931471805599453
collagens,2,0.6931471805599453
educator,2,0.6931471805599453
receptor-mediated,2,0.6931471805599453
IBM,2,0.6931471805599453
3750,2,0.6931471805599453
prevailed,2,0.6931471805599453
nanocages,2,0.6931471805599453
mosaic,2,0.6931471805599453
pretransplant,2,0.6931471805599453
palmitoyltransferase,2,0.6931471805599453
sturdy,2,0.6931471805599453
Members,2,0.6931471805599453
exemplar,2,0.6931471805599453
boards,2,0.6931471805599453
15000,2,0.6931471805599453
non-medicated,2,0.6931471805599453
overexpressing,2,0.6931471805599453
BMP-7-treated,2,0.6931471805599453
trimetazidine,2,0.6931471805599453
HRV-induced,2,0.6931471805599453
hypertriglyceridaemia,2,0.6931471805599453
8000,2,0.6931471805599453
remotely,2,0.6931471805599453
implicit,2,0.6931471805599453
prelude,2,0.6931471805599453
extra-,2,0.6931471805599453
neuroaminidase,2,0.6931471805599453
gm3,2,0.6931471805599453
738,2,0.6931471805599453
ominous,2,0.6931471805599453
authorizations,2,0.6931471805599453
detectability,2,0.6931471805599453
darkness,2,0.6931471805599453
facility-level,2,0.6931471805599453
7-8,2,0.6931471805599453
ordinarily,2,0.6931471805599453
six-week,2,0.6931471805599453
Ferrets,2,0.6931471805599453
-4,2,0.6931471805599453
carpi,2,0.6931471805599453
oestrogen,2,0.6931471805599453
progesterone,2,0.6931471805599453
radialis,2,0.6931471805599453
underlines,2,0.6931471805599453
FCR,2,0.6931471805599453
school-year,2,0.6931471805599453
justification,2,0.6931471805599453
inferiolateral,2,0.6931471805599453
Asynergies,2,0.6931471805599453
severevery,2,0.6931471805599453
maneuver,2,0.6931471805599453
Specialist,2,0.6931471805599453
resource-poor,2,0.6931471805599453
10hour,2,0.6931471805599453
cycEVA,2,0.6931471805599453
inorganic-,2,0.6931471805599453
neuroticism,2,0.6931471805599453
nanomaterials,2,0.6931471805599453
birch,2,0.6931471805599453
cladosporium,2,0.6931471805599453
crise,2,0.6931471805599453
helicase,2,0.6931471805599453
traps,2,0.6931471805599453
299,2,0.6931471805599453
NETs,2,0.6931471805599453
acupoint,2,0.6931471805599453
HBM,2,0.6931471805599453
5G,2,0.6931471805599453
hemicranial,2,0.6931471805599453
BDs,2,0.6931471805599453
Neuropsychological,2,0.6931471805599453
Things,2,0.6931471805599453
hematomas,2,0.6931471805599453
IoMT,2,0.6931471805599453
perpetuation,2,0.6931471805599453
Fann,2,0.6931471805599453
chemotherapeutic,2,0.6931471805599453
demise,2,0.6931471805599453
Fazekas,2,0.6931471805599453
videofluoroscopic,2,0.6931471805599453
computers,2,0.6931471805599453
QRS-complex,2,0.6931471805599453
absorptiometry,2,0.6931471805599453
AADs,2,0.6931471805599453
commerce,2,0.6931471805599453
ACI,2,0.6931471805599453
divides,2,0.6931471805599453
2448,2,0.6931471805599453
inlet,2,0.6931471805599453
Workup,2,0.6931471805599453
C0VID-19,2,0.6931471805599453
0049,2,0.6931471805599453
RS3PE,2,0.6931471805599453
pitting,2,0.6931471805599453
synovitis,2,0.6931471805599453
rainforest,2,0.6931471805599453
hyperplastic,2,0.6931471805599453
evaluative,2,0.6931471805599453
Sometimes,2,0.6931471805599453
psychology,2,0.6931471805599453
buccal,2,0.6931471805599453
–,2,0.6931471805599453
annular,2,0.6931471805599453
devastation,2,0.6931471805599453
cloacal,2,0.6931471805599453
task-specific,2,0.6931471805599453
post-bronchodilator,2,0.6931471805599453
decentralization,2,0.6931471805599453
855,2,0.6931471805599453
Aracaju,2,0.6931471805599453
Sergipe,2,0.6931471805599453
underlies,2,0.6931471805599453
Th2-cells,2,0.6931471805599453
Tumor,2,0.6931471805599453
LI,2,0.6931471805599453
thymus,2,0.6931471805599453
cocks,2,0.6931471805599453
Litomosoides,2,0.6931471805599453
Shot,2,0.6931471805599453
high-dimensional,2,0.6931471805599453
Proportion,2,0.6931471805599453
HMCAS,2,0.6931471805599453
Who,2,0.6931471805599453
2457,2,0.6931471805599453
deformities,2,0.6931471805599453
nonparticipants,2,0.6931471805599453
internists,2,0.6931471805599453
non-allergen,2,0.6931471805599453
transcript,2,0.6931471805599453
typesubtype-specific,2,0.6931471805599453
Ectopic,2,0.6931471805599453
transfected,2,0.6931471805599453
infodemic,2,0.6931471805599453
hpi,2,0.6931471805599453
Observed,2,0.6931471805599453
paper-and-pencil,2,0.6931471805599453
PI3KAKT,2,0.6931471805599453
interactive-critical,2,0.6931471805599453
μl,2,0.6931471805599453
aM,2,0.6931471805599453
roll-outs,2,0.6931471805599453
Cervical,2,0.6931471805599453
frustratingly,2,0.6931471805599453
TMM,2,0.6931471805599453
Anderson,2,0.6931471805599453
impedimetric,2,0.6931471805599453
toilet,2,0.6931471805599453
AIF,2,0.6931471805599453
Cranial,2,0.6931471805599453
809,2,0.6931471805599453
countrywide,2,0.6931471805599453
V1-V2,2,0.6931471805599453
GNI,2,0.6931471805599453
domain-binding,2,0.6931471805599453
adaptor,2,0.6931471805599453
Circulation,2,0.6931471805599453
n11,2,0.6931471805599453
Raised,2,0.6931471805599453
1961,2,0.6931471805599453
V3R-V5R,2,0.6931471805599453
puzzle,2,0.6931471805599453
medicaments,2,0.6931471805599453
63±2,2,0.6931471805599453
knockout,2,0.6931471805599453
ovariectomized,2,0.6931471805599453
nonsmokers,2,0.6931471805599453
diverge,2,0.6931471805599453
Order,2,0.6931471805599453
sanatoria,2,0.6931471805599453
tunnel,2,0.6931471805599453
announcement,2,0.6931471805599453
infrastructures,2,0.6931471805599453
45-year-old,2,0.6931471805599453
mucormycosis,2,0.6931471805599453
18-25,2,0.6931471805599453
Suphan,2,0.6931471805599453
Buri,2,0.6931471805599453
Nakhon,2,0.6931471805599453
Pathom,2,0.6931471805599453
Ag-RDTs,2,0.6931471805599453
subscores,2,0.6931471805599453
Impairment,2,0.6931471805599453
MENA,2,0.6931471805599453
GHD,2,0.6931471805599453
disproven,2,0.6931471805599453
telocyte,2,0.6931471805599453
cardiography,2,0.6931471805599453
Official,2,0.6931471805599453
skeptical,2,0.6931471805599453
expands,2,0.6931471805599453
mindset,2,0.6931471805599453
geopolitical,2,0.6931471805599453
Strengthening,2,0.6931471805599453
Trade,2,0.6931471805599453
demographical,2,0.6931471805599453
Cooperation,2,0.6931471805599453
arenas,2,0.6931471805599453
Mother,2,0.6931471805599453
immunodeficiencies,2,0.6931471805599453
actors,2,0.6931471805599453
nationalist,2,0.6931471805599453
inter-rater,2,0.6931471805599453
CincinnatiNorthern,2,0.6931471805599453
462,2,0.6931471805599453
0786,2,0.6931471805599453
644,2,0.6931471805599453
β-carotene,2,0.6931471805599453
IGF-I,2,0.6931471805599453
patient-to-HCW,2,0.6931471805599453
self-assembling,2,0.6931471805599453
CVID,2,0.6931471805599453
RBD-ferritin,2,0.6931471805599453
acquisitions,2,0.6931471805599453
390000,2,0.6931471805599453
623,2,0.6931471805599453
ORG,2,0.6931471805599453
insightful,2,0.6931471805599453
Fibrillation,2,0.6931471805599453
video-assisted,2,0.6931471805599453
TmeTe,2,0.6931471805599453
anemic,2,0.6931471805599453
VmaxFRC,2,0.6931471805599453
categorizing,2,0.6931471805599453
categorize,2,0.6931471805599453
tPA-treated,2,0.6931471805599453
join,2,0.6931471805599453
invite,2,0.6931471805599453
GPI,2,0.6931471805599453
Tirofiban,2,0.6931471805599453
bleed,2,0.6931471805599453
homonymous,2,0.6931471805599453
PTKs,2,0.6931471805599453
PTK,2,0.6931471805599453
LD-A,2,0.6931471805599453
portend,2,0.6931471805599453
U-wave,2,0.6931471805599453
Eighty-three,2,0.6931471805599453
Alterations,2,0.6931471805599453
hemorheological,2,0.6931471805599453
comfort,2,0.6931471805599453
purposeful,2,0.6931471805599453
extrapleural,2,0.6931471805599453
Whenever,2,0.6931471805599453
vasomotor,2,0.6931471805599453
vasospastic,2,0.6931471805599453
nonvitamin,2,0.6931471805599453
re-investigated,2,0.6931471805599453
parallel-group,2,0.6931471805599453
one-fifth,2,0.6931471805599453
VCRs,2,0.6931471805599453
EISS,2,0.6931471805599453
Scheme,2,0.6931471805599453
low-prevalence,2,0.6931471805599453
circumstantial,2,0.6931471805599453
nonintervention,2,0.6931471805599453
homoarginine,2,0.6931471805599453
dysrhythmia,2,0.6931471805599453
trapping,2,0.6931471805599453
conjecture,2,0.6931471805599453
Medicaid,2,0.6931471805599453
samplers,2,0.6931471805599453
BCVI,2,0.6931471805599453
SARS-Cov,2,0.6931471805599453
state-level,2,0.6931471805599453
male-female,2,0.6931471805599453
vivid,2,0.6931471805599453
gender-related,2,0.6931471805599453
patient-provider,2,0.6931471805599453
geo-centroid,2,0.6931471805599453
thromboemboli,2,0.6931471805599453
1941,2,0.6931471805599453
fibroelastosis,2,0.6931471805599453
554,2,0.6931471805599453
3-8,2,0.6931471805599453
network-based,2,0.6931471805599453
20-29,2,0.6931471805599453
Sporadic,2,0.6931471805599453
Incorporating,2,0.6931471805599453
Diffuse,2,0.6931471805599453
Provocative,2,0.6931471805599453
Pathological,2,0.6931471805599453
Mongolia,2,0.6931471805599453
non-traditional,2,0.6931471805599453
familiarize,2,0.6931471805599453
psychologically,2,0.6931471805599453
Cultural,2,0.6931471805599453
reconcile,2,0.6931471805599453
Drawing,2,0.6931471805599453
Separate,2,0.6931471805599453
renamed,2,0.6931471805599453
cm-5,2,0.6931471805599453
dashboards,2,0.6931471805599453
unfold,2,0.6931471805599453
5-14,2,0.6931471805599453
5-19,2,0.6931471805599453
1976-1977,2,0.6931471805599453
1976-1981,2,0.6931471805599453
wormwood-RAST,2,0.6931471805599453
Insulin-like,2,0.6931471805599453
wv,2,0.6931471805599453
IGF-1,2,0.6931471805599453
right-handed,2,0.6931471805599453
Scandinavian,2,0.6931471805599453
two-wave,2,0.6931471805599453
calibrate,2,0.6931471805599453
illustration,2,0.6931471805599453
AdC68-19RBD,2,0.6931471805599453
AdC68-19RBDs,2,0.6931471805599453
equatorial,2,0.6931471805599453
southeast,2,0.6931471805599453
1162,2,0.6931471805599453
Eosinophilic,2,0.6931471805599453
noneosinophilic,2,0.6931471805599453
X2,2,0.6931471805599453
889,2,0.6931471805599453
misdiagnose,2,0.6931471805599453
Tei,2,0.6931471805599453
morbidly,2,0.6931471805599453
Candidate,2,0.6931471805599453
TRACER,2,0.6931471805599453
TRA2P,2,0.6931471805599453
677,2,0.6931471805599453
Vorapaxar,2,0.6931471805599453
1932,2,0.6931471805599453
GCNKSS,2,0.6931471805599453
Census,2,0.6931471805599453
demand-supply,2,0.6931471805599453
878,2,0.6931471805599453
19931994,2,0.6931471805599453
pelleted,2,0.6931471805599453
2036,2,0.6931471805599453
system-level,2,0.6931471805599453
timepoint,2,0.6931471805599453
interferon-gamma,2,0.6931471805599453
notoriously,2,0.6931471805599453
≥85-year,2,0.6931471805599453
20-,2,0.6931471805599453
DTD,2,0.6931471805599453
44-year,2,0.6931471805599453
LNPs,2,0.6931471805599453
cross-infection,2,0.6931471805599453
1402,2,0.6931471805599453
825,2,0.6931471805599453
genotyped,2,0.6931471805599453
20052006,2,0.6931471805599453
IUkg,2,0.6931471805599453
neglects,2,0.6931471805599453
Instructions,2,0.6931471805599453
RSS,2,0.6931471805599453
Workshop,2,0.6931471805599453
atlas-assisted,2,0.6931471805599453
checks,2,0.6931471805599453
thirty-nine,2,0.6931471805599453
irradiance,2,0.6931471805599453
handheld,2,0.6931471805599453
IO-PDT,2,0.6931471805599453
0028,2,0.6931471805599453
tertiles,2,0.6931471805599453
Weather,2,0.6931471805599453
topmost,2,0.6931471805599453
interlinked,2,0.6931471805599453
FEEL,2,0.6931471805599453
46-fold,2,0.6931471805599453
facially,2,0.6931471805599453
dated,2,0.6931471805599453
8922,2,0.6931471805599453
multiethnic,2,0.6931471805599453
Reflecting,2,0.6931471805599453
HN,2,0.6931471805599453
guideline-driven,2,0.6931471805599453
voxel-wise,2,0.6931471805599453
transradial,2,0.6931471805599453
coherent,2,0.6931471805599453
asking,2,0.6931471805599453
professor,2,0.6931471805599453
PANDEMIC,2,0.6931471805599453
ASydney597-like,2,0.6931471805599453
harms,2,0.6931471805599453
19951996,2,0.6931471805599453
low-passage,2,0.6931471805599453
weight-adjusted,2,0.6931471805599453
pacemakers,2,0.6931471805599453
Gene-environment,2,0.6931471805599453
audiovisual,2,0.6931471805599453
2-way,2,0.6931471805599453
reexamine,2,0.6931471805599453
non-immunological,2,0.6931471805599453
Augsburg,2,0.6931471805599453
Event,2,0.6931471805599453
Managed,2,0.6931471805599453
black-blood,2,0.6931471805599453
precipitant,2,0.6931471805599453
kmono,2,0.6931471805599453
cross-education,2,0.6931471805599453
levity,2,0.6931471805599453
examiners,2,0.6931471805599453
psychometrically,2,0.6931471805599453
uncovers,2,0.6931471805599453
isolate-specific,2,0.6931471805599453
Rare,2,0.6931471805599453
handedness,2,0.6931471805599453
T85I,2,0.6931471805599453
Michael,2,0.6931471805599453
Q57H,2,0.6931471805599453
dWi,2,0.6931471805599453
terrible,2,0.6931471805599453
interleukin-10,2,0.6931471805599453
passaging,2,0.6931471805599453
antimyosin,2,0.6931471805599453
impractical,2,0.6931471805599453
2045,2,0.6931471805599453
platinum,2,0.6931471805599453
stimulator,2,0.6931471805599453
Co-occurrence,2,0.6931471805599453
heralded,2,0.6931471805599453
hypobiotic,2,0.6931471805599453
Wildfire,2,0.6931471805599453
KNOW,2,0.6931471805599453
Wisconsin,2,0.6931471805599453
attendant,2,0.6931471805599453
DO,2,0.6931471805599453
burial,2,0.6931471805599453
collectives,2,0.6931471805599453
heroes,2,0.6931471805599453
villains,2,0.6931471805599453
anesthetists,2,0.6931471805599453
IL-1A,2,0.6931471805599453
colorectal,2,0.6931471805599453
gastrostomy,2,0.6931471805599453
IL-1B,2,0.6931471805599453
self-selected,2,0.6931471805599453
12-24,2,0.6931471805599453
Gastric,2,0.6931471805599453
-003,2,0.6931471805599453
sorbent,2,0.6931471805599453
ABangkok,2,0.6931471805599453
travelled,2,0.6931471805599453
Fungal,2,0.6931471805599453
Cord,2,0.6931471805599453
pre-admission,2,0.6931471805599453
recollection,2,0.6931471805599453
Tmax,2,0.6931471805599453
spans,2,0.6931471805599453
jumping,2,0.6931471805599453
MAGLUMI,2,0.6931471805599453
1210,2,0.6931471805599453
Europes,2,0.6931471805599453
3D-echocardiography,2,0.6931471805599453
pre-selected,2,0.6931471805599453
Or,2,0.6931471805599453
LB,2,0.6931471805599453
Oulu,2,0.6931471805599453
Aside,2,0.6931471805599453
Unacceptable,2,0.6931471805599453
postpone,2,0.6931471805599453
-065,2,0.6931471805599453
familiarity,2,0.6931471805599453
CVT,2,0.6931471805599453
fMLP,2,0.6931471805599453
Oxygen,2,0.6931471805599453
Alteplase,2,0.6931471805599453
3500,2,0.6931471805599453
LMWH,2,0.6931471805599453
knew,2,0.6931471805599453
akinesia,2,0.6931471805599453
gr,2,0.6931471805599453
lethargy,2,0.6931471805599453
814,2,0.6931471805599453
792,2,0.6931471805599453
Vietnamese,2,0.6931471805599453
unchanging,2,0.6931471805599453
CCs,2,0.6931471805599453
labour-intensive,2,0.6931471805599453
landmark,2,0.6931471805599453
KPK,2,0.6931471805599453
BM1918,2,0.6931471805599453
H1N1-like,2,0.6931471805599453
Euroimmun-IgA,2,0.6931471805599453
Independence,2,0.6931471805599453
Life-threatening,2,0.6931471805599453
Euroimmun-IgG,2,0.6931471805599453
or2,2,0.6931471805599453
Vircell-IgG,2,0.6931471805599453
or5,2,0.6931471805599453
easing,2,0.6931471805599453
Sul,2,0.6931471805599453
nM,2,0.6931471805599453
NCSVT,2,0.6931471805599453
0038,2,0.6931471805599453
blindness,2,0.6931471805599453
insure,2,0.6931471805599453
50-54,2,0.6931471805599453
scheduling,2,0.6931471805599453
billions,2,0.6931471805599453
hematology-oncology,2,0.6931471805599453
mFIM,2,0.6931471805599453
weighing,2,0.6931471805599453
Eventually,2,0.6931471805599453
TSH,2,0.6931471805599453
848,2,0.6931471805599453
accommodating,2,0.6931471805599453
Neuro-occupation,2,0.6931471805599453
Below,2,0.6931471805599453
Isolation,2,0.6931471805599453
attentionworking,2,0.6931471805599453
J-hook,2,0.6931471805599453
vector-based,2,0.6931471805599453
gymnasium,2,0.6931471805599453
ngL,2,0.6931471805599453
coders,2,0.6931471805599453
Actual,2,0.6931471805599453
FT4,2,0.6931471805599453
adenoviral-based,2,0.6931471805599453
liberties,2,0.6931471805599453
one-time,2,0.6931471805599453
mercury,2,0.6931471805599453
expedient,2,0.6931471805599453
illetve,2,0.6931471805599453
Humidity,2,0.6931471805599453
tackled,2,0.6931471805599453
telemedical,2,0.6931471805599453
myocyte,2,0.6931471805599453
Indications,2,0.6931471805599453
2019-novel,2,0.6931471805599453
descend,2,0.6931471805599453
PSP,2,0.6931471805599453
postpandemic,2,0.6931471805599453
COVID-19-negative,2,0.6931471805599453
Ankara,2,0.6931471805599453
Alegre,2,0.6931471805599453
Cells,2,0.6931471805599453
Adenovirus,2,0.6931471805599453
symmetrically,2,0.6931471805599453
postinfluenza,2,0.6931471805599453
buildup,2,0.6931471805599453
conformity,2,0.6931471805599453
Hosmer-Lemeshow,2,0.6931471805599453
virus-neutralizing,2,0.6931471805599453
adamantane,2,0.6931471805599453
DESIGN,2,0.6931471805599453
Isaacs,2,0.6931471805599453
Obstetricians,2,0.6931471805599453
mid-December,2,0.6931471805599453
cavitary,2,0.6931471805599453
imaged,2,0.6931471805599453
iNOS,2,0.6931471805599453
waiting-list,2,0.6931471805599453
brewing,2,0.6931471805599453
preventingtreating,2,0.6931471805599453
NSTEMIs,2,0.6931471805599453
akut,2,0.6931471805599453
leaflet,2,0.6931471805599453
centralised,2,0.6931471805599453
lessens,2,0.6931471805599453
Hazards,2,0.6931471805599453
SIGNIFICANCE,2,0.6931471805599453
filed,2,0.6931471805599453
Zamky,2,0.6931471805599453
Cystic,2,0.6931471805599453
Következtetés,2,0.6931471805599453
Graphical,2,0.6931471805599453
STATEMENT,2,0.6931471805599453
prairie,2,0.6931471805599453
narratively,2,0.6931471805599453
mVmsec,2,0.6931471805599453
synthesise,2,0.6931471805599453
deep-learning,2,0.6931471805599453
grasp,2,0.6931471805599453
fund,2,0.6931471805599453
calibration,2,0.6931471805599453
Have,2,0.6931471805599453
0031,2,0.6931471805599453
Elecsys®,2,0.6931471805599453
Ig,2,0.6931471805599453
itching,2,0.6931471805599453
folding,2,0.6931471805599453
Issue,2,0.6931471805599453
LF-rTMS,2,0.6931471805599453
APC-PCI,2,0.6931471805599453
IgE-dependent,2,0.6931471805599453
tenecteplase,2,0.6931471805599453
87-lead,2,0.6931471805599453
erythematous,2,0.6931471805599453
sNMES,2,0.6931471805599453
1332,2,0.6931471805599453
academics,2,0.6931471805599453
nanopore,2,0.6931471805599453
91-99,2,0.6931471805599453
nonrespiratory,2,0.6931471805599453
C-terminal,2,0.6931471805599453
Nové,2,0.6931471805599453
scrutinized,2,0.6931471805599453
curing,2,0.6931471805599453
telediastolic,2,0.6931471805599453
Vigorous,2,0.6931471805599453
peridural,2,0.6931471805599453
hypothesizes,2,0.6931471805599453
Clostridium,2,0.6931471805599453
multi-scale,2,0.6931471805599453
FRET,2,0.6931471805599453
mlmin,2,0.6931471805599453
methicillin-resistant,2,0.6931471805599453
significative,2,0.6931471805599453
unmatched,2,0.6931471805599453
nutrient,2,0.6931471805599453
dont,2,0.6931471805599453
Hyperthyroidism,2,0.6931471805599453
mumol,2,0.6931471805599453
fallen,2,0.6931471805599453
frank,2,0.6931471805599453
semantic,2,0.6931471805599453
dipeptide,2,0.6931471805599453
homozonal,2,0.6931471805599453
flare-ups,2,0.6931471805599453
thermodilution,2,0.6931471805599453
scare,2,0.6931471805599453
persuade,2,0.6931471805599453
dominantly,2,0.6931471805599453
4373,2,0.6931471805599453
trusted,2,0.6931471805599453
SARSr-CoVs,2,0.6931471805599453
míg,2,0.6931471805599453
furnished,2,0.6931471805599453
C-,2,0.6931471805599453
4428,2,0.6931471805599453
non-SDIA,2,0.6931471805599453
1410,2,0.6931471805599453
exiting,2,0.6931471805599453
M2del11HAavir,2,0.6931471805599453
reintroduction,2,0.6931471805599453
revascularize,2,0.6931471805599453
FRAST,2,0.6931471805599453
common-cold,2,0.6931471805599453
Shell,2,0.6931471805599453
waviness,2,0.6931471805599453
cocaine-related,2,0.6931471805599453
paralyzed,2,0.6931471805599453
biofeedback-assisted,2,0.6931471805599453
faeces,2,0.6931471805599453
ASC,2,0.6931471805599453
skepticism,2,0.6931471805599453
transoesophageal,2,0.6931471805599453
watts,2,0.6931471805599453
non-AA,2,0.6931471805599453
outbroke,2,0.6931471805599453
caveat,2,0.6931471805599453
régiókban,2,0.6931471805599453
noon,2,0.6931471805599453
Közép-Magyarország,2,0.6931471805599453
nondippers,2,0.6931471805599453
autolysis,2,0.6931471805599453
secreting,2,0.6931471805599453
kinesis,2,0.6931471805599453
burn,2,0.6931471805599453
surrounded,2,0.6931471805599453
declare,2,0.6931471805599453
superhydrophobicity,2,0.6931471805599453
Daytime,2,0.6931471805599453
polypharmacy,2,0.6931471805599453
clinicolaboratory,2,0.6931471805599453
mere,2,0.6931471805599453
gyakoribb,2,0.6931471805599453
CiC,2,0.6931471805599453
semi-closed,2,0.6931471805599453
J-shaped,2,0.6931471805599453
Proximal,2,0.6931471805599453
left-to-right,2,0.6931471805599453
nephrologists,2,0.6931471805599453
αvβ3,2,0.6931471805599453
sgRNAs,2,0.6931471805599453
apneas,2,0.6931471805599453
over-expression,2,0.6931471805599453
testable,2,0.6931471805599453
Seventy-four,2,0.6931471805599453
veno-arterial,2,0.6931471805599453
NIH50,2,0.6931471805599453
valvuloplasty,2,0.6931471805599453
necroses,2,0.6931471805599453
chronology,2,0.6931471805599453
veno-venous,2,0.6931471805599453
Hirulog,2,0.6931471805599453
one-size,2,0.6931471805599453
simulator,2,0.6931471805599453
7909,2,0.6931471805599453
Mex09,2,0.6931471805599453
monozygotic,2,0.6931471805599453
shortens,2,0.6931471805599453
consented,2,0.6931471805599453
HERO-2,2,0.6931471805599453
össze,2,0.6931471805599453
refining,2,0.6931471805599453
ICD-10-coded,2,0.6931471805599453
CHQ-PF50,2,0.6931471805599453
RTR,2,0.6931471805599453
elected,2,0.6931471805599453
Neurologists,2,0.6931471805599453
joules,2,0.6931471805599453
Hiroshima,2,0.6931471805599453
esetén,2,0.6931471805599453
MATERIAL,2,0.6931471805599453
maternity,2,0.6931471805599453
Genetics,2,0.6931471805599453
pinpointing,2,0.6931471805599453
adjuncts,2,0.6931471805599453
Evaluate,2,0.6931471805599453
MDD,2,0.6931471805599453
Eredmények,2,0.6931471805599453
rudimentary,2,0.6931471805599453
spheres,2,0.6931471805599453
Confirmation,2,0.6931471805599453
burns,2,0.6931471805599453
984,2,0.6931471805599453
23403AG,2,0.6931471805599453
3300,2,0.6931471805599453
pyothorax,2,0.6931471805599453
landmarks,2,0.6931471805599453
non-focal,2,0.6931471805599453
Kd,2,0.6931471805599453
broncho-pleural,2,0.6931471805599453
sub-haplotype,2,0.6931471805599453
2010-2013,2,0.6931471805599453
discontinuous,2,0.6931471805599453
mastery,2,0.6931471805599453
bacilli,2,0.6931471805599453
anti-arrhythmic,2,0.6931471805599453
tryptase,2,0.6931471805599453
smoothly,2,0.6931471805599453
intraprocedural,2,0.6931471805599453
steer,2,0.6931471805599453
2790,2,0.6931471805599453
Notifiable,2,0.6931471805599453
texts,2,0.6931471805599453
wash-out,2,0.6931471805599453
heparan,2,0.6931471805599453
untreatable,2,0.6931471805599453
phenylalanine,2,0.6931471805599453
0-7,2,0.6931471805599453
antibody-avidity,2,0.6931471805599453
digitally,2,0.6931471805599453
pokeweed,2,0.6931471805599453
leucocytes,2,0.6931471805599453
dispute,2,0.6931471805599453
widen,2,0.6931471805599453
vault,2,0.6931471805599453
nők,2,0.6931471805599453
NNDSS,2,0.6931471805599453
purulent,2,0.6931471805599453
deferring,2,0.6931471805599453
eosinophil-derived,2,0.6931471805599453
sophistication,2,0.6931471805599453
inhalants,2,0.6931471805599453
clefts,2,0.6931471805599453
extended-care,2,0.6931471805599453
singularly,2,0.6931471805599453
cholesterin,2,0.6931471805599453
2-20,2,0.6931471805599453
respiratorycirculatory-coded,2,0.6931471805599453
Nonadherence,2,0.6931471805599453
Risks,2,0.6931471805599453
17-fold,2,0.6931471805599453
UAPs,2,0.6931471805599453
kd,2,0.6931471805599453
multiplier,2,0.6931471805599453
utánkövetés,2,0.6931471805599453
FluSurv-NET,2,0.6931471805599453
under-detection,2,0.6931471805599453
év,2,0.6931471805599453
Theophylline,2,0.6931471805599453
time-volume,2,0.6931471805599453
over-all,2,0.6931471805599453
sizable,2,0.6931471805599453
capitals,2,0.6931471805599453
timed,2,0.6931471805599453
5-6,2,0.6931471805599453
grounded,2,0.6931471805599453
Self-administered,2,0.6931471805599453
three-level,2,0.6931471805599453
982,2,0.6931471805599453
miscarriage,2,0.6931471805599453
ERICA,2,0.6931471805599453
Re-analysis,2,0.6931471805599453
Spices,2,0.6931471805599453
alcohol-based,2,0.6931471805599453
allele-specific,2,0.6931471805599453
reassurance,2,0.6931471805599453
tied,2,0.6931471805599453
contentious,2,0.6931471805599453
szerint,2,0.6931471805599453
orificium,2,0.6931471805599453
misattributions,2,0.6931471805599453
SC2InflAInflB-UCT,2,0.6931471805599453
entrapment,2,0.6931471805599453
Mossong,2,0.6931471805599453
right-hemispheric,2,0.6931471805599453
disputed,2,0.6931471805599453
ABI,2,0.6931471805599453
macaque,2,0.6931471805599453
inspire,2,0.6931471805599453
pupillary,2,0.6931471805599453
jails,2,0.6931471805599453
adjudicated,2,0.6931471805599453
endo-systolic,2,0.6931471805599453
Rican,2,0.6931471805599453
month-to-month,2,0.6931471805599453
radical-mediated,2,0.6931471805599453
lesion-symptom,2,0.6931471805599453
omit,2,0.6931471805599453
voxel-based,2,0.6931471805599453
Rt-PCR,2,0.6931471805599453
invested,2,0.6931471805599453
firmus,2,0.6931471805599453
Sars-CoV-2,2,0.6931471805599453
referents,2,0.6931471805599453
Autopsies,2,0.6931471805599453
trafermin,2,0.6931471805599453
EN,2,0.6931471805599453
Formulation,2,0.6931471805599453
woke,2,0.6931471805599453
RdRPN,2,0.6931471805599453
engineer,2,0.6931471805599453
constrictor,2,0.6931471805599453
Glasser,2,0.6931471805599453
specialization,2,0.6931471805599453
manoeuvres,2,0.6931471805599453
Costa,2,0.6931471805599453
thicknesses,2,0.6931471805599453
intratracheally,2,0.6931471805599453
Cl⁻,2,0.6931471805599453
burgeoning,2,0.6931471805599453
ravaging,2,0.6931471805599453
minds,2,0.6931471805599453
DAOS,2,0.6931471805599453
Na⁺,2,0.6931471805599453
paramyxoviruses,2,0.6931471805599453
K⁺,2,0.6931471805599453
imperfectly,2,0.6931471805599453
policymaking,2,0.6931471805599453
anti-thrombotic,2,0.6931471805599453
cap,2,0.6931471805599453
lipid-rich,2,0.6931471805599453
coronary-prone,2,0.6931471805599453
subdural,2,0.6931471805599453
23-SL,2,0.6931471805599453
1157,2,0.6931471805599453
informativeness,2,0.6931471805599453
assumes,2,0.6931471805599453
bare-metal,2,0.6931471805599453
Simulations,2,0.6931471805599453
immunohistochemical,2,0.6931471805599453
adipose-derived,2,0.6931471805599453
CTFC,2,0.6931471805599453
Remodeling,2,0.6931471805599453
bifascicular,2,0.6931471805599453
Mixing,2,0.6931471805599453
85-90,2,0.6931471805599453
QALYs,2,0.6931471805599453
941,2,0.6931471805599453
hydrophobicity,2,0.6931471805599453
Thanks,2,0.6931471805599453
bio-safety,2,0.6931471805599453
isoelectric,2,0.6931471805599453
998,2,0.6931471805599453
type-specific,2,0.6931471805599453
spaced,2,0.6931471805599453
well-nourished,2,0.6931471805599453
60-90,2,0.6931471805599453
CDPH,2,0.6931471805599453
unhealthy,2,0.6931471805599453
influenza-induced,2,0.6931471805599453
R1,2,0.6931471805599453
Undiagnosed,2,0.6931471805599453
sub,2,0.6931471805599453
non-specialist,2,0.6931471805599453
LVADs,2,0.6931471805599453
off-label,2,0.6931471805599453
Perception,2,0.6931471805599453
3153,2,0.6931471805599453
neoplasm,2,0.6931471805599453
Biosecurity,2,0.6931471805599453
722,2,0.6931471805599453
well-trained,2,0.6931471805599453
microembolic,2,0.6931471805599453
wisely,2,0.6931471805599453
supratherapeutic,2,0.6931471805599453
ravaged,2,0.6931471805599453
Descriptive,2,0.6931471805599453
23000,2,0.6931471805599453
odynophagia,2,0.6931471805599453
SARS-CoV-2-induced,2,0.6931471805599453
derail,2,0.6931471805599453
82A6,2,0.6931471805599453
Contrary,2,0.6931471805599453
syncopal,2,0.6931471805599453
4741,2,0.6931471805599453
Diagnosed,2,0.6931471805599453
public-private,2,0.6931471805599453
healthcare-associated,2,0.6931471805599453
adenovirus-based,2,0.6931471805599453
DNAm,2,0.6931471805599453
Sixty-six,2,0.6931471805599453
incentive,2,0.6931471805599453
post-infectious,2,0.6931471805599453
Oasys-2,2,0.6931471805599453
Unadjusted,2,0.6931471805599453
symptomless,2,0.6931471805599453
HIN1,2,0.6931471805599453
interestingly,2,0.6931471805599453
Web-based,2,0.6931471805599453
PowerChek™,2,0.6931471805599453
accomplishments,2,0.6931471805599453
registrations,2,0.6931471805599453
judging,2,0.6931471805599453
sub-populations,2,0.6931471805599453
therapy-resistant,2,0.6931471805599453
Backgroundaims,2,0.6931471805599453
sub-population,2,0.6931471805599453
199697,2,0.6931471805599453
DPIs,2,0.6931471805599453
Antalya,2,0.6931471805599453
leveraging,2,0.6931471805599453
Ct-value,2,0.6931471805599453
steep,2,0.6931471805599453
815,2,0.6931471805599453
Polymorphism,2,0.6931471805599453
multiplicative,2,0.6931471805599453
diagramming,2,0.6931471805599453
simplifications,2,0.6931471805599453
proteinase,2,0.6931471805599453
roadblock,2,0.6931471805599453
prison,2,0.6931471805599453
amply,2,0.6931471805599453
9385,2,0.6931471805599453
LabGun,2,0.6931471805599453
discourage,2,0.6931471805599453
Party,2,0.6931471805599453
Bureau,2,0.6931471805599453
Patho,2,0.6931471805599453
LVESV,2,0.6931471805599453
prevaccination,2,0.6931471805599453
Jugular,2,0.6931471805599453
silhouette,2,0.6931471805599453
cicatrices,2,0.6931471805599453
curious,2,0.6931471805599453
35-69,2,0.6931471805599453
under-used,2,0.6931471805599453
multi-disciplinary,2,0.6931471805599453
fibrolipoma,2,0.6931471805599453
Contractile,2,0.6931471805599453
subcategory,2,0.6931471805599453
Dentists,2,0.6931471805599453
caveats,2,0.6931471805599453
PRB,2,0.6931471805599453
rule-out,2,0.6931471805599453
Hawaii,2,0.6931471805599453
eco-environmental,2,0.6931471805599453
endoluminal,2,0.6931471805599453
debut,2,0.6931471805599453
encouragement,2,0.6931471805599453
dual-marker,2,0.6931471805599453
copeptin,2,0.6931471805599453
Castlemans,2,0.6931471805599453
Nonhuman,2,0.6931471805599453
574,2,0.6931471805599453
ears,2,0.6931471805599453
host-specific,2,0.6931471805599453
ENS,2,0.6931471805599453
bronchodilatation,2,0.6931471805599453
52-month,2,0.6931471805599453
Males,2,0.6931471805599453
Sarawak,2,0.6931471805599453
nesting,2,0.6931471805599453
Iba,2,0.6931471805599453
north-east,2,0.6931471805599453
amid,2,0.6931471805599453
1008,2,0.6931471805599453
holes,2,0.6931471805599453
posit,2,0.6931471805599453
35-44,2,0.6931471805599453
brown,2,0.6931471805599453
7-day,2,0.6931471805599453
Filipinos,2,0.6931471805599453
Neurointervention,2,0.6931471805599453
artifact,2,0.6931471805599453
Deep,2,0.6931471805599453
Profile,2,0.6931471805599453
faithfully,2,0.6931471805599453
manufactures,2,0.6931471805599453
ACAAI,2,0.6931471805599453
Beck,2,0.6931471805599453
AAAAI,2,0.6931471805599453
dyslipidaemia,2,0.6931471805599453
40-50,2,0.6931471805599453
Twice,2,0.6931471805599453
ushered,2,0.6931471805599453
stroke-protective,2,0.6931471805599453
1b,2,0.6931471805599453
IE,2,0.6931471805599453
E611,2,0.6931471805599453
G186V,2,0.6931471805599453
D1,2,0.6931471805599453
irreplaceable,2,0.6931471805599453
CTSL,2,0.6931471805599453
corneas,2,0.6931471805599453
waters,2,0.6931471805599453
Mismatch,2,0.6931471805599453
377,2,0.6931471805599453
epidural,2,0.6931471805599453
ACalifornia072009,2,0.6931471805599453
IADL,2,0.6931471805599453
inhabited,2,0.6931471805599453
Limitation,2,0.6931471805599453
hyperintense,2,0.6931471805599453
Fifty-six,2,0.6931471805599453
positive-stranded,2,0.6931471805599453
0538,2,0.6931471805599453
3h,2,0.6931471805599453
invisible,2,0.6931471805599453
2000-2001,2,0.6931471805599453
69-year-old,2,0.6931471805599453
Puffinus,2,0.6931471805599453
shearwaters,2,0.6931471805599453
cross-neutralization,2,0.6931471805599453
Records,2,0.6931471805599453
60th,2,0.6931471805599453
non-randomized,2,0.6931471805599453
dissimilar,2,0.6931471805599453
Schirmers,2,0.6931471805599453
994,2,0.6931471805599453
yearsThe,2,0.6931471805599453
Sendai,2,0.6931471805599453
consultative,2,0.6931471805599453
sequestering,2,0.6931471805599453
cardiac-related,2,0.6931471805599453
end-point,2,0.6931471805599453
No1-9,2,0.6931471805599453
lock-down,2,0.6931471805599453
Kussmauls,2,0.6931471805599453
hyperchloredemia,2,0.6931471805599453
1614,2,0.6931471805599453
methacoline,2,0.6931471805599453
Laboratory-confirmed,2,0.6931471805599453
Unilateral,2,0.6931471805599453
DBPCOFC,2,0.6931471805599453
hint,2,0.6931471805599453
terminus,2,0.6931471805599453
Ace2,2,0.6931471805599453
CSI,2,0.6931471805599453
0089,2,0.6931471805599453
shipping,2,0.6931471805599453
Mymensingh,2,0.6931471805599453
dyssynergic,2,0.6931471805599453
plaque-image,2,0.6931471805599453
randomForest,2,0.6931471805599453
magnet,2,0.6931471805599453
30-35,2,0.6931471805599453
AEDT,2,0.6931471805599453
mesothelioma,2,0.6931471805599453
H1N1-related,2,0.6931471805599453
KDO,2,0.6931471805599453
broncho-pulmonary,2,0.6931471805599453
382000,2,0.6931471805599453
electrophysiologic,2,0.6931471805599453
microcomputer,2,0.6931471805599453
mitigates,2,0.6931471805599453
LAV,2,0.6931471805599453
atopics,2,0.6931471805599453
moiety,2,0.6931471805599453
CIED,2,0.6931471805599453
conceivably,2,0.6931471805599453
advocating,2,0.6931471805599453
CFC-based,2,0.6931471805599453
entrusted,2,0.6931471805599453
buffers,2,0.6931471805599453
non-Emiratis,2,0.6931471805599453
networked,2,0.6931471805599453
isoetharine,2,0.6931471805599453
self-reporting,2,0.6931471805599453
bibliographic,2,0.6931471805599453
EFNS,2,0.6931471805599453
precipitates,2,0.6931471805599453
Influenzanet,2,0.6931471805599453
Decree,2,0.6931471805599453
relational,2,0.6931471805599453
watch,2,0.6931471805599453
72-108,2,0.6931471805599453
replies,2,0.6931471805599453
polarity,2,0.6931471805599453
Equally,2,0.6931471805599453
amitriptyline,2,0.6931471805599453
uncertain-AMI,2,0.6931471805599453
co-culture,2,0.6931471805599453
motivating,2,0.6931471805599453
Heat,2,0.6931471805599453
Mr,2,0.6931471805599453
BiomarkTM,2,0.6931471805599453
oil-in-water,2,0.6931471805599453
372,2,0.6931471805599453
antiseptics,2,0.6931471805599453
larvae,2,0.6931471805599453
wholesale,2,0.6931471805599453
Discontinuance,2,0.6931471805599453
colophony,2,0.6931471805599453
chemists,2,0.6931471805599453
sealing,2,0.6931471805599453
Célkitűzés,2,0.6931471805599453
seal,2,0.6931471805599453
8064,2,0.6931471805599453
célja,2,0.6931471805599453
történt,2,0.6931471805599453
Bogota,2,0.6931471805599453
Junta,2,0.6931471805599453
Socorros,2,0.6931471805599453
transcriptase-PCR,2,0.6931471805599453
cingulate,2,0.6931471805599453
PTMC,2,0.6931471805599453
seafood,2,0.6931471805599453
QIAamp,2,0.6931471805599453
transfusing,2,0.6931471805599453
filter-based,2,0.6931471805599453
Postural,2,0.6931471805599453
4305,2,0.6931471805599453
90-minute,2,0.6931471805599453
posture,2,0.6931471805599453
Threats,2,0.6931471805599453
conserve,2,0.6931471805599453
deflection,2,0.6931471805599453
dot-hybridization,2,0.6931471805599453
Infarktus,2,0.6931471805599453
SDM,2,0.6931471805599453
polycythemia,2,0.6931471805599453
stercoralis,2,0.6931471805599453
Magyar,2,0.6931471805599453
Wechsler,2,0.6931471805599453
Intelligence,2,0.6931471805599453
thresholding,2,0.6931471805599453
sialyltransferases,2,0.6931471805599453
N-linked,2,0.6931471805599453
differentials,2,0.6931471805599453
Sarbecovirus,2,0.6931471805599453
lingered,2,0.6931471805599453
bypasses,2,0.6931471805599453
carrageenan,2,0.6931471805599453
miatt,2,0.6931471805599453
ellátásának,2,0.6931471805599453
Carnosine,2,0.6931471805599453
sialyltransferase,2,0.6931471805599453
00004,2,0.6931471805599453
szívinfarktus,2,0.6931471805599453
uptakes,2,0.6931471805599453
non-infarct-related,2,0.6931471805599453
pravastatin,2,0.6931471805599453
pair-wise,2,0.6931471805599453
calprotectin,2,0.6931471805599453
nominal,2,0.6931471805599453
OP,2,0.6931471805599453
1361,2,0.6931471805599453
subtests,2,0.6931471805599453
Curcuma,2,0.6931471805599453
neutrophills,2,0.6931471805599453
PC20-HS,2,0.6931471805599453
evolutionarily,2,0.6931471805599453
cleavable,2,0.6931471805599453
Range,2,0.6931471805599453
groundbreaking,2,0.6931471805599453
self-damaging,2,0.6931471805599453
polarizing,2,0.6931471805599453
hemagglutinin-specific,2,0.6931471805599453
regionális,2,0.6931471805599453
spouse,2,0.6931471805599453
discontinuance,2,0.6931471805599453
Intranasal,2,0.6931471805599453
MMI,2,0.6931471805599453
Nemzeti,2,0.6931471805599453
W152C,2,0.6931471805599453
Mustela,2,0.6931471805599453
slurry,2,0.6931471805599453
033,2,0.6931471805599453
caretakers,2,0.6931471805599453
S13I,2,0.6931471805599453
Th1-biased,2,0.6931471805599453
B1427B1429,2,0.6931471805599453
EDC,2,0.6931471805599453
mlming,2,0.6931471805599453
Chi,2,0.6931471805599453
35326,2,0.6931471805599453
inter-subject,2,0.6931471805599453
miR-133ab,2,0.6931471805599453
immune-compromised,2,0.6931471805599453
URT,2,0.6931471805599453
exercise-related,2,0.6931471805599453
Exosomes,2,0.6931471805599453
uremia,2,0.6931471805599453
intrahost,2,0.6931471805599453
fortnightly,2,0.6931471805599453
Ferret,2,0.6931471805599453
metaregression,2,0.6931471805599453
negative-sense,2,0.6931471805599453
retaining,2,0.6931471805599453
miR-133,2,0.6931471805599453
newest,2,0.6931471805599453
Trialists,2,0.6931471805599453
obligatory,2,0.6931471805599453
headteachers,2,0.6931471805599453
Max,2,0.6931471805599453
Hgs,2,0.6931471805599453
dozen,2,0.6931471805599453
deviated,2,0.6931471805599453
mvolt,2,0.6931471805599453
nineteenth,2,0.6931471805599453
elemzése,2,0.6931471805599453
trainer,2,0.6931471805599453
CARE,2,0.6931471805599453
ACalifornia704,2,0.6931471805599453
full-scale,2,0.6931471805599453
0·0001,2,0.6931471805599453
Musteloidea,2,0.6931471805599453
VISION,2,0.6931471805599453
enterocytes,2,0.6931471805599453
widowers,2,0.6931471805599453
SSP,2,0.6931471805599453
signed,2,0.6931471805599453
prepost,2,0.6931471805599453
mono,2,0.6931471805599453
MeV-based,2,0.6931471805599453
Migraine,2,0.6931471805599453
cartridges,2,0.6931471805599453
Combinations,2,0.6931471805599453
unnecessarily,2,0.6931471805599453
Strengths,2,0.6931471805599453
Priorities,2,0.6931471805599453
magyarországi,2,0.6931471805599453
unpaired,2,0.6931471805599453
Pearson,2,0.6931471805599453
statewide,2,0.6931471805599453
mandating,2,0.6931471805599453
25°C,2,0.6931471805599453
multidetector,2,0.6931471805599453
accommodations,2,0.6931471805599453
deteriorates,2,0.6931471805599453
Swietokrzyskie,2,0.6931471805599453
OVA-induced,2,0.6931471805599453
Bt-CoV,2,0.6931471805599453
irrespectively,2,0.6931471805599453
differentiates,2,0.6931471805599453
cadet,2,0.6931471805599453
Port,2,0.6931471805599453
country-wide,2,0.6931471805599453
hypoplastic,2,0.6931471805599453
elderlies,2,0.6931471805599453
778,2,0.6931471805599453
plasmid-based,2,0.6931471805599453
antiepileptics,2,0.6931471805599453
bronchoconstrictors,2,0.6931471805599453
E4,2,0.6931471805599453
rugs,2,0.6931471805599453
inadvertent,2,0.6931471805599453
ACE2-expressing,2,0.6931471805599453
pipelines,2,0.6931471805599453
Franciscos,2,0.6931471805599453
blood-derived,2,0.6931471805599453
Zipfs,2,0.6931471805599453
signalled,2,0.6931471805599453
extravascular,2,0.6931471805599453
biomaterial,2,0.6931471805599453
behaves,2,0.6931471805599453
mLkg,2,0.6931471805599453
Recovered,2,0.6931471805599453
Heaps,2,0.6931471805599453
arguably,2,0.6931471805599453
MID,2,0.6931471805599453
Susceptible,2,0.6931471805599453
localizes,2,0.6931471805599453
biomarker-driven,2,0.6931471805599453
Deficiencies,2,0.6931471805599453
percutaneously,2,0.6931471805599453
Seroepidemiological,2,0.6931471805599453
doxepin,2,0.6931471805599453
NSCLC,2,0.6931471805599453
IIa,2,0.6931471805599453
Interobserver,2,0.6931471805599453
deleted,2,0.6931471805599453
Revision,2,0.6931471805599453
reperfusion-induced,2,0.6931471805599453
AEngland,2,0.6931471805599453
Bypass,2,0.6931471805599453
Punjab,2,0.6931471805599453
understandable,2,0.6931471805599453
intronic,2,0.6931471805599453
Sindh,2,0.6931471805599453
Critically,2,0.6931471805599453
asthma-control,2,0.6931471805599453
Play,2,0.6931471805599453
sublethal,2,0.6931471805599453
Am,2,0.6931471805599453
Seventy-eight,2,0.6931471805599453
silk,2,0.6931471805599453
nodules,2,0.6931471805599453
interfered,2,0.6931471805599453
Omalizumab,2,0.6931471805599453
1972–1973,2,0.6931471805599453
1-vessel,2,0.6931471805599453
rug,2,0.6931471805599453
DRGs,2,0.6931471805599453
diagnosis-related,2,0.6931471805599453
infection-induced,2,0.6931471805599453
HEK293T,2,0.6931471805599453
non-mucinous,2,0.6931471805599453
Radiomics,2,0.6931471805599453
infrequency,2,0.6931471805599453
anti-TNF,2,0.6931471805599453
Numerical,2,0.6931471805599453
radionuclides,2,0.6931471805599453
Polands,2,0.6931471805599453
mild-persistent,2,0.6931471805599453
co-localized,2,0.6931471805599453
reminds,2,0.6931471805599453
assuage,2,0.6931471805599453
imagings,2,0.6931471805599453
type-1,2,0.6931471805599453
Cambridge,2,0.6931471805599453
D2BT,2,0.6931471805599453
perforated,2,0.6931471805599453
ORF9b,2,0.6931471805599453
elution,2,0.6931471805599453
ORF7b,2,0.6931471805599453
eight-year,2,0.6931471805599453
1-sec,2,0.6931471805599453
ORF10,2,0.6931471805599453
incarcerated,2,0.6931471805599453
20152016,2,0.6931471805599453
adenopathy,2,0.6931471805599453
102000,2,0.6931471805599453
centrality,2,0.6931471805599453
quoted,2,0.6931471805599453
WIV-1,2,0.6931471805599453
procured,2,0.6931471805599453
dichotomizations,2,0.6931471805599453
3323,2,0.6931471805599453
transcription-Polymerase,2,0.6931471805599453
Shenzhen,2,0.6931471805599453
Richmond,2,0.6931471805599453
lambda,2,0.6931471805599453
20162017,2,0.6931471805599453
CLIA-iFlash,2,0.6931471805599453
ORF7a,2,0.6931471805599453
classifiers,2,0.6931471805599453
fast-track,2,0.6931471805599453
ending,2,0.6931471805599453
lethally,2,0.6931471805599453
PDM09,2,0.6931471805599453
unrestricted,2,0.6931471805599453
granulocytic,2,0.6931471805599453
fecal-viral,2,0.6931471805599453
Suzuki,2,0.6931471805599453
regiments,2,0.6931471805599453
impersistence,2,0.6931471805599453
Observations,2,0.6931471805599453
PCNA,2,0.6931471805599453
Grotta,2,0.6931471805599453
DT-MRI,2,0.6931471805599453
interviewer,2,0.6931471805599453
546,2,0.6931471805599453
TTC,2,0.6931471805599453
timelines,2,0.6931471805599453
landfall,2,0.6931471805599453
Toyama,2,0.6931471805599453
simplex,2,0.6931471805599453
goodness-of-fit,2,0.6931471805599453
evading,2,0.6931471805599453
chi2-test,2,0.6931471805599453
hydrokinesitherapy,2,0.6931471805599453
unknowns,2,0.6931471805599453
tables,2,0.6931471805599453
proliferating,2,0.6931471805599453
Q-MI,2,0.6931471805599453
XL,2,0.6931471805599453
high-efficiency,2,0.6931471805599453
outdoors,2,0.6931471805599453
navigation,2,0.6931471805599453
bottom-up,2,0.6931471805599453
Amidst,2,0.6931471805599453
rationalize,2,0.6931471805599453
Develop,2,0.6931471805599453
structure-activity,2,0.6931471805599453
oscillatory,2,0.6931471805599453
≥090,2,0.6931471805599453
parasitized,2,0.6931471805599453
floating-axis,2,0.6931471805599453
interrater,2,0.6931471805599453
BAC,2,0.6931471805599453
BABM,2,0.6931471805599453
ST-elevációval,2,0.6931471805599453
LLLI,2,0.6931471805599453
20-200,2,0.6931471805599453
pillar,2,0.6931471805599453
implementations,2,0.6931471805599453
generators,2,0.6931471805599453
T2-gradient,2,0.6931471805599453
mineralocorticoid,2,0.6931471805599453
V1-5QS,2,0.6931471805599453
Perspective,2,0.6931471805599453
Disruption,2,0.6931471805599453
subventricular,2,0.6931471805599453
járó,2,0.6931471805599453
pelvis,2,0.6931471805599453
herbs,2,0.6931471805599453
villages,2,0.6931471805599453
myocutaneous,2,0.6931471805599453
mouse-adapted,2,0.6931471805599453
non-IgE,2,0.6931471805599453
one-year-beforeone-year-after,2,0.6931471805599453
distorted,2,0.6931471805599453
Killed,2,0.6931471805599453
SV,2,0.6931471805599453
succeeding,2,0.6931471805599453
transdiaphragmatic,2,0.6931471805599453
regime,2,0.6931471805599453
weekday,2,0.6931471805599453
quantifiable,2,0.6931471805599453
-6,2,0.6931471805599453
subserous,2,0.6931471805599453
brunt,2,0.6931471805599453
electronics,2,0.6931471805599453
mixed-methods,2,0.6931471805599453
fostered,2,0.6931471805599453
Brisbane,2,0.6931471805599453
preexercise,2,0.6931471805599453
RPP,2,0.6931471805599453
endeavour,2,0.6931471805599453
PAEDP,2,0.6931471805599453
dual-gene,2,0.6931471805599453
Coordination,2,0.6931471805599453
EMI,2,0.6931471805599453
1976-1980,2,0.6931471805599453
renale,2,0.6931471805599453
Intracardiac,2,0.6931471805599453
denoted,2,0.6931471805599453
infarctuson,2,0.6931471805599453
lastly,2,0.6931471805599453
aero-allergens,2,0.6931471805599453
APanama200799,2,0.6931471805599453
Evidences,2,0.6931471805599453
cell-cultured,2,0.6931471805599453
understated,2,0.6931471805599453
8-15,2,0.6931471805599453
DHSS,2,0.6931471805599453
Wegeners,2,0.6931471805599453
Recombinant,2,0.6931471805599453
V1-4QS,2,0.6931471805599453
ST-depression,2,0.6931471805599453
chromogenic,2,0.6931471805599453
myocardialis,2,0.6931471805599453
granulomatosis,2,0.6931471805599453
Sudan,2,0.6931471805599453
mHealth,2,0.6931471805599453
IAA,2,0.6931471805599453
inflammometry,2,0.6931471805599453
excellence,2,0.6931471805599453
acid-base,2,0.6931471805599453
Interpretation,2,0.6931471805599453
V1-3QS,2,0.6931471805599453
LGE-CMR,2,0.6931471805599453
catastrophe,2,0.6931471805599453
reposition,2,0.6931471805599453
Hyper,2,0.6931471805599453
Overweight,2,0.6931471805599453
nationalism,2,0.6931471805599453
allergology,2,0.6931471805599453
Otsu,2,0.6931471805599453
recovers,2,0.6931471805599453
invisibility,2,0.6931471805599453
Esophageal,2,0.6931471805599453
stream,2,0.6931471805599453
metro,2,0.6931471805599453
Regions,2,0.6931471805599453
Amplatzer,2,0.6931471805599453
racism,2,0.6931471805599453
Plug,2,0.6931471805599453
NSPs,2,0.6931471805599453
virucidal,2,0.6931471805599453
Min,2,0.6931471805599453
Aga,2,0.6931471805599453
BShandong797,2,0.6931471805599453
CIDS,2,0.6931471805599453
25-75,2,0.6931471805599453
royal,2,0.6931471805599453
sorely,2,0.6931471805599453
nagyrégiók,2,0.6931471805599453
1207,2,0.6931471805599453
unseen,2,0.6931471805599453
IV-rtPA,2,0.6931471805599453
DETECTR,2,0.6931471805599453
DSP,2,0.6931471805599453
CRTx,2,0.6931471805599453
remodeled,2,0.6931471805599453
steno-occlusive,2,0.6931471805599453
premonitory,2,0.6931471805599453
self-rated,2,0.6931471805599453
Arguments,2,0.6931471805599453
dead-volume,2,0.6931471805599453
catarrhal,2,0.6931471805599453
Floating-axis,2,0.6931471805599453
protein-specific,2,0.6931471805599453
coactivator,1,0.0
RBS,1,0.0
SCH,1,0.0
H6N2,1,0.0
DScore,1,0.0
Didier,1,0.0
T1WI,1,0.0
Bioelectric,1,0.0
non-monotonic,1,0.0
fasted,1,0.0
nucleic-acid,1,0.0
costIt,1,0.0
20078,1,0.0
moieties,1,0.0
Quran,1,0.0
misalignment,1,0.0
flow-limited,1,0.0
Assay-based,1,0.0
urodynamic,1,0.0
Leys,1,0.0
history-,1,0.0
Davidson,1,0.0
locationThe,1,0.0
patient-derived,1,0.0
2887,1,0.0
pre-immobilized,1,0.0
tonsillar,1,0.0
yearWith,1,0.0
530348,1,0.0
cardioaortic,1,0.0
esophagitis,1,0.0
Thrombin-Receptor,1,0.0
captive,1,0.0
league,1,0.0
5845,1,0.0
cheetah,1,0.0
family-related,1,0.0
1268,1,0.0
1111,1,0.0
likelihoods,1,0.0
GARNET,1,0.0
Believing,1,0.0
worsening--are,1,0.0
FDA-confirmed,1,0.0
Suffering,1,0.0
season-to-season,1,0.0
fat-saturated,1,0.0
naturalistic,1,0.0
Malay,1,0.0
5817,1,0.0
48-lead,1,0.0
Plavix®,1,0.0
T25-100,1,0.0
-1029,1,0.0
self-completed,1,0.0
Aggrenox®,1,0.0
ingrained,1,0.0
etiologic-pathogenetic,1,0.0
holdbacks,1,0.0
wht,1,0.0
-5196,1,0.0
-10156,1,0.0
EISN,1,0.0
12-15-year-old,1,0.0
2-to-3-hourly,1,0.0
presumes,1,0.0
interprofessional,1,0.0
weather-dependent,1,0.0
sigmaST,1,0.0
Employer,1,0.0
BMP-7-mediated,1,0.0
Zontivity®,1,0.0
17-78,1,0.0
-5943,1,0.0
treatmentCommunicated,1,0.0
nauseavomiting,1,0.0
paving,1,0.0
nonadjacent,1,0.0
Hennerici,1,0.0
parameters--a,1,0.0
Ayurvedic,1,0.0
replied,1,0.0
094-099,1,0.0
096-098,1,0.0
palatine,1,0.0
post-ECMO,1,0.0
student-run,1,0.0
redemption,1,0.0
Multiphasic,1,0.0
yes-or-no,1,0.0
LPAI,1,0.0
fissuring,1,0.0
lengthening,1,0.0
Percordial,1,0.0
LDH1,1,0.0
outcome-driven,1,0.0
-975,1,0.0
Reliability,1,0.0
-6436,1,0.0
Interviews,1,0.0
unreasonably,1,0.0
CNS-involvement,1,0.0
cords,1,0.0
positron-emission,1,0.0
testingIn,1,0.0
latterMajor,1,0.0
RDW,1,0.0
macro-CK-BB-emia,1,0.0
Body,1,0.0
polyp,1,0.0
procoagulative,1,0.0
slides,1,0.0
CK-activity,1,0.0
CK-MB-activities,1,0.0
Brainin,1,0.0
interventionThe,1,0.0
Heinrich,1,0.0
organoid,1,0.0
irregularly,1,0.0
laryngitis,1,0.0
keynote,1,0.0
Reflux,1,0.0
mismatch-based,1,0.0
LT-alpha-Ncol,1,0.0
Lingering,1,0.0
15-17,1,0.0
intron,1,0.0
interrupts,1,0.0
LT-alpha-Ncol1,1,0.0
regret,1,0.0
STENTIM,1,0.0
staggered,1,0.0
LT-alpha-Ncol2,1,0.0
AH1N1swine,1,0.0
non-Covid-19,1,0.0
PW,1,0.0
spuriously,1,0.0
31-57,1,0.0
Hacke,1,0.0
allergenPD15,1,0.0
dedicate,1,0.0
Localization,1,0.0
Capabilities,1,0.0
CHO,1,0.0
Manens,1,0.0
Molin,1,0.0
SPectral,1,0.0
populationweek,1,0.0
Cas13-based,1,0.0
NFκB,1,0.0
low-copy,1,0.0
Sampled,1,0.0
1858,1,0.0
Filarioidea,1,0.0
ELVO,1,0.0
Plymouth,1,0.0
Easing,1,0.0
Mattle,1,0.0
Cardio-vascular,1,0.0
sub-themes,1,0.0
Nordic,1,0.0
variances,1,0.0
SPLASH,1,0.0
CK-MB-immunoinhibition,1,0.0
121-question,1,0.0
creatinkinase-isoenzyme,1,0.0
weals,1,0.0
levelbound,1,0.0
microaggregates,1,0.0
non-affected,1,0.0
Achieved,1,0.0
GM-CSFs,1,0.0
Penza,1,0.0
incomes,1,0.0
ZWOLLE,1,0.0
bi-criteria,1,0.0
rCVR,1,0.0
rs2275913,1,0.0
protease-activated,1,0.0
cold-,1,0.0
Trace,1,0.0
mA,1,0.0
saline-treated,1,0.0
substandard,1,0.0
CONOCES,1,0.0
Informants,1,0.0
nation-wise,1,0.0
ultra,1,0.0
homological,1,0.0
areolar,1,0.0
riddled,1,0.0
Merci,1,0.0
Reef,1,0.0
PAR-1,1,0.0
BSL-1,1,0.0
ICPS,1,0.0
Atrioventricular,1,0.0
versatile,1,0.0
vaccination-associated,1,0.0
Cancer-related,1,0.0
salt-spice,1,0.0
Postal,1,0.0
biomatrix,1,0.0
1471,1,0.0
ease-of-handle,1,0.0
plug-and-apply,1,0.0
Antireflux,1,0.0
1910s,1,0.0
civilization,1,0.0
TRIzol,1,0.0
LPO,1,0.0
illness-specific,1,0.0
rata,1,0.0
6359,1,0.0
Barrier,1,0.0
Werner,1,0.0
Garmisch-Partenkirchen,1,0.0
1·3,1,0.0
under-developed,1,0.0
Administration-cleared,1,0.0
Unites,1,0.0
demographically-structured,1,0.0
TNF-associated,1,0.0
H2-receptor,1,0.0
stent-like,1,0.0
non-shock,1,0.0
23-41,1,0.0
500mm3,1,0.0
resiliency,1,0.0
1000mm3,1,0.0
geospatial,1,0.0
politically,1,0.0
tale,1,0.0
Chamorro,1,0.0
G-152A,1,0.0
untenable,1,0.0
UHF,1,0.0
nutritive,1,0.0
Organoid,1,0.0
Nepali,1,0.0
755,1,0.0
plethysmographic,1,0.0
extended-release,1,0.0
6p211-6p213,1,0.0
3917,1,0.0
Polymorphisms,1,0.0
non-institutionalized,1,0.0
SRaw,1,0.0
predecessor,1,0.0
poultry-to-human,1,0.0
centrifugation,1,0.0
outbreak-oriented,1,0.0
semaglutide,1,0.0
Iftar,1,0.0
0647,1,0.0
OR0427,1,0.0
probands,1,0.0
non-insulin,1,0.0
pioglitazone,1,0.0
0228-0799,1,0.0
36365,1,0.0
RGG,1,0.0
more-frequent,1,0.0
bubble,1,0.0
ACEi,1,0.0
angiotension-converting,1,0.0
292365,1,0.0
-01507,1,0.0
gerontology,1,0.0
Transitions,1,0.0
FluGen,1,0.0
Bubble,1,0.0
centering,1,0.0
luminolo-dependent,1,0.0
2009-2016,1,0.0
Loopamp®,1,0.0
sunrise,1,0.0
229-574,1,0.0
153-246,1,0.0
sehour,1,0.0
Brussels,1,0.0
sunset,1,0.0
fosters,1,0.0
rosiglitazone,1,0.0
Saving,1,0.0
mitigative,1,0.0
cloth,1,0.0
trans-membrane,1,0.0
IFN-c,1,0.0
365406,1,0.0
HO-17-18283,1,0.0
treatments-depends,1,0.0
treatment-or,1,0.0
monitoringfeedback,1,0.0
kick,1,0.0
UniProtKB,1,0.0
WoSSVC,1,0.0
P0DTD2,1,0.0
16000,1,0.0
stick,1,0.0
Carolina-Chapel,1,0.0
P0DTD3,1,0.0
ethicists,1,0.0
96P,1,0.0
CONTENT,1,0.0
interferon-stimulated,1,0.0
27406,1,0.0
-05838,1,0.0
jurisprudence,1,0.0
Microlumat,1,0.0
NK-cell,1,0.0
AORs,1,0.0
-072,1,0.0
ICS±LABA,1,0.0
Reasonable,1,0.0
Surely,1,0.0
preinfection,1,0.0
0438-0663,1,0.0
Advantage,1,0.0
Real-world,1,0.0
couldn’t,1,0.0
141320,1,0.0
April-July,1,0.0
virus-caused,1,0.0
35-4,1,0.0
scotland,1,0.0
683-988,1,0.0
832-100,1,0.0
6-pool,1,0.0
wants,1,0.0
2D-STE,1,0.0
4504,1,0.0
14-16,1,0.0
37655,1,0.0
insonation,1,0.0
connects,1,0.0
imparted,1,0.0
36-92,1,0.0
ISG15,1,0.0
RBD-coated,1,0.0
Spine,1,0.0
58-80,1,0.0
releasability,1,0.0
paged,1,0.0
Reactions,1,0.0
34-fold,1,0.0
Speckle-tracking,1,0.0
protein-16,1,0.0
Club,1,0.0
assert,1,0.0
clarifier,1,0.0
reponding,1,0.0
non-judgmental,1,0.0
multiple-center,1,0.0
3102,1,0.0
Event-free,1,0.0
50-55,1,0.0
cross-shift,1,0.0
IgGs,1,0.0
cross-activity,1,0.0
2709,1,0.0
R229,1,0.0
non-strokes,1,0.0
perceiving,1,0.0
shipments,1,0.0
4-17,1,0.0
8745,1,0.0
univocal,1,0.0
87994,1,0.0
7954,1,0.0
2019-SARSCoV-2,1,0.0
community-scale,1,0.0
emulate,1,0.0
Betacoronaviridae,1,0.0
exacerbationsyear,1,0.0
four-week,1,0.0
uncharted,1,0.0
Terrapinns,1,0.0
Wandering,1,0.0
homogeneous-mixing,1,0.0
shunt-related,1,0.0
acid-,1,0.0
UA,1,0.0
RRI,1,0.0
Intraarterial,1,0.0
CoronaVAC,1,0.0
R254,1,0.0
tetraparesis,1,0.0
Arguably,1,0.0
9821,1,0.0
I-11,1,0.0
78-year,1,0.0
non-immunogenic,1,0.0
strokes--221,1,0.0
12105,1,0.0
10-120,1,0.0
22105,1,0.0
single-call,1,0.0
Hemiballismus,1,0.0
II-23,1,0.0
Preferential,1,0.0
impurities,1,0.0
Contents,1,0.0
LINKED,1,0.0
aspects-all,1,0.0
SSEPs,1,0.0
tissue-level,1,0.0
zeta,1,0.0
somatosensory-evoked,1,0.0
CRP-values,1,0.0
≤38,1,0.0
imdevimab,1,0.0
panic-like,1,0.0
email,1,0.0
Brethold,1,0.0
Adequacy,1,0.0
holy,1,0.0
outlets,1,0.0
EMT-led,1,0.0
telestroke--a,1,0.0
asthma-evoked,1,0.0
guesswork,1,0.0
Frame,1,0.0
variantshas,1,0.0
Akashi,1,0.0
Count,1,0.0
Collection,1,0.0
dysartria,1,0.0
093-095,1,0.0
one-shot,1,0.0
beta-blocking,1,0.0
1726,1,0.0
behaved,1,0.0
patients--compared,1,0.0
Financing,1,0.0
stammering,1,0.0
4-7,1,0.0
Thung,1,0.0
Periprocedural,1,0.0
vaccine-elicited,1,0.0
lesser-explored,1,0.0
host-directed,1,0.0
preventor,1,0.0
exonucleases,1,0.0
18-month-old,1,0.0
2SD,1,0.0
Marseille-4,1,0.0
fuming,1,0.0
1733,1,0.0
49-69,1,0.0
S477,1,0.0
Mycobacterial,1,0.0
copathogen,1,0.0
1803,1,0.0
hereby,1,0.0
27619,1,0.0
interconnects,1,0.0
Continual,1,0.0
730000,1,0.0
Personalized,1,0.0
inferiorly,1,0.0
anti-fibrosis,1,0.0
EMTs,1,0.0
agent-specific,1,0.0
pathogen-targeted,1,0.0
policys,1,0.0
Song,1,0.0
subgrouping,1,0.0
morphogenetic,1,0.0
unemployment,1,0.0
temporarily-housed,1,0.0
hematogenous,1,0.0
protein-7,1,0.0
curve--AUC,1,0.0
metabolizers,1,0.0
surfacing,1,0.0
15-fold,1,0.0
8987,1,0.0
playgroups,1,0.0
stagnation,1,0.0
agerisk,1,0.0
Islam,1,0.0
9686,1,0.0
min6,1,0.0
tunneling,1,0.0
hypercoagulative,1,0.0
PsycInfo,1,0.0
coverages,1,0.0
Six-hundred,1,0.0
inputs,1,0.0
2-16,1,0.0
leptomeningeal,1,0.0
eugylcemia,1,0.0
411726,1,0.0
Volumes,1,0.0
cineangiographic,1,0.0
4296,1,0.0
preventtreat,1,0.0
aneurism,1,0.0
Tunnel,1,0.0
Point-prevalence,1,0.0
Syndrome-associated,1,0.0
49-73,1,0.0
ratio432,1,0.0
QMEANDisCo,1,0.0
Image-guided,1,0.0
microplates,1,0.0
neurones,1,0.0
q1-q3,1,0.0
Montevideo,1,0.0
ProQ3,1,0.0
point-prevalence,1,0.0
max68,1,0.0
96P-WMP,1,0.0
rri,1,0.0
SARSCoV-2,1,0.0
Simpsons,1,0.0
stenocardia,1,0.0
FDA-proposed,1,0.0
stale,1,0.0
47324,1,0.0
insurance-based,1,0.0
CLP,1,0.0
goal-related,1,0.0
TechneCoat,1,0.0
radiolabelling,1,0.0
14-25,1,0.0
Multi-echo,1,0.0
patent-protected,1,0.0
QC,1,0.0
Sehour,1,0.0
sympathovagal,1,0.0
Rises,1,0.0
spin-echo,1,0.0
7-14-day,1,0.0
disprosodia,1,0.0
PAC-MAN,1,0.0
untested,1,0.0
S1RBD,1,0.0
risk-structured,1,0.0
Circle,1,0.0
easy-to-dose,1,0.0
Assocaitions,1,0.0
hearings,1,0.0
gastro-oesophageal,1,0.0
headedness,1,0.0
endorsement,1,0.0
immunes,1,0.0
non-insurance-based,1,0.0
48003,1,0.0
Quarterly,1,0.0
culturable,1,0.0
huMAN,1,0.0
IBDs,1,0.0
demyelinating,1,0.0
chairman,1,0.0
bootstrapped,1,0.0
parasitize,1,0.0
Partnership,1,0.0
seventeenth,1,0.0
Frontal,1,0.0
PushPull,1,0.0
29-518,1,0.0
Employee,1,0.0
Actin,1,0.0
ibuprofen,1,0.0
392883,1,0.0
Clinicopathological,1,0.0
FWF,1,0.0
Battery,1,0.0
Heath-funded,1,0.0
bureaucracy,1,0.0
perspectiveWe,1,0.0
prolific,1,0.0
Non-sentinel,1,0.0
empirically-informed,1,0.0
professionalization,1,0.0
Readying,1,0.0
cost-effectivenessIn,1,0.0
288-330,1,0.0
PRESPERO,1,0.0
23-person,1,0.0
IVD-labeled,1,0.0
Architect™,1,0.0
tenure,1,0.0
myocytolysis,1,0.0
125-676,1,0.0
DAF,1,0.0
Zuckerberg,1,0.0
MBR,1,0.0
point-of-dispensing,1,0.0
fine-grained,1,0.0
Copper,1,0.0
non-professionals,1,0.0
mildasymptomatic,1,0.0
wearer,1,0.0
Funding,1,0.0
LAUNCH,1,0.0
VACCINATION,1,0.0
PROGRAM,1,0.0
multiattribute,1,0.0
DFG,1,0.0
Push,1,0.0
881896-1904,1,0.0
Virol,1,0.0
methodically,1,0.0
BMBF,1,0.0
Chan,1,0.0
Velocity,1,0.0
-695,1,0.0
Pull,1,0.0
entrances,1,0.0
locked,1,0.0
punch,1,0.0
strategy-making,1,0.0
upheavals,1,0.0
wwwgrouptextingcom,1,0.0
PNIPH,1,0.0
androgenic,1,0.0
SYK,1,0.0
p38-MAPK,1,0.0
masculinity,1,0.0
TYK2,1,0.0
brilliantly,1,0.0
colonic,1,0.0
PERK,1,0.0
beta-MHC,1,0.0
FYN,1,0.0
Khomeini,1,0.0
FGFR2,1,0.0
Rho-associated,1,0.0
hair,1,0.0
ITK,1,0.0
PMRFs,1,0.0
H5N,1,0.0
Droplet,1,0.0
Ibrutinib,1,0.0
Forelimb,1,0.0
Asymmetry,1,0.0
Pamapimod,1,0.0
Upadacitinib,1,0.0
Tofacitinib,1,0.0
forepaw,1,0.0
fingertip,1,0.0
DTN,1,0.0
Aiming,1,0.0
testosterone,1,0.0
PCa,1,0.0
alopecia,1,0.0
Hôpital,1,0.0
67-177,1,0.0
significantRTMM,1,0.0
Européen,1,0.0
Pompidou,1,0.0
sweat,1,0.0
3639,1,0.0
health-workers,1,0.0
3637,1,0.0
past-infections,1,0.0
patientsThis,1,0.0
Apnoea,1,0.0
APACHE-II,1,0.0
Imam,1,0.0
ectopics,1,0.0
lag-time,1,0.0
Incorrect,1,0.0
notwithstanding,1,0.0
Trigger,1,0.0
laboratory-defined,1,0.0
semi-isolated,1,0.0
sebum,1,0.0
Chalmers,1,0.0
Feno,1,0.0
pushpull,1,0.0
Flushing,1,0.0
toughly,1,0.0
Microelectrode,1,0.0
filiform,1,0.0
SHS,1,0.0
μENIA,1,0.0
expound,1,0.0
EID50,1,0.0
repelling,1,0.0
microfluidics-based,1,0.0
commercialization,1,0.0
attainable,1,0.0
Staged,1,0.0
decimetric,1,0.0
103-104,1,0.0
microclimate,1,0.0
EuNPs,1,0.0
arteriopathies-might,1,0.0
limit-of-detection,1,0.0
12-fold,1,0.0
mines,1,0.0
Arteriopathy-including,1,0.0
signal-to-background,1,0.0
-036,1,0.0
EuNP,1,0.0
reflex-segmental,1,0.0
livebirths,1,0.0
superhydrophobic,1,0.0
bonding,1,0.0
warming,1,0.0
biotherapeutics,1,0.0
wettability,1,0.0
electroacupuncture,1,0.0
Tagging,1,0.0
Fifth,1,0.0
29226,1,0.0
40-76,1,0.0
-242,1,0.0
SWEDEHEART,1,0.0
Cine,1,0.0
-136,1,0.0
shop,1,0.0
Personal-level,1,0.0
veteran,1,0.0
one-stop,1,0.0
non-reactive,1,0.0
PTD,1,0.0
Face,1,0.0
IUI,1,0.0
Generalizability,1,0.0
2284,1,0.0
eighty-four,1,0.0
Discrete-time,1,0.0
062-083,1,0.0
unmarried,1,0.0
561,1,0.0
1178,1,0.0
cluster-randomized,1,0.0
immobilization,1,0.0
Revised,1,0.0
FPs,1,0.0
neuropsychologists,1,0.0
NAEPPs,1,0.0
evocative,1,0.0
80-95,1,0.0
mentor,1,0.0
denuded,1,0.0
Enhancing,1,0.0
anti-oxidant,1,0.0
bacteremia,1,0.0
CD8T-cell,1,0.0
resisted,1,0.0
reproliferation,1,0.0
S-derived,1,0.0
MCM7,1,0.0
stepped-care,1,0.0
pneumoniae-infected,1,0.0
non-neuropsychological,1,0.0
medication-specific,1,0.0
biochemically,1,0.0
446-488,1,0.0
F-specific,1,0.0
mentorship,1,0.0
disulphide,1,0.0
cysteines,1,0.0
co-analysis,1,0.0
Gait,1,0.0
Non-treated,1,0.0
8400,1,0.0
104-3,1,0.0
ATBUTH,1,0.0
C56BL6J,1,0.0
single-patient,1,0.0
transferal,1,0.0
SHPB,1,0.0
purine,1,0.0
bronchospasmic,1,0.0
9999995,1,0.0
Europium,1,0.0
outbreak-control,1,0.0
epoxy,1,0.0
401-515,1,0.0
cube,1,0.0
RBD-immunized,1,0.0
PC-polydimethylsiloxane,1,0.0
polycarbonate,1,0.0
RBDS1,1,0.0
Stride,1,0.0
∝,1,0.0
Freunds,1,0.0
≤4,1,0.0
oligodeoxinucleotideAlum,1,0.0
mN,1,0.0
polyepitopic,1,0.0
-agonist,1,0.0
Engineering,1,0.0
Bauchi,1,0.0
Ruxolitinib,1,0.0
RPP30,1,0.0
spike-in,1,0.0
4ere,1,0.0
life-shortening,1,0.0
glymphatic,1,0.0
BirdFlu2009,1,0.0
IVIgs,1,0.0
carboxylate,1,0.0
microbubble,1,0.0
sandwich,1,0.0
NEX-DAS-181,1,0.0
complement-induced,1,0.0
hyper-response,1,0.0
Smorodintsev-Luzyanina,1,0.0
Francis-Davenport,1,0.0
1949,1,0.0
binding-induced,1,0.0
pallidum,1,0.0
THATKA,1,0.0
striatum,1,0.0
transmissibility-presymptomatic,1,0.0
NexBio,1,0.0
MVA-NP-M1,1,0.0
Jenner,1,0.0
appurtenance,1,0.0
single-step,1,0.0
10-360,1,0.0
Conduction,1,0.0
presentations-may,1,0.0
subthalamic,1,0.0
anxious-hypochondriac,1,0.0
psychovegetative,1,0.0
interconnecting,1,0.0
caregiver-reported,1,0.0
obesity-,1,0.0
polypeptides,1,0.0
TMP,1,0.0
polymer-based,1,0.0
Cura,1,0.0
Orbus,1,0.0
CoronaVirus-2,1,0.0
Neich,1,0.0
B11519,1,0.0
neuroanatomicalneurobiological,1,0.0
ambiguities,1,0.0
Unexpected,1,0.0
dextrocardia,1,0.0
sirolimus-eluting,1,0.0
T732A,1,0.0
bioabsorbable,1,0.0
04-06,1,0.0
polymer-coated,1,0.0
antiproliferative,1,0.0
THA,1,0.0
Sections,1,0.0
noncrepitant,1,0.0
undermines,1,0.0
automobile,1,0.0
bioreceptor,1,0.0
reagentless,1,0.0
Ardabil,1,0.0
noyes,1,0.0
extrasystole,1,0.0
IntroductionWe,1,0.0
1242,1,0.0
three-season,1,0.0
163-1463,1,0.0
bio-assay,1,0.0
1641,1,0.0
sureyes,1,0.0
271-3657,1,0.0
-58,1,0.0
CCSs,1,0.0
869,1,0.0
UCH-L1,1,0.0
index--a,1,0.0
Believe,1,0.0
119-893,1,0.0
on-farm,1,0.0
piggeries,1,0.0
slaughterhouses,1,0.0
hydrolase-L1,1,0.0
carboxy-terminal,1,0.0
large-bore,1,0.0
ubiquitin,1,0.0
Malin,1,0.0
Srivastava,1,0.0
geomagnetic,1,0.0
138-1146,1,0.0
Lacking,1,0.0
high-threat,1,0.0
167-621,1,0.0
aptamer-based,1,0.0
disturbance--and,1,0.0
epimyocardium,1,0.0
pervenous,1,0.0
salts,1,0.0
Potassium,1,0.0
hypo-akinetic,1,0.0
hyper-,1,0.0
electrolytes,1,0.0
postrepolarization,1,0.0
proceding,1,0.0
Dyskinesias,1,0.0
sotalol,1,0.0
revive,1,0.0
10-week,1,0.0
splenectomy,1,0.0
Pneumococcal,1,0.0
13080,1,0.0
premedical,1,0.0
102-1645,1,0.0
reinvigoration,1,0.0
Dont,1,0.0
14085,1,0.0
99mTc,1,0.0
157-863,1,0.0
not-allergic-not-obese,1,0.0
allergic-not-obese,1,0.0
obese-not-allergic,1,0.0
Kaiser,1,0.0
double-centered,1,0.0
COVID-19Results,1,0.0
Traffic,1,0.0
doctorclinic,1,0.0
P0002Comparing,1,0.0
Durban,1,0.0
platelet-to-lymphocyte,1,0.0
sites-in,1,0.0
surveillance-Senegal,1,0.0
Ferritin,1,0.0
blindly,1,0.0
stage3,1,0.0
D-Dimer,1,0.0
allergic-and-obese,1,0.0
ALT,1,0.0
APTT,1,0.0
Luleå,1,0.0
asthma-specialist,1,0.0
stage1,1,0.0
20-60,1,0.0
Incident,1,0.0
1lymphocyte,1,0.0
Facilitated,1,0.0
p0002The,1,0.0
0671platelets,1,0.0
postsystolic,1,0.0
beset,1,0.0
limitedMethodology,1,0.0
earners,1,0.0
IMA,1,0.0
Peficitinib,1,0.0
opportune,1,0.0
Phocine,1,0.0
GSK2606414,1,0.0
beta-myosin,1,0.0
Herpes,1,0.0
cine-MRI,1,0.0
Filgotinib,1,0.0
Fasudil,1,0.0
Decernotinib,1,0.0
Brepocitinib,1,0.0
PhHV-1,1,0.0
1000-fold,1,0.0
Baricitinib,1,0.0
CRD42016037106,1,0.0
MMGBSA,1,0.0
SPSS15,1,0.0
Glide,1,0.0
softwareRhinosinusitis,1,0.0
self-managers,1,0.0
kinase-like,1,0.0
NiRAN,1,0.0
remedied,1,0.0
ischaemia-modified,1,0.0
woefully,1,0.0
TGEV,1,0.0
membrane-associated,1,0.0
PLP2-TM,1,0.0
G6,1,0.0
Intravascular,1,0.0
CO-VID-19-related,1,0.0
lymphomatosis,1,0.0
6C,1,0.0
Abbreviation,1,0.0
gain-loss,1,0.0
gain-framed,1,0.0
IVL,1,0.0
6D,1,0.0
G7,1,0.0
protean,1,0.0
macroautophagy,1,0.0
cell-extracellular,1,0.0
ration,1,0.0
long-lasing,1,0.0
diversified,1,0.0
loss-framed,1,0.0
1451,1,0.0
antiprotease,1,0.0
Xin,1,0.0
Jiang,1,0.0
Ga-East,1,0.0
creatine-kinase,1,0.0
disease-model,1,0.0
single-arm,1,0.0
25OH,1,0.0
BECN1,1,0.0
MEFs,1,0.0
beclin,1,0.0
lipidated,1,0.0
affections,1,0.0
LC3-II,1,0.0
non-lipidated,1,0.0
LC3-I,1,0.0
microtubule,1,0.0
1-specificity,1,0.0
govern,1,0.0
0001Conclusion,1,0.0
hemograms,1,0.0
DMVs,1,0.0
Urologic,1,0.0
annualized,1,0.0
activities-including,1,0.0
0021,1,0.0
training-was,1,0.0
EGR1,1,0.0
Declining,1,0.0
780,1,0.0
microgramskgmin,1,0.0
Vo2peak,1,0.0
G6-pdm,1,0.0
G7-pdm,1,0.0
G5,1,0.0
5th-7th,1,0.0
forgetting,1,0.0
15-75,1,0.0
5100,1,0.0
intradermally,1,0.0
ACE2-encoding,1,0.0
perforates,1,0.0
immunocytochemistry,1,0.0
postinoculation,1,0.0
malposition,1,0.0
Misplacement,1,0.0
259-281,1,0.0
Membrane-associated,1,0.0
8-session,1,0.0
170-226,1,0.0
Albuterol,1,0.0
eight-session,1,0.0
350-410,1,0.0
optimism-adjusted,1,0.0
non-adjuvant,1,0.0
Peg,1,0.0
parsing,1,0.0
aide,1,0.0
590-643,1,0.0
311-352,1,0.0
TH1-TH2,1,0.0
multinucleated,1,0.0
retraction,1,0.0
0902,1,0.0
0881,1,0.0
280-340,1,0.0
478-59,1,0.0
Consequences,1,0.0
unintentionally,1,0.0
misplaced,1,0.0
Ansan,1,0.0
directs,1,0.0
AGE,1,0.0
RaTG13-like,1,0.0
intersections,1,0.0
navigates,1,0.0
pluralistic,1,0.0
Industrialized,1,0.0
70s,1,0.0
MP789-like,1,0.0
ancestors,1,0.0
misrepresentations,1,0.0
BLASTn,1,0.0
Merely,1,0.0
rival,1,0.0
non-recombinant,1,0.0
HTS,1,0.0
PEDro,1,0.0
793-892,1,0.0
severity-specific,1,0.0
502-544,1,0.0
concavity,1,0.0
9-Hole,1,0.0
Lee,1,0.0
Strain,1,0.0
c-index,1,0.0
pycnosis,1,0.0
Deigin,1,0.0
pressors,1,0.0
propionate,1,0.0
inflammationAHR,1,0.0
Circular,1,0.0
stereology,1,0.0
120000,1,0.0
Genotypic,1,0.0
TandemHeart,1,0.0
Cardiopulmonary,1,0.0
arthropod-borne,1,0.0
pressor,1,0.0
SARS-CoV-2-dengue,1,0.0
self-resolving,1,0.0
Parkland,1,0.0
bothWe,1,0.0
arthralgias,1,0.0
reevaluatedWe,1,0.0
3-months,1,0.0
controlledpartly,1,0.0
ballon,1,0.0
uncontrolledpartly,1,0.0
hypogonadism,1,0.0
NeuN,1,0.0
asthmachronic,1,0.0
cosyntropin,1,0.0
hypophysitis,1,0.0
TGF-β,1,0.0
photothrombosis,1,0.0
salmeterolfluticasone,1,0.0
photobiomodulation,1,0.0
on-demand,1,0.0
7912,1,0.0
0375,1,0.0
coincides,1,0.0
vacuolization,1,0.0
detached,1,0.0
kappa0599,1,0.0
7718,1,0.0
steeper,1,0.0
1156,1,0.0
kappa0511,1,0.0
substratum,1,0.0
ADAM33,1,0.0
Leakage,1,0.0
anosodiaphoria,1,0.0
40-48,1,0.0
Cytopathic,1,0.0
0129,1,0.0
oxidoreductase,1,0.0
1y,1,0.0
NADPHquinone,1,0.0
pro187ser,1,0.0
judges,1,0.0
ile105val,1,0.0
CIEDs,1,0.0
promp,1,0.0
80s,1,0.0
Successfully,1,0.0
soft-tissue,1,0.0
dissipate,1,0.0
-40,1,0.0
cebids,1,0.0
rugosa,1,0.0
steroid-naive,1,0.0
marcrofocal,1,0.0
papillae,1,0.0
repressor,1,0.0
01-30,1,0.0
3-,1,0.0
MB-CK,1,0.0
40-year-old,1,0.0
obstetrics,1,0.0
24100000,1,0.0
humans--H1N1,1,0.0
Preparing,1,0.0
COVID-suspect,1,0.0
6536,1,0.0
DswineOklahoma13142011,1,0.0
first-doses,1,0.0
DOK,1,0.0
seven-plasmid-based,1,0.0
RGS-derived,1,0.0
704003,1,0.0
H1N2--and,1,0.0
COVID-negative,1,0.0
Denizli,1,0.0
-60,1,0.0
heralds,1,0.0
testing-on-a-probe,1,0.0
Yavarí-Mirín,1,0.0
STOPCovid,1,0.0
10769,1,0.0
Seven538,1,0.0
Thirteen50,1,0.0
HUDSON-SHERLOCK,1,0.0
FEVI,1,0.0
Twenty-six81,1,0.0
Sapajus,1,0.0
AdipoGen,1,0.0
mRNA1273,1,0.0
C-type,1,0.0
proteoglycans,1,0.0
Spix,1,0.0
Cebus,1,0.0
albifrons,1,0.0
HSPGs,1,0.0
Humboldt,1,0.0
1812,1,0.0
NTs,1,0.0
underrecognised,1,0.0
splice,1,0.0
Haemodynamic,1,0.0
thrombo-embolus,1,0.0
CD46,1,0.0
Cebidae,1,0.0
E697K,1,0.0
alpha-blocking,1,0.0
Oriental,1,0.0
Realistic,1,0.0
point-of-service,1,0.0
Neisseria,1,0.0
OMVs,1,0.0
patter,1,0.0
purse,1,0.0
unreliability,1,0.0
polysorbates,1,0.0
OMV,1,0.0
63-72,1,0.0
tragedies,1,0.0
13000-15000,1,0.0
50-100,1,0.0
Within-individual,1,0.0
maternities,1,0.0
pulsated,1,0.0
Anaphylactic,1,0.0
hives,1,0.0
QRS-loop,1,0.0
FcγR,1,0.0
convexity,1,0.0
FcεRI,1,0.0
Antibody-mediated,1,0.0
β-adrenergic,1,0.0
Segreto,1,0.0
abating,1,0.0
hypo-akinesia,1,0.0
Sars-Cov-2,1,0.0
interpretative,1,0.0
anaphylactoids,1,0.0
not-IgE-mediated,1,0.0
Initiating,1,0.0
L462F,1,0.0
pressurised,1,0.0
pMDIs,1,0.0
N4000,1,0.0
passports,1,0.0
spiraling,1,0.0
Pilot,1,0.0
56-year,1,0.0
ICV,1,0.0
1938-1994,1,0.0
ephedra,1,0.0
electrocardiographic-necropsy,1,0.0
pseudoephedrine,1,0.0
DVS,1,0.0
hemagglutinin-loaded,1,0.0
previously-well,1,0.0
ephedrine,1,0.0
Mildly,1,0.0
high-titer,1,0.0
low-perfusion,1,0.0
myoclonus,1,0.0
afflicting,1,0.0
IDVIMPORTANCE,1,0.0
tremor,1,0.0
epiglottitis,1,0.0
Ω-3,1,0.0
Enigma®,1,0.0
Airflow,1,0.0
2496749,1,0.0
nNOSperoxynitrite-associated,1,0.0
injurious,1,0.0
normal-appearing,1,0.0
developmentHigh-quality,1,0.0
somatization,1,0.0
112654202,1,0.0
Hundreds,1,0.0
Considerations,1,0.0
manners,1,0.0
Zazzo,1,0.0
nonspecialists,1,0.0
lead-standard,1,0.0
arrhythmiaThe,1,0.0
obesity-asthma,1,0.0
leads-standard,1,0.0
authenticity,1,0.0
epsilon,1,0.0
nQS,1,0.0
asthmaConclusions,1,0.0
nR,1,0.0
CW,1,0.0
end-inspiratory,1,0.0
cancelation,1,0.0
exhaling,1,0.0
10-meter,1,0.0
GSNO-mediated,1,0.0
paracellular,1,0.0
1969-1985,1,0.0
12202,1,0.0
diverged,1,0.0
Recker,1,0.0
biologists,1,0.0
Simplified,1,0.0
MMPs,1,0.0
BMIR,1,0.0
parallelism,1,0.0
harbouring,1,0.0
nNOS-originated,1,0.0
10-6,1,0.0
VPBsmin,1,0.0
pressure-rate-product,1,0.0
2716,1,0.0
slowdown,1,0.0
70-89,1,0.0
24th,1,0.0
-024,1,0.0
Arima,1,0.0
redox-modulating,1,0.0
junctional-cytoskeletal,1,0.0
S-nitrosoglutathione,1,0.0
Fourier,1,0.0
GSNO,1,0.0
Expected,1,0.0
peroxynitrite,1,0.0
PPLATL,1,0.0
-000,1,0.0
TaqPath™,1,0.0
Blood-brain,1,0.0
COVID-19-microbiome-immune,1,0.0
Rentrop,1,0.0
PWC170,1,0.0
microbiome-related,1,0.0
capacitymaximum,1,0.0
PDCF,1,0.0
tension-frquency,1,0.0
undeviating,1,0.0
asthmaMethods,1,0.0
mOsmL,1,0.0
efficacious-without,1,0.0
unclearObjectives,1,0.0
re-discuss,1,0.0
619000,1,0.0
synchronizing,1,0.0
vaccine-naïve,1,0.0
objectivization,1,0.0
wet-to-dry,1,0.0
EB,1,0.0
2-h,1,0.0
Halothane-anesthetized,1,0.0
psycho-somatic,1,0.0
semi-close,1,0.0
readjustment,1,0.0
diffusing,1,0.0
Osmotherapy,1,0.0
microbiome-immune,1,0.0
HEART-SENSE,1,0.0
veloergometric,1,0.0
pre-hospitalization,1,0.0
227-729,1,0.0
149-615,1,0.0
-006,1,0.0
209-478,1,0.0
FMRIB,1,0.0
Toolbox,1,0.0
66±13,1,0.0
-010,1,0.0
β-024,1,0.0
β-0241,1,0.0
162-243,1,0.0
4916,1,0.0
WMDs,1,0.0
emotive,1,0.0
transpires,1,0.0
vividness,1,0.0
tapped,1,0.0
multi-media,1,0.0
animated,1,0.0
questionnaireMeasurements,1,0.0
suckling,1,0.0
dual-energy,1,0.0
5421,1,0.0
personas,1,0.0
convince,1,0.0
0731,1,0.0
objectify,1,0.0
pick-flow,1,0.0
pancreatic,1,0.0
54-484,1,0.0
Hyperventilation,1,0.0
Pco2,1,0.0
short-lasting,1,0.0
Tainan,1,0.0
kdt,1,0.0
time-,1,0.0
PFO-related,1,0.0
Outpatient,1,0.0
7523,1,0.0
7224,1,0.0
immunoprecipitate,1,0.0
verbalizing,1,0.0
0681,1,0.0
3-dimensional,1,0.0
Dander,1,0.0
quantitates,1,0.0
mimotopes,1,0.0
IABP-treated,1,0.0
Alexithymia,1,0.0
decisiveness,1,0.0
369-540,1,0.0
099-141,1,0.0
070-089,1,0.0
066-096,1,0.0
complacency,1,0.0
113-697,1,0.0
Reduplication,1,0.0
288-760,1,0.0
bridged,1,0.0
FluAB-RSV,1,0.0
RNAm,1,0.0
acknowledges,1,0.0
Porton,1,0.0
Down,1,0.0
dilation--is,1,0.0
Salisbury,1,0.0
process--left,1,0.0
CE-IVD,1,0.0
vagally,1,0.0
adenosines,1,0.0
submicroscopic,1,0.0
Aided,1,0.0
NIDDM,1,0.0
955-994,1,0.0
astroglial,1,0.0
96-996,1,0.0
972-999,1,0.0
unproved,1,0.0
NAVIGATE-ESUS,1,0.0
archival,1,0.0
antagonized,1,0.0
peri-lesioned,1,0.0
236-940,1,0.0
164-746,1,0.0
209-303,1,0.0
SARAS-CoV-2,1,0.0
189-305,1,0.0
1148-1159,1,0.0
006-091,1,0.0
proline,1,0.0
005-085,1,0.0
virusesμL,1,0.0
Qingdao,1,0.0
non-pathogenic,1,0.0
004-093,1,0.0
jumps,1,0.0
monophyletic,1,0.0
003-087,1,0.0
confining,1,0.0
child-onset,1,0.0
cocirculate,1,0.0
clinical-anamnestical,1,0.0
0687,1,0.0
0713,1,0.0
S-binding,1,0.0
thirty-eight,1,0.0
TJ,1,0.0
pack,1,0.0
p0006,1,0.0
IMT0684,1,0.0
boi,1,0.0
pm,1,0.0
12163,1,0.0
nanowire,1,0.0
004-094,1,0.0
104-160,1,0.0
Verify,1,0.0
9991-100,1,0.0
9979-100,1,0.0
106-183,1,0.0
3a,1,0.0
Paresis,1,0.0
Dominant,1,0.0
1478,1,0.0
HES-C,1,0.0
nt28144,1,0.0
HEalth,1,0.0
21846,1,0.0
nt8782,1,0.0
3053,1,0.0
99295,1,0.0
2995,1,0.0
2947,1,0.0
2895,1,0.0
3356,1,0.0
1646,1,0.0
Establishment,1,0.0
aa,1,0.0
pre-thrombotic,1,0.0
558-569,1,0.0
627-638,1,0.0
-004,1,0.0
indifference,1,0.0
20-hydroxy-leukotriene,1,0.0
quartz,1,0.0
identified-organelle,1,0.0
cOPNP,1,0.0
8525,1,0.0
congruent,1,0.0
011-066,1,0.0
lobules,1,0.0
pharmacist-provided,1,0.0
SF-12,1,0.0
Endoplasmic,1,0.0
disorganization,1,0.0
NSTEMI-csoportban,1,0.0
adventitial,1,0.0
Radioimmunoassay,1,0.0
mucusinflammation,1,0.0
hyperplasiametaplasia,1,0.0
pentachrome-stained,1,0.0
Movats,1,0.0
ischemia-related,1,0.0
rubric,1,0.0
noncartilaginous,1,0.0
breeds,1,0.0
asthma-affected,1,0.0
13-17,1,0.0
grazing,1,0.0
7151-10000,1,0.0
complied,1,0.0
T2HIGH,1,0.0
1702-4757,1,0.0
oro-nasopharyngeal,1,0.0
nonhomogeneous,1,0.0
calamity,1,0.0
wheezing-related,1,0.0
NetEpi,1,0.0
exacerbation-prone,1,0.0
Fundeni,1,0.0
24386,1,0.0
983217,1,0.0
exposuresensitization,1,0.0
3C2a1,1,0.0
omic,1,0.0
V1-V4,1,0.0
492-a,1,0.0
BB,1,0.0
halothane,1,0.0
0164,1,0.0
professionally,1,0.0
122829,1,0.0
pioneering,1,0.0
7345-9428,1,0.0
8615,1,0.0
466-a,1,0.0
Neutrophil-to-lymphocyte,1,0.0
meg,1,0.0
109-141,1,0.0
long-rank,1,0.0
8242-8769,1,0.0
broad-scale,1,0.0
SARS-CoV-2-rtPCR,1,0.0
aftereffects,1,0.0
stagnant,1,0.0
will-power,1,0.0
Single-center,1,0.0
coarse,1,0.0
eighty-eight,1,0.0
angiographymagnetic,1,0.0
1133,1,0.0
myths,1,0.0
mindkét,1,0.0
dogma,1,0.0
sobering,1,0.0
two-pollutant,1,0.0
dear,1,0.0
mythology,1,0.0
anthropologists,1,0.0
metaphor,1,0.0
Coris,1,0.0
belies,1,0.0
betegcsoportban,1,0.0
typology,1,0.0
grand,1,0.0
PAR,1,0.0
non-traffic,1,0.0
traffic-,1,0.0
translation-associated,1,0.0
organelle,1,0.0
proteins-several,1,0.0
microenvironments,1,0.0
fleet,1,0.0
PM10-25,1,0.0
Respi-Strip,1,0.0
submicron,1,0.0
195-47,1,0.0
3077,1,0.0
durably,1,0.0
enact,1,0.0
gyms,1,0.0
41-6,1,0.0
restaurants,1,0.0
jeopardise,1,0.0
regrettable,1,0.0
1359-396,1,0.0
haematologic,1,0.0
frequency--cyanosis,1,0.0
2451,1,0.0
2042,1,0.0
1-16,1,0.0
2278,1,0.0
conducted†,1,0.0
32401,1,0.0
30-November,1,0.0
sieving,1,0.0
szakban,1,0.0
T2LOW,1,0.0
elvégzett,1,0.0
hemofiltration,1,0.0
CVVH,1,0.0
2019n-CoV,1,0.0
P006,1,0.0
Monod,1,0.0
29380,1,0.0
Granulocyte,1,0.0
cardial,1,0.0
Methodologic,1,0.0
seramaternal,1,0.0
Weber,1,0.0
WISC-III,1,0.0
4970,1,0.0
Rrs,1,0.0
beavatkozás,1,0.0
disproportionally,1,0.0
resistances,1,0.0
IFN-γ-producing,1,0.0
computer-driven,1,0.0
Woven,1,0.0
ENT,1,0.0
north-westsouth-east,1,0.0
Threshold,1,0.0
hyperkinesis,1,0.0
tonic-clonic,1,0.0
throught,1,0.0
vaccine-enhanced,1,0.0
Extraesophageal,1,0.0
eight-year-old,1,0.0
extraesophageal,1,0.0
co-infect,1,0.0
peri-infarction,1,0.0
Myopathy,1,0.0
761,1,0.0
2770,1,0.0
Montgomery,1,0.0
SDN-treated,1,0.0
Elektrocardiographic,1,0.0
ravages,1,0.0
516-ánál,1,0.0
dictated,1,0.0
01-04,1,0.0
12-222,1,0.0
25-544,1,0.0
katéteres,1,0.0
érmegnyitás,1,0.0
subendothelial,1,0.0
presumption,1,0.0
eliscrepancy,1,0.0
615-706,1,0.0
1-21,1,0.0
21-September,1,0.0
791-877,1,0.0
Surgeon,1,0.0
Nigerians,1,0.0
ingesta,1,0.0
Generals,1,0.0
acknowledging,1,0.0
1-44,1,0.0
1-71,1,0.0
502-594,1,0.0
feathers,1,0.0
stigmatisation,1,0.0
anti-receptor-binding,1,0.0
caspase-3,1,0.0
Tn-T,1,0.0
1068,1,0.0
060-090,1,0.0
syndromic4,1,0.0
virological3,1,0.0
4-238,1,0.0
1612,1,0.0
Actuarial,1,0.0
present-day,1,0.0
Schematic,1,0.0
levels12,1,0.0
test-trace-isolate,1,0.0
5-15,1,0.0
56-year-old,1,0.0
end-of-trial,1,0.0
0803,1,0.0
aversion,1,0.0
45-396,1,0.0
alatt,1,0.0
consolidations,1,0.0
B-lines,1,0.0
oesogastrectomy,1,0.0
coloplasty,1,0.0
4492,1,0.0
1569,1,0.0
2068,1,0.0
3775,1,0.0
neurorepair,1,0.0
Modifications,1,0.0
platelet-fibrin,1,0.0
6-mo,1,0.0
ACTION,1,0.0
out-groups,1,0.0
6471,1,0.0
troponin-T,1,0.0
079-127,1,0.0
097-130,1,0.0
cardiac-specific,1,0.0
ISO,1,0.0
073-120,1,0.0
081-116,1,0.0
során,1,0.0
ISO-induced,1,0.0
blaming,1,0.0
isoproternol,1,0.0
stadily,1,0.0
hospitalizations2,1,0.0
whith,1,0.0
revascularisatiós,1,0.0
szívműtét,1,0.0
sciadopitysin,1,0.0
szignifikánsan,1,0.0
fertile,1,0.0
Substantially,1,0.0
healthcare-seeking,1,0.0
Othering,1,0.0
ticked,1,0.0
studies67,1,0.0
WHO5,1,0.0
traces,1,0.0
arid,1,0.0
Bhutanese,1,0.0
Network-based,1,0.0
provokers,1,0.0
Video-oculography,1,0.0
complies,1,0.0
vHIT,1,0.0
Coinfection,1,0.0
situation-specific,1,0.0
PROMISs,1,0.0
plusieurs,1,0.0
aadditional,1,0.0
PROMIS,1,0.0
fois,1,0.0
1889-90,1,0.0
mais,1,0.0
également,1,0.0
considérer,1,0.0
scanographiques,1,0.0
Roadmap,1,0.0
comme,1,0.0
α26-linked,1,0.0
devant,1,0.0
induire,1,0.0
T-cell-mediated,1,0.0
prise,1,0.0
Fc-mediated,1,0.0
adéquate,1,0.0
Droplet-based,1,0.0
Wehn,1,0.0
ugly,1,0.0
répéter,1,0.0
DIP,1,0.0
qu´il,1,0.0
SMAD4,1,0.0
1438-1450,1,0.0
miR-449c,1,0.0
Et,1,0.0
n´est,1,0.0
qu´après,1,0.0
miR-34b,1,0.0
un,1,0.0
globus,1,0.0
Feed-Forward,1,0.0
3-node,1,0.0
troisième,1,0.0
pallidus,1,0.0
COPD-like,1,0.0
intricated,1,0.0
parahippocampus,1,0.0
été,1,0.0
positif,1,0.0
TFs,1,0.0
montre,1,0.0
proteaseantiprotease,1,0.0
centrality-based,1,0.0
pre-COVID,1,0.0
40th,1,0.0
ADCav,1,0.0
l´intérêt,1,0.0
smartphone-based,1,0.0
watched,1,0.0
age-pattern,1,0.0
508,1,0.0
saccades,1,0.0
Bithermal,1,0.0
ICD10,1,0.0
FFP2,1,0.0
STANDARDTM,1,0.0
Lumipulse®,1,0.0
onset-to-door-times,1,0.0
1968-1977,1,0.0
380-53,1,0.0
door-to-needle-times,1,0.0
Pericytes,1,0.0
cooperatively,1,0.0
71010,1,0.0
MCPs,1,0.0
SCoV-2-SP,1,0.0
11924,1,0.0
audiometry,1,0.0
horizontaltorsional,1,0.0
Dirichlet,1,0.0
59086,1,0.0
25th,1,0.0
n-grams,1,0.0
hashtags,1,0.0
stance,1,0.0
gaze-evoked,1,0.0
1473,1,0.0
AFIAS,1,0.0
hCoV-19CanadaON-VIDO-012020,1,0.0
21-year-old,1,0.0
Lao,1,0.0
cross-neutralized,1,0.0
planing,1,0.0
PDR,1,0.0
Vaccination-induced,1,0.0
counting-based,1,0.0
mRNA-vaccinated,1,0.0
CME,1,0.0
SP-pseudotyped,1,0.0
virus-was,1,0.0
Distinct,1,0.0
Baguio,1,0.0
chlorofluorocarbon,1,0.0
CPK-MB,1,0.0
cortico-ponto-cerebellar,1,0.0
resuscitative,1,0.0
Usual,1,0.0
pulsed-xenon,1,0.0
PX-UV,1,0.0
humansimian,1,0.0
dispersin,1,0.0
CFC-free,1,0.0
CCC19,1,0.0
SCoV2-SP-PVs,1,0.0
peduncle,1,0.0
NhPVSuramin,1,0.0
nonpharmacological,1,0.0
pulmonaire,1,0.0
navigable,1,0.0
embolie,1,0.0
collars,1,0.0
-0·70,1,0.0
Telemonitoring,1,0.0
nonexacerbation,1,0.0
10·50,1,0.0
Olmsted,1,0.0
bifurcation,1,0.0
Peels,1,0.0
BAV,1,0.0
installing,1,0.0
subintensive,1,0.0
deformed,1,0.0
systematical,1,0.0
után,1,0.0
EAP,1,0.0
eIND,1,0.0
maladie,1,0.0
Nelfinavir,1,0.0
déclarée,1,0.0
Chine,1,0.0
Teicoplanin,1,0.0
jobb,1,0.0
fin,1,0.0
s´est,1,0.0
Emetine,1,0.0
confirmations,1,0.0
resists,1,0.0
IRB-approved,1,0.0
defecation,1,0.0
généralisée,1,0.0
csökkentette,1,0.0
nemben,1,0.0
invocations,1,0.0
2690,1,0.0
workings,1,0.0
minden,1,0.0
inter-patient,1,0.0
extractiondetection,1,0.0
latrine,1,0.0
Gaps,1,0.0
időpontjában,1,0.0
sub-Sahara,1,0.0
KSA,1,0.0
gesture,1,0.0
különbözött,1,0.0
2·13,1,0.0
halálozást,1,0.0
-8·08,1,0.0
11·82,1,0.0
Blancmange,1,0.0
backlogs,1,0.0
4·72,1,0.0
life-span,1,0.0
translates,1,0.0
expel,1,0.0
defecate,1,0.0
régiók,1,0.0
rapidement,1,0.0
Options,1,0.0
16236,1,0.0
upended,1,0.0
Nous,1,0.0
rapportons,1,0.0
720,1,0.0
MEF2575,1,0.0
803,1,0.0
cell-and,1,0.0
proteins-the,1,0.0
pulmonology,1,0.0
Lever,1,0.0
le,1,0.0
cas,1,0.0
különbségek,1,0.0
d´un,1,0.0
proteomes,1,0.0
testé,1,0.0
négatif,1,0.0
deux,1,0.0
edema-to-normal,1,0.0
reprises,1,0.0
chez,1,0.0
retrouvait,1,0.0
1935,1,0.0
vannak,1,0.0
typiques,1,0.0
balloon-mounted,1,0.0
527,1,0.0
thoracique,1,0.0
comparé,1,0.0
aux,1,0.0
hyperlipidemic,1,0.0
AR-DRGs,1,0.0
autres,1,0.0
Son,1,0.0
synaptogenesis,1,0.0
fait,1,0.0
Version,1,0.0
infarktusos,1,0.0
ellátásában,1,0.0
AR-DRG,1,0.0
prélèvements,1,0.0
Refined,1,0.0
naso-pharyngés,1,0.0
Reform,1,0.0
wore,1,0.0
Gynaecologists,1,0.0
bien,1,0.0
wristwatches,1,0.0
preprogrammed,1,0.0
que,1,0.0
prognózisában,1,0.0
spécifique,1,0.0
open-labeled,1,0.0
est,1,0.0
d´une,1,0.0
sensibilité,1,0.0
moindre,1,0.0
65-70,1,0.0
p0025,1,0.0
vagueness,1,0.0
Pump,1,0.0
Analysing,1,0.0
6440,1,0.0
tenable,1,0.0
RADs,1,0.0
toxicant,1,0.0
3-14,1,0.0
fume,1,0.0
66250,1,0.0
voxel,1,0.0
corrosive,1,0.0
histamine-1-receptor,1,0.0
nonsedating,1,0.0
E-mediated,1,0.0
kezelt,1,0.0
occlusionstenosis,1,0.0
dialling,1,0.0
skipped,1,0.0
AH1N1pdm09-positive,1,0.0
6B1,1,0.0
brucellosis,1,0.0
digit,1,0.0
majorly,1,0.0
adataira,1,0.0
two-handed,1,0.0
One-half,1,0.0
Consumers,1,0.0
subclade,1,0.0
disease-initiating,1,0.0
Előzmény,1,0.0
disease-modifying,1,0.0
GCP,1,0.0
diverted,1,0.0
proximally,1,0.0
underreported,1,0.0
unifocal,1,0.0
holoendemic,1,0.0
Maldives,1,0.0
time-shift,1,0.0
bronchography,1,0.0
narration,1,0.0
⑤,1,0.0
inflatable,1,0.0
Serosurvey,1,0.0
expander,1,0.0
seven-level,1,0.0
bias-corrected,1,0.0
popularize,1,0.0
multi-marker,1,0.0
non-mirror,1,0.0
rs-fMRI,1,0.0
72-109,1,0.0
57-92,1,0.0
86-124,1,0.0
20-month,1,0.0
level-dependent,1,0.0
Naïve,1,0.0
1038,1,0.0
reductive,1,0.0
regularization,1,0.0
Saturday,1,0.0
right-brain,1,0.0
pre-PCI,1,0.0
post-percutaneous,1,0.0
Analyze,1,0.0
chest-pain,1,0.0
systematised,1,0.0
friability,1,0.0
Long-lasting,1,0.0
intra-household,1,0.0
pilotidőszakában,1,0.0
rögzített,1,0.0
place-related,1,0.0
downgrading,1,0.0
prohibitively,1,0.0
IIIII,1,0.0
927,1,0.0
32-month,1,0.0
switchboard,1,0.0
TLR2,1,0.0
Left-brain,1,0.0
IABP-SHOCK,1,0.0
betegeknél,1,0.0
weakening,1,0.0
identilfy,1,0.0
Explanations,1,0.0
polypathology,1,0.0
H5N1-associated,1,0.0
studiíes,1,0.0
linoleic,1,0.0
left-brain,1,0.0
symptom-onset-,1,0.0
httpswwwncbinlmnihgovresearchcoronavirus,1,0.0
diluting,1,0.0
Petersburg,1,0.0
hosszú,1,0.0
9615,1,0.0
távú,1,0.0
S162N,1,0.0
kórlefolyására,1,0.0
vonatkozó,1,0.0
TSC,1,0.0
hazai,1,0.0
accesses,1,0.0
door-to-balloon-inflation,1,0.0
CanSino,1,0.0
inflicted,1,0.0
kutatás,1,0.0
eddig,1,0.0
stability-putting,1,0.0
Thrombectomy-Capable,1,0.0
conjunctive,1,0.0
ressources,1,0.0
reallocated,1,0.0
RBDMW06,1,0.0
I216T,1,0.0
JanssenJohnsonJohnson,1,0.0
vizsgálat,1,0.0
chromogranin,1,0.0
5-month-old,1,0.0
Validity,1,0.0
HPS,1,0.0
Unraveling,1,0.0
thoracentesis,1,0.0
CMC,1,0.0
bioaffinity,1,0.0
cross-hemisphere,1,0.0
44-77,1,0.0
undervalued,1,0.0
Decidability,1,0.0
Charges,1,0.0
ASCOT,1,0.0
SarmaHighlightsCoronavirus,1,0.0
SARS-CoV-2In,1,0.0
LIPID,1,0.0
deaminase,1,0.0
2582,1,0.0
4S,1,0.0
ISPs,1,0.0
fluorescein,1,0.0
qualitative-quantitative,1,0.0
Well-confirmed,1,0.0
consecutives,1,0.0
context--analysed,1,0.0
UDE,1,0.0
triphenyl,1,0.0
CoV-2All,1,0.0
Zones,1,0.0
CTA-SI,1,0.0
OVD,1,0.0
receptorsTop,1,0.0
CgA,1,0.0
LMT-AMI,1,0.0
Executability,1,0.0
Obstruction,1,0.0
Coadministration,1,0.0
ultra-high-pressure,1,0.0
Plain,1,0.0
Generating,1,0.0
depressionanxiety,1,0.0
18-epoxy-eicosatetraenoic,1,0.0
718-EpETE,1,0.0
PIH,1,0.0
Grafting,1,0.0
implementability,1,0.0
carcinoembryonic,1,0.0
insilico,1,0.0
six-months,1,0.0
MPM,1,0.0
maestro,1,0.0
fifty-five,1,0.0
respected,1,0.0
Top,1,0.0
DPT,1,0.0
Coumarin,1,0.0
rounded,1,0.0
Asbestosis,1,0.0
39840,1,0.0
Maestro,1,0.0
CoV-2These,1,0.0
beatsminute,1,0.0
tracts--by,1,0.0
impairmentConclusion,1,0.0
introducers,1,0.0
kinesi,1,0.0
maladjustment,1,0.0
1975-1979,1,0.0
3579,1,0.0
age-sex-matched,1,0.0
639,1,0.0
maladaptation,1,0.0
Petrov,1,0.0
disease-perception,1,0.0
socioenvironmental,1,0.0
Poorer,1,0.0
Attendance,1,0.0
26-73,1,0.0
dispersing,1,0.0
76-85,1,0.0
2011-2015,1,0.0
invigorating,1,0.0
90-110,1,0.0
Pi,1,0.0
DFIPRS,1,0.0
Interest,1,0.0
thirdly,1,0.0
QEEG,1,0.0
CaNS,1,0.0
Coping,1,0.0
2020-April,1,0.0
moduleAll,1,0.0
preanalytical,1,0.0
proteomics-based,1,0.0
ODE,1,0.0
screw,1,0.0
LAC,1,0.0
LAAS,1,0.0
asthmaCOPD,1,0.0
propertiesMD,1,0.0
classification--a,1,0.0
Proteins,1,0.0
Honolulu,1,0.0
Syst-Eur,1,0.0
radius,1,0.0
psycho-educational,1,0.0
non-RSV,1,0.0
gyration,1,0.0
HOT,1,0.0
coulomb-SR,1,0.0
LJ-SR,1,0.0
1975-1995,1,0.0
2960,1,0.0
Ninety-three,1,0.0
6-21,1,0.0
superspreaders,1,0.0
stereotyped,1,0.0
18-60,1,0.0
simulates,1,0.0
non-ketotic,1,0.0
birthday,1,0.0
NSTEMI-betegek,1,0.0
ellátás,1,0.0
hypertransfusion,1,0.0
tumour-like,1,0.0
paravertebral,1,0.0
rendelkezett,1,0.0
lodge,1,0.0
optimists,1,0.0
myelofibrosis,1,0.0
GSEA,1,0.0
populációban,1,0.0
realists,1,0.0
co-membership,1,0.0
pessimists,1,0.0
PAG,1,0.0
gene-lists,1,0.0
Annotated,1,0.0
preference-based,1,0.0
Theoretical,1,0.0
partitioned,1,0.0
átesett,1,0.0
httpdiscoveryinformaticsuabeduPAGER-CoV,1,0.0
octants,1,0.0
PhysioNet,1,0.0
proof-of-the-concept,1,0.0
PTB,1,0.0
transformations,1,0.0
3-lead,1,0.0
szerepelt,1,0.0
intermedia,1,0.0
PAGER,1,0.0
IVR,1,0.0
Palkonyay,1,0.0
dimethyl,1,0.0
sulfoxide,1,0.0
Splenosis,1,0.0
anti-RdRP,1,0.0
kezeléséhez,1,0.0
neurointerventionists,1,0.0
adatgyűjtés,1,0.0
Kutatásetikai,1,0.0
Kieny,1,0.0
126000,1,0.0
Bizottság,1,0.0
autoimplants,1,0.0
Girard,1,0.0
14-15,1,0.0
Transbaikal,1,0.0
Viralbacterial,1,0.0
Enteroccocci,1,0.0
crudely,1,0.0
enterococcal,1,0.0
neurointerventionalists,1,0.0
engedélyével,1,0.0
VAERS,1,0.0
Canterbury,1,0.0
under-18,1,0.0
4210,1,0.0
Christchurch,1,0.0
feldolgozott,1,0.0
nontarget,1,0.0
adatok,1,0.0
Közép-,1,0.0
detoxify,1,0.0
purposed,1,0.0
findingspitfalls,1,0.0
Sobel,1,0.0
S-transferases,1,0.0
publishing,1,0.0
Interferon-induced,1,0.0
Nepalese,1,0.0
ACalifornia72004,1,0.0
Nyugat-,1,0.0
K145N,1,0.0
lysine-to-asparagine,1,0.0
virus-1,1,0.0
erratic,1,0.0
hasonlítottunk,1,0.0
AWyoming32003,1,0.0
HIV-1,1,0.0
rs12252,1,0.0
Full-length,1,0.0
AWyoming303,1,0.0
Hemagglutination,1,0.0
NFEQ,1,0.0
refugee,1,0.0
sulfur,1,0.0
osmolarity,1,0.0
784-ánál,1,0.0
EVAR,1,0.0
readouts,1,0.0
non-drug,1,0.0
JapanMethodology,1,0.0
octant,1,0.0
dosaged,1,0.0
betegévre,1,0.0
9728,1,0.0
covariation,1,0.0
4--8,1,0.0
vonatkoznak,1,0.0
Singaporean,1,0.0
9500,1,0.0
daysConclusion,1,0.0
testsResults,1,0.0
Nontarget,1,0.0
post-processing,1,0.0
sewer,1,0.0
severityAim,1,0.0
amelyeket,1,0.0
Backgrund,1,0.0
-0519,1,0.0
assaysGap,1,0.0
encephalopathic,1,0.0
8-year-old,1,0.0
55-96,1,0.0
lifestyle-related,1,0.0
0579,1,0.0
53-321,1,0.0
chromatography-high,1,0.0
2008264975-7,1,0.0
egg-derived,1,0.0
cryopreservative,1,0.0
evidencing,1,0.0
H274Y,1,0.0
psychoeducational,1,0.0
LATF,1,0.0
későbbi,1,0.0
let,1,0.0
bioprosthetic,1,0.0
≥16,1,0.0
cater,1,0.0
788±67,1,0.0
neve,1,0.0
sad,1,0.0
authenticate,1,0.0
aphasic,1,0.0
Harris-Benedict,1,0.0
Szívinfarktus,1,0.0
Trillium,1,0.0
reconstructions,1,0.0
facilitation,1,0.0
január,1,0.0
Canadas,1,0.0
centrumok,1,0.0
tertiary-level,1,0.0
GTA,1,0.0
flail,1,0.0
RSPC,1,0.0
homologues,1,0.0
hypercatabolic,1,0.0
Equation,1,0.0
Influenza-B,1,0.0
July-September,1,0.0
664,1,0.0
GeneFinder,1,0.0
mediator-release,1,0.0
anymore,1,0.0
Ocular,1,0.0
aged-matched,1,0.0
UDO,1,0.0
non-essential,1,0.0
gear,1,0.0
Lanka,1,0.0
reminded,1,0.0
hygene,1,0.0
consciously,1,0.0
Unknown,1,0.0
AVF,1,0.0
AVL,1,0.0
KDCA,1,0.0
nagyrégiókban,1,0.0
late-life,1,0.0
Mid-life,1,0.0
C-OCS,1,0.0
Forty-nine,1,0.0
Módszer,1,0.0
Color-coded,1,0.0
Background-,1,0.0
still-evolving,1,0.0
Overactivation,1,0.0
interhemispheric,1,0.0
Scintigrams,1,0.0
canter,1,0.0
20-64,1,0.0
caudally,1,0.0
CMR-edema,1,0.0
hozzájárultak,1,0.0
circumferences,1,0.0
1600000,1,0.0
egészségügyi,1,0.0
Thoroughbred,1,0.0
delling,1,0.0
remo-,1,0.0
trot,1,0.0
bronchoconstricting,1,0.0
ponsiveness,1,0.0
isointerval,1,0.0
klinikai,1,0.0
hyperres-,1,0.0
Jamaican,1,0.0
gallop,1,0.0
prime-boosting,1,0.0
well-perfused,1,0.0
tau,1,0.0
Multigated,1,0.0
lobeline,1,0.0
4-6-fold,1,0.0
elongation,1,0.0
adataik,1,0.0
not-so-new,1,0.0
65-year,1,0.0
önkéntes,1,0.0
insulin-mediated,1,0.0
scapula,1,0.0
enzbling,1,0.0
appendicitis,1,0.0
részvételével,1,0.0
sternoclavicular,1,0.0
Diaphragmatic,1,0.0
adatait,1,0.0
Images,1,0.0
Disturbance,1,0.0
anti-coagulant,1,0.0
rögzítette,1,0.0
ehere,1,0.0
supraphysiological,1,0.0
automated-manual,1,0.0
akik,1,0.0
non-vascular,1,0.0
97-5,1,0.0
írásban,1,0.0
inflammation-induced,1,0.0
copositivity,1,0.0
brunch,1,0.0
multi-detector,1,0.0
adrenocorticotropin,1,0.0
extra-polating,1,0.0
sepsisshock,1,0.0
Elitech,1,0.0
75th‰,1,0.0
2020-7,1,0.0
5030866,1,0.0
labstix,1,0.0
powdered,1,0.0
germvirus,1,0.0
Grasp,1,0.0
infectioninfluenza-like,1,0.0
illnesslaboratory-confirmed,1,0.0
non-fit-tested,1,0.0
maskrespirator,1,0.0
Temperate,1,0.0
Beat,1,0.0
command,1,0.0
2012-2015,1,0.0
90000-750000,1,0.0
nondescript,1,0.0
rainbow,1,0.0
Eat,1,0.0
Documented,1,0.0
2048380,1,0.0
1096663,1,0.0
Stoke,1,0.0
health-system,1,0.0
10-11,1,0.0
BEAST,1,0.0
Parametric,1,0.0
possibleto,1,0.0
over-represent,1,0.0
time-periods,1,0.0
Static,1,0.0
150000,1,0.0
min-max,1,0.0
N95P2,1,0.0
4872,1,0.0
1843,1,0.0
mastocytosis,1,0.0
self-gated,1,0.0
nonlacunar,1,0.0
SG,1,0.0
unregistered,1,0.0
recirculation,1,0.0
infarctionreperfusion,1,0.0
cross-clamp,1,0.0
601,1,0.0
Recirculation,1,0.0
4796,1,0.0
3694,1,0.0
clinically-diagnosed,1,0.0
sanatorial,1,0.0
Stroke-EAST,1,0.0
TOP-TAb,1,0.0
end-systole,1,0.0
end-diastole,1,0.0
7955,1,0.0
midportion,1,0.0
chronotherapy,1,0.0
2753,1,0.0
CZ,1,0.0
quasi-experimental,1,0.0
prosthetics,1,0.0
strokesyear,1,0.0
customary,1,0.0
MLE,1,0.0
otolaryngology-head,1,0.0
manned,1,0.0
17-75,1,0.0
ovoid,1,0.0
horrendous,1,0.0
immune-modulators,1,0.0
clinico-radiological,1,0.0
inflicts,1,0.0
Morrocan,1,0.0
headset,1,0.0
quarterly,1,0.0
Cytosorbents®,1,0.0
SARS-C0V-2,1,0.0
HIS,1,0.0
mates,1,0.0
3D-TOF,1,0.0
infarction-concomitant,1,0.0
Objectiveshypothesis,1,0.0
rtPA-treated,1,0.0
extensibility,1,0.0
Starling,1,0.0
ionol,1,0.0
obsessed,1,0.0
tomogram,1,0.0
nicotinamide,1,0.0
electrocardiograph,1,0.0
Heme,1,0.0
mid-splenium,1,0.0
signal-intensity,1,0.0
Racialethnic,1,0.0
Financial,1,0.0
systems-injury,1,0.0
messengers,1,0.0
diluent,1,0.0
150-1589,1,0.0
posology,1,0.0
alternately,1,0.0
r0614,1,0.0
intra-cellular,1,0.0
detention,1,0.0
infestations,1,0.0
2-45,1,0.0
delimiting,1,0.0
SITS-EAST,1,0.0
Renin-angiotensin,1,0.0
2006218-16,1,0.0
natives,1,0.0
triumphant,1,0.0
Craniocervical,1,0.0
hostviral,1,0.0
stabilizes,1,0.0
Multidetector,1,0.0
Calcutta,1,0.0
meticulously,1,0.0
genotoxic,1,0.0
encephalopathies,1,0.0
system-coronavirus-2,1,0.0
midnight,1,0.0
ECG-trigger,1,0.0
071-011,1,0.0
Tentacious,1,0.0
Ariadnes,1,0.0
stifles,1,0.0
CRV-infected,1,0.0
Myocarditis-related,1,0.0
H1N1v-,1,0.0
P0045,1,0.0
aftermaths,1,0.0
factorConclusion,1,0.0
left-hemisphere,1,0.0
damageWhat,1,0.0
Known•,1,0.0
humans•,1,0.0
Dec,1,0.0
MINOCAs,1,0.0
exaggerate,1,0.0
pandemicWhat,1,0.0
phenotypically,1,0.0
New•,1,0.0
resonancecomputed,1,0.0
involvement•,1,0.0
faded,1,0.0
Wepfer,1,0.0
Jakob,1,0.0
APNs,1,0.0
designations,1,0.0
bloodletting,1,0.0
thread,1,0.0
labyrinth,1,0.0
AbstractThe,1,0.0
carpeting,1,0.0
120-6038,1,0.0
oligonucleotides,1,0.0
203-943,1,0.0
reproducibilities,1,0.0
intrarater,1,0.0
1704,1,0.0
Did,1,0.0
004-097,1,0.0
Speedwell,1,0.0
103-385,1,0.0
AB®,1,0.0
Bristol,1,0.0
ingenuity,1,0.0
sympton-free,1,0.0
neurodiagnostics,1,0.0
Directigen™,1,0.0
outstrips,1,0.0
slept,1,0.0
washroom,1,0.0
FDA-EUA,1,0.0
laundry,1,0.0
0-59,1,0.0
Test-Children,1,0.0
P0033,1,0.0
dining,1,0.0
CVLT-C,1,0.0
Responsibilities,1,0.0
enemas,1,0.0
contingence,1,0.0
backscatter,1,0.0
peakABSTRACT,1,0.0
dithio,1,0.0
Injection,1,0.0
fluorine,1,0.0
1104,1,0.0
4-,1,0.0
ipsilaterally,1,0.0
5-log10,1,0.0
antipreconditioning,1,0.0
847,1,0.0
sympathomimetics,1,0.0
054-089,1,0.0
1-log10,1,0.0
openers,1,0.0
U071Results,1,0.0
100-µg,1,0.0
groupPatients,1,0.0
calendars,1,0.0
drugrelated,1,0.0
onethird,1,0.0
carotids,1,0.0
victimised,1,0.0
apidly,1,0.0
RUO,1,0.0
efficiencies,1,0.0
075-011,1,0.0
CDG,1,0.0
stirred,1,0.0
maldistribution,1,0.0
MR-based,1,0.0
transtheoretical,1,0.0
Hippocrates,1,0.0
Era,1,0.0
chemically-induced,1,0.0
discriminability,1,0.0
immunotoxic,1,0.0
21-item,1,0.0
formol-killed,1,0.0
stark,1,0.0
left-,1,0.0
Prochaskas,1,0.0
Glycan,1,0.0
diffusion-,1,0.0
pAsp614Gly,1,0.0
climbed,1,0.0
0473,1,0.0
fibres,1,0.0
Painless,1,0.0
cellularity,1,0.0
re-outbreaks,1,0.0
MUFA,1,0.0
inflations,1,0.0
anonymised,1,0.0
preconditioning-like,1,0.0
monounsaturated,1,0.0
triphosphate-sensitive,1,0.0
outspread,1,0.0
subfalcine,1,0.0
79420,1,0.0
flat,1,0.0
23-85,1,0.0
subscore,1,0.0
atrial-aortic,1,0.0
ventricular-aortic,1,0.0
38-120,1,0.0
Bayern795-like,1,0.0
Assisted,1,0.0
ONAP,1,0.0
9405,1,0.0
voluminous,1,0.0
myeloleucosis,1,0.0
medicament,1,0.0
beta-sympatholytics,1,0.0
Beijing26295-like,1,0.0
patently,1,0.0
nanorod,1,0.0
postloads,1,0.0
travel-related,1,0.0
silicon-on-insulator,1,0.0
all-dielectric,1,0.0
B11,1,0.0
anti-CCD,1,0.0
aminoacidic,1,0.0
IFN-based,1,0.0
CCDs,1,0.0
4-chamber,1,0.0
200102,1,0.0
15-35,1,0.0
premarket,1,0.0
Absenteeism,1,0.0
MRIMR,1,0.0
FLUAV,1,0.0
handicapped,1,0.0
intelligently,1,0.0
1947,1,0.0
Lima,1,0.0
0003ABSTRACT,1,0.0
D-,1,0.0
Ci,1,0.0
flowchart,1,0.0
amolmL,1,0.0
Disposable,1,0.0
proportional-hazards,1,0.0
locked-in,1,0.0
mild-pandemic,1,0.0
NN,1,0.0
APeru164199,1,0.0
anxietyconversion,1,0.0
confection,1,0.0
oligoDNAs,1,0.0
standardizations,1,0.0
slurred,1,0.0
non-MENA,1,0.0
thrombolysis-treated,1,0.0
APeru179899,1,0.0
Itabashi,1,0.0
Middle-East,1,0.0
bakers,1,0.0
ARDs,1,0.0
proven-effective,1,0.0
nos2,1,0.0
MBP,1,0.0
800-ms,1,0.0
metionin,1,0.0
glycosites,1,0.0
IVRT,1,0.0
isovolumic,1,0.0
nMPFR,1,0.0
EiAi,1,0.0
nos1,1,0.0
adaption,1,0.0
Seizures,1,0.0
echo-Doppler,1,0.0
downgraded,1,0.0
socioeconomics,1,0.0
Case-control,1,0.0
BG,1,0.0
day-by-day,1,0.0
10-ml,1,0.0
Gallopamil,1,0.0
allelic,1,0.0
obligation,1,0.0
AATn-repeat,1,0.0
1-69,1,0.0
17-0,1,0.0
13-6,1,0.0
euphoria,1,0.0
measuredABSTRACT,1,0.0
arXiv,1,0.0
Arbeitsgemeinschaft,1,0.0
log-cubic,1,0.0
mycardial,1,0.0
Hazardous,1,0.0
AGI,1,0.0
SARS1,1,0.0
endogenously,1,0.0
150-250,1,0.0
158in,1,0.0
Abruzzo,1,0.0
202012,1,0.0
synthases,1,0.0
climacteric,1,0.0
Root-mean-square,1,0.0
12q,1,0.0
Lhasa,1,0.0
mucorales,1,0.0
thromoembolism,1,0.0
Cy5-Streptavidin-polysacharide,1,0.0
onsetoffset,1,0.0
logarithm,1,0.0
12q24,1,0.0
unfiltered,1,0.0
copious,1,0.0
measurements-RMSV,1,0.0
cardio-circulatory,1,0.0
HFAV-provide,1,0.0
strikes,1,0.0
Beijing3292-like,1,0.0
85230,1,0.0
75239,1,0.0
als,1,0.0
rations,1,0.0
hypothiocyanite,1,0.0
CambodiaVietnam,1,0.0
ODEs,1,0.0
pendrin,1,0.0
80-year-old,1,0.0
fluidics,1,0.0
pendrinSLC26A4,1,0.0
Arthritis,1,0.0
rheumatologist,1,0.0
Remitting,1,0.0
unidentifiable,1,0.0
fluctuate,1,0.0
4524,1,0.0
twelve-lead,1,0.0
mono-,1,0.0
Lambda-like,1,0.0
explants,1,0.0
strips,1,0.0
lipoxygenase,1,0.0
phospholid,1,0.0
rings,1,0.0
Photon,1,0.0
polypectomy,1,0.0
fibreoptic,1,0.0
inclination,1,0.0
subdivision,1,0.0
Stockpile,1,0.0
paranasal,1,0.0
UHPLC-MS-based,1,0.0
Converting,1,0.0
countervailing,1,0.0
DUOX,1,0.0
modulations,1,0.0
H2O2,1,0.0
non-toxic,1,0.0
S-glycoproteins,1,0.0
harmoniously,1,0.0
SARS-CoV-2ACE2,1,0.0
infectivitysusceptibility,1,0.0
nonwhites,1,0.0
Peroxidases,1,0.0
forecasted,1,0.0
antibody-detection,1,0.0
hydrophilicity,1,0.0
lumens,1,0.0
N405-419,1,0.0
3kg200,1,0.0
thiocyanate,1,0.0
N349-399,1,0.0
transports,1,0.0
Pendrin,1,0.0
RWMA,1,0.0
Apropos,1,0.0
N229-269,1,0.0
pendrinDUOXperoxidase,1,0.0
pre-dispensed,1,0.0
disease-derived,1,0.0
hyperinfection,1,0.0
humanizing,1,0.0
yearsABSTRACT,1,0.0
approving,1,0.0
correspondent,1,0.0
latex-induced,1,0.0
Contemporaneous,1,0.0
11-21,1,0.0
11-35,1,0.0
two-strain,1,0.0
monotonic,1,0.0
Lyapunov,1,0.0
3178,1,0.0
Heian,1,0.0
co-housed,1,0.0
Automation,1,0.0
lentiviruses,1,0.0
influenza--Asian,1,0.0
glucocorticoides,1,0.0
fluH2N2,1,0.0
93-like,1,0.0
helminthic,1,0.0
BBeijing184,1,0.0
vaccins,1,0.0
thiabendazole,1,0.0
determinating,1,0.0
BPanama4590-,1,0.0
1969-1979,1,0.0
17-21,1,0.0
auto-AIF,1,0.0
Quite,1,0.0
984-100,1,0.0
dichorionic,1,0.0
amenorrhea,1,0.0
1042,1,0.0
Myomo,1,0.0
ESRD,1,0.0
brace,1,0.0
electromyography-controlled,1,0.0
Mendelian,1,0.0
relook,1,0.0
polygeny,1,0.0
privates,1,0.0
apprentices,1,0.0
9622-9998,1,0.0
enlistment,1,0.0
9931,1,0.0
NPFS,1,0.0
144NEG,1,0.0
derives,1,0.0
juniors,1,0.0
triplex,1,0.0
saga,1,0.0
etiopathogenic,1,0.0
HAC,1,0.0
numerically,1,0.0
co-amplify,1,0.0
Latex,1,0.0
MEK12,1,0.0
1550,1,0.0
GATA3,1,0.0
210-6885,1,0.0
Director,1,0.0
GISSI-1,1,0.0
Business,1,0.0
Pericardial,1,0.0
Socio-Economics,1,0.0
owe,1,0.0
under-investigational,1,0.0
00025-001,1,0.0
thrombolytically,1,0.0
35-40,1,0.0
3265-3824,1,0.0
COVID-19Flatten,1,0.0
1144-1819,1,0.0
postreperfusion,1,0.0
SARS-CoV-antigen,1,0.0
Simplexa,1,0.0
2568,1,0.0
Fusion,1,0.0
BioRxiv,1,0.0
MedRxiv,1,0.0
multiply-mutated,1,0.0
overviews,1,0.0
Semaphorins,1,0.0
FLU-CIN,1,0.0
allergen-mast,1,0.0
foreshadow,1,0.0
reticularis,1,0.0
731-1222,1,0.0
destructively,1,0.0
owes,1,0.0
14F,1,0.0
ng,1,0.0
post-market,1,0.0
analgesic-induced,1,0.0
experimentations,1,0.0
30-fold,1,0.0
para-aminomethylbenzoic,1,0.0
pre-licensure,1,0.0
Ⅱ,1,0.0
wire,1,0.0
191-398,1,0.0
myoglobinemia,1,0.0
148-179,1,0.0
110-160,1,0.0
6-,1,0.0
807,1,0.0
arteriotomy,1,0.0
cut-down,1,0.0
Corornaviridae,1,0.0
guaranteeing,1,0.0
compliment,1,0.0
LCx,1,0.0
Emphysema,1,0.0
Rodent,1,0.0
Flu-like,1,0.0
AnginaNon-ST-Elevation,1,0.0
Non-ST-Segment,1,0.0
ciliated,1,0.0
T-lymphocyte,1,0.0
Endobronchial,1,0.0
DMEM,1,0.0
PMIS‐TS,1,0.0
delicately,1,0.0
Luis,1,0.0
perspective1,1,0.0
penicillin,1,0.0
unexplainably,1,0.0
UmL,1,0.0
PMIS‐TS2,1,0.0
high-confidence,1,0.0
hemorrhage-a,1,0.0
orf8,1,0.0
Zn2,1,0.0
chemoattractants,1,0.0
Ubiquitously,1,0.0
midget,1,0.0
metalloproteome,1,0.0
TICI,1,0.0
Bivalirudin,1,0.0
fibrin-bound,1,0.0
Likely,1,0.0
stent-first,1,0.0
synchronize,1,0.0
disperse,1,0.0
diffusively,1,0.0
stenosisocclusion,1,0.0
90thday,1,0.0
antifoam,1,0.0
Potosí,1,0.0
agebirth,1,0.0
dives,1,0.0
rast,1,0.0
Otherwise,1,0.0
hemagglutination-inhibiting,1,0.0
basophil,1,0.0
usher,1,0.0
initiations,1,0.0
anyway,1,0.0
dive,1,0.0
sufferred,1,0.0
counsel,1,0.0
Clinic10374,1,0.0
Hsw1n1,1,0.0
logged,1,0.0
Temporally,1,0.0
7-56,1,0.0
proportionately,1,0.0
postocclusion,1,0.0
Reverse-Transcription,1,0.0
Sham-operated,1,0.0
barred,1,0.0
nebulous,1,0.0
Mallineni,1,0.0
thrombohemorrhagic,1,0.0
unsubtypeable,1,0.0
Multi‐system,1,0.0
Cilazapril,1,0.0
SLTA,1,0.0
overstimulation,1,0.0
severitycontrol,1,0.0
near-universal,1,0.0
18400,1,0.0
vulgaris,1,0.0
Prunella,1,0.0
Tyuya-Ashu,1,0.0
misclassify,1,0.0
I-TASSER,1,0.0
Nonarteritic,1,0.0
Bobath,1,0.0
TM-align,1,0.0
relearn,1,0.0
perio,1,0.0
WISO,1,0.0
paramyxovirus,1,0.0
Tien,1,0.0
ARTIC,1,0.0
mid-left,1,0.0
customers,1,0.0
Presentation,1,0.0
demolition,1,0.0
MiSeq,1,0.0
Colombian,1,0.0
sheath,1,0.0
ECDC,1,0.0
Rx,1,0.0
judgements,1,0.0
four-stage,1,0.0
310000,1,0.0
Utilising,1,0.0
Silzone,1,0.0
Aluminum,1,0.0
SCoV-2-SP-PVs,1,0.0
60240,1,0.0
SPG614,1,0.0
10535,1,0.0
speeches,1,0.0
anti-vaccination,1,0.0
systolic-volume,1,0.0
ramping,1,0.0
1022,1,0.0
PCS9832,1,0.0
non-immunologic,1,0.0
55120,1,0.0
50110,1,0.0
Shan,1,0.0
lessened,1,0.0
3590,1,0.0
SpO2,1,0.0
AlCl3-induced,1,0.0
eye-position,1,0.0
3067,1,0.0
metazoans,1,0.0
BLASTP,1,0.0
Modest,1,0.0
Tmprss2,1,0.0
off-line,1,0.0
Favourable,1,0.0
critique,1,0.0
Uruguay,1,0.0
hemoglobinuria,1,0.0
IFN-αβ,1,0.0
LTV-1000,1,0.0
Efficient,1,0.0
sex-dependent,1,0.0
undisputable,1,0.0
pyrazinamide,1,0.0
recurrently,1,0.0
Anti-tuberculosis,1,0.0
orifice,1,0.0
nodular,1,0.0
whitish,1,0.0
acid-fast,1,0.0
T-birdVSO2,1,0.0
PSL,1,0.0
ironically,1,0.0
posited,1,0.0
32-93,1,0.0
turbine,1,0.0
1600-2000,1,0.0
bronchoconstrictory,1,0.0
founder,1,0.0
hemolytic,1,0.0
hemopoietic,1,0.0
PNH,1,0.0
3-48,1,0.0
CT-verification,1,0.0
glycolysis,1,0.0
available-ambiguous,1,0.0
PPCM,1,0.0
precipitins,1,0.0
pre-training,1,0.0
February-September,1,0.0
Penicullium,1,0.0
agro-industrial,1,0.0
PVE,1,0.0
departures,1,0.0
Czapek,1,0.0
paravalvular,1,0.0
Silzone-coated,1,0.0
Petri,1,0.0
diverting,1,0.0
minimizingself-confident,1,0.0
prostheses,1,0.0
on-time,1,0.0
and-if,1,0.0
ATTP,1,0.0
digitized,1,0.0
Paragangliomas,1,0.0
5-day-lasting,1,0.0
Cytotoxicity,1,0.0
redouble,1,0.0
invest,1,0.0
altitudes,1,0.0
physician-pharmacist,1,0.0
On-site,1,0.0
Vt,1,0.0
paragangliomas,1,0.0
TICI≥2b,1,0.0
prevails,1,0.0
displacements,1,0.0
ischemia-time,1,0.0
multi-strain,1,0.0
sarcomeric,1,0.0
Prof,1,0.0
Arnon,1,0.0
turn-around,1,0.0
Multimeric-001,1,0.0
asthmasports,1,0.0
M-001,1,0.0
GATA-4,1,0.0
phonotachooscillography,1,0.0
B-Type,1,0.0
Fas-mediated,1,0.0
neurointensivist,1,0.0
piling,1,0.0
First-pass,1,0.0
perfusion-,1,0.0
immunogenesis,1,0.0
Sandman,1,0.0
cine-,1,0.0
LE-,1,0.0
high-concentration,1,0.0
twenties,1,0.0
stouter,1,0.0
pain-to-balloon,1,0.0
water-clustered,1,0.0
pain-to-balloon-time,1,0.0
Francisella,1,0.0
httpsclamputheducovidloincphp,1,0.0
heart-specific,1,0.0
rule-based,1,0.0
non-selected,1,0.0
Disodium,1,0.0
21-year,1,0.0
Nonmotor,1,0.0
sickled,1,0.0
dilute,1,0.0
cell-driven,1,0.0
automating,1,0.0
dispelling,1,0.0
H19,1,0.0
hesitate,1,0.0
allege,1,0.0
CRISPRDx,1,0.0
Codes,1,0.0
hyperreagibility,1,0.0
longtime,1,0.0
LOINC,1,0.0
T716I,1,0.0
FnCas9,1,0.0
severety,1,0.0
non-cellular,1,0.0
Logical,1,0.0
Cas9,1,0.0
Identifiers,1,0.0
Names,1,0.0
novicida,1,0.0
macro,1,0.0
non-COVID-designated,1,0.0
Estimations,1,0.0
phosphoinositide,1,0.0
Lyn,1,0.0
alcoholic,1,0.0
PSE,1,0.0
non-cancer,1,0.0
outskirts,1,0.0
Lck,1,0.0
ZAP-70,1,0.0
Btk,1,0.0
Proportional,1,0.0
cleaning-related,1,0.0
FCepsilonR1,1,0.0
invokes,1,0.0
3-kinase,1,0.0
Tyrosine,1,0.0
P0010,1,0.0
factor-kappaB,1,0.0
installed,1,0.0
TOP-SNAb,1,0.0
125-920,1,0.0
silo,1,0.0
Inhibitors,1,0.0
grain,1,0.0
transcription-1,1,0.0
icSHAPE,1,0.0
refolded,1,0.0
0791-0908,1,0.0
platelet-derived,1,0.0
apoBapoA1,1,0.0
time-based,1,0.0
autochthonous,1,0.0
DALY,1,0.0
INTERHEART,1,0.0
Inhaler,1,0.0
mmHgs,1,0.0
6742,1,0.0
pa2000Mar5811-10,1,0.0
Functionally,1,0.0
subendothelium,1,0.0
4570,1,0.0
cell-rich,1,0.0
COronaVIrus,1,0.0
migrated,1,0.0
Morphologic,1,0.0
stigmasterol,1,0.0
couplets,1,0.0
15152,1,0.0
R-on-T,1,0.0
14820,1,0.0
Hemodyamics,1,0.0
106kg,1,0.0
Granulation,1,0.0
229E-infected,1,0.0
thicker,1,0.0
over-relying,1,0.0
Attributable,1,0.0
SARS-CoV-2-reactive,1,0.0
proof-of-efficacy,1,0.0
fuels,1,0.0
igniting,1,0.0
majorities,1,0.0
149632,1,0.0
101-120,1,0.0
Altmetrics,1,0.0
Sixty-second,1,0.0
SDQ,1,0.0
deflation,1,0.0
opposite-wall,1,0.0
cross-national,1,0.0
AIMS,1,0.0
intra-observer,1,0.0
5920,1,0.0
STUDY,1,0.0
informant,1,0.0
ambulance-administered,1,0.0
AH1N1AH1N1pdm09,1,0.0
re-emerge,1,0.0
Inter-observer,1,0.0
VM,1,0.0
inter-observer,1,0.0
QTac,1,0.0
Altmetric,1,0.0
Ta,1,0.0
Spasticity,1,0.0
TIV-vaccinated,1,0.0
hyperresponsivenss,1,0.0
Wp,1,0.0
Oxide,1,0.0
cross-resistance,1,0.0
lectin-F,1,0.0
genome-based,1,0.0
decays,1,0.0
walks,1,0.0
Stent-assisted,1,0.0
Lévy,1,0.0
algebraically,1,0.0
tails,1,0.0
hypoxemic,1,0.0
SARS-CoV-2-like,1,0.0
hypercarbic,1,0.0
two-parameter,1,0.0
Dix,1,0.0
interhuman,1,0.0
Orthomyxovirus,1,0.0
illiterate,1,0.0
counterfactual,1,0.0
NL2631-I223R,1,0.0
27-day,1,0.0
precluding,1,0.0
electricity,1,0.0
Neurology®,1,0.0
Karch,1,0.0
coal-fired,1,0.0
plexinD1,1,0.0
Thomas1,1,0.0
34907,1,0.0
l-thyroxine,1,0.0
Qr,1,0.0
unipolars,1,0.0
Lymphocytes,1,0.0
Already,1,0.0
bio-pathology,1,0.0
hypochondriac,1,0.0
semaphorin3EplexinD1,1,0.0
PEF-monitor,1,0.0
Embodied,1,0.0
selectins,1,0.0
NO-exchange,1,0.0
treatments-,1,0.0
personalitys,1,0.0
virus12,1,0.0
20H,1,0.0
importance3-5,1,0.0
unwise,1,0.0
stepsmin,1,0.0
Nelson,1,0.0
Mandela,1,0.0
data-which,1,0.0
MEF50-values,1,0.0
regions-suggest,1,0.0
RG,1,0.0
plausibly,1,0.0
multi-centre,1,0.0
food-hypersensitive,1,0.0
escape6-8,1,0.0
acupuncture-treated,1,0.0
Neuropeptides,1,0.0
folate,1,0.0
cadence,1,0.0
µs,1,0.0
direct-writing,1,0.0
p095,1,0.0
30000year,1,0.0
immunoglobulin-like,1,0.0
V4-V5,1,0.0
acid-binding,1,0.0
semaphorin,1,0.0
QTa,1,0.0
dynamometer,1,0.0
receptor-beta,1,0.0
15151738,1,0.0
621121,1,0.0
Sanborn,1,0.0
photographic,1,0.0
anxious-depressive,1,0.0
VR6,1,0.0
unipolar,1,0.0
ME,1,0.0
interauricular,1,0.0
Anterolateral,1,0.0
breakneck,1,0.0
beta-adrenoceptors,1,0.0
walked,1,0.0
ergotropic,1,0.0
bet,1,0.0
6-min,1,0.0
trophotropic,1,0.0
fibrillary,1,0.0
NF1,1,0.0
cardio-thoracic,1,0.0
418480,1,0.0
FXII-driven,1,0.0
GPVI,1,0.0
paved,1,0.0
45-6,1,0.0
LEW,1,0.0
electrically,1,0.0
anesthetized,1,0.0
IONM,1,0.0
LKW,1,0.0
IOS,1,0.0
129156,1,0.0
disproving,1,0.0
146164,1,0.0
408480,1,0.0
Hemopericardium,1,0.0
discontinuing,1,0.0
Age-stratified,1,0.0
-4-21,1,0.0
4-20,1,0.0
8-31,1,0.0
14-31,1,0.0
14282,1,0.0
unraveled,1,0.0
FXIIa,1,0.0
children-years,1,0.0
propanolol,1,0.0
transendocardial,1,0.0
LFHF,1,0.0
Propranolol,1,0.0
frequency-domain,1,0.0
Sympathovagal,1,0.0
propranolol-treated,1,0.0
log-normalized,1,0.0
infarctioncongestive,1,0.0
deathacute,1,0.0
25-month,1,0.0
BHAT,1,0.0
groundwork,1,0.0
Beta-blocker,1,0.0
BUT,1,0.0
P031,1,0.0
P051,1,0.0
P019,1,0.0
HERMES,1,0.0
IgG2,1,0.0
G2,1,0.0
anti-cytokine-based,1,0.0
antithrombosis,1,0.0
14562,1,0.0
28884,1,0.0
cryoinjured,1,0.0
p-value054,1,0.0
NS1-mediated,1,0.0
cleaves,1,0.0
Fludase,1,0.0
temper,1,0.0
cyclooxygenase,1,0.0
etanercept,1,0.0
effectivity,1,0.0
incredibly,1,0.0
038-188,1,0.0
Ose-R,1,0.0
oseltamivir-,1,0.0
resistance-causing,1,0.0
dose-response-inhibition,1,0.0
microvessel,1,0.0
epoxyeicosatrienoic,1,0.0
prostacyclin,1,0.0
bother,1,0.0
aggravations,1,0.0
1717,1,0.0
1418,1,0.0
1620,1,0.0
Pathophysiological,1,0.0
longtime-circulating,1,0.0
plugs,1,0.0
r085,1,0.0
5-yr,1,0.0
437-99,1,0.0
540-106,1,0.0
744-136,1,0.0
561-41,1,0.0
n6,1,0.0
antifibrinolytic,1,0.0
menorrhagia,1,0.0
dysmenorrhoea,1,0.0
ventilation-perfusion,1,0.0
hyperoxic,1,0.0
syndrome-associated,1,0.0
anti-leakage,1,0.0
vascularize,1,0.0
p0007,1,0.0
n545,1,0.0
1995-99,1,0.0
n453,1,0.0
1990-94,1,0.0
n439,1,0.0
1985-89,1,0.0
1437,1,0.0
15-year,1,0.0
affirmed,1,0.0
Cryoinjury-induced,1,0.0
thombus,1,0.0
percolation,1,0.0
relaxing,1,0.0
originally-designed,1,0.0
Robertson,1,0.0
MMPI,1,0.0
Sub-Scales,1,0.0
Edwards,1,0.0
totalling,1,0.0
seam,1,0.0
submicrosecond,1,0.0
curveABSTRACT,1,0.0
SIIR,1,0.0
Kanpur,1,0.0
Susceptible-Infected-Isolated-Recovered,1,0.0
two-layer,1,0.0
Susceptible-Infected-Recovered,1,0.0
Surgeons1,1,0.0
pp,1,0.0
thrombectomies,1,0.0
Alawieh,1,0.0
reprinted,1,0.0
placement5-7,1,0.0
post-thrombectomy,1,0.0
sence,1,0.0
value875,1,0.0
origin4,1,0.0
WA12020,1,0.0
buffalo,1,0.0
transplanting,1,0.0
httpsbitly3m8rjHL,1,0.0
uncontrollable,1,0.0
2019-CoV,1,0.0
ventriography,1,0.0
asthma-discordant,1,0.0
undiagnostic,1,0.0
SARS-CoV-like,1,0.0
RFN-ALFQ,1,0.0
Cross-neutralization,1,0.0
value686,1,0.0
21000,1,0.0
ALFQ,1,0.0
QS-21,1,0.0
Liposomal,1,0.0
multilingual,1,0.0
Diversity,1,0.0
midway,1,0.0
providers-implemented,1,0.0
HealthCare-one,1,0.0
reservations,1,0.0
portends,1,0.0
patients1-3,1,0.0
11-dioctadecyl-3333-tetramethylindocarbocyanine,1,0.0
sulfated,1,0.0
8-19,1,0.0
11-18,1,0.0
249-392,1,0.0
284-442,1,0.0
birthdateyear,1,0.0
data-sets,1,0.0
10481,1,0.0
Rico,1,0.0
Florida-Puerto,1,0.0
raceethnicsex-related,1,0.0
non-sulfated,1,0.0
clinically-significant,1,0.0
raceethnicitysex,1,0.0
electrotonic,1,0.0
engrafted,1,0.0
upstroke,1,0.0
shams,1,0.0
MSC-positive,1,0.0
connexin-43,1,0.0
DiI-positive,1,0.0
transients,1,0.0
percholate,1,0.0
11-minute,1,0.0
racialethnicsex,1,0.0
BAOs,1,0.0
€491,1,0.0
fluoroscopic,1,0.0
NTDs,1,0.0
Neglected,1,0.0
Malaria,1,0.0
renovating,1,0.0
Ethiopian,1,0.0
demography,1,0.0
xenosorption,1,0.0
charcoals,1,0.0
Per,1,0.0
€570,1,0.0
EMS-related,1,0.0
Latest,1,0.0
cardioverter-defibrillators,1,0.0
3-45-hour,1,0.0
RHW,1,0.0
CPN,1,0.0
clients,1,0.0
grants,1,0.0
solves,1,0.0
lifecycle,1,0.0
lengthy,1,0.0
nosologic,1,0.0
nonsignificantly,1,0.0
Hajj--the,1,0.0
HiNI,1,0.0
commissurotomy,1,0.0
trans-septal,1,0.0
high-conservative,1,0.0
DNA-probes,1,0.0
DNA-copies,1,0.0
prepathological,1,0.0
McFee,1,0.0
post-ligation,1,0.0
difference-vectors,1,0.0
BShanghai36102,1,0.0
H3N2-virus,1,0.0
3CL,1,0.0
influenza-A,1,0.0
Delaying,1,0.0
Carefully,1,0.0
non-steroidal,1,0.0
Miltenyi,1,0.0
Lambda,1,0.0
Linearity,1,0.0
automatized,1,0.0
anti-severe,1,0.0
antihyperlipidemic,1,0.0
PTMC-related,1,0.0
invariant,1,0.0
Carrageenan,1,0.0
tubing,1,0.0
Lith-Gly,1,0.0
abiotic,1,0.0
2711,1,0.0
1243,1,0.0
buildings,1,0.0
non-residential,1,0.0
occupants,1,0.0
PC20-MCH,1,0.0
MCH,1,0.0
two-way,1,0.0
nebulizer,1,0.0
nonuniversity,1,0.0
09-fold,1,0.0
Hyperosmotic,1,0.0
thymomas,1,0.0
VATS,1,0.0
video-thoracoscopic,1,0.0
subxiphoid-right,1,0.0
thymectomy,1,0.0
cross-cultural,1,0.0
Intuitively,1,0.0
nationalcultural,1,0.0
recommendable,1,0.0
IBVs,1,0.0
cold-increased,1,0.0
12-30,1,0.0
mammalian-adapted,1,0.0
25-30,1,0.0
auxological,1,0.0
AGuangzhou33399,1,0.0
BBeijing18493-like,1,0.0
ABeijing26295,1,0.0
distinguishable,1,0.0
1989-1999,1,0.0
30-80,1,0.0
γ,1,0.0
θ,1,0.0
interleukin-17,1,0.0
δ,1,0.0
resonate,1,0.0
deteriorations,1,0.0
arithmetic-pulmonary,1,0.0
10-minute,1,0.0
Speed,1,0.0
Processing,1,0.0
Slowed,1,0.0
nonexistense,1,0.0
UAEs,1,0.0
tropicity,1,0.0
non-Th2-driven,1,0.0
dance,1,0.0
Hilbert-Huang,1,0.0
Cheonan,1,0.0
38-fold,1,0.0
twenty-,1,0.0
miR-133b,1,0.0
miR-133a,1,0.0
bronchitic,1,0.0
emphysematous,1,0.0
Riesz,1,0.0
Hilbert,1,0.0
decomposition,1,0.0
Decomposition,1,0.0
Accelerated,1,0.0
DEMPOT,1,0.0
corrupted,1,0.0
Gadolinium,1,0.0
Quantification,1,0.0
reexploration,1,0.0
hyperfibrinolysis,1,0.0
1453,1,0.0
graftspatient,1,0.0
triple-vessel,1,0.0
paper-sharing,1,0.0
cold-induced,1,0.0
lithocholicglycine,1,0.0
GraphPad,1,0.0
anti-immunoglobulins,1,0.0
Centro,1,0.0
Especialidades,1,0.0
tuberculoma,1,0.0
antibiotherapy,1,0.0
13-month-old,1,0.0
arachnoiditis,1,0.0
Tuberculous,1,0.0
ABayern795,1,0.0
ASydney597,1,0.0
Except,1,0.0
assesing,1,0.0
Nacional,1,0.0
mannitol-induced,1,0.0
HUCB,1,0.0
10003,1,0.0
prn,1,0.0
pretreat,1,0.0
lunchtime,1,0.0
CC50EC50,1,0.0
137370,1,0.0
Gilgit-Baltistan,1,0.0
Pakhtunkhwa,1,0.0
Médico,1,0.0
Siglo,1,0.0
coronavirus-associated,1,0.0
v902,1,0.0
2115,1,0.0
No-Surgery-On-Site,1,0.0
PAMI-2,1,0.0
2148,1,0.0
Prism,1,0.0
Forecasts,1,0.0
stochastically,1,0.0
SEIRS,1,0.0
attacked,1,0.0
Subject,1,0.0
Melody,1,0.0
EMIP,1,0.0
descendent,1,0.0
Driven,1,0.0
shops,1,0.0
inequivalence,1,0.0
premortem,1,0.0
pitfalls©RSNA,1,0.0
source-image,1,0.0
multiphase,1,0.0
pearls,1,0.0
EEC,1,0.0
Khyber,1,0.0
Pakistans,1,0.0
sialyl-N-acetyl-D-lactosamines,1,0.0
Iota,1,0.0
v1,1,0.0
Langendorff,1,0.0
Biosoft,1,0.0
coaches,1,0.0
amateur,1,0.0
decaris,1,0.0
levamisole,1,0.0
05-136,1,0.0
post-CAR-T,1,0.0
Lymphopenia,1,0.0
Donors,1,0.0
1909,1,0.0
Myeloablative,1,0.0
post-HCTCAR-T,1,0.0
Armonk,1,0.0
Kansas,1,0.0
600000,1,0.0
0599,1,0.0
-0229,1,0.0
0249,1,0.0
technetium-99m-sestamibi,1,0.0
α-26-sialyl,1,0.0
1316,1,0.0
Emax,1,0.0
RT-fluorescence,1,0.0
Rinite,1,0.0
mass-screening,1,0.0
gallbladder,1,0.0
culture-negative,1,0.0
ceftriaxone,1,0.0
vancomycin,1,0.0
antagonistic,1,0.0
Nonbacterial,1,0.0
BahiaProAR,1,0.0
na,1,0.0
Alérgica,1,0.0
Asma,1,0.0
micro-alterations,1,0.0
Controle,1,0.0
para,1,0.0
Programa,1,0.0
scalings,1,0.0
0242,1,0.0
003-063,1,0.0
Preintervention,1,0.0
monoplane,1,0.0
ABethesdaMM1H3N2,1,0.0
CalcuSyn,1,0.0
bulla,1,0.0
Arabia--is,1,0.0
gRNA,1,0.0
14·3-22·2,1,0.0
Varying,1,0.0
fraught,1,0.0
inter-contact,1,0.0
spreaders,1,0.0
Swab-negative,1,0.0
Influence,1,0.0
Lankan,1,0.0
remodel-ing,1,0.0
7·1-9·1,1,0.0
7·4-9·1,1,0.0
0·5-1·5,1,0.0
Deficiency,1,0.0
7·5-26·0,1,0.0
16·8-45·3,1,0.0
donate,1,0.0
self-interest,1,0.0
Susceptible-Infected-Removed,1,0.0
domestic-only,1,0.0
interferon-inducible,1,0.0
unconfirmed,1,0.0
replicase,1,0.0
mutation-prone,1,0.0
oxidativeantioxidative,1,0.0
supplementing,1,0.0
discredited,1,0.0
patient-physician,1,0.0
Shenyang,1,0.0
1793,1,0.0
all-stroke,1,0.0
13-163,1,0.0
27-578,1,0.0
14-89,1,0.0
17-224,1,0.0
Misery,1,0.0
non-disabled,1,0.0
simplifies,1,0.0
one-sided,1,0.0
oral-fecal,1,0.0
parenthood,1,0.0
memorable,1,0.0
repolarizing,1,0.0
Mycoplasms,1,0.0
Chlamydiae,1,0.0
colonizations,1,0.0
influenzaparainfluenza,1,0.0
GAMES-II,1,0.0
decision-support,1,0.0
hepatology,1,0.0
more-effective,1,0.0
checkpoints,1,0.0
multi-factor,1,0.0
jelen,1,0.0
ECV,1,0.0
8-24,1,0.0
af,1,0.0
bas,1,0.0
myocardium-related,1,0.0
6748,1,0.0
Darussalam,1,0.0
Belait,1,0.0
bloody,1,0.0
állása,1,0.0
tudomány,1,0.0
vespid,1,0.0
szempontjait,1,0.0
értékelésük,1,0.0
szerepét,1,0.0
helyét,1,0.0
azok,1,0.0
módszereket,1,0.0
használatos,1,0.0
gyakorlatban,1,0.0
irányuló,1,0.0
vizsgálatára,1,0.0
osteophyte,1,0.0
QSARs,1,0.0
protein-RNA,1,0.0
MANOVA,1,0.0
subclades,1,0.0
33306989,1,0.0
202139799-111,1,0.0
Madhi,1,0.0
Clemens,1,0.0
Voysey,1,0.0
agreeI,1,0.0
sub-dimension,1,0.0
nursemidwife,1,0.0
1426,1,0.0
double-effect,1,0.0
ideality,1,0.0
doctrine,1,0.0
malefic,1,0.0
Childress,1,0.0
Beauchamp,1,0.0
suspend,1,0.0
IP-10CXCL10,1,0.0
interleukin-15,1,0.0
NCT04743388,1,0.0
PfizerBioNtech,1,0.0
Dissecting,1,0.0
3726,1,0.0
non-conditional,1,0.0
immunválaszának,1,0.0
theirtheir,1,0.0
RFT,1,0.0
nonhemorrhagic,1,0.0
ineffectiveness,1,0.0
underutilised,1,0.0
Ad5,1,0.0
havent,1,0.0
SARS-Spike,1,0.0
ad5,1,0.0
Gam-COVID-Vac,1,0.0
lever,1,0.0
1004,1,0.0
3643,1,0.0
12-17,1,0.0
2186,1,0.0
60682,1,0.0
∼11,1,0.0
AAQOL-D,1,0.0
revalidation,1,0.0
multi,1,0.0
PA-409N,1,0.0
PA-356R,1,0.0
NS1-42S,1,0.0
4043,1,0.0
2528,1,0.0
ITE,1,0.0
23148,1,0.0
purporting,1,0.0
slide,1,0.0
environment-specific,1,0.0
abridged,1,0.0
zinc-SOD,1,0.0
antigen-sensitized,1,0.0
Cu-chelating,1,0.0
diethyldithiocarbamate,1,0.0
engender,1,0.0
10148,1,0.0
well-circumscribed,1,0.0
stuff,1,0.0
Mucoid,1,0.0
11-item,1,0.0
Subarachnoid,1,0.0
stabilising,1,0.0
enzyme-based,1,0.0
tag,1,0.0
signal-on,1,0.0
pathophysiologies,1,0.0
Ji-Ji,1,0.0
benefit-to-risk,1,0.0
M2-31N,1,0.0
absented,1,0.0
2874,1,0.0
85∙2,1,0.0
05–6,1,0.0
053–129,1,0.0
1–6,1,0.0
196–625,1,0.0
215–1562,1,0.0
1990–1993,1,0.0
7546,1,0.0
gradation,1,0.0
anaes,1,0.0
beta2-mimetics,1,0.0
1454,1,0.0
replenished,1,0.0
mysteries,1,0.0
Unlocking,1,0.0
IFN-α,1,0.0
Normally,1,0.0
1334-2684,1,0.0
1893,1,0.0
1297-2120,1,0.0
1658,1,0.0
1047-2154,1,0.0
1502,1,0.0
first-in-first-out,1,0.0
merchandising,1,0.0
62-64,1,0.0
wordsphrases,1,0.0
glycosylated,1,0.0
Q226L,1,0.0
H183N,1,0.0
GLF,1,0.0
↓,1,0.0
PSRSSR,1,0.0
F98-like,1,0.0
G197-like,1,0.0
BJ94-like,1,0.0
Mega,1,0.0
31-52,1,0.0
reservoir-εs,1,0.0
urbanrural,1,0.0
log-log,1,0.0
occupation-based,1,0.0
30-59,1,0.0
SD-TPS,1,0.0
PAF-patients,1,0.0
SD-T2P,1,0.0
time-to-peak,1,0.0
contraction-strain,1,0.0
conduit-εe,1,0.0
szerológiai,1,0.0
specifikus,1,0.0
Consultants,1,0.0
situational,1,0.0
clottingembolism,1,0.0
CSSR,1,0.0
lumen--the,1,0.0
administration--10,1,0.0
Reocclusions,1,0.0
complications--16,1,0.0
treatment--thrombi,1,0.0
vasodilatating,1,0.0
superselective,1,0.0
foregut,1,0.0
stereotype,1,0.0
cerebro-vasculature,1,0.0
crystallinity,1,0.0
home-use,1,0.0
multisensors,1,0.0
self-life,1,0.0
EpiSims,1,0.0
lobbies,1,0.0
antivaccination,1,0.0
vii,1,0.0
vi,1,0.0
wreaked,1,0.0
overreactivity,1,0.0
auto-regulatory,1,0.0
retrotracheal,1,0.0
680607,1,0.0
CEACAM5,1,0.0
KRT6A,1,0.0
CD44,1,0.0
-75,1,0.0
-87,1,0.0
1847,1,0.0
2405,1,0.0
2104,1,0.0
2827,1,0.0
609359,1,0.0
Adjustments,1,0.0
Admitting,1,0.0
1997-2006,1,0.0
time-trend,1,0.0
elastin-derived,1,0.0
Pollinex,1,0.0
post-hyposensitized,1,0.0
case-specific,1,0.0
nitromapping,1,0.0
arterila,1,0.0
HG,1,0.0
self-admission,1,0.0
regain,1,0.0
1SD,1,0.0
MUC5B,1,0.0
Anti-influenza,1,0.0
endo-,1,0.0
deglycosylation,1,0.0
CD11c,1,0.0
Cocultivation,1,0.0
glycovariants,1,0.0
PR834,1,0.0
interruptions,1,0.0
double-dose,1,0.0
evidence-supported,1,0.0
Mossad,1,0.0
Summarizing,1,0.0
HA-specific,1,0.0
accessories,1,0.0
batching,1,0.0
UFO,1,0.0
-041,1,0.0
Lanzhou,1,0.0
engages,1,0.0
person-centred,1,0.0
SCOHP,1,0.0
Carer,1,0.0
Imperial,1,0.0
exoglycosidases,1,0.0
line-based,1,0.0
L-1,1,0.0
SRS-A,1,0.0
H2O,1,0.0
32-40,1,0.0
cycled,1,0.0
arcane,1,0.0
medical-scientific,1,0.0
instruct,1,0.0
mercurialization,1,0.0
News,1,0.0
work-out,1,0.0
LTD4,1,0.0
Substance,1,0.0
forty-four,1,0.0
Reacting,1,0.0
Slow,1,0.0
H5N1-M2e,1,0.0
M2e-MAP,1,0.0
H5N1-M2e-MAP,1,0.0
M2e,1,0.0
tetra-branched,1,0.0
disciplining,1,0.0
family-specific,1,0.0
familys,1,0.0
LTF,1,0.0
IL-413,1,0.0
immunrendszer,1,0.0
háttérbe,1,0.0
vizsgálatok,1,0.0
diagnosztikai,1,0.0
megküzdésnek,1,0.0
való,1,0.0
pandémiával,1,0.0
része,1,0.0
elengedhetetlen,1,0.0
sürgető,1,0.0
felfrissítésük,1,0.0
szorultak,1,0.0
szakterületen,1,0.0
eszközei,1,0.0
számos,1,0.0
folyamán,1,0.0
idők,1,0.0
vakcináció,1,0.0
körű,1,0.0
széles,1,0.0
sikeressége,1,0.0
megoldások,1,0.0
terápiás,1,0.0
antimikrobás,1,0.0
fontos,1,0.0
járvány,1,0.0
kapcsolatos,1,0.0
cikkünk,1,0.0
kimutatására,1,0.0
koronavírus-2,1,0.0
okozó,1,0.0
szindrómát,1,0.0
légzőszervi,1,0.0
súlyos,1,0.0
foglalja,1,0.0
számára,1,0.0
gyakorlat,1,0.0
orvosi,1,0.0
Jelen,1,0.0
megfékezésének,1,0.0
véleményalkotáshoz,1,0.0
gyógyászati,1,0.0
korrekt,1,0.0
szükséges,1,0.0
elengedhetetlenül,1,0.0
megértése,1,0.0
interakciójának,1,0.0
szervezet,1,0.0
emberi,1,0.0
azonban,1,0.0
ismeretek,1,0.0
betegségekkel,1,0.0
HIF-1α,1,0.0
medium-term,1,0.0
Karcioglu,1,0.0
strokeSerinken,1,0.0
non-psychiatric,1,0.0
pathology-mostly,1,0.0
under-educated,1,0.0
somatoform,1,0.0
Conversion,1,0.0
2593,1,0.0
451,1,0.0
5023,1,0.0
non-permanent,1,0.0
2018334451-453,1,0.0
non-tuberculosis,1,0.0
BCG-based,1,0.0
lower-middle-income,1,0.0
low-and,1,0.0
Calmette-Guerin,1,0.0
Bacille,1,0.0
boldine,1,0.0
lomefloxacin,1,0.0
polyphenol,1,0.0
FOXA1,1,0.0
Prehosp,1,0.0
boundary-value,1,0.0
fertőző,1,0.0
laboratóriumokat,1,0.0
immunológiai,1,0.0
világában,1,0.0
specializált,1,0.0
orvostudomány,1,0.0
kollégákat,1,0.0
dolgozó,1,0.0
klinikumban,1,0.0
interpretálásában,1,0.0
eredmények,1,0.0
hanem,1,0.0
mikrobiológiai,1,0.0
backstepping,1,0.0
nemcsak,1,0.0
állította,1,0.0
elé,1,0.0
kihívás,1,0.0
komoly,1,0.0
COVID-19-pandémia,1,0.0
koronavírus-betegség,1,0.0
Antigen-detection,1,0.0
expended,1,0.0
monograph,1,0.0
17454250,1,0.0
vaccine-manufacturing,1,0.0
anti-Asian,1,0.0
zero-amplitude,1,0.0
Magnetoperiodic,1,0.0
extraterrestrial,1,0.0
quindecadal,1,0.0
cosinor,1,0.0
loosely,1,0.0
unqualified,1,0.0
magnetoperiodisms,1,0.0
transyear,1,0.0
rejected,1,0.0
no-rhythm,1,0.0
polynomials,1,0.0
plea,1,0.0
second-order,1,0.0
first-,1,0.0
detrending,1,0.0
year--transyears--reported,1,0.0
Spectral,1,0.0
6094,1,0.0
kindly,1,0.0
Yaneng,1,0.0
Liferiver,1,0.0
Daan,1,0.0
Arkansas,1,0.0
natality,1,0.0
0180,1,0.0
Ulcerative,1,0.0
4915-27174,1,0.0
18491-95390,1,0.0
114192-624435,1,0.0
Extrapolated,1,0.0
38-83,1,0.0
24-45,1,0.0
17-29,1,0.0
under-detected,1,0.0
over-estimate,1,0.0
99mTechnetium,1,0.0
EuroQol,1,0.0
unexploited,1,0.0
bei,1,0.0
Lebensqualität,1,0.0
zur,1,0.0
Fragebogen,1,0.0
FLA,1,0.0
baselines,1,0.0
imaginary,1,0.0
fiction,1,0.0
fore,1,0.0
treasure,1,0.0
Genekey,1,0.0
0898,1,0.0
71-85,1,0.0
horseness,1,0.0
texture-feature,1,0.0
denoising,1,0.0
leaky,1,0.0
household-to-household,1,0.0
hemosiderin,1,0.0
Gradient-echo,1,0.0
flexibly,1,0.0
physiotheraphy,1,0.0
rhonchi,1,0.0
polyphonic,1,0.0
therapyCorticosteroids,1,0.0
remarks,1,0.0
overinflation,1,0.0
clade-defining,1,0.0
20C,1,0.0
Importations,1,0.0
turnover,1,0.0
NSP16,1,0.0
NSP15,1,0.0
NSP14,1,0.0
NSP12,1,0.0
NSP5,1,0.0
plaque-motion,1,0.0
cCT,1,0.0
0441,1,0.0
compatibility,1,0.0
0852,1,0.0
0696,1,0.0
0658,1,0.0
over-estimation,1,0.0
pain-relieving,1,0.0
Over-estimation,1,0.0
over-estimated,1,0.0
under-estimated,1,0.0
0-10,1,0.0
Sahlgrens,1,0.0
cost-effectively,1,0.0
2D-ECHO,1,0.0
nL-range,1,0.0
end-points,1,0.0
4608,1,0.0
Fluidigm,1,0.0
nanofluidic,1,0.0
1600-h,1,0.0
non-nocturnal,1,0.0
disfunction,1,0.0
expanders,1,0.0
angiocardiography,1,0.0
54-70,1,0.0
multipliers,1,0.0
Benin,1,0.0
foaming,1,0.0
RNAscope,1,0.0
horizonWe,1,0.0
illnessesAccurate,1,0.0
26-March,1,0.0
ADO,1,0.0
MFC,1,0.0
multifunction,1,0.0
Auto,1,0.0
kinematics,1,0.0
azobisformamide,1,0.0
Azobisformamide,1,0.0
collation,1,0.0
nmolmLmin,1,0.0
granulomas,1,0.0
sarcoid-type,1,0.0
noncaseating,1,0.0
hilar,1,0.0
breathsmin,1,0.0
10565,1,0.0
38°C,1,0.0
Bell,1,0.0
patientdied,1,0.0
receptorOverall,1,0.0
NeuroFlo,1,0.0
Excision,1,0.0
NexStent,1,0.0
Data-driven,1,0.0
Gadchiroli,1,0.0
Urine,1,0.0
anticoagulate,1,0.0
cyclophosphamide,1,0.0
Coumadin,1,0.0
sediment,1,0.0
KIDIGO,1,0.0
Cupertino,1,0.0
EndoTex,1,0.0
sheet,1,0.0
SENTIS,1,0.0
coiled,1,0.0
Adaptation,1,0.0
CCSF,1,0.0
WAA,1,0.0
E2,1,0.0
1-phosphate,1,0.0
sphingosine,1,0.0
angiopoietin-like,1,0.0
vasculotide,1,0.0
alveolar-capillary,1,0.0
suturing,1,0.0
prolapsing,1,0.0
ReperfusionOcclusion,1,0.0
mixed-breed,1,0.0
immersed,1,0.0
IgG-HPR,1,0.0
Ni2,1,0.0
6xHis-tagged,1,0.0
alarms,1,0.0
high-fidelity,1,0.0
pathophysiologically,1,0.0
dioctophymosis,1,0.0
nephrectomy,1,0.0
celiotomy,1,0.0
parasitizing,1,0.0
Bead,1,0.0
Dioctophyme,1,0.0
nematode,1,0.0
Dioctophymosis,1,0.0
urgentists,1,0.0
intensivists,1,0.0
Interdisciplinary,1,0.0
RV1-V420,1,0.0
Precordial,1,0.0
pathoanatomical,1,0.0
HERO-1,1,0.0
HPR,1,0.0
6xHis,1,0.0
twisted,1,0.0
Mothers,1,0.0
loin,1,0.0
Semmelweis,1,0.0
Editorial,1,0.0
Transplacental,1,0.0
CANCOVID-Preg,1,0.0
SONPM,1,0.0
Neonatal-Perinatal,1,0.0
PAN-COVID,1,0.0
COVI-PREG,1,0.0
SET-NET,1,0.0
factor-β,1,0.0
tagged,1,0.0
infiltrating,1,0.0
Clearance,1,0.0
alarmins,1,0.0
heals,1,0.0
Mitochondrial,1,0.0
hypercholesterolemic,1,0.0
Pravastatin,1,0.0
nonsterol,1,0.0
diabetes-induced,1,0.0
amyloid-beta,1,0.0
shut,1,0.0
segmentsABSTRACT,1,0.0
geneticists,1,0.0
NAASSP,1,0.0
1226,1,0.0
contra-indication,1,0.0
chronobiological,1,0.0
low1,1,0.0
Strait,1,0.0
Torres,1,0.0
5085,1,0.0
37755,1,0.0
2721,1,0.0
59000,1,0.0
nonasthma-associated,1,0.0
CTCT,1,0.0
AASSP,1,0.0
robots,1,0.0
3097,1,0.0
0543,1,0.0
Resin,1,0.0
Chelex©,1,0.0
Mucolyse™,1,0.0
GII4,1,0.0
Norovirus,1,0.0
ectopy,1,0.0
breast-fed,1,0.0
nightclub,1,0.0
Kissler,1,0.0
93-95,1,0.0
15-32,1,0.0
27-42,1,0.0
51-57,1,0.0
n78,1,0.0
40-41,1,0.0
n81,1,0.0
eGFR30,1,0.0
57-61,1,0.0
n722,1,0.0
eGFR≥90,1,0.0
NCT02060760,1,0.0
penumbra-modifying,1,0.0
1555,1,0.0
30-,1,0.0
cTn,1,0.0
HGS,1,0.0
grip,1,0.0
violation,1,0.0
non-certified,1,0.0
certifies,1,0.0
Restrictive,1,0.0
hips,1,0.0
calcium-entry,1,0.0
Susceptible-Exposed-Infected-Recovered,1,0.0
ordinances,1,0.0
IFNϒ,1,0.0
”,1,0.0
“Cutaneous,1,0.0
stricken,1,0.0
dip,1,0.0
luteal,1,0.0
sex-steroid,1,0.0
piecing,1,0.0
nanotechnologys,1,0.0
Nanoparticles,1,0.0
ACE2-mediated,1,0.0
reignited,1,0.0
Do,1,0.0
1930s,1,0.0
multi-sectoral,1,0.0
disaggregation,1,0.0
intersectionality-informed,1,0.0
multigenerational,1,0.0
co-residence,1,0.0
non-clinical,1,0.0
unaddressed,1,0.0
racialized,1,0.0
conditions-lead,1,0.0
Recalcati,1,0.0
Continue,1,0.0
onoff,1,0.0
recuperation,1,0.0
counter-intuitive,1,0.0
grid,1,0.0
linearization,1,0.0
brute-force,1,0.0
beverages,1,0.0
preception,1,0.0
0-72,1,0.0
puffsday,1,0.0
harbour,1,0.0
Aquatic,1,0.0
reconditioning,1,0.0
pandemic-preparedness,1,0.0
gradings,1,0.0
Naughton,1,0.0
QA,1,0.0
daylong,1,0.0
Crt,1,0.0
3638,1,0.0
3648,1,0.0
4359,1,0.0
4572,1,0.0
Participant,1,0.0
rule-in,1,0.0
1427,1,0.0
volume-overload,1,0.0
102-172,1,0.0
Psychosomatic,1,0.0
delipidated,1,0.0
0001ABSTRACT,1,0.0
2928,1,0.0
7729,1,0.0
1199,1,0.0
0328,1,0.0
061-434,1,0.0
136-1644,1,0.0
106-1651,1,0.0
152-2088,1,0.0
congresses,1,0.0
158-1679,1,0.0
178-4705,1,0.0
CI110-7276,1,0.0
133-847,1,0.0
CI139-3066,1,0.0
post-DH,1,0.0
1624,1,0.0
COVID-19IMPORTANCE,1,0.0
large-territory,1,0.0
OBJECT,1,0.0
16th,1,0.0
dedication,1,0.0
geneticsgene-environment,1,0.0
non-specialists,1,0.0
Dilatation,1,0.0
CoV2,1,0.0
catch-up,1,0.0
pre-adolescent,1,0.0
hour--of,1,0.0
min--the,1,0.0
variably,1,0.0
NSMOH,1,0.0
MOH,1,0.0
specialist-in-training,1,0.0
NS-GP,1,0.0
scenes,1,0.0
respondent-defined,1,0.0
797,1,0.0
nonthoracic,1,0.0
time-outcome,1,0.0
precharacterised,1,0.0
My,1,0.0
Bio,1,0.0
Fluarix,1,0.0
poster,1,0.0
headquarters,1,0.0
interventionpreventiontherapeutics,1,0.0
9-10,1,0.0
2946,1,0.0
iCAALL,1,0.0
12-,1,0.0
1403,1,0.0
elliptical,1,0.0
patchplasty,1,0.0
endoventricular,1,0.0
Aneurysm,1,0.0
fine-tune,1,0.0
commenting,1,0.0
ICON,1,0.0
WAO,1,0.0
86-100,1,0.0
self-measured,1,0.0
post-symptoms,1,0.0
89-99,1,0.0
81-98,1,0.0
79-97,1,0.0
ECLIA,1,0.0
electro-chemiluminescence,1,0.0
CoronaCheck,1,0.0
Simtomax®,1,0.0
phenotype-targeted,1,0.0
ascribe,1,0.0
HASI,1,0.0
AASI,1,0.0
2152,1,0.0
19-item,1,0.0
2043,1,0.0
laborious,1,0.0
bronchoconstructive,1,0.0
12-25,1,0.0
40-72,1,0.0
ATS-DLD,1,0.0
salons,1,0.0
Inhalative,1,0.0
029-084,1,0.0
075-092,1,0.0
Pamplona,1,0.0
0661,1,0.0
8087,1,0.0
video-survey,1,0.0
broad-acting,1,0.0
coronavirus-2019,1,0.0
asystolia,1,0.0
temporal-spatial,1,0.0
013×10-2,1,0.0
127×10-2,1,0.0
mid-April,1,0.0
1331,1,0.0
Iterative,1,0.0
mechanism-based,1,0.0
phonological,1,0.0
9796,1,0.0
2363,1,0.0
193455,1,0.0
213818,1,0.0
hyperkalamia,1,0.0
hypokalamia,1,0.0
Hyponatremia,1,0.0
839,1,0.0
10027,1,0.0
13508,1,0.0
1674,1,0.0
13618,1,0.0
122181,1,0.0
1089,1,0.0
1062,1,0.0
1584,1,0.0
5989,1,0.0
1597,1,0.0
6080,1,0.0
2138,1,0.0
234180,1,0.0
6109,1,0.0
23418,1,0.0
552722,1,0.0
3545,1,0.0
conjures,1,0.0
infarctions-whether,1,0.0
reclaim,1,0.0
biodiversity,1,0.0
pollutions,1,0.0
livestockpet,1,0.0
SARS-CoV-2-has,1,0.0
bat-termed,1,0.0
coronavirus-strain,1,0.0
myocardials,1,0.0
clinical-autoptical,1,0.0
hospital-is,1,0.0
anti-alergic,1,0.0
3360,1,0.0
exercise-iduced,1,0.0
isoetherine,1,0.0
7-17,1,0.0
sgRNA,1,0.0
95-fold,1,0.0
18327,1,0.0
2240,1,0.0
5560,1,0.0
1323,1,0.0
20364,1,0.0
295272,1,0.0
Life-style,1,0.0
AIQP,1,0.0
antigen-induced,1,0.0
2008–10,1,0.0
2003–06,1,0.0
1968-1980,1,0.0
amphotericin,1,0.0
liposomal,1,0.0
leishmaniasis,1,0.0
Leishmania,1,0.0
45-month-old,1,0.0
multiple-gated,1,0.0
mms,1,0.0
mast-cell,1,0.0
34–44,1,0.0
dispositional,1,0.0
motivations,1,0.0
Promoting,1,0.0
2092-354706,1,0.0
27242,1,0.0
Multinomial,1,0.0
HCoV-HKU1,1,0.0
pre-existent,1,0.0
09-35,1,0.0
11-22,1,0.0
37–45,1,0.0
7–30,1,0.0
impactboth,1,0.0
Eschar,1,0.0
647,1,0.0
882,1,0.0
infraction,1,0.0
Particulate,1,0.0
LIMIT,1,0.0
dorsi,1,0.0
latissimus,1,0.0
nephritis,1,0.0
Henoch-Schonlein,1,0.0
denatured,1,0.0
fistulas,1,0.0
49–67,1,0.0
xeno-acellular,1,0.0
7th-10th,1,0.0
Fracture,1,0.0
full-thickness,1,0.0
20TBSA,1,0.0
high-voltage,1,0.0
EU-25,1,0.0
WHA,1,0.0
17–34,1,0.0
18–65,1,0.0
intra-QRS,1,0.0
sake,1,0.0
group-matched,1,0.0
pneumoniainfluenza-,1,0.0
unfulfilled,1,0.0
biorisk,1,0.0
lapse,1,0.0
H5N1virus,1,0.0
86∙6100000,1,0.0
10∙0100000,1,0.0
pneumoniainfluenza-coded,1,0.0
9∙2100000,1,0.0
1∙4100000,1,0.0
73∙5,1,0.0
Serfling,1,0.0
20132014,1,0.0
SPARCL,1,0.0
anti-IL-2,1,0.0
Addition,1,0.0
cytokine-induced,1,0.0
hydrocortisone,1,0.0
ragweed-allergic,1,0.0
unassociated,1,0.0
COVID-19SARS-CoV-2,1,0.0
frontiers,1,0.0
signifies,1,0.0
bioethical,1,0.0
Zhoushan,1,0.0
pretending,1,0.0
Crete,1,0.0
grammar,1,0.0
lexical,1,0.0
13-year-old,1,0.0
broncho-alveolar,1,0.0
standardWe,1,0.0
resource-rich,1,0.0
enhancer,1,0.0
self-quarantines,1,0.0
autistic,1,0.0
hesitated,1,0.0
FINMONICA,1,0.0
traveler,1,0.0
causes-of-death,1,0.0
QRS-complexes,1,0.0
ST-,1,0.0
schoolchildren-based,1,0.0
428-449,1,0.0
213-223,1,0.0
178669333892,1,0.0
duckschickens,1,0.0
Suspicious,1,0.0
Variants,1,0.0
sustenance,1,0.0
MPE,1,0.0
Congressional,1,0.0
companions,1,0.0
-008,1,0.0
-107,1,0.0
Bayers,1,0.0
422,1,0.0
BL-rTMS,1,0.0
HF-,1,0.0
High-,1,0.0
Longer,1,0.0
Proactive,1,0.0
Gut,1,0.0
CMBs,1,0.0
-096,1,0.0
childrearing,1,0.0
conflated,1,0.0
Caregiver,1,0.0
Zarit,1,0.0
Peds,1,0.0
Detroit,1,0.0
Asthmas,1,0.0
KTx,1,0.0
SUs,1,0.0
Budget,1,0.0
2701,1,0.0
-014,1,0.0
1979-80,1,0.0
Plastic,1,0.0
DGR,1,0.0
epidemy,1,0.0
BUSSR10083,1,0.0
28900000,1,0.0
inhabitant,1,0.0
27810000,1,0.0
toxiclethal,1,0.0
putrefaction,1,0.0
picked,1,0.0
Thorough,1,0.0
shot-1,1,0.0
-184,1,0.0
1046,1,0.0
test-1,1,0.0
4643,1,0.0
Dilation,1,0.0
infarct-size,1,0.0
1472,1,0.0
p006,1,0.0
-151,1,0.0
1252,1,0.0
-011,1,0.0
821,1,0.0
pan,1,0.0
Sensing,1,0.0
gearing,1,0.0
Concept,1,0.0
user-identified,1,0.0
human-centered,1,0.0
generative,1,0.0
7-11,1,0.0
Lagos,1,0.0
statesdistricts,1,0.0
geo-prioritization,1,0.0
geographies,1,0.0
ramped,1,0.0
isolate-test-treat-trace,1,0.0
bag,1,0.0
0-15,1,0.0
WvGS,1,0.0
model-based,1,0.0
reparation,1,0.0
reproducing,1,0.0
cryodamage,1,0.0
Ultrastructural,1,0.0
stamp,1,0.0
Macroscopic,1,0.0
risk-to-benefit,1,0.0
to-go,1,0.0
cue,1,0.0
directionally,1,0.0
mite-induced,1,0.0
valine,1,0.0
methionine,1,0.0
betaine,1,0.0
norleucine,1,0.0
tryptophan,1,0.0
hypoxanthine,1,0.0
acetylcarnitine,1,0.0
untargeted,1,0.0
rRNA-based,1,0.0
Extract,1,0.0
You-Gui-Wan,1,0.0
Usability,1,0.0
bio-signatures,1,0.0
2009-February,1,0.0
HeartWare,1,0.0
Partner,1,0.0
Albuminuria,1,0.0
herbalism,1,0.0
homoeopathy,1,0.0
Campaign,1,0.0
1974-1975,1,0.0
Human-centered,1,0.0
Self-rated,1,0.0
hypersympathetic,1,0.0
aromatic,1,0.0
thinner,1,0.0
transmission-enhancing,1,0.0
deep-sequenced,1,0.0
honorably,1,0.0
DEMATEL,1,0.0
Decision-Making,1,0.0
endotype-based,1,0.0
phenotype-,1,0.0
Cuenca,1,0.0
Brasilia,1,0.0
newalternative,1,0.0
preference-sensitive,1,0.0
SIRIO,1,0.0
hypertrophied,1,0.0
p0003,1,0.0
Hypertensive,1,0.0
myosistis,1,0.0
grey,1,0.0
axons,1,0.0
anterogradely,1,0.0
arborisation,1,0.0
reorganises,1,0.0
Ignoring,1,0.0
immune-escape,1,0.0
pneumology,1,0.0
ngl,1,0.0
Microorganisms,1,0.0
hypertensive-hyperkinetic-coronary-active,1,0.0
PRKAR1A,1,0.0
R1A,1,0.0
complex-related,1,0.0
liberally,1,0.0
fastidious,1,0.0
canister,1,0.0
Sudans,1,0.0
neuroanatomic,1,0.0
neuraxis,1,0.0
modality-dependent,1,0.0
years-163,1,0.0
gravitational,1,0.0
donningdoffing,1,0.0
Respirator,1,0.0
Purifier,1,0.0
NTD-specific,1,0.0
35-fold,1,0.0
isolate-based,1,0.0
Wuhan-1,1,0.0
CAL20C,1,0.0
2059,1,0.0
branched-chain,1,0.0
AAA,1,0.0
Hmox1,1,0.0
1090,1,0.0
antigensThis,1,0.0
type-specificity,1,0.0
-0464,1,0.0
Republican,1,0.0
0066,1,0.0
MTMs,1,0.0
27-item,1,0.0
multi-theory,1,0.0
pervasiveness,1,0.0
Friesinger,1,0.0
lipothymic,1,0.0
seraWhile,1,0.0
curtailed,1,0.0
Hu-1,1,0.0
WA1,1,0.0
SCC1,1,0.0
contentment,1,0.0
00003,1,0.0
negative-AMI,1,0.0
positive-AMI,1,0.0
134-157,1,0.0
106-113,1,0.0
agar-gel,1,0.0
sight,1,0.0
140-147,1,0.0
16-October,1,0.0
CCL2,1,0.0
IL8,1,0.0
spice-derived,1,0.0
Hyperinflammation,1,0.0
Therapeutics-Clinical,1,0.0
portfolio,1,0.0
1908,1,0.0
Accelerating,1,0.0
Divergent,1,0.0
prison-associated,1,0.0
neuromonitoring,1,0.0
simple-to-use,1,0.0
mechanisms--as,1,0.0
SD--its,1,0.0
neurobiology,1,0.0
energy-depleted,1,0.0
ascend,1,0.0
energy-compromised,1,0.0
ischemia--and,1,0.0
conditions--such,1,0.0
near-breakdown,1,0.0
CDs,1,0.0
104-112,1,0.0
Stratification,1,0.0
p-induced,1,0.0
Electroconvulsive,1,0.0
milliondeath,1,0.0
Yellow,1,0.0
Enforced,1,0.0
costdeath,1,0.0
difficile,1,0.0
beta-lactamase,1,0.0
5-monophosphate,1,0.0
double-balloon,1,0.0
hopelessness,1,0.0
abatement,1,0.0
10th-postoperative,1,0.0
1413,1,0.0
retractor,1,0.0
padron,1,0.0
grasping,1,0.0
incisions,1,0.0
telescope,1,0.0
Olympus,1,0.0
0-degree,1,0.0
mid-axillary,1,0.0
decubitus,1,0.0
44-year-old,1,0.0
Cyclophilin,1,0.0
immunophilin,1,0.0
Coexistence,1,0.0
non-tuberculous,1,0.0
SPECTCT,1,0.0
Q-single-photon,1,0.0
low-quality,1,0.0
moderate-quality,1,0.0
SLIT-tablet,1,0.0
pdmH1N1,1,0.0
presently-available,1,0.0
five-,1,0.0
1979-1985,1,0.0
non-malignant,1,0.0
extra-renal,1,0.0
peptidyl-prolyl,1,0.0
self-responsibility,1,0.0
Ways,1,0.0
Kuramoto,1,0.0
-independent,1,0.0
CypA-dependent,1,0.0
CsA,1,0.0
Cyclosporin,1,0.0
tumorigenesis,1,0.0
isomerase,1,0.0
cis-trans,1,0.0
39-49,1,0.0
13-81,1,0.0
2-mediated,1,0.0
Selectively,1,0.0
drug-related,1,0.0
neoplasia,1,0.0
non-acceptance,1,0.0
Acceptance,1,0.0
functiion,1,0.0
nonpneumonic,1,0.0
coronavirus2,1,0.0
PHEIC,1,0.0
vtiral,1,0.0
Utility,1,0.0
00001ABSTRACT,1,0.0
ascendancy,1,0.0
exercise-enhanced,1,0.0
Nit-Occlud®,1,0.0
≥38°C,1,0.0
798,1,0.0
6311,1,0.0
NIPH-NIH,1,0.0
86-165,1,0.0
2002-2007,1,0.0
Ferrara,1,0.0
antigen-binding,1,0.0
preoccupied,1,0.0
biostatistics,1,0.0
myoaggressive,1,0.0
harvest,1,0.0
redact,1,0.0
hyporesponsiveness,1,0.0
Periostin,1,0.0
75min,1,0.0
13min,1,0.0
VRS,1,0.0
Simplexa™,1,0.0
Bioline,1,0.0
Canaan,1,0.0
grateful,1,0.0
Uncertain,1,0.0
codified,1,0.0
envied,1,0.0
perturbate,1,0.0
semiology,1,0.0
resurrection,1,0.0
diaschisis,1,0.0
deactivation,1,0.0
ambidexterity,1,0.0
hoping,1,0.0
Unsettling,1,0.0
criticism,1,0.0
myoagressive,1,0.0
angiographis,1,0.0
1976-77,1,0.0
teflon,1,0.0
lineal,1,0.0
sympatho-adrenal,1,0.0
sympatho-neuronal,1,0.0
glycolytic,1,0.0
Defined,1,0.0
Ethiopians,1,0.0
Valsalvas,1,0.0
aortic-right-ventricular,1,0.0
P-like,1,0.0
gasket,1,0.0
68-year-old,1,0.0
dispatched,1,0.0
Postsurgical,1,0.0
district-level,1,0.0
dropout,1,0.0
periodicity-3,1,0.0
imbalances,1,0.0
dinucleotide,1,0.0
barcode,1,0.0
36-42,1,0.0
004-011,1,0.0
009-015,1,0.0
melioidosis,1,0.0
Tonghua,1,0.0
Exact,1,0.0
-SD,1,0.0
arteried,1,0.0
touch-screen,1,0.0
Doppler-derived,1,0.0
Simpson,1,0.0
thermodynamic,1,0.0
D501,1,0.0
Bat,1,0.0
variant-specific,1,0.0
mass-vaccinations,1,0.0
Ineligibility,1,0.0
optimising,1,0.0
Jilin,1,0.0
extra-urban,1,0.0
1188,1,0.0
2007-December,1,0.0
transportations,1,0.0
infarct-associated,1,0.0
Virtually,1,0.0
Postexercise,1,0.0
loops,1,0.0
2D-echocardiogram,1,0.0
93952,1,0.0
nonvirulent,1,0.0
Dosages,1,0.0
021-024,1,0.0
Armstrong,1,0.0
currently-in-use,1,0.0
Designing,1,0.0
httpswebsiiitdeduinraghavacoronavir,1,0.0
CoronaVIR,1,0.0
regressive,1,0.0
Statistic,1,0.0
Rostov,1,0.0
output-O2,1,0.0
multi-centers,1,0.0
weight-appropriate,1,0.0
Kinlens,1,0.0
VILLNKHIDAYKTFPPTEPKKDKKKK,1,0.0
Kinlen,1,0.0
traditions,1,0.0
meningovascular,1,0.0
myelopathy,1,0.0
gummas,1,0.0
imitator,1,0.0
Syphilis,1,0.0
near-infrared,1,0.0
oxide-related,1,0.0
antagonizing,1,0.0
LQLPQGTTLPKGFYA,1,0.0
EITVATSRTLS,1,0.0
disordersFurther,1,0.0
Quick-RNA,1,0.0
transpeptidase,1,0.0
gamma-glutamyl,1,0.0
hydrolase,1,0.0
5-nucleotide,1,0.0
atherogenicity,1,0.0
antiatherogenic,1,0.0
pre-beta,1,0.0
QiaAMP,1,0.0
ViralPathogen,1,0.0
MagMAX,1,0.0
shield,1,0.0
GKGQQQQGQTV,1,0.0
OMNIgene-GUT,1,0.0
outbreaks¶,1,0.0
parents§,1,0.0
facilities†,1,0.0
OSSE,1,0.0
Superintendent,1,0.0
cell-penetrating,1,0.0
RNA-based,1,0.0
siRNA-based,1,0.0
SELVIGAVILR,1,0.0
peroxidative,1,0.0
Sclerosis,1,0.0
heartlung,1,0.0
vocational,1,0.0
Inland,1,0.0
gold-based,1,0.0
NBs,1,0.0
nanobeads,1,0.0
protein-conjugated,1,0.0
dual-mode,1,0.0
colorimetric-fluorescent,1,0.0
top-most,1,0.0
2761121,1,0.0
193671,1,0.0
25000,1,0.0
stirking,1,0.0
NHLS,1,0.0
Africas,1,0.0
Friedemanns,1,0.0
ketolide,1,0.0
Macrolide,1,0.0
riskseverity,1,0.0
impediments,1,0.0
optometrists,1,0.0
Optometrists,1,0.0
liverlung,1,0.0
pollination,1,0.0
roof,1,0.0
Lateral,1,0.0
fluor,1,0.0
Amyotrophic,1,0.0
CSMs,1,0.0
immunochemiluminescent,1,0.0
ИХА-COVID-19-IgM,1,0.0
non-radiological,1,0.0
hypersomnia,1,0.0
parasomnias,1,0.0
bedfellows,1,0.0
out-of-home,1,0.0
2009-related,1,0.0
decision-tree,1,0.0
David,1,0.0
infectious-allergic,1,0.0
rapid-acting,1,0.0
250000-500000,1,0.0
dissections,1,0.0
HICE,1,0.0
Hairdresser-related,1,0.0
desirableABSTRACT,1,0.0
scattergram,1,0.0
Basidiomycetes,1,0.0
preseasonal,1,0.0
43-49,1,0.0
prognostical,1,0.0
Lean,1,0.0
globalization,1,0.0
Laypersons,1,0.0
puppet,1,0.0
mongering,1,0.0
plight,1,0.0
ambivalently,1,0.0
dramatized,1,0.0
laypersons,1,0.0
Collectives,1,0.0
Spokane,1,0.0
exploitation,1,0.0
Possibly,1,0.0
sorbents,1,0.0
certainties,1,0.0
legislative,1,0.0
livelihood,1,0.0
profitability,1,0.0
high-pathogenicity,1,0.0
935571,1,0.0
949225,1,0.0
978531,1,0.0
985184,1,0.0
942633,1,0.0
diverges,1,0.0
antegrade,1,0.0
0-45,1,0.0
reshape,1,0.0
alternates,1,0.0
intestinalis,1,0.0
pneumatosis,1,0.0
safeguarding,1,0.0
ones-between,1,0.0
urgentemergent,1,0.0
procedures-with,1,0.0
pediatricmaternal,1,0.0
Buzzi,1,0.0
Vittore,1,0.0
tissueABSTRACT,1,0.0
gravid,1,0.0
imagingperfusion-weighted,1,0.0
deconvolution,1,0.0
computes,1,0.0
PerfusIon,1,0.0
RApid,1,0.0
Diffusion-perfusion,1,0.0
microgramsml,1,0.0
6400,1,0.0
Amniotic,1,0.0
amniocentesis,1,0.0
609714,1,0.0
IgAIgG,1,0.0
knock-in,1,0.0
wide-ranging,1,0.0
Turnaround,1,0.0
imparts,1,0.0
Gains,1,0.0
eight-sample,1,0.0
pre-implementation,1,0.0
ten-year,1,0.0
Pori,1,0.0
2D-echocardiography,1,0.0
2D-imaging,1,0.0
Upstate,1,0.0
troops,1,0.0
heterovariant,1,0.0
059-074,1,0.0
061-077,1,0.0
066-079,1,0.0
2010s,1,0.0
Projection,1,0.0
inverse-variance,1,0.0
2002-2017,1,0.0
1981-1986,1,0.0
gathers,1,0.0
alerted,1,0.0
1997-1998,1,0.0
non-peer-reviewed,1,0.0
Ovalbumin,1,0.0
SOURCE,1,0.0
locales,1,0.0
long-awaited,1,0.0
thromboplastin,1,0.0
gentleman,1,0.0
hemophilia,1,0.0
Acquires,1,0.0
P-PCI,1,0.0
biracial,1,0.0
POPULATION,1,0.0
TARGET,1,0.0
FUNDING,1,0.0
Issuance,1,0.0
DEVELOPER,1,0.0
VERSION,1,0.0
PRIOR,1,0.0
DATE,1,0.0
RELEASE,1,0.0
Anaphylaxis-A,1,0.0
Positively,1,0.0
noncalcified,1,0.0
rescinded,1,0.0
debacle,1,0.0
unnatural,1,0.0
TMRPSS2,1,0.0
1417,1,0.0
Provider-directed,1,0.0
full-text,1,0.0
19414,1,0.0
IRF,1,0.0
Transmissions,1,0.0
outpaced,1,0.0
14182310,1,0.0
108689,1,0.0
-064,1,0.0
X3,1,0.0
Induced-sputum,1,0.0
p0015,1,0.0
hypermagnesemia,1,0.0
3367,1,0.0
Patient-created,1,0.0
revolution,1,0.0
taxation,1,0.0
noncommunicable,1,0.0
fast-increasing,1,0.0
capitalizing,1,0.0
heat-killed,1,0.0
ovalbumin-challenged,1,0.0
postrema,1,0.0
cytoskeletal,1,0.0
GINA-2005,1,0.0
dorsolateral,1,0.0
etiotropic,1,0.0
2252,1,0.0
3552,1,0.0
disintoxicational,1,0.0
oscillococcinum,1,0.0
aflubin,1,0.0
anaferon,1,0.0
nanotechnological,1,0.0
12400,1,0.0
Umifenovir,1,0.0
X1,1,0.0
vascular-risk,1,0.0
broncho-dilating,1,0.0
MATCH,1,0.0
CAPRIE,1,0.0
glycaemia,1,0.0
18-,1,0.0
platform-specific,1,0.0
glassware,1,0.0
sourcing,1,0.0
antigen-adjuvant,1,0.0
protectionimmunity,1,0.0
inflict,1,0.0
innervating,1,0.0
ovalbumin-preimmunized,1,0.0
FcγRT,1,0.0
Quervain,1,0.0
mestizo,1,0.0
disaggregated,1,0.0
HET,1,0.0
Hochu-ekki-to,1,0.0
hochuekkito,1,0.0
Kampo,1,0.0
Co-morbidities,1,0.0
setups,1,0.0
harmlessness,1,0.0
all-payer,1,0.0
httpsbitly3gzqEik,1,0.0
solid-organ,1,0.0
inter-related,1,0.0
Obstacles,1,0.0
homebound,1,0.0
620,1,0.0
naso-oropharyngeal,1,0.0
angiogenetic,1,0.0
vascularized,1,0.0
multiple-gene-copy,1,0.0
single-gene,1,0.0
coreceptors,1,0.0
commensurate,1,0.0
haemopoietic,1,0.0
Bronchopulmonary,1,0.0
promised,1,0.0
diagnosticprognostic,1,0.0
IgA-LFIA,1,0.0
semi-quantification,1,0.0
H2O2luminolenhancers,1,0.0
HRP-labelled,1,0.0
CCD,1,0.0
cooled,1,0.0
nanogold-labelled,1,0.0
smartphone-camera-based,1,0.0
opticalchemiluminescence,1,0.0
Glycoprotein,1,0.0
vaccinated--although,1,0.0
free-wall,1,0.0
Omani,1,0.0
I117M,1,0.0
NRL-induced,1,0.0
Polygraphic,1,0.0
re-enter,1,0.0
Intraoperatively,1,0.0
curettage,1,0.0
non-intubated,1,0.0
Bronchoscopy,1,0.0
hepatocyte,1,0.0
Colonial,1,0.0
strategies--thrombolytic,1,0.0
7406,1,0.0
12347,1,0.0
morphophysiological,1,0.0
chance-kappa,1,0.0
complains,1,0.0
fluctuated,1,0.0
1988-1993,1,0.0
Kraków,1,0.0
POL-MONICA,1,0.0
5194,1,0.0
1810,1,0.0
4291,1,0.0
0226-07142020,1,0.0
asparagine,1,0.0
hyperlipidemias,1,0.0
Stockpiles,1,0.0
JanuaryFebruary,1,0.0
bifacial,1,0.0
scrutinised,1,0.0
incomparable,1,0.0
agic,1,0.0
hemor,1,0.0
necroscopic,1,0.0
Brigham,1,0.0
c-statistics,1,0.0
ClinMicroNet,1,0.0
Clotting,1,0.0
meats,1,0.0
workshifts,1,0.0
embraced,1,0.0
acceleration-based,1,0.0
départements,1,0.0
69-78,1,0.0
19-28,1,0.0
59-68,1,0.0
2020-our,1,0.0
lock-downs-May,1,0.0
40-67,1,0.0
073-080,1,0.0
22-39,1,0.0
virus-vaccine,1,0.0
travel-associated,1,0.0
≤35,1,0.0
forty-seven,1,0.0
over-preferred,1,0.0
Aptima,1,0.0
specimen-pooling,1,0.0
currentpast,1,0.0
074-094,1,0.0
Pisa,1,0.0
sickle-like,1,0.0
Orthocoronavirinae,1,0.0
Laboratory-developed,1,0.0
LNPs-encapsulated,1,0.0
cell-free,1,0.0
SOD3,1,0.0
CYP1A1,1,0.0
GSTM1,1,0.0
CYP2A13,1,0.0
glutathione-S-transferases,1,0.0
CYP,1,0.0
bioactivated,1,0.0
true-positive,1,0.0
consensus-positive,1,0.0
ionizable,1,0.0
Consensus-positive,1,0.0
Ortho,1,0.0
Liaison,1,0.0
Architect,1,0.0
adherent,1,0.0
106-152,1,0.0
3254,1,0.0
controlscase-1,1,0.0
30318,1,0.0
2681,1,0.0
Fc-conjugated,1,0.0
luc,1,0.0
double-contour,1,0.0
postero-anterior,1,0.0
nipple,1,0.0
86-66,1,0.0
41-21,1,0.0
11-1,1,0.0
28-8,1,0.0
51-19,1,0.0
infra-azygos,1,0.0
41-65,1,0.0
pleuro-mediastinal,1,0.0
radio-grams,1,0.0
2196,1,0.0
Intramuscular,1,0.0
tripled,1,0.0
pneumonia-influenza,1,0.0
Civilian,1,0.0
AHIN1,1,0.0
timecourse,1,0.0
H3N3,1,0.0
06-55,1,0.0
23-123,1,0.0
LNP-based,1,0.0
LNP,1,0.0
Belonging,1,0.0
Neonatology,1,0.0
AKUH,1,0.0
emphases,1,0.0
Catheter,1,0.0
Gujarat,1,0.0
Focused,1,0.0
leucopenia,1,0.0
Leh,1,0.0
acclimatisation,1,0.0
rejoining,1,0.0
Ladakh,1,0.0
soldier,1,0.0
siloed,1,0.0
CAVITY,1,0.0
trade-off,1,0.0
PLEURAL,1,0.0
DRAINING,1,0.0
TRANSPORTATION,1,0.0
DURING,1,0.0
HERMETIZATION,1,0.0
FOR,1,0.0
road-and-traffic,1,0.0
unannounced,1,0.0
risk-groups,1,0.0
Chemoprophylactics,1,0.0
time-independent,1,0.0
End-of-life,1,0.0
SETTINGPATIENTS,1,0.0
grasped,1,0.0
in-transit,1,0.0
perspectively,1,0.0
bradycardia-hypotension,1,0.0
re-attack,1,0.0
widening,1,0.0
druggability,1,0.0
hot-spots,1,0.0
subtracted,1,0.0
phase-matched,1,0.0
densitometric,1,0.0
video-mediastinoscope,1,0.0
18270,1,0.0
thoracoscope,1,0.0
30o,1,0.0
incised,1,0.0
pretracheal,1,0.0
subcarinal,1,0.0
mediastinoscopic,1,0.0
sex-balanced,1,0.0
Peculiar,1,0.0
071-099,1,0.0
atorvastastin,1,0.0
PARTICIPANTS,1,0.0
disease-severity,1,0.0
hospitalized-based,1,0.0
azithromycine,1,0.0
multi-attribute,1,0.0
DKA,1,0.0
ketoacidosis,1,0.0
Daegu,1,0.0
reward,1,0.0
ipratropium,1,0.0
beta-2-agonists,1,0.0
outruled,1,0.0
chagasic,1,0.0
necropsied,1,0.0
novelties,1,0.0
backwards,1,0.0
lactation,1,0.0
socio-structural,1,0.0
crews,1,0.0
mothership,1,0.0
Samu,1,0.0
IP-10,1,0.0
disordersprocedures,1,0.0
materno-fetalneonatal,1,0.0
intrapartum,1,0.0
17100000,1,0.0
asthma-symptom-free,1,0.0
splenomegaly,1,0.0
willingness-to-pay,1,0.0
51-75,1,0.0
microbiotas,1,0.0
co-infecting,1,0.0
Clamydia,1,0.0
extortionate,1,0.0
archaea,1,0.0
traumatized,1,0.0
chloroquinehydroxychloroquine,1,0.0
UpToDate,1,0.0
Devastating,1,0.0
overestimates,1,0.0
epimyocardial,1,0.0
Unless,1,0.0
Epimyocardial,1,0.0
1-2-g,1,0.0
occluders,1,0.0
Awake,1,0.0
factor-binding,1,0.0
Question,1,0.0
232-227,1,0.0
rayon-budded,1,0.0
plastic-shafted,1,0.0
asynegry,1,0.0
8226,1,0.0
Khan,1,0.0
1964-65,1,0.0
oral-self,1,0.0
incapacitated,1,0.0
Swine-origine,1,0.0
fluidize,1,0.0
Performances,1,0.0
062-076,1,0.0
527-694,1,0.0
611,1,0.0
080-088,1,0.0
961-981,1,0.0
833-923,1,0.0
feed,1,0.0
interstudy,1,0.0
the-clock,1,0.0
around-,1,0.0
folic,1,0.0
558759,1,0.0
computer-assigned,1,0.0
CMV-seropositive,1,0.0
late-differentiated,1,0.0
neo-antigen,1,0.0
Vaccine-specific,1,0.0
18-30,1,0.0
laterally,1,0.0
transcription-real-time,1,0.0
1000µL,1,0.0
self-portrait,1,0.0
Taif,1,0.0
Administration-approved,1,0.0
pharmacokineticspharmacodynamics,1,0.0
UENI,1,0.0
cheating,1,0.0
tired,1,0.0
chess,1,0.0
Move,1,0.0
Your,1,0.0
feels,1,0.0
haemagglutinating,1,0.0
arrythmia,1,0.0
complement-fixing,1,0.0
nonstent,1,0.0
10-21,1,0.0
25-67,1,0.0
Lumen,1,0.0
07-16,1,0.0
08-12,1,0.0
08-13,1,0.0
22-49,1,0.0
biohumoral,1,0.0
61-78,1,0.0
petechial,1,0.0
589,1,0.0
Solanacées,1,0.0
electrophiles,1,0.0
co-crystallized,1,0.0
5-part,1,0.0
AIRE,1,0.0
complexABSTRACT,1,0.0
Lability,1,0.0
Exibards,1,0.0
Clérys,1,0.0
specialities,1,0.0
exemple,1,0.0
cigarets,1,0.0
fosfomycin,1,0.0
cigares,1,0.0
impragnated,1,0.0
powders,1,0.0
fumigation,1,0.0
Thoses,1,0.0
theyve,1,0.0
microembolism,1,0.0
aura-related,1,0.0
migraine-stroke,1,0.0
Migraineurs,1,0.0
dimethylfumarate,1,0.0
ibrutinib,1,0.0
39-year-old,1,0.0
≤45,1,0.0
bruising,1,0.0
departing,1,0.0
parentguardian,1,0.0
ss-agonist,1,0.0
expediting,1,0.0
696,1,0.0
22994,1,0.0
onsite,1,0.0
1085,1,0.0
969,1,0.0
BIOLINE,1,0.0
saxagliptin,1,0.0
SEKISUI,1,0.0
Multinational,1,0.0
sixty-one,1,0.0
2047,1,0.0
coronariography,1,0.0
immunoresponse,1,0.0
antiflu,1,0.0
anti-B,1,0.0
anti-AH3N2,1,0.0
anti-AH1N1,1,0.0
multiple-choice,1,0.0
Jeddah,1,0.0
restructured,1,0.0
1994-1995,1,0.0
Herpesvirus,1,0.0
Dibutyryl,1,0.0
multiplicities,1,0.0
Returning,1,0.0
omegadNdS265,1,0.0
973,1,0.0
codon-substitution,1,0.0
262x10-3,1,0.0
382x10-3,1,0.0
Evolutionary,1,0.0
Neighbor-Joining,1,0.0
cell-virus,1,0.0
1732,1,0.0
30-August,1,0.0
patients¶,1,0.0
833-994,1,0.0
agreement§,1,0.0
Immunoassay,1,0.0
performance†,1,0.0
EHR,1,0.0
firing,1,0.0
morphogenesis,1,0.0
hominis,1,0.0
subgroupings,1,0.0
Defects,1,0.0
Successfulness,1,0.0
physician-recruited,1,0.0
3415,1,0.0
re‐opened,1,0.0
Large‐scale,1,0.0
SARS‐CoV‐2‐infected,1,0.0
Destrict,1,0.0
Qingshan,1,0.0
COVID‐19‐associated,1,0.0
723,1,0.0
834,1,0.0
Observing,1,0.0
OH,1,0.0
5-point,1,0.0
FBiH,1,0.0
thrombogenesis,1,0.0
thromboclasis,1,0.0
Conclusively,1,0.0
BioFire®,1,0.0
Persistence,1,0.0
GS4104,1,0.0
Disadvantages,1,0.0
Scalp,1,0.0
pre-processed,1,0.0
re-distribution,1,0.0
288-358,1,0.0
χ29,1,0.0
osltamimivir,1,0.0
SPB,1,0.0
APA,1,0.0
-124,1,0.0
RMSEA,1,0.0
0989,1,0.0
GFI,1,0.0
0995,1,0.0
05298,1,0.0
16738,1,0.0
Path,1,0.0
3877,1,0.0
FFCW,1,0.0
β-agonist,1,0.0
corticosteroid-long-acting,1,0.0
worker-collected,1,0.0
Alone,1,0.0
Estrogen,1,0.0
perpetuating,1,0.0
thromboinflammatory,1,0.0
1376,1,0.0
628,1,0.0
199596,1,0.0
2791,1,0.0
radiopharmaceutical,1,0.0
NLRP3-dependent,1,0.0
GC3,1,0.0
methoxy-isobutyl-isonitrile,1,0.0
99Tcm-labelled,1,0.0
February-June,1,0.0
disease-2,1,0.0
anti-acidic,1,0.0
3014,1,0.0
Gastro-oesophageal,1,0.0
angio-CT,1,0.0
double-average,1,0.0
villain,1,0.0
1086,1,0.0
hero,1,0.0
leucine-rich,1,0.0
telomerase-associated,1,0.0
incompatibility,1,0.0
heterokaryon,1,0.0
asymptotic,1,0.0
43000,1,0.0
870000,1,0.0
sparingly,1,0.0
634,1,0.0
disgust,1,0.0
sadness,1,0.0
n29,1,0.0
Sorghum,1,0.0
nonallergen,1,0.0
FASTA,1,0.0
well-discussed,1,0.0
immunoinformatic,1,0.0
inflammasomes,1,0.0
deregulating,1,0.0
Viroporins,1,0.0
tenuis,1,0.0
clarosporoides,1,0.0
halopense,1,0.0
0-16,1,0.0
acetylation,1,0.0
allergyallergens,1,0.0
Merck,1,0.0
channelrhodopsin-2,1,0.0
light-sensitive,1,0.0
light-based,1,0.0
patient-doctor,1,0.0
racesethnicities,1,0.0
user-specific,1,0.0
Benefits,1,0.0
wearables,1,0.0
nontoxin,1,0.0
BRD2,1,0.0
concurring,1,0.0
sub-Carpathian,1,0.0
evokes,1,0.0
striving,1,0.0
tiered,1,0.0
neonatology,1,0.0
disentangling,1,0.0
Relating,1,0.0
intercritical,1,0.0
Delirium,1,0.0
driveline,1,0.0
abrasion,1,0.0
meridional,1,0.0
BRD4,1,0.0
Vîlcea,1,0.0
Rîmnicu,1,0.0
4486,1,0.0
hyperexpansion,1,0.0
hyperexpanded,1,0.0
infallible,1,0.0
tomograms,1,0.0
abuts,1,0.0
line--behind,1,0.0
retrosternally,1,0.0
mixed-effect,1,0.0
Scottish,1,0.0
Congenital-acquired,1,0.0
dia-lysis,1,0.0
A-positive,1,0.0
CBC,1,0.0
immune-prevention,1,0.0
fissum,1,0.0
palatum,1,0.0
babies--they,1,0.0
tocsoinfectious,1,0.0
asthenoadymanic,1,0.0
Togo,1,0.0
23-item,1,0.0
prognosticate,1,0.0
ileum,1,0.0
guanidine,1,0.0
beta-CoVs,1,0.0
reemerging,1,0.0
ASSENT-3,1,0.0
moon,1,0.0
double-bolus,1,0.0
reduced-dose,1,0.0
postfibrinolytic,1,0.0
fibrinolytics,1,0.0
eptifibatide,1,0.0
hippocampus,1,0.0
rectum,1,0.0
Co-circulation,1,0.0
Anti-Nogo,1,0.0
35-2013,1,0.0
11-2012,1,0.0
101640,1,0.0
ESAi,1,0.0
surface-mapping,1,0.0
metafor,1,0.0
pruned,1,0.0
hemi-cord,1,0.0
denervated,1,0.0
re-innervation,1,0.0
lineage-mismatched,1,0.0
ureter,1,0.0
WHO-recommended,1,0.0
shock-induced,1,0.0
host-range,1,0.0
Ample,1,0.0
mo-old,1,0.0
Argentinean,1,0.0
Argentinas,1,0.0
accordant,1,0.0
lymph-node,1,0.0
aortopulmonary,1,0.0
Craniotomiescraniostomies,1,0.0
executor,1,0.0
fissure,1,0.0
effort-induced,1,0.0
contact-type,1,0.0
Hebei,1,0.0
1136,1,0.0
Galton-Watson,1,0.0
rural-urban,1,0.0
low-concentration,1,0.0
R2099,1,0.0
Diuretic,1,0.0
Dyspnoea,1,0.0
figues,1,0.0
friendly,1,0.0
PAHO,1,0.0
1328,1,0.0
737,1,0.0
Hamburg,1,0.0
00039,1,0.0
cineframes,1,0.0
00152,1,0.0
dilator--papaverine--could,1,0.0
non-destructive,1,0.0
voxels,1,0.0
Myofiber,1,0.0
pre-control,1,0.0
intersectoral,1,0.0
myofiber,1,0.0
AMichigan452015,1,0.0
post-ICSLABA,1,0.0
corticosteroidslong-acting,1,0.0
indicesMethods,1,0.0
Τo,1,0.0
Indirectly,1,0.0
intermixing,1,0.0
electrocardiographie,1,0.0
and6,1,0.0
vaccine5,1,0.0
seasons4,1,0.0
following1,1,0.0
Multisectoral,1,0.0
GORE-TEX,1,0.0
autogenous,1,0.0
endarterectomies,1,0.0
chorioamnionitis,1,0.0
oligohydramnios,1,0.0
vacation,1,0.0
EchoCG,1,0.0
somnific,1,0.0
antinociceptive,1,0.0
securing,1,0.0
7-60,1,0.0
eigenvalues,1,0.0
TITAN,1,0.0
DISCLOSURES,1,0.0
064e-7,1,0.0
e-6,1,0.0
anti-CD-20,1,0.0
high-expressing,1,0.0
Kit-8,1,0.0
Counting,1,0.0
costimulatory,1,0.0
anti-coronaviral,1,0.0
2019-nCoV-induced,1,0.0
tapering,1,0.0
no-vaccine,1,0.0
061e-7,1,0.0
psychopathy,1,0.0
altruism,1,0.0
acceptant,1,0.0
Constraints,1,0.0
Complacency,1,0.0
P025,1,0.0
020-128,1,0.0
105-659,1,0.0
CD001187,1,0.0
Tandem,1,0.0
014e-6,1,0.0
078e-7,1,0.0
Apparent,1,0.0
49-lead,1,0.0
0001--and,1,0.0
conductance--r,1,0.0
85mm-3,1,0.0
350mm-3,1,0.0
prednisone-treated,1,0.0
fieldsExpert,1,0.0
interventionsAreas,1,0.0
Antonio-Lackland,1,0.0
vitiate,1,0.0
precordially,1,0.0
074-076,1,0.0
042e-7,1,0.0
068-069,1,0.0
100-100,1,0.0
105-109,1,0.0
amended,1,0.0
091-092,1,0.0
079-080,1,0.0
099-100,1,0.0
098-099,1,0.0
Salvianolic,1,0.0
1131,1,0.0
entrapped,1,0.0
aggregating,1,0.0
forced-choice,1,0.0
antipanic,1,0.0
Enriched,1,0.0
ClearCanvas,1,0.0
Markup,1,0.0
thoracostomy,1,0.0
Tube,1,0.0
HMII,1,0.0
Circulatory,1,0.0
MagLev,1,0.0
MOMENTUM,1,0.0
antianxiety,1,0.0
CBT-AE,1,0.0
Software,1,0.0
group--completed,1,0.0
participants--15,1,0.0
nurse-administered,1,0.0
immunogram,1,0.0
37years,1,0.0
Krai,1,0.0
Primorsky,1,0.0
context-specific,1,0.0
populations2-4,1,0.0
environments1,1,0.0
Stroke-phenotyping,1,0.0
annotations,1,0.0
Microvolt,1,0.0
Nicaragua,1,0.0
CCL5,1,0.0
IgG2a,1,0.0
fragmentpeptides,1,0.0
44-94,1,0.0
Intra-viral,1,0.0
Extra-viral,1,0.0
thrombolysis-coronary,1,0.0
Multi-vessel,1,0.0
microemboli,1,0.0
postsymptomatic,1,0.0
endsnbsp,1,0.0
intra-rater,1,0.0
election,1,0.0
presidential,1,0.0
demarcated,1,0.0
dyads,1,0.0
high-school,1,0.0
School-aged,1,0.0
HDI,1,0.0
indemnified,1,0.0
SIREN,1,0.0
Investigative,1,0.0
MTWA,1,0.0
deploymentConclusion,1,0.0
anti-N-protein,1,0.0
pen-limb,1,0.0
hoarseness,1,0.0
Considered,1,0.0
D9,1,0.0
D8,1,0.0
here--against,1,0.0
accumulating--and,1,0.0
1959,1,0.0
Ciba,1,0.0
phrases,1,0.0
wrote,1,0.0
fingers,1,0.0
bronhioltis,1,0.0
micrographia,1,0.0
testABSTRACT,1,0.0
small-group,1,0.0
BSL2,1,0.0
non-heat,1,0.0
15-item,1,0.0
amplifiable,1,0.0
Non-bacterial,1,0.0
Cinecoronariography,1,0.0
angiography--have,1,0.0
post-bone,1,0.0
macromolecule,1,0.0
9652-100,1,0.0
upscale,1,0.0
9648-100,1,0.0
SystemsResults,1,0.0
cycler,1,0.0
Myra,1,0.0
Logix,1,0.0
Kurabo,1,0.0
QuickGene-480,1,0.0
pandemicMethodology,1,0.0
deployable,1,0.0
trialGap,1,0.0
eventsABSTRACT,1,0.0
DSCG,1,0.0
76375,1,0.0
57349,1,0.0
60323,1,0.0
47291,1,0.0
tid,1,0.0
seventy-eight,1,0.0
DAVIT,1,0.0
Verapamil,1,0.0
dysbiotic,1,0.0
tiotropium,1,0.0
First-in-Class,1,0.0
1519,1,0.0
lytic-eligible,1,0.0
streptococci,1,0.0
clipping,1,0.0
BSAC,1,0.0
MRSA,1,0.0
CDAD,1,0.0
difficile-associated,1,0.0
jeopardize,1,0.0
quinolones,1,0.0
cephalosporins,1,0.0
Suggested,1,0.0
pyogenes,1,0.0
hard-pressed,1,0.0
Nimodipine,1,0.0
ADAPTE,1,0.0
re-working,1,0.0
SANOFI,1,0.0
EMIAT,1,0.0
monthlyABSTRACT,1,0.0
immunodeficient,1,0.0
-066,1,0.0
low-normal,1,0.0
subclasses,1,0.0
upper-respiratory,1,0.0
hydrocephaly,1,0.0
dural,1,0.0
4-15,1,0.0
ELISPOT,1,0.0
unimpeded,1,0.0
succeed,1,0.0
bioelectric,1,0.0
staggering,1,0.0
sneezes,1,0.0
1155,1,0.0
post-inflammatory,1,0.0
angiotensin-receptor,1,0.0
atherothromboembolism,1,0.0
activation-induced,1,0.0
SARS-CoV-1-convalescent,1,0.0
rebleeding,1,0.0
BNT162b2-vaccinated,1,0.0
Defining,1,0.0
QTRR,1,0.0
dynamicity,1,0.0
114-497,1,0.0
00323,1,0.0
00154,1,0.0
Suicidal,1,0.0
55-85,1,0.0
angioarchitecture,1,0.0
Outgrown,1,0.0
Niox,1,0.0
H1N1-negative,1,0.0
above-average,1,0.0
plug-and-play,1,0.0
-26,1,0.0
Vaxzevria-Comirnaty,1,0.0
ubiquity,1,0.0
commuter,1,0.0
bimodality,1,0.0
recent-onset,1,0.0
comparably,1,0.0
rehabilitation--was,1,0.0
duration--including,1,0.0
internistic,1,0.0
bacteriologically,1,0.0
Günzburg,1,0.0
peculiarity,1,0.0
best-documented,1,0.0
sartanes,1,0.0
indapamid,1,0.0
renin-angiotensin-system,1,0.0
normotension,1,0.0
oneset,1,0.0
dyscirculatory,1,0.0
Complication,1,0.0
μgg,1,0.0
3799,1,0.0
Belfast,1,0.0
HDAC-2,1,0.0
outgrow,1,0.0
Peanut,1,0.0
famotidine,1,0.0
footprints,1,0.0
leukocytopenia,1,0.0
porphyria,1,0.0
contra-indications,1,0.0
generaly,1,0.0
captivity,1,0.0
adhesivenessaggregation,1,0.0
deacetylase-2,1,0.0
1411,1,0.0
co-repressor,1,0.0
transcriptions,1,0.0
redox-sensitive,1,0.0
patient-centeredness,1,0.0
balls,1,0.0
3103,1,0.0
5716,1,0.0
lingula,1,0.0
2823,1,0.0
Cavitations,1,0.0
visitResults,1,0.0
Thereby,1,0.0
CHA2DS2VASc,1,0.0
4112,1,0.0
familly,1,0.0
maw,1,0.0
frewuency,1,0.0
metreologic,1,0.0
tovextrinsic,1,0.0
Kubos,1,0.0
protocole,1,0.0
spectar,1,0.0
sriteria,1,0.0
1743,1,0.0
3515,1,0.0
extracellularly,1,0.0
3977100000,1,0.0
Negev,1,0.0
conflictual,1,0.0
repressed,1,0.0
Pilpel,1,0.0
Goldsmith,1,0.0
inter-ventricular,1,0.0
hypercortisolism,1,0.0
monoamines,1,0.0
hypertension--thereby,1,0.0
ensnare,1,0.0
Conceivably,1,0.0
SARS-CoV-2This,1,0.0
Cardiomyocyte,1,0.0
cautionary,1,0.0
vitaminsupplement,1,0.0
aspirin-intolerance,1,0.0
fifties,1,0.0
spike-DTH,1,0.0
anti-virus,1,0.0
public-,1,0.0
consequential,1,0.0
objectivity,1,0.0
Shengmai,1,0.0
adherens-type,1,0.0
hyper-inflammation,1,0.0
Electron,1,0.0
microL,1,0.0
cells20,1,0.0
cardiac-derived,1,0.0
Transplantation,1,0.0
4507,1,0.0
108390,1,0.0
ca,1,0.0
19-70,1,0.0
Lodi,1,0.0
conditions--most,1,0.0
stymied,1,0.0
unclarified,1,0.0
proliferation-activated,1,0.0
cardioactive,1,0.0
125-year,1,0.0
Endomyocardial,1,0.0
McKinsey,1,0.0
Bader,1,0.0
budgetary,1,0.0
curtailing,1,0.0
thermolabile,1,0.0
upregulates,1,0.0
receptors-βδ,1,0.0
bezafibrate,1,0.0
SENSory,1,0.0
l-carnitine,1,0.0
dichloroacetate,1,0.0
diisopropylamine,1,0.0
disorders-cytokine,1,0.0
virus-cytokine-trypsin,1,0.0
multi-parametric,1,0.0
Autoimmune,1,0.0
antismoking,1,0.0
Siberian,1,0.0
BELT,1,0.0
Sensorimotor,1,0.0
re-learning,1,0.0
indefinite,1,0.0
122-155,1,0.0
Duration,1,0.0
titrated,1,0.0
nonanterior,1,0.0
Neurohormonal,1,0.0
foyer,1,0.0
NCAA,1,0.0
Athletic,1,0.0
Collegiate,1,0.0
varsity,1,0.0
132-270,1,0.0
GHQ-12,1,0.0
UPPer,1,0.0
4030,1,0.0
Pró-Saúde,1,0.0
Regulations,1,0.0
Crowded,1,0.0
Nord-Trøndelag,1,0.0
STEPS,1,0.0
RAINBOW,1,0.0
BMSC,1,0.0
pioneer,1,0.0
SENSUPP,1,0.0
Seizure,1,0.0
sixty-five,1,0.0
Sialidase,1,0.0
ASydney597H3N2-like,1,0.0
early-acute,1,0.0
self-insured,1,0.0
workforces,1,0.0
19961997-19992000,1,0.0
narrations,1,0.0
Intraepidemic,1,0.0
ANanchang93395-like,1,0.0
garrison,1,0.0
40-68,1,0.0
calculatory,1,0.0
41-63,1,0.0
interferon-inducing,1,0.0
33177070,1,0.0
2020371m4262,1,0.0
AbC-19,1,0.0
UK-RTC,1,0.0
Taylor-Phillips,1,0.0
Mulchandani,1,0.0
5063,1,0.0
10524,1,0.0
Gaining,1,0.0
waist-hip,1,0.0
internalization,1,0.0
Kamphaeng,1,0.0
Added,1,0.0
Employing,1,0.0
Labeling,1,0.0
Emotion,1,0.0
Facially,1,0.0
antiviral-antibiotic,1,0.0
traceable,1,0.0
Hellenic,1,0.0
endorsements,1,0.0
Republicans,1,0.0
Democrats,1,0.0
conjoint,1,0.0
anti-BHV-1,1,0.0
Phet,1,0.0
sentences,1,0.0
nutritious,1,0.0
soybean,1,0.0
Natto,1,0.0
137-282,1,0.0
17-segments,1,0.0
non-elastic,1,0.0
pneumotachogram,1,0.0
spirogram,1,0.0
physican,1,0.0
waist-thigh,1,0.0
south-east,1,0.0
Indochina,1,0.0
Viboud,1,0.0
Pronounced,1,0.0
Mathes,1,0.0
Acetylcholine-induced,1,0.0
drop-out,1,0.0
reexamination,1,0.0
1954,1,0.0
dependent-IgE-mediated,1,0.0
peanuts,1,0.0
Miller,1,0.0
Mark,1,0.0
Cécile,1,0.0
4535,1,0.0
End-stage,1,0.0
non-CKD,1,0.0
nondialysis,1,0.0
Salo,1,0.0
Oy,1,0.0
Salofa,1,0.0
Cassette,1,0.0
SIENNA™,1,0.0
antigen-rapid,1,0.0
locale,1,0.0
5228,1,0.0
abstained,1,0.0
Moravia,1,0.0
VAHNSI,1,0.0
Bohemia,1,0.0
north-western,1,0.0
strainSurveillance,1,0.0
C-65,1,0.0
KIO4,1,0.0
receptor-destroying,1,0.0
guinea-pig,1,0.0
22nd,1,0.0
1968Altogether,1,0.0
Czechoslovakia,1,0.0
IntroductionSeasonal,1,0.0
790,1,0.0
484KV2,1,0.0
VUI201201,1,0.0
383500,1,0.0
alarmed,1,0.0
resource-intensive,1,0.0
indiscriminate,1,0.0
stalled,1,0.0
Syndrome-CoronaVirus-2,1,0.0
detracts,1,0.0
rehabilitated,1,0.0
STROKE,1,0.0
black-to-white,1,0.0
monoetiological,1,0.0
72hpirespectivelyCompared,1,0.0
nonbacterial,1,0.0
H7N9-infection,1,0.0
betaPAFAH1B2in,1,0.0
acetylhydrolaseIb,1,0.0
5A-1eIF5Aproduced,1,0.0
1PCBP1and,1,0.0
aminotransferaseOATpolyrC-binding,1,0.0
ornithine,1,0.0
alpha-1CapZ-α1,1,0.0
F-actin-capping,1,0.0
33proteins,1,0.0
laryngoscopic,1,0.0
1112,1,0.0
infectionhpiThere,1,0.0
72hours,1,0.0
MALDI-TOF-MSMSat,1,0.0
approaches2DDIGE,1,0.0
0001The,1,0.0
infectionMOIof,1,0.0
H1N1pdm09influenza,1,0.0
investigatedA549,1,0.0
virusH1N1pdm09-infected,1,0.0
largemobile,1,0.0
non-responsive,1,0.0
Transitional,1,0.0
AH1N1-specific,1,0.0
SIM,1,0.0
SIH,1,0.0
SIVEPGRIPE,1,0.0
nonSTEMI,1,0.0
neointimal,1,0.0
implantations,1,0.0
nonstented,1,0.0
stroke-specialist,1,0.0
non-telestroke,1,0.0
tighter,1,0.0
influenza-seropositive,1,0.0
intubations,1,0.0
n779,1,0.0
post-outbreak,1,0.0
Townsville,1,0.0
Cairns,1,0.0
n496,1,0.0
Pre-influenza,1,0.0
semi-synthetic,1,0.0
770866,1,0.0
21732472,1,0.0
Laryngoscopic,1,0.0
crosswalk,1,0.0
degrade,1,0.0
polyetiological,1,0.0
13-fold,1,0.0
Dicer1-gene,1,0.0
RNA-interference,1,0.0
B2M,1,0.0
TLR3,1,0.0
unconscious,1,0.0
2009-014716-35,1,0.0
EudraCT,1,0.0
hranhsuk,1,0.0
NCT01226758,1,0.0
01-fold,1,0.0
39-fold,1,0.0
IL1-β,1,0.0
82-fold,1,0.0
05-fold,1,0.0
02-fold,1,0.0
AWisconsin672005,1,0.0
μg,1,0.0
Necrosis,1,0.0
Ib,1,0.0
revaccination,1,0.0
desialylated,1,0.0
alpha2-6,1,0.0
IL17,1,0.0
short-wavelength,1,0.0
transmission--can,1,0.0
Race,1,0.0
outbreak-whether,1,0.0
invoke,1,0.0
httpsdoiorg1023641asha14669715,1,0.0
Material,1,0.0
membership,1,0.0
chronic-stage,1,0.0
Occlusive,1,0.0
amendable,1,0.0
Inoculations,1,0.0
Shots,1,0.0
Got,1,0.0
saying,1,0.0
Relatives,1,0.0
Friends,1,0.0
Providence,1,0.0
Portuguese-American,1,0.0
stroke-trained,1,0.0
lay-out,1,0.0
heat-stable,1,0.0
R-,1,0.0
24-lead,1,0.0
goodbye,1,0.0
Informatics,1,0.0
DATASUS,1,0.0
LACEN-SE,1,0.0
Healthstar,1,0.0
14971±223,1,0.0
11023±537,1,0.0
р0001,1,0.0
rφ054,1,0.0
Karkashov,1,0.0
ofMiolkovska-Dmitrova,1,0.0
Unified,1,0.0
OHE-HEED,1,0.0
Economics-Health,1,0.0
Biosis,1,0.0
Cost-effectiveness,1,0.0
rs029-041,1,0.0
classics,1,0.0
premises,1,0.0
anti-vitamin,1,0.0
kitchen,1,0.0
garbage,1,0.0
air-machines,1,0.0
Thermoactinomyces,1,0.0
Trichoderma,1,0.0
Geotrichum,1,0.0
Verticillium,1,0.0
р001,1,0.0
р005,1,0.0
Meteorology,1,0.0
24-26,1,0.0
Kiev,1,0.0
1977-February,1,0.0
non-CNS,1,0.0
tells,1,0.0
nonhematologic,1,0.0
envisaged,1,0.0
videoconferencing,1,0.0
Almer,1,0.0
fibrynolytical,1,0.0
intresting,1,0.0
Metabolomic,1,0.0
n17,1,0.0
235-triphenyltetrazolium,1,0.0
GC-MS-based,1,0.0
antimetabolites,1,0.0
terrestris,1,0.0
Tribulus,1,0.0
saponins,1,0.0
betweenness,1,0.0
centralities,1,0.0
closeness,1,0.0
Provinces,1,0.0
Chrysonilia,1,0.0
Mucor,1,0.0
CFUm3,1,0.0
hands-on,1,0.0
interleukin-4,1,0.0
avian-lineage,1,0.0
AH7N2,1,0.0
cat-to-human,1,0.0
transcribe,1,0.0
SH-SY5Y,1,0.0
T98G,1,0.0
astrocytic,1,0.0
WBP,1,0.0
acupoints,1,0.0
transmission-reducing,1,0.0
mesophilic,1,0.0
maximizes,1,0.0
desertic,1,0.0
Hispanic-Mestizo,1,0.0
hyperperfusion,1,0.0
psychogenesis,1,0.0
empathy,1,0.0
Namely,1,0.0
Anger,1,0.0
reformulate,1,0.0
INMET,1,0.0
pre-mating,1,0.0
adoptive,1,0.0
Staging,1,0.0
ΔPpl,1,0.0
Antiinflammatory,1,0.0
interleukin-5,1,0.0
mnemonic,1,0.0
5-question,1,0.0
noncomplicated,1,0.0
calcineurin,1,0.0
palm,1,0.0
SARS-CoV-derived,1,0.0
protein-driven,1,0.0
Necker,1,0.0
2970,1,0.0
ΔIGF-I-q,1,0.0
ΔIGF-I-quintiles,1,0.0
ΔIGF-I,1,0.0
multi-lobar,1,0.0
rethink,1,0.0
153if,1,0.0
rotavirus,1,0.0
3100000,1,0.0
Thrombosis,1,0.0
947,1,0.0
health-namely,1,0.0
intersects,1,0.0
Hyderabad,1,0.0
counterbalancing,1,0.0
15-241,1,0.0
diethylenetriaminepentaacetic,1,0.0
aluminum-framed,1,0.0
mayor,1,0.0
stocking,1,0.0
Hanta,1,0.0
Cholera,1,0.0
1176,1,0.0
73643,1,0.0
ImmunoAssay,1,0.0
carpet,1,0.0
Philips,1,0.0
CAP-37,1,0.0
azurocidin,1,0.0
Neutrophil-derived,1,0.0
T1DM,1,0.0
cardia,1,0.0
misled,1,0.0
summaries,1,0.0
severe-controlled,1,0.0
immortalization,1,0.0
mimicry,1,0.0
Spin-echo,1,0.0
Gyroscan,1,0.0
72nd,1,0.0
LuxembourgSera,1,0.0
Benralizumab,1,0.0
Reslizumab,1,0.0
Interleukin-5,1,0.0
inhuman,1,0.0
anti-SIV,1,0.0
Luxembourg,1,0.0
ancestorsAVictoria375,1,0.0
H3N2SIV,1,0.0
antibodiestitre,1,0.0
inhibitionHI,1,0.0
SIVswas,1,0.0
Teslacon,1,0.0
Seroreactivity,1,0.0
4096,1,0.0
148067,1,0.0
exposition,1,0.0
self-patients,1,0.0
CLC,1,0.0
privately,1,0.0
PON1,1,0.0
MMP3,1,0.0
stromelysin-1,1,0.0
Tc-99m-pyrophosphate,1,0.0
48th,1,0.0
guardian,1,0.0
Category,1,0.0
dystrophy,1,0.0
Duchenne,1,0.0
Hospitalised,1,0.0
videos,1,0.0
Chemo-radiotherapy-induced,1,0.0
vasculitic,1,0.0
reproductively,1,0.0
1728,1,0.0
CHA2DS2-VA,1,0.0
sex-less,1,0.0
self-smoking,1,0.0
httprimedorgrimedicaljournal-2017-06asp,1,0.0
latitudinal,1,0.0
756-788,1,0.0
412-48,1,0.0
october,1,0.0
Arkhangelsk,1,0.0
63-168,1,0.0
67-8,1,0.0
krasnodar,1,0.0
A2Moscow2165,1,0.0
BLeningrad67,1,0.0
neuro-,1,0.0
Vagal,1,0.0
12-leads,1,0.0
virus-triggered,1,0.0
H9N2-positive,1,0.0
10874212,1,0.0
2581,1,0.0
4212,1,0.0
reorganised,1,0.0
48-hr,1,0.0
degenerated,1,0.0
atheroembolization,1,0.0
Tele-rehabilitation,1,0.0
Psychologic,1,0.0
parainfectious,1,0.0
donepezil,1,0.0
Post-treatment,1,0.0
beam,1,0.0
cone,1,0.0
stent-containing,1,0.0
unassisted,1,0.0
carotid-posterior,1,0.0
onset-to-alarm,1,0.0
incrementing,1,0.0
purchasers,1,0.0
inhitor,1,0.0
Dupilumab,1,0.0
rate692,1,0.0
H-2Kb,1,0.0
inspected,1,0.0
Above-normal,1,0.0
air-flow,1,0.0
1639,1,0.0
Scarcely,1,0.0
headings,1,0.0
super-spreading,1,0.0
Ramifications,1,0.0
ecologically,1,0.0
6225,1,0.0
ABG,1,0.0
isotype-independent,1,0.0
1273,1,0.0
domain-targeting,1,0.0
arboviral,1,0.0
disproved,1,0.0
three-hour,1,0.0
CD4CD25,1,0.0
-24,1,0.0
twice-weekly,1,0.0
denervation,1,0.0
fellowship-trained,1,0.0
doctorally,1,0.0
softer,1,0.0
tromethaminetrometamol,1,0.0
Coast,1,0.0
Assignment,1,0.0
1-mediated,1,0.0
viperin-deficient,1,0.0
Lungs,1,0.0
viperin-knockout,1,0.0
AWSN33H1N1,1,0.0
viperin-expressing,1,0.0
IFN-inducible,1,0.0
16-23,1,0.0
B1351††,1,0.0
Named,1,0.0
PANGO,1,0.0
vaccinator,1,0.0
geographically¶,1,0.0
transmissibility†§,1,0.0
Impression,1,0.0
retes,1,0.0
99026,1,0.0
PVP-I,1,0.0
povidone-iodine,1,0.0
viricidal,1,0.0
shutting,1,0.0
electrocardiographical,1,0.0
recoveries,1,0.0
Cornell,1,0.0
soliciting,1,0.0
Extent,1,0.0
ESRS,1,0.0
benzoquinones,1,0.0
flavonoids,1,0.0
terpenes,1,0.0
de-novo,1,0.0
Tau2,1,0.0
SID,1,0.0
RICeST,1,0.0
IranDoc,1,0.0
paralleling,1,0.0
dBs,1,0.0
RRE-90,1,0.0
prequisite,1,0.0
diisocyanates,1,0.0
hyperspatial,1,0.0
glucocorticosteroid,1,0.0
37213,1,0.0
5444,1,0.0
atherothrombogenesis,1,0.0
ferroconcrete,1,0.0
elevated-ST,1,0.0
assent,1,0.0
Estimator,1,0.0
self-treatment,1,0.0
PresbyterianWeill,1,0.0
instilled,1,0.0
Supposedly,1,0.0
psychopathologies,1,0.0
Serbia,1,0.0
Bosnia-Herzegovina,1,0.0
rehabilitationResults,1,0.0
BioRescue,1,0.0
strokeMethods,1,0.0
strokeObjective,1,0.0
remitted,1,0.0
apartment,1,0.0
psychotherapeutists,1,0.0
telling,1,0.0
therapeutists,1,0.0
ethiopathogenese,1,0.0
somatogenic,1,0.0
4-26,1,0.0
92--47,1,0.0
differenet,1,0.0
Neuro-psychical,1,0.0
pecularities,1,0.0
Premorbid,1,0.0
exacerating,1,0.0
BDushanbe66,1,0.0
VVLSFELL,1,0.0
Bevezetés,1,0.0
reads,1,0.0
methodologists,1,0.0
subdivisions,1,0.0
paint,1,0.0
Ind,1,0.0
r097,1,0.0
visualizer,1,0.0
otolaryngological,1,0.0
mastoiditis,1,0.0
NSABSTRACT,1,0.0
osteomyelitis,1,0.0
RmYN02s,1,0.0
Kuala,1,0.0
12-nucleotide,1,0.0
6-nucleotide,1,0.0
RmYN02RacCSxxx,1,0.0
polybasic,1,0.0
PRRA,1,0.0
PAAPVA,1,0.0
RacCSxxx,1,0.0
venting,1,0.0
current-season,1,0.0
RPF75,1,0.0
analysts,1,0.0
Lumpur,1,0.0
dB,1,0.0
anti-obesity,1,0.0
groupCONCLUSIONAntenatal,1,0.0
third-trimester,1,0.0
NRESULTSThe,1,0.0
Milliplex,1,0.0
noninfected,1,0.0
protectionMETHODSA,1,0.0
transplacentally,1,0.0
BACKGROUNDThe,1,0.0
sibutramine-induced,1,0.0
re-uptake,1,0.0
Sibutramine,1,0.0
coronarographic,1,0.0
isodivergencies,1,0.0
isochronic,1,0.0
minima,1,0.0
asynchronic,1,0.0
iso-areal,1,0.0
fibroses,1,0.0
Cakovice,1,0.0
ZPA,1,0.0
-026,1,0.0
incl,1,0.0
RPF50,1,0.0
roll-off,1,0.0
Weizmann,1,0.0
BPanama4590,1,0.0
geospatially,1,0.0
Universitys,1,0.0
five-to-one,1,0.0
agreeing,1,0.0
Compact,1,0.0
Durham,1,0.0
Marquardts,1,0.0
nomographic,1,0.0
Kinase,1,0.0
Creatine,1,0.0
AShanghai1187H3N2,1,0.0
Scale-up,1,0.0
videotape,1,0.0
technetium-99m-glucoheptonate,1,0.0
1m,1,0.0
MERS-CoV20-24,1,0.0
analogs,1,0.0
Peptides,1,0.0
insecticidal,1,0.0
fibrocystic,1,0.0
Proposals,1,0.0
gonads,1,0.0
on-,1,0.0
redeploying,1,0.0
F99,1,0.0
target-pathway,1,0.0
FW,1,0.0
noises,1,0.0
wheezing-like,1,0.0
wheezinginaudible,1,0.0
carbon-13,1,0.0
Proton,1,0.0
location-specific,1,0.0
threshold-up,1,0.0
onset-ie,1,0.0
Vina,1,0.0
multi-directional,1,0.0
automation,1,0.0
herb-component-target,1,0.0
Similarity,1,0.0
Ensemble,1,0.0
WES,1,0.0
Fanggan,1,0.0
Qingjie,1,0.0
risk-reduction,1,0.0
10265,1,0.0
68913,1,0.0
2-October,1,0.0
pregnancyFUNDINGIsrael,1,0.0
Fondazione,1,0.0
protein-expressing,1,0.0
arbidol,1,0.0
aerosol-based,1,0.0
high-severity,1,0.0
elastomeric,1,0.0
non-aerosol-generating,1,0.0
misinterpret,1,0.0
non-neurologists,1,0.0
Ar-3,1,0.0
BD-2,1,0.0
Ti-2,1,0.0
bioisosterism,1,0.0
bictegravir,1,0.0
commit,1,0.0
dolutegravir,1,0.0
Tizoxanide,1,0.0
-056,1,0.0
Law,1,0.0
11435,1,0.0
BHarbin0794,1,0.0
ASydney0597,1,0.0
Obtained,1,0.0
sonomicrometry,1,0.0
Cumulatively,1,0.0
hypovolemic,1,0.0
re-evaluating,1,0.0
208-4322,1,0.0
feral,1,0.0
contradict,1,0.0
Commensal,1,0.0
province-level,1,0.0
Door-to-needle,1,0.0
Seminar,1,0.0
1-m,1,0.0
3-m,1,0.0
desensitizations,1,0.0
PCWP,1,0.0
Egg,1,0.0
carnivores,1,0.0
raccoon,1,0.0
mink-associated,1,0.0
mink-to-humans,1,0.0
animals-to-humans,1,0.0
zoos,1,0.0
gorillas,1,0.0
pumas,1,0.0
leopards,1,0.0
ferret-to-ferret,1,0.0
cat-to-cat,1,0.0
white-tailed,1,0.0
003-072,1,0.0
1-sided,1,0.0
Henry,1,0.0
alphabeta-gliadin,1,0.0
Aptima™,1,0.0
PQQQF,1,0.0
VQVVN,1,0.0
PISCR,1,0.0
high-affinity,1,0.0
carboxylase,1,0.0
bisphosphate,1,0.0
ribulose,1,0.0
avenin,1,0.0
oat-derived,1,0.0
wheat-derived,1,0.0
Caring,1,0.0
hypochloraemia,1,0.0
Hyponatraemia,1,0.0
amino-transferase,1,0.0
Distress,1,0.0
religion-based,1,0.0
PROMIS®,1,0.0
worseness,1,0.0
15-19,1,0.0
Postconditioning,1,0.0
Krenter,1,0.0
employee-reported,1,0.0
Behaviors,1,0.0
quasi-Poisson,1,0.0
ADMASDMA,1,0.0
January-May,1,0.0
adrenoceptor,1,0.0
GPIAG,1,0.0
sixty-three,1,0.0
aggregates,1,0.0
PACT,1,0.0
Sonographers,1,0.0
upcoding,1,0.0
bariatric,1,0.0
Concordant,1,0.0
L-arginineSDMA,1,0.0
soleus,1,0.0
L-arginineADMA,1,0.0
symmetric,1,0.0
intima⁻media,1,0.0
micro-macroangiopathy,1,0.0
Eighty-eight,1,0.0
non-detected,1,0.0
appliedABSTRACT,1,0.0
-031,1,0.0
wireless,1,0.0
well-targeted,1,0.0
dampening,1,0.0
szív-,1,0.0
B44,1,0.0
multi-season,1,0.0
reinterpreting,1,0.0
6197,1,0.0
space-occupying,1,0.0
converts,1,0.0
Passing-Bablok,1,0.0
SerionVirion,1,0.0
SARS-CoV-2-naive,1,0.0
rays,1,0.0
65-15,1,0.0
booster-dose,1,0.0
strategiesExpert,1,0.0
oneself,1,0.0
populationAreas,1,0.0
51·4,1,0.0
14·0,1,0.0
age-weighted,1,0.0
4·5,1,0.0
13·8,1,0.0
hospital-stage,1,0.0
3546,1,0.0
prepregnancy,1,0.0
reverted,1,0.0
Moderated,1,0.0
persevere,1,0.0
Suicide,1,0.0
cost-offsets,1,0.0
CMississippi80,1,0.0
CAichi181,1,0.0
hemagglutinin-esterase,1,0.0
regression-based,1,0.0
operant,1,0.0
photoperiod,1,0.0
lightday,1,0.0
≤10,1,0.0
Amplitude,1,0.0
value-for-money,1,0.0
health-gains,1,0.0
self-participation,1,0.0
10-years,1,0.0
G20210A,1,0.0
Prothrombin,1,0.0
Subset,1,0.0
mottled,1,0.0
interspersing,1,0.0
inhomogeneity,1,0.0
Correspondingly,1,0.0
Consistently,1,0.0
reentrant,1,0.0
HCW-collected,1,0.0
0200,1,0.0
fingerprinting,1,0.0
Investigated,1,0.0
medals,1,0.0
won,1,0.0
heterozygosity,1,0.0
Dyads,1,0.0
8-17,1,0.0
socioemotional,1,0.0
Hodgkins,1,0.0
Grays,1,0.0
2548,1,0.0
13217,1,0.0
eudaimonic,1,0.0
strive,1,0.0
hedonic,1,0.0
46-60,1,0.0
non-anginous,1,0.0
5-18,1,0.0
1996-January,1,0.0
Population-wide,1,0.0
ratio--related,1,0.0
cholesterolhigh,1,0.0
factors--elevated,1,0.0
1983-2002,1,0.0
sideline,1,0.0
plan-do-study-act,1,0.0
2200,1,0.0
SARS-CoV-2-encoding,1,0.0
bioreactors,1,0.0
immunoreactivity,1,0.0
agronomic,1,0.0
nu,1,0.0
Rachiplusia,1,0.0
virus-exposed,1,0.0
adjutant,1,0.0
postcoronavirus,1,0.0
laboratorial,1,0.0
virally-encoded,1,0.0
tenet,1,0.0
PDSA,1,0.0
coincidentally,1,0.0
organstissues,1,0.0
undesired,1,0.0
resembles,1,0.0
Domain,1,0.0
Receptor-Binding,1,0.0
fully-closed,1,0.0
Pangolin-CoV,1,0.0
Pangolin-CoVs,1,0.0
visitation,1,0.0
T1-oligonucleotide,1,0.0
19881990,1,0.0
Progetto,1,0.0
meager,1,0.0
B191,1,0.0
VUI-NP13L-like,1,0.0
Grande,1,0.0
1533,1,0.0
Till,1,0.0
4775,1,0.0
primary-stroke,1,0.0
transfused,1,0.0
33-93,1,0.0
Case-patients,1,0.0
Králové,1,0.0
Constant,1,0.0
Hradec,1,0.0
2009-2013,1,0.0
601AM-1200PM,1,0.0
Dyslipidemia,1,0.0
preset,1,0.0
Comilla,1,0.0
pineal,1,0.0
DDX58,1,0.0
DExDH-box,1,0.0
CARD,1,0.0
B1195,1,0.0
cavitate,1,0.0
pR71H,1,0.0
rock,1,0.0
DMF,1,0.0
fumarate,1,0.0
Dimethyl,1,0.0
shoud,1,0.0
non-users,1,0.0
magazine,1,0.0
phylodynamics,1,0.0
phylogenetics,1,0.0
worst-hit,1,0.0
festival,1,0.0
tempo,1,0.0
lakes,1,0.0
founding,1,0.0
Successive,1,0.0
Year-round,1,0.0
Escalation,1,0.0
lags,1,0.0
lacus,1,0.0
diminutive,1,0.0
pit,1,0.0
-ae,1,0.0
lacune,1,0.0
pP885S,1,0.0
exome,1,0.0
CMiyagi391,1,0.0
pLOS,1,0.0
140876,1,0.0
Podlaskie,1,0.0
27181,1,0.0
75790,1,0.0
507102,1,0.0
57197,1,0.0
Zachodniopomorskie,1,0.0
11957,1,0.0
31844,1,0.0
1216285,1,0.0
qSOFA,1,0.0
200203,1,0.0
Sepsis-Related,1,0.0
propertiesThe,1,0.0
ECD,1,0.0
preregistered,1,0.0
rubra,1,0.0
Polycythemia,1,0.0
19811982,1,0.0
19801989,1,0.0
CMiyagi292,1,0.0
CMiyagi991,1,0.0
3128,1,0.0
Takayasu,1,0.0
fulminating,1,0.0
8576,1,0.0
insignificance,1,0.0
Poverty,1,0.0
15416,1,0.0
uneven,1,0.0
MACE-free,1,0.0
18002359,1,0.0
12001759,1,0.0
06001159,1,0.0
00000559,1,0.0
morning-dominant,1,0.0
11339,1,0.0
aortitis,1,0.0
19915,1,0.0
20685,1,0.0
drug-resistance,1,0.0
single-epidemic,1,0.0
10033000,1,0.0
33000,1,0.0
USFDA,1,0.0
barbers,1,0.0
prisoners,1,0.0
multi-transfused,1,0.0
CUORE,1,0.0
12-sample,1,0.0
érrendszeri,1,0.0
képezték,1,0.0
kórházi,1,0.0
került,1,0.0
nő,1,0.0
6619,1,0.0
férfi,1,0.0
9742,1,0.0
fő,1,0.0
belül,1,0.0
keretén,1,0.0
ezen,1,0.0
50276,1,0.0
életkorra,1,0.0
59321,1,0.0
16032,1,0.0
költségei,1,0.0
958-át,1,0.0
kiadás,1,0.0
teljes,1,0.0
2018-ban,1,0.0
52463,1,0.0
61902,1,0.0
16728,1,0.0
felvételre,1,0.0
számított,1,0.0
fordított,1,0.0
korcsoportban,1,0.0
Unloading,1,0.0
Dementia,1,0.0
6-13,1,0.0
162Suppl,1,0.0
költségtényezőnek,1,0.0
legfőbb,1,0.0
bizonyult,1,0.0
igénybevétele,1,0.0
nőkét,1,0.0
meghaladta,1,0.0
kivételével,1,0.0
lakosra,1,0.0
felettiek,1,0.0
száma,1,0.0
abszolút,1,0.0
tekintve,1,0.0
eloszlást,1,0.0
esetében,1,0.0
12961,1,0.0
20854,1,0.0
prevalencia,1,0.0
vetített,1,0.0
kiadása,1,0.0
szívinfarktusra,1,0.0
hypokinesia--the,1,0.0
feléért,1,0.0
finanszírozási,1,0.0
Alapkezelő,1,0.0
Egészségbiztosítási,1,0.0
Adataink,1,0.0
módszerek,1,0.0
Adatok,1,0.0
betegségteher,1,0.0
okozta,1,0.0
Vizsgálatunk,1,0.0
felelősek,1,0.0
közel,1,0.0
származnak,1,0.0
halálozások,1,0.0
európai,1,0.0
egyharmadáért,1,0.0
halálozás,1,0.0
összes,1,0.0
világszerte,1,0.0
szerepelnek,1,0.0
halálokok,1,0.0
vezető,1,0.0
betegségek,1,0.0
adatbázisából,1,0.0
2018-as,1,0.0
azonosítottuk,1,0.0
bontásban,1,0.0
kódcsoporttal,1,0.0
I21-es,1,0.0
alapján,1,0.0
revíziója,1,0.0
Osztályozásának,1,0.0
Nemzetközi,1,0.0
Betegségek,1,0.0
szívinfarktust,1,0.0
típusokra,1,0.0
egyes,1,0.0
korcsoportos,1,0.0
évre,1,0.0
kiadásokat,1,0.0
prevalenciát,1,0.0
jutó,1,0.0
főre,1,0.0
tekintetében,1,0.0
rendelkező,1,0.0
kiadással,1,0.0
legnagyobb,1,0.0
betegszámokat,1,0.0
Meghatároztuk,1,0.0
Neglect,1,0.0
allochiria--the,1,0.0
broadened,1,0.0
Nonreplicating,1,0.0
micronized,1,0.0
deaggregate,1,0.0
PIFs,1,0.0
Albans,1,0.0
Biomed,1,0.0
Innovata,1,0.0
Clickhaler,1,0.0
DPI,1,0.0
frontrunning,1,0.0
clinal,1,0.0
sums,1,0.0
6--8,1,0.0
editor-limited,1,0.0
FNCAS9,1,0.0
AIOD-CRISPR,1,0.0
CRISPR-Cas12a,1,0.0
LFA-based,1,0.0
Point,1,0.0
based-diagnosis,1,0.0
precaution,1,0.0
Post-COVID-19,1,0.0
LRTI,1,0.0
post-epidemic,1,0.0
6-years,1,0.0
capsulitis,1,0.0
5286,1,0.0
134100000,1,0.0
273100000,1,0.0
enrollees,1,0.0
manager,1,0.0
inflammatory-fibroproliferative,1,0.0
copiesPCR,1,0.0
1545,1,0.0
3333,1,0.0
2326,1,0.0
3770,1,0.0
1795,1,0.0
non-suddenly,1,0.0
2266,1,0.0
7949,1,0.0
4597,1,0.0
1355,1,0.0
71152,1,0.0
00651,1,0.0
basketball,1,0.0
Jogging,1,0.0
non-sudden,1,0.0
CH5,1,0.0
ossification,1,0.0
subluxation,1,0.0
misperceives,1,0.0
Zoom®,1,0.0
SEPAR,1,0.0
Pneumology,1,0.0
SEMG,1,0.0
semFYC,1,0.0
SEMERGEN,1,0.0
SEAIC,1,0.0
Allergology,1,0.0
fetuin-A,1,0.0
Fetuin-A,1,0.0
Interatrial,1,0.0
lectures,1,0.0
Viehmann-Wical,1,0.0
flipped,1,0.0
Mers,1,0.0
ERIC,1,0.0
Lilacs,1,0.0
meta-synthesis,1,0.0
presential,1,0.0
allochiria,1,0.0
delusional,1,0.0
EZs,1,0.0
cancels,1,0.0
immunosuppressors,1,0.0
2021172355,1,0.0
faktors,1,0.0
visuospatial,1,0.0
Brunnstrom,1,0.0
METHOD,1,0.0
CPRS,1,0.0
Transapical,1,0.0
IIIIV,1,0.0
transapical,1,0.0
1227,1,0.0
void,1,0.0
newspaper,1,0.0
4165,1,0.0
Neuropsychiatric,1,0.0
commonly-used,1,0.0
antiplateletantithrombotic,1,0.0
labile,1,0.0
Livedo,1,0.0
Etiopathogenesis,1,0.0
small-sized,1,0.0
discoloration,1,0.0
violaceous,1,0.0
livedo,1,0.0
Sneddon,1,0.0
vaccination-based,1,0.0
hypoxaemic,1,0.0
G1124V,1,0.0
omitted,1,0.0
base-line,1,0.0
cortisone-dependent,1,0.0
14-38,1,0.0
autoblood,1,0.0
2344B,1,0.0
Congo,1,0.0
AH5N8,1,0.0
4-years-old,1,0.0
WVS,1,0.0
riskIn,1,0.0
ischemias,1,0.0
bioimpedance,1,0.0
over-interpretation,1,0.0
Vaccine-induced,1,0.0
post-minor,1,0.0
ECHRS,1,0.0
breathless,1,0.0
Perceptron,1,0.0
Multi-Layer,1,0.0
Trees,1,0.0
tree-structured,1,0.0
post-consensus,1,0.0
1103,1,0.0
5-fold,1,0.0
anticoagulations,1,0.0
EQ-5D-3L,1,0.0
platelet-inhibitor,1,0.0
endonasal,1,0.0
nose-lung,1,0.0
unity,1,0.0
nonsudden,1,0.0
counterbalanced,1,0.0
23-31,1,0.0
asleep,1,0.0
1822,1,0.0
undoubted,1,0.0
thrombosisABSTRACT,1,0.0
Curative,1,0.0
Charlotte,1,0.0
Tunas,1,0.0
Las,1,0.0
Pupo,1,0.0
Font,1,0.0
Carlos,1,0.0
check-up,1,0.0
ultra-short-acting,1,0.0
esmolol,1,0.0
Angiographically,1,0.0
psychoneuroimmunology,1,0.0
SF-6D,1,0.0
AQL-5D,1,0.0
stump,1,0.0
peroxides,1,0.0
leukotriene-receptor,1,0.0
thrust,1,0.0
round-the-clock,1,0.0
Intermediate-acting,1,0.0
detoxifying,1,0.0
Garlic,1,0.0
GRD,1,0.0
glutathione-S-transferase,1,0.0
GPX,1,0.0
CAT,1,0.0
ceruloplasmin,1,0.0
bronchoprotective,1,0.0
IPL-induced,1,0.0
nanomedicinal,1,0.0
spotlight,1,0.0
thrusted,1,0.0
vastly,1,0.0
STING-activating,1,0.0
nanoformulation,1,0.0
cytosol,1,0.0
shuttling,1,0.0
agonist-mediated,1,0.0
cromogylcate,1,0.0
over-reliance,1,0.0
utilities,1,0.0
extraction-based,1,0.0
TH1TH2,1,0.0
TH1-acquired,1,0.0
16-20,1,0.0
19-23,1,0.0
Nose,1,0.0
28503,1,0.0
COVIA-19,1,0.0
beta-coronavirus,1,0.0
newly-emergent,1,0.0
anti-radical,1,0.0
copiesμl,1,0.0
1000-1200,1,0.0
nonsymptomatic,1,0.0
1716,1,0.0
8284,1,0.0
864,1,0.0
13294,1,0.0
129528,1,0.0
non-related,1,0.0
intermediate-acting,1,0.0
inordinately,1,0.0
microgday,1,0.0
microsurgery,1,0.0
1295,1,0.0
S-glycoprotein,1,0.0
Cytoscape,1,0.0
763,1,0.0
affectivity,1,0.0
syndromemyocardial,1,0.0
CREW,1,0.0
Workgroup,1,0.0
ligand-target,1,0.0
COX-2,1,0.0
PTGS2,1,0.0
PTGS1,1,0.0
pelargonidin,1,0.0
merged,1,0.0
synergetic,1,0.0
Compound-disease-target,1,0.0
DisGeNET,1,0.0
STITCH,1,0.0
OB,1,0.0
TCMSP,1,0.0
thunbergii,1,0.0
Fritillariae,1,0.0
bulbs,1,0.0
00028,1,0.0
AN1v,1,0.0
Marker-to-marker,1,0.0
D5S2011,1,0.0
2017469e332-e335,1,0.0
AH1v,1,0.0
Liberia,1,0.0
nonpsychotic,1,0.0
chemoprevention,1,0.0
Mini-Mental,1,0.0
serology-based,1,0.0
≥12yrs,1,0.0
post-onset,1,0.0
10E3,1,0.0
10E6,1,0.0
P-RDT-positive,1,0.0
Panbio-COVID-19,1,0.0
D6S305,1,0.0
Antigen-based,1,0.0
SPIO-labeled,1,0.0
superparamagnetic,1,0.0
speculates,1,0.0
self-reaction,1,0.0
note-based,1,0.0
D19S226,1,0.0
D8S1769,1,0.0
D6S1574,1,0.0
D9S286,1,0.0
pre-revascularization,1,0.0
Pediatr,1,0.0
9992,1,0.0
extramortality,1,0.0
protein‑protein,1,0.0
limma,1,0.0
nitrotyrosine,1,0.0
AF-associated,1,0.0
672–677,1,0.0
Critical-care,1,0.0
natrium,1,0.0
prokinetic,1,0.0
hypersensitivities,1,0.0
cow-milk,1,0.0
bioterrorist,1,0.0
Retrieval,1,0.0
518,1,0.0
NVRL,1,0.0
521,1,0.0
effort-limited,1,0.0
disodiumcromoglycate,1,0.0
salbuthamol,1,0.0
Gary,1,0.0
talks,1,0.0
Saville,1,0.0
Melanie,1,0.0
Search,1,0.0
Interacting,1,0.0
closely-matched,1,0.0
miR‑30c‑5p,1,0.0
Reluctance,1,0.0
Phadiatop-test,1,0.0
histamine-challenge,1,0.0
10-23,1,0.0
fifty-one,1,0.0
Five-hundred,1,0.0
Registration,1,0.0
cycle‑associated,1,0.0
inflammation‑associated,1,0.0
HtrA,1,0.0
miR‑21‑5p,1,0.0
Visualization,1,0.0
alstrom,1,0.0
metallopeptidase,1,0.0
cytokine‑cytokine,1,0.0
C‑C,1,0.0
ras‑related,1,0.0
toll‑like,1,0.0
GSE48060,1,0.0
GSE34198,1,0.0
GSE24519,1,0.0
Discovery,1,0.0
pathomechanistic,1,0.0
Multidimensional,1,0.0
Leone,1,0.0
IVF-conceived,1,0.0
diagn,1,0.0
includin,1,0.0
Bavaria,1,0.0
Wuerzburg,1,0.0
PIAH,1,0.0
2009-associated,1,0.0
PIA,1,0.0
evidentiary,1,0.0
sequela,1,0.0
18-26,1,0.0
tips,1,0.0
epidemic-originating,1,0.0
aerosol-infected,1,0.0
percent-predicted,1,0.0
dipyridamol,1,0.0
AHA∕ASA,1,0.0
OSCTC,1,0.0
HIV-,1,0.0
HIV-uninfected,1,0.0
FRS-S,1,0.0
assurances,1,0.0
visitations,1,0.0
California0709,1,0.0
non-neutral,1,0.0
non-caregivers,1,0.0
agonistic,1,0.0
jamming,1,0.0
jammed,1,0.0
solid-like,1,0.0
quiescent,1,0.0
fluid-like,1,0.0
hypermobile,1,0.0
maturing,1,0.0
innately,1,0.0
Hallmarks,1,0.0
household-level,1,0.0
factor-β1,1,0.0
governed,1,0.0
rs12212740,1,0.0
10-7,1,0.0
0868,1,0.0
leave-one-out,1,0.0
off-site,1,0.0
PyRadiomics,1,0.0
HRCTs,1,0.0
nCOVID,1,0.0
disesase,1,0.0
tipically,1,0.0
17-185,1,0.0
OSCTCs,1,0.0
experiential,1,0.0
pharmacogenomic,1,0.0
060,1,0.0
extrac-tion-free,1,0.0
futility,1,0.0
2B,1,0.0
trialists,1,0.0
humane,1,0.0
preventionmanagement,1,0.0
dyad,1,0.0
survivor-caregiver,1,0.0
PsychInfo,1,0.0
off-reserve,1,0.0
-65,1,0.0
500-530,1,0.0
515-fold,1,0.0
on-reserve,1,0.0
279-287,1,0.0
non-First,1,0.0
post-test,1,0.0
1969--70,1,0.0
Midlands,1,0.0
1967--72,1,0.0
Secunderabad,1,0.0
-98,1,0.0
levelsObjectives,1,0.0
extrahepatic,1,0.0
0903,1,0.0
ductal,1,0.0
pruritus,1,0.0
antimitochondrial,1,0.0
p002Conclusions,1,0.0
8730,1,0.0
Paretic,1,0.0
0302,1,0.0
0502,1,0.0
4538,1,0.0
useday,1,0.0
6733,1,0.0
controlsMethods,1,0.0
ULResults,1,0.0
non-dominantdominant,1,0.0
pareticnon-paretic,1,0.0
accelerometers,1,0.0
wrist-worn,1,0.0
60±11,1,0.0
23-50,1,0.0
51-66,1,0.0
61±12,1,0.0
≤4-weeks,1,0.0
dysmature,1,0.0
SRT,1,0.0
populace,1,0.0
1μg,1,0.0
Bourboule,1,0.0
spa,1,0.0
CK--MB,1,0.0
CK--MM,1,0.0
CK-isoenzymes,1,0.0
MB-isoenzyme,1,0.0
cardiospecific,1,0.0
alum-3M-052,1,0.0
TLR78,1,0.0
adjuvanting,1,0.0
Multimeric,1,0.0
FEV1VC,1,0.0
horror,1,0.0
officer,1,0.0
commanding,1,0.0
Mozambique,1,0.0
Corps,1,0.0
Martin,1,0.0
Jules,1,0.0
uncle,1,0.0
Non-specific,1,0.0
thoracis,1,0.0
seiousness,1,0.0
bronchii,1,0.0
neuroborreliosis,1,0.0
joyful,1,0.0
ever-spreading,1,0.0
already-approved,1,0.0
engulfed,1,0.0
subsegmental,1,0.0
operationallogistic,1,0.0
two-day,1,0.0
Round,1,0.0
diseaseendocarditis,1,0.0
7-December,1,0.0
socio-environmental,1,0.0
happy,1,0.0
disastolic,1,0.0
physicalfunctional,1,0.0
healthiness,1,0.0
dyssynergies,1,0.0
multiparametric,1,0.0
Elite,1,0.0
curiosity,1,0.0
milking,1,0.0
Periarterial,1,0.0
Dofetilide,1,0.0
Ls,1,0.0
gene-environmental,1,0.0
glibenclamide,1,0.0
calcific,1,0.0
QuebecThe,1,0.0
categorically,1,0.0
noncleaved,1,0.0
34-aminoacid,1,0.0
neuro-ophthalmic,1,0.0
preceed,1,0.0
demoralization,1,0.0
stumbling,1,0.0
materials-transfer,1,0.0
solo,1,0.0
next-gen,1,0.0
epigenetics,1,0.0
Np,1,0.0
axon,1,0.0
Faroe,1,0.0
PCV13,1,0.0
IPD,1,0.0
seven-valent,1,0.0
revolutionised,1,0.0
38-54,1,0.0
68-93,1,0.0
≤49,1,0.0
17-48,1,0.0
NP56--NP53,1,0.0
RNA-binding,1,0.0
NCCa-ATP,1,0.0
Medicinal,1,0.0
1-regulated,1,0.0
bleak,1,0.0
Decompressive,1,0.0
CHIS,1,0.0
659000,1,0.0
475000,1,0.0
Inadequately,1,0.0
inoperable,1,0.0
radiologically-guided,1,0.0
mechanism--spontaneous,1,0.0
character--lysis,1,0.0
corrective,1,0.0
semeiotics,1,0.0
radio-angiographic,1,0.0
hour-delayed,1,0.0
corticoids,1,0.0
122-757,1,0.0
3048,1,0.0
122-771,1,0.0
108-1197,1,0.0
kidney-liver,1,0.0
thirty-two,1,0.0
Sierra,1,0.0
absorbs,1,0.0
L5F,1,0.0
anatomopathological,1,0.0
1879047,1,0.0
domiciles,1,0.0
afflictions,1,0.0
Sur,1,0.0
Ecuadorian,1,0.0
overran,1,0.0
health-risk,1,0.0
AH9N2,1,0.0
17-month-old,1,0.0
ARWMC,1,0.0
COVID-secure,1,0.0
root-mean-square,1,0.0
dromes,1,0.0
syn-,1,0.0
pentose,1,0.0
pyrimidine,1,0.0
L-threonine,1,0.0
oxalic,1,0.0
tabolism,1,0.0
me-,1,0.0
mino-malonic,1,0.0
creased,1,0.0
Signal,1,0.0
RMS-V,1,0.0
stearic,1,0.0
Propensity,1,0.0
sniffles,1,0.0
10129,1,0.0
45150,1,0.0
POSCH,1,0.0
Hyperlipidemias,1,0.0
exercised-induced,1,0.0
generalmild,1,0.0
severecritical,1,0.0
n677,1,0.0
n289,1,0.0
n966,1,0.0
postcoronary,1,0.0
lagophthalmos,1,0.0
Severe-Acute-Respiratory-Syndrom-Corona-Virus-2,1,0.0
resorption-necrotic,1,0.0
mat,1,0.0
lactate-dehydrogenase,1,0.0
Matrix-M,1,0.0
NVX-CoV2373,1,0.0
worrisome,1,0.0
deathABSTRACT,1,0.0
tachycardiaventricular,1,0.0
de-,1,0.0
Metaboanalyst,1,0.0
pleurisy,1,0.0
Pay,1,0.0
Southwest,1,0.0
40-49,1,0.0
2206,1,0.0
2429,1,0.0
Managing,1,0.0
choke,1,0.0
immunoprivilege,1,0.0
neuroregenerative,1,0.0
anti-risk,1,0.0
epidemic-associated,1,0.0
Refine,1,0.0
underweight,1,0.0
Establish,1,0.0
matureas,1,0.0
Rochester,1,0.0
coalition,1,0.0
delay60,1,0.0
PCI-related,1,0.0
angioplasty-related,1,0.0
risk-time,1,0.0
linnaeus,1,0.0
cabro,1,0.0
vegetable-based,1,0.0
Resident,1,0.0
intergroup,1,0.0
cost-control,1,0.0
VIP,1,0.0
vari-,1,0.0
OPLS-DA,1,0.0
squares-discriminant,1,0.0
ted,1,0.0
recrui-,1,0.0
trometrymass,1,0.0
spec-,1,0.0
chromatography-mass,1,0.0
phlegm-heat,1,0.0
100-102,1,0.0
Potency,1,0.0
110-120,1,0.0
150-930,1,0.0
non-active,1,0.0
chemo-radiotherapy,1,0.0
metastases,1,0.0
4918,1,0.0
httpsbitly2KJxAbp,1,0.0
non-Asian,1,0.0
instituting,1,0.0
Deficits,1,0.0
bronchovascular,1,0.0
Complemented,1,0.0
hornet,1,0.0
tubes-containing,1,0.0
Duplicate,1,0.0
-weighting,1,0.0
birdcage,1,0.0
Na,1,0.0
H23,1,0.0
double-tuned,1,0.0
resonators,1,0.0
Non-black,1,0.0
275046,1,0.0
COVID19Speed-Antigen,1,0.0
nonduplicated,1,0.0
practicalities,1,0.0
lateral-flow,1,0.0
Trans-thoracic,1,0.0
dysorientation,1,0.0
novelvariant,1,0.0
LNP-encapsulated,1,0.0
suboptimum,1,0.0
18-20,1,0.0
Description,1,0.0
horn,1,0.0
methylamine,1,0.0
unenhanced,1,0.0
propel,1,0.0
dimethylaminohydrolase,1,0.0
hoursday,1,0.0
HLA-A6601,1,0.0
HLA-B4403,1,0.0
HLA-B4402,1,0.0
HLA-B2705,1,0.0
NetMHC,1,0.0
HLAs,1,0.0
practicality,1,0.0
real--,1,0.0
pre-test,1,0.0
Fleischner,1,0.0
Modem,1,0.0
ultraearly,1,0.0
Arterio-venous,1,0.0
Etiologies,1,0.0
Guide,1,0.0
2007-08,1,0.0
30-December,1,0.0
tombstone,1,0.0
emergency-use,1,0.0
Teijaro,1,0.0
Walsh,1,0.0
65-85,1,0.0
citrulline,1,0.0
Dimethylarginine,1,0.0
South-East,1,0.0
Dipeptidyl,1,0.0
sphincters,1,0.0
cerucal,1,0.0
metoclopramide,1,0.0
flown,1,0.0
superesophageal,1,0.0
electromanometry,1,0.0
Diminution,1,0.0
pH-metry,1,0.0
intraesophageal,1,0.0
Ishikawa,1,0.0
3818,1,0.0
Fully,1,0.0
HRT,1,0.0
lab-on-a-chip,1,0.0
IΙIIΙ,1,0.0
nanovaccines,1,0.0
nanocarriers,1,0.0
nano-coatings,1,0.0
game-changing,1,0.0
3394,1,0.0
AJohannesburg,1,0.0
adenosyncytial,1,0.0
efficacyeffectiveness,1,0.0
anti-histamines,1,0.0
breached,1,0.0
specimen-to-answer,1,0.0
centrilobular,1,0.0
pack-years,1,0.0
primordial,1,0.0
ORL,1,0.0
MAARI,1,0.0
studyConclusions,1,0.0
weak-positive,1,0.0
OPA,1,0.0
2021Results,1,0.0
SARS-CoV-2Research,1,0.0
GeneXpert®,1,0.0
anti-leukotrienes,1,0.0
polymerase-chain,1,0.0
anaphylaxic,1,0.0
ST-R,1,0.0
ceremony,1,0.0
Ceremony,1,0.0
sectoral,1,0.0
burden-of-disease,1,0.0
translations,1,0.0
acronyms,1,0.0
x03B22,1,0.0
Vespa,1,0.0
87-year-old,1,0.0
Picture,1,0.0
-77,1,0.0
Diuresis,1,0.0
-577,1,0.0
-420,1,0.0
-616,1,0.0
-324,1,0.0
MEF60TLC,1,0.0
-352,1,0.0
-160,1,0.0
MEF50VC,1,0.0
-233,1,0.0
-115,1,0.0
Epidemiologically,1,0.0
Bronchodilatation,1,0.0
Programming,1,0.0
Non-sustained,1,0.0
cardioverter,1,0.0
B2,1,0.0
B1,1,0.0
IGR,1,0.0
ANFIS-predicted,1,0.0
CRR,1,0.0
22-110,1,0.0
domiciliary,1,0.0
Genotyping,1,0.0
1637-600,1,0.0
7976-8085,1,0.0
-0852,1,0.0
PICCO,1,0.0
08-1,1,0.0
PEEP,1,0.0
26-42,1,0.0
vasodilation,1,0.0
pressurefractional,1,0.0
syndrome-induced,1,0.0
45965,1,0.0
skin-tests,1,0.0
8031,1,0.0
ThermoFishers,1,0.0
6472-6995,1,0.0
6610,1,0.0
9244-9992,1,0.0
283-333,1,0.0
physiotherapists,1,0.0
GCA,1,0.0
S982A,1,0.0
TTA,1,0.0
ACATGT,1,0.0
69-70,1,0.0
cm3,1,0.0
0489,1,0.0
2-fluoro-2-deoxycytidine,1,0.0
ASIs,1,0.0
formalin,1,0.0
buffered,1,0.0
Resected,1,0.0
measureABSTRACT,1,0.0
PCO2,1,0.0
symptom-reporting,1,0.0
Self-concept,1,0.0
paired-comparison,1,0.0
Attitude,1,0.0
Grades,1,0.0
leap,1,0.0
hematoxylin-eosin,1,0.0
Caseous,1,0.0
Pfizer-,1,0.0
AstraZeneca-Oxford,1,0.0
1581,1,0.0
2524,1,0.0
Protracted,1,0.0
3d,1,0.0
NESID,1,0.0
suspects,1,0.0
non-characteristic,1,0.0
microns-thick,1,0.0
1980-1999,1,0.0
MMCA,1,0.0
commonplace,1,0.0
Inference,1,0.0
Neuro-Fuzzy,1,0.0
precipitators,1,0.0
Mastery,1,0.0
Asthma-education,1,0.0
smooth-muscle,1,0.0
ASOR,1,0.0
host-related,1,0.0
highest-volume,1,0.0
restructure,1,0.0
enoxaparin,1,0.0
15420,1,0.0
11B,1,0.0
ESSENCE,1,0.0
Enoxaparin,1,0.0
Subcutaneous,1,0.0
Tonsillectomy,1,0.0
137-295,1,0.0
007-243,1,0.0
One-fourth,1,0.0
n139,1,0.0
n544,1,0.0
oxygenatory,1,0.0
image-based,1,0.0
scopolamine,1,0.0
-046,1,0.0
consortiums,1,0.0
Mongolian,1,0.0
enlarge,1,0.0
topologies,1,0.0
oppose,1,0.0
pandemic-deniers,1,0.0
propagates,1,0.0
Misinformation,1,0.0
02-97,1,0.0
796,1,0.0
three-armed,1,0.0
bendrofluazide,1,0.0
NASN,1,0.0
20bps,1,0.0
catalogued,1,0.0
Cardio-respiratory,1,0.0
201679895-906,1,0.0
angiotencin,1,0.0
tractable,1,0.0
gliogenesis,1,0.0
chronic-care,1,0.0
cognisant,1,0.0
CO,1,0.0
β-blocker,1,0.0
Details,1,0.0
1824-2403,1,0.0
9852,1,0.0
device-related,1,0.0
disqualified,1,0.0
21s⁢t,1,0.0
Zombie-city,1,0.0
denser,1,0.0
transmited,1,0.0
consummation,1,0.0
industry-wide,1,0.0
swarm,1,0.0
2099,1,0.0
dormant,1,0.0
1971-2570,1,0.0
2256,1,0.0
1764-2334,1,0.0
2034,1,0.0
19992001,1,0.0
199495,1,0.0
MONICAKORA,1,0.0
23∶1,1,0.0
Excel,1,0.0
resurrected,1,0.0
detract,1,0.0
cost-containing,1,0.0
monophosphate,1,0.0
670-21600,1,0.0
eagerly,1,0.0
granulocyte-macrophage,1,0.0
-5,1,0.0
Th2Th1,1,0.0
preventions,1,0.0
lipoprotein-cholesterol,1,0.0
Demonstrating,1,0.0
catheter-related,1,0.0
4-234,1,0.0
4-204,1,0.0
6521,1,0.0
IL-25,1,0.0
4366,1,0.0
325-375,1,0.0
Murray,1,0.0
cmH2,1,0.0
end-expiratory,1,0.0
450-638,1,0.0
oxygenfraction,1,0.0
21-59,1,0.0
Anzhen,1,0.0
difluoro,1,0.0
Roles,1,0.0
-33,1,0.0
digestible,1,0.0
775-982,1,0.0
customizing,1,0.0
sensitizer-induced,1,0.0
misinterpreted,1,0.0
family-based,1,0.0
sociocontextual,1,0.0
Contrastingly,1,0.0
proofreading,1,0.0
retroviruses,1,0.0
Estimate,1,0.0
578-879,1,0.0
ComirnatyVaxzevria,1,0.0
Renin-Angiotensin-Aldosterone,1,0.0
410-577,1,0.0
905-981,1,0.0
VaxzevriaComirnaty,1,0.0
first-dose,1,0.0
symptomaticconfirmed,1,0.0
Reactogenicity,1,0.0
adenoviral-vector,1,0.0
Astute,1,0.0
disconnected,1,0.0
lymphopoietin,1,0.0
immune-modulatory,1,0.0
neuro-protective,1,0.0
CT-angiography,1,0.0
incoming,1,0.0
52-year,1,0.0
SJ,1,0.0
7353,1,0.0
HEK293T-ACE2,1,0.0
lentiviral,1,0.0
BLI,1,0.0
interferometry,1,0.0
biolayer,1,0.0
AlphaLISA,1,0.0
pulldown,1,0.0
Productive,1,0.0
nonresidential,1,0.0
featuresHere,1,0.0
pathophysiology-based,1,0.0
phenotypeThe,1,0.0
Co-diagnosis,1,0.0
4-72,1,0.0
Milano,1,0.0
malnutrition-linked,1,0.0
malnutrition-induced,1,0.0
speculating,1,0.0
behave,1,0.0
Worksites,1,0.0
2020‒September,1,0.0
wide‐spread,1,0.0
young-onset,1,0.0
reorganisation,1,0.0
1972-1973,1,0.0
1982-83,1,0.0
2000-2009,1,0.0
70-80,1,0.0
microarray-based,1,0.0
Cas-9,1,0.0
humanitarian,1,0.0
potentiality,1,0.0
researching,1,0.0
negative-predictive,1,0.0
warehousing,1,0.0
positive-predictive,1,0.0
nephelometric-based,1,0.0
CAR,1,0.0
past-year,1,0.0
mail,1,0.0
reliever-only,1,0.0
Overuse,1,0.0
overshadow,1,0.0
22-September,1,0.0
hard-metal-induced,1,0.0
CRO-VAX,1,0.0
demoralisation,1,0.0
Noncommunicable,1,0.0
infarctionMI,1,0.0
Euclidean,1,0.0
correlograms,1,0.0
Mantel,1,0.0
dissimilarity,1,0.0
6-16,1,0.0
mission,1,0.0
perfusionist,1,0.0
anesthesiologist,1,0.0
oxygenator,1,0.0
cortico,1,0.0
SLEwho,1,0.0
waterbird,1,0.0
gluten,1,0.0
HLA-DQ,1,0.0
HLA-DR,1,0.0
survives,1,0.0
glucuronidation,1,0.0
intermolecular,1,0.0
π-π,1,0.0
1-piperoylpiperidine,1,0.0
inhabit,1,0.0
nigrum,1,0.0
least-cost,1,0.0
human-mediated,1,0.0
thyrotoxicosis,1,0.0
administrators,1,0.0
antihyperthyroidal,1,0.0
zerumbet,1,0.0
Alpinia,1,0.0
Ethnopharmacology,1,0.0
single-hit,1,0.0
non-productive,1,0.0
plaque-forming,1,0.0
cell-to-cell,1,0.0
re-open,1,0.0
under-equipped,1,0.0
h24,1,0.0
Baidu,1,0.0
CT-scan,1,0.0
004-013,1,0.0
37778,1,0.0
South-Eastern,1,0.0
fifty-nine,1,0.0
ARCHITECT,1,0.0
r043,1,0.0
r098,1,0.0
cyber,1,0.0
engine,1,0.0
non-lesioned,1,0.0
tolerates,1,0.0
Green,1,0.0
Co-expression,1,0.0
pre-established,1,0.0
empiricism,1,0.0
ischaemiareperfusion,1,0.0
2000-03,1,0.0
sponsor,1,0.0
segregating,1,0.0
meat-processing,1,0.0
2222,1,0.0
Catalonian,1,0.0
truncation,1,0.0
co-immunoprecipitation,1,0.0
preventively,1,0.0
His-pull-down,1,0.0
1NOLC1,1,0.0
coiled-body,1,0.0
nucleolar,1,0.0
clone,1,0.0
T7-phage,1,0.0
Nonstructural,1,0.0
membranotoxic,1,0.0
cardiosclerosis,1,0.0
postmyocarditic,1,0.0
inevitability,1,0.0
gynecologists,1,0.0
ferulas,1,0.0
projecting,1,0.0
investigatedThe,1,0.0
non-replicating,1,0.0
nonstandardized,1,0.0
motion-derived,1,0.0
RNV-LVEF,1,0.0
15x,1,0.0
nine-segment,1,0.0
LDLHDL,1,0.0
boredom,1,0.0
half-saturated,1,0.0
pre-vaccination,1,0.0
defected,1,0.0
northern-hemisphere,1,0.0
Simplifying,1,0.0
1959-73,1,0.0
Guidelines-based,1,0.0
producers,1,0.0
naming,1,0.0
geese,1,0.0
Patient-provider,1,0.0
vagaries,1,0.0
palpation,1,0.0
vascular-type,1,0.0
erythrocyte-rich,1,0.0
Sloan-Kettering,1,0.0
psycho-clinical,1,0.0
Blockers,1,0.0
SARs,1,0.0
bisection,1,0.0
paraventricular,1,0.0
imperfections,1,0.0
under-study,1,0.0
function-based,1,0.0
stifle,1,0.0
misused,1,0.0
Export,1,0.0
fatalistic,1,0.0
steroid-requiring,1,0.0
fatalism,1,0.0
biomaterial-based,1,0.0
prominence,1,0.0
vaccinesdrugs,1,0.0
Córdoba,1,0.0
Plata,1,0.0
Mar,1,0.0
mucocutaneous,1,0.0
pdm,1,0.0
therafter,1,0.0
Nonspecific,1,0.0
age-predicted,1,0.0
andperiwall,1,0.0
Orient,1,0.0
medium-size,1,0.0
arteriole,1,0.0
asphixy,1,0.0
morphofunctional,1,0.0
cassettes,1,0.0
Orientgene,1,0.0
Boson,1,0.0
Biosynex,1,0.0
Genrui,1,0.0
G614D164,1,0.0
Zheihang,1,0.0
sensitivityABSTRACT,1,0.0
Operational,1,0.0
well-characterised,1,0.0
bioaccumulation,1,0.0
cardiotoxic,1,0.0
depressor,1,0.0
T-1824,1,0.0
indulant,1,0.0
133Xenon,1,0.0
2-wk,1,0.0
interposed,1,0.0
Piper,1,0.0
Longa,1,0.0
dEfiniTion,1,0.0
Presenting,1,0.0
bone-marrow,1,0.0
core-clinical,1,0.0
036-9529,1,0.0
13-3378,1,0.0
core-not-too-large,1,0.0
176-643,1,0.0
746-180,1,0.0
extraneous,1,0.0
Eligibility,1,0.0
Roys,1,0.0
Wake,1,0.0
-09,1,0.0
55-year,1,0.0
658,1,0.0
2795,1,0.0
1918-type,1,0.0
Pandemic-level,1,0.0
asthma-management,1,0.0
non-urgent,1,0.0
postponing,1,0.0
Unprecedented,1,0.0
≈8400-12600,1,0.0
double-blinding,1,0.0
inductor,1,0.0
≈82,1,0.0
variants1314,1,0.0
identificationexclusion,1,0.0
divergences,1,0.0
VATT,1,0.0
VIPIT,1,0.0
variously,1,0.0
profileefficiency,1,0.0
bottleneck--is,1,0.0
transmission--the,1,0.0
error-prone,1,0.0
counsellors,1,0.0
103-124-fold,1,0.0
LENS,1,0.0
94-fold,1,0.0
Africa12,1,0.0
UK11,1,0.0
COVID-19910,1,0.0
promise8,1,0.0
development4-7,1,0.0
authorization1-3,1,0.0
poludanum,1,0.0
0058,1,0.0
Pharm,1,0.0
neuraminidase-inhibiting,1,0.0
nonembolic,1,0.0
over-diagnose,1,0.0
Approach,1,0.0
resilient,1,0.0
besieged,1,0.0
phenotypesendotypes,1,0.0
submolecular,1,0.0
pathobiologic,1,0.0
groupings,1,0.0
1359,1,0.0
Trim-and-fill,1,0.0
trim-and-fill,1,0.0
Egger,1,0.0
CAMARADES,1,0.0
scourge,1,0.0
truths,1,0.0
textbooks,1,0.0
8860,1,0.0
TGF-beta1,1,0.0
co-regulated,1,0.0
Networks,1,0.0
Nevada,1,0.0
Valley,1,0.0
geographically-distant,1,0.0
miles,1,0.0
unearthed,1,0.0
suburbanization,1,0.0
reexposed,1,0.0
cardiomiocytes,1,0.0
acarabose,1,0.0
triflusal,1,0.0
XYFXYM,1,0.0
XXFXXM,1,0.0
XYwt,1,0.0
Sry,1,0.0
testis,1,0.0
Genotype,1,0.0
dimorphic,1,0.0
triiodothyronine,1,0.0
T4,1,0.0
Community-Led,1,0.0
bed-care,1,0.0
red-blood-cell,1,0.0
sero-epidemiologic,1,0.0
expediate,1,0.0
non-normal,1,0.0
0303,1,0.0
Appropriately,1,0.0
Orally,1,0.0
ozonation,1,0.0
CLTS,1,0.0
heparin-induced,1,0.0
PF4-ELISA,1,0.0
ayurvedic,1,0.0
Membrane,1,0.0
genus-,1,0.0
interspersed,1,0.0
sickle-cell,1,0.0
80-yr-old,1,0.0
extramedullary,1,0.0
Fine-needle,1,0.0
hematopoiesis,1,0.0
lays,1,0.0
inserts,1,0.0
shallower,1,0.0
helix-turn-helix,1,0.0
cross-talking,1,0.0
D839-F855,1,0.0
S816-G838,1,0.0
postfusion,1,0.0
Ageing,1,0.0
16-24,1,0.0
26-36,1,0.0
thirty-day,1,0.0
239-291,1,0.0
214-266,1,0.0
258-320,1,0.0
species-specificity,1,0.0
Saud,1,0.0
want--less,1,0.0
handicaps,1,0.0
kick-off,1,0.0
41-67,1,0.0
sapiens,1,0.0
Homo,1,0.0
Ethical,1,0.0
Convenience,1,0.0
manpower,1,0.0
neuralgia,1,0.0
Twentieth,1,0.0
Generic,1,0.0
airspaces,1,0.0
KSMC,1,0.0
endorse,1,0.0
transgender,1,0.0
gaylesbian,1,0.0
bisexualpansexual,1,0.0
Transgender,1,0.0
minoritized,1,0.0
disease-causing,1,0.0
cross-exploration,1,0.0
Privacy,1,0.0
Riyadh,1,0.0
196-250,1,0.0
25-years,1,0.0
W-shaped,1,0.0
reconstituted,1,0.0
023-084,1,0.0
024-106,1,0.0
009-056,1,0.0
0-073,1,0.0
RBs,1,0.0
seroresponse,1,0.0
ketitofen,1,0.0
depots,1,0.0
intraorganelle,1,0.0
calcium-dependent,1,0.0
assemble,1,0.0
Mitogen-activated,1,0.0
anti-pneumococcal,1,0.0
Primitive,1,0.0
camphor,1,0.0
codeine,1,0.0
salicylates,1,0.0
valerianate,1,0.0
quinine,1,0.0
antiseptic,1,0.0
Pre-existing,1,0.0
morbiditymortality,1,0.0
incrementally,1,0.0
signal-regulated,1,0.0
looked-for,1,0.0
anti-immunoglobulin,1,0.0
Postprocedural,1,0.0
1081,1,0.0
4392,1,0.0
11872,1,0.0
Bach2-deficient,1,0.0
hyporeactivity,1,0.0
Depletion,1,0.0
dsmCRIPSR,1,0.0
Alveolar,1,0.0
aspirin-induced,1,0.0
Segregation,1,0.0
ERK,1,0.0
coresidents,1,0.0
Examining,1,0.0
oval,1,0.0
SP600125,1,0.0
p38alpha,1,0.0
SB239063,1,0.0
U0126,1,0.0
accentuating,1,0.0
NH2-terminal,1,0.0
c-Jun,1,0.0
INfarction,1,0.0
J-MINUET,1,0.0
Diffusion-weightedimaging-fluid-attenuated,1,0.0
Gestational,1,0.0
unvalidated,1,0.0
hardest,1,0.0
March-May,1,0.0
2331175,1,0.0
code-based,1,0.0
Positivity,1,0.0
Listening,1,0.0
presession,1,0.0
Relaxation-group,1,0.0
prestabilized,1,0.0
unlocks,1,0.0
Test™,1,0.0
potentiostat,1,0.0
MIP-endowed,1,0.0
interfaced,1,0.0
desperately,1,0.0
MIP-based,1,0.0
antibody-like,1,0.0
MIPs,1,0.0
Molecularly,1,0.0
transplantable,1,0.0
sequester,1,0.0
ionizing,1,0.0
extrasystolic,1,0.0
notch-transfected,1,0.0
fluidic,1,0.0
Theories,1,0.0
A9™-eluting,1,0.0
Biolimus,1,0.0
120bpm,1,0.0
levelled,1,0.0
regurgitant,1,0.0
mm-58,1,0.0
evidence-practice,1,0.0
Tasmania,1,0.0
single-use,1,0.0
micropillar,1,0.0
subcontinent,1,0.0
resonator,1,0.0
nitride,1,0.0
rice-sized,1,0.0
photonics,1,0.0
CMOS,1,0.0
photonic,1,0.0
immunopathobiological,1,0.0
worldwideThe,1,0.0
Wuhan-related,1,0.0
Fabreceptor,1,0.0
SB623,1,0.0
CTX0E03,1,0.0
Stoughton,1,0.0
BioNTechs,1,0.0
CNJ176,1,0.0
CAA159,1,0.0
httpsbitly3gZqA7Z,1,0.0
pneumothoraxpneumomediastinum,1,0.0
Senior,1,0.0
532340,1,0.0
11327790,1,0.0
-0104,1,0.0
-0517,1,0.0
-0602,1,0.0
self-estimated,1,0.0
mid-portion,1,0.0
1625,1,0.0
eosinopenia,1,0.0
whole-blood,1,0.0
pharmacovigillence,1,0.0
anti-PD1,1,0.0
IFN-γIL-2RIL-18IL-16IL-10,1,0.0
anti-PD-1,1,0.0
vaccine-in,1,0.0
tozinameran-the,1,0.0
BTN162b2,1,0.0
Mich,1,0.0
thrombosis-occluded,1,0.0
c-mycERTAM,1,0.0
endosomes,1,0.0
NT2N,1,0.0
neuron-like,1,0.0
Ntera2D1,1,0.0
teratocarcinoma-derived,1,0.0
iPSCs,1,0.0
milk-derived,1,0.0
extraembryonic,1,0.0
VSELs,1,0.0
embryonic-like,1,0.0
HSCs,1,0.0
Internalized,1,0.0
anastomosed,1,0.0
25-hydroxycholesterol,1,0.0
VSV-SARS-CoV-2,1,0.0
VSV-SARS-CoV,1,0.0
25-hydroxylase,1,0.0
Cholesterol,1,0.0
boycotting,1,0.0
victimisation,1,0.0
SMVR,1,0.0
MitraClip,1,0.0
TMVR,1,0.0
Carmichael,1,0.0
McKenzie,1,0.0
Polymorphous,1,0.0
innocent,1,0.0
Carnosine-stimulated,1,0.0
N-β-alanyl-1-methyl-L-histidine,1,0.0
β-alanyl-L-histidine,1,0.0
Polymorphonuclear,1,0.0
grapples,1,0.0
Katrina,1,0.0
underrecognition,1,0.0
Underdiagnosis,1,0.0
co-exist,1,0.0
white-matter,1,0.0
Purposes,1,0.0
histidine,1,0.0
sIgADcommon,1,0.0
wrestling,1,0.0
headlock,1,0.0
hypocoagulability,1,0.0
ADCs,1,0.0
direction-dependent,1,0.0
nondestructive,1,0.0
disfiguring,1,0.0
thoracoplasty,1,0.0
flaps,1,0.0
unappreciated,1,0.0
imidazole-containing,1,0.0
httpwwwcdcgovfluweeklyfluactivitysurvhtm,1,0.0
neuro-humoral,1,0.0
diisocyanate-induced,1,0.0
Ground,1,0.0
2381,1,0.0
8211234,1,0.0
01ABSTRACT,1,0.0
Subendocardial,1,0.0
1720,1,0.0
Indices,1,0.0
dihydropyridine,1,0.0
Amlodipine,1,0.0
biotherapeutic,1,0.0
histidine-containing,1,0.0
vote,1,0.0
streptokinase-induced,1,0.0
high-rate,1,0.0
TSP,1,0.0
neurorehabilitative,1,0.0
connotation,1,0.0
L-carnosine,1,0.0
non-hydrolized,1,0.0
histidine-containg,1,0.0
nonhydrolized,1,0.0
29-December,1,0.0
compiles,1,0.0
corticosteroid-sensitive,1,0.0
eluates,1,0.0
HERNS,1,0.0
CARASIL,1,0.0
delusions,1,0.0
Dysfunction,1,0.0
GXST,1,0.0
Guanxinshutong,1,0.0
promotional,1,0.0
NIVW,1,0.0
COVIDISC,1,0.0
microliter,1,0.0
naso-pharyngal,1,0.0
Provincial,1,0.0
intercalating,1,0.0
isothermally,1,0.0
microfluidics,1,0.0
harnessing,1,0.0
A-derived,1,0.0
Defective,1,0.0
p036,1,0.0
p0043,1,0.0
resolution70,1,0.0
CMR-defined,1,0.0
accompaniments,1,0.0
casirimabimdevimab,1,0.0
Bowel,1,0.0
60ies,1,0.0
06-09,1,0.0
n33,1,0.0
post-MT,1,0.0
anterior-circulation,1,0.0
Editions,1,0.0
Tenth,1,0.0
seminal,1,0.0
dermatophytes,1,0.0
well-selected,1,0.0
70ies,1,0.0
refinements,1,0.0
jeopardy,1,0.0
Specificities,1,0.0
066-093,1,0.0
088-111,1,0.0
5507,1,0.0
Beggs,1,0.0
Cochrans,1,0.0
ISI,1,0.0
Alborz,1,0.0
T2-weigthed,1,0.0
T2w-CMR,1,0.0
polymorphous,1,0.0
6-17months,1,0.0
3283,1,0.0
AH1N1-induced,1,0.0
intraabdominal,1,0.0
forceful,1,0.0
motoric,1,0.0
domineering,1,0.0
overprotection,1,0.0
psychomatic,1,0.0
Arab-speaking,1,0.0
immune-efficacy,1,0.0
inhalational,1,0.0
anthracis,1,0.0
unimaginable,1,0.0
membranaceous,1,0.0
2423,1,0.0
celery,1,0.0
1122,1,0.0
8060,1,0.0
sativa,1,0.0
Nigella,1,0.0
Beta-adrenergic,1,0.0
PB,1,0.0
graftABSTRACT,1,0.0
nonbypassed,1,0.0
pushes,1,0.0
psychoneurogenic,1,0.0
nonpositive,1,0.0
37-40,1,0.0
Pre-pandemic,1,0.0
Dioro,1,0.0
commune,1,0.0
CoPanFlu-Mali,1,0.0
complimentary,1,0.0
45-157,1,0.0
prevalence-to-incidence,1,0.0
70-86,1,0.0
29-33,1,0.0
46-52,1,0.0
DiaSorinThe,1,0.0
dsmCRISPR,1,0.0
54357,1,0.0
per-country,1,0.0
22WABSTRACT,1,0.0
LVSWI,1,0.0
I-II,1,0.0
cath,1,0.0
EC-Graphic,1,0.0
antero-inferior,1,0.0
infero-dorsal,1,0.0
CRISPRCas12a,1,0.0
Mannitol,1,0.0
LFB,1,0.0
seroconversions,1,0.0
Xiong,1,0.0
well-conserved,1,0.0
crRNA--1,1,0.0
scaffold,1,0.0
biopolymers,1,0.0
neuromotor,1,0.0
False-negative,1,0.0
noninvasiveness,1,0.0
treatmentIHD,1,0.0
011-084,1,0.0
03-fold,1,0.0
Chuan,1,0.0
Macaque,1,0.0
Dan,1,0.0
methodThere,1,0.0
1345,1,0.0
patientsTaiwanese,1,0.0
nonrecognition,1,0.0
flowAntiplatelet,1,0.0
angiographyPre-procedural,1,0.0
2182,1,0.0
689,1,0.0
2262,1,0.0
Lacunar-type,1,0.0
lacunar-type,1,0.0
CrRNAs,1,0.0
re-infarctions,1,0.0
ssDNA,1,0.0
CRISPR-Cas12a-based,1,0.0
Subcommittee,1,0.0
Biodefense,1,0.0
Nowhere,1,0.0
nephelometric,1,0.0
annealing,1,0.0
satisfactoryABSTRACT,1,0.0
hypofixation,1,0.0
scintigraphies,1,0.0
ST-changes,1,0.0
gliosis,1,0.0
CK-group,1,0.0
l-1,1,0.0
401-800,1,0.0
201-400,1,0.0
extra-systole,1,0.0
GABAergic,1,0.0
valproate,1,0.0
NSF,1,0.0
managementtreatment,1,0.0
140000,1,0.0
≥180,1,0.0
124-149,1,0.0
602days,1,0.0
long-read,1,0.0
Shizuoka,1,0.0
TAUNS,1,0.0
0·82,1,0.0
7165,1,0.0
35000,1,0.0
three-site,1,0.0
TRS-independent,1,0.0
RNA-RNA,1,0.0
template-switching,1,0.0
polyA,1,0.0
TRS-dependent,1,0.0
841-931,1,0.0
transcription-regulating,1,0.0
Creation,1,0.0
NAAT-based,1,0.0
contract-tracing,1,0.0
Drug-resistant,1,0.0
Rimantadine,1,0.0
0994,1,0.0
L2-regularized,1,0.0
learning-based,1,0.0
brush-based,1,0.0
938-989,1,0.0
874-999,1,0.0
8985,1,0.0
insertiondeletion,1,0.0
24days,1,0.0
Right-sided,1,0.0
505days,1,0.0
univariable,1,0.0
diathermy,1,0.0
posttranslational,1,0.0
micro-RNA,1,0.0
17-59,1,0.0
105-170,1,0.0
angiotensin-1-converting,1,0.0
826,1,0.0
821-979,1,0.0
two-third,1,0.0
1287,1,0.0
self-administrated,1,0.0
hesitance,1,0.0
752-1401,1,0.0
1026,1,0.0
619-1712,1,0.0
1029,1,0.0
Sf9,1,0.0
alarm-to-treatment,1,0.0
2010-2017,1,0.0
65-item,1,0.0
0-19-year,1,0.0
modern-day,1,0.0
oxyfedrine,1,0.0
Epi,1,0.0
Sons,1,0.0
Copyright,1,0.0
antivirus,1,0.0
trimesters,1,0.0
H7N1,1,0.0
anti-oxidative,1,0.0
Bilirubin,1,0.0
value-based,1,0.0
single-disease,1,0.0
electrophoretic,1,0.0
consternation,1,0.0
hospitalists,1,0.0
Internists,1,0.0
lopinavir,1,0.0
darunavir,1,0.0
ritonavir,1,0.0
mesylate,1,0.0
camostat,1,0.0
fruitless,1,0.0
160-184,1,0.0
2325,1,0.0
fibrinogenic,1,0.0
1748,1,0.0
usedAt,1,0.0
persons-week,1,0.0
proportional-hazard,1,0.0
11240,1,0.0
meantimes,1,0.0
Jin-Yin-Tan,1,0.0
allergen-,1,0.0
Virus-specific,1,0.0
antigen-independent,1,0.0
falsepositive,1,0.0
infarctionOf,1,0.0
assistanceOf,1,0.0
mgkg-1d-1,1,0.0
IMIR,1,0.0
-6713,1,0.0
ΔCT,1,0.0
Nanchang,1,0.0
LMI,1,0.0
Zooming,1,0.0
drove,1,0.0
Infecting,1,0.0
myofibrils,1,0.0
reoperation,1,0.0
Geographically-close,1,0.0
distance-based,1,0.0
between-state,1,0.0
I290,1,0.0
LL-37,1,0.0
cathelicidin,1,0.0
post-therapeutic,1,0.0
Ile,1,0.0
angiotension,1,0.0
fration,1,0.0
1827,1,0.0
2563,1,0.0
recensed,1,0.0
contusions,1,0.0
apologize,1,0.0
Unequivocal,1,0.0
Rhythm,1,0.0
Summit,1,0.0
AFib,1,0.0
Lecture,1,0.0
Plenary,1,0.0
Scherf,1,0.0
delighted,1,0.0
wisdom,1,0.0
Lewis,1,0.0
MacKenzie,1,0.0
multimode,1,0.0
Ck,1,0.0
voyage,1,0.0
Rich,1,0.0
preidentifying,1,0.0
highest-effect,1,0.0
down-to-up,1,0.0
COVAX,1,0.0
GAVI,1,0.0
relegates,1,0.0
gasping,1,0.0
SDG,1,0.0
testimony,1,0.0
purchases,1,0.0
ran,1,0.0
EDTA-plasma,1,0.0
Agenda,1,0.0
strictest,1,0.0
Pharmacogenomic,1,0.0
sharpen,1,0.0
Causative,1,0.0
alkanes,1,0.0
010-026,1,0.0
307-1121,1,0.0
159-1533,1,0.0
PRISMA-oriented,1,0.0
Wenckebach,1,0.0
fantastic,1,0.0
tICA,1,0.0
transcription-plymerase,1,0.0
2532-15542,1,0.0
-150,1,0.0
1724,1,0.0
31384,1,0.0
copiestest,1,0.0
425-489,1,0.0
3565-15516,1,0.0
2-∆∆Ct,1,0.0
758,1,0.0
ΔΔCt,1,0.0
circumventing,1,0.0
embodiment,1,0.0
abnormalitiesABSTRACT,1,0.0
breeding,1,0.0
sheep,1,0.0
8858,1,0.0
Cardiological,1,0.0
New-York,1,0.0
gymnastics,1,0.0
designate,1,0.0
synchronicity,1,0.0
habited,1,0.0
140-219,1,0.0
understandingsexperiences,1,0.0
careers,1,0.0
1654100000,1,0.0
Ewings,1,0.0
SDCA,1,0.0
nonREM,1,0.0
latencies,1,0.0
sex-,1,0.0
reverts,1,0.0
liable,1,0.0
9406,1,0.0
copiesml,1,0.0
nares,1,0.0
Real-Time,1,0.0
Mindful,1,0.0
29713100000,1,0.0
side-by-side,1,0.0
Guardwire,1,0.0
Invatec,1,0.0
Diver,1,0.0
sociology,1,0.0
negotiated,1,0.0
Attentive,1,0.0
discursively,1,0.0
dietnutrition,1,0.0
time-lagged,1,0.0
Residues,1,0.0
1-17-year,1,0.0
bleeds,1,0.0
cold-chain,1,0.0
re-configured,1,0.0
metatranscriptomic,1,0.0
deteoriorating,1,0.0
TFSO,1,0.0
Eosinophil-mediated,1,0.0
QiuckVue,1,0.0
deprived,1,0.0
microbubbles,1,0.0
well-based,1,0.0
targetable,1,0.0
nongenetic,1,0.0
storm-triggered,1,0.0
heralding,1,0.0
multi-territory,1,0.0
baths,1,0.0
Inducible,1,0.0
group-successful,1,0.0
0·03,1,0.0
0·3-7·6,1,0.0
4·0,1,0.0
33·3,1,0.0
easy-to-adapt,1,0.0
bronchial-airway-on-a-chip,1,0.0
41·3,1,0.0
elongated,1,0.0
ultra-deep,1,0.0
last-mile,1,0.0
freight,1,0.0
IDDs,1,0.0
insulin-dependent,1,0.0
vested,1,0.0
ARAA,1,0.0
location-based,1,0.0
Susceptible-Latent-Infected-Recovered,1,0.0
wide-spread,1,0.0
commendation,1,0.0
lined,1,0.0
FFP2FFP3,1,0.0
proceduresThe,1,0.0
bicaudate,1,0.0
prophylactics,1,0.0
airway-on-a-chip,1,0.0
treatment-time,1,0.0
nafamostat,1,0.0
co-administration,1,0.0
strain-dependent,1,0.0
bronchial-airway,1,0.0
23·6,1,0.0
14·6,1,0.0
A570D,1,0.0
020-098,1,0.0
exon,1,0.0
domain-containing-3,1,0.0
leucine-rich-containing,1,0.0
Nucleotide-binding,1,0.0
modifies,1,0.0
Phet0047,1,0.0
091-167,1,0.0
072-109,1,0.0
016-076,1,0.0
019-072,1,0.0
10-unit,1,0.0
thrombomodulin,1,0.0
Versus,1,0.0
417-778,1,0.0
12-60,1,0.0
spatiotemporally,1,0.0
pre-reperfusion,1,0.0
ADC-derived,1,0.0
in-bore,1,0.0
WRA-like,1,0.0
greately,1,0.0
distant-but-conserved,1,0.0
Hematologic,1,0.0
22182,1,0.0
2·2,1,0.0
ghost,1,0.0
notifiable,1,0.0
131-372,1,0.0
1091,1,0.0
Rational,1,0.0
cavitation,1,0.0
days-23,1,0.0
neo-vascularization,1,0.0
days-53,1,0.0
3-37,1,0.0
n14,1,0.0
n2,1,0.0
Anomaly,1,0.0
twenty-two,1,0.0
four-centre,1,0.0
diaphragms,1,0.0
Diaphragms,1,0.0
inchoate,1,0.0
psychotic,1,0.0
0918,1,0.0
score-based,1,0.0
deepnets,1,0.0
ensembles,1,0.0
Insects,1,0.0
22-68,1,0.0
phosholipases,1,0.0
patients’,1,0.0
Park,1,0.0
neurostimulation,1,0.0
texture,1,0.0
Bolus,1,0.0
videofluroscopy,1,0.0
bronchodilators--is,1,0.0
asthma--use,1,0.0
bottles,1,0.0
multidose,1,0.0
piece,1,0.0
Tehran,1,0.0
Motility,1,0.0
Shariati,1,0.0
groupsexaminations,1,0.0
kilometres,1,0.0
PRAGUE-1,1,0.0
52217430,1,0.0
equates,1,0.0
n79808293,1,0.0
corridor,1,0.0
sits,1,0.0
31Conclusions,1,0.0
Neurogastroenterology,1,0.0
750000,1,0.0
1043,1,0.0
4300,1,0.0
stress-related,1,0.0
shipboard,1,0.0
epoch,1,0.0
plt001,1,0.0
plt0001,1,0.0
COMPASS,1,0.0
anti-T,1,0.0
non-concave,1,0.0
bad-risk,1,0.0
social-based,1,0.0
quests,1,0.0
coder,1,0.0
pronouncements,1,0.0
35954,1,0.0
32933,1,0.0
mine,1,0.0
2444,1,0.0
Soft,1,0.0
non-infarcts,1,0.0
preprocessed,1,0.0
supervisor,1,0.0
arbitration,1,0.0
1032,1,0.0
modeResults,1,0.0
melding,1,0.0
141-254,1,0.0
analysers,1,0.0
Zabrze,1,0.0
Central-Eastern,1,0.0
STN,1,0.0
Mumbai,1,0.0
109-240,1,0.0
123-318,1,0.0
hyperintensitiy,1,0.0
043-089,1,0.0
047-094,1,0.0
141-247,1,0.0
reimposition,1,0.0
110-190,1,0.0
169-243,1,0.0
142-202,1,0.0
118-166,1,0.0
110-152,1,0.0
5035,1,0.0
dimerization,1,0.0
folded,1,0.0
llama-derived,1,0.0
FLAIR-mismatch,1,0.0
OxCGRT,1,0.0
self-,1,0.0
oversampled,1,0.0
telemedicine-based,1,0.0
Antibody-based,1,0.0
IslandMethods,1,0.0
transcoronary-applied,1,0.0
no-perfusion,1,0.0
over-the-wire,1,0.0
inflated,1,0.0
transcoronary,1,0.0
CD34,1,0.0
99Tc-HMPAO-labelled,1,0.0
ex-vivo,1,0.0
instructs,1,0.0
self-capacity,1,0.0
remote-controlled,1,0.0
radiographer,1,0.0
Out-of-hours,1,0.0
Hallingdal,1,0.0
stigmata,1,0.0
second-,1,0.0
fifty-four,1,0.0
074-146,1,0.0
058-145,1,0.0
074-157,1,0.0
time-intensive,1,0.0
039-216,1,0.0
hydroxy,1,0.0
075-170,1,0.0
Aberrant,1,0.0
Natick,1,0.0
Watchman™,1,0.0
agnostically,1,0.0
Affair,1,0.0
or70,1,0.0
statin-pretreatment,1,0.0
non-lipid-lowering,1,0.0
121-166,1,0.0
0565,1,0.0
125-202,1,0.0
mechanistically,1,0.0
Vs,1,0.0
Girls,1,0.0
Periods,1,0.0
discontinue,1,0.0
compels,1,0.0
West-African,1,0.0
penalizing,1,0.0
wrapped,1,0.0
lasers,1,0.0
materially,1,0.0
blunting,1,0.0
DIC,1,0.0
754-933,1,0.0
hyperemic,1,0.0
chloro,1,0.0
Cic6,1,0.0
azide,1,0.0
Cic4,1,0.0
Ciclesonide,1,0.0
True,1,0.0
flowLV,1,0.0
-372-275,1,0.0
SI-upslopeglobal,1,0.0
40-99,1,0.0
13NH13-PET,1,0.0
amoeboid,1,0.0
transition-transversion,1,0.0
CpG-loss-associated,1,0.0
3UTRs,1,0.0
nucleocapside,1,0.0
nucleotidic,1,0.0
pathogen-associated,1,0.0
reserving,1,0.0
0221-462,1,0.0
35800,1,0.0
glias,1,0.0
two-,1,0.0
unadjuvanted,1,0.0
021-130,1,0.0
outpouching,1,0.0
Herbal,1,0.0
homeopathic,1,0.0
acupunture,1,0.0
allopathic,1,0.0
orthodox,1,0.0
105-318,1,0.0
P0004,1,0.0
forty-six,1,0.0
Uni-,1,0.0
non-ESUS,1,0.0
stroke-were,1,0.0
pyschologic,1,0.0
INTERRSeCT-a,1,0.0
4-log10,1,0.0
Göta,1,0.0
19-21,1,0.0
Rya,1,0.0
Gothenburg,1,0.0
client-centred,1,0.0
200607,1,0.0
Standing,1,0.0
Massachussets,1,0.0
expectorant,1,0.0
LYS-Pro,1,0.0
deleting,1,0.0
1327,1,0.0
528-931,1,0.0
610-915,1,0.0
579097,1,0.0
87699097,1,0.0
Greenflu-S™,1,0.0
X-179AH1N1,1,0.0
NYMC,1,0.0
15μg,1,0.0
otolaryngologic,1,0.0
4-month,1,0.0
reportable,1,0.0
113-116,1,0.0
1964-1965,1,0.0
hacking,1,0.0
differential-diagnostic,1,0.0
demarcate,1,0.0
occupational-type,1,0.0
016-087,1,0.0
disease-association,1,0.0
Ser249Pro,1,0.0
amino-acid,1,0.0
resequenced,1,0.0
freeze,1,0.0
quickness,1,0.0
gestational-age,1,0.0
nonhaemorrhagic,1,0.0
httpsfuncoupsbcsuse,1,0.0
disconfirms,1,0.0
¬V,1,0.0
C-were,1,0.0
specificity-and,1,0.0
construe,1,0.0
negation,1,0.0
Anecdotal,1,0.0
laminin,1,0.0
circumstance,1,0.0
Rodents,1,0.0
redundancy-weighted,1,0.0
cumulatively,1,0.0
biomolecule,1,0.0
biospecimens,1,0.0
intricacies,1,0.0
seroprevalence-to-case,1,0.0
microparticle,1,0.0
5125,1,0.0
8108,1,0.0
4-June,1,0.0
community-representative,1,0.0
genesproteins,1,0.0
orthology,1,0.0
extraoral,1,0.0
attachmententry,1,0.0
7590,1,0.0
dataResultsCompared,1,0.0
FilmArray,1,0.0
201819,1,0.0
settingsMethodsWe,1,0.0
interventionsAimTo,1,0.0
rationalising,1,0.0
BackgroundInfluenza,1,0.0
products-based,1,0.0
assemblyrelease,1,0.0
Prevailing,1,0.0
FunCoups,1,0.0
BeclinLC3,1,0.0
Baxcaspases,1,0.0
1592,1,0.0
782,1,0.0
1431,1,0.0
GHS,1,0.0
NMIMR,1,0.0
Noguchi,1,0.0
combatting,1,0.0
bi-ethnic,1,0.0
strides,1,0.0
inexorably,1,0.0
S331R,1,0.0
marketing,1,0.0
isovolumetric,1,0.0
Galerkin,1,0.0
element-free,1,0.0
invariant-based,1,0.0
weakens,1,0.0
under-supply,1,0.0
invalidization,1,0.0
sociomedical,1,0.0
MVA-BN-Filo,1,0.0
Ad26ZEBOV,1,0.0
Ad26-targeting,1,0.0
fibre,1,0.0
114000,1,0.0
3912,1,0.0
unblinded,1,0.0
thermostability,1,0.0
manufacturability,1,0.0
incompetent,1,0.0
E1,1,0.0
V3SWG,1,0.0
Replication-incompetent,1,0.0
discouraged,1,0.0
isochoric,1,0.0
child-child,1,0.0
impinging,1,0.0
Seventy-three,1,0.0
pharmacologists,1,0.0
immunities,1,0.0
touch,1,0.0
decade-long,1,0.0
hilus,1,0.0
participations,1,0.0
borderlines,1,0.0
topographic-anatomic,1,0.0
fire-damp,1,0.0
reckon,1,0.0
systematizes,1,0.0
child-adult,1,0.0
constellations,1,0.0
hyptonics,1,0.0
arenot,1,0.0
hypotonic,1,0.0
undesirable,1,0.0
cases--of,1,0.0
furanthril,1,0.0
unelucidated,1,0.0
Prototypic,1,0.0
nonphysician,1,0.0
8490,1,0.0
intra-subtype,1,0.0
consultants,1,0.0
interleukin-1,1,0.0
0968,1,0.0
ISLES,1,0.0
Segmentation,1,0.0
Lesion,1,0.0
SVM,1,0.0
SAE,1,0.0
multi-spectral,1,0.0
OIE,1,0.0
CQ,1,0.0
pro-IL-1β,1,0.0
autolysosomes,1,0.0
0924,1,0.0
H1N1-triggered,1,0.0
obstructs,1,0.0
astragalus,1,0.0
Surrogate,1,0.0
Astragaloside,1,0.0
cell-intrinsic,1,0.0
Icelandic,1,0.0
≈319,1,0.0
Atlantic,1,0.0
Logsdon,1,0.0
0943,1,0.0
0904,1,0.0
Dizziness,1,0.0
LateTIME,1,0.0
Encephalopathy,1,0.0
Influenza-Associated,1,0.0
Intensity,1,0.0
destabilisation,1,0.0
mid-right,1,0.0
mucolytics,1,0.0
≤045,1,0.0
cells-to-placebo,1,0.0
CCTRN,1,0.0
moderate-to-large,1,0.0
pre-outbreak,1,0.0
2571,1,0.0
outcome-related,1,0.0
Deciphering,1,0.0
SYNTAX,1,0.0
non-inactive,1,0.0
dual-target,1,0.0
Hecin,1,0.0
clinicomorphological,1,0.0
Proceeding,1,0.0
1696,1,0.0
3667,1,0.0
Choi,1,0.0
hemogram,1,0.0
refuted,1,0.0
sculpting,1,0.0
competes,1,0.0
sub-type,1,0.0
semi-intensive,1,0.0
persuaded,1,0.0
schoolsnurseries,1,0.0
60-65,1,0.0
schoolnursery,1,0.0
cooperating,1,0.0
inserting,1,0.0
non-cooperation,1,0.0
beneficiary,1,0.0
NAI,1,0.0
lionized,1,0.0
the-counter,1,0.0
revolutions,1,0.0
SWiTCH,1,0.0
Hydroxyurea,1,0.0
Transfusions,1,0.0
Helton,1,0.0
stewardship,1,0.0
metagenomeConclusionNanopore,1,0.0
community-circulating,1,0.0
NAI-resistant,1,0.0
2-layer,1,0.0
intraobserver,1,0.0
postdating,1,0.0
introversion,1,0.0
extroversion,1,0.0
252-286,1,0.0
outputs,1,0.0
bioassay,1,0.0
Diasorin,1,0.0
touristic,1,0.0
valley,1,0.0
Gardena,1,0.0
2244,1,0.0
co-circulate,1,0.0
sac,1,0.0
phylogenetically-distinct,1,0.0
HO-13-14054,1,0.0
identifier,1,0.0
NACI,1,0.0
chilblains,1,0.0
champions,1,0.0
Skills,1,0.0
Appraisal,1,0.0
superdominant,1,0.0
coincidental,1,0.0
4500,1,0.0
Pre-challenge,1,0.0
theaters,1,0.0
atheroprotective,1,0.0
N501YD614G,1,0.0
HuH7,1,0.0
HEK293hACE2,1,0.0
bisbenzylisoquinoline,1,0.0
directives,1,0.0
-049,1,0.0
CD163low-Reflow,1,0.0
CD163high-Reflow,1,0.0
TIMI-3,1,0.0
CD163low,1,0.0
Extracellular,1,0.0
013-041,1,0.0
Intraplaque,1,0.0
siRNA-mediated,1,0.0
nonimmunostimulatory,1,0.0
oncologic,1,0.0
Curiously,1,0.0
duplexes,1,0.0
Benign,1,0.0
renowned,1,0.0
244000,1,0.0
Coronavirus-19,1,0.0
501YV3,1,0.0
-dependent,1,0.0
interior,1,0.0
Vmax50,1,0.0
-125,1,0.0
-102,1,0.0
-200,1,0.0
sealed,1,0.0
cotreatment,1,0.0
antagomiR,1,0.0
microRNA,1,0.0
enhanceosome,1,0.0
inductions,1,0.0
PKR-mediated,1,0.0
2273,1,0.0
pan-coronaviruses,1,0.0
QQS,1,0.0
partioning,1,0.0
variable--heart,1,0.0
r-tPA,1,0.0
Tyneside,1,0.0
Québec,1,0.0
OSCE,1,0.0
CPGs,1,0.0
sixty-eight,1,0.0
anticoronavirus,1,0.0
cyclodextrin-soluble,1,0.0
XAP,1,0.0
kitchens,1,0.0
10405420,1,0.0
069-096,1,0.0
sidewall,1,0.0
087-098,1,0.0
planting,1,0.0
090-095,1,0.0
109-144,1,0.0
107-149,1,0.0
odors,1,0.0
103-149,1,0.0
pesticides,1,0.0
5420,1,0.0
043-084,1,0.0
greenhouses,1,0.0
5880,1,0.0
Liaoning,1,0.0
stratified-cluster-random,1,0.0
conjoined,1,0.0
breathed,1,0.0
debaters,1,0.0
irritating,1,0.0
psychologicalemotional,1,0.0
hereditarycongenital,1,0.0
073-099,1,0.0
5234,1,0.0
paste,1,0.0
well-chosen,1,0.0
Xiaochuangao,1,0.0
cold-causing,1,0.0
territorywide,1,0.0
miracle,1,0.0
extracranial-intracranial,1,0.0
methylprednisone,1,0.0
cerebellitis,1,0.0
bradyphrenia,1,0.0
1925105,1,0.0
4901,1,0.0
nonimmediate,1,0.0
1997-2001,1,0.0
musical,1,0.0
polished,1,0.0
sanded,1,0.0
joiner,1,0.0
rosewood,1,0.0
airport,1,0.0
brain-derived,1,0.0
p-PCI,1,0.0
Homeostasis,1,0.0
42806,1,0.0
sucked,1,0.0
non-O-wave,1,0.0
instantly,1,0.0
intersect,1,0.0
Camelidae,1,0.0
HCAbs,1,0.0
Heavy,1,0.0
Omsk,1,0.0
return-to-work,1,0.0
COVID-19Communicated,1,0.0
ACE2-Spike,1,0.0
PRISMA-ScR,1,0.0
SARS-CoV-2To,1,0.0
Sgarbossa,1,0.0
institutionABSTRACT,1,0.0
sub-scores,1,0.0
near-death,1,0.0
Carnegie,1,0.0
1300-bed,1,0.0
medical-alone,1,0.0
prognosis-validated,1,0.0
dyn,1,0.0
Physiology,1,0.0
NCT00469248,1,0.0
McGills,1,0.0
nucleus-VPL,1,0.0
Nanobodies,1,0.0
pulmologists´,1,0.0
metaheuristic,1,0.0
chromatography-multiple,1,0.0
butcheries,1,0.0
disinfectant,1,0.0
Gender-related,1,0.0
Gold,1,0.0
Choosing,1,0.0
ECL,1,0.0
analyte,1,0.0
rAspN,1,0.0
LC-MRM-MS-based,1,0.0
monitoring-mass,1,0.0
1116,1,0.0
Missing,1,0.0
1283,1,0.0
1692,1,0.0
1-OR×100,1,0.0
case-test,1,0.0
one-factor,1,0.0
two-factor,1,0.0
two-factorial,1,0.0
Spearman´s,1,0.0
Cronbach´s,1,0.0
unsystematic,1,0.0
Ventroposterolateral,1,0.0
PVG,1,0.0
periventricular,1,0.0
advisory,1,0.0
Granulocyte-colony,1,0.0
fromCOVID-19,1,0.0
30-150,1,0.0
minweek,1,0.0
60-240,1,0.0
39-56,1,0.0
long-COVID-19,1,0.0
Danang,1,0.0
hypocoagulatory,1,0.0
normalizes,1,0.0
june,1,0.0
tall,1,0.0
independency,1,0.0
Gradually,1,0.0
Overweightobese,1,0.0
F1,1,0.0
9726,1,0.0
9866,1,0.0
9813,1,0.0
9811,1,0.0
MosMedData,1,0.0
predator,1,0.0
mobilises,1,0.0
twindemic,1,0.0
high-impact,1,0.0
discerning,1,0.0
V8,1,0.0
Klüver-Bucy,1,0.0
microthrombosis,1,0.0
haemolytic,1,0.0
consumptive,1,0.0
1535982,1,0.0
thirty-six,1,0.0
January-October,1,0.0
Metro,1,0.0
Neutropenia,1,0.0
Tai,1,0.0
enumerating,1,0.0
teasing,1,0.0
non-molecular,1,0.0
overlook,1,0.0
isolatespatients,1,0.0
stemmed,1,0.0
co-admission,1,0.0
patientsviral,1,0.0
time-scaled,1,0.0
chainschannels,1,0.0
fifty-three,1,0.0
≥100°F,1,0.0
Org10172,1,0.0
still-viable,1,0.0
71225,1,0.0
3662218,1,0.0
832443,1,0.0
4382443,1,0.0
recently-infarcted,1,0.0
hot-spot,1,0.0
clearinghouse,1,0.0
Expertise,1,0.0
Grippe,1,0.0
dInformation,1,0.0
dExpertise,1,0.0
Groupement,1,0.0
GEIG,1,0.0
re-testing,1,0.0
studies9-11,1,0.0
dilutions,1,0.0
30-48-fold,1,0.0
expert-review,1,0.0
hypercube,1,0.0
test8,1,0.0
groups1-7,1,0.0
cold-spot,1,0.0
Syndrome-Coronavirus-1,1,0.0
SARS-CoV-2-Spike,1,0.0
doulbe-radionuclide,1,0.0
Boards,1,0.0
Endogenous,1,0.0
detriment,1,0.0
Adopting,1,0.0
genioplasty,1,0.0
mandibular,1,0.0
maxillary,1,0.0
1759,1,0.0
bimaxillary,1,0.0
4259,1,0.0
plc©,1,0.0
Spire,1,0.0
catherization,1,0.0
arteririography,1,0.0
scintigram,1,0.0
offerings,1,0.0
cold-like,1,0.0
2000000,1,0.0
100000000,1,0.0
Syndrome-Coronavirus,1,0.0
8089,1,0.0
low-to-middle-income,1,0.0
Reverse-transcription,1,0.0
Suppressing,1,0.0
arteriograms,1,0.0
Ma,1,0.0
B1106,1,0.0
African-specific,1,0.0
B1156,1,0.0
B1154,1,0.0
1365,1,0.0
infections2,1,0.0
785000,1,0.0
currentprevious,1,0.0
allergen-free,1,0.0
climatized,1,0.0
Wijngaarden,1,0.0
Lind,1,0.0
SARS-CoV-Spike,1,0.0
C19-S-I-IFA,1,0.0
Leeuwen,1,0.0
Storm,1,0.0
pre-RIPerC,1,0.0
105-110,1,0.0
exogenously,1,0.0
constricting,1,0.0
Huang,1,0.0
Tang,1,0.0
mecanism,1,0.0
UNV,1,0.0
fifty-two,1,0.0
built-up,1,0.0
croplands,1,0.0
BRT,1,0.0
agro-ecological,1,0.0
Kalafong,1,0.0
intern,1,0.0
bird-to-human,1,0.0
taper,1,0.0
MRS4,1,0.0
Befelatanana,1,0.0
NIHSS8,1,0.0
6784,1,0.0
7753,1,0.0
5022,1,0.0
3612,1,0.0
5154,1,0.0
5541,1,0.0
Success,1,0.0
3650,1,0.0
low-fat,1,0.0
Injuries,1,0.0
GBD,1,0.0
leukotriens,1,0.0
Random-effects,1,0.0
moderators,1,0.0
22-27,1,0.0
amrinone,1,0.0
Madrid,1,0.0
CBMSO,1,0.0
anti-EGFR,1,0.0
double-staining,1,0.0
self-cleaving,1,0.0
T2A,1,0.0
huEGFRt,1,0.0
normalizing,1,0.0
weaknessnumbness,1,0.0
stably,1,0.0
Jurkat,1,0.0
non-adherent,1,0.0
cytometer-friendly,1,0.0
PAs,1,0.0
cognitiveaffective,1,0.0
Stratified,1,0.0
Panic,1,0.0
kPas,1,0.0
630,1,0.0
non-sinus,1,0.0
etesivimab,1,0.0
Al,1,0.0
amotosalenUVA,1,0.0
15-64,1,0.0
Asthma-COPD,1,0.0
pathogeneses,1,0.0
Biontech,1,0.0
8-fold,1,0.0
17-26,1,0.0
B11281,1,0.0
R‑value,1,0.0
nonfailing,1,0.0
KentUnited,1,0.0
waiver,1,0.0
Porcine,1,0.0
Heq2,1,0.0
Heq1,1,0.0
enlist,1,0.0
H0,1,0.0
monospecific,1,0.0
1991-92,1,0.0
tromboxanes,1,0.0
conditionings,1,0.0
1990-2010,1,0.0
athopy,1,0.0
pre-retinal,1,0.0
Replies,1,0.0
BDA,1,0.0
heart-lung,1,0.0
mastering,1,0.0
Principally,1,0.0
subdue,1,0.0
Futhermore,1,0.0
glitch,1,0.0
insubsequent,1,0.0
15841,1,0.0
spreadsheet,1,0.0
ImmunoDiagnostics,1,0.0
hemoglobinopathy,1,0.0
bland,1,0.0
neuro-disability,1,0.0
ascertains,1,0.0
1099,1,0.0
Terminology,1,0.0
thrombolysisHighlights,1,0.0
Performed,1,0.0
simple-advice,1,0.0
stroke-risk,1,0.0
refines,1,0.0
European-CDC,1,0.0
working-out,1,0.0
Non-pharmaceutical,1,0.0
coalescent-based,1,0.0
aboard,1,0.0
Beijings,1,0.0
validates,1,0.0
Claims,1,0.0
Taiwan-CDC,1,0.0
USA-CDC,1,0.0
biocompatibility,1,0.0
injurydisorders,1,0.0
recombine,1,0.0
Professional,1,0.0
agencieshealth,1,0.0
vaccinesmass,1,0.0
questionnaire-the,1,0.0
evaluate-via,1,0.0
self-protection,1,0.0
VHA,1,0.0
kilogram,1,0.0
150-min,1,0.0
Dawley,1,0.0
1961--before,1,0.0
RNA-directed,1,0.0
CRISPR-,1,0.0
Repeats,1,0.0
Palindromic,1,0.0
Regularly-Interspaced,1,0.0
Clustered,1,0.0
fabric,1,0.0
straining,1,0.0
Micronutrients,1,0.0
cases--that,1,0.0
attacks--were,1,0.0
Se,1,0.0
Mn,1,0.0
manganese,1,0.0
crop,1,0.0
acidophilic,1,0.0
theobromine,1,0.0
TF,1,0.0
theaflavin,1,0.0
EGCG,1,0.0
gallate,1,0.0
epigallocatechin,1,0.0
CRISPR-associated,1,0.0
Applications,1,0.0
Sprague,1,0.0
wit,1,0.0
aerobiology,1,0.0
overinfected,1,0.0
pre-washout,1,0.0
IV-tPa,1,0.0
Catheter-based,1,0.0
offsprings,1,0.0
trustworthy,1,0.0
succinct,1,0.0
BNT162,1,0.0
risk-factors,1,0.0
haunting,1,0.0
non-neurologic,1,0.0
granularity,1,0.0
manifolds,1,0.0
auspicious,1,0.0
obviated,1,0.0
IgG-specific,1,0.0
IgA-,1,0.0
Commercially,1,0.0
optimistically,1,0.0
Homologous,1,0.0
shoots,1,0.0
sinensis,1,0.0
Camellia,1,0.0
Transcriptome,1,0.0
unblinding,1,0.0
maleficence,1,0.0
medicineIn,1,0.0
contended,1,0.0
academically,1,0.0
birthed,1,0.0
post-developmental,1,0.0
Need,1,0.0
MES-positive,1,0.0
P0027,1,0.0
1235-3125,1,0.0
6172,1,0.0
P0019,1,0.0
1345-29457,1,0.0
6294,1,0.0
P0016,1,0.0
40-80,1,0.0
US104,1,0.0
US164,1,0.0
earnings,1,0.0
MES,1,0.0
cannulas,1,0.0
active-controlled,1,0.0
trialsIt,1,0.0
2·9,1,0.0
Docking,1,0.0
ligating,1,0.0
Genomics-led,1,0.0
Flint,1,0.0
misconstrued,1,0.0
18-54,1,0.0
0·02,1,0.0
31980,1,0.0
0·0-6·7,1,0.0
1·1,1,0.0
20Fr,1,0.0
5·1,1,0.0
18·4,1,0.0
58·1,1,0.0
60·1,1,0.0
Wedge,1,0.0
66·5,1,0.0
84·7,1,0.0
84·9,1,0.0
18·1,1,0.0
pathophysiobiology,1,0.0
Alternaria-induced,1,0.0
unsustainable,1,0.0
F7,1,0.0
non-coronary,1,0.0
antimediator,1,0.0
genegene,1,0.0
LDLRLOX-1,1,0.0
PON123,1,0.0
apoa,1,0.0
Medium,1,0.0
CIII,1,0.0
ABCA1,1,0.0
CETP,1,0.0
MTR,1,0.0
CBS,1,0.0
ANX5,1,0.0
PZ,1,0.0
THBD,1,0.0
TAFI,1,0.0
GP1BA,1,0.0
ITGA2,1,0.0
ITGB3ITGA2B,1,0.0
SERPINE1,1,0.0
F12,1,0.0
coved,1,0.0
15750,1,0.0
2007-2010,1,0.0
HA0--HA1HA2,1,0.0
ACA,1,0.0
Spike-variants,1,0.0
inter-provider,1,0.0
perconditioning,1,0.0
Remote,1,0.0
ATexas,1,0.0
Multiplication,1,0.0
low-detectible,1,0.0
virus-activating,1,0.0
APR834,1,0.0
Neurogenic,1,0.0
AMemphis1496,1,0.0
AMoscow4502003,1,0.0
AMoscow5012011,1,0.0
AHamburg0509,1,0.0
mcgdL,1,0.0
Insular,1,0.0
reportsseries,1,0.0
non-hemorrhagic,1,0.0
informs,1,0.0
F13A1,1,0.0
FGAFGB,1,0.0
vaccine‑induced,1,0.0
F2,1,0.0
persons†,1,0.0
670,1,0.0
2020-January,1,0.0
Reopening,1,0.0
cold-recombinant,1,0.0
recombining,1,0.0
crystalloid,1,0.0
Turner-Warwick,1,0.0
immunosurveillance,1,0.0
non‑modifiable,1,0.0
dizzinessweakness,1,0.0
BAnn,1,0.0
Arbor166,1,0.0
380±264,1,0.0
448±279,1,0.0
non‑smokers,1,0.0
P0007,1,0.0
±284,1,0.0
444±270,1,0.0
423±276,1,0.0
690±235,1,0.0
Susceptible§,1,0.0
contacts¶,1,0.0
1041,1,0.0
unfunded,1,0.0
F5,1,0.0
haemostasis,1,0.0
penetrates,1,0.0
Ct≤29,1,0.0
gargle,1,0.0
equaled,1,0.0
PAMI-I,1,0.0
GUSTO-IIB,1,0.0
simplistic,1,0.0
Transportation,1,0.0
school-associated,1,0.0
-door,1,0.0
cause-effect,1,0.0
sMMPi,1,0.0
self-image,1,0.0
MMP-1,1,0.0
Learys,1,0.0
16PF,1,0.0
isotypes,1,0.0
seats,1,0.0
unknown--apart,1,0.0
ecosystems,1,0.0
-152,1,0.0
0972,1,0.0
0574,1,0.0
Snakebites,1,0.0
neuromyopathies,1,0.0
intraparenchymal,1,0.0
Bothrops,1,0.0
S98F,1,0.0
N439K,1,0.0
H69V70,1,0.0
Expansion,1,0.0
7441,1,0.0
B1129,1,0.0
1501,1,0.0
B1258,1,0.0
1537,1,0.0
B1221,1,0.0
skyline,1,0.0
birth-death,1,0.0
high-coverage,1,0.0
FebruaryMarch,1,0.0
antigenemia,1,0.0
jararaca,1,0.0
0220,1,0.0
0276,1,0.0
mankinds,1,0.0
non-infarction,1,0.0
ischaemia-induced,1,0.0
awardee,1,0.0
PHEP,1,0.0
Representatives,1,0.0
MiniPAQLQ,1,0.0
wary,1,0.0
ChAdOx1nCoV-19,1,0.0
trekker,1,0.0
summiteer,1,0.0
aspiring,1,0.0
post-pathway,1,0.0
setback,1,0.0
deep-vein,1,0.0
Mississippi,1,0.0
annexes,1,0.0
interdepartmental,1,0.0
0348,1,0.0
0169,1,0.0
0815,1,0.0
0247,1,0.0
0504,1,0.0
Reconcavo,1,0.0
paucisymptomaticasymptomatic,1,0.0
4-slice,1,0.0
AH5N1cases,1,0.0
quit,1,0.0
high-titre,1,0.0
GARCM,1,0.0
Life--optimally,1,0.0
ET-eligible,1,0.0
controllability,1,0.0
PN,1,0.0
DG,1,0.0
GG,1,0.0
prometaphase,1,0.0
NCBA,1,0.0
PCBA,1,0.0
CBA,1,0.0
bulge,1,0.0
leveling,1,0.0
real‐life,1,0.0
7945,1,0.0
Malta,1,0.0
ESWIs,1,0.0
ever-mutating,1,0.0
background--a,1,0.0
dislodgement,1,0.0
Beta-blockers,1,0.0
rampant,1,0.0
destiny,1,0.0
cardiomyocytic,1,0.0
Connective,1,0.0
softening,1,0.0
petrificate,1,0.0
Extra-respiratory,1,0.0
Tc,1,0.0
FluINsure,1,0.0
Intellivax,1,0.0
lacteal,1,0.0
immune-phenomena,1,0.0
Bioactive,1,0.0
RNA-vaccines,1,0.0
Virus-like-Particle,1,0.0
subunit-vaccines,1,0.0
Earthquake,1,0.0
Chuetsu,1,0.0
8-year,1,0.0
radiopharmaceuticals,1,0.0
SARS-CoV-2-explicit,1,0.0
non-tobacco,1,0.0
disease-a,1,0.0
well-publicized,1,0.0
Consultation,1,0.0
111120,1,0.0
goal-directed,1,0.0
multipronged,1,0.0
data-all,1,0.0
Mobitz,1,0.0
second-degree,1,0.0
cost-,1,0.0
Allegheny,1,0.0
thermometer-sales,1,0.0
manpower-saving,1,0.0
symptomatically,1,0.0
concernedABSTRACT,1,0.0
PHASIFY™,1,0.0
1835,1,0.0
downsloping,1,0.0
Reciprocal,1,0.0
2359,1,0.0
one-quarter,1,0.0
NucliSENS®,1,0.0
easyMAG®,1,0.0
deter,1,0.0
push-pull,1,0.0
Latinxs,1,0.0
preteen,1,0.0
teenaged,1,0.0
beta-Blockers,1,0.0
system-of-care,1,0.0
childbirths,1,0.0
1975-90,1,0.0
PDF,1,0.0
SnapShot,1,0.0
immunomodulators,1,0.0
Therapeutics,1,0.0
antagonistsABSTRACT,1,0.0
bradycardiac,1,0.0
deterioate,1,0.0
cleavability,1,0.0
extirpating,1,0.0
hydrocephalus,1,0.0
ventriculopleural,1,0.0
loculated,1,0.0
costophrenic,1,0.0
recess,1,0.0
systems-based,1,0.0
Hesitance,1,0.0
Ilorin,1,0.0
tightrope,1,0.0
108120,1,0.0
nightmares,1,0.0
discredit,1,0.0
banking,1,0.0
sweets,1,0.0
3-9,1,0.0
Spike-binding,1,0.0
socialised,1,0.0
grapple,1,0.0
associated-with-thromboembolic-event,1,0.0
1520,1,0.0
immunoturbidimetric,1,0.0
endsystolic,1,0.0
Rosen,1,0.0
folklore,1,0.0
VigiGripes,1,0.0
Mixovirus,1,0.0
originates,1,0.0
depicts,1,0.0
1055,1,0.0
sweats,1,0.0
ascertaining,1,0.0
coronarycircumflex,1,0.0
LCA,1,0.0
cuisines,1,0.0
neurointensive,1,0.0
nonstatin,1,0.0
QTLs,1,0.0
emotionally-based,1,0.0
Swine-origin,1,0.0
Electroencephalography,1,0.0
kHz,1,0.0
UCLH,1,0.0
HASU,1,0.0
Multi-Frequency,1,0.0
5360,1,0.0
4960,1,0.0
inbred,1,0.0
interconnectedness,1,0.0
susceptible-exposed-infectious-removed,1,0.0
List,1,0.0
concoctions,1,0.0
Licorice,1,0.0
Gancao,1,0.0
ICAI,1,0.0
impact-,1,0.0
Pinyin,1,0.0
pandemicepidemic,1,0.0
lurks,1,0.0
breathtaking,1,0.0
seven-item,1,0.0
scents,1,0.0
doctorspecialist,1,0.0
organogram,1,0.0
Calibration,1,0.0
Accreditation,1,0.0
assures,1,0.0
--30,1,0.0
ajmaline,1,0.0
Mantel-Haenszel,1,0.0
age-corrected,1,0.0
--003,1,0.0
nongenomic,1,0.0
cursory,1,0.0
whipped,1,0.0
cant,1,0.0
manageable,1,0.0
disruptor,1,0.0
immune-assays,1,0.0
H-coil,1,0.0
Hesed,1,0.0
116017,1,0.0
httpsbitly3aZUAPB,1,0.0
teleconferences,1,0.0
capsaicin,1,0.0
Smoking-related,1,0.0
cocreation,1,0.0
Postischemic,1,0.0
science-based,1,0.0
BZ,1,0.0
border-zone,1,0.0
PAI,1,0.0
cocreation-based,1,0.0
competences,1,0.0
Sexuality,1,0.0
TÜBİTAK,1,0.0
C1-2,1,0.0
dura,1,0.0
transversarium,1,0.0
well-equipped,1,0.0
coalitions,1,0.0
Self-reports,1,0.0
2046,1,0.0
Alabama,1,0.0
equated,1,0.0
interpretability,1,0.0
scalability,1,0.0
clinical-radiological,1,0.0
rRt-PCR,1,0.0
14933,1,0.0
€3047,1,0.0
n15,1,0.0
2074,1,0.0
preconditions,1,0.0
PACMANS,1,0.0
Proteases,1,0.0
nondrug,1,0.0
richer,1,0.0
PIE,1,0.0
Breathlessness,1,0.0
Medically,1,0.0
4-quadrant,1,0.0
intrapatient,1,0.0
interpatient,1,0.0
Automated,1,0.0
technology--to,1,0.0
tools--evidence-based,1,0.0
Vincent,1,0.0
247-393,1,0.0
vicinity,1,0.0
nonregistration,1,0.0
understatement,1,0.0
reorganized,1,0.0
≤12,1,0.0
494,1,0.0
spasmogens,1,0.0
Bacteroicles,1,0.0
€43129,1,0.0
n72,1,0.0
Internationally,1,0.0
ultrasonically,1,0.0
ICTUSCARE,1,0.0
Regimens,1,0.0
Hyperperceivers,1,0.0
biodata,1,0.0
Proteus,1,0.0
Endotoxin,1,0.0
disintegrin,1,0.0
half-standardized,1,0.0
crescendo-course,1,0.0
q24-q31,1,0.0
RNASE3,1,0.0
DP1,1,0.0
PHD,1,0.0
dipeptidyl,1,0.0
ADAM-33,1,0.0
metalloprotease,1,0.0
stimulatory,1,0.0
factor-I,1,0.0
factor-2,1,0.0
KCHS,1,0.0
≈7,1,0.0
074-100,1,0.0
070-355,1,0.0
-196-591,1,0.0
604674,1,0.0
Kenyan,1,0.0
Possessing,1,0.0
quasi-infinite,1,0.0
THz,1,0.0
terahertz,1,0.0
lineshapes,1,0.0
ultranarrow,1,0.0
electrodynamics,1,0.0
squeeze,1,0.0
exquisite,1,0.0
metasensor,1,0.0
Operation,1,0.0
femtomolar,1,0.0
Life-table,1,0.0
socio-occupational,1,0.0
tenets,1,0.0
lucky,1,0.0
5-25,1,0.0
062-089,1,0.0
neighbors,1,0.0
15-24,1,0.0
ex-smokers,1,0.0
LMU,1,0.0
Ludwig-Maximilians-University,1,0.0
Periodontology,1,0.0
Dentistry,1,0.0
funders,1,0.0
Cambodias,1,0.0
asks,1,0.0
case-a,1,0.0
05-1,1,0.0
non-vaccination,1,0.0
065-092,1,0.0
cardiotropic,1,0.0
Post-influenza,1,0.0
cheapest,1,0.0
075-102,1,0.0
health--that,1,0.0
changeability,1,0.0
eradicatedas,1,0.0
Association-American,1,0.0
Research-based,1,0.0
noncompaction,1,0.0
neuro-interventional,1,0.0
timeframes,1,0.0
ultra-rapid,1,0.0
workloads,1,0.0
theranostic,1,0.0
apostolic,1,0.0
xii,1,0.0
Calixtinus,1,0.0
Codex,1,0.0
evil,1,0.0
Apostle,1,0.0
tradition,1,0.0
pre-scientific,1,0.0
Galician,1,0.0
asymptomaticsymptomatic,1,0.0
tabs,1,0.0
overstrained,1,0.0
crushing,1,0.0
AChA,1,0.0
agile,1,0.0
trabecular,1,0.0
compaction,1,0.0
rethinking,1,0.0
immovable,1,0.0
crippled,1,0.0
antigen-detection,1,0.0
580,1,0.0
post-recanalization,1,0.0
rea-ltime,1,0.0
Trinidadian,1,0.0
und,1,0.0
neural-microglial,1,0.0
CX3CL1,1,0.0
fractalkine,1,0.0
weeks-a,1,0.0
widely-used,1,0.0
SARS-CoV-2-spike-encoding,1,0.0
dismissed,1,0.0
disinfect,1,0.0
communicated,1,0.0
recruitable,1,0.0
methological,1,0.0
tracheotomy,1,0.0
thrombolyis,1,0.0
best-fitting,1,0.0
infectees,1,0.0
non-taking,1,0.0
-1185,1,0.0
W-Z,1,0.0
985,1,0.0
Influenza-like-Illness,1,0.0
IGM,1,0.0
silkworms,1,0.0
oak,1,0.0
wild-growing,1,0.0
Wild-silk,1,0.0
Elimination,1,0.0
upperlower,1,0.0
1-36,1,0.0
Dried,1,0.0
cardiorrhexis,1,0.0
stenosing,1,0.0
ishemic,1,0.0
detailing,1,0.0
Tabular,1,0.0
httpsdoiorg107937tcia20206c7y-gq39,1,0.0
NIfTI,1,0.0
expert-vetted,1,0.0
figuring,1,0.0
anti-hypertrophic,1,0.0
hilum,1,0.0
lab-based,1,0.0
476,1,0.0
echocardiographical,1,0.0
meditated,1,0.0
Nick,1,0.0
OPNP,1,0.0
end-labelling,1,0.0
footballers,1,0.0
Technogenetics,1,0.0
spun,1,0.0
millilitres,1,0.0
anal-swabs,1,0.0
nasopharyngeal-,1,0.0
oropharyngeal-,1,0.0
Governor,1,0.0
httpsbitly372Xdhw,1,0.0
YHLO,1,0.0
High-altitude,1,0.0
pathology23,1,0.0
subjects24,1,0.0
CLIA-LIAISON®,1,0.0
COVID-1923,1,0.0
liver1,1,0.0
ECLIA-Elecsys®,1,0.0
Euroimmune,1,0.0
atelectatic,1,0.0
U-Net,1,0.0
anti-fibrotic,1,0.0
anti-hypertensive,1,0.0
Schiff,1,0.0
longa,1,0.0
rhizomes,1,0.0
diferuloylmethane,1,0.0
Anti-asthmatic,1,0.0
admissionABSTRACT,1,0.0
HA-CHO,1,0.0
hydrazided,1,0.0
710-905,1,0.0
952-979,1,0.0
14-59,1,0.0
One-dose,1,0.0
AS03-adjuvanted,1,0.0
obtains,1,0.0
HHA,1,0.0
groups--133,1,0.0
single-mode,1,0.0
HA-CHOHHA,1,0.0
mgd,1,0.0
painting,1,0.0
GelDADA-PPy,1,0.0
DA-PPy,1,0.0
polypyrrole,1,0.0
constant-volume,1,0.0
knowns,1,0.0
ourselves,1,0.0
tissue-engineering,1,0.0
non-small,1,0.0
hydrogels,1,0.0
coadministration,1,0.0
infarction-associated,1,0.0
self-adhesive,1,0.0
Fe3-induced,1,0.0
Qwaves,1,0.0
reassigned,1,0.0
p00399,1,0.0
ORF3d,1,0.0
ORF9c,1,0.0
dopamine-gelatin,1,0.0
GelDA,1,0.0
ORF3b,1,0.0
dopamine-functionalized,1,0.0
Accessory,1,0.0
OVA-sensitized,1,0.0
p00043,1,0.0
condensation,1,0.0
GMW,1,0.0
mini-Wright,1,0.0
chorioamniotitis,1,0.0
Sero-conversion,1,0.0
defy,1,0.0
httpsbitly3eJ5b35,1,0.0
HBEpC,1,0.0
alpha7-nicotinic,1,0.0
Nicotine,1,0.0
119-402,1,0.0
041-091,1,0.0
19-39,1,0.0
5912,1,0.0
4226,1,0.0
10138,1,0.0
2008-2013,1,0.0
RT-PCR-negative,1,0.0
emboligenic,1,0.0
polysomnogram,1,0.0
20-fold,1,0.0
OSA-induced,1,0.0
oseltamivir-based,1,0.0
Cheyne-Stokes,1,0.0
PSG,1,0.0
Mx1-,1,0.0
BALB,1,0.0
A2G-Mx1,1,0.0
CD45,1,0.0
multitarget,1,0.0
stabilities,1,0.0
primersprobes,1,0.0
RBDs,1,0.0
9206,1,0.0
CoronaVirus,1,0.0
natu-ral,1,0.0
Westcott,1,0.0
α-SMA,1,0.0
arteriogenesis,1,0.0
Mx-,1,0.0
degrees-120,1,0.0
synd4-deficient,1,0.0
degrees-60,1,0.0
proteoglycan,1,0.0
Syndecan-4,1,0.0
acaricides,1,0.0
changingcleaning,1,0.0
Poste,1,0.0
Visp,1,0.0
listeriosis,1,0.0
interpersonalfamily,1,0.0
bronchialbronchiolar,1,0.0
workphysical,1,0.0
devided,1,0.0
Citicoline,1,0.0
co-treatment,1,0.0
Treadmill,1,0.0
neuroblasts,1,0.0
099-112,1,0.0
143-182,1,0.0
155-197,1,0.0
104-118,1,0.0
1566,1,0.0
1430,1,0.0
8678,1,0.0
5533,1,0.0
Offspring,1,0.0
Pathologically,1,0.0
recognizable,1,0.0
transcribing,1,0.0
ERMs,1,0.0
Friedman,1,0.0
Promotion,1,0.0
Excitingly,1,0.0
nanomolar,1,0.0
182IU,1,0.0
activity-based,1,0.0
primo-infection,1,0.0
therapyself-care,1,0.0
troubling,1,0.0
phenomenological,1,0.0
Lazarus,1,0.0
132-390,1,0.0
odds-ratio,1,0.0
EGEA,1,0.0
cross-sectionally,1,0.0
pyelonephritis,1,0.0
HITS,1,0.0
Mechanism,1,0.0
PageRank,1,0.0
enterovirus,1,0.0
1192,1,0.0
p004,1,0.0
PageRank-like,1,0.0
commutes,1,0.0
bi-directionally,1,0.0
Commuting,1,0.0
Apoptosis,1,0.0
anasarca,1,0.0
HD--35,1,0.0
929-100,1,0.0
pan-CoV,1,0.0
anti-coronavirus,1,0.0
spawn,1,0.0
synthesizing,1,0.0
beensubstantially,1,0.0
Saskatchewan,1,0.0
reconsider,1,0.0
noticing,1,0.0
endow,1,0.0
random-digit,1,0.0
dialing,1,0.0
kg-1,1,0.0
Realtime,1,0.0
Pinggan,1,0.0
Yinghua,1,0.0
CPRintubation,1,0.0
foothold,1,0.0
cornea,1,0.0
SARS-CoV‑1,1,0.0
-coronavirus‑1,1,0.0
Mitigating,1,0.0
vulnerabilities,1,0.0
β-CoV-Bs,1,0.0
Taubenberger,1,0.0
DD--20,1,0.0
Tumpey,1,0.0
easy-to-produce,1,0.0
Inspiringly,1,0.0
pseudovirion,1,0.0
ligand-binding,1,0.0
Ile359,1,0.0
Gly353,1,0.0
GKGDFRI,1,0.0
Aldhous,1,0.0
virus-related,1,0.0
discovers,1,0.0
Committees,1,0.0
Ethics,1,0.0
COVID-19-convalescent,1,0.0
SARS-CoV2The,1,0.0
treatments»,1,0.0
«serious,1,0.0
CP-,1,0.0
pVAD,1,0.0
45-day,1,0.0
FFS,1,0.0
Fee-for-Service,1,0.0
Ocean,1,0.0
migrate,1,0.0
tenuirostris,1,0.0
short-tailed,1,0.0
Nariva,1,0.0
PVM,1,0.0
Yucaipavirus,1,0.0
pest,1,0.0
fowl,1,0.0
NDV,1,0.0
Ridge,1,0.0
Paramyxoviruses,1,0.0
opposition,1,0.0
Goggle,1,0.0
audiences,1,0.0
Myxoviruses,1,0.0
“consensus”,1,0.0
MBCK,1,0.0
LVG,1,0.0
endo,1,0.0
1918–19,1,0.0
“Spanish,1,0.0
school-closures,1,0.0
inter-generational,1,0.0
two-level,1,0.0
bovinerespiratory,1,0.0
SV5,1,0.0
SV41,1,0.0
pacificus,1,0.0
leucogaster,1,0.0
Sula,1,0.0
gannets,1,0.0
anaetheta,1,0.0
Sterna,1,0.0
bridled,1,0.0
minutus,1,0.0
Anous,1,0.0
noddy,1,0.0
wedge-tailed,1,0.0
pelagic,1,0.0
AFM1,1,0.0
ABEL,1,0.0
adsorption,1,0.0
AFM147,1,0.0
H0N1,1,0.0
ABEL42,1,0.0
avidity,1,0.0
Oak,1,0.0
Asian57,1,0.0
could--through,1,0.0
immunity--significantly,1,0.0
subtly,1,0.0
1125,1,0.0
mL-dose,1,0.0
thimerosal,1,0.0
Kong14342002,1,0.0
Kong3302001,1,0.0
disulphine,1,0.0
RR-31-31,1,0.0
200251,1,0.0
187000,1,0.0
disseminators,1,0.0
peri-interventional,1,0.0
Switch,1,0.0
Toehold,1,0.0
mens,1,0.0
⩽,1,0.0
Latour,1,0.0
Bruno,1,0.0
panorama,1,0.0
global-scale,1,0.0
socio-technical,1,0.0
ANT,1,0.0
Actor-Network,1,0.0
203T,1,0.0
httpwwwcdcgovncidoddiseasesflufluvirushtm,1,0.0
reactors,1,0.0
sedatives,1,0.0
PD--95,1,0.0
Insertion,1,0.0
HD--time,1,0.0
DD--time,1,0.0
PD--time,1,0.0
MeV,1,0.0
Haemostatic,1,0.0
Willebrands,1,0.0
Locked-In,1,0.0
intensifies,1,0.0
S203T,1,0.0
naysayers,1,0.0
Circumstantial,1,0.0
balloon-catheter,1,0.0
Exposed,1,0.0
tonifying,1,0.0
early-passage,1,0.0
mass-fabricated,1,0.0
well-positioned,1,0.0
April-December,1,0.0
Resorting,1,0.0
visibility,1,0.0
brisk,1,0.0
1725,1,0.0
0639,1,0.0
1996-97,1,0.0
right-heart,1,0.0
Etiology,1,0.0
infarction-related,1,0.0
Impella™,1,0.0
V6R,1,0.0
arteriolopathies,1,0.0
Fab,1,0.0
c7E3,1,0.0
third-generation,1,0.0
GUSTO-IIb,1,0.0
Anistreplase,1,0.0
Grampian,1,0.0
middle-apical,1,0.0
68-year,1,0.0
Chance,1,0.0
underperfused,1,0.0
recatheterized,1,0.0
angina-free,1,0.0
mmyocardial,1,0.0
0565-0722,1,0.0
1997-98,1,0.0
0601,1,0.0
whom--that,1,0.0
HIVSIDA,1,0.0
Prior-season,1,0.0
prior-season,1,0.0
1528,1,0.0
COVID-19-induced,1,0.0
upsurge,1,0.0
conditionClinical,1,0.0
X24073,1,0.0
likeliest,1,0.0
antagonistically,1,0.0
0527-0687,1,0.0
indooroutdoor,1,0.0
mini-monograph,1,0.0
etiopathogenia,1,0.0
gastroenterological,1,0.0
holosystolic,1,0.0
US-Russian,1,0.0
pretibial,1,0.0
dynamics-modellers,1,0.0
epidemics-and,1,0.0
Electrostatic,1,0.0
862-972,1,0.0
25-300,1,0.0
countriesterritories,1,0.0
H1r,1,0.0
supposition,1,0.0
non-H1,1,0.0
74922,1,0.0
Asp614Gly,1,0.0
peinfarction,1,0.0
post-cardiac,1,0.0
Sixty-seven-year-old,1,0.0
pharmaco-proteomic,1,0.0
under-utilized,1,0.0
tachycardic,1,0.0
high-reward,1,0.0
peripherally,1,0.0
Neurovascular,1,0.0
genetic-related,1,0.0
treatmentsvaccines,1,0.0
Well-understanding,1,0.0
Fifty-eight,1,0.0
expelled,1,0.0
ICER,1,0.0
Adamantane-resistant,1,0.0
10-90,1,0.0
Ala222Val,1,0.0
VWF-encoding,1,0.0
unsuspected,1,0.0
faecal,1,0.0
vector-mediated,1,0.0
aquaculture,1,0.0
salads,1,0.0
vegetatble,1,0.0
Between-group,1,0.0
cooked,1,0.0
wastewaters,1,0.0
canalization,1,0.0
Ruptured,1,0.0
unblocked,1,0.0
Fibrin,1,0.0
laboratory-controlled,1,0.0
job-related,1,0.0
immunopathogenic,1,0.0
infarciton,1,0.0
ill-effects,1,0.0
14-month,1,0.0
BLITZ-1,1,0.0
Fresh,1,0.0
cirrhotic,1,0.0
MEASURES,1,0.0
OUTCOME,1,0.0
INTERVENTION,1,0.0
SUBJECTS,1,0.0
A23187,1,0.0
ionophore,1,0.0
32000,1,0.0
001ABSTRACT,1,0.0
0130,1,0.0
0076,1,0.0
0240,1,0.0
0075,1,0.0
0138,1,0.0
0086,1,0.0
0181,1,0.0
nonfiltered,1,0.0
BRFSS,1,0.0
Virgin,1,0.0
80-250,1,0.0
bandwidth,1,0.0
USVI,1,0.0
1297,1,0.0
Mapping,1,0.0
PLD1,1,0.0
GPIbalphaVWF,1,0.0
29713,1,0.0
Peridural,1,0.0
De-identified,1,0.0
vector-carried,1,0.0
Resistant,1,0.0
CHSA-,1,0.0
Describe,1,0.0
induced-asthma,1,0.0
experimenter,1,0.0
replications,1,0.0
perish,1,0.0
lifted,1,0.0
Informing,1,0.0
RNADNA,1,0.0
conventially,1,0.0
food-ingested,1,0.0
pre-human,1,0.0
retrotransposon,1,0.0
SARS-CoV-2-causing,1,0.0
Eighty-nine,1,0.0
Polynesians,1,0.0
strategys,1,0.0
22-23,1,0.0
rRTPCR,1,0.0
street,1,0.0
vending,1,0.0
unhygienic,1,0.0
unveiled,1,0.0
VII,1,0.0
679,1,0.0
Quantitation,1,0.0
cigarette-smoking,1,0.0
desirability,1,0.0
pride,1,0.0
Osnabrück,1,0.0
8-level,1,0.0
footing,1,0.0
eminently,1,0.0
SYST-Eur,1,0.0
patient-identified,1,0.0
SYST-China,1,0.0
pretested,1,0.0
Berhan,1,0.0
Debre,1,0.0
precampaign,1,0.0
WHOInternational,1,0.0
ISH,1,0.0
group-1,1,0.0
150-cavity,1,0.0
q-wave,1,0.0
al1,1,0.0
Carli,1,0.0
6-15-fold,1,0.0
paper-based,1,0.0
F-18,1,0.0
deoxyglucose,1,0.0
flow-based,1,0.0
suspecting,1,0.0
dispatcher,1,0.0
autosomic,1,0.0
IL4,1,0.0
vocabulary,1,0.0
N-nitroso,1,0.0
Coding,1,0.0
carcinogenic,1,0.0
“Is,1,0.0
multiple-treatments,1,0.0
COVID‐19”,1,0.0
Test-Revised,1,0.0
Spelling,1,0.0
Arithmetic,1,0.0
Reading,1,0.0
Children-Revised,1,0.0
Southwestern,1,0.0
intercellular,1,0.0
funeral,1,0.0
thing,1,0.0
2280247,1,0.0
2040611,1,0.0
2460092,1,0.0
pHCWs,1,0.0
SARS-CoV-2-antibody,1,0.0
CASOD,1,0.0
athero-stenotic,1,0.0
indifferent,1,0.0
1309,1,0.0
18141,1,0.0
1643,1,0.0
workschool,1,0.0
9652,1,0.0
8822,1,0.0
6329,1,0.0
hydrate,1,0.0
octanoate,1,0.0
Laninamivir,1,0.0
Intraclass,1,0.0
overrepresenting,1,0.0
CHQs,1,0.0
1305,1,0.0
criticisms,1,0.0
040009,1,0.0
2307,1,0.0
thiazide-type,1,0.0
IMAC,1,0.0
NZiS,1,0.0
non-atheromatic,1,0.0
respirologists,1,0.0
damping,1,0.0
multi-country,1,0.0
2408,1,0.0
patient-preference-sensitive,1,0.0
first-vaccine-dose,1,0.0
024004,1,0.0
deferral,1,0.0
second-dose,1,0.0
Amid,1,0.0
AARs,1,0.0
5LV,1,0.0
8LV,1,0.0
6LV,1,0.0
10LV,1,0.0
021004,1,0.0
Secreted,1,0.0
hydrodynamic,1,0.0
931,1,0.0
abusive,1,0.0
pharynxes,1,0.0
Snoring,1,0.0
cephalometric,1,0.0
cranio-mandibular,1,0.0
NREM,1,0.0
non-rapid,1,0.0
Le,1,0.0
Bonheur,1,0.0
snored,1,0.0
LBCH,1,0.0
seraplasma,1,0.0
3879,1,0.0
serodiagnosis,1,0.0
serodiagnostic,1,0.0
PLWH,1,0.0
lactosamine,1,0.0
sialylated,1,0.0
sugars,1,0.0
N-acetylglucosamine,1,0.0
4-position,1,0.0
beta-elimination,1,0.0
Müller,1,0.0
Envelope,1,0.0
VWF--,1,0.0
RdRPEN,1,0.0
AFI,1,0.0
H3N2v-associated,1,0.0
hemorrhaghic,1,0.0
888,1,0.0
454,1,0.0
subtherapeutic,1,0.0
EPPY,1,0.0
barns,1,0.0
Heartware,1,0.0
Heartmate,1,0.0
9538,1,0.0
9231,1,0.0
9692,1,0.0
9462,1,0.0
Hex,1,0.0
CY5IC,1,0.0
FAMN,1,0.0
hematochemical,1,0.0
Kogenebiotech,1,0.0
RdRPNIC,1,0.0
RdRPNInternal,1,0.0
anhydro-KDO,1,0.0
trisaccharide,1,0.0
heptose,1,0.0
22158,1,0.0
postinjury,1,0.0
cross-study,1,0.0
Queens,1,0.0
vasculopathic,1,0.0
lymphoproliferative,1,0.0
gammopathy,1,0.0
endocrinopathy,1,0.0
organomegaly,1,0.0
polyneuropathy,1,0.0
1156-bed,1,0.0
APhilippines,1,0.0
pseudochilblain,1,0.0
Itching,1,0.0
chickenpox‐like,1,0.0
urticarial,1,0.0
sequence-independent,1,0.0
1888,1,0.0
single-primer,1,0.0
httpsqapecdceuropaeupublicextensionsCOVID-19COVID-19html,1,0.0
CT-alternative,1,0.0
redone,1,0.0
otorhinolaryngologic,1,0.0
otorhinolaryngology,1,0.0
de-escalation,1,0.0
L-glycero-D-manno-heptoses,1,0.0
12434,1,0.0
watershedhypoperfusion,1,0.0
size-exclusion,1,0.0
N-acetylhexosamine,1,0.0
PEA,1,0.0
phosphoethanolamine,1,0.0
diphosphorylated,1,0.0
174700,1,0.0
3-deoxy-D-manno-octulosonic,1,0.0
hexoses,1,0.0
lipooligosaccharides,1,0.0
34164,1,0.0
22778,1,0.0
electrospray,1,0.0
32500,1,0.0
hydrazine,1,0.0
anhydrous,1,0.0
O-deacylation,1,0.0
nonstroke,1,0.0
glycolipids,1,0.0
GLPSS,1,0.0
15-May,1,0.0
on-campus,1,0.0
1996-2002,1,0.0
tracheitis,1,0.0
ratio88,1,0.0
114-144,1,0.0
74-88,1,0.0
household-interviews,1,0.0
13010,1,0.0
telephone-surveys,1,0.0
stress-echocardiography,1,0.0
11195,1,0.0
centThe,1,0.0
No10-35,1,0.0
culture-proven,1,0.0
-73,1,0.0
No10-29,1,0.0
illnessILI,1,0.0
MBT,1,0.0
beans,1,0.0
Reverse-transcriptase-polymerase-chain-reaction,1,0.0
paraneoplastic,1,0.0
oncohematological,1,0.0
uropoetic,1,0.0
otolaryngology,1,0.0
Mitral,1,0.0
swabsMethods,1,0.0
recurred,1,0.0
CVE,1,0.0
shear-induced,1,0.0
France--antigenic,1,0.0
consider--from,1,0.0
GISN,1,0.0
Copeptin,1,0.0
bicycle-exercise,1,0.0
thwarted,1,0.0
10-case,1,0.0
0-case,1,0.0
misuses,1,0.0
unmitigated,1,0.0
all-community,1,0.0
stylized,1,0.0
agent-based,1,0.0
mgkgtwice,1,0.0
intraperitoneal,1,0.0
5mgkgday,1,0.0
Objecive,1,0.0
IKKNF-kappaB,1,0.0
15512,1,0.0
Mikulas,1,0.0
dormitories,1,0.0
Liptovsky,1,0.0
9The,1,0.0
wave-by-wave,1,0.0
infection-acquired,1,0.0
2288,1,0.0
amygdalitis,1,0.0
03Conclusion,1,0.0
wind-heat,1,0.0
NMPA,1,0.0
Lianhua-Qingwen,1,0.0
invadability,1,0.0
Actually,1,0.0
Tables,1,0.0
smoking--for,1,0.0
variables--age,1,0.0
pound,1,0.0
calculator,1,0.0
receptor-lipopolysaccharide,1,0.0
TLR-LPS,1,0.0
unifying,1,0.0
B11222,1,0.0
undergraduate-aged,1,0.0
sero-epidemiological,1,0.0
influenza-experienced,1,0.0
population-age,1,0.0
pitch,1,0.0
performedResults,1,0.0
elastase,1,0.0
No1-29,1,0.0
No30-35,1,0.0
1165,1,0.0
hyperfibrinogenemia,1,0.0
90th,1,0.0
sings,1,0.0
loudness,1,0.0
misattribution,1,0.0
no21,1,0.0
Crus,1,0.0
VIIb,1,0.0
Lobules,1,0.0
Voxel-based,1,0.0
lesion-behavior,1,0.0
higher-order,1,0.0
no132131,1,0.0
voices,1,0.0
miscarriages,1,0.0
substituting,1,0.0
URTIs,1,0.0
28000,1,0.0
n1,1,0.0
callosal,1,0.0
n28,1,0.0
331125,1,0.0
Friendship,1,0.0
China-Japan,1,0.0
746,1,0.0
maximized,1,0.0
commissural,1,0.0
（CCS）,1,0.0
snack,1,0.0
infarction）,1,0.0
（including,1,0.0
（SCD）,1,0.0
machineries,1,0.0
Host-based,1,0.0
host-based,1,0.0
pharmaceutics,1,0.0
pressuregeomagnetic,1,0.0
excessing,1,0.0
Anadyr,1,0.0
Tynda,1,0.0
disconnection,1,0.0
diffuselarge,1,0.0
palliation,1,0.0
Policlinico,1,0.0
millionyear,1,0.0
134-46,1,0.0
recapitulated,1,0.0
carryover,1,0.0
weak-spot,1,0.0
cross-cutting,1,0.0
population-specific,1,0.0
Protecting,1,0.0
1-week,1,0.0
vaccinators,1,0.0
G2P2,1,0.0
evidence-to-practice,1,0.0
concertation,1,0.0
technietium,1,0.0
Factoring,1,0.0
0368,1,0.0
0680,1,0.0
035x1000mL,1,0.0
weight-dependent,1,0.0
Sapienza,1,0.0
Umberto,1,0.0
Stroke-case,1,0.0
Anadyr--348,1,0.0
Tynda--329,1,0.0
Krasnoyarsk--325,1,0.0
hyperdynamic,1,0.0
-291,1,0.0
prioritisation,1,0.0
thrombolyzed,1,0.0
1730,1,0.0
last-well,1,0.0
Lausanne,1,0.0
9-OH,1,0.0
deoxygenated,1,0.0
Y406,1,0.0
cytopathologists,1,0.0
N-acetylamino-235-trideoxy-23-difluoro-d-erythro-β-l-manno-2-nonulopyranosonic,1,0.0
Competitive,1,0.0
inter-epidemic,1,0.0
Northumbria,1,0.0
Anglia,1,0.0
Dyfed,1,0.0
Devon,1,0.0
Cumbria,1,0.0
parish,1,0.0
Deferral,1,0.0
3C3a,1,0.0
9297,1,0.0
1261,1,0.0
information-sharing,1,0.0
1987-1988,1,0.0
alerting,1,0.0
underusing,1,0.0
haematology-oncology,1,0.0
Covid-19-related,1,0.0
overusing,1,0.0
quantiles,1,0.0
quantile,1,0.0
infectives,1,0.0
MiRs,1,0.0
-70,1,0.0
maximization,1,0.0
Studied,1,0.0
Extraordinary,1,0.0
Postdischarge,1,0.0
2643,1,0.0
-72,1,0.0
-49,1,0.0
-18,1,0.0
-8,1,0.0
ncHi,1,0.0
nonsurgical,1,0.0
infarct-free,1,0.0
Kruskall,1,0.0
LVET,1,0.0
PEP,1,0.0
preejection,1,0.0
non-traumatic,1,0.0
non-iatrogenic,1,0.0
in-utero,1,0.0
in-vitroin-vivo,1,0.0
gene-editing-based,1,0.0
Inadequacies,1,0.0
patientsOur,1,0.0
mildpersistent,1,0.0
evaluatedNineteen,1,0.0
Mofid,1,0.0
aspergillosisNinety-six,1,0.0
Show,1,0.0
0783,1,0.0
Host-directed,1,0.0
9893,1,0.0
9691-,1,0.0
225-281,1,0.0
Stata,1,0.0
amylnitrate,1,0.0
Judging,1,0.0
exclusions,1,0.0
Triple,1,0.0
871234,1,0.0
measles-mumps-rubella,1,0.0
cheat,1,0.0
divert,1,0.0
case-mix,1,0.0
Audits,1,0.0
second-largest,1,0.0
LVOs,1,0.0
ETIS,1,0.0
Post-hoc,1,0.0
approvalimplementation,1,0.0
Feasibility,1,0.0
642,1,0.0
3-17,1,0.0
Pima,1,0.0
3419,1,0.0
well-received,1,0.0
nonhypotensive,1,0.0
nonbiomedical,1,0.0
botanical,1,0.0
Wallis,1,0.0
Dia-Pro,1,0.0
patencyABSTRACT,1,0.0
ACE2-RBD,1,0.0
Controlled-release,1,0.0
chronopharmacology,1,0.0
Appreciation,1,0.0
AHong-KongI68,1,0.0
elevating,1,0.0
23--24,1,0.0
ammounted,1,0.0
Hib,1,0.0
1971--1972,1,0.0
AHong-Kong,1,0.0
nonencapsulated,1,0.0
undeveloped,1,0.0
complications--most,1,0.0
Nonregular,1,0.0
Misidentification,1,0.0
conveyance,1,0.0
Introductionbackground,1,0.0
Iowa,1,0.0
subanalyses,1,0.0
18-50,1,0.0
drug-caused,1,0.0
Uniphyl,1,0.0
meal,1,0.0
corticosteroid-induced,1,0.0
Behaviorally,1,0.0
Centaur®,1,0.0
ADVIA,1,0.0
COV2T®,1,0.0
1053,1,0.0
anti-infection,1,0.0
reacts,1,0.0
Aging,1,0.0
synchrony,1,0.0
interhemisphere,1,0.0
eculizumab,1,0.0
high-potency,1,0.0
Aggregation,1,0.0
Autoantibodies,1,0.0
self-protective,1,0.0
Metformin,1,0.0
sinusoid-coronary,1,0.0
sinusoid,1,0.0
sinusoid-left,1,0.0
inhospital,1,0.0
sustained-action,1,0.0
freshly,1,0.0
mucoviscidosis,1,0.0
Trial-Italy,1,0.0
NATURE,1,0.0
040050049,1,0.0
nickle,1,0.0
Willey,1,0.0
thrombo-embolic,1,0.0
non-compaction,1,0.0
trabeculations,1,0.0
ALPHA,1,0.0
BETA,1,0.0
GAMMA,1,0.0
VOIs,1,0.0
Theta,1,0.0
Kent,1,0.0
20-bed,1,0.0
aetiology-oriented,1,0.0
1-103,1,0.0
147-901,1,0.0
115-1046,1,0.0
Diseases-9,1,0.0
Misericordia,1,0.0
Della,1,0.0
Maria,1,0.0
metalloporphyrin,1,0.0
siderosis,1,0.0
subjectsABSTRACT,1,0.0
seated,1,0.0
casting,1,0.0
ergometrine,1,0.0
ravished,1,0.0
deuterated,1,0.0
Altering,1,0.0
microextraction,1,0.0
chromatography-high-resolution,1,0.0
maleate,1,0.0
casework,1,0.0
plasmin-alpha,1,0.0
rectification,1,0.0
2-plasmin,1,0.0
dawn,1,0.0
over-aggressive,1,0.0
T-705,1,0.0
Airport,1,0.0
Schiphol,1,0.0
CIbRIVM,1,0.0
flight-contact,1,0.0
rows,1,0.0
row,1,0.0
411e27-e32,1,0.0
37584,1,0.0
Foster,1,0.0
juxtaposition,1,0.0
dead-on-arrival,1,0.0
Pre-admission,1,0.0
Yokohama,1,0.0
Bokutoh,1,0.0
localisable,1,0.0
hypercontractile,1,0.0
mid-apical,1,0.0
Shortly,1,0.0
thirty-two-year-old,1,0.0
lumbar,1,0.0
Bodyweight,1,0.0
fluororadiographs,1,0.0
Oppression,1,0.0
3D-printed,1,0.0
interstitium,1,0.0
undigested,1,0.0
digested,1,0.0
1458,1,0.0
RdRP-amplified,1,0.0
cuts,1,0.0
345-bp,1,0.0
DOA,1,0.0
non-DOA,1,0.0
83-year-old,1,0.0
pre-moistened,1,0.0
ensues,1,0.0
spirituality,1,0.0
References,1,0.0
ordeals,1,0.0
lifes,1,0.0
receptacle,1,0.0
Narrative,1,0.0
McGill,1,0.0
fountain,1,0.0
Sterile,1,0.0
catastrophes,1,0.0
CO-RADS,1,0.0
Nurse,1,0.0
posterolaterally,1,0.0
hyperechogenic,1,0.0
color-coded,1,0.0
trending,1,0.0
renewable,1,0.0
unter,1,0.0
AFAS,1,0.0
Peloponnesian,1,0.0
Athenian,1,0.0
historian,1,0.0
innate-to-adaptive,1,0.0
sinusoidal-cell,1,0.0
nonparenchymal,1,0.0
phylogenetically,1,0.0
neuropilin-1,1,0.0
childbirth,1,0.0
250000,1,0.0
4000000,1,0.0
G11083T,1,0.0
PFO-mediated,1,0.0
Confounding,1,0.0
G26144T,1,0.0
decomposed,1,0.0
C14805T,1,0.0
test-elasticity,1,0.0
benchmarking,1,0.0
speaks,1,0.0
V7-V9,1,0.0
Naturally,1,0.0
varicella,1,0.0
8-18,1,0.0
meat,1,0.0
shreds,1,0.0
Implementing,1,0.0
3-million,1,0.0
FHMI-by-risk,1,0.0
latrogenic,1,0.0
wave--the,1,0.0
808,1,0.0
topographically,1,0.0
Euroglyphus,1,0.0
maynei,1,0.0
cancer-associated,1,0.0
Af,1,0.0
goiters,1,0.0
DHS,1,0.0
weeksmonths,1,0.0
Dallas,1,0.0
upholstered,1,0.0
furniture,1,0.0
agglutination,1,0.0
mammalian-derived,1,0.0
scFv,1,0.0
HDMs,1,0.0
Sensitized,1,0.0
Travel,1,0.0
well-cooked,1,0.0
CD16,1,0.0
Thucydides,1,0.0
Plasmodium,1,0.0
RH5-basigin,1,0.0
recombinantly,1,0.0
OVA-specific,1,0.0
Pristimerin,1,0.0
Thromboembolic,1,0.0
Thrombi,1,0.0
MSC-based,1,0.0
ILK-engineered,1,0.0
anti-basigin,1,0.0
promisingly,1,0.0
poly-L-lysine,1,0.0
ILK,1,0.0
integrin-linked,1,0.0
MSCs-based,1,0.0
storm-induced,1,0.0
Opportunities,1,0.0
E6,1,0.0
onset-to-reperfusion,1,0.0
Confirming,1,0.0
Hilleman,1,0.0
Maurice,1,0.0
MAPKs,1,0.0
RH5,1,0.0
33-83,1,0.0
ACalifornia042009,1,0.0
24-756,1,0.0
falciparum,1,0.0
1440,1,0.0
VLP,1,0.0
PR8,1,0.0
intrasubgroup,1,0.0
im,1,0.0
FFU,1,0.0
1×107,1,0.0
virus-like-particle,1,0.0
reticulocyte,1,0.0
baculovirus-based,1,0.0
envelope-coated,1,0.0
HERV,1,0.0
retrovirus,1,0.0
baculoviral,1,0.0
18449,1,0.0
empowerment,1,0.0
confidentiality,1,0.0
forums,1,0.0
MMR-vaccinated,1,0.0
randomisation,1,0.0
1975-6,1,0.0
ColdZyme®,1,0.0
14-296,1,0.0
cause-of-death,1,0.0
impatient-care,1,0.0
buttress,1,0.0
entertain,1,0.0
behooves,1,0.0
encountering,1,0.0
above-matched,1,0.0
anxiety-like,1,0.0
Prefrontal,1,0.0
win-shiftwin-stay,1,0.0
Barnes,1,0.0
light-dark,1,0.0
set-shifting,1,0.0
known-onset,1,0.0
prefrontal,1,0.0
MRI-guided,1,0.0
apneahypopnea,1,0.0
transcription-quantitative,1,0.0
nanotheranostics,1,0.0
∼32,1,0.0
intelligence-based,1,0.0
86-year-old,1,0.0
Río,1,0.0
glycerol,1,0.0
K-5,1,0.0
2000106S144-52,1,0.0
CFIp,1,0.0
interview-based,1,0.0
child-parent,1,0.0
differIn,1,0.0
equate,1,0.0
Biotelemetric,1,0.0
swimming-was,1,0.0
exercise-running,1,0.0
Ventilatory,1,0.0
Cesarean,1,0.0
Seventy-six,1,0.0
UAI,1,0.0
RASis,1,0.0
emergences,1,0.0
2019-2021,1,0.0
Separated,1,0.0
pre-visit,1,0.0
nasopharyngolaryngoscopy,1,0.0
cod,1,0.0
downtown,1,0.0
submillimeter,1,0.0
field-of-view,1,0.0
autofluorescence,1,0.0
barky,1,0.0
free-standing,1,0.0
monocytosis,1,0.0
factor-based,1,0.0
impact-of-asthma,1,0.0
xenon-enhanced,1,0.0
K-antagonists,1,0.0
arterio-arterial,1,0.0
6753,1,0.0
non-photodynamic,1,0.0
202021,1,0.0
FluView,1,0.0
non-photoactivated,1,0.0
APOEε2,1,0.0
adipokines,1,0.0
4D,1,0.0
phosphodiesterase,1,0.0
endproducts,1,0.0
glycation,1,0.0
androgens,1,0.0
SerologicDiagnostic,1,0.0
racemic,1,0.0
heliox,1,0.0
Pathogen,1,0.0
hostenvironment,1,0.0
bioimaging,1,0.0
Eu-luminescent,1,0.0
two-photon,1,0.0
thoracoepigastric,1,0.0
May-September,1,0.0
intra-country,1,0.0
confusable,1,0.0
defuzzification,1,0.0
seamless,1,0.0
adapts,1,0.0
unravelled,1,0.0
Pulse,1,0.0
8864,1,0.0
httpswwwgisaidorg,1,0.0
beclouded,1,0.0
RNA-negative,1,0.0
Phenotype-driven,1,0.0
Th2-expression,1,0.0
TorontoABSTRACT,1,0.0
inflammation-predominant,1,0.0
K-8,1,0.0
intrasubtypic,1,0.0
prescriber,1,0.0
HO1,1,0.0
enolase,1,0.0
neuron-specific,1,0.0
subsidies,1,0.0
€6956559,1,0.0
€13024,1,0.0
Stage,1,0.0
€557549,1,0.0
€1044,1,0.0
Methodology,1,0.0
automotive,1,0.0
toe,1,0.0
hemostimulating,1,0.0
endowed,1,0.0
Used,1,0.0
minerals,1,0.0
barcodes,1,0.0
Vasoactive,1,0.0
DP2kpHO1,1,0.0
HIF-1α-negative,1,0.0
HIF-1α-positive,1,0.0
factor-1α,1,0.0
NSE,1,0.0
generalizability,1,0.0
barcoded,1,0.0
baseline-free,1,0.0
substitutes,1,0.0
workarounds,1,0.0
Fayad,1,0.0
MCIs,1,0.0
Keller,1,0.0
existential,1,0.0
mirrors,1,0.0
anticipatory,1,0.0
five-years,1,0.0
SBL,1,0.0
ceasing,1,0.0
MMV,1,0.0
Frequency-Constrained,1,0.0
adjustable,1,0.0
coils,1,0.0
gradiometer,1,0.0
Electromagnetic,1,0.0
multi-frequency,1,0.0
non-radiative,1,0.0
bio-impedance,1,0.0
hypoxia-inducible,1,0.0
Lipofectamine,1,0.0
verifying,1,0.0
polyethylenimine-25k,1,0.0
hydroxychloroquine-a,1,0.0
sensibility,1,0.0
renal-related,1,0.0
cardiac-,1,0.0
neurological-,1,0.0
1100000,1,0.0
39000000,1,0.0
conservatively--560,1,0.0
misdiagnoses,1,0.0
Eight-year,1,0.0
life-interfering,1,0.0
well-proven,1,0.0
ultrafiltration,1,0.0
electrostatically,1,0.0
PEG-based,1,0.0
must-have,1,0.0
570,1,0.0
practices--yogasanas,1,0.0
kriyas--and,1,0.0
metaanalysis,1,0.0
mega,1,0.0
beginning-were,1,0.0
Occipital,1,0.0
transorbital,1,0.0
anti-RAGE,1,0.0
Cerebellar,1,0.0
box-1,1,0.0
RAGE-binding,1,0.0
over-expressed,1,0.0
Cerebellum,1,0.0
polyethylenimine-2k,1,0.0
deoxycholate-conjugated,1,0.0
oxygenase-1,1,0.0
AICA,1,0.0
self-assembled,1,0.0
rtACS,1,0.0
Adrenergic,1,0.0
PICA,1,0.0
1875,1,0.0
toxicmetabolic,1,0.0
sham-stimulation,1,0.0
EEG-spectra,1,0.0
vision-related,1,0.0
hemianopic,1,0.0
REVIS,1,0.0
appraised,1,0.0
Roberto,1,0.0
HRCs,1,0.0
thrombophilic,1,0.0
donating,1,0.0
semipermeable,1,0.0
Raynauds,1,0.0
prolapse,1,0.0
valinomycin,1,0.0
equal-tailed,1,0.0
CrIs,1,0.0
p0028,1,0.0
co-operate,1,0.0
783,1,0.0
non-city,1,0.0
676were,1,0.0
Off,1,0.0
pre-designed,1,0.0
points-of-entry,1,0.0
Bioanalytical,1,0.0
102950,1,0.0
unblocking,1,0.0
imatinib,1,0.0
Augmenting,1,0.0
variant-dominant,1,0.0
P-selectin,1,0.0
Hyogo,1,0.0
httpsdoiorg107196SAMJ2021v111i615740,1,0.0
Prefectures,1,0.0
10-dose,1,0.0
Extrapolations,1,0.0
lódzkie,1,0.0
35825,1,0.0
lubuskie,1,0.0
14348,1,0.0
15431,1,0.0
mazowieckie,1,0.0
16904,1,0.0
swietokrzyskie,1,0.0
6604,1,0.0
251815,1,0.0
targetsdrugs,1,0.0
settling,1,0.0
741808,1,0.0
scorings,1,0.0
unchangeduncertain,1,0.0
brackets,1,0.0
UI,1,0.0
pneumothoraces,1,0.0
posteroanterior,1,0.0
colchicine,1,0.0
Cretan,1,0.0
beside,1,0.0
305-310,1,0.0
pepsin-insoluble,1,0.0
hydroxyproline,1,0.0
brand,1,0.0
covalently,1,0.0
peptidomimetic,1,0.0
Yichang,1,0.0
axis-45,1,0.0
Zealand-Sydney,1,0.0
Sydney-New,1,0.0
Alaskan,1,0.0
proxalutamide,1,0.0
-B,1,0.0
HLA-A,1,0.0
virus-immune,1,0.0
encapsulate,1,0.0
multi-symptomatic,1,0.0
overdiagnosing,1,0.0
ice-hockey,1,0.0
oversimplification,1,0.0
lmin,1,0.0
Athletes,1,0.0
noncollagenouscollagenous,1,0.0
noncollagenous,1,0.0
1991-1996,1,0.0
modernization,1,0.0
Chin,1,0.0
eye-nose,1,0.0
coronavirus2019-nCoV,1,0.0
ExT,1,0.0
tofacitinib,1,0.0
single-pill,1,0.0
sarilumab,1,0.0
nitazoxanide,1,0.0
14090,1,0.0
unification,1,0.0
OLSA,1,0.0
centurys,1,0.0
in-flight,1,0.0
lung-function,1,0.0
pig-to-pig,1,0.0
SwONT97,1,0.0
piglet,1,0.0
350-500000,1,0.0
stasus,1,0.0
universe,1,0.0
alcoholism,1,0.0
infectionABSTRACT,1,0.0
poliomyelitis-like,1,0.0
7172,1,0.0
hyper-acute,1,0.0
first-hand,1,0.0
chronic-phase,1,0.0
evolutions,1,0.0
Atelectasis,1,0.0
1234,1,0.0
Less-frequent,1,0.0
1534,1,0.0
evacuee,1,0.0
repatriation,1,0.0
2821103,1,0.0
year-by-year,1,0.0
H1-H13,1,0.0
Haemodynamically,1,0.0
1616,1,0.0
groups--Group,1,0.0
LTCF,1,0.0
1516,1,0.0
Bauhins,1,0.0
long-term--care,1,0.0
Persistently,1,0.0
argatroban,1,0.0
ozagrel,1,0.0
adept,1,0.0
intraarterial,1,0.0
20211116522-523,1,0.0
Afr,1,0.0
rhetoric,1,0.0
Dial,1,0.0
Schoub,1,0.0
Venter,1,0.0
Letter,1,0.0
MOI,1,0.0
IHUMI-3,1,0.0
CmaxEC50,1,0.0
lyophilized,1,0.0
storable,1,0.0
0966-1000,1,0.0
0986,1,0.0
CmaxEC90,1,0.0
949-998,1,0.0
974-1000,1,0.0
Cross-reactivity,1,0.0
CT3412,1,0.0
Primer,1,0.0
spectrometry-based,1,0.0
6176,1,0.0
dead-space,1,0.0
6766,1,0.0
mi-AGTP,1,0.0
AdiFLAP,1,0.0
NCT01473433,1,0.0
non-invasiveness,1,0.0
nephrology,1,0.0
care--the,1,0.0
Goals,1,0.0
Essentials,1,0.0
learner,1,0.0
dose-capacity,1,0.0
ergonomic,1,0.0
Flutrade,1,0.0
Qigong,1,0.0
42-58,1,0.0
80-99,1,0.0
92-100,1,0.0
18-35,1,0.0
graders,1,0.0
17-year-olds,1,0.0
10-,1,0.0
9-year-olds,1,0.0
microflora,1,0.0
grappling,1,0.0
endogenic,1,0.0
schematic,1,0.0
re-assortment,1,0.0
notoriety,1,0.0
phage-displayed,1,0.0
streptavidin-coated,1,0.0
biotin-conjugated,1,0.0
biotin-streptavidin,1,0.0
cytometers,1,0.0
manometry,1,0.0
afflicts,1,0.0
drills,1,0.0
100-year,1,0.0
RealOpt-based,1,0.0
parameterizing,1,0.0
countys,1,0.0
parameterize,1,0.0
duodenography,1,0.0
duodenal,1,0.0
RealOpt-POD-v802,1,0.0
dysbacteriosis,1,0.0
anniversary,1,0.0
396-bp,1,0.0
Primers,1,0.0
STT-wave,1,0.0
P3,1,0.0
discrupted,1,0.0
rhythmogram,1,0.0
Segments,1,0.0
RKAS-1,1,0.0
arrthythmias,1,0.0
well-recognised,1,0.0
Th2-associated,1,0.0
disinformation,1,0.0
3-15,1,0.0
smoke-free,1,0.0
magnesemia,1,0.0
plasmatic,1,0.0
rhetorical,1,0.0
brazilians,1,0.0
COVID-denialist,1,0.0
corrupt,1,0.0
elites,1,0.0
Serfling-type,1,0.0
ANetherlands21903,1,0.0
AShanghai213,1,0.0
H6N1,1,0.0
RRsigma,1,0.0
sensitised,1,0.0
inflammatory-induced,1,0.0
Thursday,1,0.0
21132,1,0.0
MSDB,1,0.0
1992-1995,1,0.0
Xplore,1,0.0
IEEE,1,0.0
acknowledge,1,0.0
cardiac-rehabilitation,1,0.0
CCS-1,1,0.0
ISIS-4,1,0.0
GISSI-3,1,0.0
long-term-,1,0.0
tazobactam,1,0.0
piperacillin,1,0.0
bilobar,1,0.0
Reflective,1,0.0
pharyngitis,1,0.0
H1N1-influenza,1,0.0
bedridden,1,0.0
CD25,1,0.0
P-ECP,1,0.0
Tuesday,1,0.0
KongSF401,1,0.0
AchickenHong,1,0.0
KongG997,1,0.0
AIndiana0811,1,0.0
British-German,1,0.0
3950,1,0.0
ketotifen,1,0.0
48711,1,0.0
isonicotinate,1,0.0
Aerosolized,1,0.0
indomethacin,1,0.0
MDH,1,0.0
delayed-enhancement,1,0.0
mAs,1,0.0
euthanased,1,0.0
re-arrangements,1,0.0
12-day,1,0.0
non-Hodgkins,1,0.0
High-grade,1,0.0
Shorthair,1,0.0
neutered,1,0.0
prodrome,1,0.0
facility-based,1,0.0
unmasks,1,0.0
COVID-19-convalescence,1,0.0
17q12,1,0.0
Aiolos,1,0.0
GSDML,1,0.0
Pichia,1,0.0
Kong107399,1,0.0
AJapan3051957,1,0.0
48-64,1,0.0
Reproducibility,1,0.0
Yeast,1,0.0
DLS,1,0.0
SEC-HPLC,1,0.0
liter,1,0.0
pastoris,1,0.0
5-L,1,0.0
guilty,1,0.0
1-L,1,0.0
Lymphangio-MRI,1,0.0
cGMPs,1,0.0
Alhydrogel®,1,0.0
contrast-enhancing,1,0.0
Rafsanjan,1,0.0
Taleb,1,0.0
Ali-Ibne-Abi,1,0.0
digits,1,0.0
Motivational,1,0.0
11-74,1,0.0
CI12-93,1,0.0
drug-refractory,1,0.0
thalamo-parietal,1,0.0
HV,1,0.0
VV,1,0.0
modalityies,1,0.0
-78,1,0.0
-85,1,0.0
pushers,1,0.0
documentations,1,0.0
non-participants,1,0.0
-45,1,0.0
rod,1,0.0
DMP-,1,0.0
rightwards-leftwards,1,0.0
drum,1,0.0
drum-like,1,0.0
restrained,1,0.0
sat,1,0.0
DMPs,1,0.0
self-isolate,1,0.0
moderate-grade,1,0.0
ventriculoplasty,1,0.0
somaesthetic,1,0.0
graviceptive,1,0.0
Tilts,1,0.0
adversities,1,0.0
medicalization,1,0.0
2008-2018,1,0.0
sect,1,0.0
2006-2012,1,0.0
nightclubs,1,0.0
Koreas,1,0.0
action-centered,1,0.0
Cause,1,0.0
Routinely,1,0.0
tract-level,1,0.0
1718,1,0.0
6-54,1,0.0
Δ-9-tetrahydrocannabinol,1,0.0
Exhaustive,1,0.0
re-employed,1,0.0
marijuana-associated,1,0.0
platform-based,1,0.0
sulphate,1,0.0
erroneous,1,0.0
erect,1,0.0
defibrillating,1,0.0
pre-clinically,1,0.0
hemineglect,1,0.0
austerity,1,0.0
110574,1,0.0
LVMMs,1,0.0
broadens,1,0.0
MF59,1,0.0
emulsion,1,0.0
non-adjuvanted,1,0.0
fascinating,1,0.0
Anti-neuraminidase,1,0.0
receptor-blocking,1,0.0
endosomal,1,0.0
cathepsin-mediated,1,0.0
organoids,1,0.0
multibasic,1,0.0
anti-remodelling,1,0.0
CysLT2,1,0.0
articulating,1,0.0
T-waves,1,0.0
reiterates,1,0.0
postregistration,1,0.0
775,1,0.0
Patient-centered,1,0.0
13157,1,0.0
n266,1,0.0
42-79,1,0.0
Socio-economic,1,0.0
colossal,1,0.0
6–86,1,0.0
24–89,1,0.0
gene-modified,1,0.0
DipHE,1,0.0
Exosomal,1,0.0
revascularizing,1,0.0
revitalizing,1,0.0
infarct-limiting,1,0.0
marking,1,0.0
n171,1,0.0
sending,1,0.0
n153,1,0.0
95189,1,0.0
phase-2,1,0.0
68240,1,0.0
phase-1,1,0.0
Phase-1,1,0.0
NPSs,1,0.0
placements,1,0.0
MI-induced,1,0.0
recognized-including,1,0.0
STEMI-equivalents,1,0.0
3-2,1,0.0
bronchodilatorsreduction,1,0.0
nongravid,1,0.0
1506,1,0.0
0024,1,0.0
BJiangsu102003-like,1,0.0
intends,1,0.0
dilutional,1,0.0
re-pooling,1,0.0
screeningsurveillance,1,0.0
chyle,1,0.0
Pleurovenous,1,0.0
non-unified,1,0.0
intensiv,1,0.0
NIAID,1,0.0
confines,1,0.0
SENTINEL,1,0.0
beta-coronaviruses,1,0.0
faith,1,0.0
situates,1,0.0
raged,1,0.0
Connecticut--diverged,1,0.0
Disposition,1,0.0
AWyoming32003-like,1,0.0
6346,1,0.0
AMIWe,1,0.0
26-45,1,0.0
735-992,1,0.0
325-473,1,0.0
345-490,1,0.0
375-523,1,0.0
418-565,1,0.0
pre-December,1,0.0
n163,1,0.0
n173,1,0.0
non-duplicated,1,0.0
Pradesh,1,0.0
Uttar,1,0.0
Lucknow,1,0.0
822-35463,1,0.0
5399,1,0.0
3-vessel,1,0.0
infarction-0-flow,1,0.0
Preinterventional,1,0.0
symptom-to-intervention,1,0.0
monthsPatients,1,0.0
ST-elevated,1,0.0
Haven,1,0.0
cities--New,1,0.0
4049,1,0.0
Hematological,1,0.0
selfmanagement,1,0.0
Underpinned,1,0.0
patient-centred,1,0.0
EURASPIRE,1,0.0
glimpses,1,0.0
IL-12IL-23,1,0.0
IL-6R,1,0.0
interleukin-6R,1,0.0
Janus,1,0.0
Abatacept,1,0.0
noninsulin-diabetes,1,0.0
antirheumatic,1,0.0
accuracies,1,0.0
cytokine-producing,1,0.0
polyfunctional,1,0.0
Wouldnt,1,0.0
cardiodiabetic,1,0.0
diabetologists,1,0.0
Heterologous,1,0.0
ECC,1,0.0
regressors,1,0.0
returnees,1,0.0
cargo,1,0.0
well-contained,1,0.0
B1427,1,0.0
neutrophileosinophil,1,0.0
1567,1,0.0
factored,1,0.0
socio-sanitary,1,0.0
7178,1,0.0
22696,1,0.0
firms,1,0.0
17260,1,0.0
19471,1,0.0
Basque,1,0.0
pedicle,1,0.0
SARS-CoV-19,1,0.0
Procedure,1,0.0
feminist,1,0.0
disablement,1,0.0
SWD,1,0.0
Sleep-disordered,1,0.0
B1526,1,0.0
sestamibi,1,0.0
99m-labeled,1,0.0
828-999,1,0.0
0963,1,0.0
0885-10,1,0.0
fetotoxicity,1,0.0
hijacks,1,0.0
kinase-dead,1,0.0
NFkB-promoter,1,0.0
DBA2,1,0.0
IAV-susceptible,1,0.0
Focal,1,0.0
∼500000,1,0.0
STCS,1,0.0
upheaval,1,0.0
SHCS,1,0.0
IFN-independent,1,0.0
IFN-induced,1,0.0
cis,1,0.0
β-propiolactone-inactivated,1,0.0
LVH,1,0.0
helper-2,1,0.0
acutechronic,1,0.0
co-authors,1,0.0
Figueroa,1,0.0
2831,1,0.0
embryo-,1,0.0
multimorbidity,1,0.0
1991-1993,1,0.0
Climatology,1,0.0
dolantine,1,0.0
ResearchKit,1,0.0
Apples,1,0.0
iPhone,1,0.0
practices†,1,0.0
Discrepancies,1,0.0
B117s,1,0.0
Hantavirus,1,0.0
surgeries,1,0.0
narcotics,1,0.0
time-bound,1,0.0
11-yr,1,0.0
anesthetist,1,0.0
Aerosol,1,0.0
Oregon,1,0.0
oceanic,1,0.0
summers,1,0.0
cool,1,0.0
Warm,1,0.0
coldest,1,0.0
1980-1990,1,0.0
countriesExpert,1,0.0
teratogenic,1,0.0
pauci-symptomatic,1,0.0
2152021,1,0.0
infused,1,0.0
4h,1,0.0
Drug-delivery,1,0.0
HiSpeedZXi,1,0.0
GEMedical,1,0.0
high-speed,1,0.0
OctoberNovember,1,0.0
Highest,1,0.0
1172,1,0.0
1714,1,0.0
8726,1,0.0
10957,1,0.0
9805,1,0.0
EPI-Info,1,0.0
husbandry,1,0.0
typesubtype,1,0.0
n420,1,0.0
seroprevalences,1,0.0
parainfluenzavirus,1,0.0
DIFA,1,0.0
688,1,0.0
1h,1,0.0
spectrophotometrically,1,0.0
caseload,1,0.0
lodging,1,0.0
resultsResults,1,0.0
pubmedorg,1,0.0
diseaseMethods,1,0.0
FLAIR-positive,1,0.0
FLAIR-negative,1,0.0
0-45h,1,0.0
NAb,1,0.0
n66,1,0.0
Robustness,1,0.0
altherosclerotic,1,0.0
cytolytic,1,0.0
lodged,1,0.0
infaction,1,0.0
Mural,1,0.0
myocardiopathy,1,0.0
autopsy-studied,1,0.0
TD1,1,0.0
Anxious,1,0.0
2003-2007,1,0.0
non-cirrhotic,1,0.0
stipulated,1,0.0
technology-based,1,0.0
leveled,1,0.0
TEMs,1,0.0
sub-3Å,1,0.0
nodavirus,1,0.0
rosenbergii,1,0.0
Macrobrachium,1,0.0
Arctica,1,0.0
Talos,1,0.0
high-end,1,0.0
∼27,1,0.0
grouper,1,0.0
kV,1,0.0
β-sheet,1,0.0
forbidden,1,0.0
N450-F456,1,0.0
High-Dose®,1,0.0
low-burden,1,0.0
parent-completed,1,0.0
program--Prevention,1,0.0
counteraction,1,0.0
Economical,1,0.0
Authority,1,0.0
Operating,1,0.0
capsids,1,0.0
nonanchoring,1,0.0
€15,1,0.0
locks,1,0.0
PARP-1,1,0.0
polymerase-1,1,0.0
oxidativenitrosative,1,0.0
antigonists,1,0.0
Self-collected,1,0.0
Daniloski,1,0.0
solvent-accessible,1,0.0
SASA,1,0.0
anchor-locker,1,0.0
Chittagong,1,0.0
rages,1,0.0
Kobe,1,0.0
Y473-F490,1,0.0
conceptually,1,0.0
anchor,1,0.0
AhR,1,0.0
CATHEPSINs,1,0.0
G496-V503,1,0.0
2942,1,0.0
HDL-based,1,0.0
antiapoptotic,1,0.0
H1N1pdm-vaccinated,1,0.0
85-100,1,0.0
84-100,1,0.0
hospitalization--after,1,0.0
Revascularisation,1,0.0
FRagmin,1,0.0
seasonal-influenza,1,0.0
frequented,1,0.0
masquerading,1,0.0
subspecialists,1,0.0
Color,1,0.0
venerability,1,0.0
Fibrinolysis,1,0.0
transducers,1,0.0
swabsaliva,1,0.0
ageenvironment,1,0.0
causable,1,0.0
epiphenomenon,1,0.0
Difference,1,0.0
naso-bronchial,1,0.0
dripping,1,0.0
postnasal,1,0.0
Wuchang,1,0.0
treatment-it,1,0.0
syndrome--but,1,0.0
InStability,1,0.0
moderate-,1,0.0
LVPW,1,0.0
dolichoectasia,1,0.0
ED--discharge,1,0.0
Puerto,1,0.0
001-098,1,0.0
AIRS-S,1,0.0
Representation,1,0.0
Supporting,1,0.0
Idiopathic,1,0.0
controllerreliever,1,0.0
supervising,1,0.0
under-use,1,0.0
neuroprotectant,1,0.0
brainstem-,1,0.0
dictation,1,0.0
copying,1,0.0
sentence,1,0.0
blindfolded,1,0.0
duplications,1,0.0
Afferent,1,0.0
unproven,1,0.0
unachievable,1,0.0
macrodomain,1,0.0
glycohydrolase,1,0.0
melastatin,1,0.0
2318,1,0.0
Integrins,1,0.0
arginine-glycine-aspartate,1,0.0
pandemic-variant,1,0.0
triple-reassortant,1,0.0
JUST,1,0.0
intermitting,1,0.0
routined,1,0.0
arguing,1,0.0
9085,1,0.0
NA-specific,1,0.0
oro-,1,0.0
q-RTPCR,1,0.0
Toxicologists,1,0.0
rNP,1,0.0
WVA,1,0.0
Monocytes,1,0.0
unfractioned,1,0.0
venography,1,0.0
One-Step,1,0.0
Cosinor,1,0.0
acrophase,1,0.0
microthrombi,1,0.0
virion-integrin,1,0.0
Patient-specific,1,0.0
1387,1,0.0
≥2690,1,0.0
2005-08,1,0.0
2014-17,1,0.0
≤50,1,0.0
2005-06,1,0.0
transcriptase-,1,0.0
ICTV,1,0.0
Carraro,1,0.0
08-20,1,0.0
noncardiovascular,1,0.0
VUI,1,0.0
immunotherapies,1,0.0
α-synuclein,1,0.0
nigrostriatal,1,0.0
Reddy,1,0.0
SNpc,1,0.0
compacta,1,0.0
pars,1,0.0
dopaminergic,1,0.0
20201201,1,0.0
bathyphase,1,0.0
Multi-centre,1,0.0
trehalose,1,0.0
terbutaline,1,0.0
Semantic,1,0.0
Probabilistic,1,0.0
Resting-state,1,0.0
parenchymatous,1,0.0
Countermeasures,1,0.0
drift-variant,1,0.0
30-s,1,0.0
Listerine-like,1,0.0
Listerine,1,0.0
mouthwashgargle,1,0.0
2-min,1,0.0
Victoria75,1,0.0
rinse,1,0.0
shampoo,1,0.0
mouthwashesgargles,1,0.0
oxides,1,0.0
dots,1,0.0
dendrimers,1,0.0
quenching,1,0.0
flufenamic,1,0.0
tannins,1,0.0
Fluency,1,0.0
impressions,1,0.0
6-hour,1,0.0
sword,1,0.0
triamcinolone,1,0.0
depot,1,0.0
low-to-moderate,1,0.0
quicker,1,0.0
astma,1,0.0
clinicopathogenetic,1,0.0
modus,1,0.0
hystero-hypochondriacal,1,0.0
intrapsychic,1,0.0
double-edged,1,0.0
Immunofluorescence,1,0.0
death-related,1,0.0
Th2-adaptive,1,0.0
on-pump,1,0.0
2583,1,0.0
1839,1,0.0
2350,1,0.0
monastral,1,0.0
bolus5,1,0.0
1969-1983,1,0.0
epigastric,1,0.0
malonylation,1,0.0
succinylation,1,0.0
Worcester,1,0.0
≤16,1,0.0
Sepsis-like,1,0.0
porous,1,0.0
Operations,1,0.0
creep,1,0.0
Mini-log,1,0.0
sepsis-like,1,0.0
5778,1,0.0
incapacity,1,0.0
Tissue-type,1,0.0
recanalizationreperfusion,1,0.0
ADF,1,0.0
SC2,1,0.0
pointof-care,1,0.0
neurotoxicity,1,0.0
fungibles,1,0.0
147100000,1,0.0
229100000,1,0.0
156100000,1,0.0
133100000,1,0.0
280100000,1,0.0
coinfer,1,0.0
within-country,1,0.0
2·5-,1,0.0
Azerbaijan,1,0.0
invasiveness,1,0.0
bronchofiberoscopy,1,0.0
aptamer-modified,1,0.0
AFM,1,0.0
unbound,1,0.0
2530,1,0.0
TristaniaThe,1,0.0
attacksThe,1,0.0
23-2430,1,0.0
Exploratory,1,0.0
2·0-fold,1,0.0
diffusions,1,0.0
low-high-highest-high-low,1,0.0
QNG,1,0.0
ATurkey655962006,1,0.0
AHK2132003,1,0.0
MEGA40,1,0.0
ClustalX183,1,0.0
nonobese,1,0.0
nondisabling,1,0.0
254100000,1,0.0
communitywide,1,0.0
pre-certification,1,0.0
PTCAstent,1,0.0
PTCRABSTRACT,1,0.0
SpyTag-SpyCatcher,1,0.0
colloid,1,0.0
poly-gelin,1,0.0
hand-agitated,1,0.0
AddaVax,1,0.0
Adjuvant,1,0.0
flu-illness,1,0.0
parentage,1,0.0
1110,1,0.0
120-fold,1,0.0
low-power,1,0.0
corroborating,1,0.0
anoxic,1,0.0
experianced,1,0.0
troubled,1,0.0
cannulated,1,0.0
credentialing,1,0.0
Stem-,1,0.0
Arrays,1,0.0
€18,1,0.0
120-mer,1,0.0
RBD-I53-50,1,0.0
κ07-09,1,0.0
disproportion,1,0.0
5-2,1,0.0
RBD-Ferritin,1,0.0
sustainably,1,0.0
Dual,1,0.0
IVO,1,0.0
anterior-wall,1,0.0
Radiologists,1,0.0
RBD-mi3,1,0.0
cicatricial,1,0.0
RAEV-ratio,1,0.0
weakest,1,0.0
TMA-time,1,0.0
RMS-ratio,1,0.0
hypervirulent,1,0.0
Histopathology,1,0.0
60-mer,1,0.0
unevenly,1,0.0
1918-1921,1,0.0
observer-dependent,1,0.0
κ01-06,1,0.0
Modalities,1,0.0
Symbol-Digit,1,0.0
trustworthiness,1,0.0
quenched,1,0.0
approximates,1,0.0
Ovid,1,0.0
adjusted-dose,1,0.0
secondarily,1,0.0
pipetting,1,0.0
Comparable,1,0.0
QIAcube,1,0.0
benchmarked,1,0.0
non-commercial,1,0.0
germicidal,1,0.0
steam,1,0.0
microwave-generated,1,0.0
charcteristics,1,0.0
efflux,1,0.0
presupposes,1,0.0
recollections,1,0.0
solutes,1,0.0
costbenefit,1,0.0
semi-Markov,1,0.0
10-years-olds,1,0.0
VeroE6,1,0.0
Subdividing,1,0.0
≤48,1,0.0
RR19,1,0.0
3116,1,0.0
nurse-based,1,0.0
1384,1,0.0
glutarylation,1,0.0
48-117,1,0.0
23186686,1,0.0
5576999,1,0.0
287513685,1,0.0
1619,1,0.0
3422,1,0.0
6520,1,0.0
28126,1,0.0
6316,1,0.0
8671,1,0.0
Non-approved,1,0.0
11761,1,0.0
Approved,1,0.0
heterogenity,1,0.0
1996-98,1,0.0
cortisolaemia,1,0.0
simplifying,1,0.0
protein-mediated,1,0.0
Tudor,1,0.0
surpass,1,0.0
methylarginine,1,0.0
Reproduction,1,0.0
extant,1,0.0
oligemia,1,0.0
discriminates,1,0.0
ect,1,0.0
H1N1H3N2,1,0.0
766,1,0.0
Epicardial,1,0.0
formamide,1,0.0
one-tube,1,0.0
labor-extensive,1,0.0
RT-qPCR-mediated,1,0.0
halfway,1,0.0
Norrbotten,1,0.0
VTs,1,0.0
19-37,1,0.0
1818,1,0.0
RT-real-time,1,0.0
025-25,1,0.0
Stroke-Canadian,1,0.0
recombinase-polymerase-amplification,1,0.0
09-21,1,0.0
Reed,1,0.0
Thorax,1,0.0
methyltransferases,1,0.0
coexpression,1,0.0
N-mediated,1,0.0
R95K,1,0.0
Methylation,1,0.0
G3BP1,1,0.0
HEK293,1,0.0
5-UTR,1,0.0
methylates,1,0.0
PRMTs,1,0.0
glial-expressed,1,0.0
897-902,1,0.0
receptorstargets,1,0.0
24-68,1,0.0
matinal,1,0.0
misconception,1,0.0
spirometrically,1,0.0
age-of-onset,1,0.0
2921,1,0.0
Age-of-asthma,1,0.0
self-referred,1,0.0
multi-level,1,0.0
Endo-diastolic,1,0.0
RMW,1,0.0
courseABSTRACT,1,0.0
cyclically,1,0.0
faciliate,1,0.0
latitudes,1,0.0
1154,1,0.0
BK,1,0.0
respondents’,1,0.0
COVID-19–related,1,0.0
test-based,1,0.0
incredible,1,0.0
Basketball,1,0.0
rapid-turnaround,1,0.0
cortically,1,0.0
respectful,1,0.0
MI-based,1,0.0
brain-machine,1,0.0
2003-February,1,0.0
canonical,1,0.0
Canonical,1,0.0
four-,1,0.0
medical-diagnostic,1,0.0
progestagen,1,0.0
mid-latitudes,1,0.0
progress-would,1,0.0
Orf3a,1,0.0
hyperuricaemia,1,0.0
Nigerias,1,0.0
Metal-conjugates,1,0.0
3Clike,1,0.0
creatinemia,1,0.0
subtentorial,1,0.0
Intraparenchymal,1,0.0
Hemiplegia,1,0.0
ATexas177,1,0.0
myopathic,1,0.0
clinico-epidemiological,1,0.0
spillage,1,0.0
corticobulbar,1,0.0
next-of-kin,1,0.0
107-809,1,0.0
148-1001,1,0.0
13-99,1,0.0
years--2,1,0.0
108-53,1,0.0
daily--3,1,0.0
emergency-department,1,0.0
accused,1,0.0
progesterone-only,1,0.0
extensor,1,0.0
flexor,1,0.0
conditioning-test,1,0.0
330000,1,0.0
NHs,1,0.0
25-74,1,0.0
1012,1,0.0
1021,1,0.0
mirror-aided,1,0.0
DEFINITE,1,0.0
POSSIBLE,1,0.0
plethysmograph,1,0.0
symptom-monitoring,1,0.0
kappas,1,0.0
Pairs,1,0.0
fellows,1,0.0
Observers,1,0.0
deaths1,1,0.0
countries2,1,0.0
20113,1,0.0
requisite,1,0.0
incurring,1,0.0
Vero-derived,1,0.0
possession,1,0.0
Hyperuricemia,1,0.0
hyperuricemia,1,0.0
H1N1pdmsH1N1,1,0.0
n519,1,0.0
interstimulus,1,0.0
influenza-virus,1,0.0
AO,1,0.0
cytokinemia,1,0.0
asthma-chronic,1,0.0
2008-9,1,0.0
p090,1,0.0
062-152,1,0.0
n518,1,0.0
paients,1,0.0
authories,1,0.0
1037,1,0.0
injury-causing,1,0.0
6600000,1,0.0
animate,1,0.0
unanimate,1,0.0
infectuousness,1,0.0
virus-epithelial,1,0.0
equipments,1,0.0
intra-virion,1,0.0
1821,1,0.0
8638,1,0.0
radioassay,1,0.0
shingles,1,0.0
ferritin-antibody,1,0.0
deceive,1,0.0
24-meric,1,0.0
contingent,1,0.0
counterarguments,1,0.0
enpaneled,1,0.0
Work-Related,1,0.0
senators,1,0.0
congressmen,1,0.0
“long,1,0.0
concisely,1,0.0
COVID”,1,0.0
removingrecanalizing,1,0.0
httpsbitly3y8n0Bt,1,0.0
disaggregate,1,0.0
117276,1,0.0
5·3,1,0.0
Westminster,1,0.0
2-part,1,0.0
ex-workers,1,0.0
mgm3,1,0.0
ferritin-haemagglutinin,1,0.0
MITI,1,0.0
Georgian,1,0.0
attachments,1,0.0
lipidomics,1,0.0
non-elderly,1,0.0
dawning,1,0.0
stagnated,1,0.0
mgmL,1,0.0
rechallenged,1,0.0
epithelial-mesenchymal,1,0.0
164-285,1,0.0
resorting,1,0.0
mediator-generating,1,0.0
practitioner-based,1,0.0
Beneath,1,0.0
thebasis,1,0.0
camouflaged,1,0.0
hemoreologic,1,0.0
cooperates,1,0.0
clinical-pathogenetic,1,0.0
laboratory-instrumental,1,0.0
Limit,1,0.0
Collected,1,0.0
Modelling,1,0.0
2931,1,0.0
7976,1,0.0
Xiangtan,1,0.0
CDSC,1,0.0
heparine,1,0.0
CDR,1,0.0
particle-like,1,0.0
uninformed,1,0.0
editions,1,0.0
60-140,1,0.0
EUEEA,1,0.0
2008-09,1,0.0
singled,1,0.0
metal-conjugates,1,0.0
Basing,1,0.0
Arbor,1,0.0
Cannabis,1,0.0
Metal,1,0.0
complexes-,1,0.0
illicit,1,0.0
bismuth,1,0.0
duplex-unwinding,1,0.0
Q-RT-PCR,1,0.0
7328,1,0.0
OPCS,1,0.0
erythaematosus,1,0.0
MOSA,1,0.0
guarded,1,0.0
176-419,1,0.0
610-728,1,0.0
902,1,0.0
radiocardiography,1,0.0
Publicly,1,0.0
eukinetic,1,0.0
after-load,1,0.0
inter-country,1,0.0
2009-July,1,0.0
astograph,1,0.0
evades,1,0.0
adduction,1,0.0
Spotter,1,0.0
Y41H,1,0.0
Bats,1,0.0
E42,1,0.0
Schemes,1,0.0
RCGP,1,0.0
Officers,1,0.0
macrotis,1,0.0
nsp2,1,0.0
pandemic-fighting,1,0.0
bronchoscopically,1,0.0
unprecedentedly,1,0.0
infectioninflammation,1,0.0
post-surgery,1,0.0
Thoroughly,1,0.0
Conduct,1,0.0
enterostomy,1,0.0
goggle,1,0.0
intubationpercutaneous,1,0.0
Transnasal,1,0.0
EGJ,1,0.0
esophagogastricjunction,1,0.0
3unresectable,1,0.0
2rectal,1,0.0
Interleukin-1A,1,0.0
NCCN,1,0.0
Neoadjuvant,1,0.0
anti-tumor,1,0.0
MDT,1,0.0
periodSurgical,1,0.0
Interleukin-1B,1,0.0
disinfected,1,0.0
rs1304037,1,0.0
Single-room,1,0.0
win,1,0.0
replication-competent,1,0.0
TLCO,1,0.0
confluence,1,0.0
SARS-CoV-3,1,0.0
exploding,1,0.0
travels,1,0.0
THAWS,1,0.0
Unclear-Onset,1,0.0
selling,1,0.0
SARS-CoV-22019,1,0.0
MERS-CoV2012,1,0.0
SARS-CoV-12003,1,0.0
OC431890,1,0.0
animal-to-human,1,0.0
HKU5,1,0.0
HKU4,1,0.0
MERS-related,1,0.0
SARS-related-CoVs,1,0.0
civet,1,0.0
1918-AH1N1,1,0.0
1894-plague,1,0.0
-071,1,0.0
Endothelin-1,1,0.0
screen-negative,1,0.0
rs16347,1,0.0
373℃,1,0.0
rs17561,1,0.0
geo-mapping,1,0.0
EVT-center,1,0.0
trauma-models,1,0.0
15-,1,0.0
aftermath,1,0.0
Clarifying,1,0.0
Model-A,1,0.0
hormone-dependent,1,0.0
greedy,1,0.0
age-by-sex,1,0.0
EVT-centers,1,0.0
Model-B,1,0.0
pleuropericardial,1,0.0
drive-time,1,0.0
cardiophrenic,1,0.0
coelom,1,0.0
Intrathoracic,1,0.0
drug-gene,1,0.0
DGIDb,1,0.0
miRWalk,1,0.0
stroke-centers,1,0.0
filers,1,0.0
cyclones,1,0.0
SARS-Co,1,0.0
Defibrillator,1,0.0
rs2071373,1,0.0
IL1A,1,0.0
rs1143623,1,0.0
intent-to-treat,1,0.0
rs3917345,1,0.0
rs1143627,1,0.0
normal-to-normal,1,0.0
IL1B,1,0.0
DINAMIT,1,0.0
cardioverterdefibrillator,1,0.0
MERS-Cov,1,0.0
matrix-assisted,1,0.0
Coordinated,1,0.0
13500,1,0.0
desorptionionization,1,0.0
bright,1,0.0
TOPCAB,1,0.0
MALDI-TOF,1,0.0
undercontrolled,1,0.0
stroke-treating,1,0.0
antiviral-resistant,1,0.0
cardiogram,1,0.0
entrenching,1,0.0
106-179,1,0.0
lacunae,1,0.0
scan-derived,1,0.0
ICMR,1,0.0
quantifies,1,0.0
spilling,1,0.0
pathomorphologic,1,0.0
150300,1,0.0
immunosuppressiveimmunomodulating,1,0.0
Topic,1,0.0
diseasesauthors,1,0.0
vasculatures,1,0.0
085-128,1,0.0
047-168,1,0.0
072-136,1,0.0
059-162,1,0.0
024-030,1,0.0
over-production,1,0.0
021-028,1,0.0
109-130,1,0.0
anti-proinflammatory,1,0.0
092-117,1,0.0
atlas-guided,1,0.0
Similarities,1,0.0
atlas-quantified,1,0.0
CCL19,1,0.0
successors,1,0.0
ADunedin73,1,0.0
AEngland72,1,0.0
reemerge,1,0.0
inflammation-prone,1,0.0
bronchus-associated,1,0.0
iBALTs,1,0.0
1968-1969,1,0.0
1889-1890,1,0.0
CXCL13,1,0.0
atlas-defined,1,0.0
Press,1,0.0
Prussian,1,0.0
Poznań,1,0.0
patented,1,0.0
Atlas-to-scan,1,0.0
nineteenth-century,1,0.0
application-dependent,1,0.0
applicator,1,0.0
handles,1,0.0
anti-infectious,1,0.0
accrual,1,0.0
harmonized,1,0.0
Audit,1,0.0
Veille,1,0.0
Sanitaire,1,0.0
postexercise,1,0.0
AH3N2-related,1,0.0
36-55,1,0.0
8th-10th,1,0.0
monophasic,1,0.0
polyphasic,1,0.0
anonymously,1,0.0
evaluable,1,0.0
Increasingly,1,0.0
regionallyABSTRACT,1,0.0
ABangkokH3N2,1,0.0
pre-contrast,1,0.0
Pre-contrast,1,0.0
p0036,1,0.0
underutilize,1,0.0
splitsubunit,1,0.0
recalcitrant,1,0.0
30-70,1,0.0
Combating,1,0.0
Institut,1,0.0
Acceptability,1,0.0
Acceptable,1,0.0
chaired,1,0.0
2003-2013,1,0.0
300161,1,0.0
envenomated,1,0.0
heel,1,0.0
Achilles,1,0.0
Allens,1,0.0
cries,1,0.0
Fedson,1,0.0
heart-disease,1,0.0
100--109,1,0.0
gateways,1,0.0
FDPS,1,0.0
hoarding,1,0.0
outbreak--or,1,0.0
shuttle,1,0.0
all-encompassing,1,0.0
wavelength,1,0.0
whom--and,1,0.0
tough,1,0.0
104--110,1,0.0
breathomics,1,0.0
unsurprising,1,0.0
Coagulation,1,0.0
epithalaxia,1,0.0
eosinophile,1,0.0
-08050,1,0.0
intercorrelated,1,0.0
Attribution,1,0.0
773,1,0.0
Isosorbide,1,0.0
6-17,1,0.0
30-62,1,0.0
caregiver-directed,1,0.0
32-70,1,0.0
CVVs,1,0.0
1258,1,0.0
2013-February,1,0.0
Watch,1,0.0
Discover,1,0.0
Exposures,1,0.0
point-of,1,0.0
Chlorine,1,0.0
proofs,1,0.0
Existence,1,0.0
manuals,1,0.0
exoserosis,1,0.0
guinea-pigs,1,0.0
re-enrollment,1,0.0
lightened,1,0.0
tetratricopeptide,1,0.0
repeats,1,0.0
squat,1,0.0
toilets,1,0.0
ours,1,0.0
Undocumented,1,0.0
IFIT2,1,0.0
vipirin,1,0.0
quiddity,1,0.0
Gene-expression,1,0.0
co-delivery,1,0.0
interleukin-1β,1,0.0
Hindu,1,0.0
Secretion,1,0.0
twice--4,1,0.0
rebuilding,1,0.0
osteo-costochondromyelitis,1,0.0
karma,1,0.0
Haemorrhagic,1,0.0
Clues,1,0.0
isosoratory,1,0.0
impinge,1,0.0
spliced,1,0.0
Nueces,1,0.0
40-100,1,0.0
weekFindings,1,0.0
systemMaterials,1,0.0
Neurowave,1,0.0
Diarrhoea,1,0.0
demic,1,0.0
Organiza,1,0.0
tobacco-associated,1,0.0
leucopoenia,1,0.0
070-082,1,0.0
077-095,1,0.0
PCIs,1,0.0
23078,1,0.0
19875,1,0.0
42953,1,0.0
HUMIR,1,0.0
Villa,1,0.0
Libman-Sacks,1,0.0
Sneddons,1,0.0
Dinkihaler,1,0.0
office-based,1,0.0
microbiologic,1,0.0
3-12,1,0.0
ERP,1,0.0
valuesConclusion,1,0.0
Bolton,1,0.0
perimenstrually,1,0.0
32-yr,1,0.0
vacillating,1,0.0
gonadotrophin,1,0.0
dips,1,0.0
microlevels,1,0.0
meso-,1,0.0
hormone-analogue,1,0.0
Visitation,1,0.0
Pathology,1,0.0
P300,1,0.0
flocks,1,0.0
broiler,1,0.0
pullet,1,0.0
1524,1,0.0
epornitic,1,0.0
yolk,1,0.0
2019-2019-nCoV,1,0.0
attentive,1,0.0
neurosensory,1,0.0
intraseasonal,1,0.0
Interferon-regulated,1,0.0
gene-expression,1,0.0
record-based,1,0.0
bones,1,0.0
stutter,1,0.0
bloc,1,0.0
reverting,1,0.0
rampantly,1,0.0
Endoscopic,1,0.0
RBD-binding,1,0.0
Translation,1,0.0
revisiting,1,0.0
realise,1,0.0
NIC,1,0.0
199091,1,0.0
two-route,1,0.0
H3-AShanghai1688,1,0.0
H1-ATaiwan186,1,0.0
multi-agent,1,0.0
51-64,1,0.0
31-40,1,0.0
enforcement,1,0.0
Patient-clinician,1,0.0
Arapahoe,1,0.0
rickets,1,0.0
osteomalacia,1,0.0
dysprosody,1,0.0
bromhexine,1,0.0
120-14080-90,1,0.0
Ontarios,1,0.0
helpless,1,0.0
worker-led,1,0.0
J-,1,0.0
numbersThis,1,0.0
blinding,1,0.0
moderate-to-high,1,0.0
careplacebo,1,0.0
non-dipping,1,0.0
sun,1,0.0
investigatedCurrently,1,0.0
exercise-ECG,1,0.0
high-tech,1,0.0
hyperthyroid,1,0.0
os,1,0.0
self-manage,1,0.0
iodine,1,0.0
euthyroid,1,0.0
sunshine,1,0.0
Define,1,0.0
2004-14,1,0.0
PAT,1,0.0
violent,1,0.0
frame-1,1,0.0
48-hour,1,0.0
bus,1,0.0
bordercustoms,1,0.0
biosensing-related,1,0.0
9722,1,0.0
NPP,1,0.0
9961,1,0.0
6986,1,0.0
cardiac-embolic,1,0.0
Tarapacá,1,0.0
syndromeinfarct,1,0.0
semi-experimental,1,0.0
optical-chemical,1,0.0
Counterpulsation,1,0.0
nano-layer,1,0.0
myocarial,1,0.0
In-situ,1,0.0
embolisms,1,0.0
temporo-occipital,1,0.0
sit,1,0.0
3N,1,0.0
hereof,1,0.0
Balancing,1,0.0
community-led,1,0.0
AMCC,1,0.0
β2-adrenergic,1,0.0
EPI,1,0.0
sandstorm,1,0.0
eighty-six,1,0.0
Lea,1,0.0
Xga,1,0.0
Dispatchers,1,0.0
G6PD,1,0.0
hyper-homocysteinemia,1,0.0
decelerating,1,0.0
3122,1,0.0
612,1,0.0
Comments,1,0.0
influencer-driven,1,0.0
2019-20,1,0.0
2018-19,1,0.0
influencers,1,0.0
opponents,1,0.0
opinionated,1,0.0
algebraic,1,0.0
inflate,1,0.0
GKV-Modernisierungsgesetz,1,0.0
0798,1,0.0
0860,1,0.0
predicativity,1,0.0
midregional,1,0.0
proatrial,1,0.0
Florence,1,0.0
MR-proANP,1,0.0
257000,1,0.0
predictivity,1,0.0
determinate,1,0.0
481000,1,0.0
047-088,1,0.0
37-year,1,0.0
postolateral,1,0.0
166-277,1,0.0
prefecture-level,1,0.0
3-variable,1,0.0
demographers,1,0.0
inV1,1,0.0
2-variable,1,0.0
197-202,1,0.0
JAB1,1,0.0
0870,1,0.0
advices,1,0.0
re-enrolled,1,0.0
Inter-rater,1,0.0
Kigali,1,0.0
Rebuilding,1,0.0
microvesicles,1,0.0
LAD-ligation,1,0.0
re-evaluated,1,0.0
or--if,1,0.0
indicated--pulmonary,1,0.0
negotiating,1,0.0
Economy,1,0.0
Solidarity,1,0.0
whichever,1,0.0
diplomacy,1,0.0
multilateralism,1,0.0
Atherosclerosis-small,1,0.0
touchstone,1,0.0
disease-cardiac,1,0.0
rivalries,1,0.0
source-other,1,0.0
post-coronavirus,1,0.0
categorizes,1,0.0
Characteristics,1,0.0
Jun,1,0.0
Iba1,1,0.0
ionized,1,0.0
362-371,1,0.0
dispensability,1,0.0
unsupported,1,0.0
instrumentation-based,1,0.0
Chemistry,1,0.0
IFCC,1,0.0
Taskforce,1,0.0
pre-analytical,1,0.0
SFD,1,0.0
specialty-based,1,0.0
Breathmobile,1,0.0
121-297,1,0.0
124-171,1,0.0
147-358,1,0.0
121-162,1,0.0
ampliconread,1,0.0
length-based,1,0.0
MinIONGridION,1,0.0
Amplicons,1,0.0
5136,1,0.0
RSLAs,1,0.0
Herzinfarktverbund,1,0.0
well-accepted,1,0.0
Pathophysiologically,1,0.0
unremittent,1,0.0
Informal,1,0.0
p025,1,0.0
67±3,1,0.0
47±4,1,0.0
70±3,1,0.0
littermates,1,0.0
Ovariectomized,1,0.0
29±3,1,0.0
infarct±SEM,1,0.0
72h,1,0.0
wildtype,1,0.0
destroying,1,0.0
MCAO90min,1,0.0
674,1,0.0
scintigraphically,1,0.0
PwDs,1,0.0
99Tcm,1,0.0
clinico-functional,1,0.0
PyP,1,0.0
ingenious,1,0.0
demolishing,1,0.0
host-switching,1,0.0
marsupials,1,0.0
catabolic,1,0.0
“Pandemic,1,0.0
allergistspulmonologists,1,0.0
countered,1,0.0
host-Influenza,1,0.0
Micro,1,0.0
Perceptions,1,0.0
record-breaking,1,0.0
Build-up,1,0.0
Tatum,1,0.0
toilet-related,1,0.0
defecationmicturition,1,0.0
approch,1,0.0
brachiocephalic,1,0.0
Oligoryzomys,1,0.0
medistinum,1,0.0
subdividing,1,0.0
anatomists,1,0.0
fascial,1,0.0
nigripes,1,0.0
openness,1,0.0
httpwwwhhsgovnvpopandemicplan,1,0.0
Rodentia,1,0.0
downregulates,1,0.0
Everolimus,1,0.0
restrains,1,0.0
DNMDNB,1,0.0
re-enroll,1,0.0
Alsace,1,0.0
Haguenau,1,0.0
begging,1,0.0
unveils,1,0.0
suicidesuicide,1,0.0
DNM-based,1,0.0
DNM,1,0.0
tipping,1,0.0
markerbiomarker,1,0.0
telephone-based,1,0.0
-T1702A,1,0.0
intertwining,1,0.0
-C1562T,1,0.0
thriceprior,1,0.0
Jaeger,1,0.0
Bronchoscreen,1,0.0
R279Q,1,0.0
C6T,1,0.0
Beclocort-Polfa,1,0.0
Plan”,1,0.0
Muridae,1,0.0
macromolecules,1,0.0
semideciduous,1,0.0
aperture,1,0.0
unawareness,1,0.0
protruded,1,0.0
togheter,1,0.0
microfilaria,1,0.0
Maybe,1,0.0
sheathed,1,0.0
door-balloon,1,0.0
door-needle,1,0.0
pain-door,1,0.0
petteri,1,0.0
Holt,1,0.0
tangled,1,0.0
allergy-free,1,0.0
Holts,1,0.0
Patrick,1,0.0
Fido,1,0.0
mop,1,0.0
Drop,1,0.0
virus-regulated,1,0.0
Atg,1,0.0
antibody-laden,1,0.0
transcribrial,1,0.0
Naegleria,1,0.0
groups—as,1,0.0
Nicholson,1,0.0
Anticipating,1,0.0
Misiones,1,0.0
odilae,1,0.0
carinii,1,0.0
amphids,1,0.0
penicillinresistant,1,0.0
out-of-the-home,1,0.0
dorsally,1,0.0
roles—sources,1,0.0
fowleri,1,0.0
legionellosis,1,0.0
Nile,1,0.0
attributions,1,0.0
toxemia,1,0.0
neuro,1,0.0
breach,1,0.0
trivial,1,0.0
glandular,1,0.0
COVID-1,1,0.0
15-minute,1,0.0
Flipping,1,0.0
pre-post,1,0.0
VP,1,0.0
Pcom,1,0.0
expectancies,1,0.0
Irreversible,1,0.0
pentane,1,0.0
engines,1,0.0
giver,1,0.0
intra-host,1,0.0
Unequal,1,0.0
ASAT,1,0.0
time--at,1,0.0
year--must,1,0.0
endures,1,0.0
IE1,1,0.0
reaffirmed,1,0.0
therapy-related,1,0.0
childfamily,1,0.0
unhappy,1,0.0
evaluator,1,0.0
prioritised,1,0.0
slow-reacting,1,0.0
Flusurvey,1,0.0
asthma-smoking,1,0.0
non-diagnostic,1,0.0
27th,1,0.0
welcomed,1,0.0
Syst,1,0.0
Takwoingi,1,0.0
Dinnes,1,0.0
Deeks,1,0.0
Etiologic,1,0.0
pathochemical,1,0.0
PL,1,0.0
A4,1,0.0
dienes,1,0.0
dialdehyde,1,0.0
malonic,1,0.0
Fe2-induced,1,0.0
UV-monitor,1,0.0
Divided,1,0.0
Gel-filtration,1,0.0
Poorly,1,0.0
organisational,1,0.0
losing,1,0.0
Paramedian,1,0.0
Intercollegiate,1,0.0
SocietyScottish,1,0.0
Delft,1,0.0
community-orientated,1,0.0
Vicenza,1,0.0
Pedemontana,1,0.0
disrespectful,1,0.0
health-service,1,0.0
blame,1,0.0
6355,1,0.0
Followup,1,0.0
Greatest,1,0.0
assistants,1,0.0
gavestinel,1,0.0
Genova,1,0.0
Glycine,1,0.0
RHA,1,0.0
0044Our,1,0.0
physicians--syndromic,1,0.0
EuroSCORE,1,0.0
modes-of-action,1,0.0
MC-ventricular,1,0.0
Cleaning,1,0.0
-associated,1,0.0
SLUCVD,1,0.0
state-of-science,1,0.0
10-100,1,0.0
2006-March,1,0.0
finger-to-nose,1,0.0
P0467,1,0.0
equating,1,0.0
AULSS7,1,0.0
inferior--posterior--left,1,0.0
23–87,1,0.0
1–30,1,0.0
myocarditis-associated,1,0.0
11–80,1,0.0
20–40,1,0.0
mid-season,1,0.0
152585,1,0.0
ssRNA,1,0.0
62-41,1,0.0
Neonates,1,0.0
serological-immunological,1,0.0
aso,1,0.0
Hepatology,1,0.0
accomplishment,1,0.0
ESPGHAN,1,0.0
P0771,1,0.0
58-61,1,0.0
P0037,1,0.0
Rev,1,0.0
20206CD013652,1,0.0
32584464,1,0.0
n109,1,0.0
vaccinationStudy,1,0.0
choroiditis,1,0.0
prasugrel,1,0.0
or75,1,0.0
pre-emptive,1,0.0
coagulation-like,1,0.0
d-dimer,1,0.0
18F-fluorodeoxyglucose,1,0.0
Low-dose,1,0.0
post-Covid-19,1,0.0
BiomarkersImaging,1,0.0
respiratory-directed,1,0.0
oximeter,1,0.0
immune-based,1,0.0
superantigen,1,0.0
humeral,1,0.0
endotheliitis,1,0.0
coregistered,1,0.0
PETcomputed,1,0.0
1980-1984,1,0.0
individual-patient,1,0.0
reportResults,1,0.0
34-year,1,0.0
detachment,1,0.0
well-researched,1,0.0
073-093,1,0.0
078-097,1,0.0
eighty-nine,1,0.0
soda,1,0.0
066-087,1,0.0
070-090,1,0.0
Pasteur,1,0.0
Drinking,1,0.0
PAIS,1,0.0
ATexas185,1,0.0
macula,1,0.0
100-mg,1,0.0
council,1,0.0
macroangiopathy,1,0.0
vignette,1,0.0
antiphosholipid,1,0.0
uveitis,1,0.0
Ophthalmologists,1,0.0
subsequentlyConclusions,1,0.0
detachments,1,0.0
nonprocedural,1,0.0
gmL,1,0.0
poly-specific,1,0.0
P0025,1,0.0
COVID-191,1,0.0
fewest,1,0.0
report2,1,0.0
42-86,1,0.0
15-45,1,0.0
18-55,1,0.0
33-fold,1,0.0
amplifiers,1,0.0
CAFOs,1,0.0
IHD-patients,1,0.0
peptide-MHC,1,0.0
multimer,1,0.0
BNT162b2-induced,1,0.0
technologys,1,0.0
epitope-specific,1,0.0
Radiological,1,0.0
effector-memory,1,0.0
002-292,1,0.0
001-028,1,0.0
tracheo-esophageal,1,0.0
Subglottic,1,0.0
2834,1,0.0
intra-bronchial,1,0.0
prefectural,1,0.0
unattended,1,0.0
11-43,1,0.0
098-55,1,0.0
n196,1,0.0
2010-2019,1,0.0
Suggestive,1,0.0
BiPAP,1,0.0
bilevel,1,0.0
141-339,1,0.0
PAP,1,0.0
Well-established,1,0.0
Sport,1,0.0
15-1396,1,0.0
P0008,1,0.0
quartiles,1,0.0
upfront,1,0.0
059-078,1,0.0
064-096,1,0.0
cognitions,1,0.0
fiberoscope,1,0.0
intrabronchial,1,0.0
chemical-induced,1,0.0
toxicological,1,0.0
EVT-capable,1,0.0
Whatever,1,0.0
Wausau,1,0.0
tune,1,0.0
fibrillating,1,0.0
Emboli,1,0.0
pressured,1,0.0
actualizes,1,0.0
citizen,1,0.0
hyperparameters,1,0.0
fittest,1,0.0
attest,1,0.0
lighten,1,0.0
antidote,1,0.0
compassion,1,0.0
Memetic,1,0.0
318599,1,0.0
4806299,1,0.0
declaring,1,0.0
rumors,1,0.0
negating,1,0.0
Rumors,1,0.0
stroke-miRNA,1,0.0
corticosteroid-refractory,1,0.0
atopia,1,0.0
hyper-production,1,0.0
thirteen-year-old,1,0.0
Infrastructure,1,0.0
Medica,1,0.0
Excerpta,1,0.0
ankle-brachial,1,0.0
Continuum,1,0.0
iteration,1,0.0
distirbances,1,0.0
multidirectional,1,0.0
protagonists,1,0.0
obliges,1,0.0
IL10-A592C,1,0.0
IL10A-1082G,1,0.0
IL6-C174G,1,0.0
IL4-C590T,1,0.0
IL1B-C-31T,1,0.0
IL1B-C511T,1,0.0
TNF-A238G,1,0.0
TNF-A308G,1,0.0
TNF-A863C,1,0.0
expecting,1,0.0
addiction,1,0.0
Evolution,1,0.0
MADE,1,0.0
chest-Computed,1,0.0
inexorable,1,0.0
type-A,1,0.0
greater-than-normal,1,0.0
Tens,1,0.0
Osteopathic,1,0.0
1202,1,0.0
averts,1,0.0
osteopaths,1,0.0
intra-abdominal,1,0.0
diathesis,1,0.0
Withholding,1,0.0
elderlys,1,0.0
wishes,1,0.0
finished,1,0.0
Ximelagatran,1,0.0
optimalization,1,0.0
thermotools,1,0.0
CD401,1,0.0
myeloperaxidase,1,0.0
anginanon-Q,1,0.0
malapposition,1,0.0
balloon-expandable,1,0.0
disbelief,1,0.0
host-environment,1,0.0
arteriolar,1,0.0
Polypeptide,1,0.0
Globe,1,0.0
inapparent,1,0.0
Electrophoresis,1,0.0
Links,1,0.0
CK-MM,1,0.0
Accuracies,1,0.0
CK-BB,1,0.0
sisters,1,0.0
S-100B,1,0.0
sNIHSS-5,1,0.0
omitting,1,0.0
20E,1,0.0
20W,1,0.0
80S,1,0.0
20N,1,0.0
gaze,1,0.0
Franks,1,0.0
contributive,1,0.0
4-item,1,0.0
sNIHSS-4,1,0.0
preprinted,1,0.0
Paper,1,0.0
polyvascular,1,0.0
20-117,1,0.0
transatrial,1,0.0
human-to-human-transmitted,1,0.0
syndrome-2,1,0.0
Bashkortostan,1,0.0
Solapur,1,0.0
Ayurveda,1,0.0
homeopathy,1,0.0
allopathy,1,0.0
unclearWe,1,0.0
fixed-effects,1,0.0
Recognising,1,0.0
usedSix,1,0.0
distort,1,0.0
Goolishian,1,0.0
Hoffman,1,0.0
Foucaults,1,0.0
consensual,1,0.0
theorizing,1,0.0
69990,1,0.0
goal-concordant,1,0.0
Completed,1,0.0
Repair,1,0.0
deviant,1,0.0
personalities,1,0.0
reproducibly,1,0.0
irritancy,1,0.0
irritant-based,1,0.0
assessors,1,0.0
hazard-based,1,0.0
proactively,1,0.0
statuses,1,0.0
bail,1,0.0
Complement,1,0.0
cobra,1,0.0
conspecifics,1,0.0
pre-trial,1,0.0
livestock,1,0.0
medico-legal,1,0.0
Cricetidae,1,0.0
fur,1,0.0
inducers,1,0.0
Phenotyping,1,0.0
Compelling,1,0.0
inextricably,1,0.0
deviance,1,0.0
Postantithrombotic,1,0.0
13-64,1,0.0
pressure-wire-,1,0.0
12-78,1,0.0
8333,1,0.0
6361-9388,1,0.0
9928,1,0.0
assembling,1,0.0
9851-9967,1,0.0
7407,1,0.0
thoughtful,1,0.0
5503-8714,1,0.0
9959,1,0.0
first-responders,1,0.0
acceptanceConclusions,1,0.0
9893-9986,1,0.0
409-431,1,0.0
Henan,1,0.0
OGDs,1,0.0
3-week-old,1,0.0
ip,1,0.0
acceptanceResults,1,0.0
vaccineMethods,1,0.0
milligrams,1,0.0
echocardiography-based,1,0.0
bronchioles,1,0.0
caseness,1,0.0
resorbed,1,0.0
033-054,1,0.0
23-101,1,0.0
059-087,1,0.0
conversation,1,0.0
063-086,1,0.0
067-083,1,0.0
Forty-five,1,0.0
085-108,1,0.0
043-123,1,0.0
directive,1,0.0
typeThe,1,0.0
pores,1,0.0
Ability,1,0.0
anion,1,0.0
qualitative-descriptive,1,0.0
antiradical,1,0.0
EMRs,1,0.0
17y,1,0.0
invitation,1,0.0
2014-December,1,0.0
Kohn,1,0.0
697,1,0.0
158902,1,0.0
3146,1,0.0
inspections,1,0.0
admirable,1,0.0
Incorporated,1,0.0
down-regulating,1,0.0
paresis,1,0.0
Goethe,1,0.0
antibody-discovery,1,0.0
AOF,1,0.0
ILBI,1,0.0
contextualize,1,0.0
audit-feedback,1,0.0
antibody-secreting,1,0.0
Graham,1,0.0
control-based,1,0.0
11-54,1,0.0
14-82,1,0.0
53-298,1,0.0
856,1,0.0
questionnaire-guided,1,0.0
Oxford-AstraZeneca,1,0.0
1-yr,1,0.0
singletons,1,0.0
Regulators,1,0.0
advertisement,1,0.0
0698,1,0.0
Monde,1,0.0
1738,1,0.0
Contrast-induced,1,0.0
meriting,1,0.0
contrast-induced,1,0.0
haematologists,1,0.0
inductive,1,0.0
18-28,1,0.0
2-63,1,0.0
1-75,1,0.0
HRM,1,0.0
Dry,1,0.0
Syrup,1,0.0
cross-correlation,1,0.0
Kanagawa,1,0.0
Income,1,0.0
876,1,0.0
uneducated,1,0.0
Karen,1,0.0
house-,1,0.0
boder,1,0.0
Facebook,1,0.0
742-940,1,0.0
739-939,1,0.0
0126,1,0.0
hyperstimulation,1,0.0
tuned,1,0.0
intrahypothalamic,1,0.0
1970-1995,1,0.0
Neuroinvasion,1,0.0
8-102,1,0.0
AH1N1B,1,0.0
varianceABSTRACT,1,0.0
sub-scales,1,0.0
rotations,1,0.0
inter-item,1,0.0
Crombachs,1,0.0
conveniently,1,0.0
Highland,1,0.0
perceives,1,0.0
speedily,1,0.0
4408,1,0.0
Inspection,1,0.0
alphahydroxybutyrate,1,0.0
04p0006,1,0.0
alphahydroxybutytrate,1,0.0
withinbetween,1,0.0
Hypothalamic,1,0.0
immunoglobin,1,0.0
Simplification,1,0.0
unify,1,0.0
657,1,0.0
IVFintracytoplasmic,1,0.0
ICSI,1,0.0
IVFICSI,1,0.0
Measles,1,0.0
redeveloped,1,0.0
ischaemiaABSTRACT,1,0.0
100-384,1,0.0
subfertility,1,0.0
V-shaped,1,0.0
helical,1,0.0
ventrally,1,0.0
air-filled,1,0.0
honeycomb-like,1,0.0
4887,1,0.0
2594,1,0.0
2376,1,0.0
ventrodorsal,1,0.0
Ramphastos,1,0.0
Appointment,1,0.0
1432,1,0.0
1205-1816,1,0.0
Single-dose,1,0.0
7641-9782,1,0.0
floaters,1,0.0
heretofore,1,0.0
disarrayed,1,0.0
downstroke,1,0.0
Prolonging,1,0.0
Dacron,1,0.0
transected,1,0.0
fusiform,1,0.0
demostrated,1,0.0
plexectomy,1,0.0
680000,1,0.0
re-assessment,1,0.0
Vasculitis,1,0.0
month-long,1,0.0
Severely,1,0.0
Gene-disease,1,0.0
7649-9884,1,0.0
4244,1,0.0
4853-8268,1,0.0
2131,1,0.0
4079-7578,1,0.0
ChADOx1,1,0.0
lavendustin,1,0.0
venogram,1,0.0
neuraminidase-inhibitors,1,0.0
Bypassing,1,0.0
Optimization,1,0.0
Isocapnic,1,0.0
fresh-blood,1,0.0
erythropoietic,1,0.0
ATRIA,1,0.0
Erythropoietin,1,0.0
atrial-to-femoral,1,0.0
HAIS,1,0.0
low-pathogenic,1,0.0
liasing,1,0.0
live-bird,1,0.0
nontreated,1,0.0
Lately,1,0.0
Laparoscopic,1,0.0
unsurvivable,1,0.0
craniotomy,1,0.0
idarucizumab,1,0.0
hemianopia,1,0.0
haematologist,1,0.0
5938,1,0.0
9167,1,0.0
multi-wave,1,0.0
3336,1,0.0
shrews,1,0.0
attends,1,0.0
potentialities,1,0.0
Refractoriness,1,0.0
allergistsimmunologists,1,0.0
Clock,1,0.0
demographicpre-stroke,1,0.0
mortalityABSTRACT,1,0.0
dynes,1,0.0
1253,1,0.0
1713,1,0.0
Orientation,1,0.0
Reintegration,1,0.0
Pathogenicity,1,0.0
fall-off,1,0.0
1978-1979,1,0.0
Deterioration,1,0.0
counterproductive,1,0.0
AdC68,1,0.0
M-shape,1,0.0
left-handed,1,0.0
lentiviral-based,1,0.0
steel,1,0.0
return-visits,1,0.0
IGRA,1,0.0
6646-9410,1,0.0
8437,1,0.0
2732,1,0.0
anti-SARS-CoV-2-IgG,1,0.0
7300-9638,1,0.0
3236,1,0.0
SARS-CoV-2-IgG,1,0.0
3829-7167,1,0.0
694,1,0.0
MI-related,1,0.0
SVCs,1,0.0
antipandemic,1,0.0
drug-target-disease,1,0.0
virus-appeared,1,0.0
worries,1,0.0
non-MI,1,0.0
empower,1,0.0
Pre-school,1,0.0
contrifugation,1,0.0
shutdown,1,0.0
introspective,1,0.0
LIAISON,1,0.0
thirty-seven,1,0.0
Bland-White-Garland,1,0.0
elovanoids,1,0.0
pro-homeostatic,1,0.0
75750,1,0.0
regressed,1,0.0
confrontation,1,0.0
recession,1,0.0
222750,1,0.0
paindiscomfort,1,0.0
147000,1,0.0
Covod-19,1,0.0
e-health,1,0.0
servant,1,0.0
2885,1,0.0
Lumipulse,1,0.0
2564,1,0.0
22-item,1,0.0
7-point,1,0.0
033-093,1,0.0
022-059,1,0.0
self-rating,1,0.0
Localisation,1,0.0
nicotinism,1,0.0
very-long-chain,1,0.0
VLC-PUFA,1,0.0
Locations,1,0.0
robotics,1,0.0
1916,1,0.0
ERCHS,1,0.0
ropes,1,0.0
Fogartys,1,0.0
filaments,1,0.0
mesentery,1,0.0
reactants,1,0.0
Bamako,1,0.0
noncerebral,1,0.0
n-3,1,0.0
1277,1,0.0
plead,1,0.0
Pneumo-phthisiology,1,0.0
fixes,1,0.0
unicentric,1,0.0
disease-modifiable,1,0.0
CHU,1,0.0
1595,1,0.0
ELV,1,0.0
progeria,1,0.0
Branchburg,1,0.0
years-155,1,0.0
miR-based,1,0.0
2005-6,1,0.0
8-hour,1,0.0
human-wildlife,1,0.0
racoons,1,0.0
black-tailed,1,0.0
Examinee,1,0.0
Wyoming,1,0.0
fox,1,0.0
cottontail,1,0.0
skunks,1,0.0
striped,1,0.0
woodrats,1,0.0
bushy-tailed,1,0.0
peridomestic,1,0.0
cautions,1,0.0
0942,1,0.0
0408,1,0.0
0620,1,0.0
2004-2016,1,0.0
0951,1,0.0
0512,1,0.0
2006-7,1,0.0
repeatedfurther,1,0.0
0954-0976,1,0.0
research-in-humans,1,0.0
cell-type-specific,1,0.0
manufacturer-independent,1,0.0
2129,1,0.0
posttranscriptional,1,0.0
speeding,1,0.0
20922129,1,0.0
proportionate,1,0.0
discoverybasic,1,0.0
processesExamining,1,0.0
stagesphases,1,0.0
0965,1,0.0
976-987,1,0.0
961961,1,0.0
easesTo,1,0.0
996-100,1,0.0
11311168,1,0.0
957-977,1,0.0
0-18-year-olds,1,0.0
19-60-year-olds,1,0.0
0-18,1,0.0
mobility-dependent,1,0.0
chi2516,1,0.0
chip-integrated,1,0.0
foodwater,1,0.0
Abbreviations,1,0.0
time-density,1,0.0
injuryinfarction,1,0.0
000year,1,0.0
CoVCoVs,1,0.0
infarctioninjury,1,0.0
rejuvenate,1,0.0
2019-coronavirus,1,0.0
overriding,1,0.0
coronaviruscoronaviruses,1,0.0
Cerebrospinal-fluid,1,0.0
task-shifting,1,0.0
multiples,1,0.0
apoliopoproteina,1,0.0
neurohormone,1,0.0
014-097,1,0.0
worker-years,1,0.0
ORC4,1,0.0
012-080,1,0.0
ratioORC2,1,0.0
1095,1,0.0
reprocess,1,0.0
0435,1,0.0
densitytime,1,0.0
Contrast-enhanced,1,0.0
Non-SARS-CoV-2,1,0.0
small-volume,1,0.0
pathogen-monitoring,1,0.0
system-integrated,1,0.0
desires,1,0.0
past-COVID-19,1,0.0
perceptiveness,1,0.0
blending,1,0.0
symptom-to-reperfusion,1,0.0
Bari,1,0.0
TDC-derived,1,0.0
symptom-to-balloon,1,0.0
hind,1,0.0
Accomplishment,1,0.0
ostia,1,0.0
take-off,1,0.0
Fluid-attenuated,1,0.0
manipulating,1,0.0
macroautophagyautophagy,1,0.0
extrapolations,1,0.0
pens,1,0.0
containers,1,0.0
Morning,1,0.0
HO,1,0.0
neutralizationvirological,1,0.0
sterilizing,1,0.0
vaccinesantivirals,1,0.0
sludging,1,0.0
atelectases,1,0.0
aerohematic,1,0.0
kinins,1,0.0
knockouts,1,0.0
Mot,1,0.0
commentators,1,0.0
Syncytial,1,0.0
CI057-075,1,0.0
CI046-064,1,0.0
95CI076-090,1,0.0
Community-based,1,0.0
007-031,1,0.0
076-092,1,0.0
P042,1,0.0
n110,1,0.0
n191,1,0.0
phlegmy,1,0.0
nucleocapsid-based,1,0.0
nucleocapsid-specific,1,0.0
AUSSR9277,1,0.0
Mycophenolic,1,0.0
8003,1,0.0
Fluctuation,1,0.0
BOSS,1,0.0
self-reactivity,1,0.0
8004,1,0.0
794,1,0.0
Pfuml,1,0.0
GTP,1,0.0
depleting,1,0.0
D414,1,0.0
P1821S,1,0.0
CPE-based,1,0.0
TCID50ml,1,0.0
nsp3,1,0.0
choriomeningitis,1,0.0
A1812D,1,0.0
off-labeled,1,0.0
FDA-licensed,1,0.0
Arenaviruses,1,0.0
non-VKA,1,0.0
MOSES,1,0.0
035-091,1,0.0
Jacquez,1,0.0
electroencephalography-functional,1,0.0
rarest,1,0.0
exhaustively,1,0.0
Mihaljević,1,0.0
Fran,1,0.0
student-days¶,1,0.0
angiocardiographic,1,0.0
fluorochrome,1,0.0
1-96,1,0.0
Flex,1,0.0
Kingfisher,1,0.0
EZ1,1,0.0
Low-throughput,1,0.0
Pfeiffer,1,0.0
Protocols,1,0.0
189091,1,0.0
disadvantageous,1,0.0
pre-analytic,1,0.0
interchanged,1,0.0
thesis,1,0.0
Nasopharyngealoropharyngeal,1,0.0
httpscoronavirusjhuedumaphtml,1,0.0
ObjectiveIn,1,0.0
neurofeedback,1,0.0
between-scatter,1,0.0
109752,1,0.0
Morphological,1,0.0
school-wide,1,0.0
enteropathy,1,0.0
2020-March,1,0.0
NCCT,1,0.0
noncontrast,1,0.0
volume-weighted,1,0.0
59552,1,0.0
Pregnancies,1,0.0
Step-care,1,0.0
taskSignificanceTo,1,0.0
self-inhibitory,1,0.0
resultsOur,1,0.0
areasMain,1,0.0
athletics,1,0.0
multisession,1,0.0
events§,1,0.0
areasApproachWe,1,0.0
Stay,1,0.0
interfaces,1,0.0
cortices,1,0.0
postwar,1,0.0
NISSS,1,0.0
school-building,1,0.0
Pa,1,0.0
age-groups,1,0.0
6238,1,0.0
rubs,1,0.0
payers,1,0.0
PRIMVAC,1,0.0
Gas,1,0.0
fraction--by,1,0.0
Proyecto,1,0.0
Rat,1,0.0
Registro,1,0.0
oncological,1,0.0
enrol,1,0.0
Infarto,1,0.0
agudo,1,0.0
imaging-defined,1,0.0
foodstuff,1,0.0
Seaweed,1,0.0
Miocardio,1,0.0
Alicante,1,0.0
assiduous,1,0.0
slump,1,0.0
4208,1,0.0
1856,1,0.0
exercise-wheezing,1,0.0
re-construct,1,0.0
doors,1,0.0
chinine,1,0.0
Sichuan,1,0.0
polypragmasy,1,0.0
operability,1,0.0
unrecognisable,1,0.0
archaeology,1,0.0
9-21,1,0.0
reductionism,1,0.0
immensely,1,0.0
Under-recognition,1,0.0
postlytic,1,0.0
postthrombolytic,1,0.0
Resilient,1,0.0
IL-6-STAT3,1,0.0
angiotestin,1,0.0
Hoffmann,1,0.0
Zhou,1,0.0
tepid,1,0.0
integumentary,1,0.0
revived,1,0.0
Stay†,1,0.0
forty-three,1,0.0
Nonrandomized,1,0.0
140062,1,0.0
270596,1,0.0
Mexico-specific,1,0.0
Hemo-vascular,1,0.0
age-stratified,1,0.0
20202021,1,0.0
Mexicos,1,0.0
complement-mediated,1,0.0
immune-histochemical,1,0.0
C5a,1,0.0
anaphylatoxin,1,0.0
C5b-9,1,0.0
specificnon-specific,1,0.0
highly-touted,1,0.0
explode,1,0.0
hemo-vascular,1,0.0
hydroxychloroquineazithromycin,1,0.0
anti-malarialantibiotic,1,0.0
anti-malarial,1,0.0
failuresuncertain,1,0.0
menace,1,0.0
Mex214,1,0.0
US108,1,0.0
225497,1,0.0
O-linked,1,0.0
end-users,1,0.0
71-81,1,0.0
stables,1,0.0
TTR,1,0.0
derivates,1,0.0
N-acetylneuraminic,1,0.0
acidsN-glycolylneuraminic,1,0.0
a-specific,1,0.0
molecules-ie,1,0.0
BL,1,0.0
85000,1,0.0
TMMPRSS2,1,0.0
fuse,1,0.0
intermediately,1,0.0
highjacks,1,0.0
mismatched,1,0.0
US9,1,0.0
Mex178,1,0.0
2769,1,0.0
116718,1,0.0
onsets,1,0.0
ic,1,0.0
Thiel-embalmed,1,0.0
tau-b,1,0.0
leukocytic,1,0.0
protein-5,1,0.0
lipooxygenase-activating,1,0.0
Lipooxigenase-5,1,0.0
lipooxygenase,1,0.0
Production,1,0.0
nonresponder,1,0.0
PRNT,1,0.0
anti-nucleocapsidN,1,0.0
Burbelo,1,0.0
Hachim,1,0.0
IIb,1,0.0
technetium-99m,1,0.0
Infarct-avid,1,0.0
immunosuppressing,1,0.0
cell-associated,1,0.0
thoracocentesis,1,0.0
Anastomoses,1,0.0
costal,1,0.0
coursing,1,0.0
non-anastomosing,1,0.0
chemoattractant,1,0.0
Sulfidopeptid,1,0.0
D4,1,0.0
pinhole,1,0.0
Kendalls,1,0.0
10729,1,0.0
theory-informed,1,0.0
observationally,1,0.0
1298,1,0.0
3235,1,0.0
fecal-viral-excreting,1,0.0
Dunedin,1,0.0
glucarate,1,0.0
fructose,1,0.0
Tunisian,1,0.0
dicarboxylic,1,0.0
six-carbon,1,0.0
Technetium-99m-glucarate,1,0.0
symptom-driven,1,0.0
quarantines,1,0.0
Specially,1,0.0
Fontan,1,0.0
ameliorates,1,0.0
manages,1,0.0
Castellón,1,0.0
low-dimensional,1,0.0
117-294,1,0.0
COVID-19‒positive,1,0.0
Reinforcement,1,0.0
SLC-SiOH,1,0.0
9-15,1,0.0
23-29,1,0.0
IChildrens,1,0.0
subunit-based,1,0.0
Inspired,1,0.0
apicomplexan,1,0.0
anneal,1,0.0
211833,1,0.0
2341,1,0.0
99116,1,0.0
71111,1,0.0
test-and-travel,1,0.0
astonishing,1,0.0
PCR-testing,1,0.0
22400,1,0.0
22986,1,0.0
20722,1,0.0
20495,1,0.0
axilla,1,0.0
impingement,1,0.0
pH1N1IFVA,1,0.0
Fibrous,1,0.0
H3N2IFVA,1,0.0
acrylic,1,0.0
Lai,1,0.0
Yung,1,0.0
Hsien,1,0.0
gowns,1,0.0
face-shields,1,0.0
glove,1,0.0
glasses,1,0.0
P2N95,1,0.0
neuromodulating,1,0.0
contradicting,1,0.0
levodopa,1,0.0
fluoxetine,1,0.0
nortriptyline,1,0.0
trazodone,1,0.0
methylphenidate,1,0.0
10848,1,0.0
PREDAC-H1,1,0.0
line‒associated,1,0.0
victoriaIFVB,1,0.0
yamagataIFVB,1,0.0
Center-Myocardial,1,0.0
lump,1,0.0
conundrum,1,0.0
1848,1,0.0
433-437,1,0.0
20-75,1,0.0
2001-2014,1,0.0
00369,1,0.0
05708,1,0.0
08961,1,0.0
59019,1,0.0
1-18,1,0.0
bpm,1,0.0
four-grade,1,0.0
-038,1,0.0
Dobutamine-induced,1,0.0
haulers,1,0.0
symptoms-the,1,0.0
demystified,1,0.0
unconvincing,1,0.0
supra-,1,0.0
broncholytic,1,0.0
sand,1,0.0
matched-volume,1,0.0
NCT02414854,1,0.0
Congruity,1,0.0
0·77,1,0.0
0·71,1,0.0
existsin,1,0.0
supraclavicular,1,0.0
earthbound,1,0.0
aerosol-droplet,1,0.0
H5N1H9N2H7N7,1,0.0
axillary,1,0.0
Virchow,1,0.0
low-neck,1,0.0
sinister,1,0.0
print,1,0.0
Non-ST,1,0.0
0·74,1,0.0
162020,1,0.0
Guangxi,1,0.0
188-193,1,0.0
Zhuang,1,0.0
inquiring,1,0.0
conjunctivitis-related,1,0.0
1667±929,1,0.0
genotype-phenotype,1,0.0
2019Chin,1,0.0
March‒October,1,0.0
069-106,1,0.0
078-098,1,0.0
nationality,1,0.0
Influent,1,0.0
pro-B-type,1,0.0
TND,1,0.0
chameleon,1,0.0
-0635,1,0.0
BSMMU,1,0.0
Mujib,1,0.0
Sheikh,1,0.0
Bangabandhu,1,0.0
40-45,1,0.0
22–39,1,0.0
patient-oriented,1,0.0
58–63,1,0.0
educates,1,0.0
GeSa,1,0.0
partnership-based,1,0.0
helpers-a,1,0.0
Trained,1,0.0
volunteer-supported,1,0.0
Help,1,0.0
Bochum,1,0.0
200-5000,1,0.0
electronegative,1,0.0
membrane-vortex,1,0.0
dif-,1,0.0
streptococcus,1,0.0
foetus,1,0.0
0954,1,0.0
Virus-like,1,0.0
toms,1,0.0
symp-,1,0.0
VLPs,1,0.0
biopharmaceuticals,1,0.0
ferences,1,0.0
knowl-,1,0.0
pepper,1,0.0
high-exposure,1,0.0
re-sampled,1,0.0
Abbotts,1,0.0
Västerås,1,0.0
redirecting,1,0.0
102-25,1,0.0
103-82,1,0.0
NSarbeco,1,0.0
mottle,1,0.0
championship,1,0.0
overestimating,1,0.0
interactional,1,0.0
Progression,1,0.0
nonelective,1,0.0
859,1,0.0
Roubin,1,0.0
Gianturco,1,0.0
Sjögren,1,0.0
groceries,1,0.0
sadderdepressive,1,0.0
thematically,1,0.0
Chikwawa,1,0.0
agitatedanxious,1,0.0
Camperdown,1,0.0
reawakening,1,0.0
glia,1,0.0
Intracellular,1,0.0
Nut,1,0.0
Tohoku,1,0.0
tsunami,1,0.0
476181,1,0.0
90-magnitude,1,0.0
083-098,1,0.0
Stratifying,1,0.0
196-514,1,0.0
108-185,1,0.0
073-118,1,0.0
E484KN501Y,1,0.0
fuchsinorrhagia,1,0.0
polymorphonucleosis,1,0.0
myofibers,1,0.0
microscopical,1,0.0
Light,1,0.0
32-point,1,0.0
third-dose,1,0.0
RBD-vaccines,1,0.0
three-dose,1,0.0
pseudo-,1,0.0
Former,1,0.0
37015,1,0.0
interrupting,1,0.0
242-244,1,0.0
complementarity,1,0.0
VH3-53VH3-66,1,0.0
K417NE484KN501Y,1,0.0
VDJ,1,0.0
4326,1,0.0
120-158,1,0.0
101-208,1,0.0
102-167,1,0.0
sacrificed,1,0.0
checklists,1,0.0
down-trend,1,0.0
COSI,1,0.0
bend,1,0.0
native-born,1,0.0
resettlement,1,0.0
recency,1,0.0
hibernation,1,0.0
Akershus,1,0.0
cross-neutralize,1,0.0
vis-à-vis,1,0.0
3-19,1,0.0
pseudostroke,1,0.0
6-11,1,0.0
eyelids,1,0.0
fibrolipomas,1,0.0
lipoma,1,0.0
Fibrolipoma,1,0.0
Mayor,1,0.0
od,1,0.0
laboratory-generated,1,0.0
host-to-host,1,0.0
Jadad,1,0.0
split-virion,1,0.0
TRACK,1,0.0
emulsion-based,1,0.0
Budapest,1,0.0
immuno-allergological,1,0.0
socialist,1,0.0
East-West,1,0.0
Inversion,1,0.0
dose-efficacy,1,0.0
single-spin,1,0.0
resonant,1,0.0
hand-lung,1,0.0
tesla,1,0.0
loneliness,1,0.0
Beclojet,1,0.0
hallways,1,0.0
Jet,1,0.0
Put,1,0.0
Improve,1,0.0
Combine,1,0.0
neurorecovery,1,0.0
rhythmological,1,0.0
amendment,1,0.0
antigen-sparing,1,0.0
butchering,1,0.0
17-90,1,0.0
Seroepidemiologic,1,0.0
Hawaiis,1,0.0
deltaF508,1,0.0
heterozygous,1,0.0
test--cardiopulmonary,1,0.0
pfumL,1,0.0
H-d,1,0.0
possible--before,1,0.0
hydrolyzes,1,0.0
N-,1,0.0
quencher,1,0.0
fluorophore,1,0.0
dipeptides,1,0.0
ELSIA,1,0.0
unaltered,1,0.0
estimable,1,0.0
subepicardiac,1,0.0
3221,1,0.0
lessening,1,0.0
coronarygraphy,1,0.0
maneuveres,1,0.0
metalic,1,0.0
thyrotropin,1,0.0
Bursa,1,0.0
fundamentals,1,0.0
Looking,1,0.0
GIHSN,1,0.0
ERs,1,0.0
newcomers,1,0.0
Kona,1,0.0
Late-Presenting,1,0.0
stentrievers,1,0.0
CLEAN,1,0.0
Endoluminal,1,0.0
ECASS,1,0.0
3-45h,1,0.0
26-h,1,0.0
CCA,1,0.0
Nondetectable,1,0.0
entry-related,1,0.0
SIS-16,1,0.0
Scale-16,1,0.0
Spielberger,1,0.0
tension-anxiety,1,0.0
GOF-type,1,0.0
depression-dejection,1,0.0
vigor-activity,1,0.0
Sialic,1,0.0
23-sialyllactose,1,0.0
23-SL-modified,1,0.0
10674,1,0.0
JAMA,1,0.0
planet,1,0.0
Influenza-attributed,1,0.0
noninfarcting,1,0.0
Managerial,1,0.0
5442,1,0.0
34866,1,0.0
91-365,1,0.0
31-90,1,0.0
survival-dependent,1,0.0
Accounting,1,0.0
Syntax,1,0.0
TDR,1,0.0
thioldisulfide,1,0.0
Labor,1,0.0
Hannover,1,0.0
agegroups,1,0.0
Smokers,1,0.0
inquired,1,0.0
variablesstrategies,1,0.0
reevaluate,1,0.0
anti-G2B3A,1,0.0
Catel,1,0.0
IPTA,1,0.0
replicable,1,0.0
Nold,1,0.0
among-group,1,0.0
Feng,1,0.0
generality,1,0.0
tractability,1,0.0
practice-based,1,0.0
Levins,1,0.0
to5,1,0.0
theory-based,1,0.0
cytokinechemokine,1,0.0
co-create,1,0.0
propaga-tion,1,0.0
interferon-2b,1,0.0
Chloroquine,1,0.0
conduct-ing,1,0.0
immunostimulation,1,0.0
pol-ymerase,1,0.0
comor-bidity,1,0.0
parentscaregivers,1,0.0
appreciative,1,0.0
oligosymptomatics,1,0.0
8661-12687,1,0.0
three-way,1,0.0
situationally,1,0.0
intricately,1,0.0
diet-induced,1,0.0
lipokine,1,0.0
HbA1c,1,0.0
well-child,1,0.0
30-43,1,0.0
OPOs,1,0.0
44-68,1,0.0
monetary,1,0.0
10-13,1,0.0
PB1-F2,1,0.0
pandemic-2009,1,0.0
forewarning,1,0.0
treated--respiratory,1,0.0
common--and,1,0.0
glycocluster,1,0.0
Rico0834,1,0.0
APuerto,1,0.0
104-fold,1,0.0
strand,1,0.0
Hashimotos,1,0.0
overwhelm,1,0.0
tPA-induced,1,0.0
phage-to-yeast,1,0.0
n43,1,0.0
2538,1,0.0
overlooking,1,0.0
2112-2964,1,0.0
respectivelyConclusion,1,0.0
5522,1,0.0
4223,1,0.0
4834-6210,1,0.0
3793,1,0.0
assayResults,1,0.0
3375-4211,1,0.0
PtY,1,0.0
24-31,1,0.0
cobas6800Methodology,1,0.0
51-74,1,0.0
infectionAim,1,0.0
hemisphereGap,1,0.0
DISA,1,0.0
of99mTc-MIBI18F-FDG-dual-isotope,1,0.0
clinical-stage,1,0.0
ChiCTR2100042150,1,0.0
thyroxin,1,0.0
tent,1,0.0
≥80,1,0.0
complacent,1,0.0
ignorance,1,0.0
Twin,1,0.0
4026,1,0.0
laypeople,1,0.0
prerolandic,1,0.0
fragmentary,1,0.0
best-practice,1,0.0
diverging,1,0.0
Agent-based,1,0.0
Simulator,1,0.0
viral-load-based,1,0.0
loss-to-follow-up,1,0.0
asthma-trained,1,0.0
micro-targeting,1,0.0
Headteacher-reported,1,0.0
Dealing,1,0.0
Junior,1,0.0
Infant,1,0.0
Implemented,1,0.0
cute,1,0.0
Python,1,0.0
Mandatory,1,0.0
Non-smokers,1,0.0
prognosing,1,0.0
resourced,1,0.0
inhalationnebulization,1,0.0
Polymers,1,0.0
supramolecular,1,0.0
Multivalent,1,0.0
Essay,1,0.0
spaciously,1,0.0
electromotive,1,0.0
opposing,1,0.0
2415,1,0.0
2126,1,0.0
0285,1,0.0
0224,1,0.0
Antananarivo,1,0.0
0331,1,0.0
WWW,1,0.0
0163,1,0.0
22-80,1,0.0
1948,1,0.0
saps,1,0.0
ill-health,1,0.0
intermixed,1,0.0
laptop,1,0.0
beating,1,0.0
ciliostasis,1,0.0
palates,1,0.0
AMI-RV,1,0.0
bed-ridden,1,0.0
non-reperfused,1,0.0
delirium294,1,0.0
pneumonia173,1,0.0
shock119,1,0.0
edema203,1,0.0
death236,1,0.0
success748,1,0.0
angioplasty286,1,0.0
group608,1,0.0
groupunder,1,0.0
group70,1,0.0
126-575,1,0.0
vetting,1,0.0
325-844,1,0.0
126-447,1,0.0
submission,1,0.0
349-715,1,0.0
015-071,1,0.0
160-329,1,0.0
widows,1,0.0
rateespecially,1,0.0
self-help,1,0.0
Mammography,1,0.0
frogs,1,0.0
sols,1,0.0
±006,1,0.0
0197,1,0.0
freeze-thaw,1,0.0
±0019,1,0.0
34670,1,0.0
unfrozen,1,0.0
49-83,1,0.0
1998-2008,1,0.0
neuraminidase-inhibitor,1,0.0
1680,1,0.0
telematics,1,0.0
1993-94,1,0.0
administrations,1,0.0
sends,1,0.0
Telematics,1,0.0
existent,1,0.0
1310,1,0.0
0·05,1,0.0
CoV-2Covid-19,1,0.0
multivalent,1,0.0
rightful,1,0.0
rythmical,1,0.0
133-384,1,0.0
134-219,1,0.0
4502,1,0.0
newly-developed,1,0.0
Databases,1,0.0
EDN,1,0.0
Ro,1,0.0
highlow,1,0.0
journeys,1,0.0
simptoms,1,0.0
monitered,1,0.0
electrocution,1,0.0
stabilitation,1,0.0
mantained,1,0.0
steroides,1,0.0
Pneumothorax,1,0.0
mESC,1,0.0
cilengitide,1,0.0
129S6,1,0.0
It´s,1,0.0
Angiogenesis,1,0.0
118-565,1,0.0
006-069,1,0.0
Modulation,1,0.0
second-most,1,0.0
Youth,1,0.0
immunotests,1,0.0
DOHMH,1,0.0
re-adapted,1,0.0
Caxias,1,0.0
Discrete,1,0.0
insurmountable,1,0.0
mass-produced,1,0.0
populous,1,0.0
Mashhad,1,0.0
target-rich,1,0.0
12-hour,1,0.0
8085,1,0.0
conical,1,0.0
purport,1,0.0
cylindrical,1,0.0
jugulars,1,0.0
7572,1,0.0
exits,1,0.0
572,1,0.0
cocaine-induced,1,0.0
echocardiographies,1,0.0
employability,1,0.0
Hypereosinophilic,1,0.0
fixed-needle,1,0.0
syringe-needle,1,0.0
neuroimmune,1,0.0
Acute-onset,1,0.0
four-chamber,1,0.0
fixed-,1,0.0
soja,1,0.0
bean,1,0.0
castor,1,0.0
elicitating,1,0.0
dial,1,0.0
Altitude,1,0.0
1973--4,1,0.0
0--4,1,0.0
EWI,1,0.0
individual-specific,1,0.0
procession,1,0.0
AimsIntroduction,1,0.0
cardio-,1,0.0
wages,1,0.0
workedweek,1,0.0
µL,1,0.0
Ph,1,0.0
adsorb,1,0.0
GeneFinder™-COVID-19-Plus-RealAmpKit,1,0.0
shielded,1,0.0
worriers,1,0.0
sizeable,1,0.0
outward,1,0.0
directindirect,1,0.0
proclaimed,1,0.0
eighty-one,1,0.0
Gyeonggi-do,1,0.0
OSANG,1,0.0
bulging,1,0.0
operator-dependent,1,0.0
Masovia,1,0.0
FluShield,1,0.0
Fluogen,1,0.0
eletrocardiogram,1,0.0
ABo,1,0.0
antiviral-based,1,0.0
reinforcements,1,0.0
Examinations,1,0.0
2760,1,0.0
ASTHMA,1,0.0
LIBERTY,1,0.0
isg15,1,0.0
TaqI,1,0.0
titled,1,0.0
Haider,1,0.0
precisions,1,0.0
6603,1,0.0
3213,1,0.0
2773,1,0.0
7613,1,0.0
score20,1,0.0
Z-3928,1,0.0
January-April,1,0.0
P0001and,1,0.0
trans-neuronal,1,0.0
2992,1,0.0
2531,1,0.0
trivaccine-immunized,1,0.0
ice-pick,1,0.0
χ28616,1,0.0
echocarciographic,1,0.0
2348,1,0.0
zanamavir,1,0.0
χ26267,1,0.0
2417,1,0.0
BsmI,1,0.0
ratio049,1,0.0
ApaI,1,0.0
4-mm,1,0.0
isodose,1,0.0
re-consideration,1,0.0
Minimally,1,0.0
tactile,1,0.0
scalp,1,0.0
bloodserum,1,0.0
centromedian,1,0.0
radiosurgical,1,0.0
non-antigen-dependent,1,0.0
antigen-dependent,1,0.0
AH1N1pdm2009,1,0.0
retested,1,0.0
Demonstration,1,0.0
1480,1,0.0
499,1,0.0
third-level,1,0.0
Croup,1,0.0
fourth-grade,1,0.0
levelaccording,1,0.0
FokI,1,0.0
non-contagious,1,0.0
-047,1,0.0
1479,1,0.0
4110,1,0.0
hypertension-related,1,0.0
Krichel,1,0.0
stainless-steel,1,0.0
coauthors,1,0.0
Env,1,0.0
VERIPRO®,1,0.0
assimilated,1,0.0
psychomotor,1,0.0
emotionalism,1,0.0
nsp,1,0.0
athymhormia,1,0.0
post-immunisation,1,0.0
amotivational,1,0.0
confusional,1,0.0
17-120,1,0.0
confabulations,1,0.0
perceptionidentification,1,0.0
months-old,1,0.0
20-59,1,0.0
psychopathology,1,0.0
I212,1,0.0
20-hydroxy-5,1,0.0
14-eicosatetraenoic,1,0.0
61--80min,1,0.0
Palliative,1,0.0
2737,1,0.0
P0012,1,0.0
2601,1,0.0
score21,1,0.0
gamma-GT,1,0.0
gamma-glutamyltransferase,1,0.0
Z-9190,1,0.0
3266,1,0.0
PCU,1,0.0
2220,1,0.0
141--16081--100,1,0.0
χ249614,1,0.0
one-sixth,1,0.0
χ224267,1,0.0
HVE,1,0.0
Plzen,1,0.0
prehospitalization,1,0.0
Aerobic,1,0.0
three-years,1,0.0
vasoconstrictors,1,0.0
collimator,1,0.0
helmet,1,0.0
encephalomalacia,1,0.0
Product,1,0.0
-057,1,0.0
34×103,1,0.0
43×103,1,0.0
14×104,1,0.0
58×104,1,0.0
neurotropism,1,0.0
disbalanced,1,0.0
Descriptions,1,0.0
rennin-angiotensin,1,0.0
surpassing,1,0.0
artery-specific,1,0.0
crossclamp,1,0.0
Immunisations,1,0.0
Cardioplegia,1,0.0
EuropeConclusions,1,0.0
acknowledgement,1,0.0
First-ever,1,0.0
1721,1,0.0
tabulatedResults,1,0.0
sideadverseundesirable,1,0.0
vaccinesData,1,0.0
KAPs,1,0.0
HPAI-related,1,0.0
whole-school,1,0.0
compound—,1,0.0
BFB-menthol—showed,1,0.0
two—BFB-borneol,1,0.0
whearas,1,0.0
BFDBSC,1,0.0
effectsthan,1,0.0
BFB-gallate—,1,0.0
compounds—FPBFDBSC,1,0.0
anti-,1,0.0
BFDBSC—can,1,0.0
analogy,1,0.0
primaryjunior,1,0.0
mesenteric,1,0.0
small-bowel,1,0.0
spleno-porto-mesenteric,1,0.0
veincerebral,1,0.0
policiespractices,1,0.0
lightheaded,1,0.0
asthma-oriented,1,0.0
non-intervention,1,0.0
Pupils,1,0.0
monographs,1,0.0
MHRAStudy,1,0.0
vascularisation,1,0.0
EMAEuropean,1,0.0
Forces,1,0.0
Highly-pathogenic,1,0.0
medihalers,1,0.0
veterinarians,1,0.0
679631,1,0.0
DallasFort,1,0.0
polyDL-lactide-co-glycolide,1,0.0
leakiness,1,0.0
PLGA-based,1,0.0
biodegradable,1,0.0
60-69,1,0.0
low-airborne,1,0.0
Otariidae,1,0.0
Phocidae,1,0.0
habitat,1,0.0
shoreline,1,0.0
hunting,1,0.0
short-termed,1,0.0
Neurosurgical,1,0.0
Thalamic,1,0.0
irradiation-based,1,0.0
13426,1,0.0
infarction--including,1,0.0
Sørlandet,1,0.0
pseudocyst,1,0.0
Northern-Hemisphere,1,0.0
BWisconsin012010-like,1,0.0
HA1-domain,1,0.0
composing,1,0.0
QI,1,0.0
BVictoria-lineage,1,0.0
HQoL,1,0.0
utilitarian,1,0.0
Nash,1,0.0
125-135,1,0.0
Arendal,1,0.0
ACCORD,1,0.0
17114,1,0.0
ACCCORD,1,0.0
DoD,1,0.0
poststress,1,0.0
64E,1,0.0
veterinarian,1,0.0
immuno-deficient,1,0.0
Armed,1,0.0
030-081,1,0.0
sero-susceptibility,1,0.0
stat,1,0.0
17-1064,1,0.0
preschool-aged,1,0.0
insofar,1,0.0
acrimonious,1,0.0
6-20,1,0.0
infection-precipitated,1,0.0
gkg,1,0.0
IVIG-treated,1,0.0
Alarmin,1,0.0
monthsABSTRACT,1,0.0
Re-elevation,1,0.0
enervating,1,0.0
∼2789,1,0.0
105558,1,0.0
hypopsia,1,0.0
hyposmia,1,0.0
disquiets,1,0.0
droplet-PCR,1,0.0
£187682,1,0.0
echoDoppler,1,0.0
echocardiographicDoppler,1,0.0
instrument-free,1,0.0
sociodemographical,1,0.0
11-82,1,0.0
021-097,1,0.0
14-52,1,0.0
conundrums,1,0.0
geared,1,0.0
hostile,1,0.0
Preconditioning,1,0.0
close-ended,1,0.0
May-June,1,0.0
necrophorum,1,0.0
Fusobacterium,1,0.0
thrombophlebitis,1,0.0
X-Ray,1,0.0
Lemierre,1,0.0
serviced,1,0.0
TGE,1,0.0
orf1ab,1,0.0
five-category,1,0.0
Cartridge,1,0.0
Prep,1,0.0
architectures,1,0.0
three9,1,0.0
COVID-Net,1,0.0
COVIDNet-CT,1,0.0
Caution,1,0.0
overhang,1,0.0
biotinylated,1,0.0
double-stranded,1,0.0
PRoFESS,1,0.0
Avoiding,1,0.0
Effectively,1,0.0
modified-Rankin,1,0.0
1134,1,0.0
well-founded,1,0.0
justifiable,1,0.0
suppressants,1,0.0
engendered,1,0.0
radiating,1,0.0
groupAcute,1,0.0
2-13,1,0.0
Biphasic,1,0.0
arterio-venous,1,0.0
1995-2010,1,0.0
138-1159,1,0.0
enzyme-histochemically,1,0.0
light-microscopical,1,0.0
histopathologically,1,0.0
pathomorphologically,1,0.0
128-1003,1,0.0
Atherothrombotic,1,0.0
Stabilization,1,0.0
CHARISMA,1,0.0
milk-based,1,0.0
rRNAs,1,0.0
poisons,1,0.0
embodying,1,0.0
BACA,1,0.0
006-026,1,0.0
Epi-aortic,1,0.0
Liver,1,0.0
Monetarised,1,0.0
antibiotic-resistant,1,0.0
somatotropin,1,0.0
EuropeanAustralasian,1,0.0
sputa,1,0.0
heat-sterilized,1,0.0
storing,1,0.0
pathogen-free,1,0.0
replenishing,1,0.0
102-1630,1,0.0
18-45,1,0.0
aspirindipyridamole,1,0.0
ESPRIT,1,0.0
hindbrain,1,0.0
forebrain,1,0.0
AGF,1,0.0
SATIS-Stroke,1,0.0
reactogenic,1,0.0
PIMS-TS,1,0.0
RT-iiPCR,1,0.0
immunising,1,0.0
downsides,1,0.0
905-100,1,0.0
931-100,1,0.0
RT-3DE,1,0.0
μL-1,1,0.0
fg,1,0.0
hemiparetic,1,0.0
facile,1,0.0
dissolved,1,0.0
red-colored,1,0.0
illumination,1,0.0
trisodium,1,0.0
Enterococcus,1,0.0
ultraviolet-induced,1,0.0
Schwann,1,0.0
PRR,1,0.0
epileptiform,1,0.0
post-marketing,1,0.0
forged,1,0.0
risk-benefits,1,0.0
III-type,1,0.0
ratio045,1,0.0
136-317,1,0.0
ratio207,1,0.0
161-376,1,0.0
ratio246,1,0.0
1102,1,0.0
swH3N2,1,0.0
ASydney51997,1,0.0
pre-immunisation,1,0.0
PSD-95,1,0.0
Alternatives,1,0.0
oxidases,1,0.0
ebselen,1,0.0
NXY-059,1,0.0
Roundtable,1,0.0
single-target,1,0.0
orf,1,0.0
transcription-insulated,1,0.0
mid-1960s,1,0.0
plus-strand,1,0.0
Epileptic,1,0.0
AMI-indicative,1,0.0
siphon,1,0.0
CLT,1,0.0
2824,1,0.0
2662,1,0.0
2985,1,0.0
Transplanted,1,0.0
IAH,1,0.0
667–671,1,0.0
CABP,1,0.0
Reviewed,1,0.0
informations,1,0.0
2019”,1,0.0
“coronavirus,1,0.0
aquired,1,0.0
2”,1,0.0
“severe,1,0.0
dysphagiaaspiration,1,0.0
ARussia,1,0.0
S-mediated,1,0.0
high-profile,1,0.0
Hypoxaemia,1,0.0
case-report,1,0.0
assigning,1,0.0
jfoxupmc-biosecurityorg,1,0.0
2852,1,0.0
Ig-E-mediated,1,0.0
Hunter,1,0.0
Origin,1,0.0
strabismus,1,0.0
Prince,1,0.0
Halifax,1,0.0
Hamilton,1,0.0
anticonvulsant,1,0.0
advocacy,1,0.0
APACI,1,0.0
Initiatives,1,0.0
866000,1,0.0
2562,1,0.0
pH1N1-associated,1,0.0
rheopolyglucin,1,0.0
rheologic,1,0.0
fractionator,1,0.0
PF-05,1,0.0
ORF1,1,0.0
2707,1,0.0
Gravitation,1,0.0
diagnostical,1,0.0
solubility,1,0.0
INTRODUCTION,1,0.0
OBJECTIVES,1,0.0
abulia,1,0.0
radiopacity,1,0.0
180110,1,0.0
Han,1,0.0
V729I,1,0.0
D641V,1,0.0
I559N,1,0.0
malfunction,1,0.0
Nontraumatic,1,0.0
34-54,1,0.0
∼18-50,1,0.0
free-serum,1,0.0
PC12,1,0.0
Overexpression,1,0.0
outgrowth-associated,1,0.0
∼5,1,0.0
Bioinformatics,1,0.0
DNA-centric,1,0.0
transcription‑quantitative,1,0.0
synapse-associated,1,0.0
outgrowth,1,0.0
74-113,1,0.0
AH1N1v-associated,1,0.0
carina,1,0.0
PATIENTS,1,0.0
releaser,1,0.0
Check™,1,0.0
Check,1,0.0
60-60,1,0.0
77-87,1,0.0
64-77,1,0.0
90-90,1,0.0
65-82,1,0.0
73-80,1,0.0
offs,1,0.0
meta,1,0.0
mixed-effects,1,0.0
QALY,1,0.0
commodities,1,0.0
emphatically,1,0.0
FPV,1,0.0
RDV,1,0.0
Dipole,1,0.0
predominates,1,0.0
non-dipolar,1,0.0
apices,1,0.0
4880,1,0.0
20-27,1,0.0
136-146,1,0.0
PAIMS,1,0.0
over-generalization,1,0.0
emergen-ce,1,0.0
algetic,1,0.0
clinico-statistical,1,0.0
benchmarks,1,0.0
near-elimination,1,0.0
shelter-in-place,1,0.0
protomers,1,0.0
testings,1,0.0
catch-22,1,0.0
G614D,1,0.0
httpssars3dcom,1,0.0
GISSI-Avoidable,1,0.0
melt,1,0.0
SARS-CoV-2-PCR,1,0.0
50-fold,1,0.0
065ABSTRACT,1,0.0
0300,1,0.0
1217-1436,1,0.0
non-AMI,1,0.0
1001-1146,1,0.0
back-titration,1,0.0
target-based,1,0.0
perseverance,1,0.0
20172018,1,0.0
Hangzhou,1,0.0
nuances,1,0.0
more-severe,1,0.0
nightsmonth,1,0.0
daysweek,1,0.0
connectedness,1,0.0
second-hand,1,0.0
INFR,1,0.0
Tailored,1,0.0
mutagenicity,1,0.0
neuro-imaging,1,0.0
1560,1,0.0
cardiotoxicity,1,0.0
electro-encephalographic,1,0.0
molecule-1,1,0.0
fibrinopeptid,1,0.0
hematologically,1,0.0
inherits,1,0.0
HbS,1,0.0
decedents,1,0.0
non-hERG,1,0.0
gut-lung,1,0.0
IgM-IgG,1,0.0
61-90,1,0.0
4720,1,0.0
Consonant,1,0.0
20-MHz,1,0.0
enteroviral,1,0.0
TMPRSS,1,0.0
3725,1,0.0
pandemicExpert,1,0.0
implementedAreas,1,0.0
moderatesevere,1,0.0
group-at-risk,1,0.0
Errors,1,0.0
Inborn,1,0.0
049Conclusions,1,0.0
962Results,1,0.0
3026,1,0.0
2080,1,0.0
Enrolled,1,0.0
3145,1,0.0
Non-probability,1,0.0
vaccinationMethods,1,0.0
Behavior,1,0.0
Planned,1,0.0
Statewide,1,0.0
Aimed,1,0.0
460-466,1,0.0
low-flow,1,0.0
scn10a,1,0.0
Intra-airway,1,0.0
neutrally,1,0.0
intra-airway,1,0.0
double-lumen,1,0.0
nodose,1,0.0
epithelia,1,0.0
airway-nervous,1,0.0
imaging-derived,1,0.0
CO₂,1,0.0
480-487,1,0.0
macromoleculeligand,1,0.0
waterbodies,1,0.0
soiled,1,0.0
Enzyme-linked,1,0.0
POP,1,0.0
MHI,1,0.0
494-496,1,0.0
490-492,1,0.0
490-491,1,0.0
15-56,1,0.0
1441,1,0.0
31-60,1,0.0
Ct≤30,1,0.0
05-25,1,0.0
drains,1,0.0
starch,1,0.0
allergen-carrying,1,0.0
diet--primarily,1,0.0
salt--was,1,0.0
Pollen,1,0.0
Napoli,1,0.0
27000,1,0.0
prevalently,1,0.0
Thunderstorms,1,0.0
24--96,1,0.0
closed-chest,1,0.0
OPS,1,0.0
PLAATO,1,0.0
membrane-,1,0.0
notched,1,0.0
nitinol,1,0.0
curved,1,0.0
tapes,1,0.0
timepoints,1,0.0
thunderstorm-asthma,1,0.0
grasses,1,0.0
CFA,1,0.0
4327,1,0.0
96100,1,0.0
5865,1,0.0
5957,1,0.0
Suwon,1,0.0
3876,1,0.0
8253246,1,0.0
1209,1,0.0
19373172,1,0.0
4954635,1,0.0
18839,1,0.0
Francs,1,0.0
78426,1,0.0
32614442,1,0.0
12052,1,0.0
33573,1,0.0
608,1,0.0
1777,1,0.0
Lowns,1,0.0
currency,1,0.0
Senegalese,1,0.0
immunoenzymometric,1,0.0
Inhalers,1,0.0
Short-acting,1,0.0
ATGs,1,0.0
VEMP,1,0.0
vestibulum,1,0.0
1141,1,0.0
SCM,1,0.0
sternocleidomastoid,1,0.0
picking,1,0.0
CV-1,1,0.0
JOYSBIO,1,0.0
myogenic,1,0.0
Assure,1,0.0
Vestibular,1,0.0
Tech,1,0.0
NCT04358211FUNDINGDepartment,1,0.0
REGISTRATIONClinicalTrialsgov,1,0.0
infectionTRIAL,1,0.0
resultsCONCLUSIONResults,1,0.0
VivaChek,1,0.0
comparisonsRESULTSCRISPR-augmented,1,0.0
NDFOS,1,0.0
samplesMETHODSA,1,0.0
Sensitivities,1,0.0
restenotic,1,0.0
IIB,1,0.0
inverted,1,0.0
macro-environment,1,0.0
12514,1,0.0
12023,1,0.0
every-day,1,0.0
uderdiagnosis,1,0.0
patomechanisms,1,0.0
precisionpersonalized,1,0.0
theratype,1,0.0
Endotype,1,0.0
custom-tailored,1,0.0
11402,1,0.0
0763,1,0.0
112-241,1,0.0
133-362,1,0.0
RT-LAMP-based,1,0.0
071-191,1,0.0
B3,1,0.0
040-055,1,0.0
062-194,1,0.0
thermocyclers,1,0.0
haemodynamically,1,0.0
BACKGROUNDCirculating,1,0.0
9775,1,0.0
SARS-Co-V-2,1,0.0
four-specimen,1,0.0
RGD-binding,1,0.0
GRs,1,0.0
Arg-Gly-Asp,1,0.0
K403R,1,0.0
desperate,1,0.0
tradeoffs,1,0.0
re-hospitalizations,1,0.0
unidimensional,1,0.0
Bronchoprovocation,1,0.0
physics,1,0.0
Rales,1,0.0
subsystems,1,0.0
bibasilar,1,0.0
≥375°C,1,0.0
Pyrexia,1,0.0
inactivity-related,1,0.0
Month,1,0.0
cefuroxime,1,0.0
2250,1,0.0
antibacterials,1,0.0
DDD,1,0.0
Integrin,1,0.0
Cilengitide,1,0.0
1846,1,0.0
automaticity,1,0.0
copiesreaction,1,0.0
petrol,1,0.0
supermarket,1,0.0
Corrected,1,0.0
COVID-19-compatible,1,0.0
augmenting,1,0.0
81-97,1,0.0
well-performing,1,0.0
uncompleted,1,0.0
emitters,1,0.0
2092,1,0.0
individual-based,1,0.0
midpoint,1,0.0
lysate,1,0.0
sensible,1,0.0
self-grown,1,0.0
lysates,1,0.0
SERS-based,1,0.0
CAMI,1,0.0
MOB,1,0.0
viral-induced,1,0.0
angioedema,1,0.0
overdiagnosis,1,0.0
lingual,1,0.0
IncDynPort,1,0.0
Baxter,1,0.0
Lyon,1,0.0
subtending,1,0.0
S-033188,1,0.0
JNJ63623872,1,0.0
T705,1,0.0
DAS181,1,0.0
Nitazoxanide,1,0.0
receiver-operator,1,0.0
15-50,1,0.0
explicate,1,0.0
opercular,1,0.0
Foix-Chavany-Marie,1,0.0
Wash,1,0.0
Issaquah,1,0.0
BaxterBartels,1,0.0
Md,1,0.0
Cockeysville,1,0.0
Dickinson,1,0.0
Becton,1,0.0
FP-01,1,0.0
FluGEM,1,0.0
Mucosis,1,0.0
astuprotimut-r,1,0.0
secondforced,1,0.0
Parenchymal,1,0.0
harmonic,1,0.0
immunophenotyping,1,0.0
co-cultures,1,0.0
Optison,1,0.0
utilises,1,0.0
pulsing,1,0.0
Plateau,1,0.0
Vical,1,0.0
BV,1,0.0
VCL-CB01,1,0.0
Biopharmaceuticals,1,0.0
Nabi,1,0.0
StaphVAX,1,0.0
plc,1,0.0
PentaStaph,1,0.0
Biosciences,1,0.0
Vivaldi,1,0.0
protein-1-altered,1,0.0
Connection,1,0.0
mastication,1,0.0
toracostomy,1,0.0
Hereditary,1,0.0
pleuritis,1,0.0
tnine,1,0.0
single-level,1,0.0
DTPA,1,0.0
gadolinium-diethylenetriaminepentaacetic,1,0.0
syndrome--two,1,0.0
six--with,1,0.0
2-14,1,0.0
sectional-analytic,1,0.0
centABSTRACT,1,0.0
accentuate,1,0.0
Heparin,1,0.0
ans,1,0.0
medicalised,1,0.0
Cysteiny,1,0.0
zafirlukast,1,0.0
Departments,1,0.0
Somme,1,0.0
Oise,1,0.0
Aisne,1,0.0
picardy,1,0.0
Ultrafast,1,0.0
gadolinium-DTPA-enhanced,1,0.0
LAAO,1,0.0
cent--were,1,0.0
phagocytose,1,0.0
opercula,1,0.0
well-localized,1,0.0
thioglycolate-treated,1,0.0
caspase-dependent,1,0.0
AUdon72,1,0.0
patients--48,1,0.0
patients--24,1,0.0
S-gene,1,0.0
SARs-CoV-2,1,0.0
Amplatzer™,1,0.0
chuankezhi,1,0.0
materialize,1,0.0
patients--24--were,1,0.0
Opponents,1,0.0
frustrate,1,0.0
rest--10--between,1,0.0
new-acquired,1,0.0
febrility,1,0.0
Amulet™,1,0.0
MCI,1,0.0
Angiotensin-Converting,1,0.0
custommune,1,0.0
state-based,1,0.0
post-hoc,1,0.0
Kappa-scores,1,0.0
LHS,1,0.0
RHS,1,0.0
goal-oriented,1,0.0
MIDs,1,0.0
intentional,1,0.0
GFYAQGSR,1,0.0
ADETQALPQR,1,0.0
nanoLC-MSMS,1,0.0
simili,1,0.0
peptidome,1,0.0
shotgun,1,0.0
immunodiagnostics,1,0.0
Accurately,1,0.0
multiprofessional,1,0.0
realigning,1,0.0
co-ordination,1,0.0
clarity,1,0.0
Thailands,1,0.0
64-91,1,0.0
visualizations,1,0.0
VUM,1,0.0
11-year-old-girl,1,0.0
flatten,1,0.0
current-day,1,0.0
30-DEM,1,0.0
England4272,1,0.0
8951000,1,0.0
midshipman,1,0.0
midshipmen,1,0.0
naval,1,0.0
22711000,1,0.0
17081000,1,0.0
3935,1,0.0
1974—The,1,0.0
100216–221,1,0.0
Corrado,1,0.0
Kolonel,1,0.0
78236,1,0.0
AFB,1,0.0
Brooks,1,0.0
Aerospace,1,0.0
USAF,1,0.0
Blouse,1,0.0
Optimizing,1,0.0
wealthy,1,0.0
mRNA-COVID-19,1,0.0
19-,1,0.0
better-customized,1,0.0
expansive,1,0.0
implanting,1,0.0
retarded,1,0.0
one-week,1,0.0
theophyllinemia,1,0.0
fade,1,0.0
urbanized,1,0.0
naturally-induced,1,0.0
non-pandemic,1,0.0
Bacteroides,1,0.0
odor,1,0.0
milk-coffee-like,1,0.0
conjectural,1,0.0
electro-mechanical,1,0.0
63012,1,0.0
102679,1,0.0
NRMI,1,0.0
410x,1,0.0
compute,1,0.0
regions-for,1,0.0
Pepitope-a,1,0.0
CardioWest,1,0.0
femoro-femoral,1,0.0
Cardio,1,0.0
stoma,1,0.0
hobbies,1,0.0
sewage-based,1,0.0
biorepositories,1,0.0
Gore-Tex,1,0.0
protrusion,1,0.0
tracheostoma,1,0.0
manubriectomy,1,0.0
hemiclaviculectomy,1,0.0
unbalanced,1,0.0
postradiotherapy,1,0.0
enterocolic,1,0.0
syntactic,1,0.0
lexical-semantic,1,0.0
Theft,1,0.0
Cookie,1,0.0
Etfal,1,0.0
Hamidiye,1,0.0
Sisli,1,0.0
60s,1,0.0
dicumarol,1,0.0
F-measure,1,0.0
voluntarism,1,0.0
dichotomizing,1,0.0
1995-March,1,0.0
antibody-maturation,1,0.0
avidities,1,0.0
nanostructured,1,0.0
near-infrared-fluorescence,1,0.0
appears-unlike,1,0.0
reside,1,0.0
low-population,1,0.0
resource-heavy,1,0.0
experimenting,1,0.0
behavior-not,1,0.0
alarmingly,1,0.0
attributional,1,0.0
biography,1,0.0
monitoringcontainment,1,0.0
constraining,1,0.0
LRIs,1,0.0
acceptanceThe,1,0.0
populationAlmost,1,0.0
Agencies,1,0.0
company-sponsored,1,0.0
cost-savings,1,0.0
entertainment,1,0.0
65-69,1,0.0
Dominican,1,0.0
28-,1,0.0
questionnaireEighteen,1,0.0
strokeA,1,0.0
settingsTo,1,0.0
phosphorylated,1,0.0
non-normative,1,0.0
35-39,1,0.0
misreporting,1,0.0
biorhythm,1,0.0
33-day,1,0.0
23-,1,0.0
fast-paced,1,0.0
Biorhythm,1,0.0
biorhythmic,1,0.0
HEK,1,0.0
flow-cytometric,1,0.0
psittaci,1,0.0
963,1,0.0
Vircell-IgMIgA,1,0.0
Vircell-IgMA,1,0.0
inequitable,1,0.0
2622,1,0.0
3Ms,1,0.0
inflammation--into,1,0.0
Pre-infarction,1,0.0
1582,1,0.0
phonocardiography,1,0.0
stannous,1,0.0
technetium-99,1,0.0
three-base,1,0.0
agriculture,1,0.0
bystander-initiated,1,0.0
Chapter,1,0.0
vs7391,1,0.0
7742,1,0.0
5652,1,0.0
6130,1,0.0
9565,1,0.0
5217,1,0.0
6129,1,0.0
8696,1,0.0
k-nearest,1,0.0
neighbor,1,0.0
endotypes--has,1,0.0
TH2-low,1,0.0
TH2-high,1,0.0
unforced,1,0.0
alignment-free,1,0.0
waived,1,0.0
TL-LFA,1,0.0
PVD,1,0.0
malefemale,1,0.0
factorssubtypes,1,0.0
Hashimoto,1,0.0
JES,1,0.0
chemoradiotherapy,1,0.0
9714,1,0.0
RT-RPA,1,0.0
transcription-recombinase,1,0.0
triple-line,1,0.0
Amendments,1,0.0
CRISPRCas9-mediated,1,0.0
increments,1,0.0
dPAP,1,0.0
rate-pressure,1,0.0
dAP,1,0.0
Airways,1,0.0
academies,1,0.0
PRACTALL,1,0.0
nominated,1,0.0
angioresonance,1,0.0
excision,1,0.0
Inhibitor,1,0.0
3120,1,0.0
2295,1,0.0
4053,1,0.0
38-59,1,0.0
Cuiaba,1,0.0
60-78,1,0.0
175-223,1,0.0
127-142,1,0.0
82-91,1,0.0
49-77,1,0.0
Teresina,1,0.0
97-105,1,0.0
147-187,1,0.0
129-161,1,0.0
114-134,1,0.0
142-177,1,0.0
137-160,1,0.0
121-139,1,0.0
74589,1,0.0
3486,1,0.0
self-filled,1,0.0
macro-regions,1,0.0
2078,1,0.0
290000,1,0.0
outperforming,1,0.0
venopathy,1,0.0
flours,1,0.0
cereal,1,0.0
wheat,1,0.0
Bakers,1,0.0
carpet-making,1,0.0
gums,1,0.0
vegetal,1,0.0
customisation,1,0.0
conceptualisation,1,0.0
stressorssocial,1,0.0
culturallylinguistically,1,0.0
Facilitators,1,0.0
defensiveness,1,0.0
partisan,1,0.0
tumultuous,1,0.0
swayed,1,0.0
Seventy-nine,1,0.0
involved-is,1,0.0
unclassifiable,1,0.0
general-embolism,1,0.0
that-for,1,0.0
representativeness,1,0.0
Ψ,1,0.0
e1e2,1,0.0
throughly,1,0.0
275x106,1,0.0
extractions,1,0.0
copyμl,1,0.0
Nsp3,1,0.0
ADP-ribosylhydrolase,1,0.0
Rockefeller,1,0.0
Darnell,1,0.0
abstinent,1,0.0
non-residents,1,0.0
Work-exacerbated,1,0.0
vasointestinal,1,0.0
bombesin,1,0.0
neurotensin,1,0.0
prolactin,1,0.0
corticotrophin,1,0.0
vasopressin,1,0.0
glucagon,1,0.0
host-mediated,1,0.0
volume-outcome,1,0.0
FRSCV,1,0.0
furo,1,0.0
PFUml,1,0.0
co-collected,1,0.0
3724,1,0.0
High-sensitivity,1,0.0
ultrasound-virtual,1,0.0
adduce,1,0.0
intima,1,0.0
likely--scenario,1,0.0
the--very,1,0.0
Antibacterial,1,0.0
2009-like,1,0.0
gender-neutral,1,0.0
HsTn,1,0.0
populationThe,1,0.0
pods,1,0.0
8528,1,0.0
156803,1,0.0
vaccinationData,1,0.0
anonymized,1,0.0
Case-based,1,0.0
patientsICD-10-based,1,0.0
diseasesThe,1,0.0
COVIDCareHome,1,0.0
medicine-led,1,0.0
sesame,1,0.0
alpha-amylase,1,0.0
Alpha-amylase,1,0.0
receptor-inhibiting,1,0.0
65-week,1,0.0
52-,1,0.0
Pathogenetic,1,0.0
K2O·6TiO2,1,0.0
octatitanate,1,0.0
Cepheids,1,0.0
easiest,1,0.0
Discrepant,1,0.0
bioMérieux,1,0.0
eMag,1,0.0
eso-bronchial,1,0.0
m2000,1,0.0
1758,1,0.0
Upregulation,1,0.0
adipocyte,1,0.0
oesofagus,1,0.0
Peroxisome,1,0.0
SARS-cov,1,0.0
cov,1,0.0
MERS-,1,0.0
string,1,0.0
fiber-shaped,1,0.0
AJ,1,0.0
ovary,1,0.0
bicycling,1,0.0
00017,1,0.0
Marmosets,1,0.0
cohabitating,1,0.0
human-like,1,0.0
unadapted,1,0.0
mate,1,0.0
jacchus,1,0.0
Callithrix,1,0.0
productively,1,0.0
LoE,1,0.0
TISMO-infused,1,0.0
risk-factor,1,0.0
diabetes-associated,1,0.0
race-ethnic,1,0.0
doubtfulness,1,0.0
Germanys,1,0.0
ministers,1,0.0
Campinas,1,0.0
non-variant,1,0.0
mesotheliomas,1,0.0
immune-induced,1,0.0
humanised,1,0.0
orizae,1,0.0
normocholesterolemic,1,0.0
p0034,1,0.0
r034,1,0.0
p0017,1,0.0
r037,1,0.0
mch,1,0.0
PD20FEV1,1,0.0
p02,1,0.0
r-020,1,0.0
NIHWHO,1,0.0
1987-97,1,0.0
compensating,1,0.0
synchronously,1,0.0
H7N9A,1,0.0
proton-pump,1,0.0
discarding,1,0.0
immuno,1,0.0
Gypsophila,1,0.0
Ginseng,1,0.0
Ficus,1,0.0
floral,1,0.0
Plant,1,0.0
underevaluate,1,0.0
damageimpairment,1,0.0
esogastroscopy,1,0.0
self-collect,1,0.0
eprosartan,1,0.0
dipyridamole-aspirine,1,0.0
hypocholesterolemic,1,0.0
alimentary,1,0.0
Storage,1,0.0
0738-1000,1,0.0
near-perfect,1,0.0
heparin-treated,1,0.0
µl,1,0.0
postage,1,0.0
FR,1,0.0
Capillary,1,0.0
pseudomyocardial,1,0.0
hyperkalemia-induced,1,0.0
pseudoacute,1,0.0
Ossong,1,0.0
KCDC,1,0.0
arrivals,1,0.0
Headquarters,1,0.0
MerciPenumbra,1,0.0
Activated,1,0.0
sensitivity-96,1,0.0
mustelids,1,0.0
top-down,1,0.0
Presidents,1,0.0
syphilis,1,0.0
pool-testing,1,0.0
Pool-testing,1,0.0
Radiography,1,0.0
reconciliation,1,0.0
geneticist,1,0.0
CLEIA,1,0.0
multiplexed-chimeric,1,0.0
RsSHC014,1,0.0
InfluSim,1,0.0
subgenus,1,0.0
sphenoid,1,0.0
herniating,1,0.0
encephalocele,1,0.0
Beta-2-transferrin,1,0.0
coryzal,1,0.0
nostril,1,0.0
spill-over,1,0.0
discounting,1,0.0
time-period,1,0.0
Consumer,1,0.0
downgrade,1,0.0
decimated,1,0.0
TRL-7,1,0.0
ABangkok179,1,0.0
AAichi268,1,0.0
ELISA-positive,1,0.0
H1-H15,1,0.0
TRL-4,1,0.0
caspica,1,0.0
Phoca,1,0.0
ill-suboptimal,1,0.0
video-EEG,1,0.0
pension,1,0.0
Blair,1,0.0
tribe,1,0.0
Nicobarese,1,0.0
aboriginal,1,0.0
settler,1,0.0
Nicobar,1,0.0
Andaman,1,0.0
EPR3,1,0.0
reperformed,1,0.0
AHI,1,0.0
apnea-hypopnea,1,0.0
scholarly,1,0.0
cost-containment,1,0.0
political-institutional,1,0.0
citys,1,0.0
nick,1,0.0
dUTP-biotin,1,0.0
transferase-mediated,1,0.0
deoxynucleotidyl,1,0.0
disease-controlling,1,0.0
susceptible-infectious-recovered,1,0.0
-10,1,0.0
SVS-,1,0.0
-11,1,0.0
105-574,1,0.0
2b-3,1,0.0
NGO,1,0.0
Ministers,1,0.0
1782-1782,1,0.0
countries--the,1,0.0
bloodlettings,1,0.0
emetics,1,0.0
laxatives,1,0.0
expectorants,1,0.0
king,1,0.0
Wide-spread,1,0.0
end-labeling,1,0.0
TUNEL,1,0.0
caspases,1,0.0
RPE,1,0.0
Bogotás,1,0.0
packages,1,0.0
wax,1,0.0
glues,1,0.0
non-industrial,1,0.0
tyre,1,0.0
Colophony,1,0.0
eyewear,1,0.0
shieldsvisors,1,0.0
virus-infested,1,0.0
6-months,1,0.0
DCW,1,0.0
0155,1,0.0
Auricle,1,0.0
polygraphic,1,0.0
19500,1,0.0
tabletop,1,0.0
espoused,1,0.0
precocultured,1,0.0
peri-infarcted,1,0.0
1979-1981,1,0.0
ABangkok179-like,1,0.0
CED,1,0.0
up-titration,1,0.0
2857,1,0.0
9633,1,0.0
2904,1,0.0
7143,1,0.0
8159,1,0.0
4286,1,0.0
Thickness,1,0.0
MAGPIX,1,0.0
anticipatory-guidance,1,0.0
Requirement,1,0.0
250↔640,1,0.0
380↔2812,1,0.0
1034,1,0.0
15T,1,0.0
SMART-MR,1,0.0
disease-Magnetic,1,0.0
ARTerial,1,0.0
Manifestations,1,0.0
1003,1,0.0
Neurodegenerative,1,0.0
contra,1,0.0
4867,1,0.0
subepithelial-layer,1,0.0
9932,1,0.0
lenvatinib,1,0.0
Subepithelial-layer,1,0.0
time-of-addition,1,0.0
RTKs,1,0.0
mechanism-of-action,1,0.0
sunitinib,1,0.0
pazopanib,1,0.0
broadly-acting,1,0.0
Lenvatinib,1,0.0
serendipitously,1,0.0
µM,1,0.0
Hemoglobin,1,0.0
anti-protozoal,1,0.0
diclazuril,1,0.0
replication-inhibition,1,0.0
protease-inhibition,1,0.0
chymotrypsin-like,1,0.0
6000,1,0.0
varicella-zoster,1,0.0
RNa,1,0.0
mM,1,0.0
Newborns,1,0.0
re-presented,1,0.0
TRL-2,1,0.0
non-diseased,1,0.0
IL-1βIL-1F2,1,0.0
disorderly,1,0.0
TLR-2,1,0.0
TLR-4,1,0.0
Clinicaltrialsgov,1,0.0
inflammation-associated,1,0.0
virus-,1,0.0
angio-invasive,1,0.0
airway-invasive,1,0.0
condensed,1,0.0
kindred,1,0.0
Hutterite,1,0.0
TLR-7,1,0.0
Unobserved,1,0.0
Start,1,0.0
Build,1,0.0
pan-European,1,0.0
Europe-wide,1,0.0
polypill,1,0.0
physician-confirmed,1,0.0
Tucson,1,0.0
miR-323,1,0.0
miR-491,1,0.0
miR-654,1,0.0
phosphate-buffered,1,0.0
Prinzmetals,1,0.0
NICUs,1,0.0
3183,1,0.0
1143,1,0.0
1992-93,1,0.0
Agrippal,1,0.0
mutifactorial,1,0.0
Foreign,1,0.0
HCoV-specific,1,0.0
fg⋅mL-1,1,0.0
defending,1,0.0
Electrochemical,1,0.0
Low-cost,1,0.0
devastate,1,0.0
83-185,1,0.0
47-87,1,0.0
somehow,1,0.0
74-122,1,0.0
crudeness,1,0.0
volunteering,1,0.0
NI-resistant,1,0.0
eighteenth,1,0.0
Fibrillary,1,0.0
sterically,1,0.0
gellan,1,0.0
mucoadhesive,1,0.0
polysaccharide-based,1,0.0
bFGF,1,0.0
Trafermin,1,0.0
noninfarcts,1,0.0
9509,1,0.0
unlicensed,1,0.0
risk-informed,1,0.0
flebography,1,0.0
Transoesophageal,1,0.0
Hodgkin,1,0.0
BPs,1,0.0
SARS‑CoV,1,0.0
non‑expensive,1,0.0
SARS‑coronavirus,1,0.0
Zinc,1,0.0
3C‑like,1,0.0
RNA‑polymerase,1,0.0
RNA‑dependent,1,0.0
TEAM,1,0.0
λ-carrageenan,1,0.0
viscous,1,0.0
weal,1,0.0
LpPLA2,1,0.0
Speech,1,0.0
5939234,1,0.0
367255,1,0.0
westernized,1,0.0
case-referent,1,0.0
22727,1,0.0
58871,1,0.0
825731,1,0.0
11280,1,0.0
Hubeiin,1,0.0
Binomial,1,0.0
Pleasure,1,0.0
treatment-decision,1,0.0
risperidone,1,0.0
Risperidone,1,0.0
beta-adrenoreceptor,1,0.0
Hypertrophy,1,0.0
eight-week,1,0.0
httpwwwbiomedcentralcom1741-701510117,1,0.0
communitySee,1,0.0
aged≤45,1,0.0
Eminase,1,0.0
nontraumatic,1,0.0
definition-based,1,0.0
pneumonia--cause,1,0.0
p0049,1,0.0
colonized,1,0.0
Inside,1,0.0
exposure-type,1,0.0
805,1,0.0
H1NI,1,0.0
forty-two,1,0.0
TDI-induced,1,0.0
isocyanate-related,1,0.0
toluene-diisocyanate,1,0.0
isocyanate-sensitive,1,0.0
Well-standardized,1,0.0
Estonia,1,0.0
imagingdiffusion-weighted,1,0.0
typesOur,1,0.0
specificity-,1,0.0
Retinol,1,0.0
sensitivity-,1,0.0
specificity-100,1,0.0
cohort-specific,1,0.0
Acidic,1,0.0
justifying,1,0.0
nosological,1,0.0
myocardiosclerosis,1,0.0
enpowerment,1,0.0
complications--including,1,0.0
Macrophages,1,0.0
Potent,1,0.0
transsternal,1,0.0
transclavicular,1,0.0
Metabolically,1,0.0
obesity-associated,1,0.0
implements,1,0.0
Personalised,1,0.0
Consultations,1,0.0
terrain,1,0.0
≥71,1,0.0
Bydgoszcz,1,0.0
Medicum,1,0.0
Collegium,1,0.0
35-74,1,0.0
neighbourhood,1,0.0
Carbohydrate,1,0.0
Pathophysiologic,1,0.0
endometriosis,1,0.0
accelerometer,1,0.0
habitual,1,0.0
or18,1,0.0
Vertical,1,0.0
regional-level,1,0.0
Muscular,1,0.0
Appeared,1,0.0
A5,1,0.0
annexin,1,0.0
Gd-based,1,0.0
Gd-containing,1,0.0
Manganese,1,0.0
non-targeted,1,0.0
athmagenic,1,0.0
asthmagenic,1,0.0
Running,1,0.0
sub-sets,1,0.0
dovetailed,1,0.0
4th-grade,1,0.0
3rd-,1,0.0
3rd-grade,1,0.0
radiopager,1,0.0
influenzapneumonia,1,0.0
ridership,1,0.0
infero-lateral,1,0.0
susceptible-exposed-infected-recovered,1,0.0
parameterized,1,0.0
USA‒specific,1,0.0
wean,1,0.0
Placebo,1,0.0
Lomudal,1,0.0
uphill,1,0.0
co-location,1,0.0
Revolution--will,1,0.0
aquaculture--the,1,0.0
Striking,1,0.0
neuroepidemiological,1,0.0
cooperate,1,0.0
bioprosthesis,1,0.0
disease‒related,1,0.0
repaired,1,0.0
J-curve,1,0.0
protein-related,1,0.0
J501YV3,1,0.0
20H501YV2,1,0.0
20I501YV1,1,0.0
eased,1,0.0
scenario-based,1,0.0
March‒June,1,0.0
Supportive,1,0.0
IMPACT,1,0.0
Paradoxical,1,0.0
OLS,1,0.0
156176,1,0.0
11645,1,0.0
2212,1,0.0
Emiratis,1,0.0
58176,1,0.0
72176,1,0.0
112176,1,0.0
89176,1,0.0
101176,1,0.0
67176,1,0.0
161176,1,0.0
852,1,0.0
150176,1,0.0
128176,1,0.0
158176,1,0.0
176193,1,0.0
sufficiency,1,0.0
PR-interval,1,0.0
Guatemala,1,0.0
mosquito-borne,1,0.0
disjuncture,1,0.0
Empirical,1,0.0
candidate-predictors,1,0.0
family-provider,1,0.0
comorbidityExpert,1,0.0
deductive,1,0.0
syntax,1,0.0
semantics,1,0.0
phonology,1,0.0
aphasias,1,0.0
B-associated,1,0.0
hemiplegias,1,0.0
IL-17F,1,0.0
fulfilment,1,0.0
diseaseAreas,1,0.0
IADLs,1,0.0
mixedChronic,1,0.0
weeksyear,1,0.0
E611PR8,1,0.0
AEngland61107,1,0.0
PR8-based,1,0.0
replication-mediating,1,0.0
unimportant,1,0.0
Nidovirales,1,0.0
airtrapping,1,0.0
putorius,1,0.0
ADP-ribosylation,1,0.0
solvents,1,0.0
unethical,1,0.0
personalization,1,0.0
re-hospitalization,1,0.0
microalbuminuria,1,0.0
already-existing,1,0.0
coxsackievirus,1,0.0
Undernutrition,1,0.0
Al-OH,1,0.0
Kzyl-Orda,1,0.0
vector-vaccinated,1,0.0
life-threating,1,0.0
benefited,1,0.0
persulphates,1,0.0
NIOSH,1,0.0
after-effects,1,0.0
p0019,1,0.0
SABA,1,0.0
p0026,1,0.0
2072,1,0.0
3069,1,0.0
5141,1,0.0
GAN,1,0.0
PDB,1,0.0
Cardioaortic,1,0.0
15-11,1,0.0
One-quarter,1,0.0
US-Mexican,1,0.0
pre-screening,1,0.0
wanes,1,0.0
Fluctuations,1,0.0
Reusable,1,0.0
Interoperable,1,0.0
Accessible,1,0.0
Findable,1,0.0
FAIR,1,0.0
visualisations,1,0.0
httpswwwcovid19dataportalorg,1,0.0
antiepidemic,1,0.0
apidemiological,1,0.0
roubles,1,0.0
1979--1980,1,0.0
chemoreceptor,1,0.0
Salmeterol,1,0.0
small-molecular,1,0.0
MRI-in,1,0.0
imaging-transthoracic,1,0.0
redefined,1,0.0
Morgantown,1,0.0
Palmeri,1,0.0
mediums,1,0.0
etiopathogeny,1,0.0
Rabdomyolysis,1,0.0
fibrillations,1,0.0
time-limited,1,0.0
antibody-antigen,1,0.0
psycho-socioeconomic,1,0.0
embedding,1,0.0
diesel-related,1,0.0
Marginalized,1,0.0
segregated,1,0.0
low-SES,1,0.0
beta-Blocker,1,0.0
nonwhite,1,0.0
ASLRPL,1,0.0
nisoldipine,1,0.0
PGP,1,0.0
girdle,1,0.0
better-understand,1,0.0
automic,1,0.0
aborting,1,0.0
15-127,1,0.0
15-27,1,0.0
adage,1,0.0
forgotten,1,0.0
broncholithiasis,1,0.0
2x75,1,0.0
closed-loop,1,0.0
sorted,1,0.0
non-nucleic,1,0.0
PKUPH,1,0.0
Peking,1,0.0
ribavirin-treated,1,0.0
recoverable,1,0.0
disguised,1,0.0
1-beta-D-Ribofuranosyl-124-triazole-3-carboxamide,1,0.0
radiogram,1,0.0
nihilist,1,0.0
1-mm,1,0.0
8040,1,0.0
three-day,1,0.0
jjfoxupmcedu,1,0.0
ethiopathogeny,1,0.0
intrarterial,1,0.0
mainstone,1,0.0
protocolised,1,0.0
EMEA,1,0.0
semistructured,1,0.0
indigent,1,0.0
40-year,1,0.0
incline,1,0.0
pandemic-like,1,0.0
venous-based,1,0.0
shunts,1,0.0
Palestinians,1,0.0
Palestinian,1,0.0
coatings,1,0.0
virus-deactivating,1,0.0
transformative,1,0.0
engineers,1,0.0
620-113,1,0.0
Tc-99,1,0.0
angiocardioscintigraphy,1,0.0
angor,1,0.0
TDaP,1,0.0
Pertussis,1,0.0
acellular,1,0.0
Diphtheria,1,0.0
7448,1,0.0
9263,1,0.0
386-421min,1,0.0
macrophagemicroglial,1,0.0
anti-IL-5,1,0.0
TSLP,1,0.0
anti-cytokine,1,0.0
COVID-infected,1,0.0
Infu,1,0.0
20012002,1,0.0
Tested,1,0.0
Trauma-associated,1,0.0
hockey,1,0.0
chest-first,1,0.0
dermatology,1,0.0
gripped,1,0.0
anosmiadysgeusia,1,0.0
3985,1,0.0
40-fold,1,0.0
atrophic,1,0.0
men-with,1,0.0
po,1,0.0
in-Soult,1,0.0
0-30,1,0.0
Anastomotic,1,0.0
Baru,1,0.0
Badak,1,0.0
reimbursing,1,0.0
dwk,1,0.0
mmin,1,0.0
supine-standing-supine,1,0.0
100-day-old,1,0.0
carinatum,1,0.0
pectum,1,0.0
dysplastic,1,0.0
ptosis,1,0.0
microcephaly,1,0.0
consanguineous,1,0.0
Lebanese,1,0.0
CG,1,0.0
anthropometrics,1,0.0
fulfils,1,0.0
ventriculoatrial,1,0.0
bifida,1,0.0
spina,1,0.0
smokeABSTRACT,1,0.0
interplays,1,0.0
psycho-behavioural,1,0.0
first-trimester,1,0.0
015-05,1,0.0
005-015,1,0.0
VLF,1,0.0
002-05,1,0.0
arched,1,0.0
tubulointerstitial,1,0.0
hemi-arches,1,0.0
albumincreatinine,1,0.0
ACST-1,1,0.0
Trial-1,1,0.0
0·039,1,0.0
2·3,1,0.0
0·019,1,0.0
3·1,1,0.0
Visiting,1,0.0
53·5,1,0.0
82·1,1,0.0
expressivity,1,0.0
C7,1,0.0
dysmorphic,1,0.0
exons,1,0.0
PTPN11,1,0.0
mgmg,1,0.0
peg,1,0.0
odontoid,1,0.0
lippalate,1,0.0
sister,1,0.0
sagittal-cleft,1,0.0
01-09,1,0.0
waist-to-hip,1,0.0
Preexisting,1,0.0
avian-human,1,0.0
Extension,1,0.0
neuroscientific,1,0.0
exercise-test,1,0.0
bronchoprovocations,1,0.0
corner,1,0.0
isotopic,1,0.0
bi-dimensional,1,0.0
gamma-angiography,1,0.0
faculty,1,0.0
affairs,1,0.0
multimedia,1,0.0
75000,1,0.0
Tomographic,1,0.0
Anderson-Wilkins,1,0.0
ninety-five,1,0.0
corpses,1,0.0
pmMRI,1,0.0
encompassed,1,0.0
subcategorization,1,0.0
equivalences,1,0.0
numbering,1,0.0
non-Stroke,1,0.0
readying,1,0.0
002-04,1,0.0
virtuous,1,0.0
mCIMT,1,0.0
constraint-induced,1,0.0
qRT-PCR-based,1,0.0
sometime,1,0.0
20-1152,1,0.0
12-128,1,0.0
turkey,1,0.0
H11,1,0.0
H8,1,0.0
co-infective,1,0.0
flavus,1,0.0
Co-pathogens,1,0.0
non-survivors,1,0.0
P0005,1,0.0
7980,1,0.0
115123,1,0.0
7589,1,0.0
imaging--DWI,1,0.0
imaging--MRI,1,0.0
behaviours-that,1,0.0
conditions-multilevel,1,0.0
Nobusawa,1,0.0
0033,1,0.0
Wolverhampton,1,0.0
mv,1,0.0
first-generation,1,0.0
once-daily,1,0.0
prebronchodilator,1,0.0
midexpiratory,1,0.0
4400,1,0.0
19535,1,0.0
-098,1,0.0
18922,1,0.0
false-negatives,1,0.0
false-positives,1,0.0
medicationsamantadine,1,0.0
spirals,1,0.0
Zimbabweans,1,0.0
Coloured,1,0.0
Parirenyatwa,1,0.0
3-hour,1,0.0
Etiological,1,0.0
1--4,1,0.0
or99,1,0.0
concentration-into,1,0.0
72327,1,0.0
skin-blister,1,0.0
inoculation-with,1,0.0
heat-inactivation,1,0.0
paints,1,0.0
Kathmandu,1,0.0
Bir,1,0.0
Maharajgunj,1,0.0
TU,1,0.0
ICUCCU,1,0.0
Does,1,0.0
Interactions,1,0.0
industrializing,1,0.0
Computer,1,0.0
Isocyanates,1,0.0
ethnographic,1,0.0
bakerss,1,0.0
--however,1,0.0
--some,1,0.0
EBP,1,0.0
RP-control,1,0.0
clerks,1,0.0
replaces,1,0.0
extractionpurification,1,0.0
Tijuana,1,0.0
precipitous,1,0.0
THERAPEUTIC,1,0.0
ROLE,1,0.0
675,1,0.0
06389,1,0.0
-02876,1,0.0
05331,1,0.0
-003757,1,0.0
614G,1,0.0
4715L,1,0.0
ORF1abRdRp,1,0.0
hoarse,1,0.0
confinements,1,0.0
09207,1,0.0
uta,1,0.0
00186,1,0.0
04822,1,0.0
Endogenic,1,0.0
Epithelium,1,0.0
Compounds,1,0.0
Epithelial,1,0.0
Structure,1,0.0
491-567,1,0.0
14917,1,0.0
85593,1,0.0
0997,1,0.0
regional-specific,1,0.0
2775,1,0.0
carency,1,0.0
unconditional,1,0.0
excretions,1,0.0
radio-allergo-sorbent-test,1,0.0
Overt,1,0.0
allergen-sensitive,1,0.0
detrimentally,1,0.0
actine,1,0.0
alpha-smooth,1,0.0
Log,1,0.0
14-months,1,0.0
0-12,1,0.0
low-volume,1,0.0
Diuretics,1,0.0
Symptom-limited,1,0.0
rekindled,1,0.0
dysrhythmias,1,0.0
Ischemia-related,1,0.0
CKMB,1,0.0
Beneficial,1,0.0
25-36,1,0.0
601-735,1,0.0
10-June,1,0.0
ULTRASOUND,1,0.0
11581,1,0.0
Tasmanian,1,0.0
rerouting,1,0.0
venosus-type,1,0.0
NASH,1,0.0
steatohepatitis,1,0.0
high-degree,1,0.0
WMF,1,0.0
Bradycardia,1,0.0
alpha-hydroxybutyrate,1,0.0
5110,1,0.0
17462,1,0.0
reassortation,1,0.0
Genetical,1,0.0
pathogenesistransmission,1,0.0
Coincidence,1,0.0
envenomed,1,0.0
6-24h,1,0.0
Augmentation,1,0.0
SONOTHROMBOLYSIS,1,0.0
MECHANISM,1,0.0
POTENTIAL,1,0.0
aerodigestive,1,0.0
650000,1,0.0
WHO-defined,1,0.0
Weekly,1,0.0
33160,1,0.0
700-788,1,0.0
3862,1,0.0
17407,1,0.0
21-August,1,0.0
predominated¶,1,0.0
1-May,1,0.0
NHSN§,1,0.0
CMS-certified,1,0.0
variant†,1,0.0
west-to-east,1,0.0
Terminal,1,0.0
Pre-stroke,1,0.0
suddenness,1,0.0
OTC,1,0.0
between-countries,1,0.0
WHO-developed,1,0.0
extra-European,1,0.0
bordering,1,0.0
south-to-north,1,0.0
mofetil,1,0.0
nontriaged,1,0.0
UC,1,0.0
age-oriented,1,0.0
myocardiun,1,0.0
mealtime,1,0.0
Predicted,1,0.0
Observer,1,0.0
129Cs,1,0.0
sodium--as,1,0.0
therapy--inhaled,1,0.0
inconvenience,1,0.0
regenerate,1,0.0
doesnt,1,0.0
collapsibility,1,0.0
air-trapping,1,0.0
enjoyment,1,0.0
PPMS,1,0.0
RRMS,1,0.0
Ocrelizumab,1,0.0
890-1000,1,0.0
Vaxigrip,1,0.0
transportrequirement,1,0.0
torr,1,0.0
hemoglobin-oxygen,1,0.0
suffice,1,0.0
Backgrounds,1,0.0
1-1-2005,1,0.0
salivation,1,0.0
7-month,1,0.0
PTFE-covered,1,0.0
c-ACT,1,0.0
Campaigns,1,0.0
Virologic,1,0.0
anti-atherosclerotic,1,0.0
hypertriglyceridemia,1,0.0
biomechanics,1,0.0
t-PAPAI-1,1,0.0
prothromboticantifibrinolytic,1,0.0
Disclosure,1,0.0
JH,1,0.0
cross-disciplinary,1,0.0
embrace,1,0.0
capitalize,1,0.0
yearsExpert,1,0.0
solutionsAreas,1,0.0
actionable,1,0.0
hypotheses-generating,1,0.0
Big,1,0.0
Immunotyping,1,0.0
pharyngolaryngeal,1,0.0
thoracolithiasis,1,0.0
-80°C,1,0.0
ROCHE,1,0.0
Seroprotection,1,0.0
Choice,1,0.0
AH1AH3B,1,0.0
modernize,1,0.0
maxingshigan-yinqiaosan,1,0.0
7895,1,0.0
Pattern-based,1,0.0
gum,1,0.0
rEDV,1,0.0
NHIS,1,0.0
DHCPs,1,0.0
Aerosol-generating,1,0.0
58189,1,0.0
UIl,1,0.0
410,1,0.0
24275,1,0.0
131-257,1,0.0
137-277,1,0.0
81245,1,0.0
108226,1,0.0
189471,1,0.0
tranquillisers,1,0.0
benzo-diazepines,1,0.0
antiaggregants,1,0.0
non-exercise,1,0.0
ABBOTT,1,0.0
deglutition,1,0.0
GENERIC,1,0.0
asynchronism,1,0.0
Pretransplant,1,0.0
CTP-based,1,0.0
MA-SM,1,0.0
pAMPK,1,0.0
peNOS,1,0.0
stroked,1,0.0
UV-inactivated,1,0.0
L-NIO,1,0.0
p-T172-AMPK,1,0.0
AMPK,1,0.0
p-S1177-eNOS,1,0.0
Exercised,1,0.0
minday,1,0.0
HIIT,1,0.0
eNOS-induced,1,0.0
5×105,1,0.0
fibrillationABSTRACT,1,0.0
Wnt,1,0.0
LiCl,1,0.0
EIPs,1,0.0
colloquially,1,0.0
short-time,1,0.0
SAITR,1,0.0
20082009,1,0.0
20072008,1,0.0
AStockholm182011H3N2,1,0.0
nonrandomized,1,0.0
allocates,1,0.0
Subperiod,1,0.0
433-519,1,0.0
527-608,1,0.0
1-July,1,0.0
Montana,1,0.0
stroke-injured,1,0.0
ascribable,1,0.0
1983-1984,1,0.0
winterly,1,0.0
520,1,0.0
substrate-binding,1,0.0
months-17,1,0.0
noninstitutionalized,1,0.0
Quantum,1,0.0
2-6-a,1,0.0
QPLD,1,0.0
effect-represented,1,0.0
32867,1,0.0
gynecologic,1,0.0
Becks,1,0.0
Mitford,1,0.0
Barisal,1,0.0
centers--one,1,0.0
lesionbehavioural,1,0.0
segments-as,1,0.0
connecting,1,0.0
presenter,1,0.0
XP,1,0.0
Hochberg-Holm,1,0.0
ADP-ribose-1,1,0.0
ZINC,1,0.0
Prespecifying,1,0.0
pre-specification,1,0.0
formalizing,1,0.0
SWIFT-PRIME,1,0.0
Illustrative,1,0.0
favoring,1,0.0
random-digit-dialed,1,0.0
36000,1,0.0
optimizes,1,0.0
acceptor,1,0.0
stabilogram,1,0.0
stabilometric,1,0.0
Isiskate,1,0.0
omnidirectional,1,0.0
01-05,1,0.0
medial-lateral,1,0.0
Post-CVA,1,0.0
Thammasat,1,0.0
ever-expanding,1,0.0
infarction-remains,1,0.0
VISTA,1,0.0
proof-of-principle,1,0.0
costliness,1,0.0
insecticide,1,0.0
cholinesterase,1,0.0
organophosphorous,1,0.0
656,1,0.0
Wnt1,1,0.0
Wnt1gene,1,0.0
SkM,1,0.0
myoblast,1,0.0
PCA-related,1,0.0
four-part,1,0.0
Unlabelled,1,0.0
Affect,1,0.0
5827,1,0.0
9868,1,0.0
9987,1,0.0
PANS,1,0.0
1171,1,0.0
1219,1,0.0
2774,1,0.0
2081,1,0.0
2661,1,0.0
self-evaluation,1,0.0
74-87,1,0.0
well-adopt,1,0.0
AAFP,1,0.0
semiclosed,1,0.0
aestheticians,1,0.0
instructors,1,0.0
Hospitality,1,0.0
1-dose,1,0.0
87-97,1,0.0
≥7,1,0.0
12-31-2014,1,0.0
151-293,1,0.0
positivenegative,1,0.0
FWI,1,0.0
DIF,1,0.0
akin,1,0.0
precariousness,1,0.0
year’s,1,0.0
Immunohistochemical,1,0.0
metastasis,1,0.0
glomangiosarcomas,1,0.0
pleomorphism,1,0.0
nucleoli,1,0.0
inconspicuous,1,0.0
homogenous,1,0.0
Histologically,1,0.0
Anatomically,1,0.0
hemoptysis,1,0.0
≈4,1,0.0
handrails,1,0.0
sickbed,1,0.0
cans,1,0.0
trash,1,0.0
environmentallifestyle,1,0.0
urbanicity,1,0.0
Indies,1,0.0
overland,1,0.0
DREP-Secto,1,0.0
stuffy,1,0.0
Cacajao,1,0.0
Saint-Hilaire,1,0.0
Geoffroy,1,0.0
É,1,0.0
Pithecia,1,0.0
pitheciid,1,0.0
free-living,1,0.0
vasoconstrictory,1,0.0
Muller,1,0.0
Diagne,1,0.0
Bain,1,0.0
1929,1,0.0
Faust,1,0.0
Mansonella,1,0.0
1861,1,0.0
Diesing,1,0.0
Leiper,1,0.0
breast-feeding,1,0.0
rooming-in,1,0.0
12-63,1,0.0
13-37,1,0.0
rural-town-city,1,0.0
gaselectricity,1,0.0
cooking,1,0.0
179-435,1,0.0
cortico-hypothalamic,1,0.0
uncrossed,1,0.0
lenticulostriate,1,0.0
Pediatric-specific,1,0.0
Donor,1,0.0
Prospects,1,0.0
sensitivespecific,1,0.0
nanoscopic,1,0.0
versatility,1,0.0
nanobiotechnology,1,0.0
Absent,1,0.0
mycophenolate,1,0.0
nodosome-targeting,1,0.0
RIPK2,1,0.0
serinethreonine,1,0.0
receptor-interacting,1,0.0
alphaviruses,1,0.0
flaviviruses,1,0.0
oligomerization,1,0.0
nucleotide-binding,1,0.0
orientations,1,0.0
oculosympathetic,1,0.0
thrombolytic-treated,1,0.0
50000000,1,0.0
salt-loaded,1,0.0
160-292,1,0.0
138-248,1,0.0
171-316,1,0.0
1115,1,0.0
555,1,0.0
conurbation,1,0.0
spectrographic,1,0.0
Stroke-prone,1,0.0
translatable,1,0.0
microsyringe,1,0.0
1250000,1,0.0
transarterial,1,0.0
Lyte-A,1,0.0
mid-LAD,1,0.0
Multipotent,1,0.0
patientprovider,1,0.0
immunosuppressant,1,0.0
health-systems,1,0.0
Enzymes,1,0.0
syndrome-CoV,1,0.0
calvus,1,0.0
ucayalii,1,0.0
Pitheciidae,1,0.0
clarithromycin,1,0.0
Confocal,1,0.0
coimmunoprecipitation,1,0.0
two-hybrid,1,0.0
protein-heat,1,0.0
popularly,1,0.0
separable,1,0.0
time-domain,1,0.0
nonstationary,1,0.0
Wigner,1,0.0
Time-frequency,1,0.0
728013,1,0.0
19718030,1,0.0
aglobal,1,0.0
anovel,1,0.0
Wadsworth,1,0.0
-h,1,0.0
NeuMoDx,1,0.0
NeuMoDx™,1,0.0
Mitigation,1,0.0
1995-2005,1,0.0
J11,1,0.0
colocalized,1,0.0
triphosphatase,1,0.0
17-N-allylamino-17-demethoxygeldanamycin,1,0.0
pre-administered,1,0.0
DREP-S,1,0.0
104-293,1,0.0
self-replicating,1,0.0
DNA-launched,1,0.0
alphavirus-based,1,0.0
043-092,1,0.0
048-097,1,0.0
cfu,1,0.0
1x1011,1,0.0
867-66,1,0.0
17AAG,1,0.0
BADGE,1,0.0
ether,1,0.0
diglycidyl,1,0.0
bisphenol,1,0.0
Isoprenaline,1,0.0
isoprenaline-induced,1,0.0
Infarct-like,1,0.0
NA-Hsp90,1,0.0
client,1,0.0
J10,1,0.0
stain,1,0.0
Yavari-Mirin,1,0.0
Bangkokian,1,0.0
surmise,1,0.0
79-87,1,0.0
557-637,1,0.0
357-393,1,0.0
R2375,1,0.0
145-153,1,0.0
R1149,1,0.0
agrees,1,0.0
identifiability,1,0.0
Canton,1,0.0
narrowly,1,0.0
1980-83,1,0.0
1970-73,1,0.0
Stay-at-Home,1,0.0
25-37,1,0.0
2953,1,0.0
COVID-like,1,0.0
Indianapolis,1,0.0
iNfection,1,0.0
CORonavirus,1,0.0
Morphometric,1,0.0
guarantees,1,0.0
Hyperactivity,1,0.0
coevolution,1,0.0
mPEG-b-PCL,1,0.0
Calculated,1,0.0
S-CK,1,0.0
psychodiagnostic,1,0.0
91-97,1,0.0
92-94,1,0.0
polymersomes,1,0.0
Coomassie,1,0.0
copolymers,1,0.0
diblock,1,0.0
glycol-b-polycaprolactone,1,0.0
subforms,1,0.0
methoxy,1,0.0
Polymersomes,1,0.0
sulfate-polyacrylamide,1,0.0
dodecyl,1,0.0
nanoparticles-based,1,0.0
serums,1,0.0
polymersome,1,0.0
dye-loaded,1,0.0
hyperactive,1,0.0
361538,1,0.0
Non-Hispanic,1,0.0
25-29,1,0.0
43·1,1,0.0
bronchomotor,1,0.0
holder,1,0.0
cross-check,1,0.0
Saxonians,1,0.0
insured,1,0.0
anonymisation,1,0.0
cross-checking,1,0.0
seven-fold,1,0.0
Contract,1,0.0
union,1,0.0
Saxonian,1,0.0
off-work,1,0.0
fungal-sensitized,1,0.0
techniques-rhinomanometry,1,0.0
13-20,1,0.0
1-17,1,0.0
8-20,1,0.0
≤8,1,0.0
Postintervention,1,0.0
interpreters,1,0.0
confoundingmimicking,1,0.0
unmasking,1,0.0
-26·8-74·5,1,0.0
ObstetricsMaternal,1,0.0
sublineage,1,0.0
Judkins,1,0.0
Sones,1,0.0
promptness,1,0.0
726,1,0.0
4388,1,0.0
supervise,1,0.0
autologic,1,0.0
treats,1,0.0
Methacholine,1,0.0
Litres,1,0.0
kul,1,0.0
0-180,1,0.0
KuL,1,0.0
wheezer,1,0.0
Prospectively,1,0.0
Birth,1,0.0
Wight,1,0.0
Isle,1,0.0
supranormal,1,0.0
3C1,1,0.0
3C3,1,0.0
inquires,1,0.0
nonemergency,1,0.0
4-step,1,0.0
article--a,1,0.0
307750,1,0.0
30₊6-40,1,0.0
Rohani,1,0.0
Ayatollah,1,0.0
multi-parameter,1,0.0
home-monitoring,1,0.0
1553,1,0.0
Susceptible-Exposed-Infectious-Recovered,1,0.0
Guillain-Barre,1,0.0
Underrecognized,1,0.0
keen,1,0.0
postbronchodilator,1,0.0
surfing,1,0.0
Usefulness,1,0.0
re-occurring,1,0.0
chloride-based,1,0.0
monoazide,1,0.0
discerned,1,0.0
PolyPHb,1,0.0
polymerized,1,0.0
Manizales,1,0.0
69764,1,0.0
1720-3900,1,0.0
≥9,1,0.0
describedThirty-three,1,0.0
developed--and,1,0.0
interpreter,1,0.0
novice,1,0.0
collapses,1,0.0
125The,1,0.0
Pure,1,0.0
interlobular,1,0.0
836,1,0.0
collectedThe,1,0.0
chain-reaction,1,0.0
targethome,1,0.0
reverse-transcription-polymerase,1,0.0
BCT,1,0.0
Dysfunctional,1,0.0
2013-14,1,0.0
BYamagata-lineage,1,0.0
sixteenth,1,0.0
13312,1,0.0
type-,1,0.0
megapascal,1,0.0
197374,1,0.0
197477,1,0.0
period-prevalence,1,0.0
app,1,0.0
JSSRS,1,0.0
suprainfected,1,0.0
postuberculosis,1,0.0
hyperergy,1,0.0
bronchic,1,0.0
Missouri,1,0.0
Portland,1,0.0
constitutional-familial,1,0.0
rejecting,1,0.0
grandfathers,1,0.0
grandmothers,1,0.0
OAS-like,1,0.0
transporting,1,0.0
cardiosurgery,1,0.0
66-year-old,1,0.0
DcoVA,1,0.0
arrests,1,0.0
hypercapnic,1,0.0
broncho-obstructive,1,0.0
factor-1,1,0.0
182359,1,0.0
radioangiography,1,0.0
radioangiographically,1,0.0
Anatomic,1,0.0
draw-backs,1,0.0
DAPT,1,0.0
TAPT,1,0.0
sarpogrelate-based,1,0.0
5-hydroxytryptamine,1,0.0
wholeness,1,0.0
body-mind-spirit,1,0.0
flooded,1,0.0
reticent,1,0.0
contradiction,1,0.0
encumbered,1,0.0
incoherence,1,0.0
non-Asians,1,0.0
ether-treated,1,0.0
Ether,1,0.0
Guideline-based,1,0.0
Hypnotic,1,0.0
SMAD,1,0.0
TGF-b1,1,0.0
Transforming,1,0.0
changeable,1,0.0
2622571,1,0.0
onlinemobile,1,0.0
retrospect,1,0.0
pointers,1,0.0
midazolam,1,0.0
benzodiazepines,1,0.0
Unsolved,1,0.0
rehabilitate,1,0.0
invalidism,1,0.0
qualification,1,0.0
step-by-step,1,0.0
ABAO,1,0.0
hemocorrection,1,0.0
pathogenetically,1,0.0
Algeria,1,0.0
Blida,1,0.0
gamma-deficient,1,0.0
ovalbumin-induced,1,0.0
cullers,1,0.0
3-kinases,1,0.0
Phosphoinositide,1,0.0
wide-spectrum,1,0.0
himself,1,0.0
712,1,0.0
1249,1,0.0
gamma-aminobutyric,1,0.0
acidA,1,0.0
GABAA,1,0.0
transmission-preventing,1,0.0
super-spreader,1,0.0
real-or,1,0.0
toughest,1,0.0
expensive--financially,1,0.0
cogent,1,0.0
neuro-immune,1,0.0
Scanty,1,0.0
WQ,1,0.0
non-familial,1,0.0
young-,1,0.0
mis-diagnosed,1,0.0
84-year,1,0.0
65-,1,0.0
198-225,1,0.0
263-301,1,0.0
163-185,1,0.0
215-242,1,0.0
9733,1,0.0
Out-of-hospital,1,0.0
≥20,1,0.0
Fetal,1,0.0
manic,1,0.0
hyperglycosylation,1,0.0
between-group,1,0.0
PEIPKGRG,1,0.0
goal-setting,1,0.0
R292K,1,0.0
multibehavioral,1,0.0
diphtheria-tetanus-pertussis,1,0.0
dermatological,1,0.0
arised,1,0.0
SARS-Cov2,1,0.0
Nonessential,1,0.0
backup,1,0.0
HLA-haplotype-matched,1,0.0
shipped,1,0.0
cryopreserved,1,0.0
HLA-matched,1,0.0
Precardiac,1,0.0
dual-receptor,1,0.0
galvanization,1,0.0
transcardiac,1,0.0
pyrexia,1,0.0
hydration,1,0.0
immunogenetic,1,0.0
Between-groups,1,0.0
Juniper,1,0.0
surviellance,1,0.0
AQLQ-J,1,0.0
PHM,1,0.0
SS-QOL,1,0.0
questionary,1,0.0
CEACAM6,1,0.0
Carcinoembryonic,1,0.0
pre-incubated,1,0.0
non-IAV,1,0.0
DC-SIGN,1,0.0
Rasch,1,0.0
continous,1,0.0
tedious,1,0.0
Diffusion-tensor,1,0.0
winter--spring,1,0.0
Moldavia,1,0.0
athma-specific,1,0.0
reassured,1,0.0
less-sensitive,1,0.0
Kunming,1,0.0
precious,1,0.0
mainline,1,0.0
targetting,1,0.0
herding,1,0.0
organssystems,1,0.0
hyper-inflammatory,1,0.0
571000,1,0.0
pneumopericardium,1,0.0
reoperated,1,0.0
Forum,1,0.0
Neuro,1,0.0
DFA,1,0.0
14114,1,0.0
5-week,1,0.0
6090,1,0.0
juxtaposed,1,0.0
infarction--most,1,0.0
coexisted,1,0.0
35-86,1,0.0
2514,1,0.0
excercised,1,0.0
Times,1,0.0
sphingolipidosis,1,0.0
embolize,1,0.0
Fabrys,1,0.0
overstrain,1,0.0
rheoplethysmography,1,0.0
phono-,1,0.0
Center-based,1,0.0
1s,1,0.0
Fundamentals-Revised,1,0.0
Swallowing,1,0.0
phones,1,0.0
Self-report,1,0.0
pET-28,1,0.0
CTxB,1,0.0
B-subunit,1,0.0
linkers,1,0.0
fused,1,0.0
multi-epitope,1,0.0
septa,1,0.0
qd,1,0.0
Receptive,1,0.0
q12,1,0.0
caseswhite,1,0.0
illdead,1,0.0
yearsranging,1,0.0
Taizhou,1,0.0
SAM,1,0.0
first-wave,1,0.0
Immunosuppression,1,0.0
Expressive,1,0.0
Triggers,1,0.0
migraines,1,0.0
herbarum,1,0.0
malabsorption,1,0.0
coach,1,0.0
operationABSTRACT,1,0.0
39-55,1,0.0
objections,1,0.0
sized,1,0.0
Debates,1,0.0
over-reperfusion,1,0.0
unaccompanied,1,0.0
Likert-graded,1,0.0
HRQOLISP,1,0.0
Ibadan,1,0.0
Nigerian,1,0.0
prices,1,0.0
64€,1,0.0
103€,1,0.0
Clínic,1,0.0
like-illness,1,0.0
Brno,1,0.0
Cognition,1,0.0
vascular-cognitive,1,0.0
misunderstanding,1,0.0
inhaler-specific,1,0.0
One-on-one,1,0.0
forget,1,0.0
146-480,1,0.0
pre-empt,1,0.0
Non,1,0.0
aerosol--together,1,0.0
orciprenaline,1,0.0
reactivity--defined,1,0.0
outcompete,1,0.0
0-758,1,0.0
303-653,1,0.0
426-858,1,0.0
323-546,1,0.0
elapses,1,0.0
under-ascertainment,1,0.0
model-inference,1,0.0
packs,1,0.0
lighter,1,0.0
956,1,0.0
132-415,1,0.0
142-439,1,0.0
107-361,1,0.0
pm-0600,1,0.0
crossmatch-compatible,1,0.0
62-year,1,0.0
Horner,1,0.0
Resveratrol,1,0.0
V2-4,1,0.0
workshift,1,0.0
motor-tracking,1,0.0
nonwork-related,1,0.0
endows,1,0.0
App,1,0.0
computing,1,0.0
server,1,0.0
cloud,1,0.0
fog,1,0.0
Bluetooth,1,0.0
IPTV,1,0.0
hardware,1,0.0
UCNPsmSiO2,1,0.0
up-conversion,1,0.0
mesoporous,1,0.0
5G-enabled,1,0.0
IoT,1,0.0
Continuing,1,0.0
Genome-wide,1,0.0
risk-recognition,1,0.0
laterocervical,1,0.0
interferences,1,0.0
Dissections,1,0.0
trademark,1,0.0
ALI,1,0.0
air-liquid,1,0.0
replenishment,1,0.0
analog,1,0.0
-090,1,0.0
single-shot,1,0.0
single-injection,1,0.0
Cross-clade,1,0.0
CSL,1,0.0
ISCOMATRIX,1,0.0
theory-a,1,0.0
AVietnam11942004,1,0.0
inoculations,1,0.0
Examined,1,0.0
asthmawheezing,1,0.0
Heredity,1,0.0
thalictroides,1,0.0
Caulophyllum,1,0.0
indecisive,1,0.0
Ordinary,1,0.0
unshielded,1,0.0
Aas,1,0.0
AsianPacific,1,0.0
airspace,1,0.0
mismatching,1,0.0
diffusion-perfusion,1,0.0
MHC-I,1,0.0
non-farm,1,0.0
9542,1,0.0
Gambela,1,0.0
9704,1,0.0
Tigray,1,0.0
9754,1,0.0
Oromia,1,0.0
9930,1,0.0
SNNPR,1,0.0
Nationalities,1,0.0
receiveCOVID-19,1,0.0
9233,1,0.0
2178,1,0.0
Phone,1,0.0
Post-vaccination,1,0.0
dermatologic,1,0.0
over-activation,1,0.0
lobbying,1,0.0
inhaledexhaled,1,0.0
influenza-containing,1,0.0
2793398,1,0.0
environment-virus-host,1,0.0
supercontactors,1,0.0
1185-9683,1,0.0
3387,1,0.0
1486-9697,1,0.0
OR3797,1,0.0
SBP-the,1,0.0
1271-21595,1,0.0
OR5239,1,0.0
drop-low,1,0.0
ENI,1,0.0
0219-0727,1,0.0
0399,1,0.0
0219-0919,1,0.0
0448,1,0.0
drop-high,1,0.0
1008-7467,1,0.0
population-mixing,1,0.0
droplet-induced,1,0.0
µm,1,0.0
0·3-0·4,1,0.0
size-specific,1,0.0
Denmarks,1,0.0
lobby,1,0.0
lieu,1,0.0
role-models,1,0.0
Interfering,1,0.0
Approaches,1,0.0
BHonk,1,0.0
0-,1,0.0
Participating,1,0.0
HIA,1,0.0
Inhibiting,1,0.0
co‐detected,1,0.0
MERS‐CoV,1,0.0
SARS‐CoV‐1,1,0.0
HCoV‐HKU1,1,0.0
HCoV‐NL63,1,0.0
HCoV‐OC43,1,0.0
HCoV‐229E,1,0.0
‐2,1,0.0
Ca-antagonist,1,0.0
antiaggregation,1,0.0
Cigarettes,1,0.0
1181,1,0.0
10-9,1,0.0
FBS,1,0.0
super-potent,1,0.0
γ1,1,0.0
tetramerization,1,0.0
multispace,1,0.0
house-to-house,1,0.0
role-modeling,1,0.0
welcomes,1,0.0
MHC-II,1,0.0
resolutions,1,0.0
Epsilon,1,0.0
Eta,1,0.0
Delta-plus,1,0.0
fascicle,1,0.0
Balbc,1,0.0
p53,1,0.0
3175,1,0.0
Sustained-release,1,0.0
Adolescence,1,0.0
in-comparison,1,0.0
multimeric,1,0.0
tetrameric,1,0.0
out-performs,1,0.0
equip,1,0.0
Quad,1,0.0
Relations,1,0.0
Assessments,1,0.0
panic-fear,1,0.0
ministry,1,0.0
5944-1303,1,0.0
Extracranial,1,0.0
Virchows,1,0.0
longings,1,0.0
authoritarian,1,0.0
neoliberal,1,0.0
MNC,1,0.0
Autologous,1,0.0
lacrimal,1,0.0
rinsing,1,0.0
nasolacrimal,1,0.0
extraocular,1,0.0
LQSYGFQPT,1,0.0
single-breath,1,0.0
IRGDEVRQIAPGQTGKIADYNYKLPD,1,0.0
Manchester,1,0.0
Doubts,1,0.0
lab-modified,1,0.0
Ags,1,0.0
N-specific,1,0.0
FSQILPDPSKPSKRS,1,0.0
6838-1769,1,0.0
fluorocein,1,0.0
Procurement,1,0.0
METHODS-DESIGN,1,0.0
Neurosonological,1,0.0
ECG-Holter,1,0.0
transthoracal,1,0.0
haemoglobine,1,0.0
glycated,1,0.0
non-acute,1,0.0
creatinekinase,1,0.0
pro-atrial,1,0.0
NT,1,0.0
embalmed,1,0.0
NOK,1,0.0
QTGKIADYNYK,1,0.0
synchronization,1,0.0
TEIYQASTPCNGVEG,1,0.0
grating,1,0.0
supraconducting,1,0.0
imager,1,0.0
CGR,1,0.0
slippage,1,0.0
non-collagenous,1,0.0
runes,1,0.0
re-engineering,1,0.0
Moderates,1,0.0
landed,1,0.0
lipocalin-2,1,0.0
impermeability,1,0.0
misclassified,1,0.0
misassignment,1,0.0
coronavirus-NL63,1,0.0
three-step,1,0.0
headspace,1,0.0
decelerate,1,0.0
20-659,1,0.0
16-416,1,0.0
10-194,1,0.0
15-195,1,0.0
12-79,1,0.0
17-107,1,0.0
26-161,1,0.0
Interaction,1,0.0
Square,1,0.0
CHi,1,0.0
post-reperfusion,1,0.0
minimization,1,0.0
rehospitalized,1,0.0
C-C-motif,1,0.0
pro-epidermal,1,0.0
trefoil,1,0.0
serine-type,1,0.0
asylum-seekers,1,0.0
refugees,1,0.0
34154,1,0.0
rapport,1,0.0
propensity-score,1,0.0
910,1,0.0
23517,1,0.0
PFAMQMAYRFNG,1,0.0
Guanajuato,1,0.0
haemoglobinopathy,1,0.0
retinol-binding,1,0.0
haemoglobinopathies,1,0.0
Chemotherapy,1,0.0
3215,1,0.0
BAME,1,0.0
Ethnic,1,0.0
withhold,1,0.0
chitinase-3-like,1,0.0
interleukin-8,1,0.0
C-X-C,1,0.0
surface-to-volume,1,0.0
2214,1,0.0
AVictoria375-like,1,0.0
senegalese,1,0.0
evoking,1,0.0
proportionnal,1,0.0
flacid,1,0.0
S-beta0,1,0.0
thalassemia,1,0.0
rechecked,1,0.0
Royer,1,0.0
Albert,1,0.0
encephalic,1,0.0
bactérial,1,0.0
Gugging,1,0.0
Landesnervenklinik,1,0.0
vit-D,1,0.0
Vit-D,1,0.0
defends,1,0.0
IFN-IIFN-III,1,0.0
Pathogens,1,0.0
invests,1,0.0
Hospitalizations,1,0.0
group--366,1,0.0
005--whereas,1,0.0
crebrovascular,1,0.0
oro-esophageal,1,0.0
fixatives,1,0.0
IOE,1,0.0
nine-minute,1,0.0
famous,1,0.0
Sellars,1,0.0
Newcastle,1,0.0
stars,1,0.0
Grove,1,0.0
Byker,1,0.0
teenage-asthma,1,0.0
epidemiosurveillance,1,0.0
HiN2,1,0.0
asia,1,0.0
0486,1,0.0
0106,1,0.0
0052,1,0.0
0344,1,0.0
Non-adherence,1,0.0
CO-VID-19,1,0.0
re-canalization,1,0.0
350000,1,0.0
decotion,1,0.0
Xuanqiaoliyan,1,0.0
therapy--2,1,0.0
eventuality,1,0.0
heading,1,0.0
BYamagata1688-lineage,1,0.0
Multivitamin,1,0.0
methylenetetrahydrofolate,1,0.0
hyperhomocysteinemia,1,0.0
Guardia,1,0.0
Calderon,1,0.0
Rica,1,0.0
bicycle-ergometric,1,0.0
exempted,1,0.0
cross-sectoral,1,0.0
laboratorys,1,0.0
Appraising,1,0.0
Proficiency-testing,1,0.0
Validating,1,0.0
RTs,1,0.0
riding,1,0.0
proficiency-testing,1,0.0
inter-laboratory,1,0.0
hinging,1,0.0
spring-summer,1,0.0
neurraminidase,1,0.0
rationed,1,0.0
etiopathophysiological,1,0.0
mystery,1,0.0
membrane-virus,1,0.0
else,1,0.0
BVictoria287-lineage,1,0.0
BShangdong797,1,0.0
predate,1,0.0
binge-drinking,1,0.0
V1-6,1,0.0
drunk,1,0.0
main-group,1,0.0
19-year-old,1,0.0
reconceptualize,1,0.0
anything,1,0.0
Initiation,1,0.0
dyadic,1,0.0
steered,1,0.0
fusogenic,1,0.0
10-22,1,0.0
checkups,1,0.0
prolines,1,0.0
replica,1,0.0
Spikes,1,0.0
quaternary,1,0.0
pop,1,0.0
karaoke,1,0.0
posters,1,0.0
intra-class,1,0.0
rains,1,0.0
Extreme,1,0.0
Hemophagocytosis,1,0.0
Vessels,1,0.0
HbSS,1,0.0
invoking,1,0.0
Gaussian,1,0.0
evaporating,1,0.0
turbulent,1,0.0
emitted,1,0.0
humidities,1,0.0
qualify,1,0.0
25-27,1,0.0
atria,1,0.0
closes,1,0.0
slit-like,1,0.0
long-debated,1,0.0
Ovale,1,0.0
Foramen,1,0.0
test-retest,1,0.0
Jebsen-Taylor,1,0.0
drought,1,0.0
hurricanes,1,0.0
tornadoes,1,0.0
81404,1,0.0
high-containment,1,0.0
Naul,1,0.0
cyclosporine,1,0.0
nicorandil,1,0.0
rotatablator,1,0.0
cytopenia,1,0.0
vaccine-reported,1,0.0
non-hematologic,1,0.0
CD19-based,1,0.0
2019-nCoVCommunicated,1,0.0
meteorologic,1,0.0
μgL,1,0.0
H-bond,1,0.0
h-bonds,1,0.0
-82,1,0.0
non-homologous,1,0.0
5013-6083,1,0.0
co-crystal,1,0.0
protrude,1,0.0
crown-like,1,0.0
etoposide,1,0.0
aberrantly,1,0.0
T-shirts,1,0.0
psychometrics,1,0.0
Vaccine-related,1,0.0
Transverse,1,0.0
Pregnancy-induced,1,0.0
Capturing,1,0.0
asthmatogens,1,0.0
Amines,1,0.0
isopropyly,1,0.0
well-rounded,1,0.0
IN,1,0.0
70-95,1,0.0
Swedens,1,0.0
Finlands,1,0.0
alprenolol,1,0.0
patients--intention,1,0.0
Snow,1,0.0
1965,1,0.0
opinion-,1,0.0
7-,1,0.0
REVEAL,1,0.0
5–10,1,0.0
quiz,1,0.0
mix-and-match,1,0.0
unrelenting,1,0.0
migraine-like,1,0.0
ANA,1,0.0
Reactants,1,0.0
RF,1,0.0
SS-A,1,0.0
ENA,1,0.0
speckled,1,0.0
15120,1,0.0
1320,1,0.0
1160,1,0.0
title,1,0.0
itchy,1,0.0
Headaches,1,0.0
immuno-stimulation,1,0.0
oedematous,1,0.0
purplish,1,0.0
IgG-IgM,1,0.0
policy-making,1,0.0
Ready,1,0.0
Commissions,1,0.0
18-county,1,0.0
NUTS,1,0.0
electro-,1,0.0
RBD-nanoparticles,1,0.0
washes,1,0.0
spinhaler,1,0.0
Works,1,0.0
Pharmaceuticals,1,0.0
EGIS,1,0.0
Prototypes,1,0.0
ready-to-use,1,0.0
myriads,1,0.0
antigenicepitopic,1,0.0
formats,1,0.0
immunizationimmunotherapy,1,0.0
fieldwork,1,0.0
soon-to-be-available,1,0.0
FABP,1,0.0
IFN-gamma,1,0.0
monokine,1,0.0
10316,1,0.0
Microarray,1,0.0
rhombencephalitis,1,0.0
xerostomic,1,0.0
denture,1,0.0
candidiasis,1,0.0
preallocation,1,0.0
Intal,1,0.0
polyproteins,1,0.0
classifies,1,0.0
RNA-dependent-RNA-polymerase,1,0.0
05-mL,1,0.0
Pregnancy-associated,1,0.0
CRISPRCas‑based,1,0.0
repeatsCas,1,0.0
palindromic,1,0.0
interspaced,1,0.0
RT‑PCR,1,0.0
immunoenzymatic,1,0.0
infectionsepsis,1,0.0
30100000,1,0.0
Reye,1,0.0
Bronchial-,1,0.0
1799,1,0.0
1468,1,0.0
1605,1,0.0
1088,1,0.0
Rosettes,1,0.0
placebos,1,0.0
Ribomunyl,1,0.0
mutation-introduced,1,0.0
low-fidelity,1,0.0
preallocated,1,0.0
phantom,1,0.0
CCHs,1,0.0
resistivity,1,0.0
9192,1,0.0
10198,1,0.0
recede,1,0.0
work-associated,1,0.0
antiapoptosis,1,0.0
PUBMED,1,0.0
SCIENCEDIRECT,1,0.0
3-11,1,0.0
HDAC9,1,0.0
CDKN2AB,1,0.0
Locus,1,0.0
INK4,1,0.0
Non-coding,1,0.0
ANRIL,1,0.0
ZFHX3,1,0.0
PITX2,1,0.0
architecturePrevious,1,0.0
occupation-specific,1,0.0
Poultry,1,0.0
stepping-down,1,0.0
relieverrescue,1,0.0
1267,1,0.0
II-R,1,0.0
FSII-R,1,0.0
non-verbal,1,0.0
dosesml,1,0.0
15-60,1,0.0
dosesmlrange,1,0.0
strategiesWe,1,0.0
isoquinoline,1,0.0
BBR,1,0.0
Berberine,1,0.0
touchscreen,1,0.0
slider,1,0.0
Analog,1,0.0
equips,1,0.0
tablet-based,1,0.0
appraises,1,0.0
language-based,1,0.0
collate,1,0.0
ambitions,1,0.0
financially,1,0.0
market-driven,1,0.0
CFROverall,1,0.0
centre-based,1,0.0
hemagglutinin-inhibiting,1,0.0
7422-572604,1,0.0
phenytoin-treated,1,0.0
bronchoobturation,1,0.0
toxin-insensitive,1,0.0
chlamydia,1,0.0
IgGII,1,0.0
microorganism,1,0.0
phagocyte,1,0.0
resides,1,0.0
lectinophagocytosis,1,0.0
Quant,1,0.0
infliction,1,0.0
self-surveillance,1,0.0
macrophagesmonocytes,1,0.0
lesioning,1,0.0
affirmative,1,0.0
AMI-related,1,0.0
0024-0042,1,0.0
0025-0078,1,0.0
0034,1,0.0
0013-0051,1,0.0
22-75,1,0.0
oral-steroid,1,0.0
1773,1,0.0
particulars,1,0.0
primitive,1,0.0
nonself,1,0.0
8-90,1,0.0
Bla,1,0.0
precondition,1,0.0
oriental,1,0.0
beeswax,1,0.0
jelly,1,0.0
propolis,1,0.0
honeybee,1,0.0
nutraceutical,1,0.0
36-96,1,0.0
ment,1,0.0
undeniable,1,0.0
treat-,1,0.0
floating,1,0.0
1977-1998,1,0.0
Yaoundé,1,0.0
schistosomiasis,1,0.0
co-associations,1,0.0
Darwinian,1,0.0
owed,1,0.0
Musashino,1,0.0
ENFUMOSA,1,0.0
5-lipoxygenase,1,0.0
microgramsmL,1,0.0
biochemical--for,1,0.0
B-,1,0.0
institutionally,1,0.0
venotonic,1,0.0
nootropic,1,0.0
antisclerotic,1,0.0
proserin,1,0.0
galanthamine,1,0.0
dibazol,1,0.0
troxevasin,1,0.0
solkoseryl,1,0.0
cardio-lumbosacral,1,0.0
cardio-intercostal,1,0.0
cardiohumerospinal,1,0.0
radicular,1,0.0
CARPS,1,0.0
5291,1,0.0
Fetuin,1,0.0
483-87114,1,0.0
principals,1,0.0
188369,1,0.0
fronts,1,0.0
immunoresponsiveness,1,0.0
first-ever-in-a-lifetime,1,0.0
Grodno,1,0.0
150-mg,1,0.0
cartograms,1,0.0
methods--electrocardiographic,1,0.0
ultrasonographic,1,0.0
coronavirussevere,1,0.0
75mg,1,0.0
CrCL,1,0.0
150mg,1,0.0
0-311,1,0.0
110-mg,1,0.0
Long-Term,1,0.0
Belarus,1,0.0
PTINR,1,0.0
0-395,1,0.0
trigger-defined,1,0.0
tachyarrythmias,1,0.0
Simulating,1,0.0
pre-stent,1,0.0
badges,1,0.0
desquamated,1,0.0
endothelium-dependent,1,0.0
symptomsawakening,1,0.0
recognises,1,0.0
20-month-old,1,0.0
death‑1,1,0.0
off‑label,1,0.0
boom,1,0.0
coronavirus‑2,1,0.0
penetrance,1,0.0
IFN-mediated,1,0.0
TLR3-have,1,0.0
IRF9,1,0.0
GATA2,1,0.0
pneumonitis-deficiencies,1,0.0
non-negligible,1,0.0
depresses,1,0.0
adiuvant,1,0.0
premorbidity,1,0.0
p05,1,0.0
p07,1,0.0
08-09,1,0.0
tissue-toxic,1,0.0
Penetration,1,0.0
germinal,1,0.0
schizophrenic,1,0.0
factories,1,0.0
immune‑checkpoint,1,0.0
PD‑1PD,1,0.0
unvarying,1,0.0
ligand-1,1,0.0
AIIRDs,1,0.0
infection-to-delivery,1,0.0
antineuraminidase,1,0.0
antihaemagglutinin,1,0.0
swineTaiwan731070,1,0.0
pet-associated,1,0.0
pet-allergic,1,0.0
re-establishment,1,0.0
carrying-out,1,0.0
LABAs,1,0.0
SABAs,1,0.0
post-monitoring,1,0.0
High-affinity,1,0.0
Cleaners,1,0.0
winning,1,0.0
T‑cells,1,0.0
non‑cancer,1,0.0
anti‑PD‑L1,1,0.0
viral-infected,1,0.0
anti‑tumoral,1,0.0
PD‑L1,1,0.0
estro-progestinic,1,0.0
trusts,1,0.0
family-centred,1,0.0
conflicted,1,0.0
Olfactive,1,0.0
acinar,1,0.0
P4,1,0.0
unravelling,1,0.0
informationABSTRACT,1,0.0
2461,1,0.0
3761,1,0.0
survivals,1,0.0
staving,1,0.0
aseptic,1,0.0
1389,1,0.0
B15261,1,0.0
B1427429,1,0.0
S-L450R,1,0.0
S-H69-V70del,1,0.0
S-E484K,1,0.0
S-N501Y,1,0.0
httpswwwcdcgovcoronavirus2019-ncov,1,0.0
mutation-specific,1,0.0
acculturation,1,0.0
Acculturation,1,0.0
Tfh-mediated,1,0.0
classificate,1,0.0
Cyranose,1,0.0
OCTA,1,0.0
decadal,1,0.0
Doubling,1,0.0
AH1N1-2009,1,0.0
42-63,1,0.0
Pan-American,1,0.0
reported58,1,0.0
half-hour,1,0.0
wasps,1,0.0
stung,1,0.0
choriocapillaris,1,0.0
Smith,1,0.0
allergy-associated,1,0.0
Early-onset,1,0.0
Youden,1,0.0
cross-validated,1,0.0
CON,1,0.0
penalized,1,0.0
breathprints,1,0.0
Pasadena,1,0.0
Detections,1,0.0
midturbinate,1,0.0
675-962,1,0.0
economization,1,0.0
SSAHOS,1,0.0
seize,1,0.0
Concerned,1,0.0
universally-recognized,1,0.0
VPD,1,0.0
VPDs,1,0.0
p000036,1,0.0
p00061,1,0.0
p000009,1,0.0
p00018,1,0.0
p00173,1,0.0
hyperlipemia,1,0.0
34425-21096,1,0.0
157-094,1,0.0
ascent,1,0.0
VRF,1,0.0
discriminator,1,0.0
00060,1,0.0
849,1,0.0
rVSV-ZEBOV,1,0.0
17D,1,0.0
MenAfriVac,1,0.0
revitalized,1,0.0
30-year,1,0.0
Miller-Fisher,1,0.0
Satisfactory,1,0.0
severe-persistent,1,0.0
moderate-persistent,1,0.0
dispensary,1,0.0
unites,1,0.0
Belgorod,1,0.0
Phe,1,0.0
Tyr,1,0.0
Reyes,1,0.0
hypercholesteremia,1,0.0
Self-regulation,1,0.0
GQ,1,0.0
Early-life,1,0.0
Dog,1,0.0
scrapings,1,0.0
flunisolide,1,0.0
inhale,1,0.0
asthma-severity,1,0.0
ophthalmoplegia,1,0.0
Bickerstaffs,1,0.0
1b-positive,1,0.0
transferable,1,0.0
clot-selective,1,0.0
enlighten,1,0.0
diphenylmethane,1,0.0
Ro64-0802,1,0.0
prodrug,1,0.0
Almeria,1,0.0
polycystosis,1,0.0
hepatorenal,1,0.0
quadruple,1,0.0
identifications,1,0.0
Deepening,1,0.0
Betacoronavirus-like,1,0.0
host-associated,1,0.0
bioinformatics-driven,1,0.0
speculations,1,0.0
causalities,1,0.0
platelet-release,1,0.0
fuelling,1,0.0
FAM,1,0.0
noncoated,1,0.0
neuroinfluenza,1,0.0
smokers--vitamin,1,0.0
and--in,1,0.0
5197,1,0.0
GS4071,1,0.0
n117,1,0.0
1311,1,0.0
mono-infected,1,0.0
two-hourly,1,0.0
Aneurysms,1,0.0
bread,1,0.0
butter,1,0.0
catalysed,1,0.0
short-distance,1,0.0
tease,1,0.0
outwards,1,0.0
105-1925,1,0.0
Selection,1,0.0
P0002,1,0.0
2111,1,0.0
2759,1,0.0
Predominance,1,0.0
AH1N109v,1,0.0
n112,1,0.0
last-day,1,0.0
n58,1,0.0
P00005,1,0.0
958,1,0.0
precoditions,1,0.0
Metapneumovirus,1,0.0
applicableClass,1,0.0
perfusion-weighted-diffusion-weighted,1,0.0
fluoromisonidazole,1,0.0
flumazenil,1,0.0
lactacidosis,1,0.0
excitatory,1,0.0
peri,1,0.0
depolarisations,1,0.0
Waves,1,0.0
coined,1,0.0
stroke-associated,1,0.0
multi-consistency,1,0.0
fulminans,1,0.0
2-month,1,0.0
1985-1990,1,0.0
348-621,1,0.0
serendipitous,1,0.0
dataevidence,1,0.0
provenance,1,0.0
-28,1,0.0
pneumonia-related,1,0.0
sub-sample,1,0.0
11-33,1,0.0
diffusionperfusion-weighted,1,0.0
379-679,1,0.0
Subtypes,1,0.0
post-transplantation,1,0.0
associates,1,0.0
3152,1,0.0
Heather,1,0.0
sclerosing,1,0.0
bioelectrical,1,0.0
3617,1,0.0
cholestasis,1,0.0
PRACTIC,1,0.0
759,1,0.0
5467,1,0.0
434,1,0.0
1191,1,0.0
2506,1,0.0
Universities,1,0.0
post-graduate,1,0.0
300-651,1,0.0
BUN,1,0.0
SGPT,1,0.0
anti-hyperuricemic,1,0.0
36th,1,0.0
-181-152,1,0.0
ACF,1,0.0
ACFs,1,0.0
aged-care,1,0.0
cluster-randomised,1,0.0
fluent,1,0.0
nonfluent,1,0.0
PMIP,1,0.0
IIABSTRACT,1,0.0
transmurality,1,0.0
reperfusionp,1,0.0
transversely,1,0.0
EDL-ESLEDL,1,0.0
ESL,1,0.0
End-diastolic,1,0.0
piezoelectric,1,0.0
titanate-zirconate,1,0.0
enigmatic,1,0.0
Surprising,1,0.0
NCT04422457,1,0.0
first-in-human,1,0.0
nonshock,1,0.0
Delineation,1,0.0
supplier,1,0.0
Umbilical,1,0.0
interstate,1,0.0
collor,1,0.0
agnosia,1,0.0
alexia,1,0.0
well-respected,1,0.0
necropsies,1,0.0
plugged,1,0.0
overdistended,1,0.0
1967,1,0.0
Registrar,1,0.0
Copies,1,0.0
513-824,1,0.0
Nonparticipation,1,0.0
fully-developed,1,0.0
workflows,1,0.0
Balints,1,0.0
-574-608,1,0.0
psychiatry,1,0.0
neuropsychology,1,0.0
Disorientation,1,0.0
haemorrhages,1,0.0
Intraventricular,1,0.0
caudate,1,0.0
Abulia,1,0.0
declarative,1,0.0
IgG-detecting,1,0.0
RNA-persistence,1,0.0
frequents,1,0.0
004-036,1,0.0
triterpenes,1,0.0
azolo-adamantanes,1,0.0
httpsbitly2AZHiVg,1,0.0
memantine,1,0.0
α7-nAChR,1,0.0
Memantine,1,0.0
inflammationasthma,1,0.0
Cross-regulation,1,0.0
Th1-cells,1,0.0
secrete,1,0.0
Th-cell,1,0.0
apheresis,1,0.0
Inefficiency,1,0.0
glomectomy,1,0.0
plasmacytapheresis,1,0.0
pore,1,0.0
mK-ATP,1,0.0
diabolical,1,0.0
leucocyte,1,0.0
hypercontracture,1,0.0
oxygen-radical,1,0.0
benzimidazole,1,0.0
usnic,1,0.0
heterocyclic,1,0.0
elucidates,1,0.0
Sixteen-,1,0.0
pylori-bullfrog,1,0.0
Helicobacter,1,0.0
VIST,1,0.0
phylogenomics,1,0.0
constant-rate,1,0.0
nitrate-poor,1,0.0
Nitrate,1,0.0
gravitation,1,0.0
Extra,1,0.0
virus-inhibiting,1,0.0
1700,1,0.0
hygienists,1,0.0
recalculated,1,0.0
all-causes,1,0.0
unrealistically,1,0.0
re-estimation,1,0.0
myth,1,0.0
socio-historical,1,0.0
re-estimated,1,0.0
reoxygenating,1,0.0
018-036,1,0.0
Todays,1,0.0
029-077,1,0.0
medically-attended,1,0.0
TGF-β1Smad,1,0.0
RhoRock,1,0.0
Bentham,1,0.0
Springer,1,0.0
degrades,1,0.0
spline,1,0.0
Cataract,1,0.0
742,1,0.0
1094,1,0.0
lg,1,0.0
117-17,1,0.0
383-17,1,0.0
500-00,1,0.0
367-17,1,0.0
AChickenKurganRussia0205,1,0.0
intranazally,1,0.0
4759,1,0.0
directing,1,0.0
pro-atherogenetic,1,0.0
obliterates,1,0.0
VAI,1,0.0
23-97,1,0.0
20089,1,0.0
anti-T2,1,0.0
out-of-household,1,0.0
Lesser,1,0.0
015-042,1,0.0
024-070,1,0.0
Aichi,1,0.0
ICC090,1,0.0
eosinophil-driven,1,0.0
9-week,1,0.0
questions7,1,0.0
examinees,1,0.0
96-174,1,0.0
neuroradiologically,1,0.0
low-threshold,1,0.0
NIH-SS,1,0.0
IgGAM,1,0.0
non-CE,1,0.0
indexrecurrent,1,0.0
00275,1,0.0
467-611,1,0.0
326-448,1,0.0
establishments,1,0.0
JVP,1,0.0
n13,1,0.0
Exploiting,1,0.0
immune-selected,1,0.0
oxtriphylline,1,0.0
1971-85,1,0.0
INAIL,1,0.0
Turin,1,0.0
non-occlusive,1,0.0
reactivate,1,0.0
evidence-base,1,0.0
Logistical,1,0.0
4146,1,0.0
637,1,0.0
3757,1,0.0
57194,1,0.0
Ninety194,1,0.0
rampart,1,0.0
supplanted,1,0.0
dispatch,1,0.0
embracing,1,0.0
brilliant,1,0.0
enamored,1,0.0
hard-won,1,0.0
VSV-eGFP-SARS-CoV-2-S,1,0.0
S477N,1,0.0
escaped,1,0.0
250Approximately,1,0.0
012-079,1,0.0
004-058,1,0.0
Telephone,1,0.0
2162,1,0.0
nasally,1,0.0
Asthma-specific,1,0.0
adhesions,1,0.0
Digitalis,1,0.0
mortalityThe,1,0.0
testify,1,0.0
Beard,1,0.0
Sphingosine-1-phosphate,1,0.0
Sphingolipids,1,0.0
105-286,1,0.0
108-1203,1,0.0
micro-aggregation,1,0.0
α2-adrenoreceptors,1,0.0
P2Y12,1,0.0
Micro-aggregation,1,0.0
VANQWISH,1,0.0
fared,1,0.0
2002-SARS-CoV,1,0.0
-053,1,0.0
attomolar,1,0.0
capnography,1,0.0
DDR,1,0.0
anthropomorphic,1,0.0
dissolution,1,0.0
anistreplase,1,0.0
Ultraviolet,1,0.0
ADMIRAL,1,0.0
Stents,1,0.0
6112,1,0.0
Honghu,1,0.0
Chair,1,0.0
wherever,1,0.0
Metered-dose,1,0.0
nebulisers,1,0.0
Pirogov,1,0.0
25-49,1,0.0
2001-2006,1,0.0
Black-white,1,0.0
eachABSTRACT,1,0.0
subtotally,1,0.0
Elsewhere,1,0.0
1984-1985,1,0.0
in-patients,1,0.0
diagnostic-tactical,1,0.0
rate-systolic,1,0.0
Cas13a-based,1,0.0
desthiobiotin-modified,1,0.0
adsorbing,1,0.0
assemblies,1,0.0
hairpin,1,0.0
construed,1,0.0
enzyme-free,1,0.0
easy-to-implement,1,0.0
Institutionalized,1,0.0
leader,1,0.0
prognosticating,1,0.0
recounting,1,0.0
childrenparents,1,0.0
after-school,1,0.0
before-,1,0.0
debatted,1,0.0
Marx,1,0.0
toxicities,1,0.0
immune-modifier,1,0.0
Leipzig,1,0.0
-042,1,0.0
-030,1,0.0
hypotension-bradycardia,1,0.0
Private,1,0.0
HibMenCY,1,0.0
Y-tetanus,1,0.0
Hib-Neisseria,1,0.0
−104,1,0.0
CI22–79,1,0.0
31–73,1,0.0
Scotland-wide,1,0.0
gown,1,0.0
pleuritic,1,0.0
Engraftment,1,0.0
leukopenic,1,0.0
Infective,1,0.0
PreventionUS,1,0.0
forbiddingly,1,0.0
Tamiflu®,1,0.0
AIndia64272014,1,0.0
MIT,1,0.0
concatenated,1,0.0
genogroup,1,0.0
39000,1,0.0
pvaccination,1,0.0
single-centre,1,0.0
amortized,1,0.0
sub-clinical,1,0.0
CoVHKU1,1,0.0
n85,1,0.0
n135,1,0.0
necessaryThe,1,0.0
Specialists,1,0.0
enhancements,1,0.0
expects,1,0.0
CoV229E,1,0.0
CoVOC43,1,0.0
CoVNL63,1,0.0
Kendall,1,0.0
erythema,1,0.0
200-260,1,0.0
260-320,1,0.0
320-400,1,0.0
UVA,1,0.0
Sunlight,1,0.0
11-12,1,0.0
15-16,1,0.0
parvovirus,1,0.0
infectiosum,1,0.0
pvaccine,1,0.0
embark,1,0.0
-058,1,0.0
Ablative,1,0.0
Abnormalities,1,0.0
Consolidation,1,0.0
Radiographic,1,0.0
within-session,1,0.0
One-second,1,0.0
impressively,1,0.0
W135,1,0.0
polysaccharide,1,0.0
4-valent,1,0.0
Isolations,1,0.0
35389,1,0.0
ABeijing,1,0.0
children--which,1,0.0
population--school,1,0.0
nasalthroat,1,0.0
byproducts,1,0.0
azoles,1,0.0
macrolides,1,0.0
fibrointimal,1,0.0
abuser,1,0.0
SARS-CoV-2-associated,1,0.0
cocaine-mediated,1,0.0
ablative,1,0.0
neurotoxic,1,0.0
pre-intervention,1,0.0
T1-threshold,1,0.0
T2-threshold,1,0.0
neurosurgeries,1,0.0
locker,1,0.0
precession,1,0.0
T2-prepared,1,0.0
turbospin,1,0.0
fat-suppressed,1,0.0
33-36,1,0.0
Tc99m-sestamibi,1,0.0
privet,1,0.0
reentry,1,0.0
staff-visitor,1,0.0
acute-care,1,0.0
complementation-derived,1,0.0
Hamsters,1,0.0
Trans-complementation,1,0.0
producer,1,0.0
ORF3,1,0.0
BSL-3,1,0.0
thermometers,1,0.0
infrared,1,0.0
non-contact,1,0.0
Cytokine-mediated,1,0.0
High-Dose,1,0.0
APerth162009,1,0.0
2010--11,1,0.0
temporality,1,0.0
months--8,1,0.0
or6,1,0.0
RR-10,1,0.0
vaccine---recommendations,1,0.0
RR-8,1,0.0
unchecked,1,0.0
assuages,1,0.0
slows,1,0.0
tangles,1,0.0
neurofibrillary,1,0.0
three-fourths,1,0.0
fivefold,1,0.0
three-,1,0.0
autoregulatory,1,0.0
150mmHg,1,0.0
1232791,1,0.0
48539872,1,0.0
httpwwwcdcgovflu,1,0.0
IL-1-related,1,0.0
ant,1,0.0
anxietydepression,1,0.0
pleasantly,1,0.0
Failing,1,0.0
precuneus,1,0.0
aura-like,1,0.0
Relenza,1,0.0
aptitude,1,0.0
-020,1,0.0
PES,1,0.0
health-promoting,1,0.0
paclitaxel-eluting,1,0.0
sirolimus-,1,0.0
mistakenly,1,0.0
Comment,1,0.0
vasodilators,1,0.0
dilating,1,0.0
80-85,1,0.0
out-of-danger,1,0.0
Unvaccinated,1,0.0
improvementimmunity,1,0.0
Brain-derived,1,0.0
fine-tuning,1,0.0
ARTIs,1,0.0
self-degradative,1,0.0
refuting,1,0.0
Crying-induced,1,0.0
ILH,1,0.0
CLH,1,0.0
contra-,1,0.0
MEG,1,0.0
magnetoencephalography,1,0.0
autophagy-mediated,1,0.0
19-channel,1,0.0
monohemispheric,1,0.0
regains,1,0.0
re-targeted,1,0.0
usurped,1,0.0
genome-scale,1,0.0
arrayed,1,0.0
-42,1,0.0
4310,1,0.0
3477,1,0.0
6550,1,0.0
reperfusion-associated,1,0.0
crossroads,1,0.0
Alsace-Lorraine,1,0.0
Mulhouse,1,0.0
Low-band,1,0.0
allergen-driven,1,0.0
low-band,1,0.0
overactive,1,0.0
2010-2015,1,0.0
Radiology,1,0.0
lysosome,1,0.0
renovation,1,0.0
liquefactive,1,0.0
Principal,1,0.0
starvation,1,0.0
echogenicity,1,0.0
immunometabolic,1,0.0
FluWeb,1,0.0
ipsi-,1,0.0
modellers,1,0.0
counterpart--a,1,0.0
hitchhiking,1,0.0
drug-sensitive,1,0.0
approximations,1,0.0
turmeric,1,0.0
α-tocopherol,1,0.0
diphenylheptanoids,1,0.0
Diarylheptanoids,1,0.0
Monocyte,1,0.0
Chemoattractant,1,0.0
MCP-1CCL2,1,0.0
stretches,1,0.0
detector,1,0.0
four-view,1,0.0
20SD,1,0.0
Sa,1,0.0
99mTc-pyrophosphate,1,0.0
neighborhood-based,1,0.0
graph-theory-based,1,0.0
GNN,1,0.0
GNNs,1,0.0
co-ordinate,1,0.0
interoperable,1,0.0
Framing,1,0.0
ATianjinhedongSWL442011H1,1,0.0
pregnancyExpert,1,0.0
non-pharmacologic,1,0.0
PUBMEDMEDLINE,1,0.0
Covered,1,0.0
importanceAreas,1,0.0
afflict,1,0.0
WhatsApp,1,0.0
ATianjinjinnanSWL412011H1,1,0.0
halves,1,0.0
bichromic,1,0.0
Planar,1,0.0
IL-10-induced,1,0.0
CLL,1,0.0
Kettering,1,0.0
Sloan,1,0.0
leukemias,1,0.0
clinicallaboratory,1,0.0
cytopenias,1,0.0
adipokine,1,0.0
Adiponectin,1,0.0
IL-10-secreting,1,0.0
salbutamol-induced,1,0.0
specificityABSTRACT,1,0.0
BMC-secreted,1,0.0
10-3,1,0.0
Plastic-adherent,1,0.0
COIVD-19-associated,1,0.0
bacterialallergic,1,0.0
skews,1,0.0
S179N,1,0.0
K180T,1,0.0
Diagnosticat,1,0.0
remoteruraldistrict,1,0.0
Space,1,0.0
CCR2,1,0.0
strenghten,1,0.0
dihydroorotate,1,0.0
101-129,1,0.0
100-131,1,0.0
DHODH,1,0.0
102-133,1,0.0
112-151,1,0.0
pre-eclampsia,1,0.0
revisionsThe,1,0.0
asthmaA,1,0.0
intergenerational,1,0.0
Door-to-balloon,1,0.0
180-360,1,0.0
90-180,1,0.0
3C-like,1,0.0
non-transferred,1,0.0
1190,1,0.0
non-admitted,1,0.0
Influenzas,1,0.0
non-East,1,0.0
non-infarctive,1,0.0
MCP-1-mediated,1,0.0
105-139,1,0.0
113-133,1,0.0
lifeAsthma,1,0.0
ATianjinningheSWL492009H1,1,0.0
2337,1,0.0
BRL,1,0.0
63753,1,0.0
75663,1,0.0
157126,1,0.0
147072,1,0.0
microsimulation,1,0.0
transbronchial,1,0.0
D239N,1,0.0
oseltamivir-resistance,1,0.0
co-variables,1,0.0
DRC,1,0.0
DCP,1,0.0
super-infections,1,0.0
sickened,1,0.0
host-targeted,1,0.0
VSS,1,0.0
three-state,1,0.0
piecewise,1,0.0
38-349,1,0.0
Haut-Rhin,1,0.0
acuteischemic,1,0.0
p047,1,0.0
latecomer,1,0.0
nonresolution,1,0.0
Ticagrelor,1,0.0
Prasugrel,1,0.0
sonothrombolysis,1,0.0
SPD,1,0.0
earthing,1,0.0
alkalization,1,0.0
baroreflex,1,0.0
Alkaline,1,0.0
Shao,1,0.0
Bai,1,0.0
guava,1,0.0
pomegranate,1,0.0
carnosic,1,0.0
Echinacea,1,0.0
berries,1,0.0
ginseng,1,0.0
antiwei,1,0.0
maoto,1,0.0
Apical,1,0.0
sutured,1,0.0
formoterol,1,0.0
Ion,1,0.0
Anesthesiologists,1,0.0
Torrent,1,0.0
lift,1,0.0
shaft,1,0.0
Rint,1,0.0
pendular,1,0.0
pro-brain,1,0.0
nonventilated,1,0.0
analyzedCCC,1,0.0
encouragementsupport,1,0.0
validationfeedback,1,0.0
nurse-coached,1,0.0
attentions,1,0.0
Unpartnered,1,0.0
hPSC-derived,1,0.0
hPSC,1,0.0
P0·025,1,0.0
80·5,1,0.0
P0·001,1,0.0
prereperfusion,1,0.0
pre-community-outbreak,1,0.0
unsuitability,1,0.0
PGM,1,0.0
2-mm,1,0.0
tendon,1,0.0
enthusiastic,1,0.0
-blockers,1,0.0
COVID-19-suspected,1,0.0
RTq-PCR,1,0.0
acquaints,1,0.0
endured,1,0.0
5-28,1,0.0
39-86,1,0.0
isotonic,1,0.0
42-60,1,0.0
cephalalgia,1,0.0
alpha-thalassemia,1,0.0
homozygotous,1,0.0
polygon,1,0.0
sudden-onset,1,0.0
hemicorporal,1,0.0
ruinous,1,0.0
1971-1977,1,0.0
0-777,1,0.0
24-49,1,0.0
HIR,1,0.0
SSR,1,0.0
Estonian,1,0.0
989-100,1,0.0
679-782,1,0.0
≤30,1,0.0
Himalayas,1,0.0
115ABSTRACT,1,0.0
meta-analytic,1,0.0
084-149,1,0.0
048-082,1,0.0
053-086,1,0.0
4000,1,0.0
Prinzmetal,1,0.0
trekking,1,0.0
vascularity,1,0.0
sub-epithelial,1,0.0
brain-specific,1,0.0
Ug,1,0.0
not-withstanding,1,0.0
Non-steroidal,1,0.0
Technetium-99m,1,0.0
Arthralgia,1,0.0
arthropathy,1,0.0
polyarthralgia,1,0.0
Guro,1,0.0
non-exhaustive,1,0.0
sub-groups,1,0.0
fundament,1,0.0
neurorehabilitationThis,1,0.0
disruptors,1,0.0
ganciclovir,1,0.0
strains-severe,1,0.0
bat-derived,1,0.0
strives,1,0.0
non-type,1,0.0
2-high,1,0.0
Misclassification,1,0.0
post-load,1,0.0
32-45,1,0.0
22-34,1,0.0
35-49,1,0.0
electro-cardiographic,1,0.0
3272,1,0.0
extrafine,1,0.0
CovaxinTM,1,0.0
BBV-152,1,0.0
CovishieldTM,1,0.0
ChAdOx1-nCOV,1,0.0
bit,1,0.0
SanSure,1,0.0
0107,1,0.0
acyclovir,1,0.0
interferon-β,1,0.0
LysGlu,1,0.0
talked,1,0.0
Means,1,0.0
descriptivecomparative,1,0.0
whole-brain,1,0.0
swept-source,1,0.0
SS-OCT,1,0.0
SPT,1,0.0
1450,1,0.0
Brescia,1,0.0
ACVA,1,0.0
ACVIs,1,0.0
Glu,1,0.0
non-rural,1,0.0
LaSalle,1,0.0
Davis,1,0.0
Jefferson,1,0.0
Caldwell,1,0.0
Parish,1,0.0
snake,1,0.0
14401,1,0.0
21398,1,0.0
GeneFinderTM,1,0.0
14-October,1,0.0
Person,1,0.0
flow-limiting,1,0.0
patientsA,1,0.0
1339,1,0.0
relapsing-remitting,1,0.0
non-CCC,1,0.0
Summarising,1,0.0
concomittant,1,0.0
kringing,1,0.0
VSN,1,0.0
Valencian,1,0.0
geostatistical,1,0.0
universalize,1,0.0
inequity,1,0.0
guidewire,1,0.0
Antegrade,1,0.0
splatter,1,0.0
saliva-containing,1,0.0
ubiquitously,1,0.0
synthesisResults,1,0.0
criteriaData,1,0.0
dataStudy,1,0.0
Non-systematically,1,0.0
1945,1,0.0
Joseph,1,0.0
Winston,1,0.0
miscommunication,1,0.0
micro-RNAs,1,0.0
ulcerated,1,0.0
2h,1,0.0
1375,1,0.0
deducing,1,0.0
ACE2-S-protein,1,0.0
Administering,1,0.0
Cold,1,0.0
Union-miscommunication,1,0.0
post-WWII,1,0.0
Crimea,1,0.0
ramifications,1,0.0
Suez,1,0.0
Britains,1,0.0
resignation,1,0.0
minister,1,0.0
resign,1,0.0
Churchills,1,0.0
WWII,1,0.0
post-World,1,0.0
p028,1,0.0
0-06,1,0.0
Adult-Onset,1,0.0
E-selection,1,0.0
NIEHS,1,0.0
Pranlukast,1,0.0
amplifications,1,0.0
naked,1,0.0
orange,1,0.0
two-color,1,0.0
transcriptase-loop,1,0.0
Salient,1,0.0
disutility,1,0.0
puffs,1,0.0
microgliosis,1,0.0
Magdeburg,1,0.0
Neurorepair,1,0.0
hypochondriacal,1,0.0
disadaptation,1,0.0
Twelve-lead,1,0.0
sphere,1,0.0
neuro-mental,1,0.0
asthenization,1,0.0
adrenomedullary,1,0.0
psycho-autonomic,1,0.0
Extramural,1,0.0
reaction-restriction,1,0.0
methosulphate,1,0.0
PCR-RFLP,1,0.0
8254,1,0.0
23254,1,0.0
32254,1,0.0
43254,1,0.0
miscellaneous,1,0.0
55254,1,0.0
92254,1,0.0
allergyimmunology,1,0.0
fellowship,1,0.0
tallied,1,0.0
Nanotechnology,1,0.0
Epidemiologists,1,0.0
HIVAIDS,1,0.0
Ser128Arg,1,0.0
128Arginine,1,0.0
307-1086,1,0.0
128Arg,1,0.0
Ono,1,0.0
Frequencies,1,0.0
P0,1,0.0
ex-smoker,1,0.0
adaptative,1,0.0
asthma-friendly,1,0.0
toolkits,1,0.0
ADA,1,0.0
StrOke,1,0.0
aFter,1,0.0
HYPOTHESIS,1,0.0
vaccine-selection,1,0.0
strain-selection,1,0.0
interprets,1,0.0
3-factor,1,0.0
enacted,1,0.0
Jean,1,0.0
staunch,1,0.0
Chrétien,1,0.0
enzymes--superoxide,1,0.0
coronary-occlusion,1,0.0
walkers,1,0.0
KR,1,0.0
6MWT,1,0.0
6-minute,1,0.0
diaphorase,1,0.0
tetrazolium-reductase,1,0.0
circumvent,1,0.0
electron-acceptor,1,0.0
SAFFO,1,0.0
hesitation,1,0.0
four-point,1,0.0
Algorithms,1,0.0
allergistimmunologist,1,0.0
NIHNIAID,1,0.0
SICAS,1,0.0
less-examined,1,0.0
timings,1,0.0
Discoveries,1,0.0
nasooropharyngeal,1,0.0
DTS,1,0.0
putamen,1,0.0
seroconvert,1,0.0
1159,1,0.0
Temporal,1,0.0
anti-receptor,1,0.0
2424,1,0.0
Matched,1,0.0
weakened,1,0.0
Imbalance,1,0.0
11-28,1,0.0
350-406,1,0.0
30-49,1,0.0
00023,1,0.0
555-4993,1,0.0
intravital,1,0.0
Cree,1,0.0
ECG-defined,1,0.0
Middlesex,1,0.0
ultra-cold,1,0.0
geo-data,1,0.0
defeated,1,0.0
scale-back,1,0.0
566,1,0.0
non-ischemic,1,0.0
Cantonal,1,0.0
archeo-epidemiologic,1,0.0
avian-to-human,1,0.0
inhibiters,1,0.0
bata-2,1,0.0
finalizing,1,0.0
Economics,1,0.0
1916-1922,1,0.0
bronchomalacia,1,0.0
difficult-to,1,0.0
care-seeking,1,0.0
Bronchoalveolar-lavage,1,0.0
Subarctic,1,0.0
bronchidilators,1,0.0
Assurance,1,0.0
aQua,1,0.0
hydrogen-bonding,1,0.0
Multi-Hit,1,0.0
GPCRs,1,0.0
SMCs,1,0.0
bedsize,1,0.0
cortisol-induced,1,0.0
362065,1,0.0
corticosteroid-responsive,1,0.0
Ironically,1,0.0
co-incubation,1,0.0
packing,1,0.0
transaxial,1,0.0
sub-nanomolar,1,0.0
sorting,1,0.0
overdose,1,0.0
teicoplanin,1,0.0
Troponin,1,0.0
30-60,1,0.0
crescendo,1,0.0
scintillation,1,0.0
nitroblue-tetrazolium,1,0.0
Hudsons,1,0.0
influenza-July,1,0.0
Adam,1,0.0
nonrandom,1,0.0
Immunodiagnostic,1,0.0
Neutralising,1,0.0
years--pharmacotherapy,1,0.0
nitroglycerine,1,0.0
Szymonowicz,1,0.0
Latkowski,1,0.0
Napoleon,1,0.0
beginnings,1,0.0
Franke,1,0.0
Marian,1,0.0
Gluziński,1,0.0
Antoni,1,0.0
Dmochowski,1,0.0
Zdzisław,1,0.0
Pawiński,1,0.0
Biegański,1,0.0
anatomopathology,1,0.0
1887,1,0.0
Krakow,1,0.0
1878,1,0.0
Hammer,1,0.0
72-hour,1,0.0
A-29,1,0.0
B-35,1,0.0
inferoseptal,1,0.0
Briefly,1,0.0
Urged,1,0.0
Stroke-prevention,1,0.0
eight-colored,1,0.0
CERX-CQ3001,1,0.0
Colored,1,0.0
stentriever,1,0.0
surgical-treated,1,0.0
595,1,0.0
Apicoseptal,1,0.0
C-53,1,0.0
1919-were,1,0.0
541,1,0.0
Intramyocardial,1,0.0
1962-1972,1,0.0
1985-1986,1,0.0
10554,1,0.0
8308,1,0.0
fallwinter,1,0.0
Eq,1,0.0
PMS,1,0.0
Phenazine,1,0.0
06-17,1,0.0
lowpathogenicity,1,0.0
adamantine,1,0.0
neuramidinase,1,0.0
stigmatization,1,0.0
HIor40,1,0.0
mini-mental,1,0.0
post-immunization,1,0.0
community-living,1,0.0
A-H1N1,1,0.0
titreor140,1,0.0
EBBx,1,0.0
12089,1,0.0
12693068,1,0.0
hundred-six,1,0.0
16961000,1,0.0
Weeks,1,0.0
17921000,1,0.0
Inpatient-based,1,0.0
inpatient-based,1,0.0
clinically-useful,1,0.0
-36,1,0.0
1921269,1,0.0
Q226I,1,0.0
tri-assortment,1,0.0
localising,1,0.0
activations,1,0.0
bow,1,0.0
force-matching,1,0.0
vision-guided,1,0.0
risk-modifying,1,0.0
bereavement-related,1,0.0
24-fold,1,0.0
first-degree,1,0.0
hunters,1,0.0
Bereavement,1,0.0
Left-sided,1,0.0
menses,1,0.0
monocellular,1,0.0
antiplatelet-aggregating,1,0.0
subaxial,1,0.0
Causal,1,0.0
many-sided,1,0.0
Amazingly,1,0.0
Christchurch485-like,1,0.0
000067,1,0.0
CBVI,1,0.0
rcso2,1,0.0
-14,1,0.0
n344,1,0.0
n431,1,0.0
mid-201314,1,0.0
orientated,1,0.0
electrically-heated,1,0.0
Infantile,1,0.0
Stroke-associated,1,0.0
biodistribution,1,0.0
polycations,1,0.0
highly-conserved,1,0.0
sequence-specific,1,0.0
tow-,1,0.0
single-,1,0.0
-22,1,0.0
Identity,1,0.0
ACalifornia072009H1N1,1,0.0
MGCBS,1,0.0
STABSTRACT,1,0.0
nay,1,0.0
07-26,1,0.0
PWP,1,0.0
ith,1,0.0
postacute,1,0.0
p019,1,0.0
feather-bedding,1,0.0
soft-toy,1,0.0
aeration,1,0.0
Farmers,1,0.0
2009-March,1,0.0
httpsbitly38JaUmB,1,0.0
Tayside,1,0.0
cultivate,1,0.0
001-104,1,0.0
nonsensitized,1,0.0
9301346,1,0.0
2010-March,1,0.0
220523,1,0.0
cultivated,1,0.0
sub-cohort,1,0.0
infectiondeath,1,0.0
splicing,1,0.0
BAUmL,1,0.0
16-685,1,0.0
Luminex-based,1,0.0
baculovirus-insect,1,0.0
backbones,1,0.0
Ex,1,0.0
6769,1,0.0
5-s,1,0.0
0-3-Hz,1,0.0
hypometabolism,1,0.0
anti-2019-nCoV,1,0.0
unwieldy,1,0.0
noting,1,0.0
pledge,1,0.0
Sept,1,0.0
GD96,1,0.0
AgooseGuangdong96-like,1,0.0
pause,1,0.0
gavage,1,0.0
antiangiogenic,1,0.0
antimetastatic,1,0.0
antitumor,1,0.0
inferobasal,1,0.0
straight-line,1,0.0
intercepts,1,0.0
prescribes,1,0.0
Nonhospitalized,1,0.0
Handwashing,1,0.0
Lethal,1,0.0
Murrays,1,0.0
PaO2\FiO2,1,0.0
pandemias,1,0.0
862,1,0.0
1-comprised,1,0.0
2-comprised,1,0.0
secondard,1,0.0
Pledge,1,0.0
attact,1,0.0
arouses,1,0.0
unconstrained,1,0.0
immune-response,1,0.0
strain-transcending,1,0.0
constancy,1,0.0
license,1,0.0
Methodical,1,0.0
elaborating,1,0.0
employable,1,0.0
unhelpful,1,0.0
ACO1,1,0.0
consensus-based,1,0.0
issue23,1,0.0
COPD1,1,0.0
Elliott,1,0.0
intercontinental,1,0.0
trip,1,0.0
Traveling,1,0.0
Computational-based,1,0.0
Precious,1,0.0
nonparetic,1,0.0
mass-spectrometric,1,0.0
drowsy,1,0.0
heparinoids,1,0.0
sonothrombosis,1,0.0
Trade-offs,1,0.0
Ineffective,1,0.0
orbitofrontal,1,0.0
1045,1,0.0
surveying,1,0.0
insultology,1,0.0
assimilation,1,0.0
sanogenetic,1,0.0
pontine-cerebellar,1,0.0
saccade,1,0.0
aVOR,1,0.0
vestibulo-ocular,1,0.0
Physician,1,0.0
plan-do-check-act,1,0.0
2010-May,1,0.0
aged≥65,1,0.0
recalling,1,0.0
vision-,1,0.0
Inefficient,1,0.0
evasive,1,0.0
Covaxin,1,0.0
7640,1,0.0
sedimented,1,0.0
tryptic,1,0.0
isopropanol,1,0.0
mass-spectrometry-based,1,0.0
1123,1,0.0
Assoc,1,0.0
Formosan,1,0.0
465-469,1,0.0
Eurosurveillance,1,0.0
characterizationclassification,1,0.0
B11282,1,0.0
11132,1,0.0
httpvirologicalorg,1,0.0
SARS-CoV-2virus,1,0.0
macroscopically,1,0.0
embarrassment,1,0.0
broach,1,0.0
mesial,1,0.0
indecision,1,0.0
metereological,1,0.0
unsteadiness,1,0.0
canal,1,0.0
semicircular,1,0.0
Porous,1,0.0
multiplexer,1,0.0
visuomotor,1,0.0
cursor,1,0.0
fluorescence-Based,1,0.0
nested-PCR,1,0.0
Microfluidic,1,0.0
Re-education,1,0.0
kinesthetic,1,0.0
ICM,1,0.0
Stigma,1,0.0
audio-recorded,1,0.0
Discussions,1,0.0
24-question,1,0.0
pre-assessment,1,0.0
re-purposing,1,0.0
outfitted,1,0.0
countriesregions,1,0.0
TOCC,1,0.0
human-virus,1,0.0
Enteric,1,0.0
Incidentally,1,0.0
healthy-controls,1,0.0
Silicon,1,0.0
supporters,1,0.0
Nanowire,1,0.0
Gowtage-Sequeria,1,0.0
Latham,1,0.0
Taylor,1,0.0
Poel,1,0.0
Van,1,0.0
Fooks,1,0.0
Cutler,1,0.0
Cascio,1,0.0
Coker,1,0.0
senses,1,0.0
pneumocyte,1,0.0
ΔpsaB,1,0.0
ΔclpL,1,0.0
Mn2,1,0.0
psaB,1,0.0
clpL,1,0.0
wt,1,0.0
virus-bacterial,1,0.0
HAV,1,0.0
kinesthetic-,1,0.0
visual-dominant,1,0.0
County-specific,1,0.0
departmentinpatients,1,0.0
1659,1,0.0
1912,1,0.0
FDACancer,1,0.0
Nail,1,0.0
Vaxira,1,0.0
Racotumomab,1,0.0
anti-idiotype,1,0.0
idiotype,1,0.0
2017Other,1,0.0
Gatti-Mays,1,0.0
Fold,1,0.0
Mastelic-Gavillet,1,0.0
Wang,1,0.0
2012Dendritic,1,0.0
Jaffee,1,0.0
Keenan,1,0.0
whole-cell,1,0.0
Whole-Cell,1,0.0
Tagliamonte,1,0.0
Destroy,1,0.0
Disis,1,0.0
Stanton,1,0.0
Bialkowski,1,0.0
2020a,1,0.0
Dozens,1,0.0
Nius,1,0.0
IMLYGIC,1,0.0
only-based,1,0.0
Baylor,1,0.0
eosinophil-depleting,1,0.0
ever-intriguing,1,0.0
MRI-based,1,0.0
Maderno,1,0.0
BioNTechamp39s,1,0.0
PROVENGE,1,0.0
KYMRIAH,1,0.0
YESCARTA,1,0.0
Tian,1,0.0
TECARTUS,1,0.0
BREYANZI,1,0.0
Amisha,1,0.0
everywhere,1,0.0
Millions,1,0.0
ampndash,1,0.0
Bout,1,0.0
shown2,1,0.0
2020b,1,0.0
Fauci,1,0.0
Priority,1,0.0
smokelaparoscopic,1,0.0
obstruction-is,1,0.0
warns,1,0.0
register-based,1,0.0
imprecision,1,0.0
perpetual,1,0.0
follow-upIn,1,0.0
132-409,1,0.0
121-332,1,0.0
HRRs,1,0.0
ivabradine,1,0.0
≥100,1,0.0
≥11,1,0.0
deathAnxiety,1,0.0
objectivized,1,0.0
forty-one,1,0.0
predictorThe,1,0.0
prooxidative,1,0.0
Spermatozoa,1,0.0
immuno-unbalance,1,0.0
S-groups,1,0.0
targetted,1,0.0
mechano-chronotropic,1,0.0
Barnett,1,0.0
Haddon,1,0.0
T-tests,1,0.0
2849,1,0.0
30100,1,0.0
48-72,1,0.0
knowlegde,1,0.0
ovreview,1,0.0
extra-hospital,1,0.0
Segmental,1,0.0
1981-82,1,0.0
caucasians,1,0.0
114-189,1,0.0
gauged,1,0.0
Hounsfield,1,0.0
preliminarily,1,0.0
-138,1,0.0
0728,1,0.0
sub-grouped,1,0.0
SPECT-detected,1,0.0
incontrovertibly,1,0.0
non-statistically,1,0.0
chronotropic,1,0.0
bradycardic,1,0.0
withstands,1,0.0
asthma-variable,1,0.0
pneumoperitoneum,1,0.0
cookers,1,0.0
C3037T,1,0.0
T8782C,1,0.0
C14408T,1,0.0
C28144T,1,0.0
purifying,1,0.0
NC045512,1,0.0
downloaded,1,0.0
pyroptosis,1,0.0
nonimmune,1,0.0
mink-to-human-cat,1,0.0
felids,1,0.0
non-domestic,1,0.0
ABCD,1,0.0
Cat,1,0.0
Felids,1,0.0
FIP,1,0.0
peritonitis,1,0.0
FCoV,1,0.0
jumped,1,0.0
nonsensitizing,1,0.0
long-recognized,1,0.0
C1059T,1,0.0
G25563T,1,0.0
spike-ACE2,1,0.0
hepato-pancreato-biliary,1,0.0
twenty-six,1,0.0
rampaging,1,0.0
concentrates,1,0.0
oleic,1,0.0
attendees,1,0.0
Al-Ain,1,0.0
Hoc,1,0.0
Ad,1,0.0
Eurotransplant,1,0.0
AgooseGuangdong196,1,0.0
intervariability,1,0.0
Arabic,1,0.0
phenotypic-directed,1,0.0
railed,1,0.0
2017381361-1363,1,0.0
Hosp,1,0.0
Infect,1,0.0
Workforce,1,0.0
subserving,1,0.0
anatomical-functional,1,0.0
Geynisman,1,0.0
Microcirculation,1,0.0
meso-diencephalic,1,0.0
fast-tracked,1,0.0
EPR,1,0.0
3136,1,0.0
contagions,1,0.0
99-166,1,0.0
744,1,0.0
Dox-cells,1,0.0
homeokinetic,1,0.0
4203,1,0.0
upset,1,0.0
Precipitating,1,0.0
afternoon,1,0.0
1970-1989,1,0.0
252AG,1,0.0
nonparametric,1,0.0
11136,1,0.0
SAPALDIA,1,0.0
Pollution,1,0.0
therapy-Adler,1,0.0
guanine,1,0.0
Chen,1,0.0
Bystrup,1,0.0
revisions,1,0.0
ischaemi,1,0.0
cropping,1,0.0
ECST,1,0.0
Lu,1,0.0
Microbe,1,0.0
Asturias,1,0.0
RIMAS,1,0.0
reoperations,1,0.0
cine-NMR,1,0.0
postcardiotomy-syndrome,1,0.0
respecified,1,0.0
decortication,1,0.0
segmentectomy,1,0.0
reasoned,1,0.0
Tet-notch4,1,0.0
embryoid,1,0.0
Besat,1,0.0
uninduced,1,0.0
Hydrocarbon,1,0.0
primary-care,1,0.0
18500,1,0.0
ACAS,1,0.0
NASCET,1,0.0
Endarterectomy,1,0.0
excuse,1,0.0
Kaplan,1,0.0
mind-body,1,0.0
N9,1,0.0
thrombovasculitis,1,0.0
Laflamme,1,0.0
possibleThere,1,0.0
villi,1,0.0
avascular,1,0.0
decidual,1,0.0
thromboinflammation-mediated,1,0.0
neonateThe,1,0.0
immunodefensive,1,0.0
womenIn,1,0.0
syndrome-coronavirus‑2,1,0.0
Fourty,1,0.0
2489,1,0.0
lighted,1,0.0
Authorizations,1,0.0
Administration-Emergency,1,0.0
DB14826,1,0.0
DB03714,1,0.0
DB02651,1,0.0
DB08248,1,0.0
-ACE2,1,0.0
influenza--H5N1,1,0.0
H7N9--has,1,0.0
appropriated,1,0.0
Briley-Saebo,1,0.0
N66,1,0.0
non-RCT,1,0.0
N65,1,0.0
duplicates,1,0.0
N197,1,0.0
EBM,1,0.0
undertakes,1,0.0
CBF-blood,1,0.0
Giovannone,1,0.0
Kattman,1,0.0
Mani,1,0.0
Qinggan,1,0.0
Jinhua,1,0.0
Yinqiao,1,0.0
Shigan,1,0.0
Maxing,1,0.0
Qingwen,1,0.0
Lianhua,1,0.0
Jiedu,1,0.0
Shufeng,1,0.0
single-molecule,1,0.0
Flk1,1,0.0
receptor-accessible,1,0.0
2002-2004,1,0.0
certifications,1,0.0
underusage,1,0.0
non-availability,1,0.0
briefing,1,0.0
Pathologists,1,0.0
SARS-coronavirus-2,1,0.0
Cats,1,0.0
5678,1,0.0
mlmin173,1,0.0
11120microl,1,0.0
2633,1,0.0
6079,1,0.0
053-082,1,0.0
perceptibly,1,0.0
host-host,1,0.0
Modulating,1,0.0
monotonically,1,0.0
050-090,1,0.0
outsized,1,0.0
Analogous,1,0.0
Structured,1,0.0
1994-95,1,0.0
1995-96,1,0.0
nosocominal,1,0.0
cannabidiol,1,0.0
microcirculatory,1,0.0
coasts,1,0.0
encephalitic,1,0.0
post-influenzal,1,0.0
Parkinsonism,1,0.0
neuro-psychiatric,1,0.0
guessed,1,0.0
1927,1,0.0
oromucosal,1,0.0
tetrahydrocannabinol,1,0.0
082-097,1,0.0
pregabalin,1,0.0
gabapentin,1,0.0
shooting,1,0.0
tingling,1,0.0
Wallenberg,1,0.0
Constitution,1,0.0
dispositions,1,0.0
Gulf,1,0.0
Habana,1,0.0
30-45,1,0.0
concealed,1,0.0
on-path,1,0.0
mid-2005,1,0.0
Elucidation,1,0.0
Remodelling,1,0.0
door-to-reperfusion,1,0.0
hyperfunction,1,0.0
impotence,1,0.0
Bladder,1,0.0
sudomotor,1,0.0
mesencephalon,1,0.0
doxcycline,1,0.0
co-medication,1,0.0
Drug-drug,1,0.0
epileptogenesis,1,0.0
CAVE,1,0.0
SeLECT,1,0.0
tet-notch4,1,0.0
ischemically,1,0.0
BNP-associated,1,0.0
natriuretric,1,0.0
ESCs,1,0.0
post-cocaine,1,0.0
conformations,1,0.0
ppm,1,0.0
cardialgia,1,0.0
high-hit,1,0.0
2000-2005,1,0.0
diagnostic-therapy-organizational,1,0.0
049-088,1,0.0
personalizing,1,0.0
028-072,1,0.0
re-assorted,1,0.0
cleave,1,0.0
026-070,1,0.0
-00032,1,0.0
-0027,1,0.0
city-specific,1,0.0
hypnosuggestive,1,0.0
dew,1,0.0
exposome,1,0.0
5301,1,0.0
Mini-Mult,1,0.0
hens,1,0.0
9266,1,0.0
GISRS,1,0.0
Sulfonylureas,1,0.0
scientometric,1,0.0
cardiac-penetrating,1,0.0
total-Ig,1,0.0
hints,1,0.0
displace,1,0.0
neuropharmacological,1,0.0
training-induced,1,0.0
denominators,1,0.0
neurodegenerationageing,1,0.0
paediatricdevelopmental,1,0.0
mentaladdictive,1,0.0
injurystroke,1,0.0
Blueprint,1,0.0
reorganizing,1,0.0
HDL-,1,0.0
S447X,1,0.0
124-534,1,0.0
HRR,1,0.0
123-1515,1,0.0
X447-containing,1,0.0
epsilon4-carrying,1,0.0
epsilon2-,1,0.0
S291-carrying,1,0.0
disseminates,1,0.0
escalates,1,0.0
Polar,1,0.0
synapses,1,0.0
gleaned,1,0.0
B-cell-,1,0.0
nitroxide,1,0.0
15N,1,0.0
MedlinePubMed,1,0.0
seacoast,1,0.0
Bilbao,1,0.0
IL-12-mediated,1,0.0
extragenic,1,0.0
proteo-genomic,1,0.0
speculative,1,0.0
ia,1,0.0
necrosed,1,0.0
acyl,1,0.0
sited,1,0.0
infae,1,0.0
29th,1,0.0
seletive,1,0.0
Oklahoma,1,0.0
widoweddivorced,1,0.0
36-item,1,0.0
Semnan,1,0.0
ethology,1,0.0
Feline,1,0.0
congressional,1,0.0
15-billion-a-year,1,0.0
protrudes,1,0.0
LRI,1,0.0
COVID-19-suspect,1,0.0
1114,1,0.0
isotype-specific,1,0.0
Favorable,1,0.0
agglomerated,1,0.0
January-30,1,0.0
Layer-PBL,1,0.0
Boundary,1,0.0
Planetary,1,0.0
Salivary,1,0.0
inhalable,1,0.0
creatinine-kinase,1,0.0
RFA-ablated,1,0.0
regenerated,1,0.0
RFA,1,0.0
Radiofrequency,1,0.0
improverestore,1,0.0
Engineered,1,0.0
microstructural,1,0.0
Indigenous-led,1,0.0
co-led,1,0.0
finger-prick,1,0.0
Multiple-target,1,0.0
LMT,1,0.0
reopenings,1,0.0
SFlu,1,0.0
26-19,1,0.0
7-fold,1,0.0
4-600,1,0.0
48-fold,1,0.0
Interval,1,0.0
Credible,1,0.0
753,1,0.0
Alinity™,1,0.0
580000,1,0.0
Robot-assisted,1,0.0
-2019,1,0.0
RNAish,1,0.0
IHC,1,0.0
formalin-fixed,1,0.0
PAO,1,0.0
pretraining,1,0.0
kinematic,1,0.0
immersive,1,0.0
assist-as-needed,1,0.0
flaccid,1,0.0
paraparesis,1,0.0
man-ifestations,1,0.0
activiation,1,0.0
1960s--may,1,0.0
case-fatality--which,1,0.0
serum-cholesterol,1,0.0
disease-prone,1,0.0
20th-century,1,0.0
source-subpopulation,1,0.0
expansions,1,0.0
somewhere,1,0.0
Gould,1,0.0
Jay,1,0.0
Stephen,1,0.0
WC,1,0.0
vascular-brain,1,0.0
185-187,1,0.0
Invest,1,0.0
waist-height,1,0.0
breakthroughs,1,0.0
T-V6,1,0.0
T-V1,1,0.0
deranged,1,0.0
kgm,1,0.0
Ecologic,1,0.0
Cross-reactive,1,0.0
auto-immune,1,0.0
0629,1,0.0
mesencephalic,1,0.0
swaying,1,0.0
4-32,1,0.0
Midbrain,1,0.0
Swaying,1,0.0
pontomedullary,1,0.0
hypercholesterolaemic,1,0.0
non-haemorrhagic,1,0.0
HMG-CoA,1,0.0
I20,1,0.0
BROCA,1,0.0
0325,1,0.0
I2135,1,0.0
147-253,1,0.0
149-260,1,0.0
5years,1,0.0
7days,1,0.0
9173,1,0.0
meta-analytical,1,0.0
Mimicry,1,0.0
45-50th,1,0.0
Veloergometry,1,0.0
micelles,1,0.0
093-097,1,0.0
T2-w,1,0.0
gradient-echo,1,0.0
Lobar,1,0.0
buried,1,0.0
tachyarrthythmias,1,0.0
laboratory-proven,1,0.0
calciﬁcation,1,0.0
primeval,1,0.0
viral-cell,1,0.0
deploys,1,0.0
no-touch,1,0.0
anaortic,1,0.0
tangential,1,0.0
transforms,1,0.0
Adoption,1,0.0
side-biting,1,0.0
cross-clamping,1,0.0
Worsening,1,0.0
Chronical,1,0.0
bilayered,1,0.0
recombined,1,0.0
MRIs,1,0.0
non-major,1,0.0
65-75,1,0.0
1613,1,0.0
WHtR,1,0.0
097-100,1,0.0
065-081,1,0.0
097-099,1,0.0
098-100,1,0.0
079-090,1,0.0
SROC,1,0.0
1485,1,0.0
2282,1,0.0
FQHC,1,0.0
denoting,1,0.0
Qualified,1,0.0
Federally,1,0.0
disease-state,1,0.0
one-on-one,1,0.0
340B,1,0.0
Ole,1,0.0
low-socioeconomic,1,0.0
65-74,1,0.0
Doubled-Vascular,1,0.0
rectify,1,0.0
Metis,1,0.0
susceptible-exposed-infectious-recovered,1,0.0
5414,1,0.0
redirection,1,0.0
acid-inducible,1,0.0
2014-April,1,0.0
kappa-light-chain-enhancer,1,0.0
IFN-λ3-treated,1,0.0
IFN-λ2-treated,1,0.0
P00028,1,0.0
A549-IFN-λ3,1,0.0
IFN-λ,1,0.0
shortlist,1,0.0
iPred,1,0.0
TCR,1,0.0
9-mer,1,0.0
Theranostics,1,0.0
NetMHCpan,1,0.0
outlier,1,0.0
72000,1,0.0
18-February-2020,1,0.0
0520,1,0.0
0978,1,0.0
Brewer,1,0.0
IFPMA,1,0.0
Supply,1,0.0
Middle-east,1,0.0
teen-caregiver,1,0.0
134±08,1,0.0
STAY,1,0.0
INF,1,0.0
-0713,1,0.0
-0655,1,0.0
peak-LDH,1,0.0
peak-GOT,1,0.0
peak-CPK,1,0.0
symptom-days,1,0.0
theranostics,1,0.0
volume1,1,0.0
high-consequence,1,0.0
Edition,1,0.0
increasement,1,0.0
unsatisfied,1,0.0
false‐negative,1,0.0
oropharyngealnasal,1,0.0
real‐time,1,0.0
unforeseeable,1,0.0
Baye,1,0.0
nonatrial,1,0.0
NHIRD,1,0.0
HADS-D,1,0.0
Camp,1,0.0
WV,1,0.0
GP-based,1,0.0
Conditions,1,0.0
subspecialty,1,0.0
Overcrowding,1,0.0
stood,1,0.0
SMILE,1,0.0
alpha2-adrenergic,1,0.0
Unrecognized,1,0.0
scuba,1,0.0
Calculations,1,0.0
β-chain,1,0.0
1481,1,0.0
5868,1,0.0
5763,1,0.0
transmediastinal,1,0.0
gunshot,1,0.0
conquer,1,0.0
extracardiac,1,0.0
Micro-neutralisation,1,0.0
T-cell-stimulating,1,0.0
suspensions,1,0.0
83-90,1,0.0
Cross-detection,1,0.0
Least,1,0.0
CEC,1,0.0
Registry-based,1,0.0
Contextual,1,0.0
Formula,1,0.0
iGLS,1,0.0
dirty,1,0.0
dishes,1,0.0
estimators,1,0.0
Squares,1,0.0
Galicia,1,0.0
A-5,1,0.0
waveform,1,0.0
flies,1,0.0
intervensions,1,0.0
crowding,1,0.0
gainfully,1,0.0
perimetric,1,0.0
D-5,1,0.0
C-6,1,0.0
B-6,1,0.0
HADS-A,1,0.0
imaging-fluid-attenuated,1,0.0
worst-case,1,0.0
trahydrofolate,1,0.0
hypo-methylated,1,0.0
coordinately,1,0.0
trans-acting,1,0.0
cis-acting,1,0.0
per-site,1,0.0
immune-relevant,1,0.0
50-74,1,0.0
radiologically,1,0.0
awake-onset,1,0.0
nonambulatory,1,0.0
drug-testing,1,0.0
Pharmacogenetics,1,0.0
task-oriented,1,0.0
2000-years,1,0.0
high-incidence,1,0.0
PPIs,1,0.0
TRFE,1,0.0
Transferrin,1,0.0
HPT,1,0.0
Haptoglobin,1,0.0
MTHFR677TT,1,0.0
polycomb-group,1,0.0
FOXP2,1,0.0
HLA-B,1,0.0
05-10,1,0.0
DHR,1,0.0
Alutard,1,0.0
PC35Gaw,1,0.0
607,1,0.0
Virologically,1,0.0
inotropics,1,0.0
cellsmL,1,0.0
186-485,1,0.0
2945,1,0.0
6952,1,0.0
HLA-DQB2,1,0.0
Chulalongkorn,1,0.0
RRT-requiring,1,0.0
HIV-related,1,0.0
mycoplasma,1,0.0
crystals,1,0.0
RESCUE,1,0.0
Fr,1,0.0
Thrombotic,1,0.0
impactful,1,0.0
677th,1,0.0
methylte,1,0.0
Laryngeal,1,0.0
tetrahydrofolate,1,0.0
‒,1,0.0
IJME,1,0.0
quickest,1,0.0
215-138,1,0.0
123-57,1,0.0
n12,1,0.0
Hanoi,1,0.0
pulsatile,1,0.0
osteocyte-derived,1,0.0
thombolytic,1,0.0
dwindling,1,0.0
Mid-April,1,0.0
197000,1,0.0
CUS3,1,0.0
A895V,1,0.0
long-segment,1,0.0
flap-like,1,0.0
A41V,1,0.0
S813I,1,0.0
protein-disrupting,1,0.0
gapless,1,0.0
Outdoor,1,0.0
Hua,1,0.0
Zhong,1,0.0
Rosenbergs,1,0.0
catalyzes,1,0.0
Reductase,1,0.0
Tetrahydrofolate,1,0.0
unfavorably,1,0.0
marginality,1,0.0
situate,1,0.0
redress,1,0.0
historiography,1,0.0
n59,1,0.0
morbimortality,1,0.0
nonmalignant,1,0.0
1–3,1,0.0
2–7,1,0.0
35–59,1,0.0
transesophagical,1,0.0
Ns,1,0.0
Sanger,1,0.0
HSPC,1,0.0
B-lineage,1,0.0
cocirculated,1,0.0
Endocrine,1,0.0
menopausal,1,0.0
Chengdu,1,0.0
Anaferon,1,0.0
Exon,1,0.0
S507C,1,0.0
F506L,1,0.0
NSP2,1,0.0
R203M,1,0.0
homology-based,1,0.0
Tendency,1,0.0
Silhouette,1,0.0
Hamming,1,0.0
ischemia--that,1,0.0
insults--such,1,0.0
-71·4,1,0.0
20·7,1,0.0
67·1,1,0.0
-40·9,1,0.0
31·9,1,0.0
Crude,1,0.0
92·6,1,0.0
40-y-old,1,0.0
nonintensive,1,0.0
post-EVT,1,0.0
gamma-interferon,1,0.0
children®,1,0.0
Nontransmural,1,0.0
AC®,1,0.0
0-002,1,0.0
code-level,1,0.0
4360,1,0.0
1996-1998,1,0.0
12577,1,0.0
Board-approved,1,0.0
16623,1,0.0
compelled,1,0.0
9899,1,0.0
SARS-CoV-2-positives,1,0.0
19-69,1,0.0
RNA-RT-PCR,1,0.0
bestoptimal,1,0.0
all-campus,1,0.0
sanitizer,1,0.0
microfoci,1,0.0
intermediary,1,0.0
precocity,1,0.0
transaminases,1,0.0
100-4800,1,0.0
Bates,1,0.0
Evidently,1,0.0
QS-wave,1,0.0
AMIpicture,1,0.0
ofpatients,1,0.0
protein-drug,1,0.0
pro-viral,1,0.0
benzomorphan,1,0.0
extralimbic,1,0.0
sigma-2,1,0.0
Orf9c,1,0.0
hypermetabolism,1,0.0
ameliorative,1,0.0
androgen,1,0.0
breeders,1,0.0
breeder,1,0.0
region-wide,1,0.0
2006-07,1,0.0
FES,1,0.0
four-channel,1,0.0
cineangiographically,1,0.0
hypermetabolic,1,0.0
cineventriculographic,1,0.0
10-yr-old,1,0.0
Neurons,1,0.0
Immunosuppressive,1,0.0
NSP6-drug,1,0.0
MESSAGES,1,0.0
•Inhibitors,1,0.0
Assessement,1,0.0
RAMI,1,0.0
Tomsk,1,0.0
dyskinesias,1,0.0
PSIs,1,0.0
Tab,1,0.0
CD81,1,0.0
CD66,1,0.0
CD69,1,0.0
dose--PD20,1,0.0
aer,1,0.0
•Antipsychotic,1,0.0
Tilade,1,0.0
PETCT,1,0.0
hyperresponsivness,1,0.0
Nedocromil,1,0.0
intermediate-risk,1,0.0
infection-naive,1,0.0
•Haloperidol,1,0.0
•These,1,0.0
•Dextromethorphan,1,0.0
multiplex-type,1,0.0
«SEIMC,1,0.0
2016»,1,0.0
immunotherapeutic,1,0.0
GWTG-Stroke,1,0.0
1028,1,0.0
RESULTS-,1,0.0
BACKGROUND-,1,0.0
lipohyalinosis,1,0.0
noninferiority,1,0.0
coumadin,1,0.0
preferring,1,0.0
Giulia,1,0.0
Venezia,1,0.0
Friuli,1,0.0
cutoffs,1,0.0
к,1,0.0
More-severe,1,0.0
Atheroma,1,0.0
cocirculation,1,0.0
postintubation,1,0.0
near-complete,1,0.0
narcosis,1,0.0
Tracheal,1,0.0
patientes,1,0.0
CONCLUSIONS-,1,0.0
first-grade,1,0.0
Anchorage,1,0.0
523194,1,0.0
reanalyzed,1,0.0
biometeorological,1,0.0
99mTc-diphosphonate,1,0.0
uremic,1,0.0
hyperparathyroidism,1,0.0
disables,1,0.0
depletes,1,0.0
tallies,1,0.0
5331,1,0.0
116771,1,0.0
Geographical,1,0.0
outright,1,0.0
refuses,1,0.0
Lipohyalinosis,1,0.0
Concurrently,1,0.0
overemphasized,1,0.0
00097,1,0.0
exposure-effect,1,0.0
123651,1,0.0
streets,1,0.0
Hip,1,0.0
gamut,1,0.0
Microbiologists,1,0.0
stairs,1,0.0
Coinciding,1,0.0
fo,1,0.0
Premonitory,1,0.0
multiparous,1,0.0
tumorigenesis-2,1,0.0
10-68,1,0.0
35-65,1,0.0
dynamin-dependent,1,0.0
clathrin-,1,0.0
CNE-2Z,1,0.0
Clínica,1,0.0
Microbiología,1,0.0
Infecciosasy,1,0.0
Enfermedades,1,0.0
Española,1,0.0
Sociedad,1,0.0
SLU,1,0.0
España,1,0.0
Elsevier,1,0.0
Melguizo,1,0.0
Soria,1,0.0
Illustrated,1,0.0
behavior-modification,1,0.0
conjointly,1,0.0
undiscovered,1,0.0
3032,1,0.0
MIDUS,1,0.0
Midlife,1,0.0
Niigata,1,0.0
long-term-care,1,0.0
t12-10-9s,1,0.0
•OH,1,0.0
Fenton,1,0.0
comprehend,1,0.0
thromboticfibrinolytic,1,0.0
Electromyography,1,0.0
antidiuretic,1,0.0
postresuscitation,1,0.0
hypothalamopituitary,1,0.0
nosologically,1,0.0
response--biofeedback,1,0.0
EDR--a,1,0.0
electrodermal,1,0.0
tension--and,1,0.0
EMG--a,1,0.0
direct-PTCA,1,0.0
ST--T,1,0.0
investigator-determined,1,0.0
NCT00712101,1,0.0
camper,1,0.0
38059,1,0.0
-of,1,0.0
protocol-defined,1,0.0
site-specific,1,0.0
5218,1,0.0
1955,1,0.0
years†,1,0.0
podding,1,0.0
7173,1,0.0
postarrival,1,0.0
pulsation,1,0.0
isolator,1,0.0
Santo,1,0.0
Espírito,1,0.0
CAST,1,0.0
Wingspan,1,0.0
neuro-interventionist,1,0.0
plowing,1,0.0
end-anastomosing,1,0.0
calibers,1,0.0
AIDA,1,0.0
TATORT,1,0.0
Anginal,1,0.0
NCT01612312,1,0.0
Chico,1,0.0
13th,1,0.0
WHOannounced,1,0.0
membersvisitors,1,0.0
Globalization,1,0.0
over-dispersion,1,0.0
integer-value,1,0.0
heteroscedastic,1,0.0
GARCH,1,0.0
integer-valued,1,0.0
log-linear,1,0.0
accumulative,1,0.0
Granger,1,0.0
25μm,1,0.0
Almeida,1,0.0
recentclose,1,0.0
Feature,1,0.0
anyone,1,0.0
ILIH1N1,1,0.0
rotated,1,0.0
1235,1,0.0
NAHA,1,0.0
0022Conclusions,1,0.0
241,1,0.0
studyResults,1,0.0
orthogonally,1,0.0
fear-appeal,1,0.0
70-year,1,0.0
2733,1,0.0
operable,1,0.0
sensitizer,1,0.0
vitality,1,0.0
bodily,1,0.0
shoes,1,0.0
socks,1,0.0
echoes,1,0.0
remembering,1,0.0
individualistic,1,0.0
medical-surgical,1,0.0
pentasaccharide,1,0.0
Xa-specific,1,0.0
forego,1,0.0
incident-definite,1,0.0
Organised,1,0.0
Limits,1,0.0
2010-2012,1,0.0
Extended,1,0.0
threatlow,1,0.0
efficacylow,1,0.0
RVPFR,1,0.0
32-92,1,0.0
SF-8,1,0.0
1006,1,0.0
OLIN,1,0.0
controlMethods,1,0.0
stress-redistribution,1,0.0
ck-levels,1,0.0
compliances,1,0.0
Proclamation,1,0.0
RVPER,1,0.0
between-subjects,1,0.0
Three-dimensional,1,0.0
longitidinal,1,0.0
dementias,1,0.0
precerebral,1,0.0
rheumatism,1,0.0
response-efficacy,1,0.0
high-efficacy,1,0.0
Dependent,1,0.0
pre-operative,1,0.0
SEREMI,1,0.0
august,1,0.0
6171,1,0.0
PARP1,1,0.0
treatment-naïve,1,0.0
OTV-treated,1,0.0
292K,1,0.0
119V,1,0.0
OTV-resistance,1,0.0
bled,1,0.0
deadline,1,0.0
serum-specific,1,0.0
510,1,0.0
intracranially,1,0.0
P1314,1,0.0
unilaterally,1,0.0
P15,1,0.0
N20,1,0.0
thalamic-pain-like,1,0.0
lemniscus,1,0.0
chemistrybiology,1,0.0
dominates,1,0.0
asparagine-to-glycine,1,0.0
PREVESE,1,0.0
N2013,1,0.0
274Y-containing,1,0.0
2336,1,0.0
re-occlusion,1,0.0
∼20,1,0.0
anxiety-related,1,0.0
experimentally-induced,1,0.0
P75,1,0.0
Crhr1,1,0.0
corticotropin,1,0.0
5Htr1a,1,0.0
∼50,1,0.0
SERT,1,0.0
P60,1,0.0
methacholine-induced,1,0.0
anxiety-,1,0.0
inflammationLabored,1,0.0
onceweek,1,0.0
Labored,1,0.0
timesweek,1,0.0
non-selective,1,0.0
N98,1,0.0
7-57,1,0.0
BALBcJ,1,0.0
depression-related,1,0.0
post-translational,1,0.0
Poly,1,0.0
2248,1,0.0
1914,1,0.0
105-167,1,0.0
3111,1,0.0
5-4,1,0.0
5-3,1,0.0
4-4,1,0.0
4-3,1,0.0
REGARDS,1,0.0
64-year-olds,1,0.0
well-informed,1,0.0
Standardizing,1,0.0
CDEs,1,0.0
Elements,1,0.0
IFNγ-based,1,0.0
immunotolerance,1,0.0
Interferon-gamma,1,0.0
-508,1,0.0
t233,1,0.0
829,1,0.0
1007,1,0.0
0346,1,0.0
0498,1,0.0
100-162,1,0.0
Multifactorial,1,0.0
stroke-in,1,0.0
preselection,1,0.0
Preceding,1,0.0
significant--age,1,0.0
prevous,1,0.0
sprayed,1,0.0
Glostrup,1,0.0
pulp,1,0.0
moldy,1,0.0
Symptomatology,1,0.0
influenza--a,1,0.0
step-like,1,0.0
dyslipidaemia-will,1,0.0
inducibility,1,0.0
Programmed,1,0.0
Parameters,1,0.0
Stroke-TPI,1,0.0
Instrument,1,0.0
Stroke-Thrombolytic,1,0.0
hypoglycaemia,1,0.0
normoglycaemia,1,0.0
Hyperglycaemia,1,0.0
NINDS,1,0.0
BPTs,1,0.0
alleviates,1,0.0
p00469,1,0.0
aerated,1,0.0
4-164,1,0.0
600years,1,0.0
27-81,1,0.0
ATI,1,0.0
nephrotoxic,1,0.0
hematuria,1,0.0
5-23,1,0.0
14741,1,0.0
underreporting,1,0.0
broncho,1,0.0
mined,1,0.0
desquamating,1,0.0
platn,1,0.0
Uninfected,1,0.0
outpatient-treated,1,0.0
LTRs,1,0.0
Mycology,1,0.0
unresponsive,1,0.0
low-output,1,0.0
random-mixing,1,0.0
DLVpulmonary,1,0.0
p00161,1,0.0
JMEI,1,0.0
10-34,1,0.0
dynamism,1,0.0
1910,1,0.0
dysregulations,1,0.0
witnesses,1,0.0
16760,1,0.0
prodigious,1,0.0
shadowed,1,0.0
case-matched,1,0.0
psychiatrists,1,0.0
still-developing,1,0.0
clozapine,1,0.0
blurred,1,0.0
jurisdiction,1,0.0
curve60,1,0.0
GASROS,1,0.0
Affecting,1,0.0
ICD8,1,0.0
1969-78,1,0.0
1979-88,1,0.0
mid-1970s,1,0.0
35-59,1,0.0
absorbed,1,0.0
A2009H1N1,1,0.0
dissipation,1,0.0
non-smoker,1,0.0
vertebro-basilar,1,0.0
Medullary,1,0.0
GAPs,1,0.0
policy-makers,1,0.0
Seventy-seven,1,0.0
httpwwwwhointinfluenzavaccinesplanen,1,0.0
indicted,1,0.0
didnt,1,0.0
Dosage,1,0.0
fetusesnewborns,1,0.0
pro-resolving,1,0.0
-054,1,0.0
-044,1,0.0
SDcord,1,0.0
2-299,1,0.0
controlsABSTRACT,1,0.0
decoded,1,0.0
disagreeing,1,0.0
Sumarokov,1,0.0
Bashliaeva,1,0.0
ZA,1,0.0
Medulla,1,0.0
conglomerate,1,0.0
tiny,1,0.0
disproportional,1,0.0
Descending,1,0.0
RIVA,1,0.0
interferon-α2a,1,0.0
DABI,1,0.0
Interruption,1,0.0
Cocaine-induced,1,0.0
efferent,1,0.0
H1N1S-OIV,1,0.0
stuffiness,1,0.0
HeadPoST,1,0.0
Forensic,1,0.0
Positioning,1,0.0
indwelling,1,0.0
interalveolar,1,0.0
fibrin-macrophagic,1,0.0
proteinaceous,1,0.0
Mehedinţi,1,0.0
Severin,1,0.0
Turnu,1,0.0
Drobeta,1,0.0
SHARP,1,0.0
cholesterol-absorption,1,0.0
ezetimide,1,0.0
multiple-vessel,1,0.0
Senescence,1,0.0
PGD2-related,1,0.0
vasodilation-extravasation,1,0.0
DP-mediated,1,0.0
VTM-3941,1,0.0
PGD2-induced,1,0.0
D2,1,0.0
Prostaglandin,1,0.0
endoscopic-related,1,0.0
jaundice,1,0.0
microbiologists,1,0.0
technologists,1,0.0
Well-trained,1,0.0
investing,1,0.0
293-2870,1,0.0
bibasal,1,0.0
BHH,1,0.0
Heartlands,1,0.0
semi-emergent,1,0.0
balloon-dependent,1,0.0
unyielding,1,0.0
Senescent,1,0.0
influenza-mediated,1,0.0
multimers,1,0.0
fibrinogen-beta,1,0.0
mixes,1,0.0
times-to-inactivation,1,0.0
primerprobe-set,1,0.0
vasotherapeutics,1,0.0
choline,1,0.0
brain-protective,1,0.0
brain-based,1,0.0
50-kb,1,0.0
fibrinogen-gamma,1,0.0
fibrinogen-alpha,1,0.0
microcirculatures,1,0.0
hypobaric,1,0.0
2021-With,1,0.0
119-127,1,0.0
Biol,1,0.0
Alt,1,0.0
Grissom,1,0.0
Colin,1,0.0
Andrew,1,0.0
Luks,1,0.0
SKPTCA,1,0.0
stablished,1,0.0
Single-radial-immunodiffusion,1,0.0
unveiling,1,0.0
granular,1,0.0
post-PCR,1,0.0
PCRTaqMan,1,0.0
Yoga,1,0.0
Nm2,1,0.0
Frictional,1,0.0
flowing,1,0.0
caught,1,0.0
2002--2003,1,0.0
2000--2001,1,0.0
High-resolution,1,0.0
9624,1,0.0
BYamagata1688-like,1,0.0
BVictoria287-like,1,0.0
3C,1,0.0
proteome-wide,1,0.0
heritability,1,0.0
high-attenuation,1,0.0
meta-analyse,1,0.0
contralesioned,1,0.0
Conflicting,1,0.0
numberrate,1,0.0
psoralen,1,0.0
morphea,1,0.0
3D-CTA,1,0.0
CESI,1,0.0
VTM-4141,1,0.0
AHK21203-like,1,0.0
AHK21303,1,0.0
AHK21203,1,0.0
GH,1,0.0
UH,1,0.0
VTM-8181,1,0.0
Classified,1,0.0
MRIor,1,0.0
socioeconomical,1,0.0
infarctionNINDS-III,1,0.0
Supra-tentorial,1,0.0
serum-expanded,1,0.0
auto,1,0.0
uniformity,1,0.0
SACAWG,1,0.0
inherit,1,0.0
DNA-,1,0.0
delegates,1,0.0
49-54,1,0.0
laboratory-verified,1,0.0
long-held,1,0.0
embolectomy,1,0.0
Bloom,1,0.0
Iwai,1,0.0
LN,1,0.0
Sekhar,1,0.0
republished,1,0.0
bail-out,1,0.0
punctures,1,0.0
stroke23,1,0.0
Radial,1,0.0
patients1,1,0.0
Healthcare-acquired,1,0.0
Transcriptomic,1,0.0
suppressor,1,0.0
labyrinthine,1,0.0
neuro-otologists,1,0.0
central-type,1,0.0
skew,1,0.0
gaze-holding,1,0.0
4421,1,0.0
MEFR75--p,1,0.0
MEFR50--p,1,0.0
Vein,1,0.0
1993334723-727,1,0.0
3-35-fold,1,0.0
interventionist,1,0.0
1118,1,0.0
1060,1,0.0
1063,1,0.0
626,1,0.0
Implementations,1,0.0
albuminuria,1,0.0
Publishing,1,0.0
©2013,1,0.0
201469652-657,1,0.0
Transcervical,1,0.0
Grandhi,1,0.0
Ribo,1,0.0
Jadkhav,1,0.0
antilipidemic,1,0.0
Power,1,0.0
Sarah,1,0.0
©The,1,0.0
2019117647-652,1,0.0
Looby,1,0.0
Griffin,1,0.0
Surgeons,1,0.0
MEFR25,1,0.0
flowmetric,1,0.0
pneumotachometry,1,0.0
Dynamics,1,0.0
seat,1,0.0
UCLA,1,0.0
Kids,1,0.0
normalised,1,0.0
enhancement-magnetic,1,0.0
Genevas,1,0.0
hyperrepsonsiveness,1,0.0
Bland,1,0.0
commence,1,0.0
dosimeter,1,0.0
repeatabilty,1,0.0
preemptively,1,0.0
imitate,1,0.0
caudodorsal,1,0.0
α-smooth,1,0.0
histomorphometry,1,0.0
pulmonale,1,0.0
cor,1,0.0
Junipers,1,0.0
463,1,0.0
normoglycemia,1,0.0
signals--red,1,0.0
green--pediatricians,1,0.0
aggravators,1,0.0
Stage-by-stage,1,0.0
bubbling,1,0.0
Auscultation,1,0.0
subfebrile,1,0.0
thigh-focused,1,0.0
unproductive,1,0.0
Peripartum,1,0.0
reoriented,1,0.0
non-optimal,1,0.0
counterbalance,1,0.0
E-POL,1,0.0
twitchy,1,0.0
theophylline-sensitive,1,0.0
alpha-galactosidase,1,0.0
LiTR,1,0.0
liver-to-thoracic,1,0.0
L-CDH,1,0.0
inquire,1,0.0
hubs,1,0.0
Consequentially,1,0.0
non-existent,1,0.0
00325,1,0.0
WMA,1,0.0
glutaryl-Coenzyme-A,1,0.0
lectured,1,0.0
VIRAMED-SARS-CoV-2-ViraChip,1,0.0
Roche-Elecsys-Anti-SARS-CoV-2,1,0.0
Euroimmun-Anti-SARS-CoV-2-ELISA-IgAIgG,1,0.0
n5374,1,0.0
n1091,1,0.0
true-negatives,1,0.0
n193,1,0.0
6658,1,0.0
neededWe,1,0.0
seroassays,1,0.0
DUS,1,0.0
doppler,1,0.0
thromboembolus,1,0.0
ceaseless,1,0.0
fine-tuned,1,0.0
ASMs,1,0.0
deflated,1,0.0
spurious,1,0.0
httpsdoiorg101016jscitotenv2020138704,1,0.0
doi,1,0.0
authored,1,0.0
Mikrogen-recomLine-SARS-CoV-2-IgG,1,0.0
Euroimmun-anti-S1-IgG,1,0.0
772798,1,0.0
recomLine-RBD,1,0.0
1981-1984,1,0.0
SE-AZh,1,0.0
3-7-year-old,1,0.0
1983--first,1,0.0
autumn-winter,1,0.0
1515,1,0.0
Verona,1,0.0
80000,1,0.0
Head-to-head,1,0.0
GeneScriptcPassTM,1,0.0
manufacturersoptimised,1,0.0
Optimised,1,0.0
Mikrogen-recomLine-RBD,1,0.0
Neutralisation,1,0.0
Virus-neutralisation,1,0.0
RT-PCR-positivity,1,0.0
-IgG,1,0.0
998997,1,0.0
855886,1,0.0
980978,1,0.0
Pulmonology,1,0.0
LASS,1,0.0
1218,1,0.0
Lara,1,0.0
hospitalization，,1,0.0
day，,1,0.0
heat，,1,0.0
patients，,1,0.0
3A,1,0.0
systemHIS,1,0.0
space-time，,1,0.0
40-60,1,0.0
benefitted,1,0.0
nitrate-treated,1,0.0
radioisotopes,1,0.0
3-hydroxy-3,1,0.0
phenylephrine,1,0.0
urgencies,1,0.0
teeth,1,0.0
repairs,1,0.0
nullomer,1,0.0
reverse-vaccinology,1,0.0
legitimate,1,0.0
Alarms,1,0.0
ND,1,0.0
stasis，,1,0.0
drugs，,1,0.0
phlegm,1,0.0
Fulton,1,0.0
ATAQ,1,0.0
tangible,1,0.0
redistribute,1,0.0
contemporarily,1,0.0
gingivitis,1,0.0
non-statistical,1,0.0
calculus,1,0.0
gingival,1,0.0
3395,1,0.0
Fowkes,1,0.0
refreshing,1,0.0
OpenGrey,1,0.0
LILACS,1,0.0
out，,1,0.0
dug,1,0.0
patient-syndrome-drug-time-effective,1,0.0
theory，,1,0.0
space-time,1,0.0
research，,1,0.0
urgent，,1,0.0
Influenza-for,1,0.0
NOW®,1,0.0
tests-BD,1,0.0
AstraZenecas,1,0.0
tessutal,1,0.0
vasopressor,1,0.0
volemic,1,0.0
breath-ing,1,0.0
130000,1,0.0
acute-stage,1,0.0
sympathoexcitation,1,0.0
cannabinoid,1,0.0
endocannabinoid,1,0.0
085-162,1,0.0
socieoeconomic,1,0.0
113-193,1,0.0
agesex-adjusted,1,0.0
113-202,1,0.0
sociodemographics,1,0.0
91000,1,0.0
101000,1,0.0
131000,1,0.0
69±10,1,0.0
3298,1,0.0
Multivariable-adjusted,1,0.0
PfizerBioNTechs,1,0.0
Gamaleyas,1,0.0
Hypercoagulability,1,0.0
PWIDWI,1,0.0
I63,1,0.0
cross-regionally,1,0.0
interleukine-6,1,0.0
deceased-donor,1,0.0
allografts,1,0.0
31-58,1,0.0
Quartile,1,0.0
Inter,1,0.0
post-diagnosis,1,0.0
Fifty-five,1,0.0
epicenters,1,0.0
Bronx,1,0.0
propagules,1,0.0
hearing,1,0.0
somnolence,1,0.0
32-38,1,0.0
25-32,1,0.0
Fam,1,0.0
subgrouped,1,0.0
roentgenography,1,0.0
MEP,1,0.0
14±7,1,0.0
Manhattan,1,0.0
whereof,1,0.0
paraspinous,1,0.0
adhering,1,0.0
friable,1,0.0
open-cell,1,0.0
procedure-related,1,0.0
Procedure-related,1,0.0
SARS-CoV-2hepatitis,1,0.0
continuance,1,0.0
inclusivityopenness,1,0.0
httpisaregistriesorg,1,0.0
intraoperability,1,0.0
carotid-plaque,1,0.0
reinvigorated,1,0.0
small-cell,1,0.0
octreotide,1,0.0
non-winter,1,0.0
non-professional,1,0.0
extinguished,1,0.0
fundus,1,0.0
pucker,1,0.0
macular,1,0.0
decides,1,0.0
thromboatherosclerotic,1,0.0
e-stim,1,0.0
Urokinase,1,0.0
008-014,1,0.0
para-aortic,1,0.0
Azygos-pleural,1,0.0
disappears,1,0.0
fuel,1,0.0
posteriorly,1,0.0
damp,1,0.0
marginated,1,0.0
contours,1,0.0
2821-2849,1,0.0
CCL81,1,0.0
clot-specific,1,0.0
MIsABSTRACT,1,0.0
subsetting,1,0.0
12490,1,0.0
17187,1,0.0
11712,1,0.0
3539,1,0.0
Techniques,1,0.0
ST-segments,1,0.0
reestablished,1,0.0
well-organised,1,0.0
Dermatology,1,0.0
hyposensitation,1,0.0
bowling,1,0.0
strokestransitory,1,0.0
thereunder,1,0.0
less-focused,1,0.0
purposefully,1,0.0
distorts,1,0.0
clarifies,1,0.0
1170,1,0.0
samplespotentially,1,0.0
proportion-positive,1,0.0
p031,1,0.0
thresholdCt,1,0.0
refrigeration,1,0.0
027–093,1,0.0
95confidence,1,0.0
arteriogrpahy,1,0.0
7833,1,0.0
8°C,1,0.0
4°Cfor,1,0.0
challengingGuidelines,1,0.0
httpsbitly3gpBC75,1,0.0
jogging,1,0.0
TH1-type,1,0.0
alternata,1,0.0
acid-human,1,0.0
everybody,1,0.0
non-progressing,1,0.0
kringle,1,0.0
full-dose,1,0.0
IV-IA,1,0.0
intravenous-inter-arterial,1,0.0
35Lmin,1,0.0
microaxial,1,0.0
cardiac-assist,1,0.0
counter-shocks,1,0.0
sea-side,1,0.0
PA-HSA,1,0.0
Eysenck,1,0.0
carried-out,1,0.0
asthma-prurigo,1,0.0
berry,1,0.0
hypoglycaemic,1,0.0
coagulopathies,1,0.0
vasculitides,1,0.0
cursorily,1,0.0
beforehand,1,0.0
gateball,1,0.0
golf,1,0.0
MVA,1,0.0
prodromata,1,0.0
trombolytic,1,0.0
unadvisable,1,0.0
titrate,1,0.0
calcium-antagonists--the,1,0.0
nitrodrivatives,1,0.0
therapies--ie,1,0.0
shRNA,1,0.0
pDNA,1,0.0
cargos,1,0.0
lung-targeted,1,0.0
transfect,1,0.0
NF55,1,0.0
PF14,1,0.0
didactic,1,0.0
httpbiszjueducnovercovid,1,0.0
discretely,1,0.0
Teams,1,0.0
Bringing,1,0.0
interatomic,1,0.0
infuse,1,0.0
81-year-old,1,0.0
BackgroundEvidence,1,0.0
incompleteAimsThis,1,0.0
oseltamivirMethodsParticipants,1,0.0
Enjoyment,1,0.0
B--70,1,0.0
A--55,1,0.0
southwest,1,0.0
subepidermal,1,0.0
blistering,1,0.0
MLC601,1,0.0
CHIMES,1,0.0
devolution,1,0.0
asset-based,1,0.0
7-12,1,0.0
analysisResultsThe,1,0.0
50-500,1,0.0
XPS,1,0.0
photoelectron,1,0.0
nanostructures,1,0.0
Laser-scribed,1,0.0
complying,1,0.0
IDSA,1,0.0
influenzaConclusionsOseltamivir,1,0.0
011-093,1,0.0
sepsis-induced,1,0.0
creeping,1,0.0
dihydrate,1,0.0
non-cognitive,1,0.0
HypAir,1,0.0
Medisoft,1,0.0
electrochemical-based,1,0.0
on-and-off,1,0.0
triples,1,0.0
uncharacteristic,1,0.0
Microbiological,1,0.0
subordinate,1,0.0
Pneumococcus,1,0.0
CRB-65,1,0.0
anti-BPO-IgE,1,0.0
anti-BPO-IgG,1,0.0
C1q-binding,1,0.0
turboinhaler,1,0.0
Spinhaler,1,0.0
chloramphenicol,1,0.0
ampicillin,1,0.0
hyperventilated,1,0.0
BPO,1,0.0
benzylpenicilloyl,1,0.0
nephroureterotomy,1,0.0
chemiluminescence-based,1,0.0
navigateaccess,1,0.0
Catarina,1,0.0
5-HL,1,0.0
helpfulABSTRACT,1,0.0
woken,1,0.0
lmin-1,1,0.0
non-enveloped,1,0.0
2020433e151-e158,1,0.0
embroidery,1,0.0
0628-0885,1,0.0
0749,1,0.0
0663-0871,1,0.0
0762,1,0.0
Xa,1,0.0
2614-5406,1,0.0
3824,1,0.0
knitting,1,0.0
2272,1,0.0
TKAs,1,0.0
153245,1,0.0
Humana,1,0.0
uPA,1,0.0
urokinase-type,1,0.0
renin-aldosterone-angiotensin-system,1,0.0
nephrolithiasis,1,0.0
antibiotic-producing,1,0.0
clinimetric,1,0.0
AHSN,1,0.0
vi-,1,0.0
Interhospital,1,0.0
hu-,1,0.0
entific,1,0.0
sci-,1,0.0
foetal,1,0.0
Obviously,1,0.0
ritodrine,1,0.0
13826,1,0.0
flowmeter,1,0.0
nonlinearity,1,0.0
AmpliQuick®,1,0.0
Rapids,1,0.0
treatment--could,1,0.0
individuals--eg,1,0.0
Paradoxically,1,0.0
airborne-transmissible,1,0.0
Zoonotic,1,0.0
study--ten,1,0.0
radiotopography,1,0.0
cardiotopography,1,0.0
rus,1,0.0
patholog-,1,0.0
ical,1,0.0
effectsOur,1,0.0
CG180,1,0.0
villagers,1,0.0
well-identified,1,0.0
diasthesis,1,0.0
12-37,1,0.0
tantamount,1,0.0
emergencycompassionate,1,0.0
Phases,1,0.0
raging,1,0.0
55-75,1,0.0
epithe-,1,0.0
13-22,1,0.0
∼3,1,0.0
6-9,1,0.0
statusOf,1,0.0
≥450,1,0.0
±6,1,0.0
non-OCS,1,0.0
EuropeWe,1,0.0
lial,1,0.0
immobility,1,0.0
Avant,1,0.0
reciprocally,1,0.0
communicability,1,0.0
strokes-196,1,0.0
4038,1,0.0
Station,1,0.0
Hydrometeorological,1,0.0
sensibilisation,1,0.0
sulphite-sensitive,1,0.0
themed,1,0.0
Claiborne-Johnston,1,0.0
Chalela,1,0.0
Sulphites,1,0.0
subtropicaltropical,1,0.0
vapour,1,0.0
2000-2007,1,0.0
Territory,1,0.0
Kongs,1,0.0
June-September,1,0.0
November-March,1,0.0
mid-way,1,0.0
Necessarily,1,0.0
Bronchiale,1,0.0
Difficult-to-Treat,1,0.0
-0016,1,0.0
IgE-allergen,1,0.0
-0006,1,0.0
hastened,1,0.0
Tubarão,1,0.0
profuse,1,0.0
lacrimation,1,0.0
Xe133,1,0.0
intrarenal,1,0.0
necrobiotic,1,0.0
dystrophic,1,0.0
histometric,1,0.0
One-fifth,1,0.0
pine,1,0.0
-0003,1,0.0
unremittingly,1,0.0
non-Jewish,1,0.0
faster-spreading,1,0.0
Cominarty,1,0.0
sixfold,1,0.0
histamine-PC20,1,0.0
Cockroft,1,0.0
gargling,1,0.0
55-64,1,0.0
Cold-adapted,1,0.0
ALLHAT,1,0.0
OSHA,1,0.0
ANBP2,1,0.0
tragically,1,0.0
reverse-transcriptase-polymerase-chain-reaction,1,0.0
rhinorhea,1,0.0
cardiotonic,1,0.0
Glucagon,1,0.0
reanimation,1,0.0
abort,1,0.0
recurrent--are,1,0.0
VF--primary,1,0.0
281010135,1,0.0
5713811,1,0.0
18756008,1,0.0
Jakarta,1,0.0
2011-September,1,0.0
BA44,1,0.0
compartmentalization,1,0.0
Goroka,1,0.0
Self-protection,1,0.0
inconveniences,1,0.0
PURPOSE,1,0.0
PTAS,1,0.0
Morris,1,0.0
Mission11918,1,0.0
shoppong,1,0.0
self-awareness,1,0.0
SCOPE,1,0.0
NORDIL,1,0.0
HOPE,1,0.0
CAPPP,1,0.0
PATS,1,0.0
rupturing,1,0.0
Charcot-Bouchard,1,0.0
SITS-MOST,1,0.0
PROSIT,1,0.0
crystallization,1,0.0
basket,1,0.0
immersion,1,0.0
Interpretive,1,0.0
interpretive,1,0.0
pessimism,1,0.0
Carrying,1,0.0
sustained-handgrip,1,0.0
convalescing,1,0.0
ABrevig,1,0.0
rucksack,1,0.0
Intermediate,1,0.0
stroke-affected,1,0.0
one-to-one,1,0.0
Vecuronium,1,0.0
isoflurane,1,0.0
enflurane,1,0.0
Halothane,1,0.0
etomidate,1,0.0
histamine-induced,1,0.0
minimizes,1,0.0
Lidocaine,1,0.0
≥55,1,0.0
Anaesthetic,1,0.0
infarctionrevascularizationangina,1,0.0
deathmyocardial,1,0.0
1995-1998,1,0.0
pairwise,1,0.0
ANOVAs,1,0.0
Kruskal-Wallis,1,0.0
40-44,1,0.0
6971,1,0.0
4272,1,0.0
Specimens,1,0.0
explorations,1,0.0
Aetiological,1,0.0
Sevoflurane,1,0.0
rocuronium,1,0.0
fractionate,1,0.0
cisatracurium,1,0.0
multiyear,1,0.0
HAIVEN,1,0.0
NAVY,1,0.0
hyperpyretic,1,0.0
Accountancy,1,0.0
Latent,1,0.0
servicemen,1,0.0
compulsory-duty,1,0.0
hipurgia,1,0.0
long-termed,1,0.0
hospices,1,0.0
gravidas,1,0.0
teen-agers,1,0.0
eruption,1,0.0
syb-type,1,0.0
783180968,1,0.0
piggy,1,0.0
dose-dependently,1,0.0
mivacurium,1,0.0
atracurium,1,0.0
pancuronium,1,0.0
appeal,1,0.0
Deciding,1,0.0
Age-,1,0.0
children5,1,0.0
archetypes,1,0.0
inferiorlateral,1,0.0
140690-700e8,1,0.0
204352,1,0.0
YM,1,0.0
Encouragingly,1,0.0
nalmefene,1,0.0
clomethiazole,1,0.0
anti-leucocyte,1,0.0
lysing,1,0.0
α-26-linked,1,0.0
vv,1,0.0
inactivator,1,0.0
β-propiolactone,1,0.0
whole-virus,1,0.0
aortography,1,0.0
Neutral,1,0.0
Non-uniform,1,0.0
NSP12b,1,0.0
parsimony,1,0.0
ws-SNPsGO,1,0.0
flow-related,1,0.0
Nonsevere,1,0.0
Constricted,1,0.0
-310,1,0.0
CVEs,1,0.0
same-household,1,0.0
packed,1,0.0
Percheron,1,0.0
quasispecies,1,0.0
NS1-T123V,1,0.0
PB2-E627K,1,0.0
D222E,1,0.0
HA-D222N,1,0.0
D222G,1,0.0
impinged,1,0.0
writing-up,1,0.0
STROBE,1,0.0
Searches,1,0.0
metabisulphites,1,0.0
metabisulphates,1,0.0
Sulfites,1,0.0
cluster-specific,1,0.0
depositions,1,0.0
bifurcations,1,0.0
breath-omics,1,0.0
aftercare,1,0.0
1943421452,1,0.0
ascaris-endemic,1,0.0
Papanicolaou,1,0.0
cervix,1,0.0
eluded,1,0.0
software-generated,1,0.0
9944,1,0.0
UNG,1,0.0
glycosylase,1,0.0
uracil-DNA,1,0.0
Thermus,1,0.0
KOD1,1,0.0
kodakarensis,1,0.0
Thermococcus,1,0.0
K4,1,0.0
petrophila,1,0.0
Thermotoga,1,0.0
Moloney,1,0.0
heat-resistant,1,0.0
polymerases,1,0.0
transcriptases,1,0.0
pharmacoinvasive,1,0.0
protein-aided,1,0.0
LBC,1,0.0
symposium,1,0.0
heptamer,1,0.0
grey60,1,0.0
Phosphate,1,0.0
EPM2AIP1,1,0.0
SPRTN,1,0.0
KLHL28,1,0.0
RP11-847H182,1,0.0
lncRNA-mRNAs,1,0.0
lncRNAmRNA,1,0.0
darkred,1,0.0
lightgreen,1,0.0
saddlebrown,1,0.0
brain-saving,1,0.0
co-expression,1,0.0
multisectoral,1,0.0
volunteerism,1,0.0
Counterbalancing,1,0.0
theater,1,0.0
aides,1,0.0
7-year-old,1,0.0
n125,1,0.0
nine-week,1,0.0
Faecal,1,0.0
Tanzanian,1,0.0
Th1-type,1,0.0
470000,1,0.0
elder,1,0.0
B-types,1,0.0
inhibitorsThe,1,0.0
Wave,1,0.0
IWK,1,0.0
showcasing,1,0.0
rabies,1,0.0
spitting,1,0.0
deliberately,1,0.0
multiplying,1,0.0
disregarding,1,0.0
self-confinement,1,0.0
super-emitters,1,0.0
super-spreaders,1,0.0
irresponsible,1,0.0
odd,1,0.0
mortal,1,0.0
outcomes-it,1,0.0
Human-severe,1,0.0
astute,1,0.0
allergen-related,1,0.0
precedence,1,0.0
Scotia,1,0.0
foal,1,0.0
FKBP4,1,0.0
Implicit,1,0.0
artery-associated,1,0.0
emanating,1,0.0
punctate,1,0.0
mHla,1,0.0
E627K,1,0.0
Windsor,1,0.0
Nova,1,0.0
Hsp70,1,0.0
Alteration,1,0.0
Hypersensitivity,1,0.0
signal-associated,1,0.0
iTRAQ,1,0.0
627K,1,0.0
tachycardias,1,0.0
mgHg,1,0.0
Saxony-Anhalt,1,0.0
cortico-subcortical,1,0.0
filly,1,0.0
sulfonamide,1,0.0
PROVEAN,1,0.0
SIFT,1,0.0
Detective,1,0.0
Glycomics,1,0.0
500000,1,0.0
Consumption,1,0.0
consume,1,0.0
drink,1,0.0
Illinois,1,0.0
20-71,1,0.0
bulgaricus,1,0.0
ssp,1,0.0
delbrueckii,1,0.0
Lactobacillus,1,0.0
physical-activity-related,1,0.0
federally,1,0.0
Fomite,1,0.0
director,1,0.0
Endpoint,1,0.0
≥34,1,0.0
3237,1,0.0
Ct≥34,1,0.0
Modular,1,0.0
dietitian,1,0.0
Li,1,0.0
turning,1,0.0
Suzhou,1,0.0
leftventricular,1,0.0
audited,1,0.0
purpose-built,1,0.0
preconfigured,1,0.0
upload,1,0.0
biobank,1,0.0
Biobanks,1,0.0
screenings,1,0.0
facilities--these,1,0.0
methylxanthines,1,0.0
step--elimination,1,0.0
criterion-based,1,0.0
Physiotherapy,1,0.0
neighborhood-level,1,0.0
individual-,1,0.0
toxics,1,0.0
antinflammatory,1,0.0
reexposure,1,0.0
arming,1,0.0
beneath,1,0.0
Histopathologic,1,0.0
predicated,1,0.0
Zixiao,1,0.0
alphabet,1,0.0
V4-V6,1,0.0
habitats,1,0.0
Hospitalisations,1,0.0
F₂-isoprostanes,1,0.0
E₂-isoprostanes,1,0.0
D₂-,1,0.0
F₂-isoprostane,1,0.0
isoprostane,1,0.0
prostane,1,0.0
non-enzymatic,1,0.0
PG-like,1,0.0
Isoprostanes,1,0.0
halved,1,0.0
confidential,1,0.0
BTA,1,0.0
insulo-opercular,1,0.0
enrichment-based,1,0.0
contig,1,0.0
24-hours,1,0.0
UFH,1,0.0
LMWHs,1,0.0
praise,1,0.0
disregard,1,0.0
Biochemistry,1,0.0
lady,1,0.0
negotiate,1,0.0
cladribine,1,0.0
proofing,1,0.0
ARIs,1,0.0
Oviedo,1,0.0
Huelva,1,0.0
Galdakao,1,0.0
Albacete,1,0.0
Mexican-American,1,0.0
photovoice,1,0.0
Coordinating,1,0.0
alemtuzumab,1,0.0
anti-anginal,1,0.0
ofatumumab,1,0.0
ocrelizumab,1,0.0
cell-depleting,1,0.0
natalizumab,1,0.0
fumarates,1,0.0
teriflunomide,1,0.0
glatiramer,1,0.0
Interferon-beta,1,0.0
Live-attenuated,1,0.0
V1-V3,1,0.0
10144,1,0.0
MEGA,1,0.0
aircrafts,1,0.0
DBPC,1,0.0
1X108CFU,1,0.0
17938,1,0.0
DSM,1,0.0
protein-bound,1,0.0
Antigen-induced,1,0.0
httpcovdbpopgeneticsnet,1,0.0
subcellular,1,0.0
Baltic,1,0.0
exemplifies,1,0.0
self-quarantine,1,0.0
Resurgences,1,0.0
barely,1,0.0
agreedExpert,1,0.0
send,1,0.0
controlledAreas,1,0.0
Modern,1,0.0
rhino-,1,0.0
onboard,1,0.0
aircraft,1,0.0
laryngo-bronchial,1,0.0
T-2,1,0.0
108CFU,1,0.0
exaled,1,0.0
human-transmissible,1,0.0
Mutational,1,0.0
Inaccurate,1,0.0
intra-alveolar,1,0.0
desquamation,1,0.0
broncho-interstitial,1,0.0
euthanatized,1,0.0
Kong15697,1,0.0
fascicularis,1,0.0
Macaca,1,0.0
DNA-binding,1,0.0
p0045,1,0.0
S3P,1,0.0
40S,1,0.0
Ribosomal,1,0.0
annually6,1,0.0
vaccinations5,1,0.0
viruses4,1,0.0
flares,1,0.0
Aeroallergens,1,0.0
CFU,1,0.0
Air-Mobile,1,0.0
nil,1,0.0
Meta-Analysis,1,0.0
well-managed,1,0.0
coronaviruss,1,0.0
endotoxins,1,0.0
dependant,1,0.0
antiparasites,1,0.0
fungicides,1,0.0
herbicides,1,0.0
arthropod,1,0.0
textiles,1,0.0
cereals,1,0.0
polysensitization,1,0.0
3-77,1,0.0
Couples,1,0.0
Self-ratings,1,0.0
Peri-hematomal,1,0.0
alligator-tooth,1,0.0
hood,1,0.0
pylorus,1,0.0
neck-chest-abdominal,1,0.0
half-broken,1,0.0
swallowed,1,0.0
Timing,1,0.0
hijacking,1,0.0
1991-1995,1,0.0
1999-2009,1,0.0
Metropolitan,1,0.0
polypous,1,0.0
clips,1,0.0
stapling,1,0.0
18-39,1,0.0
60-81,1,0.0
institutionalization,1,0.0
grocery,1,0.0
Anxieties,1,0.0
Confirmative,1,0.0
editorials,1,0.0
2392,1,0.0
colonial,1,0.0
Original,1,0.0
monocausalism,1,0.0
contagionism,1,0.0
sadly,1,0.0
Samoan,1,0.0
Characterised,1,0.0
assertion,1,0.0
quarter-century-old,1,0.0
8139,1,0.0
